Citrus Sinensis ID: 015076

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410---
Protein Sequence
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEEccccccHHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHccccccccccccccccccccccccHHHccc
Secondary Structure Prediction (SSPRO)
ccEEcccccccccccccccccccccccEEccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccHHEEccccccEEEEEEEcccccccHHHHHccccccccHHHHHHHEEEHHHcccccccccccccccHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHccccHcHcccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MAVTGSVIERQAlllpleeesptgynKIHVHigkdnricypgngsgggsgdQVAAVVPevshlgwghwYTLRELevstngfsddkvigeGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNgnleqwlhgdvgpcspltwEIRMNIILGTAKGLSylheglepkvvhrdikssnilidkhwnpkvsdfglakllgsessyITTRVmgtfgyvapeyastgmlnersdvySFGILIMEVIsgripvdysrppeeVNLIEWLKKMVtnrnpegvldpklpekptsRLLKRILLVALRcvdpnaqkrpkmghvvhmleaqespskepsnsfqdryraspkneliekqvtesgdnstnetgvhtneTRWQHQEFQKEKH
Flexible Loop (DISEMBL)
mavtgsvierqalllpleeesptgYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNnrgqaerefkveveaigrvrhknLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSnilidkhwnpkvSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISgripvdysrPPEEVNLIEWLKKMVTnrnpegvldpklpekptSRLLKRILLVALRCVdpnaqkrpkmgHVVHMLEaqespskepsnsfQDRYRASPKNELIekqvtesgdnstnetgvhtnetrwqhqefqkekh
Low Complexity Region (SEG)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPgngsgggsgDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKvigeggygivyyglleDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Disordered region (IsUnstruct)
***********ALLLPL*****TGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN*****************RLLKRILLVALRCVD*****************************************************************************
Disordered Region (DISOPRED)
******************************************************************HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN**QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE*********************************************************
Disordered Region (DISEMBL)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA**************RYRASPKNELIEK****************TNETR***********
Disordered Region (DISPRO)
************************************************************SHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ**********************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAVTGSVIERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	413	2.2.26 [Sep-21-2011]
Q3EDL4	472	Probable serine/threonine	no	no	0.883	0.773	0.671	1e-148
Q6NKZ9	437	Probable receptor-like se	no	no	0.748	0.707	0.704	1e-134
Q9SJG2	494	Probable receptor-like pr	no	no	0.871	0.728	0.598	1e-124
Q8LEB6	484	Probable receptor-like pr	no	no	0.731	0.623	0.678	1e-124
Q9LRP3	467	Probable receptor-like pr	no	no	0.731	0.646	0.662	1e-124
Q9LV48	652	Proline-rich receptor-lik	no	no	0.697	0.441	0.472	3e-75
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.818	0.469	0.433	5e-75
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.743	0.432	0.458	3e-74
Q9C660	762	Proline-rich receptor-lik	no	no	0.699	0.379	0.459	9e-74
Q9LK03	717	Proline-rich receptor-lik	no	no	0.714	0.411	0.457	1e-73

>sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2

 Score =  524 bits (1349), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 253/377 (67%), Positives = 302/377 (80%), Gaps = 12/377 (3%)

Query: 27  KIHVHIGK-DNRICYP-----GNGSGGGSGDQVAAVV------PEVSHLGWGHWYTLREL 74
           +I V IGK ++R+ +      G   G  S  + A+        PEVSHLGWG WYTLREL
Sbjct: 88  EIQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLREL 147

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E +TNG  ++ VIGEGGYGIVY G+L D +KVAVKNLLNNRGQAE+EFKVEVE IGRVRH
Sbjct: 148 EAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH 207

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           KNLVRLLGYC EGA+RMLVY++V+NGNLEQW+HGDVG  SPLTW+IRMNIILG AKGL+Y
Sbjct: 208 KNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAY 267

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LHEGLEPKVVHRDIKSSNIL+D+ WN KVSDFGLAKLLGSESSY+TTRVMGTFGYVAPEY
Sbjct: 268 LHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEY 327

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           A TGMLNE+SD+YSFGILIME+I+GR PVDYSRP  E NL++WLK MV NR  E V+DPK
Sbjct: 328 ACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPK 387

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASP 374
           +PE P+S+ LKR+LLVALRCVDP+A KRPKMGH++HMLEA++   ++   + +D      
Sbjct: 388 IPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRDHGSRER 447

Query: 375 KNELIEKQVTESGDNST 391
           +   +    +ESG++ +
Sbjct: 448 QETAVVAAGSESGESGS 464

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 219/311 (70%), Positives = 262/311 (84%), Gaps = 2/311 (0%)

Query: 63  LGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF 122
           +GWG WY+L++LE++T GFSDD +IGEGGYG+VY     D S  AVKNLLNN+GQAE+EF
Sbjct: 127 MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEF 186

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           KVEVEAIG+VRHKNLV L+GYCA+ A   RMLVYEY++NGNLEQWLHGDVGP SPLTW+I
Sbjct: 187 KVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDI 246

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
           RM I +GTAKGL+YLHEGLEPKVVHRD+KSSNIL+DK WN KVSDFGLAKLLGSE+SY+T
Sbjct: 247 RMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVT 306

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
           TRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR PVDYSRPP E+NL++W K 
Sbjct: 307 TRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKG 366

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK 360
           MV +R  E V+DPK+   P  R LKR LLV LRC+D ++ KRPKMG ++HMLEA++ P +
Sbjct: 367 MVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFR 426

Query: 361 EPSNSFQDRYR 371
               S Q+R +
Sbjct: 427 PEHRSNQERSK 437

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1

 Score =  445 bits (1145), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 221/369 (59%), Positives = 272/369 (73%), Gaps = 9/369 (2%)

Query: 31  HIGKDNRICYPGNGSGGGSGDQVAAV-VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGE 89
           H G++      G   GGG       V +PE+SHLGWGHW+TLR+LE++TN F+   V+GE
Sbjct: 132 HSGEEGGFGSAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGE 191

Query: 90  GGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH 149
           GGYG+VY G L + ++VAVK LLNN GQAE+EF+VEVEAIG VRHKNLVRLLGYC EG H
Sbjct: 192 GGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVH 251

Query: 150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           RMLVYEYVN+GNLEQWLHG +     LTWE RM II GTA+ L+YLHE +EPKVVHRDIK
Sbjct: 252 RMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIK 311

Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           +SNILID  +N K+SDFGLAKLL S  S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSF
Sbjct: 312 ASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSF 371

Query: 270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
           G+L++E I+GR PVDY RP  EVNL+EWLK MV  R  E V+DP+L  +P+   LKR LL
Sbjct: 372 GVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALL 431

Query: 330 VALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDN 389
           V+LRCVDP A+KRP+M  V  MLE+ E P          + R + +++    ++ E+ D 
Sbjct: 432 VSLRCVDPEAEKRPRMSQVARMLESDEHPFH--------KERRNKRSKTAGMEIVETKDE 483

Query: 390 STNETGVHT 398
           S   +G  T
Sbjct: 484 SLGPSGSET 492

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  444 bits (1143), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 205/302 (67%), Positives = 250/302 (82%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           +PE SHLGWGHW+TLR+L+++TN FS D +IG+GGYG+VY G L + + VAVK LLNN G
Sbjct: 142 LPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLG 201

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           QA+++F+VEVEAIG VRHKNLVRLLGYC EG  RMLVYEYVNNGNLEQWL GD      L
Sbjct: 202 QADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYL 261

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           TWE R+ I++GTAK L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG++ 
Sbjct: 262 TWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADK 321

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
           S+ITTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+L+E
Sbjct: 322 SFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVE 381

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
           WLK MV  R  E V+DP L  KP++  LKR LL ALRCVDP ++KRP+M  V  MLE++E
Sbjct: 382 WLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEE 441

Query: 357 SP 358
            P
Sbjct: 442 YP 443

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1

 Score =  444 bits (1141), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 200/302 (66%), Positives = 256/302 (84%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           +PEVSH+GWGHW+TLR+L+++TN FS + +IG+GGYG+VY+G L + + VAVK LLNN G
Sbjct: 130 LPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPG 189

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           QA+++F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+NNGNLEQWLHGD+     L
Sbjct: 190 QADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHL 249

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           TWE R+ +++GTAK L+YLHE +EPKVVHRDIKSSNIL+D +++ K+SDFGLAKLLG++S
Sbjct: 250 TWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADS 309

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
           +Y++TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EEV+++E
Sbjct: 310 NYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVE 369

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
           WLK MV  +  E V+D +L  KPT+  LKR LL ALRCVDP+A KRPKM  V  MLE+ E
Sbjct: 370 WLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDE 429

Query: 357 SP 358
            P
Sbjct: 430 YP 431

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  282 bits (722), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/296 (47%), Positives = 201/296 (67%), Gaps = 8/296 (2%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA 128
           +T  EL  +TNGFS+  ++G+GG+G V+ G+L    +VAVK L    GQ EREF+ EVE 
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           I RV H++LV L+GYC  G  R+LVYE+V N NLE  LHG   P   + W  R+ I LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT--MEWSTRLKIALGS 385

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           AKGLSYLHE   PK++HRDIK+SNILID  +  KV+DFGLAK+    +++++TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--- 305
           Y+APEYA++G L E+SDV+SFG++++E+I+GR PVD +    + +L++W + ++ NR   
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL-NRASE 504

Query: 306 --NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             + EG+ D K+  +     + R++  A  CV  +A++RP+M  +V  LE   S S
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLS 560

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  281 bits (720), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 153/353 (43%), Positives = 224/353 (63%), Gaps = 15/353 (4%)

Query: 57  VPEVSHLGWGHW-YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR 115
            P+ + LG G   ++  EL   T GF+   ++GEGG+G VY G L+D   VAVK L    
Sbjct: 346 TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGS 405

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
           GQ +REFK EVE I RV H++LV L+GYC    HR+L+YEYV+N  LE  LHG   P   
Sbjct: 406 GQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV-- 463

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L W  R+ I +G+AKGL+YLHE   PK++HRDIKS+NIL+D  +  +V+DFGLA+L  + 
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            ++++TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P  E +L+
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583

Query: 296 EW----LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           EW    L K +   +   ++D +L ++     + R++  A  CV  +  KRP+M  VV  
Sbjct: 584 EWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRA 643

Query: 352 LEAQESPSKEPSNSFQ----DRYRASPKNELIEK--QVTESGDNSTNETGVHT 398
           L+  +  S + SN  +      Y +   NE I K  ++   GDNS  E+G+++
Sbjct: 644 LDC-DGDSGDISNGIKIGQSTTYDSGQYNEDIMKFRKMAFGGDNSV-ESGLYS 694

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  279 bits (714), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 144/314 (45%), Positives = 201/314 (64%), Gaps = 7/314 (2%)

Query: 47  GGSGDQVAAVVPEVSHLGWGHW-YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK 105
           GG G   +   P+ + +G G   +T  EL   T GFS   ++GEGG+G VY G L D   
Sbjct: 318 GGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKL 377

Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L    GQ +REFK EVE I RV H++LV L+GYC   + R+L+YEYV N  LE  
Sbjct: 378 VAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHH 437

Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           LHG   P   L W  R+ I +G+AKGL+YLHE   PK++HRDIKS+NIL+D  +  +V+D
Sbjct: 438 LHGKGRPV--LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVAD 495

Query: 226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
           FGLAKL  S  ++++TRVMGTFGY+APEYA +G L +RSDV+SFG++++E+I+GR PVD 
Sbjct: 496 FGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555

Query: 286 SRPPEEVNLIEW----LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
            +P  E +L+EW    L K +   +   ++D +L +      + R++  A  CV  +  K
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query: 342 RPKMGHVVHMLEAQ 355
           RP+M  VV  L+++
Sbjct: 616 RPRMVQVVRALDSE 629

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  277 bits (709), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 137/298 (45%), Positives = 198/298 (66%), Gaps = 9/298 (3%)

Query: 64  GWGH---WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAER 120
           G+G     ++  EL ++TNGFSD+ ++GEGG+G VY G+L D   VAVK L    GQ +R
Sbjct: 410 GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDR 469

Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           EFK EV+ I RV H+NL+ ++GYC     R+L+Y+YV N NL   LH    P   L W  
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWAT 527

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
           R+ I  G A+GL+YLHE   P+++HRDIKSSNIL++ +++  VSDFGLAKL    +++IT
Sbjct: 528 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT 587

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
           TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR PVD S+P  + +L+EW + 
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647

Query: 301 MVTNRNP----EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +++N         + DPKL        + R++  A  C+  +A KRP+M  +V   ++
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDS 705

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  277 bits (709), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 139/304 (45%), Positives = 199/304 (65%), Gaps = 9/304 (2%)

Query: 63  LGWGHW---YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE 119
           LG G +   +   EL  +TNGFS+  ++G+GG+G V+ G+L +  +VAVK L     Q E
Sbjct: 333 LGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGE 392

Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           REF+ EV  I RV H++LV L+GYC   A R+LVYE+V N  LE  LHG   P   + W 
Sbjct: 393 REFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPT--MEWS 450

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
            R+ I +G+AKGLSYLHE   PK++HRDIK+SNILID  +  KV+DFGLAK+    ++++
Sbjct: 451 SRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHV 510

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           +TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR P+D +    + +L++W +
Sbjct: 511 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWAR 570

Query: 300 KMVTN----RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
            ++       N E V+D KL  +     + R++  A  CV   A +RP+M  V  +LE  
Sbjct: 571 PLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN 630

Query: 356 ESPS 359
            SPS
Sbjct: 631 ISPS 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	413
359480850	516	PREDICTED: probable serine/threonine-pro	0.983	0.786	0.777	0.0
296082408	434	unnamed protein product [Vitis vinifera]	0.866	0.824	0.831	1e-178
225458659	519	PREDICTED: probable serine/threonine-pro	0.944	0.751	0.758	1e-177
449450231	842	PREDICTED: uncharacterized protein LOC10	0.968	0.475	0.737	1e-173
255538254	528	Serine/threonine-protein kinase PBS1, pu	0.978	0.765	0.730	1e-173
307135852	842	serine/threonine-protein kinase [Cucumis	0.968	0.475	0.737	1e-173
255565232	509	BRASSINOSTEROID INSENSITIVE 1-associated	0.951	0.772	0.768	1e-173
449482676	521	PREDICTED: probable serine/threonine-pro	0.968	0.767	0.737	1e-172
357482863	492	BRASSINOSTEROID INSENSITIVE 1-associated	0.946	0.794	0.754	1e-171
356496904	503	PREDICTED: probable serine/threonine-pro	0.939	0.771	0.753	1e-171

>gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  665 bits (1715), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/418 (77%), Positives = 362/418 (86%), Gaps = 12/418 (2%)

Query: 8   IERQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSG--DQVAAVVPEVSHLGW 65
           IE QALLLP  EESP G ++IH+ +GKD+RI YP     G +   +Q + V PEVSHLGW
Sbjct: 99  IEGQALLLPPGEESPGGVHRIHIELGKDHRISYPERVVSGEARAVEQASIVAPEVSHLGW 158

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR-------GQA 118
           GHWYTLRELE STN F+DD VIGEGGYGIVY+G+LEDN++VAVKNLLNNR       GQA
Sbjct: 159 GHWYTLRELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQA 218

Query: 119 EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW 178
           E+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP SPLTW
Sbjct: 219 EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTW 278

Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY
Sbjct: 279 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSY 338

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           +TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME+ISGR PVDYSRPPEEVNL++WL
Sbjct: 339 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLVDWL 398

Query: 299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
           K+MVT+RNPEGVLDPK+PEKPTSR LKR LLVALRCVDPN+QKRPKMGHV+HMLEA+ESP
Sbjct: 399 KRMVTSRNPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAEESP 458

Query: 359 SKEPSNSFQDRYRA---SPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEKH 413
            ++   + +D  RA   SP+N L+EK+VTESGD+S  E+G H N  RW+ +E Q EK 
Sbjct: 459 FRDDRRAGRDSVRAHRDSPRNGLMEKRVTESGDSSGYESGAHANRQRWRQEESQAEKQ 516

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296082408|emb|CBI21413.3| unnamed protein product [Vitis vinifera]

 Score =  631 bits (1627), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 300/361 (83%), Positives = 330/361 (91%), Gaps = 3/361 (0%)

Query: 56  VVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR 115
           + PEVSHLGWGHWYTLRELE STN F+DD VIGEGGYGIVY+G+LEDN++VAVKNLLNNR
Sbjct: 74  IAPEVSHLGWGHWYTLRELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNR 133

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
           GQAE+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP SP
Sbjct: 134 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSP 193

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LTWEIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE
Sbjct: 194 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSE 253

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            SY+TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME+ISGR PVDYSRPPEEVNL+
Sbjct: 254 HSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLV 313

Query: 296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
           +WLK+MVT+RNPEGVLDPK+PEKPTSR LKR LLVALRCVDPN+QKRPKMGHV+HMLEA+
Sbjct: 314 DWLKRMVTSRNPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAE 373

Query: 356 ESPSKEPSNSFQDRYRA---SPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQKEK 412
           ESP ++   + +D  RA   SP+N L+EK+VTESGD+S  E+G H N  RW+ +E Q EK
Sbjct: 374 ESPFRDDRRAGRDSVRAHRDSPRNGLMEKRVTESGDSSGYESGAHANRQRWRQEESQAEK 433

Query: 413 H 413
            
Sbjct: 434 Q 434

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera]

 Score =  626 bits (1614), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 311/410 (75%), Positives = 344/410 (83%), Gaps = 20/410 (4%)

Query: 14  LLPLEEESPTGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHLGWG 66
           LL   EESP G  +IH+ IGKD+RI YP  G G         SGDQV   VPEVSHLGWG
Sbjct: 108 LLQPGEESPVGLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIAVPEVSHLGWG 167

Query: 67  HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEV 126
           HWYTLRELE+STNGF+D+ VIGEGGYGIVY G+LEDN++VAVKNLLNNRGQAE+EFKVEV
Sbjct: 168 HWYTLRELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQAEKEFKVEV 227

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQWLHGDVGP SPLTW+IRMNII+
Sbjct: 228 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLTWDIRMNIII 287

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
           GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRVMGT
Sbjct: 288 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRVMGT 347

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           FGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGR PVDYSRPP EVNL+EWLK MVTNRN
Sbjct: 348 FGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLVEWLKAMVTNRN 407

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            EGVLDPK+PEKP+SR LKR LLVALRCVDPNAQKRPKMGHV+HMLEA + P ++    F
Sbjct: 408 AEGVLDPKIPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADDFPFRD----F 463

Query: 367 QDR---------YRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQE 407
           QDR          R   K+  +EK++ ESGD+S  E+G   N + W+  E
Sbjct: 464 QDRRAGREHGRAQRDGMKDRFLEKRMIESGDSSGYESGAQNNRSLWKKPE 513

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus]

 Score =  615 bits (1586), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 303/411 (73%), Positives = 348/411 (84%), Gaps = 11/411 (2%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 425 ATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 484

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 485 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 544

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 545 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 604

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 605 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 664

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 665 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 724

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPS 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++  
Sbjct: 725 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 784

Query: 364 NSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 412
              ++  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 785 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 834

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  615 bits (1586), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 311/426 (73%), Positives = 352/426 (82%), Gaps = 22/426 (5%)

Query: 7   VIERQALLLPLEEESPTG-YNKIHVHIGKDNRICYP----GNGSGGG-------SGDQV- 53
           V E + +LL  EE SP G  N+IH+ IGKD+RI YP    G+G+G G       SGDQ  
Sbjct: 104 VPESEPVLLE-EENSPVGGRNRIHIEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAG 162

Query: 54  -AAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL 112
            A VVPEVSHLGWGHWYTLRELEVSTN F+D+ VIGEGGYGIVY G+L+DN+ VAVK  L
Sbjct: 163 GAIVVPEVSHLGWGHWYTLRELEVSTNCFADENVIGEGGYGIVYRGILDDNTNVAVKICL 222

Query: 113 NNR-------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
                     GQAE+EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQW
Sbjct: 223 TTACTFWWCMGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQW 282

Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           LHGDVGPCSPLTWEIRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+D+ WN KVSD
Sbjct: 283 LHGDVGPCSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSD 342

Query: 226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
           FGLAKLLGSE SY+TTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGR PVDY
Sbjct: 343 FGLAKLLGSERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDY 402

Query: 286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           SRPP EVNL+EWLK MVTNRN EGVLDP+LPEKP+SR LKR LLVALRCVDPNAQKRPKM
Sbjct: 403 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLPEKPSSRALKRALLVALRCVDPNAQKRPKM 462

Query: 346 GHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQH 405
           GHV+HMLEA E P ++   + ++  R++ +    +K+V+ESGD+S  E+G  TN T W+ 
Sbjct: 463 GHVIHMLEADEFPFRDDRRTGREHVRSNREGMKTDKRVSESGDSSGYESGAQTNRTLWRK 522

Query: 406 QEFQKE 411
           QE +++
Sbjct: 523 QEGEEQ 528

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|307135852|gb|ADN33721.1| serine/threonine-protein kinase [Cucumis melo subsp. melo]

 Score =  615 bits (1585), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 303/411 (73%), Positives = 348/411 (84%), Gaps = 11/411 (2%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 425 ATLLETEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 484

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 485 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 544

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 545 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 604

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 605 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 664

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 665 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 724

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPS 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++  
Sbjct: 725 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 784

Query: 364 NSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 412
              ++  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 785 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 834

Source: Cucumis melo subsp. melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  615 bits (1585), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 312/406 (76%), Positives = 344/406 (84%), Gaps = 13/406 (3%)

Query: 9   ERQALLL-PLEEESPTGYN----KIHVHIGKDNRICYP---GNGSGGGSGDQVAAVV-PE 59
           ERQALLL P EEESP GY+     I + IGK + I YP   G    GG GDQ+A VV P+
Sbjct: 100 ERQALLLMPPEEESPMGYHHGTGNIQIEIGKGHLISYPVSSGEAPRGG-GDQLAMVVGPD 158

Query: 60  VSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE 119
           VSHLGWGHWYTLRELE STNGF+D+ VIG+GGYGIVYYG+L DN++VAVKNLLNNRGQAE
Sbjct: 159 VSHLGWGHWYTLRELEASTNGFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAE 218

Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           +EFKVEVEAIGRVRHKNLVRLLGYCAEG+HRMLVYEYVNNGNLEQWLHGDVG CSPLTWE
Sbjct: 219 KEFKVEVEAIGRVRHKNLVRLLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWE 278

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
           IRMNIILGTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WN KVSDFGLAKLL  ESSYI
Sbjct: 279 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYI 338

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           TTRVMGTFGYVAPEYASTGM+NERSDV+ FGILIME+ISGR PVDYSRPP+EVNL+EWLK
Sbjct: 339 TTRVMGTFGYVAPEYASTGMVNERSDVFGFGILIMEIISGRNPVDYSRPPDEVNLVEWLK 398

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           +MVTNRNPEGVLDPKLPE+P+SR LKR+LLVALRCVDPNAQKRPKMGHVVHMLEA E P 
Sbjct: 399 RMVTNRNPEGVLDPKLPERPSSRALKRVLLVALRCVDPNAQKRPKMGHVVHMLEADEFPF 458

Query: 360 KEPSNSFQDRYRA---SPKNELIEKQVTESGDNSTNETGVHTNETR 402
           ++     +D       + K+ L+E  +TESGD S  + G     TR
Sbjct: 459 RDDRRGGKDPRGTQCDNNKDALMENSMTESGDRSGVQDGDVIKNTR 504

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus]

 Score =  610 bits (1574), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/411 (73%), Positives = 348/411 (84%), Gaps = 11/411 (2%)

Query: 12  ALLLPLEEESP-TGYNKIHVHIGKDNRICYPGNGSG-------GGSGDQVAAVVPEVSHL 63
           A LL  EE SP +G ++IH+ IGKD+RI YP  G G         SGDQ    VPEVSHL
Sbjct: 104 ATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHL 163

Query: 64  GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GWGHWYTLRELE STN F+D+ VIGEGGYGIVY G+LEDN+ VA+KNLLNNRGQAE+EFK
Sbjct: 164 GWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFK 223

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           VEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEY++NGNLEQWLHG+VGPCSPLTW+IRMN
Sbjct: 224 VEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMN 283

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II+GTAKGL+YLHEGLEPKVVHRDIKSSNIL+DK WNPKVSDFGLAKLLGSE SY+TTRV
Sbjct: 284 IIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRV 343

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           MGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGR PVDYSRP  EVNL+EWLK MV+
Sbjct: 344 MGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMVS 403

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPS 363
           NRN EGVLDPKLPEKP++R LKR LLVALRCVDPN QKRPKMGHV+HMLEA E P ++  
Sbjct: 404 NRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDR 463

Query: 364 NSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETR--WQHQEFQKEK 412
              ++  R+  K +L+E+ V+ESG++S  E+G  T  +R  W+ QE ++++
Sbjct: 464 RVGREPGRSLLKEKLMERLVSESGESSGYESGA-TQASRHLWRKQELEEQQ 513

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357482863|ref|XP_003611718.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula] gi|355513053|gb|AES94676.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula]

 Score =  606 bits (1563), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 304/403 (75%), Positives = 332/403 (82%), Gaps = 12/403 (2%)

Query: 16  PLEEESPTGYNKIHVHIGKDNRICYP-GNGSGGGSG-------DQVAAVVPEVSHLGWGH 67
           P EE +P  Y +I   IGK++RI YP   GS   SG       DQV AV+P+VSHLGWGH
Sbjct: 86  PEEETAPLSYKRIQFEIGKNHRISYPEQRGSVEHSGERESRPLDQVNAVIPQVSHLGWGH 145

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           WYTLRELE +TN FS D VIGEGGYGIVY+G+L+DN+ +A+KNLLNNRGQAEREFKVEVE
Sbjct: 146 WYTLRELEDATNEFSPDNVIGEGGYGIVYHGILKDNTNIAIKNLLNNRGQAEREFKVEVE 205

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           AIGRVRHKNLVRLLGYCAEGAHRMLVYE+V+NGNLEQWLHGDVGPCSPLTWEIRMNIILG
Sbjct: 206 AIGRVRHKNLVRLLGYCAEGAHRMLVYEFVDNGNLEQWLHGDVGPCSPLTWEIRMNIILG 265

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           TAKGL+YLHEGLEPKVVHRDIKSSNIL+ K WN KVSDFGLAKLL  ESSYITTRVMGTF
Sbjct: 266 TAKGLTYLHEGLEPKVVHRDIKSSNILLSKQWNSKVSDFGLAKLLSPESSYITTRVMGTF 325

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           GYVAPEYASTGMLNERSDVYSFGILIMEVI+GR PV+YSRP EEVNL+EWLKKMV+NRNP
Sbjct: 326 GYVAPEYASTGMLNERSDVYSFGILIMEVITGRNPVEYSRPAEEVNLVEWLKKMVSNRNP 385

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQ 367
           EGVLDPKLPEKPTSR LKR LLVALRC DPNAQKRPKMGHV+HMLEA++SP KE     +
Sbjct: 386 EGVLDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEERRVRR 445

Query: 368 DRYRASPKNELIEKQVTE----SGDNSTNETGVHTNETRWQHQ 406
           D    S     IE +  E    S D+   E    TNET   H+
Sbjct: 446 DPGVGSSPTTSIEDRSKEEAAVSIDDGMLENEKCTNETSSNHE 488

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max]

 Score =  606 bits (1562), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 302/401 (75%), Positives = 335/401 (83%), Gaps = 13/401 (3%)

Query: 18  EEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGD-------QVAAVVPEVSHLGWGHWYT 70
           EE +P GY++I   IGK++RI YP       S +       QV  V+PEVSHLGWGHWYT
Sbjct: 100 EETTPLGYHRIQFEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWYT 159

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           LRELE STN F+ + VIGEGGYGIVY+G+L DN+ VA+KNLLNNRGQAE+EFKVEVEAIG
Sbjct: 160 LRELEDSTNAFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIG 219

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           RVRHKNLVRLLGYCAEGAHRMLVYEYV+NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK
Sbjct: 220 RVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 279

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL+YLHEGLEPKVVHRDIKSSNIL+ K WN KVSDFGLAKLLGS++SYITTRVMGTFGYV
Sbjct: 280 GLTYLHEGLEPKVVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGYV 339

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APEYASTGMLNERSDVYSFGILIME+I+GR PVDYSRPPEEVNL++WLKKMV+NRNPEGV
Sbjct: 340 APEYASTGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEVNLVDWLKKMVSNRNPEGV 399

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRY 370
           LDPKLPEKPTSR LKR LLVALRC DPNAQKRPKMGHV+HMLEA++SP KE   + +D  
Sbjct: 400 LDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDRRAKRDAG 459

Query: 371 RASPKNEL-----IEKQVTESGDNSTNETGVHTNETRWQHQ 406
             SP + +      E  V+ S D+   E GV  NETR   Q
Sbjct: 460 H-SPNDRVGDGLKEEVTVSVSVDDGKLENGVCANETRSNLQ 499

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	413
TAIR|locus:2132353	492	AT4G02630 [Arabidopsis thalian	0.941	0.790	0.655	2.5e-136
TAIR|locus:2025396	472	AT1G01540 [Arabidopsis thalian	0.808	0.707	0.688	2.9e-126
TAIR|locus:2139559	437	AT4G34500 [Arabidopsis thalian	0.743	0.702	0.679	9.1e-116
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.825	0.666	0.612	5.5e-109
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.808	0.676	0.596	9.2e-107
TAIR|locus:2146203	484	AT5G18500 [Arabidopsis thalian	0.813	0.694	0.589	4e-106
TAIR|locus:2093591	467	GPK1 "glyoxysomal protein kina	0.796	0.704	0.589	1.4e-105
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.835	0.740	0.564	5.8e-105
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.791	0.664	0.597	1.6e-104
TAIR|locus:2028911	720	PERK12 "proline-rich extensin-	0.815	0.468	0.406	6e-64

TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)]

 Score = 1335 (475.0 bits), Expect = 2.5e-136, P = 2.5e-136
 Identities = 266/406 (65%), Positives = 308/406 (75%)

Query:    16 PLEEESPTGYNKIHVHIGKDNRICYPX------XXXXXXXXDQVAAVV--PEVSHLGWGH 67
             P + +     NKIH+ IGKD+RI YP               DQ   ++  PEVSHLGWGH
Sbjct:    89 PHQNQQREDDNKIHIEIGKDHRIAYPERGGWTGSGSGSGSGDQGLLMLSGPEVSHLGWGH 148

Query:    68 WYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVE 127
             WYTLRELEVSTNGF+D+                 D S VA+KNLLNNRGQAE+EFKVEVE
Sbjct:   149 WYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVE 208

Query:   128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIIL 186
             AIGRVRHKNLVRLLGYC EGAHRMLVYEYV+NGNLEQW+HG  +G  SPLTWEIRMNI+L
Sbjct:   209 AIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVL 268

Query:   187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             GTAKGL YLHEGLEPKVVHRDIKSSNIL+DK WN KVSDFGLAKLLGSE SY+TTRVMGT
Sbjct:   269 GTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGT 328

Query:   247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
             FGYVAPEYASTGMLNERSDVYSFG+L+ME+ISGR PVDYSR P EVNL+EWLK++VTNR+
Sbjct:   329 FGYVAPEYASTGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRD 388

Query:   307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPS-NS 365
              EGVLDP++ +KP+ R LKR LLVALRCVDPNAQKRPKMGH++HMLEA++  SK+   NS
Sbjct:   389 AEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHMLEAEDLVSKDDRRNS 448

Query:   366 FQD----RYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQE 407
                        SP+ +     V ES D S N   ++ ++   ++++
Sbjct:   449 GGGGGGIEQGRSPRRKT---NVNESEDESGNSVLINNDQLALENKQ 491

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0042546 "cell wall biogenesis" evidence=RCA

TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
 Identities = 230/334 (68%), Positives = 271/334 (81%)

Query:    58 PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
             PEVSHLGWG WYTLRELE +TNG  ++                 D +KVAVKNLLNNRGQ
Sbjct:   131 PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQ 190

Query:   118 AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
             AE+EFKVEVE IGRVRHKNLVRLLGYC EGA+RMLVY++V+NGNLEQW+HGDVG  SPLT
Sbjct:   191 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLT 250

Query:   178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
             W+IRMNIILG AKGL+YLHEGLEPKVVHRDIKSSNIL+D+ WN KVSDFGLAKLLGSESS
Sbjct:   251 WDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESS 310

Query:   238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
             Y+TTRVMGTFGYVAPEYA TGMLNE+SD+YSFGILIME+I+GR PVDYSRP  E NL++W
Sbjct:   311 YVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDW 370

Query:   298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES 357
             LK MV NR  E V+DPK+PE P+S+ LKR+LLVALRCVDP+A KRPKMGH++HMLEA++ 
Sbjct:   371 LKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDL 430

Query:   358 PSKEPSNSFQDRYRASPKNELIEKQVTESGDNST 391
               ++   + +D      +   +    +ESG++ +
Sbjct:   431 LYRDERRTTRDHGSRERQETAVVAAGSESGESGS 464

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
 Identities = 210/309 (67%), Positives = 250/309 (80%)

Query:    63 LGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREF 122
             +GWG WY+L++LE++T GFSDD                 D S  AVKNLLNN+GQAE+EF
Sbjct:   127 MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEF 186

Query:   123 KVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
             KVEVEAIG+VRHKNLV L+GYCA+ A   RMLVYEY++NGNLEQWLHGDVGP SPLTW+I
Sbjct:   187 KVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDI 246

Query:   181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
             RM I +GTAKGL+YLHEGLEPKVVHRD+KSSNIL+DK WN KVSDFGLAKLLGSE+SY+T
Sbjct:   247 RMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVT 306

Query:   241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             TRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR PVDYSRPP E+NL++W K 
Sbjct:   307 TRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKG 366

Query:   301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK 360
             MV +R  E V+DPK+   P  R LKR LLV LRC+D ++ KRPKMG ++HMLEA++ P +
Sbjct:   367 MVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFR 426

Query:   361 EPSNSFQDR 369
                 S Q+R
Sbjct:   427 PEHRSNQER 435

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
 Identities = 212/346 (61%), Positives = 257/346 (74%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE+SHLGWGHW+TLR+L+++TN F+ +                 + + VAVK LLNN G
Sbjct:   166 LPEISHLGWGHWFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLG 225

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEVEAIG VRHKNLVRLLGYC EG +RMLVYEYVN+GNLEQWLHG +G  S L
Sbjct:   226 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTL 285

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM I++GTA+ L+YLHE +EPKVVHRDIK+SNILID  +N K+SDFGLAKLL S  
Sbjct:   286 TWEARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGE 345

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR PVDY RP  EVNL+E
Sbjct:   346 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVE 405

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+D ++   P +R LKR LLVALRCVDP AQKRPKM  VV MLE+ E
Sbjct:   406 WLKMMVGTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDE 465

Query:   357 SPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETR 402
              P +E   + + R  AS   E++E    ES D S    G   N T+
Sbjct:   466 HPFREERRNRKSR-TASM--EIVET-TEESADTSKGP-GHSENTTK 506

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 1056 (376.8 bits), Expect = 9.2e-107, P = 9.2e-107
 Identities = 204/342 (59%), Positives = 251/342 (73%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE+SHLGWGHW+TLR+LE++TN F+                   + ++VAVK LLNN G
Sbjct:   159 LPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLG 218

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEYVN+GNLEQWLHG +     L
Sbjct:   219 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNL 278

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM II GTA+ L+YLHE +EPKVVHRDIK+SNILID  +N K+SDFGLAKLL S  
Sbjct:   279 TWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGE 338

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR PVDY RP  EVNL+E
Sbjct:   339 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVE 398

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP+L  +P+   LKR LLV+LRCVDP A+KRP+M  V  MLE+ E
Sbjct:   399 WLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDE 458

Query:   357 SPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHT 398
              P       F  + R + +++    ++ E+ D S   +G  T
Sbjct:   459 HP-------FH-KERRNKRSKTAGMEIVETKDESLGPSGSET 492

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1050 (374.7 bits), Expect = 4.0e-106, P = 4.0e-106
 Identities = 201/341 (58%), Positives = 248/341 (72%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE SHLGWGHW+TLR+L+++TN FS D                 + + VAVK LLNN G
Sbjct:   142 LPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLG 201

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QA+++F+VEVEAIG VRHKNLVRLLGYC EG  RMLVYEYVNNGNLEQWL GD      L
Sbjct:   202 QADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYL 261

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE R+ I++GTAK L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG++ 
Sbjct:   262 TWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADK 321

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S+ITTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+L+E
Sbjct:   322 SFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVE 381

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP L  KP++  LKR LL ALRCVDP ++KRP+M  V  MLE++E
Sbjct:   382 WLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEE 441

Query:   357 SPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVH 397
              P        +DR R   +N              T+++  H
Sbjct:   442 YPIAR-----EDRRRRRSQNGTTRDSDPPRNSTDTDKSEYH 477

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 197/334 (58%), Positives = 256/334 (76%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PEVSH+GWGHW+TLR+L+++TN FS +                 + + VAVK LLNN G
Sbjct:   130 LPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPG 189

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QA+++F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+NNGNLEQWLHGD+     L
Sbjct:   190 QADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHL 249

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE R+ +++GTAK L+YLHE +EPKVVHRDIKSSNIL+D +++ K+SDFGLAKLLG++S
Sbjct:   250 TWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADS 309

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             +Y++TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EEV+++E
Sbjct:   310 NYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVE 369

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  +  E V+D +L  KPT+  LKR LL ALRCVDP+A KRPKM  V  MLE+ E
Sbjct:   370 WLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDE 429

Query:   357 SPSKEPSNSFQDRYRASPKNELIEKQVTESG-DN 389
              P   P    ++R R   +N    ++ T++  DN
Sbjct:   430 YPVM-PR---EERRRRRNQNAETHRESTDTNKDN 459

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=RCA

GO:0043161 "proteasomal ubiquitin-dependent protein catabolic process" evidence=RCA

GO:0043248 "proteasome assembly" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0051788 "response to misfolded protein" evidence=RCA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 1039 (370.8 bits), Expect = 5.8e-105, P = 5.8e-105
 Identities = 198/351 (56%), Positives = 252/351 (71%)

Query:    13 LLLPLEEESPTGYNKIHVHIGKDNRICYPXXXXXXXX-----XDQVAAVVPEVSHLGWGH 67
             L L +E+    G +      GK+  +C                    + +PE SHLGWGH
Sbjct:    85 LNLEMEKNRENGLSSSRSGSGKEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGH 143

Query:    68 WYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVE 127
             W+TLR+LE++TN FS +                 + S VAVK +LN+ GQAE+EF+VEV+
Sbjct:   144 WFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVD 203

Query:   128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
             AIG VRHKNLVRLLGYC EG +R+LVYEY+NNGNLE+WLHG +     LTWE RM ++ G
Sbjct:   204 AIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTG 263

Query:   188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             T+K L+YLHE +EPKVVHRDIKSSNILID  +N K+SDFGLAKLLG   S++TTRVMGTF
Sbjct:   264 TSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTF 323

Query:   248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
             GYVAPEYA+TG+LNE+SDVYSFG+L++E I+GR PVDY+RP  EVNL+EWLK MV ++  
Sbjct:   324 GYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRL 383

Query:   308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
             E V+DP +  +P +R LKR+LL ALRC+DP+++KRPKM  VV MLE++E P
Sbjct:   384 EEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLESEEYP 434

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
 Identities = 200/335 (59%), Positives = 247/335 (73%)

Query:    57 VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             +PE SHLGWGHW+TLR+LE +TN FS +                 + + VAVK +LN  G
Sbjct:   156 LPE-SHLGWGHWFTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLG 214

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             QAE+EF+VEV+AIG VRHKNLVRLLGYC EG HR+LVYEYVNNGNLEQWLHG +     L
Sbjct:   215 QAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYL 274

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
             TWE RM +++GT+K L+YLHE +EPKVVHRDIKSSNILI+  +N KVSDFGLAKLLG+  
Sbjct:   275 TWEARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGK 334

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             S++TTRVMGTFGYVAPEYA++G+LNE+SDVYSFG++++E I+GR PVDY RP  EVNL++
Sbjct:   335 SHVTTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVD 394

Query:   297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE 356
             WLK MV  R  E V+DP +  KP +R LKR LL ALRCVDP++ KRPKM  VV MLE++E
Sbjct:   395 WLKMMVGTRRSEEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 454

Query:   357 SPSKEPSNSFQDRYRASPKNELIEKQVTESGDNST 391
              P        +DR R+  +   +E  +    D ST
Sbjct:   455 YPIPR-----EDRRRSRTREGSME--INSDTDMST 482

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 143/352 (40%), Positives = 211/352 (59%)

Query:    58 PEVSHLGWGHW-YTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
             P+ + LG G   ++  EL   T GF+                   D   VAVK L    G
Sbjct:   347 PDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSG 406

Query:   117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             Q +REFK EVE I RV H++LV L+GYC    HR+L+YEYV+N  LE  LHG   P   L
Sbjct:   407 QGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV--L 464

Query:   177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
              W  R+ I +G+AKGL+YLHE   PK++HRDIKS+NIL+D  +  +V+DFGLA+L  +  
Sbjct:   465 EWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQ 524

Query:   237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
             ++++TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P  E +L+E
Sbjct:   525 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVE 584

Query:   297 WLKKMVTNRNPEG----VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             W + ++      G    ++D +L ++     + R++  A  CV  +  KRP+M  VV  L
Sbjct:   585 WARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644

Query:   353 EAQESPSKEPSNSFQ----DRYRASPKNELIEK--QVTESGDNSTNETGVHT 398
             +  +  S + SN  +      Y +   NE I K  ++   GDNS  E+G+++
Sbjct:   645 DC-DGDSGDISNGIKIGQSTTYDSGQYNEDIMKFRKMAFGGDNSV-ESGLYS 694

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032502 "developmental process" evidence=IMP

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	413
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-44
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-30
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-04

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  174 bits (444), Expect = 5e-52
 Identities = 82/279 (29%), Positives = 127/279 (45%), Gaps = 35/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L+         VAVK L  +   Q   EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           V+LLG C E     +V EY+  G+L  +L  +        L+    ++  L  A+G+ YL
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGMEYL 118

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
                   +HRD+ + N L+ ++   K+SDFGL++ L  +  Y          ++APE  
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y     EEV  +E+LK     R P      
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV--LEYLKNG--YRLP------ 223

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             P      L      + L+C   + + RP    +V +L
Sbjct: 224 -QPPNCPPELYD----LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  172 bits (439), Expect = 3e-51
 Identities = 84/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L+         VAVK L  +   Q   EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           V+LLG C E    M+V EY+  G+L  +L  +        L+    ++  L  A+G+ YL
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYL 119

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
                   +HRD+ + N L+ ++   K+SDFGL++ L  +  Y          ++APE  
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y      EV  +E+LKK    R P      
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEV--LEYLKKG--YRLP------ 224

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             P      L K    + L+C   + + RP    +V +L
Sbjct: 225 -KPPNCPPELYK----LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (426), Expect = 5e-50
 Identities = 68/193 (35%), Positives = 107/193 (55%), Gaps = 11/193 (5%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           +GEGG+G VY     +   KVA+K +   +      E   E+E + ++ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +  H  LV EY   G+L+  L  + G    L+ +  + I+L   +GL YLH      ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 205 HRDIKSSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNE 262
           HRD+K  NIL+D  +   K++DFGL+KLL S+ S + T V GT  Y+APE        +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 263 RSDVYSFGILIME 275
           +SD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (413), Expect = 2e-47
 Identities = 86/288 (29%), Positives = 130/288 (45%), Gaps = 45/288 (15%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK----VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVR 139
           K +GEG +G VY G L+        VAVK L  +   +  ++F  E   + ++ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           LLG C E     LV EY+  G+L  +L            S L+ +  ++  +  AKG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-------RVMGTF 247
           L      K VHRD+ + N L+ +    K+SDFGL++ +  +  Y          R M   
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYS-RPPEEVNLIEWLKKMVTNR 305
              APE    G+   +SDV+SFG+L+ E+ + G  P  Y     EEV  +E+L+K     
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--LEYLRKGYRLP 227

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            PE   D              +  + L C   + + RP    +V  LE
Sbjct: 228 KPEYCPD-------------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (408), Expect = 1e-46
 Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 32/279 (11%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           +   + +G G +G VY          VAVK     + + + ++  + E+  + R+ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRL+    +  H  LV EY   G+L  +L        PL+ +    I L   +GL YLH 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHS 116

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE---- 253
                ++HRD+K  NIL+D++   K++DFGLAK L   SS +TT V GT  Y+APE    
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                      + DV+S G+++ E+++G+ P         ++ ++ +++++         
Sbjct: 173 GNGYGP-----KVDVWSLGVILYELLTGKPPF---SGENILDQLQLIRRILGPPLEFDEP 224

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
                 +    L+K+ L       DP+  KRP    ++ 
Sbjct: 225 KWSSGSEEAKDLIKKCL-----NKDPS--KRPTAEEILQ 256

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (408), Expect = 1e-46
 Identities = 89/279 (31%), Positives = 132/279 (47%), Gaps = 34/279 (12%)

Query: 84  DKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            K +GEG +G VY G L        +KVAVK L     + ER EF  E   + ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRLLG C +G    +V EY+  G+L  +L         LT +  + + L  AKG+ YL  
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES 120

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
                 VHRD+ + N L+ ++   K+SDFGL++ +  +  Y   R  G     ++APE  
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESL 176

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             G    +SDV+SFG+L+ E+ + G  P  Y     EEV  +E L+     R P      
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV--LELLEDG--YRLPR----- 225

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
             PE      L  ++   L+C   + + RP    +V  L
Sbjct: 226 --PENCPDE-LYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 1e-44
 Identities = 74/266 (27%), Positives = 125/266 (46%), Gaps = 26/266 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +   + +GEG +G VY     +    VA+K +   + + +RE    E++ + +++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGLSYLHE 197
           RL     +     LV EY   G+L   L         L+  E R   +      L YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +VHRD+K  NIL+D+  + K++DFGLA+ L       TT V GT  Y+APE    
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLG 170

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
               +  D++S G+++ E+++G+ P      P +  L+E  KK+   + P    +  +  
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
           +    L++++L       DP   KR 
Sbjct: 226 EAKD-LIRKLL-----VKDPE--KRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (327), Expect = 5e-35
 Identities = 86/274 (31%), Positives = 126/274 (45%), Gaps = 40/274 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           IG+G +G V  G      KVAVK L ++   A+  F  E   +  +RH NLV+LLG   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 147 GAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           G    +V EY+  G+L  +L   G     + +T   ++   L   +G+ YL    E   V
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNE 262
           HRD+ + N+L+ +    KVSDFGLAK    E+S    +  G     + APE       + 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQ--GQDSGKLPVKWTAPEALREKKFST 178

Query: 263 RSDVYSFGILIMEVIS-GRIPVDYSRPP--EEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
           +SDV+SFGIL+ E+ S GR+P  Y R P  + V  +E   +M     PEG          
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGYRM---EAPEGCPPE------ 227

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                  +  V   C + +  KRP    +   L 
Sbjct: 228 -------VYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (326), Expect = 8e-35
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 27/265 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +++G G +G VY  L +D  + +AVK   L  +  +     + E+  +  ++H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 142 GYCAEGAHRML-VY-EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           G   +     L ++ EYV+ G+L   L    G             IL   +GL+YLH   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQIL---EGLAYLHSN- 120

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTG 258
              +VHRDIK +NIL+D     K++DFG AK LG   +   T  + GT  ++APE     
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
                +D++S G  ++E+ +G+ P       E  N +  L K+ ++  P     P++PE 
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSGEP-----PEIPEH 228

Query: 319 PTSRLLKRILLVALRCVDPNAQKRP 343
             S   K  L    +C+  + +KRP
Sbjct: 229 -LSEEAKDFL---RKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 23/279 (8%)

Query: 80  GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH-K 135
            +   + +GEG +G VY  L  D   VA+K L   L ++ +    F  E++ +  + H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+L  +  +     LV EYV+ G+LE  L   +G   PL+    + I+      L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 196 HEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESS-----YITTRVMGTFGY 249
           H      ++HRDIK  NIL+D+     K+ DFGLAKLL    S      + +  +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 250 VAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           +APE     S    +  SD++S GI + E+++G  P +  +     +      K++    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP 231

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
              +  P  P  P         L+  + +  + + R   
Sbjct: 232 TPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  127 bits (320), Expect = 6e-34
 Identities = 68/200 (34%), Positives = 120/200 (60%), Gaps = 13/200 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           +G G +G V+ GL ++  +VA+K L ++    +++F+ EV+A+ R+RHK+L+ L   C+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 147 GAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           G    ++ E +  G+L  +L    G V P + L     +++    A+G++YL    E   
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE---EQNS 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+ + NIL+ +    KV+DFGLA+L+  E  Y+++     + + APE AS G  + +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 264 SDVYSFGILIMEVIS-GRIP 282
           SDV+SFGIL+ E+ + G++P
Sbjct: 185 SDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 2e-31
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 27/283 (9%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       ++ +G G +G V+ G     +KVAVK L       E  F  E + + ++RH
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L   C+E     +V EY++ G+L  +L    G    L   + M   +  A+G++Y
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMAY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           L        +HRD+ + NIL+ ++   K++DFGLA+L+  E    T R    F   + AP
Sbjct: 119 LES---RNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAP 173

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           E A+ G    +SDV+SFGIL+ E+++ GR+P       E +  +E   +M          
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------- 223

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            P+ P  P    L  ++   L+C D + ++RP   ++   LE 
Sbjct: 224 -PRPPNCPEE--LYDLM---LQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (299), Expect = 5e-31
 Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 23/264 (8%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + IG+GG+G VY         +VA+K +     + + +   E++ + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
             G   +     +V E+ + G+L+  L         LT      +     KGL YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              ++HRDIK++NIL+      K+ DFGL+  L    +     ++GT  ++APE  +   
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKP 173

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            + ++D++S GI  +E+  G+ P     P +       L K+ TN  P G+ +P+     
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIATN-GPPGLRNPEKWSDE 226

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
               LK       +C+  N +KRP
Sbjct: 227 FKDFLK-------KCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  117 bits (294), Expect = 2e-30
 Identities = 76/264 (28%), Positives = 137/264 (51%), Gaps = 33/264 (12%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGY 143
           IG+G +G+V+  + + + +V A+K + L+   + ERE  + E   + ++    ++R    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT----WEIRMNIILGTAKGLSYLHEGL 199
             +     +V EY  NG+L + L    G   PL     W   + I+LG    L++LH   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LAHLHSK- 120

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             K++HRDIKS N+ +D + N K+ D G+AKLL   +++  T ++GT  Y++PE      
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            NE+SDV++ G+++ E  +G+ P D +    +  LI  LK +       GV  P + +  
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI--LKII------RGVFPP-VSQMY 225

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
           + +L + I     +C+  + ++RP
Sbjct: 226 SQQLAQLI----DQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (294), Expect = 3e-30
 Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 39/270 (14%)

Query: 85  KVIGEGGYGIVYYGL---LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVR 139
           K IG+G +G VY  L     D     +K + L+N  + ERE  + EV+ + ++ H N+++
Sbjct: 6   KQIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                 E     +V EY + G+L Q +        P   E  ++  +     L YLH   
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             K++HRDIK  NI +  +   K+ DFG++K+L S      T V GT  Y++PE      
Sbjct: 122 -RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKP 179

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
           Y      N +SD++S G ++ E+ + +       P E  NL+E L   +          P
Sbjct: 180 Y------NYKSDIWSLGCVLYELCTLK------HPFEGENLLE-LALKILKGQY-----P 221

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +P +  S  L+ ++      +  + ++RP
Sbjct: 222 PIPSQY-SSELRNLV---SSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 3e-30
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 27/261 (10%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +IG G +G+VY GL LE    VA+K  +L   + +A +    E++ +  ++H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    ++ EY  NG+L Q +    GP       + +  +L   +GL+YLHE     
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVL---QGLAYLHE---QG 119

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           V+HRDIK++NIL  K    K++DFG+A  L   S    + V+GT  ++APE       + 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAST 178

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR 322
            SD++S G  ++E+++G  P  Y   P        L ++V +        P LPE   S 
Sbjct: 179 ASDIWSLGCTVIELLTGNPPY-YDLNPMAA-----LFRIVQDD------HPPLPEG-ISP 225

Query: 323 LLKRILLVALRCVDPNAQKRP 343
            LK  L   ++C   +   RP
Sbjct: 226 ELKDFL---MQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  116 bits (293), Expect = 4e-30
 Identities = 81/286 (28%), Positives = 143/286 (50%), Gaps = 28/286 (9%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAER-EFKVEVEAI 129
           E+  +  +  KVIG G +G V+ G+L+        VA+K L     + +R +F  E   +
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           G+  H N++RL G   +    M++ EY+ NG L+++L    G  S       + ++ G A
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIA 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTF 247
            G+ YL    +   VHRD+ + NIL++ +   KVSDFGL+++L    E +Y T+      
Sbjct: 118 AGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            + APE  +       SDV+SFGI++ EV+S        RP  +++  E +K +      
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAI-----N 224

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +G   P   + P++     +  + L+C   +  +RP+   +V++L+
Sbjct: 225 DGFRLPAPMDCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-29
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLV 138
           +KVIG G +G V  G L+   K    VA+K L      +   +F  E   +G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G   +    M++ EY+ NG+L+++L  + G     T    + ++ G A G+ YL E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSE- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------YVAP 252
                VHRD+ + NIL++ +   KVSDFGL++ L    +  TT+     G      + AP
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAP 177

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS 278
           E  +       SDV+SFGI++ EV+S
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (275), Expect = 1e-27
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 85  KVIGEGGYGIVYYGLL-EDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           KV+G+G  G+VY           A+K + ++   +  ++   E++ +       +V+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 -YCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-----CSPLTWEIRMNIILGTAKGLSYLH 196
            +  EG    +V EY++ G+L   L   VG       + +  +I         KGL YLH
Sbjct: 67  AFYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLH 116

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 ++HRDIK SN+LI+     K++DFG++K+L +      T V GT  Y++PE   
Sbjct: 117 TKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               +  +D++S G+ ++E   G+ P  +  PP + +  E L + + +  P     P LP
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFP--FL-PPGQPSFFE-LMQAICDGPP-----PSLP 224

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +  S   +  +     C+  + +KRP       +L+
Sbjct: 225 AEEFSPEFRDFI---SACLQKDPKKRP---SAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  110 bits (277), Expect = 1e-27
 Identities = 82/272 (30%), Positives = 122/272 (44%), Gaps = 39/272 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + + + IGEG  G VY         +VA+K +   R Q +     E+  +   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMN------IILGTAKGL 192
                  G    +V EY++ G+L      D+     +T   +RMN      +     +GL
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      V+HRDIKS NIL+ K  + K++DFG A  L  E S   + V GT  ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVL 311
           E         + D++S GI+ +E+  G  P  Y R PP        L  + T     G+ 
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPPLRA-----LFLITTK----GIP 234

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
             K PEK  S   K  L    +C+  + +KRP
Sbjct: 235 PLKNPEK-WSPEFKDFL---NKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 6e-27
 Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 37/271 (13%)

Query: 85  KVIGEGGYGIVYYGL---LEDNSK--VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+     +  K  VA+K L      +A +E   E   +  V H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C       L+ + +  G L  ++     ++G    L W +++      AKG+SYL
Sbjct: 73  RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLAKLL   E  Y          ++A E 
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
               +   +SDV+S+G+ + E+++ G  P +     E  +L+E           E     
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---------KGE----- 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           +LP+ P   +   + +V ++C   +A+ RP 
Sbjct: 229 RLPQPPICTI--DVYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  106 bits (266), Expect = 2e-26
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 9/207 (4%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           IG G +G+V+ G   +  KVA+K +      +E +F  E + + ++ H  LV+L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR 206
            +   LV+E++ +G L  +L    G     + E  + + L   +G++YL       V+HR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHR 124

Query: 207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDV 266
           D+ + N L+ ++   KVSDFG+ + +  +    +T       + +PE  S    + +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 267 YSFGILIMEVIS-GRIPVDYSRPPEEV 292
           +SFG+L+ EV S G+ P + +R   EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (264), Expect = 7e-26
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 47/285 (16%)

Query: 85  KVIGEGGYGIVY---YGLLEDNS--KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K +GEG +G V    Y  L DN+  +VAVK+L ++   Q   +F+ E+E +  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 139 RLLGYCAEGAHR---MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT------- 188
           +  G   E        L+ EY+ +G+L  +L              R  I L         
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRH-----------RDQINLKRLLLFSSQ 117

Query: 189 -AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG-- 245
             KG+ YL      + +HRD+ + NIL++     K+SDFGLAK+L  +  Y   +  G  
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 246 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT- 303
             F Y APE   T   +  SDV+SFG+ + E+ +       S P E + +I   +  +  
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIV 232

Query: 304 ----NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                   EG   P+ P  P       +  +   C +   Q RP 
Sbjct: 233 TRLLELLKEGERLPRPPSCPDE-----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  105 bits (263), Expect = 9e-26
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 36/296 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSK--VAVKNLLNN-RGQAEREFKVEVE 127
           EV  +  +  + +G G +G VY GL      D  +  VAVK L  +   Q E +F +E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD---VGPCSPLTWEIRMNI 184
            + +  H+N+VRL+G   E   R ++ E +  G+L+ +L  +       S LT +  +  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAK-LLGSESSYI 239
               AKG  YL E      +HRDI + N L+     P    K++DFG+A+ +  +     
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL 298
             R M    ++ PE    G+   ++DV+SFG+L+ E+ S G +P    R  +EV      
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVME---- 232

Query: 299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              VT     G LDP     P       +  +   C     + RP    ++  ++ 
Sbjct: 233 --FVTG---GGRLDPP-KGCPG-----PVYRIMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 11/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + +G G +G V+ GL  + + VAVK L       + +F  E + + ++RH  L++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  +V E +  G+L ++L G  G    L   I M   +  A G++YL        +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLEA---QNYI 125

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNE 262
           HRD+ + N+L+ ++   KV+DFGLA+++  E  Y   R    F   + APE A     + 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSI 183

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFGIL+ E+++ GR+P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  103 bits (259), Expect = 3e-25
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 31/282 (10%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNL 137
             +G G +G V+             + V VK L   + +  + EF+ E++   ++ HKN+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILGTAKGL 192
           VRLLG C E     ++ EY + G+L+Q+L       +     PL+ + ++ +    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            +L      + VHRD+ + N L+      KVS   L+K + +   Y     +    ++AP
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           E       + +SDV+SFG+L+ EV + G +P  Y    EE          V NR   G L
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEE----------VLNRLQAGKL 236

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +  +PE   SRL K    +  RC   N + RP    +V  L 
Sbjct: 237 ELPVPEGCPSRLYK----LMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (257), Expect = 6e-25
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 87  IGEGGYGIVYYGLL------EDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +GEG +G VY G L         + VA+K L  N   + ++EF+ E E +  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPC-------SPLTWEIRMNIILG 187
           LLG C +     +++EY+ +G+L ++L     H DVG         S L     ++I + 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT- 246
            A G+ YL        VHRD+ + N L+ +    K+SDFGL++ + S   Y   RV    
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186

Query: 247 ---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                ++ PE    G     SD++SFG+++ E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 1e-24
 Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 22/266 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVR 133
           EV        K +G G +G V+ G    ++KVA+K+L   +G    E F  E   + +++
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQ 59

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H  LVRL     +     ++ EY+ NG+L  +L    G    +   I M   +  A+G++
Sbjct: 60  HPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGMA 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVA 251
           ++        +HRD++++NIL+ +    K++DFGLA+L+  E +  T R    F   + A
Sbjct: 117 FIER---KNYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 171

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN-PEG 309
           PE  + G    +SDV+SFGIL+ E+++ GRIP      PE +  +E   +M    N PE 
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231

Query: 310 VLD-------PKLPEKPTSRLLKRIL 328
           + +        K  E+PT   L+ +L
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (252), Expect = 2e-24
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 33/280 (11%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR 131
           E E   +   +  V+G+G YGIVY    L    ++A+K +     +  +    E+     
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI----ILG 187
           ++H+N+V+ LG  +E     +  E V  G+L   L    GP      E  +      IL 
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIIFYTKQIL- 118

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGT 246
             +GL YLH+    ++VHRDIK  N+L++ +    K+SDFG +K L   +   T    GT
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGT 172

Query: 247 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIP-VDYSRPPEEVNLIEWLKKMVT 303
             Y+APE    G       +D++S G  I+E+ +G+ P ++   P   +  +   K    
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--- 229

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                    P++PE  ++     I    LRC +P+  KR 
Sbjct: 230 --------HPEIPESLSAEAKNFI----LRCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (261), Expect = 4e-24
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 25/282 (8%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           ++ VI  G  G  Y G    N  +  VK + +       E       +G+++H N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA----DMGKLQHPNIVKLI 749

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
           G C       L++EY+   NL + L         L+WE R  I +G AK L +LH    P
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            VV  ++    I+ID    P +    L  LL +++    +       YVAPE   T  + 
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDIT 856

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVN--LIEWLKKMVTNRNPEGVLDPKLPEKP 319
           E+SD+Y FG++++E+++G+ P D       V+  ++EW +   ++ + +  +DP +    
Sbjct: 857 EKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913

Query: 320 TS--RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           +     +  ++ +AL C   +   RP    V+  LE+    S
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           IG G +G VY  + L+    +AVK   + +N  +  +E   E++ +  ++H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66

Query: 144 CAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             E  HR  VY   EY + G LE+ L    G            + L   +GL+YLH    
Sbjct: 67  -VE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH-- 118

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV---MGTFGYVAPEYAST 257
             +VHRDIK +NI +D +   K+ DFG A  L + ++ +   V    GT  Y+APE  + 
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 258 GMLNER---SDVYSFGILIMEVISGRIP 282
           G        +D++S G +++E+ +G+ P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 38/285 (13%)

Query: 87  IGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVR 139
           +G+G +G+VY GL       E  ++VA+K +  N    ER EF  E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHG------DVGPCSPLTWEIRMNIILGTAKGLS 193
           LLG  + G   ++V E +  G+L+ +L        +     P T +  + +    A G++
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTFGYVA 251
           YL      K VHRD+ + N ++ +    K+ DFG+ + +  E+ Y     + +    ++A
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEG 309
           PE    G+   +SDV+SFG+++ E+ +    P  Y     EEV       K V +    G
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--YQGLSNEEV------LKFVIDG---G 238

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            LD  LPE    +LL+    +   C   N + RP    +V  L+ 
Sbjct: 239 HLD--LPENCPDKLLE----LMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 20/220 (9%)

Query: 87  IGEGGYGIVYYGLLEDNS----KVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLL 141
           +G G +G V  G+    S    +VAVK L      A ++EF  E   + ++ H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           G C +G   MLV E    G L ++L    ++ P S L       +    A G++YL    
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREI-PVSDLK-----ELAHQVAMGMAYLES-- 113

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAST 257
               VHRD+ + N+L+      K+SDFG+++ LG+ S Y      G +   + APE  + 
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
           G  + +SDV+S+G+ + E  S G  P    +  E + ++E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 49/235 (20%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKV-----EVEAIGRV-R 133
           F   K+IGEG +  V      E N + A+K L  ++ Q  +E KV     E E + R+  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 134 HKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCS-PLTWEIRMNIILGTAKG 191
           H  +++L  Y  +    +  V EY  NG L Q++    G      T      I+L     
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLA---- 114

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM------- 244
           L YLH      ++HRD+K  NIL+DK  + K++DFG AK+L   SS  + +         
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 245 ------------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRIP 282
                       GT  YV+PE     +LNE      SD+++ G +I ++++G+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 82/280 (29%), Positives = 133/280 (47%), Gaps = 32/280 (11%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G V  G L+   K    VA+K L +   + +R +F  E   +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L G   +    M++ E++ NG L+ +L  + G  + +     + ++ G A G+ YL E 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSE- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEY 254
                VHRD+ + NIL++ +   KVSDFGL++ L  ++S  T T  +G      + APE 
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
            +       SDV+S+GI++ EV+S G  P       + +N IE               D 
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ--------------DY 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +LP           L+  L C   +   RPK G +V  L+
Sbjct: 229 RLPPPMDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 71/244 (29%), Positives = 117/244 (47%), Gaps = 25/244 (10%)

Query: 85  KVIGEGGYGIVYYG----LLEDNSK--VAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNL 137
           + +GEG +G V+ G    L  +N K  VAVK L       A ++F+ E E +   +H+N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HG--------DVGPCSPLTWEIRMNIILG 187
           V+  G C EG   ++V+EY+ +G+L ++L  HG           P   LT    + I + 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGT 246
            A G+ YL        VHRD+ + N L+      K+ DFG+++ + +   Y +    M  
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
             ++ PE          SDV+SFG+++ E+ + G+ P  Y    EEV  IE + +    +
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEV--IECITQGRLLQ 244

Query: 306 NPEG 309
            P  
Sbjct: 245 RPRT 248

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 30/278 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +KVIG G +G V  G L+   K    VA+K L      +  R+F  E   +G+  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L G   +    M+V EY+ NG+L+ +L    G  + +     + ++ G A G+ YL + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSD- 124

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYAS 256
                VHRD+ + NIL++ +   KVSDFGL+++L    E++Y T        + APE  +
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
                  SDV+S+GI++ EV+S      Y  RP  E++  + +K +      EG   P  
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI-----EEGYRLPAP 231

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            + P +  L +++   L C   +  +RPK   +V +L+
Sbjct: 232 MDCPAA--LHQLM---LDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.6 bits (240), Expect = 8e-23
 Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 22/203 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           ++IGEG +G V  G      KVAVKN+  +   QA   F  E   + ++ HKNLVRLLG 
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67

Query: 144 CA-EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
               G +  +V E ++ GNL  +L         +   ++ +  L  A+G+ YL      K
Sbjct: 68  ILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KK 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVMGTFGYVAPEYASTGML 260
           +VHRD+ + NIL+ +    KVSDFGLA++  +G ++S +  +      + APE       
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKF 174

Query: 261 NERSDVYSFGILIMEVIS-GRIP 282
           + +SDV+S+G+L+ EV S GR P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAE---REFKVEVEAIGRVRHKNLV 138
           +++G G +G VY GL L+D    AVK  +L ++    +   ++ + E+  + +++H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           + LG   E  +  +  E V  G+L + L    G        +          GL YLH+ 
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-AST 257
                VHRDIK +NIL+D +   K++DFG+AK +  E S+  +   G+  ++APE  A  
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS-FKGSPYWMAPEVIAQQ 176

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
           G     +D++S G  ++E+ +G+ P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)

Query: 87  IGEGGYGIVYYG----LLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+      LL +  K  VAVK L      A ++F+ E E +  ++H+++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLH-----------GDVGPCSPLTWEIRMNIILGTA 189
            G C EG   ++V+EY+ +G+L ++L            G+      LT    + I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFG 248
            G+ YL   L    VHRD+ + N L+ +    K+ DFG+++ + S   Y +  R M    
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++ PE          SD++SFG+++ E+ + G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 41/238 (17%)

Query: 87  IGEGGYGIVYY----GLL--EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVR 139
           IG+G +G V+     GLL  E  + VAVK L        + +F+ E   +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDV------GPCSPLTWEIR 181
           LLG CA G    L++EY+  G+L ++L            H             PL+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------GS 234
           + I    A G++YL E    K VHRD+ + N L+ ++   K++DFGL++ +        S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           E+  I  R M       PE          SDV+++G+++ E+ S  +   Y    EEV
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)

Query: 85  KVIGEGGYGI-VYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +V+G+G +G    Y   ED+S V  K  NL     +  R+   E+  +  ++H N++   
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            +  +    ++  EY N G L   +    G       E+ +  +      +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKA--- 120

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            ++HRDIK+ NI + K    K+ DFG++K+LGSE S   T V+GT  Y++PE       N
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            +SD+++ G ++ E+++ +   D + P   V  I     +  N  P            +S
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI-----VQGNYTPV-------VSVYSS 227

Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
            L   I LV    +  + +KRP    V+   
Sbjct: 228 EL---ISLVH-SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           IGEG YG+VY          VA+K +     + G  +   + E++ +  + H N+++LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    LV+E+++  +L + +         L   +  + +    +GL++ H      
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---G 118

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLN 261
           ++HRD+K  N+LI+     K++DFGLA+  GS     T  V+ T  Y APE        +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 262 ERSDVYSFGILIMEVISGRI 281
              D++S G +  E++S R 
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.0 bits (233), Expect = 7e-22
 Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 28/270 (10%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE 146
           +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR 206
                +V EY++ G+L  +L G++G    L   + M   +  A G++Y+        VHR
Sbjct: 73  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126

Query: 207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERS 264
           D++++NIL+ ++   KV+DFGLA+L+  E +  T R    F   + APE A  G    +S
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P      P  VN      + V ++   G   P  PE P S  
Sbjct: 185 DVWSFGILLTELTTKGRVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-- 231

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           L  ++    +C     ++RP   ++   LE
Sbjct: 232 LHDLM---CQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 70/269 (26%), Positives = 131/269 (48%), Gaps = 27/269 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGRVRHKNLVRLL 141
           +V+G G +GIV+    + + K+ +   +      + E    + E + +  + H N++   
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               E    M+V EY   G L +++       S L  +  ++  +     L ++H  L  
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 202 KVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML 260
            ++HRD+K+ NIL+DKH    K+ DFG++K+L S+S   T  V+GT  Y++PE       
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPY 178

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
           N++SD+++ G ++ E+ S +   + +  P  V     LK M     P    D   P+   
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIMSGTFAPIS--DRYSPD--- 228

Query: 321 SRLLKRILLVALRCVDPNAQKRPKMGHVV 349
              L++++L  L  +DP+  KRP++  ++
Sbjct: 229 ---LRQLILSMLN-LDPS--KRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 24/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
             +G G  G+V   L     K+ AVK +     +A + +   E++ + +     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                    +  EY++ G+L++ L    G    +   I   I +   KGL+YLHE    K
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           ++HRD+K SNIL++     K+ DFG++  L   +S   T V GT  Y+APE       + 
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSV 178

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR 322
           +SD++S G+ ++E+ +GR P      P +  + E L+ +V N  P     P+LP    S 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPP-----PRLPSGKFSP 231

Query: 323 LLKRILLVALRCVDPNAQKRPK----MGH 347
             +  +     C+  + ++RP     + H
Sbjct: 232 DFQDFV---NLCLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 33/275 (12%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCA 145
           IG+G +G VY G+L+ N++VAVK   +      +  F  E E + +  H N+V+L+G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VV 204
           +     +V E V  G+L  +L       + LT +  + + L  A G+ Y    LE K  +
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEY----LESKNCI 115

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGML 260
           HRD+ + N L+ ++   K+SDFG+++    E   I T   G       + APE  + G  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
              SDV+S+GIL+ E  S G  P       +    IE   +M           P+L  + 
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---------PQLCPEE 223

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
             RL+       L+C   + + RP    + + L+ 
Sbjct: 224 IYRLM-------LQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 70/222 (31%), Positives = 114/222 (51%), Gaps = 14/222 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSK---VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           +G G +G V  G+ +   K   VA+K L N   ++ R E   E E + ++ +  +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
            C E    MLV E  + G L ++L    G    +T    + ++   + G+ YL       
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
            VHRD+ + N+L+      K+SDFGL+K LG++ SY   R  G +   + APE  +    
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM 301
           + RSDV+S+GI + E  S G+ P    + PE ++ IE  K++
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 24/264 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + +GEG YG VY  +  E    VA+K +     +  +E   E+  + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
             G   +     +V EY   G++   +         LT E    I+  T KGL YLH   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             K +HRDIK+ NIL+++    K++DFG++  L    +   T V+GT  ++APE      
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            N ++D++S GI  +E+  G+ P     P   +  I     M+ N+ P  + DP+     
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP---MRAI----FMIPNKPPPTLSDPEKWSPE 228

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
            +  +K       +C+  + ++RP
Sbjct: 229 FNDFVK-------KCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 20/210 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLL---NNRGQAEREFKV---EVEAIGRVRHKNLV 138
           +V+G+G YG VY GL      +AVK +    +N   AE+E++    EV+ +  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           + LG C +     +  E+V  G++   L+   GP     +      IL    G++YLH  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL------GSESSYITTRVMGTFGYVAP 252
               VVHRDIK +N+++  +   K+ DFG A+ L      G+ S+ + + + GT  ++AP
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS-MHGTPYWMAP 177

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E  +      +SD++S G  + E+ +G+ P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 22/212 (10%)

Query: 86  VIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE---------FKVEVEAIGRVRHK 135
           +IG G +G VY G+   + ++ AVK +      A  +            E+  +  ++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+ LG   +  H  +  EYV  G++   L+        L   +R N +    KGL+YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-----VMGTFGYV 250
           H      ++HRDIK +NIL+D     K+SDFG++K L + S    T      + G+  ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE         ++D++S G L++E+++G+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 4e-21
 Identities = 72/273 (26%), Positives = 108/273 (39%), Gaps = 61/273 (22%)

Query: 87  IGEGGYGIVY----------YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           +G+G +G V           Y +     KV  K  +  R + E     E   + R+ H  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAM-----KVLKKKKIIKRKEVEH-TLTERNILSRINHPF 54

Query: 137 LVRLLGYCA--EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK---- 190
           +V+L  + A        LV EY   G L  + H                     A+    
Sbjct: 55  IVKL--HYAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAA 100

Query: 191 ----GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                L YLH      +++RD+K  NIL+D   + K++DFGLAK L SE S   T   GT
Sbjct: 101 EIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GT 156

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNR 305
             Y+APE        +  D +S G+L+ E+++G+ P  Y+   +E+   I  LK      
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKI--LKD----- 208

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
                   + PE  +     R L+  L   DP 
Sbjct: 209 ------PLRFPEFLSPEA--RDLISGLLQKDPT 233

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 64/299 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV----EVEAIGRVRHK 135
           +   + +GEG YG+VY     +    VA+K +  +    E         E+  +  ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V+LL          LV+EY +  +L+++L    GP SP    I+ +I+    +GL+Y 
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--IK-SIMYQLLRGLAYC 114

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H     +++HRD+K  NILI++    K++DFGLA+  G      T  V+ T  Y APE  
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI- 169

Query: 256 STGMLNERS-----DVYSFGILIMEVISGR--------------------IPVDYSRPPE 290
              +L  +      D++S G +  E+I+G+                     P +    P 
Sbjct: 170 ---LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE-ESWPG 225

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKRP 343
              L ++               PK P K   ++L R+      LL  +   +P   KR 
Sbjct: 226 VTKLPDYKPTF-----------PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA--KRI 271

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 67/273 (24%), Positives = 125/273 (45%), Gaps = 34/273 (12%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAER---EFKVEVEAIGRVRHKNL 137
           + +G G +   Y    ++  + +AVK +    N   + E      + E+  + R+ H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +R+LG   E +H  L  E++  G++   L    G        + +N      +GLSYLHE
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHE 121

Query: 198 GLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPE 253
               +++HRD+K +N+LID      +++DFG A  L ++   +     +++GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                      DV+S G +I+E+ + + P +     +  N +  + K+ +         P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE---KHSNHLALIFKIASATTA-----P 230

Query: 314 KLPE--KPTSRLLKRILLVALRCVDPNAQKRPK 344
            +PE   P  R       V LRC++   + RP 
Sbjct: 231 SIPEHLSPGLR------DVTLRCLELQPEDRPP 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 9/206 (4%)

Query: 80  GFSDDKVIGEGGYGIVY-YGLLEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKN 136
            F   K +G+G YG VY    L DN   A+K + L +  Q ERE  V E+  +  V H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           ++       +G    +V EY   G+L + +         +  +    I +   +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E    K++HRD+KS+NIL+  +   K+ D G++K+L    +      +GT  Y+APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWK 174

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               + +SD++S G L+ E+ +   P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V+ G       VA+K ++     +E +F  E + + ++ H NLV+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA----KGLSYLHEGLE 200
            +     +V EY+ NG L  +L    G       ++    +L       + + YL     
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN-- 119

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYAST 257
              +HRD+ + N L+ +    KVSDFGLA+ +  +  Y  T   GT     +  PE    
Sbjct: 120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQY--TSSQGTKFPVKWAPPEVFDY 175

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPVD 284
              + +SDV+SFG+L+ EV S G++P +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 12/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+        K +G G +G V+ G    N+KVAVK L       E  F  E + + ++RH
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L    +E     +V EY++ G+L  +L    G    L   + M   +  A G++Y
Sbjct: 61  DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV--AAGMAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++S+NIL+      K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E A  G    +SDV+SFGIL+ E+++ GR+P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 74/283 (26%), Positives = 134/283 (47%), Gaps = 30/283 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       +K +G G +G V+      ++KVAVK +       E  F  E   +  ++H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV+L     +     ++ E++  G+L  +L  D G   PL   I  +  +  A+G+++
Sbjct: 61  DKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           + +      +HRD++++NIL+      K++DFGLA+++  E +  T R    F   + AP
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMV-TNRNPEGV 310
           E  + G    +SDV+SFGIL+ME+++ GRIP      PE +  +E   +M      PE +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +                 + +RC     ++RP   ++  +L+
Sbjct: 233 YN-----------------IMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 19/264 (7%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE--REFKVEVEAIGRVRHKNLVRLLGYC 144
           +GEG  G V    L++   +     +      +  ++   E+E     +   +V+  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 145 AEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWE-IRMNIILGTAKGLSYLHEGLEP 201
            + +   +    EY   G+L+  ++  V        E +   I     KGLSYLH     
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGML 260
           K++HRDIK SNIL+ +    K+ DFG++ +L+ S +   T    GT  Y+APE       
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPY 180

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
           +  SDV+S G+ ++EV   R P      P  +  IE L  +V   NPE   +P    K  
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMPNPELKDEPGNGIK-W 238

Query: 321 SRLLKRILLVALRCVDPNAQKRPK 344
           S   K  +    +C++ +  +RP 
Sbjct: 239 SEEFKDFI---KQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 81/258 (31%), Positives = 119/258 (46%), Gaps = 30/258 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG+G +G V  G    N KVAVK + N+     + F  E   + ++RH NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 145 AEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            E    + +V EY+  G+L  +L       S L  +  +   L   + + YL        
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           VHRD+ + N+L+ +    KVSDFGL K    E+S           + APE       + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179

Query: 264 SDVYSFGILIMEVIS-GRIPVDYSRPP--EEVNLIEWLKKM-VTNRNPEGV--------- 310
           SDV+SFGIL+ E+ S GR+P  Y R P  + V  +E   KM   +  P  V         
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237

Query: 311 LDPKLPEKPTSRLLKRIL 328
           LD     +P+   L+  L
Sbjct: 238 LDAAT--RPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+        K +G G +G V+ G   +++KVAVK L       +  F  E   +  ++H
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LVRL     +     ++ EY+  G+L  +L  D G    +     ++     A+G++Y
Sbjct: 61  DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++++N+L+ +    K++DFGLA+++  E +  T R    F   + AP
Sbjct: 119 IER---KNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 173

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E  + G    +SDV+SFGIL+ E+++ G+IP
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 5e-20
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 39/213 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YG VY     +    VA+K +   R + E+E F +    E++ + ++RH N+VRL
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 141 LGYCAEGAHR--MLVYEYVN---NGNLEQWLHGDVGPCSPLTW-EIR--MNIILGTAKGL 192
                        +V+EY++    G L+        P    T  +I+  M  +L   +GL
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EGL 113

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      ++HRDIK SNILI+     K++DFGLA+     +S   T  + T  Y  P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170

Query: 253 EYASTGMLNERS-----DVYSFGILIMEVISGR 280
           E     +L         D++S G ++ E+  G+
Sbjct: 171 EL----LLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 21/204 (10%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLV 138
           V+GEG YG+V           VA+K    +         A RE KV    + ++RH+N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKV----LRQLRHENIV 63

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            L           LV+EYV    L + L    G   P    +R   I    + ++Y H  
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDA--VRS-YIWQLLQAIAYCHSH 119

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPE-YAS 256
               ++HRDIK  NIL+ +    K+ DFG A+ L    +S +T  V  T  Y APE    
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVG 175

Query: 257 TGMLNERSDVYSFGILIMEVISGR 280
                +  DV++ G ++ E++ G 
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 51/286 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNL-LNNRGQAEREFKVEVEAIGRVRH-KNLVRLLG- 142
           IG G +G V   L + +  + AVK +      + ++   ++++ + R      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 143 --------YCAE------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
                    C E            VYE V    + +              EI   I + T
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILGKIAVAT 116

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L+YL E L  K++HRD+K SNIL+D++ N K+ DFG++  L    S   TR  G   
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRP 172

Query: 249 YVAPEYASTGMLNE---RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
           Y+APE       +    RSDV+S GI + EV +G+ P      P+  ++ + L ++V   
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY-----PKWNSVFDQLTQVVKGD 227

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
            P  +L      + +   +  I L    C+  +  KRPK   ++  
Sbjct: 228 PP--ILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 8e-20
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 28/229 (12%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIV----YYGLLEDN--SKVAVKNLLNNRGQAEREFK--- 123
           E E+  +  +  K +GEG +G V      GL   N  S VAVK L ++    E++     
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLV 63

Query: 124 VEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------------GDV 170
            E+E +  + +HKN++ LLG C +     +V EY  +GNL  +L                
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
            P   LT +  ++     A+G+ +L      K +HRD+ + N+L+ +    K++DFGLA+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Query: 231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +     Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 22/176 (12%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVR 139
           IGEG +GIV+     E    VA+K +   R       QA RE K    A+   +H  +V+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVVK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHE 197
           LL     G+  +LV EY+ +  L + L  +  P      +++  M ++L   KG++Y+H 
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHA 117

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
                ++HRD+K +N+LI      K++DFGLA+L   E   + +  + T  Y APE
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 20/213 (9%)

Query: 87  IGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+    Y L  +  K  VAVK L +    A ++F  E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWL--HG-------DVGPCSPLTWEIRMNIILGTAKG 191
            G C EG   ++V+EY+ +G+L ++L  HG       +    + LT    ++I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYV 250
           + YL        VHRD+ + N L+ ++   K+ DFG+++ + S   Y +    M    ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            PE          SDV+S G+++ E+ + G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 39/281 (13%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSK---VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVR 139
           K +G+G +G+V  G       K   VAVK L +++      +F  E   +  + H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT--WEIRMNIILGTAKGLSYLHE 197
           L G        M+V E    G+L   L  D      ++   +  + I    A G+ YL  
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES 115

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPE 253
               + +HRD+ + NIL+      K+ DFGL + L     +       +V   F + APE
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLD 312
              T   +  SDV+ FG+ + E+ +      Y   P   ++  + LKK+  ++  E +  
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKKI--DKEGERLER 222

Query: 313 PK-LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
           P+  P+         I  V L+C   N   RP    +   L
Sbjct: 223 PEACPQ--------DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 83/301 (27%), Positives = 129/301 (42%), Gaps = 59/301 (19%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V    Y  L+DN+   VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWL--HGDVGPCSPL---TWEIRMNIILGTAKGL 192
             G C     R   LV EY+  G+L  +L  H +      L     +I         KG+
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGM 121

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG---TFGY 249
            YL      + VHRD+ + NIL++     K+ DFGL K+L  +  Y   R  G    F Y
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV----------------N 293
            APE  +    +  SDV+SFG+++ E+ +     D S  P                   +
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           LIE LK             P  P  P       I  +   C + +  +RP    +   +E
Sbjct: 235 LIELLK--------NNGRLPAPPGCPA-----EIYAIMKECWNNDPSQRPSFSELALQVE 281

Query: 354 A 354
           A
Sbjct: 282 A 282

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 7/191 (3%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           +G G YG VY G+ +  S  VAVK L  +  + E EF  E   +  ++H NLV+LLG C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 ++ E++  GNL  +L  +      +   + + +    +  + YL +      +H
Sbjct: 73  REPPFYIITEFMTYGNLLDYLR-ECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSD 265
           RD+ + N L+ ++   KV+DFGL++L+  ++            + APE  +    + +SD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 266 VYSFGILIMEV 276
           V++FG+L+ E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 21/223 (9%)

Query: 85  KVIGEGGYGIVYYGLL--EDNS---KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K++G G +G V+ G+   E +S    VA+K + +  G Q  +E    + A+G + H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C  GA   LV +    G+L   +      + P   L W +++      AKG+ YL
Sbjct: 73  RLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEY 254
            E    ++VHR++ + NIL+      +++DFG+A LL   +  Y  +       ++A E 
Sbjct: 126 EE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
              G    +SDV+S+G+ + E++S G  P    RP E  +L+E
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 33/270 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS-KVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           VIG G   +VY  +   N+ KVA+K + L     +  E + EV+A+ +  H N+V+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPK 202
              G    LV  Y++ G+L   +     P   L   I   ++    KGL YLH  G    
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYITTRVMGTFGYVAPEYASTGM 259
            +HRDIK+ NIL+ +  + K++DFG++  L   G  +  +    +GT  ++APE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 260 -LNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
             + ++D++SFGI  +E+ +G  P  YS+ PP +V +      +    +P     P L  
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP--YSKYPPMKVLM------LTLQNDP-----PSLET 229

Query: 318 ----KPTSRLLKRILLVALRCVDPNAQKRP 343
               K  S+  ++  +++L C+  +  KRP
Sbjct: 230 GADYKKYSKSFRK--MISL-CLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 71/248 (28%), Positives = 123/248 (49%), Gaps = 27/248 (10%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLN-NRGQAEREFKVEV 126
           EL +S   F ++  +GE  +G +Y G L     +    VA+K L + N  Q   EF+ E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIR 181
             +  + H N+V LLG   +     +++EY+N G+L ++L     H DVG  S     ++
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 182 --------MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
                   ++I +  A G+ YL        VH+D+ + NILI +  + K+SD GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 234 SESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           S   Y +  + +    ++ PE    G  +  SD++SFG+++ E+ S  +   Y    +EV
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 293 NLIEWLKK 300
             IE ++K
Sbjct: 236 --IEMVRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 37/272 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+     +     VA+K L    G +A  EF  E   +  + H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C     + LV + + +G L  ++H    ++G    L W +++      AKG+ YL
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLA+LL G E  Y          ++A E 
Sbjct: 126 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   +SDV+S+G+ I E+++ G  P D     E  +L+E                 
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--------------KGE 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           +LP+ P   +   + +V ++C   +A  RPK 
Sbjct: 229 RLPQPPICTI--DVYMVMVKCWMIDADSRPKF 258

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 50/260 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLL 141
           + IG+G +G V       D   +  K +   N  + E++  V EV  +  ++H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63

Query: 142 GYCAEGAHRM---------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
            Y      R+         +V EY   G+L Q +         +  E    I+      L
Sbjct: 64  -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 193 SYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
              H   +P   V+HRD+K +NI +D + N K+ DFGLAK+LG +SS+  T V GT  Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISG----------------------RIPVDYSRP 288
           +PE  +    +E+SD++S G LI E+ +                       RIP  YS  
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS-- 235

Query: 289 PEEVNLIEWLKKMVTNRNPE 308
             E+N +  +K M+ N +P+
Sbjct: 236 -SELNEV--IKSML-NVDPD 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 31/223 (13%)

Query: 84  DKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKN 136
            K +GEG +G V              + VAVK L  N   +E R+   E   + +V H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD--VGPC------------------SPL 176
           +++L G C++    +L+ EY   G+L  +L     VGP                     L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T    ++     ++G+ YL E    K+VHRD+ + N+L+ +    K+SDFGL++ +  E 
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 237 SYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           SY+  ++      ++A E     +   +SDV+SFG+L+ E+++
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 85.3 bits (211), Expect = 9e-19
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 85  KVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH 134
             +G G +G VY G   D         +VAVK L   +G   Q ++EF  E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKG 191
            N+V+LLG C     + ++ E +  G+L  +L     +      LT +  ++I L  AKG
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 192 LSYLHEGLEPKVVHRDIKSSNILI-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             YL +      +HRD+ + N L+     D     K+ DFGLA+ +   S Y      G 
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYRKEGEGL 174

Query: 247 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
               ++APE    G    +SDV+SFG+L+ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 39/210 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRG---QAEREFKVEVEAIGRVRHKNLVR 139
           IGEG YG VY    L     VA+K +   L+  G      RE  + ++ +    H N+VR
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65

Query: 140 LLGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL---TWEIRMNIILGTAKG 191
           LL  C            LV+E+V     +Q L   +  C         I+ +++    +G
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + +LH     ++VHRD+K  NIL+      K++DFGLA++   E +   T V+ T  Y A
Sbjct: 120 VDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYRA 174

Query: 252 PE------YASTGMLNERSDVYSFGILIME 275
           PE      YA+        D++S G +  E
Sbjct: 175 PEVLLQSSYATP------VDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 40/277 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE----------FKVEVEAIGRVR 133
           ++IG+G YG VY  L     ++ AVK +      A R            + E+E +  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKG 191
           H N+V+ LG+     +  +  EYV  G++   L  +G       L       ++    +G
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--QLVRFFTEQVL----EG 120

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY---ITTRVMGTFG 248
           L+YLH      ++HRD+K+ N+L+D     K+SDFG++K   S+  Y       + G+  
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVF 175

Query: 249 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           ++APE   +     + + D++S G +++E+ +GR      RP  +   I  + K+   R+
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNKRS 229

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 P +P   +  L    L     C   N   RP
Sbjct: 230 A-----PPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           ++++G G +G +  G L+  SK    VA+  L       +R  F  E   +G+  H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G    G   M+V EY++NG L+ +L    G    L     M ++ G A G+ YL E 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE- 125

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
                VH+ + +  +L++     K+S F   +   SE+ Y T        + APE     
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 259 MLNERSDVYSFGILIMEVIS 278
             +  SDV+SFGI++ EV+S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 8/212 (3%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V+ G      KVA+K + N    +E +F  E + + ++ H  LV+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     +V E++ NG L  +L    G  S    ++ +++     +G+ YL        +
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFI 122

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L+      KVSDFG+ + +  +    ++       +  PE  +    + +S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI 295
           DV+SFG+L+ EV + G++P +     E V +I
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 84/287 (29%), Positives = 124/287 (43%), Gaps = 36/287 (12%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHK 135
           T  F   +VIGEG YG VY     +    VA+K +++     E E K E   + +   H 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 136 NLVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           N+    G +  +          LV E    G++   + G       L  E    I+  T 
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +GL+YLHE    KV+HRDIK  NIL+ K+   K+ DFG++  L S      T + GT  +
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYW 179

Query: 250 VAPE-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           +APE            + RSDV+S GI  +E+  G+ P+    P   +  I         
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-------- 231

Query: 305 RNPEGVLDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           RNP     P L  PE  + +    I      C+  N ++RP M  ++
Sbjct: 232 RNPP----PTLKSPENWSKKFNDFI----SECLIKNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 34/283 (12%)

Query: 85  KVIGEGGYGIVY----YGLLEDNS--KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKN 136
           K +G G +G V     YGL + ++  KVAVK L      +ERE    E++ +  +  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V LLG C  G   +++ EY   G+L  +L       S LT E  ++     AKG+++L 
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA 158

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVAPE 253
                  +HRD+ + N+L+      K+ DFGLA+ + ++S+Y+     R+     ++APE
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPE 213

Query: 254 YASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                +    SDV+S+GIL+ E+ S G  P  Y   P +    + +K+      PE    
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFSLGSNP--YPGMPVDSKFYKLIKEGYRMAQPE---- 267

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
                         I  +   C D +  KRP    +V ++  Q
Sbjct: 268 ---------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 30/263 (11%)

Query: 86  VIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRH---KNLVRL 140
           +IG G YG VY G  +     VA+K + L+       + + EV  + ++R     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
            G   +G    ++ EY   G++   +    GP +     +   II      L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISV---IIREVLVALKYIHKV-- 120

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-M 259
             V+HRDIK++NIL+    N K+ DFG+A LL   SS  +T V GT  ++APE  + G  
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            + ++D++S GI I E+ +G  P         + LI   K             P+L +  
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PRLEDNG 226

Query: 320 TSRLLKRILLVALRCVDPNAQKR 342
            S+LL+    VA  C+D   ++R
Sbjct: 227 YSKLLRE--FVAA-CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 64/227 (28%), Positives = 116/227 (51%), Gaps = 26/227 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYY----GLLEDNSK----VAVKNLLNNRGQAE-REFKVE 125
           E S +  +  K +GEG +G V      G+ +D  K    VAVK L ++  + +  +   E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----------DVG--P 172
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L            D+   P
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              +T++  ++     A+G+ YL      K +HRD+ + N+L+ ++   K++DFGLA+ +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +   Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 41/294 (13%)

Query: 87  IGEGGYGIVYY----GLLE-----------DNSKVAVKNLLNNRGQAER-EFKVEVEAIG 130
           +GEG +G V+     GL E               VAVK L  +  +  R +F  E++ + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------HGDVGPCSPLTWEI 180
           R+++ N++RLLG C       ++ EY+ NG+L Q+L          H +  P   +   +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-I 239
            M + +  A G+ YL        VHRD+ + N L+  H+  K++DFG+++ L S   Y I
Sbjct: 133 YMAVQI--ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
             R +    ++A E    G     SDV++FG+ + E+ +      YS   +E  +IE   
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-QVIENTG 246

Query: 300 KMVTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
           +   N+  +  L    L   P  +L+       +RC   + + RP    + H L
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVFKLM-------MRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 85  KVIGEGGYG---IVYYGLLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +V+GEG +G   +V +     + K A+K + L     A  + + E   + +++H N+V  
Sbjct: 6   RVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLH 196
                   H  +V EY + G+L Q +    G   P    L W ++M +      G+ ++H
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E    +V+HRDIKS NI + ++   K+ DFG A+LL S  +Y  T V GT  YV PE   
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               N +SD++S G ++ E+ + + P
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 12/211 (5%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           E+       D  +G+G +G V+ G     +KVA+K L       E  F  E + + ++RH
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             LV L    +E     +V E++  G+L  +L    G    L   + M   +  A G++Y
Sbjct: 61  DKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAP 252
           +        +HRD++++NIL+  +   K++DFGLA+L+  E +  T R    F   + AP
Sbjct: 118 IER---MNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           E A  G    +SDV+SFGIL+ E+++ GR+P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 23/204 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  VY G      + VA+K  +L    G      + E+  +  ++H+N+VRL   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66

Query: 144 CAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                  MLV+EY++  +L++++  HG  G   P T +     +L   KG+++ HE    
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRD+K  N+LI+K    K++DFGLA+  G   +  +  V+ T  Y AP+     +L 
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV----LLG 174

Query: 262 ERS-----DVYSFGILIMEVISGR 280
            R+     D++S G ++ E+I+GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 34/215 (15%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAE--------REFKVEVEAIGRVR 133
            K +GEG Y +VY     E    VA+K + L  R +A+        RE K+  E    ++
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LK 60

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N++ LL      ++  LV+E++   +LE+ +       +P   +I+ + +L T +GL 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLE 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH      ++HRD+K +N+LI      K++DFGLA+  GS +  +T +V+ T  Y APE
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGRIP 282
                 +   G+     D++S G +  E++  R+P
Sbjct: 173 LLFGARHYGVGV-----DMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 36/227 (15%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYC 144
           IG G  G VY  +     ++ A+K +  N      R+   E+E +  V H N+V+     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  ++ E+++ G+LE     D    + +  +I          G++YLH      +V
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHR---RHIV 190

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-- 262
           HRDIK SN+LI+   N K++DFG++++L        + V GT  Y++PE  +T  LN   
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNHGA 248

Query: 263 ----RSDVYSFGILIMEVISGRIP---------------VDYSRPPE 290
                 D++S G+ I+E   GR P               +  S+PPE
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295

Length = 353

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG G YG VY    +     VA+K +    G      + E+  +   RH N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   +V EY   G+L+       GP S L  +I   +   T KGL+YLHE      
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHE---TGK 122

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA---STGML 260
           +HRDIK +NIL+ +  + K++DFG++  L +  +   + + GT  ++APE A     G  
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181

Query: 261 NERSDVYSFGILIMEVISGRIP 282
           + + D+++ GI  +E+   + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 22/165 (13%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I +   K L YLH  L   V+HRD+K SN+LI+++   K+ DFG++  L    S   T  
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163

Query: 244 MGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
            G   Y+APE  +  +     + +SDV+S GI ++E+ +GR P D  + P      + LK
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK 218

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           ++V    P     P+LP +  S           +C+  N ++RP 
Sbjct: 219 QVV--EEPS----PQLPAEKFS---PEFQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)

Query: 87  IGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V+    Y L     K  VAVK L +    A ++F+ E E +  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWL--HG-------DVGPCSP---LTWEIRMNIILGT 188
            G C +G   ++V+EY+ +G+L ++L  HG       D  P      L     ++I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTF 247
           A G+ YL        VHRD+ + N L+  +   K+ DFG+++ + S   Y +    M   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            ++ PE          SDV+SFG+++ E+ + G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 72/281 (25%), Positives = 133/281 (47%), Gaps = 33/281 (11%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRV 132
              F  +K IG+G + +VY  + L D   VA+K +    + +    +   K E++ + ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPCSPLTWEIRMNIILG 187
            H N+++ L    E     +V E  + G+L + +        + P     W+  + +   
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTIWKYFVQL--- 115

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
               L ++H     +++HRDIK +N+ I      K+ D GL +   S+++   + V GT 
Sbjct: 116 -CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE       N +SD++S G L+ E+ + + P  Y    +++NL    KK+      
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------ 220

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
           E    P LP    S  L+   LV+ RC++P+ +KRP + +V
Sbjct: 221 EKCDYPPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 31/180 (17%)

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLG 233
           P+  EI   I +   +GL+YL+     +++HRDIK SNIL++     K+ DFG++ +L+ 
Sbjct: 99  PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156

Query: 234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN 293
           S    I    +GT  Y++PE    G    +SDV+S GI I+E+  G+ P  +S   ++  
Sbjct: 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212

Query: 294 LIEWLKKMVTNRNPEGVLD----------PKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                       +P G+LD          P+LP       L+  +     C+  +  +RP
Sbjct: 213 D-----------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV---DACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 24/227 (10%)

Query: 87  IGEGGYGIV---YYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           +G G +G V    Y + +    VAVK L N  N    + E   E   + ++ +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           G C E    MLV E    G L ++L    H      + L  ++ M        G+ YL E
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
                 VHRD+ + N+L+      K+SDFGL+K LG++ +Y   +  G +   + APE  
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM 301
           +    + +SDV+SFG+L+ E  S G+ P    +  E   +IE  ++M
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V YG       VA+K ++     +E EF  E + + ++ H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLH-GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK- 202
            +     +V EY++NG L  +L               + + +L   K +      LE K 
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRF--------QPSQLLEMCKDVCEGMAYLESKQ 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGM 259
            +HRD+ + N L+D     KVSDFGL++ +  +  Y ++  +G+     +  PE      
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSK 177

Query: 260 LNERSDVYSFGILIMEVIS-GRIPVD 284
            + +SDV++FG+L+ EV S G++P +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 87  IGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKVEVEAIGR-VRHKNLVRLLG 142
           IGEG  GIV   +  D S   +VAVK + + R Q  RE       I R  +H N+V +  
Sbjct: 27  IGEGSTGIVC--IATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
               G    +V E++  G L      D+   + +  E    + L   K LS+LH      
Sbjct: 84  SYLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QG 135

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGML 260
           V+HRDIKS +IL+      K+SDFG    +  E   +  R  ++GT  ++APE  S    
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPY 192

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPP 289
               D++S GI+++E++ G  P  ++ PP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY-FNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 80/290 (27%), Positives = 138/290 (47%), Gaps = 42/290 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLN-NRGQAEREFKV 124
           L+E E     F   KV+G G +G VY GL     +     VA+K L      +A +E   
Sbjct: 4   LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGD-VGPCSPLTWEIR 181
           E   +  V + ++ RLLG C     + L+ + +  G L  ++  H D +G    L W ++
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYIT 240
           +      AKG++YL E    ++VHRD+ + N+L+    + K++DFGLAKLLG+ E  Y  
Sbjct: 118 I------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK 299
                   ++A E     +   +SDV+S+G+ + E+++ G  P D     E  +++E   
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--- 225

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
                   E     +LP+ P   +   + ++ ++C   +A  RPK   ++
Sbjct: 226 ------KGE-----RLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 31/229 (13%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNN-RGQAEREFKVE 125
           E+ +ST  F ++  +GE  +G VY G L      E    VA+K L +   G    EFK E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-----HGDVGPC------- 173
                R++H N+V LLG   +     +++ Y ++ +L ++L     H DVG         
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
           S L     ++I+   A G+ +L       VVH+D+ + N+L+    N K+SD GL + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 234 SESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           +   Y   ++MG       +++PE    G  +  SD++S+G+++ EV S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 87  IGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           IG G +G V+ G L  DN+ VAVK+         + +F  E   + +  H N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-V 203
            +     +V E V  G+   +L  + GP   +   I+M  +   A G+ YL    E K  
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYL----ESKHC 115

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLN 261
           +HRD+ + N L+ +    K+SDFG+++    +  Y +T  M      + APE  + G  +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 262 ERSDVYSFGILIMEVIS-GRIP 282
             SDV+SFGIL+ E  S G +P
Sbjct: 175 SESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLE-DNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           K IGEG +G +Y    + D+    +K  +L     + +   K EV  + +++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC----SPLTWEIRMNIILGTAKGLSYLHE 197
               E     +V EY + G+L + ++   G        L+W +++++      GL ++H+
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
               K++HRDIKS NI + K+    K+ DFG+A+ L        T  +GT  Y++PE   
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVD 284
               N ++D++S G ++ E+ + + P +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV---EVEAIGRVRHKN 136
           F+  + IG+G +G VY  +    N  VA+K +  +  +AE E +    E++ + + R   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           + +  G   +G+   ++ EY   G+       D+     L       I+     GL YLH
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E      +HRDIK++NIL+ +  + K++DFG++  L S  S   T V GT  ++APE   
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               +E++D++S GI  +E+  G  P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 40/284 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +VIG+G +G VY+G L D+       AVK+L  + +  + E +F  E   +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 139 RLLGYC--AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            LLG C  +EG+  ++V  Y+ +G+L  ++          T +  +   L  AKG+ YL 
Sbjct: 60  SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL- 114

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPE 253
                K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  Y      G      ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN---LIEWLKKMVTNRNPEGV 310
              T     +SDV+SFG+L+ E+++   P     P  +V+   +  +L +      PE  
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQPEYC 227

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            DP             +  V L C  P  + RP    +V  +E 
Sbjct: 228 PDP-------------LYEVMLSCWHPKPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRL 140
           VIGEG +G V    ++ +      A+K +     + + R+F  E+E + ++  H N++ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC--------SPLTWEIRMNIILGT 188
           LG C    +  L  EY  +GNL  +L      +  P         S L+ +  ++     
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++    +  Y+  + MG   
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLP 186

Query: 249 --YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +     R +F  EV+ + R+   N+ RLLG C       ++ EY+ NG+L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 165 WLHGDVGPCS-------PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +L   V   S        L++   + +    A G+ YL        VHRD+ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 218 HWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           ++  K++DFG+++ L S   Y +  R      ++A E    G    +SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 277 IS 278
           ++
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 26/214 (12%)

Query: 84  DKVIGEGGYGIVYYGLLE-DNSKV--AVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLV 138
           + VIGEG +G V   +++ D  K+  A+K L     + + R+F  E+E + ++  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLTWEIRMNIIL 186
            LLG C    +  +  EY   GNL  +L              + G  S LT +  +    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A G+ YL E    + +HRD+ + N+L+ ++   K++DFGL++    E  Y+  + MG 
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179

Query: 247 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
               ++A E  +  +   +SDV+SFG+L+ E++S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE-----REFKVEVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +AVK +  +    E        + E++ +  ++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +     +  EY+  G+++  L  +G       LT  +         +G+ YLH
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLH 121

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEY 254
                 +VHRDIK +NIL D   N K+ DFG +K L +  S  T    V GT  +++PE 
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S G  ++E+++ + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 32/279 (11%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKV-----EVEAIG-RVR 133
           +G G +G VY    ++N        ++ V N    + + ER+  +     EV  I  ++R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N+VR      E     +V + +    L +  +         T E   NI +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH+  E ++VHRD+  +NI++ +     ++DFGLAK    ES    T V+GT  Y  PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILYSCPE 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   E++DV++FG ++ ++ + + P  YS      N++    K+V     E V +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ-PPFYS-----TNMLSLATKIV-----EAVYEP 232

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
            LPE   S   + +  V   C+ P+A+ RP +  V  M+
Sbjct: 233 -LPEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 19/214 (8%)

Query: 85  KVIGEGGYGIVYYGLL--EDNS--KVAVKNL-LNNRGQAE-REFKVEVEAIGRVRHKNLV 138
           K++GEG +G V  G L  +D S  KVAVK + L+    +E  EF  E   +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 139 RLLGYCAEGAHR------MLVYEYVNNGNLEQWLHGDVGPCSP--LTWEIRMNIILGTAK 190
           +L+G C E +        M++  ++ +G+L  +L        P  L  +  +  ++  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGY 249
           G+ YL        +HRD+ + N ++ +     V+DFGL+K + S   Y   R+      +
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           +A E  +  +   +SDV++FG+ + E+ + G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 61/215 (28%), Positives = 111/215 (51%), Gaps = 22/215 (10%)

Query: 85  KVIGEGGYGIVYYGLL-EDNS--KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K +GEG +G V  G L +D+S  KVAVK +   +  R + E +F  E   +    H N++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVM 63

Query: 139 RLLGYCAEGAHR------MLVYEYVNNGNLEQWL-HGDVGPCSPLTWEIRMNIILGT--A 189
           RL+G C +          +++  ++ +G+L  +L +  +G C P     +M +   T  A
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-PQYLPTQMLVKFMTDIA 122

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FG 248
            G+ YL        +HRD+ + N +++++ N  V+DFGL+K + +   Y   R+      
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++A E  +  +   +SDV+SFG+ + E+ + G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 46/217 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--------EVEAIGRV-RH 134
           K +G+G +G VY     E    VA+K +       +++F          EV+++ ++  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+V+L     E      V+EY+  GNL Q +    G   P +  +  +II    +GL++
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAH 114

Query: 195 LHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES---SYITTRVMGTFGYV 250
           +H+ G      HRD+K  N+L+      K++DFGLA+ + S      Y++TR      Y 
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYR 165

Query: 251 APE-------YASTGMLNERSDVYSFGILIMEVISGR 280
           APE       Y+S        D+++ G ++ E+ + R
Sbjct: 166 APEILLRSTSYSSP------VDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV------EVEAIGRVRHKNLVR 139
           IGEG YG+VY          VA+K +   R + E E  V      E+  +  + H N+VR
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           LL          LV+E+++  +L++++  D  P + L   +  + +    +G++Y H   
Sbjct: 63  LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             +V+HRD+K  N+LID+    K++DFGLA+  G      T  V+ T  Y APE      
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
             ST +     D++S G +  E+++ R
Sbjct: 176 QYSTPV-----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 53/229 (23%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +   K IG G YG+V   +      KVA+K + N   +   A+R  + E++ +  +RH+N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHEN 60

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGN------------LEQWLHGDVGPCSPLTWEIRMNI 184
           ++ L          +L      + N            L + +        PLT +     
Sbjct: 61  IIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSP----QPLTDDHIQYF 108

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-------SS 237
           +    +GL YLH      V+HRD+K SNIL++ + + K+ DFGLA+ +  +       + 
Sbjct: 109 LYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRI 281
           Y+ TR      Y APE     +L+        D++S G +  E+++ + 
Sbjct: 166 YVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 86  VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRL 140
           VIGEG +G V    ++ +      A+K +     + + R+F  E+E + ++  H N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLTWEIRMNIILGT 188
           LG C    +  L  EY  +GNL  +L                   S L+ +  ++     
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++    +  Y+  + MG   
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLP 174

Query: 249 --YVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YGIVY          VA+K +   R   ER+   +    E+  +  +RH N+V L
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 141 LGYCAEGAHR---MLVYEYVNNGNLEQWLHG--DVGPCSPLTWEIRMNIILGTAKGLSYL 195
                 G H     LV EY      EQ L    D  P  P +      ++L   +GL YL
Sbjct: 72  K-EVVVGKHLDSIFLVMEYC-----EQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYL 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           HE     ++HRD+K SN+L+      K++DFGLA+  G  +  +T +V+ T  Y APE  
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180

Query: 256 STGMLNERS--DVYSFGILIMEVISGR 280
             G     +  D+++ G ++ E+++ +
Sbjct: 181 -LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 67/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)

Query: 85  KVIGEGGYG-IVYYGLLEDNSKVAVKNLLNNRGQA-ER-EFKVEVEAIGRVRHKNLVRLL 141
           K IGEG +G  +     ED  +  +K +  ++    ER E + EV  +  ++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLHE 197
               E  +  +V +Y   G+L + ++   G   P    L W +++ +       L ++H+
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               K++HRDIKS NI + K    K+ DFG+A++L S      T  +GT  Y++PE    
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICEN 175

Query: 258 GMLNERSDVYSFGI-------------------LIMEVISGR---IPVDYSRPPEEVNLI 295
              N +SD+++ G                    L++++I G    +   YS   +  NL+
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYS--YDLRNLV 233

Query: 296 EWLKKMVTNRNP 307
             L K    RNP
Sbjct: 234 SQLFK----RNP 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGY 143
           +++G+G +G V+ G L+D + VAVK    +  Q  + +F  E   + +  H N+V+L+G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C +     +V E V  G+   +L         L  +  +   L  A G++YL        
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNC 114

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +HRD+ + N L+ ++   K+SDFG+++    G  SS    ++     + APE  + G  +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYS 172

Query: 262 ERSDVYSFGILIMEVIS 278
             SDV+S+GIL+ E  S
Sbjct: 173 SESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 63/263 (23%), Positives = 102/263 (38%), Gaps = 40/263 (15%)

Query: 80  GFSDDKVIGEGGYGIV----------YYGLLEDN-----SKVAVKNLLNNRGQAEREFKV 124
            F   +VIG+G +G V           + +   N      K +V+N+LN           
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN----------- 49

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E   +  + H  LV L     +  +  LV + +  G+L   L   V      + E     
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEEQVKFW 105

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           I      L YLH      ++HRDIK  NIL+D+  +  ++DF +A  + +  +  T+   
Sbjct: 106 ICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS- 160

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY-SRPPEEVNLIEWLKKMVT 303
           GT GY+APE       +   D +S G+   E + G+ P    SR   +    +   K  T
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET 216

Query: 304 NRNPEGVLDPKLPEKPTSRLLKR 326
                            ++LL+R
Sbjct: 217 ADVLYPATWSTEAIDAINKLLER 239

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 12/200 (6%)

Query: 84  DKVIGEGGYGIVY---YGLLEDNS-KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
            + IGEG +G VY   Y   E+    VAVK   N    + RE F  E   + +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +L+G   E     +V E    G L  +L  +      L     +      +  L+YL   
Sbjct: 71  KLIGVITENP-VWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES- 125

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              + VHRDI + N+L+      K+ DFGL++ L  ES Y  ++      ++APE  +  
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 259 MLNERSDVYSFGILIMEVIS 278
                SDV+ FG+ + E++ 
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCA 145
           IGEG  GIV    ++ + K+     ++ R Q  RE    EV  +   +H+N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
            G    +V E++  G L      D+   + +  E    + L   K LS LH      V+H
Sbjct: 88  VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSD 265
           RDIKS +IL+      K+SDFG    +  E     + V GT  ++APE  S        D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198

Query: 266 VYSFGILIMEVISGRIPVDYSRPP 289
           ++S GI+++E++ G  P  ++ PP
Sbjct: 199 IWSLGIMVIEMVDGEPPY-FNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 15/206 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDN---SKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKN 136
           F+  + IG+G +G V+ G+  DN     VA+K +     + E E  + E+  + +     
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           + +  G   +G    ++ EY+  G+    L    GP         +  IL   KGL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                K +HRDIK++N+L+ +  + K++DFG+A  L +++       +GT  ++APE   
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               + ++D++S GI  +E+  G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 26/258 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA+K + N + Q ++E  + E+  +   +H N+V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D++S GI+ +E++ G  P     P   + LI       TN  PE      L        +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE------LQNPEKLSAI 244

Query: 325 KRILLVALRCVDPNAQKR 342
            R  L   RC++ + +KR
Sbjct: 245 FRDFLN--RCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 19/247 (7%)

Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +  + A  +F  E++ + R++  N++RLL  C       ++ EY+ NG+L Q
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 165 WLHGDVGPCSPLTWEIR-------MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +L       +    ++        + +    A G+ YL        VHRD+ + N L+ K
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165

Query: 218 HWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           ++  K++DFG+++ L S   Y I  R +    +++ E    G     SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
           ++      YS+  +E  +IE   +   ++  +  L PK    P S     +  + L C  
Sbjct: 226 LTLCKEQPYSQLSDE-QVIENTGEFFRDQGRQVYL-PKPALCPDS-----LYKLMLSCWR 278

Query: 337 PNAQKRP 343
            NA++RP
Sbjct: 279 RNAKERP 285

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNLVR 139
           IGEG YG+VY          VA+K +   R   E E  V   AI  +       H N+V+
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETE-GVPSTAIREISLLKELNHPNIVK 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           LL          LV+E+++  +L++++  D  P S +   +  + +    +GL++ H   
Sbjct: 64  LLDVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------ 253
             +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+ T  Y APE      
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 176

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
           Y ST +     D++S G +  E+++ R
Sbjct: 177 YYSTAV-----DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 26/217 (11%)

Query: 85  KVIGEGGYGIVYY----GLLEDN----SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RH 134
           K +GEG +G V      GL ++     +KVAVK L ++  + +  +   E+E +  + +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP---------CSP---LTWEIRM 182
           KN++ LLG C +     ++ EY + GNL ++L     P           P   L+++  +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITT 241
           +     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  TT
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                  ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F+D + IG G +G VY+      ++ VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCS--------PLTWEIRMNIILG 187
            +   G C    H   LV EY             +G  S        PL       I  G
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYC------------LGSASDILEVHKKPLQEVEIAAICHG 123

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             +GL+YLH     + +HRDIK+ NIL+ +    K++DFG A L+   +S++     GT 
Sbjct: 124 ALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTP 175

Query: 248 GYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIP 282
            ++APE       G  + + DV+S GI  +E+   + P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 34/300 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQAER-EFKVEVE 127
           EVS    +  + +G+G +G+VY G   D       ++VAVK +  +    ER EF  E  
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH-----GDVGPCSPL-TWEIR 181
            +      ++VRLLG  ++G   ++V E + +G+L+ +L       +  P  P  T +  
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           + +    A G++YL+     K VHRD+ + N ++   +  K+ DFG+ + +  E+ Y   
Sbjct: 122 IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRK 177

Query: 242 RVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
              G     ++APE    G+    SD++SFG+++ E+ S       +  P +    E + 
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVL 231

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
           K V +    G LD   P+    R+   + +    C   N + RP    +V++L+    PS
Sbjct: 232 KFVMD---GGYLDQ--PDNCPERVTDLMRM----CWQFNPKMRPTFLEIVNLLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 85  KVIGEGGYG--IVY-YGLLEDNSK--VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +V+GEG +G   +Y Y    D +   VAVK L    GQ     +K E+  +  + H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C+E   +   L+ EYV  G+L  +L     P   L     +       +G++YLH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG---TFGYVAPE 253
                  +HRD+ + N+L+D     K+ DFGLAK +     Y   R  G    F Y A E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180

Query: 254 YASTGMLNERSDVYSFGILIMEVIS 278
                  +  SDV+SFG+ + E+++
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)

Query: 85  KVIGEGGYGIVY----YGLLEDN----SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RH 134
           K +GEG +G V     YG+ +        VAVK L +N    +  +   E+E +  + +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC------------SPLTWEIRM 182
           KN++ LLG C +     ++ EY   GNL ++L     P               L+++  +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITT 241
           +     A+G+ YL      + +HRD+ + N+L+ +    K++DFGLA+ +     Y  T+
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
                  ++APE     +   +SDV+SFGIL+ E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IGEG  GIV     +   K VAVK + + R Q  RE    EV  +    H+N+V +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V E++  G L      D+   + +  E    + L   + LSYLH      V+
Sbjct: 89  LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVI 140

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS +IL+      K+SDFG    +  E       ++GT  ++APE  S        
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP------------EGVLD 312
           D++S GI+++E+I G  P  ++ PP     ++ ++++  N  P             G LD
Sbjct: 200 DIWSLGIMVIEMIDGEPPY-FNEPP-----LQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253

Query: 313 PKLPEKPTSRLLKRILLVA--LRCVDPNAQKRPKMGH 347
             L  +P+ R   + LL    L+   P +   P M  
Sbjct: 254 LMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQ 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 41/236 (17%)

Query: 105 KVAVKNLLNNRGQAERE---FKVEVEAIGRVRHKNLVRLL--GYCAEGAHRMLVYEYVNN 159
           +VA+K L  +  + E +   F+ E     R+ H N+V LL  G    G     V+EYV  
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPG 63

Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---D 216
             L + L  D G          M  +L     L+  H      +VHRD+K  NI++    
Sbjct: 64  RTLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQTG 116

Query: 217 KHWNPKVSDFGLAKLL-GSESSYI-----TTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
              + KV DFG+  LL G   + +     TT V+GT  Y APE      +   SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 271 ILIMEVISGRI----------------PVDYSRPP--EEVNLIEWLKKMVTNRNPE 308
           ++ +E ++G+                 PVD S PP      L + L+K   N++P 
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRK-ALNKDPR 231

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 41/270 (15%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL-GYC 144
           +G+G +G VY    ++    A   ++    + E E F VE++ +   +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMNIILGTAKGLSYLHEGLEPKV 203
            E    +L+ E+ + G L+  +   +     LT  +IR  +     + L++LH     KV
Sbjct: 73  YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE----SSYITTRVMGTFGYVAPEYASTGM 259
           +HRD+K+ NIL+    + K++DFG++    S      ++I     GT  ++APE  +   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACET 179

Query: 260 L-----NERSDVYSFGILIMEVISGRIPVDYSRPPE-EVNLIEWLKKMVTNRNPEGVLDP 313
                 + ++D++S GI ++E+           PP  E+N +  L K +    P  +  P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQM-------EPPHHELNPMRVLLK-ILKSEPPTLDQP 231

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                  +  LK        C+  +   RP
Sbjct: 232 SKWSSSFNDFLK-------SCLVKDPDDRP 254

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 26/227 (11%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYY----GLLEDNSK----VAVKNLLNNRGQAE-REFKVE 125
           E+S    +  K +GEG +G V      G+ +D       VAVK L ++    +  +   E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP--------C--- 173
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L     P        C   
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 174 -SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              LT++  ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +   Y  TT       ++APE     +   +SDV+SFG+L+ E+ +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 56/217 (25%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVE 127
           EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER EF  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-----DVGPC-SPLTWEIR 181
            +      ++VRLLG  ++G   +++ E +  G+L+ +L       +  P  +P + +  
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +  E+ Y   
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRK 177

Query: 242 RVMGTFG--YVAPEYASTGMLNERSDVYSFGILIMEV 276
              G     +++PE    G+    SDV+SFG+++ E+
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.4 bits (182), Expect = 7e-15
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 35/285 (12%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA++ + N + Q ++E  + E+  +   ++ N+V  L   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
             G    +V EY+  G+L   +     D G  + +  E          + L +LH     
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALEFLHSN--- 135

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRDIKS NIL+    + K++DFG    +  E S   + ++GT  ++APE  +     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYG 194

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            + D++S GI+ +E+I G  P     P   + LI       TN  PE     + PEK  S
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPE----LQNPEK-LS 243

Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            + +  L    RC+D + +KR   G    +L+ Q     +P +S 
Sbjct: 244 AIFRDFL---NRCLDMDVEKR---GSAKELLQHQFLKIAKPLSSL 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 22/279 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKN 136
           F  +K IG G +  VY    L D   VA+K +        +A ++   E++ + ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +++ L    E     +V E  + G+L Q +         +         +     + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE   
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               N +SD++S G L+ E+ + + P  Y    +++NL    +K+      E    P LP
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLFSLCQKI------EQCDYPPLP 229

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
            +  S  L+   LV++ C+ P+  +RP +G+ VH +  Q
Sbjct: 230 TEHYSEKLRE--LVSM-CIYPDPDQRPDIGY-VHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 75/290 (25%), Positives = 133/290 (45%), Gaps = 40/290 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           KV+G G +G VY G+   + +     VA+K L  N   +A +E   E   +  V    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           RLLG C     + LV + +  G L  ++      +G    L W +++      AKG+SYL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEY 254
            E    ++VHRD+ + N+L+    + K++DFGLA+LL   E+ Y          ++A E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                   +SDV+S+G+ + E+++ G  P D     E  +L+E                 
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--------------KGE 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPS 363
           +LP+ P       + ++ ++C   +++ RP+   +V         +++PS
Sbjct: 229 RLPQPPICT--IDVYMIMVKCWMIDSECRPRFRELVDEFSRM---ARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 28/259 (10%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    ++   K+ A K L   R    + E+    E + + +V     +  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 143 YCAEG-AHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           Y  E      LV   +N G+L+  +   G+ G            II G    L +LH+  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++V+RD+K  N+L+D H N ++SD GLA  L      I  R  GT GY+APE     +
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMAPEVLQGEV 170

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            +   D ++ G  + E+I+GR P  + +  E+V   E LK+          +  + P+K 
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVEKEE-LKRRTLE------MAVEYPDKF 221

Query: 320 TSRLLKRILLVALRCVDPN 338
           +     + L  AL   DP 
Sbjct: 222 SPEA--KDLCEALLQKDPE 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 78/283 (27%), Positives = 121/283 (42%), Gaps = 63/283 (22%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           I +G YG V+  L +  S       KV  K  +  + Q ++    E + + + +   +V+
Sbjct: 1   ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPYVVK 57

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           L  Y  +G   + LV EY+  G+L   L  +VG    L  ++    I      L YLH  
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSN 112

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI--------TTRVMGTFGYV 250
               ++HRD+K  NILID + + K++DFGL+K +G     I          R++GT  Y+
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 251 APEYASTGMLNE----RSDVYSFGILIMEVISGRIPVDYSRPPEEV------NLIEWLKK 300
           APE     +L +      D +S G ++ E + G IP  +   PEE+        IEW   
Sbjct: 169 APEV----ILGQGHSKTVDWWSLGCILYEFLVG-IPPFHGETPEEIFQNILNGKIEW--- 220

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 PE V          S+LL            P+ +KR 
Sbjct: 221 ------PEDVEVSDEAIDLISKLL-----------VPDPEKRL 246

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 20/190 (10%)

Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK L  +  + A  +F  EV+ + R++  N++RLLG C +     ++ EY+ NG+L Q
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 165 WL------------HGDVGPCSPL---TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           +L            +  V P   L   ++   +++ L  A G+ YL        VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165

Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ ++   K++DFG+++ L +   Y I  R +    ++A E    G     SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 269 FGILIMEVIS 278
           FG+ + E++ 
Sbjct: 226 FGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 87  IGEGGYGIV---YYGLLEDNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +GEG +G V    Y    DN+  +VAVK+L   + G    + K E+E +  + H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 LGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            G C E       L+ E++ +G+L+++L  +    + +  + ++   +   KG+ YL   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS- 127

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYA 255
              + VHRD+ + N+L++     K+ DFGL K + ++  Y T         F Y APE  
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
                   SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 33/192 (17%)

Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV EY+N G+    L   +G   P  W  +   I     G+  LH+     ++HRDIK  
Sbjct: 74  LVMEYLNGGDCAS-LIKTLGGL-PEDW-AK-QYIAEVVLGVEDLHQR---GIIHRDIKPE 126

Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           N+LID+  + K++DFGL     S +     + +GT  Y+APE       ++ SD +S G 
Sbjct: 127 NLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181

Query: 272 LIMEVISGRIPVDYSRPPE-----EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           +I E + G  P     P           I W +++    +PE V            L+ R
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV-----------DLINR 230

Query: 327 ILLVALRCVDPN 338
           +L     C+DP 
Sbjct: 231 LL-----CMDPA 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 24/227 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G VY  + +    +VA+K + N + Q ++E  + E+  +   ++ N+V  L   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
             G    +V EY+  G+L   +     D G  + +  E          + L +LH     
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE--------CLQALDFLHSN--- 134

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           +V+HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +     
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
            + D++S GI+ +E++ G  P     P   + LI       TN  PE
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 68/229 (29%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLN---NRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           +G+G YGIV+  +     + VA+K + +   N   A+R F+ E+  +  +  H N+V+LL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73

Query: 142 GYCAEGAHRM-------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI---------- 184
                   +        LV+EY     +E  LH  V         IR NI          
Sbjct: 74  N-----VIKAENDKDIYLVFEY-----METDLHA-V---------IRANILEDVHKRYIM 113

Query: 185 --ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
             +L   K L Y+H G    V+HRD+K SNIL++     K++DFGLA+ L          
Sbjct: 114 YQLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 243 VM----GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 280
           V+     T  Y APE       Y + G+     D++S G ++ E++ G+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF---KVEVEAIGRVRHKNL 137
           F+  + IG+G +G VY G+ ++ +K  V   + +  +AE E    + E+  + +     +
Sbjct: 6   FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            R  G   +G    ++ EY+  G+       D+    PL       I+    KGL YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               + +HRDIK++N+L+ +  + K++DFG+A  L +++       +GT  ++APE    
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
              + ++D++S GI  +E+  G  P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 26/258 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IG+G  G V+  + +    +VA+K + N + Q ++E  + E+  +  +++ N+V  L   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    +V EY+  G+L      DV   + +       +     + L +LH     +V+
Sbjct: 86  LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS N+L+    + K++DFG    +  E S  +T V GT  ++APE  +      + 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D++S GI+ +E++ G  P     P   + LI       TN  PE     + PEK  S + 
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSPIF 245

Query: 325 KRILLVALRCVDPNAQKR 342
           +  L    RC++ + +KR
Sbjct: 246 RDFL---NRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 68/277 (24%), Positives = 129/277 (46%), Gaps = 25/277 (9%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRH 134
           F  +K IG G +  VY    L D   VA+K     +L++   +A  +   E++ + ++ H
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+++      E     +V E  + G+L + +         +  +      +     L +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           +H     +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE 
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
                 N +SD++S G L+ E+ + + P  Y    +++NL    KK+      E    P 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------EQCDYPP 227

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           LP    S  L++++ +   C++P+ +KRP + +V  +
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 34/274 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKV---EVEAIGRVRHKNLVRLL 141
           +V+G+G YG V       + K  V   LN R  + RE K    E + + +++H N+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 142 -GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----LTWEIRMNIILGTAKGLSYLH 196
             +  E     +V  +   G+L   L    G   P    + W +++      A  L YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH 119

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
           E     ++HRD+K+ N+ + +    KV D G+A++L ++    +T ++GT  Y++PE  S
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFS 175

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
               N +SDV++ G  + E+ + +    ++   +++N + +       R  EG L P +P
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK----HAFNAKDMNSLVY-------RIIEGKL-PPMP 223

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           +  +  L +  L+  +    P  +KRP +  ++ 
Sbjct: 224 KDYSPELGE--LIATMLSKRP--EKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNN------RGQAEREFKVEVEAIGRVRHKNLVR 139
           IGEG YG+V+     +  + VA+K  + +      +  A RE ++    + +++H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRM----LKQLKHPNLVN 64

Query: 140 LLGYCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L+          LV+EY ++     LE+   G       +   +   II  T + +++ H
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--- 253
           +      +HRD+K  NILI K    K+ DFG A++L       T  V  T  Y APE   
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLV 173

Query: 254 ----YASTGMLNERSDVYSFGILIMEVISG 279
               Y          DV++ G +  E+++G
Sbjct: 174 GDTQYGPP------VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 37/305 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN------NRGQAEREFKVEVEA 128
           E+  + F     +G G  G+V+    + +  +  + L++       R Q  RE +V  E 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
                   +V   G         +  E+++ G+L+Q L         +  +I   + +  
Sbjct: 61  ----NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 112

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G     +    +GT  
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRS 167

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y++PE       + +SD++S G+ ++E+  GR P+    PP +   +E +       +P 
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGCPVEGDPA 223

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE--AQESPSKEPSNSF 366
                  P  P            L    P++  RP M  +  +L+    E P K PS  F
Sbjct: 224 ESETSPRPRPPGR---------PLSSYGPDS--RPPMA-IFELLDYIVNEPPPKLPSGVF 271

Query: 367 QDRYR 371
              ++
Sbjct: 272 GAEFQ 276

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K IG G YGIV      E N KVA+K   N  +NR  A+R  + E++ +  + H+N++ +
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 141 LGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
                   HR       +VYE ++       LH  +     L+ +     +    +GL Y
Sbjct: 70  KD-IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           +H      V+HRD+K SN+L++ + + K+ DFGLA+    +  ++T  V+ T  Y APE 
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL 179

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGRIPV 283
               +LN        DV+S G +  E++ GR P+
Sbjct: 180 ----LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 78  TNGFSDDKVIGEGGYGIV--YYGLLEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRV 132
           TN + D + +G G +G+V      L     VA+K ++        A+R ++ E++ +  +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66

Query: 133 RHKNLVRLLG-YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           RH+N++ L   + +       V E +   +L + L     P      +  +  IL   +G
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL---RG 120

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYV 250
           L Y+H      VVHRD+K SNILI+++ + K+ DFGLA++   + + Y++TR      Y 
Sbjct: 121 LKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172

Query: 251 APEYASTGM-LNERSDVYSFGILIMEVISGR 280
           APE   T    +   D++S G +  E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 42/291 (14%)

Query: 86  VIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE-REFKV-EVEAIGRVRHKNLVRLLG 142
           ++GEG YG+V     ++  + VA+K  L +      ++  + E+  + ++RH+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 143 YCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                    LV+E+V++    +LE++ +G       L        +    +G+ + H   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE----SSYITTRVMGTFGYVAPEYA 255
              ++HRDIK  NIL+ +    K+ DFG A+ L +     + Y+ TR      Y APE  
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELL 172

Query: 256 STGMLNERS-DVYSFGILIMEVISGR--IPVD------YSRPPEEVNLIEWLKKMVTNRN 306
                  R+ D+++ G L+ E+++G    P D      Y       NLI   +++   +N
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKN 231

Query: 307 P--EGVLDPKLPE-KPTSRLLKRILLVAL----RCVDPNAQKRPKMGHVVH 350
           P   G+  P++ E +P  +   ++  + L    +C+  +   RP    ++H
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F+D + IG G +G VY+   +  N  VA+K +  +  Q+  +++    EV+ + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYL 195
            +   G         LV EY   G+    L     P      E+ +  I  G  +GL+YL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAITHGALQGLAYL 141

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY- 254
           H      ++HRDIK+ NIL+ +    K++DFG A +    +S++     GT  ++APE  
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193

Query: 255 --ASTGMLNERSDVYSFGILIMEVISGRIPV 283
                G  + + DV+S GI  +E+   + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            ++  G         LV EY   G+    L     P   +  EI   +  G  +GL+YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV--EIAA-VTHGALQGLAYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-- 254
                 ++HRD+K+ NIL+ +    K+ DFG A ++   + ++     GT  ++APE   
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 255 -ASTGMLNERSDVYSFGILIMEVISGRIPV 283
               G  + + DV+S GI  +E+   + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 13/218 (5%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF---KVEVEAIGRVRHKNL 137
           F+  + IG+G +G V+ G+     KV    +++   +AE E    + E+  + +     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYV 64

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            +  G   +     ++ EY+  G+    L        PL       I+    KGL YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               K +HRDIK++N+L+ +H   K++DFG+A  L +++       +GT  ++APE    
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
              + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 41/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG- 142
           +++G G YG VY G      ++A   +++  G  E E K E+  + +   H+N+    G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 143 YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +  +    M     LV E+   G++   +    G  + L  E    I     +GLS+LH+
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ 129

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPE 253
               KV+HRDIK  N+L+ ++   K+ DFG    L + +G  +++I     GT  ++APE
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 181

Query: 254 YAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
             +         + +SD++S GI  +E+  G  P+    P   + LI         RNP 
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA 233

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P+L  K  S+  +  +     C+  N  +RP
Sbjct: 234 ----PRLKSKKWSKKFQSFI---ESCLVKNHSQRP 261

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 12/198 (6%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYC 144
           IGEG  GIV     + + + VAVK +++ R Q  RE    EV  +   +H+N+V +    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
             G    ++ E++  G L      D+   + L  E    +     + L YLH      V+
Sbjct: 88  LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVI 139

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRDIKS +IL+      K+SDFG    + S+       ++GT  ++APE  S        
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 265 DVYSFGILIMEVISGRIP 282
           D++S GI+++E++ G  P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +A K +  +    E   +V     E++ +  ++H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 139 RLLGYCAEGAHRMLV--YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   + A + L    EY+  G+++  L         +T +    I+    +G+SYLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K L +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S G  ++E+++ + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 41/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGY 143
           +V+G G YG VY G      ++A   +++     E E K+E+  + +   H+N+    G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 144 CAEGA------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             + +         LV E+   G++   +    G      W     I     +GL++LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHA 139

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPE 253
               KV+HRDIK  N+L+ ++   K+ DFG    L + +G  +++I     GT  ++APE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 191

Query: 254 YAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
             +         + RSD++S GI  +E+  G  P+    P   + LI         RNP 
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPP 243

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               PKL  K  S   K+ +     C+  N   RP
Sbjct: 244 ----PKLKSKKWS---KKFIDFIEGCLVKNYLSRP 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K +G G +G V     + + K  A+K L  ++ +  +  +V     E   +  +RH  LV
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAKGLSYL 195
            L G   + ++  LV EYV  G L   L        P     R     ++L     L YL
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVLA----LEYL 117

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGYVAP 252
           H      +V+RD+K  N+L+D     K++DFG AK        +  R     GT  Y+AP
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAP 167

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E   +    +  D ++ GILI E+++G  P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 30/171 (17%)

Query: 185 ILG-----TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGSESSY 238
           ILG       K L YL E  +  V+HRD+K SNIL+D   N K+ DFG++ +L+ S++  
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171

Query: 239 ITTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             TR  G   Y+APE       N     R+DV+S GI ++E+ +G+ P    +   EV  
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-- 227

Query: 295 IEWLKKMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRPK 344
              L K +    P     P LP  +  S      +     C+  + +KRPK
Sbjct: 228 ---LTK-ILQEEP-----PSLPPNEGFSPDFCSFV---DLCLTKDHRKRPK 266

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 87  IGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +G GG+G V   L++  S       K   K  +   GQ +     E E +    H  +V+
Sbjct: 1   LGVGGFGRVE--LVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVK 57

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L     +  +  ++ EY   G L   L  D G      +  R   I        YLH   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHN-- 111

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D +   K+ DFG AK L S     T    GT  YVAPE      
Sbjct: 112 -RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKG 168

Query: 260 LNERSDVYSFGILIMEVISGRIP 282
            +   D +S GIL+ E+++GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 32/217 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS--KVAVK---NLLNNRGQAEREFKVEVEAIGRVRHK 135
           +   + IG G YG+V   + +  S  KVA+K   +  +    A+R  + E++ +   +H 
Sbjct: 7   YKPIENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64

Query: 136 NLVRLLG-YCAEGAHRMLVYEYVN--NGNLEQWLHGDVGPCSPLTWE-IR--MNIILGTA 189
           N++ +       GA    VY  ++    +L   +H D     PLT E IR  +  +L   
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL--- 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES---SYITTRVMGT 246
           +GL Y+H      V+HRD+K SN+L+++    ++ DFG+A+ L S      Y  T  + T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 247 FGYVAPEYASTGMLNERS---DVYSFGILIMEVISGR 280
             Y APE   +  L E +   D++S G +  E++ GR
Sbjct: 175 RWYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 19/222 (8%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKNLVR 139
           D+ IG G +G+V+      D  +VA+K + N   N    +R F+ E++ +   +H N++ 
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLS 63

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE-IRMNI--ILGTAKGLSYLH 196
            L              YV    ++  LH  +    PL+ + +++ +  IL   +GL YLH
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLH 120

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEYA 255
                 ++HRDIK  N+L++ +   K+ DFGLA++    ES ++T  V+  + Y APE  
Sbjct: 121 SA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEIL 176

Query: 256 STGMLNERS--DVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             G  +  S  D++S G +  E++  RI      P ++++LI
Sbjct: 177 -MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 34/281 (12%)

Query: 85  KVIGEGGYGIVY-YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG 142
           + IG+G YG VY     +D S  AVK +L+     + E + E   +  +  H N+V+  G
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 143 --YCAE---GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             Y A+   G    LV E  N G++ + + G +     L   +   I+ G   GL +LH 
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               +++HRD+K +NIL+      K+ DFG++  L S      T V GT  ++APE  + 
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202

Query: 258 GM-----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                   + R DV+S GI  +E+  G  P+    P + +  I         RNP   L 
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--------RNPPPTL- 253

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
              PEK        I     +C+  + + RP    V H+LE
Sbjct: 254 -LHPEKWCRSFNHFI----SQCLIKDFEARPS---VTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 56/284 (19%), Positives = 121/284 (42%), Gaps = 49/284 (17%)

Query: 86  VIGEGGYGIVYYGLLEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +I E     +Y G+  +N +V ++                + E++ + R+   N++++ G
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 143 Y----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +      +     L+ EY   G L + L  +      L+++ ++++ +   KGL  L++ 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK- 140

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYAST 257
                 ++++ S + L+ +++  K+   GL K+L S     +   V          Y S 
Sbjct: 141 -YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----------YFSY 189

Query: 258 GMLN-------ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL-IEWLKKMVTNRNPEG 309
            MLN        + D+YS G+++ E+ +G+IP +        NL  + +  ++ N+N   
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE--------NLTTKEIYDLIINKNNSL 241

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            L    P       +K I+     C   ++ KRP +  +++ L 
Sbjct: 242 KLPLDCP-----LEIKCIV---EACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 33/261 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G+G +G VY     D  + +AVK +  +    E   +V     E++ +  + H+ +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 139 RLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +   R L    E++  G+++  L         +T +    I+    +G+SYLH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K L +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDP 313
            S      ++D++S G  ++E+++        +PP  E   +  + K+ T        +P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT-------EKPPWAEFEAMAAIFKIATQPT-----NP 228

Query: 314 KLP---EKPTSRLLKRILLVA 331
            LP          LKRI + A
Sbjct: 229 VLPPHVSDHCRDFLKRIFVEA 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 59/229 (25%), Positives = 115/229 (50%), Gaps = 30/229 (13%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGLL--EDNSK---VAVKNLLNNRGQAEREFKV-EVE 127
           + +S +  +   ++ EG +G ++YG+L  E   K   V VK + ++  + +    + E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 128 AIGRVRHKNLVRLLGYCAE-GAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRM 182
            +  + H+N++ +L  C E G    ++Y Y+N GNL+ +L     G+      L+ +  +
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--------LLGS 234
           ++ +  A G+SYLH+     V+H+DI + N +ID+    K++D  L++         LG 
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG- 176

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           ++     + M      A E       +  SDV+SFG+L+ E+++ G+ P
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 39/99 (39%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I +   KGL+YL   L  K++HRD+K SN+L++     K+ DFG++  L +    I    
Sbjct: 100 IAVAVVKGLTYLW-SL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTY 153

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +GT  Y+APE  S       SDV+S GI  ME+  GR P
Sbjct: 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 12/201 (5%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGY 143
           IGEG YG V+     E +  VA+K + L++  +      + E+  +  ++HKN+VRL   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY +  +L+++     G   P   +  M  +L   KGL++ H      V
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+K  N+LI+K+   K++DFGLA+  G      +  V+ T  Y  P+      L   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179

Query: 264 S-DVYSFGILIMEVISGRIPV 283
           S D++S G +  E+ +   P+
Sbjct: 180 SIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 37/214 (17%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K IG G  GIV   Y  +   N  VA+K L     N   A+R ++ E+  +  V HKN++
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNII 78

Query: 139 RLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKG 191
            LL          E     LV E ++  NL Q +  D      L  E RM+ +L     G
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHE-RMSYLLYQMLCG 130

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFG 248
           + +LH      ++HRD+K SNI++      K+ DFGLA+  G+    + Y+ TR      
Sbjct: 131 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 182

Query: 249 YVAPEYASTGM-LNERSDVYSFGILIMEVISGRI 281
           Y APE    GM   E  D++S G ++ E+I G +
Sbjct: 183 YRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 87  IGEGGYGIVYYGLLED---NSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLV 138
           IGEG YG+VY     D   N  +A+K +   R + E E        E+  +  ++H N+V
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL           LV+EY++   L+   H D  P       +    +    +G++Y H  
Sbjct: 65  RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
              +V+HRD+K  N+LID+  N  K++DFGLA+  G      T  V+ T  Y APE    
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI--- 174

Query: 258 GMLNERS-----DVYSFGILIMEVISGR 280
            +L  R      D++S G +  E+++ +
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 49/225 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK-------NLLNNRGQAEREFKVEVEAIGRV 132
           + +   IGEG YG+V          KVA+K            R    RE K+    + R 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR--TLREIKI----LRRF 60

Query: 133 RHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           +H+N++ +L               +V E      +E  L+  +     L+ +     +  
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY-KLIKTQHLSNDHIQYFLYQ 114

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-------SYIT 240
             +GL Y+H      V+HRD+K SN+L++ + + K+ DFGLA++   E         Y+ 
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 241 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           TR      Y APE     MLN +      D++S G ++ E++S R
Sbjct: 172 TR-----WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 49/287 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV--EVEAIGRVR---HKNLVRL 140
           IG G YG VY      +   VA+K++     +         EV  + R+    H N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 141 LGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +  CA           LV+E+V+  +L  +L     P  P   E   +++    +GL +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H      +VHRD+K  NIL+      K++DFGLA++   + +   T V+ T  Y APE  
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179

Query: 256 STGMLNERSDVYSFGILIMEVIS--------------GRIPVDYSRPPEEVNLIEWLKKM 301
                    D++S G +  E+                G+I      PPE+    +W + +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED----DWPRDV 235

Query: 302 VTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKR 342
                P G   P+ P +P   ++  I      LL+ +   +P   KR
Sbjct: 236 TL---PRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNP--HKR 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLV 138
           K IG G +G V  G  E NS     +V VK L  +   Q + +F  E +    ++H NL+
Sbjct: 1   KEIGNGWFGKVILG--EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH----GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           + LG C E    +LV E+   G+L+ +L      ++    P T + RM   +  A GL +
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLH 115

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPE 253
           LH+      +H D+   N L+      K+ D+GL+     E  Y+T  ++     ++APE
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Query: 254 YASTGMLN-------ERSDVYSFGILIMEV 276
                  N       + S+V+S G+ I E+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV-----EVEAIGRVRHKNLV 138
           K++G G +G VY     D  + +AVK +  +    E   +V     E++ +  +RH  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 139 RLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G   +   + L    EY+  G+++  L         LT  +         +G+SYLH
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH 123

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--ESSYITTRVMGTFGYVAPEY 254
             +   +VHRDIK +NIL D   N K+ DFG +K + +   S      V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIP 282
            S      ++DV+S    ++E+++ + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 55/245 (22%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG--- 142
           +G+G +G VY    ++   +A   +++ + + E E + VE++ +    H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 143 ----------YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKG 191
                     +CA GA   ++ E      LE+          PLT E ++ ++   T + 
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLE------LER----------PLT-EPQIRVVCKQTLEA 115

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA----KLLGSESSYITTRVMGTF 247
           L+YLHE    K++HRD+K+ NIL     + K++DFG++    + +    S+I     GT 
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTP 167

Query: 248 GYVAPEYASTGMLNER-----SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV 302
            ++APE        +R     +DV+S GI ++E+           P  E+N +  L K+ 
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM------AQIEPPHHELNPMRVLLKIA 221

Query: 303 TNRNP 307
            +  P
Sbjct: 222 KSEPP 226

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 40/213 (18%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLVRL 140
           IGEG YG+VY G   +    VA+K +   R ++E E        E+  +  ++H N+V L
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                + +   L++E+++  +L+++L             +     +      SYL++ L+
Sbjct: 65  QDVLMQESRLYLIFEFLSM-DLKKYLD-----------SLPKGQYMDAELVKSYLYQILQ 112

Query: 201 P-------KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
                   +V+HRD+K  N+LID     K++DFGLA+  G      T  V+ T  Y APE
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171

Query: 254 YA------STGMLNERSDVYSFGILIMEVISGR 280
                   ST +     D++S G +  E+ + +
Sbjct: 172 VLLGSPRYSTPV-----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 58/293 (19%)

Query: 87  IGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAE---------REFKVEVEAIGRVRHK 135
           IGEG YG V+    L      VA+K +   R Q           RE  V +  +    H 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAV-LRHLETFEHP 64

Query: 136 NLVRLLGYCA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++    +
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLLR 121

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL +LH     +VVHRD+K  NIL+      K++DFGLA++   +     T V+ T  Y 
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS--------------GRIPVDYSRPPEEVNLIE 296
           APE           D++S G +  E+                G+I      P EE    +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE----D 232

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI------LLVALRCVDPNAQKRP 343
           W + +     P      K   +P  + +  I      LL  L+C+  N  KR 
Sbjct: 233 WPRDVAL---PRQAFHSK-SAQPIEKFVTDIDELGKDLL--LKCLTFNPAKRI 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 67/269 (24%), Positives = 123/269 (45%), Gaps = 39/269 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG-YC 144
           +G+G +G VY    ++   +A   ++  + + E E + VE+E +    H  +V+LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 145 AEGAHRMLVYEYVNNGNLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            +G   +++ E+   G ++   L  D G   P   +I++ I     + L YLH     K+
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGM 259
           +HRD+K+ N+L+    + K++DFG++    K L    S+I     GT  ++APE      
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186

Query: 260 LNE-----RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           + +     ++D++S GI ++E+           P  E+N +  L K +    P  +  P 
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM------AQIEPPHHELNPMRVLLK-IAKSEPPTLSQPS 239

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                    LK  L       D + + RP
Sbjct: 240 KWSMEFRDFLKTAL-------DKHPETRP 261

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 11/157 (7%)

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           E     RH  LV L        H   V EY   G+L   +H DV    P        ++L
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL-LGSESSYITTRVMG 245
           G    L YLHE    K+V+RD+K  N+L+D     K++DFGL K  +G      T+   G
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCG 163

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T  ++APE  +        D +  G+LI E++ G  P
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G G YG V      +   +VAVK L     +   A+R ++ E+  +  ++H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                       E  N+  L   L G    ++  C  LT +    +I    +GL Y+H  
Sbjct: 84  VFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYAST 257
               ++HRD+K SN+ +++    K+ DFGLA+    E + Y+ TR      Y APE    
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 191

Query: 258 GM-LNERSDVYSFGILIMEVISGR 280
            M  N+  D++S G ++ E+++GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           +G G YG VY    L      AVK +    G      + E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 +  EY   G+L+   H   GP S L       +   T +GL+YLH   +   +H
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY---VCRETLQGLAYLHSKGK---MH 129

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYAS---TGML 260
           RDIK +NIL+  + + K++DFG+A  +   ++ I  R   +GT  ++APE A+    G  
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 261 NERSDVYSFGILIMEV 276
           N+  D+++ GI  +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 20/213 (9%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLG-Y 143
           +G+G YG VY  L        A+K +     +++  +  +E++ + +     +V   G +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             EGA  M + EY++ G+L++ L+        +  ++   I     KGL +L E  E  +
Sbjct: 69  FIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRD+K +N+L++ +   K+ DFG++  L   +S   T + G   Y+APE   +G  N+ 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQN 181

Query: 264 ------SDVYSFGILIMEVISGRIPVDYSRPPE 290
                 SDV+S G+ I+E+  GR P     PPE
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPY----PPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGY 143
           + IG+G YG V+  L + N   A   +L+     + E + E   +  +  H N+V+  G 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 144 -----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                   G    LV E  N G++   + G +     +   I   I+     GL +LH  
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST- 257
              K +HRD+K +NIL+      K+ DFG++  L S      T V GT  ++APE  +  
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199

Query: 258 ----GMLNERSDVYSFGILIMEVISGRIPV 283
                  + R DV+S GI  +E+  G  P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 18/172 (10%)

Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+++ G+L+Q L         +  EI   + +   +GL+YL E  + +++HRD+K SNIL
Sbjct: 83  EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
           ++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 275 EVISGRIPVDYSRPPEEVNLIEWL--KKMVTNRNPEG---VLDPKLPEKPTS 321
           E+  GR P+    PP +   +E +  + +V     E       P+ P +P S
Sbjct: 194 ELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 241

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 41/219 (18%)

Query: 86  VIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVR 139
            IGEG YG VY    +D    VA+K +   R   E+E F +    E++ + ++ H+N+V 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 140 L----------LGYCAEGAHRMLVYEYVNN---GNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           L          L +  +     LV+EY+++   G LE  L          + +   + + 
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VHFSEDHIKSFMK 123

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
              +GL+Y H+      +HRDIK SNIL++     K++DFGLA+L  SE S   T  + T
Sbjct: 124 QLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 247 FGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
             Y  PE     +L E       DV+S G ++ E+ + +
Sbjct: 181 LWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 60/223 (26%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKN-LLNNRGQ-----AEREFKVEVEAIGRVRHKNLVR 139
           IG+G +G V+    +   + VA+K  L+ N  +     A RE K+    +  ++H+N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKI----LQLLKHENVVN 75

Query: 140 LLGYC---AEGAHR-----MLVYEY--------VNNGNLEQWLHGDVGPCSPLTWEIR-- 181
           L+  C   A   +R      LV+E+        ++N N++  L            EI+  
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS-----------EIKKV 124

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----GSESS 237
           M ++L    GL Y+H     K++HRD+K++NILI K    K++DFGLA+       S+ +
Sbjct: 125 MKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
             T RV+ T  Y  PE     +L ER      D++  G ++ E
Sbjct: 179 RYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 93/355 (26%), Positives = 151/355 (42%), Gaps = 68/355 (19%)

Query: 81  FSDDKVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH 134
           + + K IG G  GIV   Y  +LE N  VA+K L     N+  A+R ++ E+  +  V H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82

Query: 135 KNLVRLLGY-----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL 186
           KN++ LL         E    + +   + + NL          C  +  E+   RM+ +L
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL----------CQVIQMELDHERMSYLL 132

Query: 187 -GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
                G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G  +S++ T  + 
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVV 187

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---------E 296
           T  Y APE        E  D++S G ++ E+I G +    +   ++ N +         E
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247

Query: 297 WLKKM-------VTNRNPEG----------VLDP------KLPEKPTSRLLKRILLV--A 331
           ++KK+       V NR              VL P      KL       LL ++L++  +
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307

Query: 332 LRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDR-YRASPKNELIEKQVTE 385
            R     A + P +       EA+  P K P     +R +      ELI K+V +
Sbjct: 308 KRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD 362

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 40/268 (14%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           F     IG G +G VY+      N  VAVK +  +  Q   +++    EV+ + +++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            +   G   +     LV EY   G+    L     P   +  EI   I  G  +GL+YLH
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEV--EIAA-ITHGALQGLAYLH 138

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-- 254
                 ++HRDIK+ NIL+ +    K++DFG A      +S++     GT  ++APE   
Sbjct: 139 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190

Query: 255 -ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP------ 307
               G  + + DV+S GI  +E ++ R P     P   +N +  L  +  N +P      
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIE-LAERKP-----PLFNMNAMSALYHIAQNDSPTLQSNE 244

Query: 308 -----EGVLD---PKLP-EKPTSRLLKR 326
                 G +D    K+P E+P S  L R
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    +++  K+ A K L   R +    E+   +E E + +V    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMN-IILGTAK---GLSYLH 196
                 H  LV   +N G+L+  ++  G+ G        + M  +I  +A+   G+ +LH
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHLH 112

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +V+RD+K  N+L+D   N ++SD GLA  L    +   T+  GT GY+APE   
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILK 167

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
               +   D ++ G  I E+++GR P
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKN 136
           KV+G+G +G V    L+        KV  K+++      E    E +V   A    +H  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA---GKHPF 57

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L +L            V EYVN G+L   +        P        I+LG    L +LH
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLH 113

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEY 254
           E     +++RD+K  N+L+D   + K++DFG+ K  +LG  +   T+   GT  Y+APE 
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEI 167

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            S        D ++ G+L+ E+++G+ P +
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 31/280 (11%)

Query: 84  DKVIGEGGYGIVYYG-LLEDNSKVAVKNL--------LNNRGQAEREFKVEVEAIGRVR- 133
            +V+G G  G V     + D    AVK +          NR QAE    +  +    V+ 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 134 HKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           H++  +      E    + LV +Y N G+L Q +                 + +     +
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVA 251
            ++H      ++HRDIKS+NIL+  +   K+ DFG +K+  +  S    R   GT  YVA
Sbjct: 157 HHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE       ++++D++S G+L+ E+++ +      RP +  N+ E     V ++   G  
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLK------RPFDGENMEE-----VMHKTLAGRY 262

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           DP LP   +  +  + ++ AL   DP  ++RP    +++M
Sbjct: 263 DP-LPPSISPEM--QEIVTALLSSDP--KRRPSSSKLLNM 297

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)

Query: 81  FSDDKVIGEGGYGIV---YYGLLEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRH 134
           + + K IG G  GIV   Y  +L+ N  VA+K L     N+  A+R ++ E+  +  V H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 135 KNLVRLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNII 185
           KN++ LL          E     LV E +           D   C  +  E+   RM+ +
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELM-----------DANLCQVIQMELDHERMSYL 124

Query: 186 L-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           L     G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G  +S++ T  +
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
            T  Y APE        E  D++S G ++ E++  +I
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 28/264 (10%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNR---GQAEREFKVEVEAIGRVRHKN 136
           F   +V+G+GG+G V    +    K+ A K L   R    + E     E + + +V  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLS 193
           +V L  Y  E    + LV   +N G+L+  ++  G+ G            I  G    L 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LE 116

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
            LH+    ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+APE
Sbjct: 117 DLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMAPE 171

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                      D ++ G L+ E+I+G+ P    +   +   +E L K V     E     
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF--- 228

Query: 314 KLPEKPTSRLLKRILLVALRCVDP 337
                P +R L ++LL    C DP
Sbjct: 229 ----SPDARSLCKMLL----CKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 17/134 (12%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KLLGS-ESSYITTRVMGTF 247
           +GL+YL E  + K++HRD+K SNIL++     K+ DFG++ +L+ S  +S++ TR     
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR----- 162

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE         +SD++S G+ ++E+  GR P+    PP +   +E     +  R  
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELE----AMFGRPV 214

Query: 308 EGVLDPKLPEKPTS 321
                 +     + 
Sbjct: 215 SEGEAKESHRPVSG 228

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           K IG G  GIV      D      VAVK L     N+  A+R ++ E+  +  V HKN++
Sbjct: 27  KPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNII 83

Query: 139 RLLGY------CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKG 191
            LL          E     LV E ++  NL Q +H ++          RM+ +L     G
Sbjct: 84  SLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD-------HERMSYLLYQMLCG 135

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + +LH      ++HRD+K SNI++      K+ DFGLA+   + ++++ T  + T  Y A
Sbjct: 136 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRA 190

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRI 281
           PE        E  D++S G ++ E++ G +
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 65/234 (27%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVR 139
           +GEG +G VY    ++    VA+K +L +  +      A RE K+    + +++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI----LKKLKHPNVVP 71

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP----------------LTWEIRMN 183
           L+          +  E  +     +   G V   +P                LT      
Sbjct: 72  LID---------MAVERPDK---SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----------- 232
            +L   +G++YLHE     ++HRDIK++NILID     K++DFGLA+             
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 233 -GSESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            G    Y  T ++ T  Y  PE     +L ER      D++  G +  E+ + R
Sbjct: 177 GGGTRKY--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)

Query: 85  KVIGEGGYGIVYY----GLLEDNS----KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           +V+G G YG V+     G  +       KV  K  +  + +     + E + +  VR   
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSY 194
            +  L Y  +   ++ L+ +YVN G L   L+           E  + + +      L +
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDH 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH+     +++RDIK  NIL+D   +  ++DFGL+K   +E         GT  Y+APE 
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 255 ASTGML--NERSDVYSFGILIMEVISGRIP 282
              G    ++  D +S G+L  E+++G  P
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 85  KVIGEGGYGIV----------YYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KVIG+G +G V          +Y +     K  +K    N   AER   ++      ++H
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK-----NLKH 55

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGL 192
             LV L  Y  + A ++  V +YVN G L  + H     C     E R        A  +
Sbjct: 56  PFLVGL-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERC---FLEPRARFYAAEVASAI 109

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      +++RD+K  NIL+D   +  ++DFGL K  G E    T+   GT  Y+AP
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAP 165

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR 287
           E       +   D +  G ++ E++ G +P  YSR
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 85  KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFK---VEVEAIGRV-RHKNLVR 139
           K++G+G +G V+   L+  N   A+K L  +    + + +   VE   +     H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLE---QWLHG-DVGPCSPLTWEIRMNIILGTAKGLSYL 195
           L        +   V EY+N G+L    Q  H  D+   +    EI          GL +L
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--------GLQFL 112

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPE 253
           H      +V+RD+K  NIL+D   + K++DFG+ K  +LG      T    GT  Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPE 166

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
                  N   D +SFG+L+ E++ G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 70/254 (27%), Positives = 117/254 (46%), Gaps = 31/254 (12%)

Query: 85  KVIGEGGYGIV----------YYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           K++G+G +G V          YY +     K+  K ++  + +       E   +   RH
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAM-----KILKKEVIIAKDEVAHTL-TESRVLKNTRH 54

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
             L  L  Y  +   R+  V EYVN G L   L  +       T      I+      L 
Sbjct: 55  PFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SALD 109

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH G   K+V+RD+K  N+++DK  + K++DFGL K   ++++ + T   GT  Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE---EVNLIEWLKKMVT-NRNPEG 309
                      D +  G+++ E++ GR+P  Y++  E   E+ L+E +K   T + + + 
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEDIKFPRTLSADAKS 224

Query: 310 VLDPKLPEKPTSRL 323
           +L   L + P  RL
Sbjct: 225 LLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 21/207 (10%)

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           E   +   RH  L  L  Y  +   R+  V EY N G L   L  +              
Sbjct: 45  ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITT 241
           I+      L YLH      VV+RD+K  N+++DK  + K++DFGL K      S      
Sbjct: 104 IVSA----LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 153

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE---EVNLIEWL 298
              GT  Y+APE           D +  G+++ E++ GR+P  Y++  E   E+ L+E +
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEI 212

Query: 299 KKMVTNRNPEG--VLDPKLPEKPTSRL 323
            +     +PE   +L   L + P  RL
Sbjct: 213 -RFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 75/248 (30%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-------KVAVKNLLNNRGQ-----AEREFKVEVEAIGRV 132
           KVIG G +G V+  L+ D         KV  K+ +  R Q     AER+   +  A    
Sbjct: 7   KVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--ADSPW 62

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAK- 190
               +V+L     +  H  LV EY+  G+L             +   IR ++    TA+ 
Sbjct: 63  ----IVKLYYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARF 105

Query: 191 -------GLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK------------ 230
                   L  +H+ G     +HRDIK  NILID   + K++DFGL K            
Sbjct: 106 YIAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 231 -----------LLGSESSYITTRVM-----GTFGYVAPEYASTGMLNERSDVYSFGILIM 274
                      +L     +   RV      GT  Y+APE           D +S G+++ 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 275 EVISGRIP 282
           E++ G  P
Sbjct: 222 EMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 40/234 (17%)

Query: 85  KVIGEGGYGIV---YYGLLEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVR-HKNL 137
           K +G+G YGIV         +   VA+K   N+ + +  A+R  + E++ +   R HKN+
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNI 64

Query: 138 VRL--LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
             L  +     G    L +YE +   +L Q +        PLT     + I     GL Y
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKY 120

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL----GSESSYITTRVMGTFGYV 250
           +H      V+HRD+K  N+L++     K+ DFGLA+      G  + ++T  V  T  Y 
Sbjct: 121 IHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYR 176

Query: 251 APEYASTGMLNERS-----DVYSFGILIMEVISGRIPV----DYSRPPEEVNLI 295
           APE     ML+ +S     DV+S G ++ E++ GR PV    DY    +++N I
Sbjct: 177 APEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYV---DQLNQI 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 31/212 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSK-------VAVKNLLNNRGQAEREFKVEVEAIG---RVRHKN 136
           +G+G +  +Y G+L   S          V  +L   G   R+     E      ++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L G C    + M V EYV  G L+ +LH +      L W  ++++    A  L YL 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118

Query: 197 EGLEPKVVHRDIKSSNILIDKH-----WNP--KVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +    K+VH ++   NIL+ ++     + P  K+SD G+   + S       R+     +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-EERVERI----PW 170

Query: 250 VAPEYASTGMLNERS--DVYSFGILIMEVISG 279
           +APE    G  +     D +SFG  ++E+ S 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)

Query: 85  KVIGEGGYGIVY-------------YGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR 131
           KV+G+G +G V+             Y +     KV  K  L  R +     K+E + +  
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-----KVLKKATLKVRDRVRT--KMERDILAE 54

Query: 132 VRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E     +   A 
Sbjct: 55  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELAL 109

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGY 249
            L +LH  L   +++RD+K  NIL+D+  + K++DFGL+K  +  E         GT  Y
Sbjct: 110 ALDHLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEY 164

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +APE  +     + +D +SFG+L+ E+++G +P       E + +I
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 55/160 (34%), Positives = 79/160 (49%), Gaps = 15/160 (9%)

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E   +  V H  ++RL  +  E   R L  + EYV  G L  +L  + G  S  T     
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYA 107

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           + I+     L YLH   E  +V+RD+K  NIL+DK  + K++DFG AK L       T  
Sbjct: 108 SEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT 157

Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           + GT  Y+APE   +   N+  D ++ GILI E++ G  P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           +E   +  V H +++R+      GA   +V  + ++ +L  +L     P   L  +  + 
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRP---LPIDQALI 161

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I     +GL YLH     +++HRD+K+ NI I+      + D G A+      +++   +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPEE--VNLIEWLK 299
            GT    APE  +    N ++D++S GI++ E+++    I  D    PEE   +    L 
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 300 KMVTNR--NPEGVLDPKLPEKPTSRL 323
           K+++    +PE     + P  P SRL
Sbjct: 277 KIISTLKVHPE-----EFPRDPGSRL 297

Length = 357

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 14/154 (9%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE- 308
           APE    G+  + S D +S G ++ +++ G  P    +  ++      + +M      E 
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAVEL 218

Query: 309 -GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
                P+L       LL+R +   L C+   AQ+
Sbjct: 219 PDSFSPEL-RSLLEGLLQRDVNRRLGCLGRGAQE 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  V+ G   L +N  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY+++ +L+Q+L       S    +I M  +L   +GLSY H+    K+
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKI 124

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP-------EYAS 256
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P       EY++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
                   D++  G ++ E+ +GR     S   EE++LI
Sbjct: 184 P------IDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 22/250 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA-----IGRVRHKNLVR 139
           KVIG+G +G V     + + K     +L  +   +++ +  + A     +  V+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHE 197
           L  Y  + A ++  V +YVN G L  + H       P   E R        A  L YLH 
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHS 114

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +++RD+K  NIL+D   +  ++DFGL K  G E S  T+   GT  Y+APE    
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPE--GVLDP 313
              +   D +  G ++ E++ G +P  YSR   E+  N++    ++  N +     +L+ 
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG-LPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEG 229

Query: 314 KLPEKPTSRL 323
            L +  T RL
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 13/213 (6%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  V+ G   L +N  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY++  +L+Q++       S    +I +  IL   +GL+Y H     KV
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKV 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNE 262
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P+    +   + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           + D++  G +  E+ SGR     S   +E++LI
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 13/226 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV----AVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG G Y  V    L+ N ++     VK  L +  +     + E     +      +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  C +   R+ LV EYVN G+L   +         L  E            L++LHE  
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHE-- 114

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                D ++ G+L+ E+++GR P D      ++N  ++L +++  +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 12/204 (5%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG+G YG+V   +      KVA+K   ++  +   A R  + E++ +  +RH ++V +
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEI 64

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                  + R     YV    +E  LH  +     LT E     +    + L Y+H    
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA-- 122

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEYAST- 257
             V HRD+K  NIL +     K+ DFGLA+     + ++   T  + T  Y APE   + 
Sbjct: 123 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181

Query: 258 -GMLNERSDVYSFGILIMEVISGR 280
                   D++S G +  EV++G+
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 28/248 (11%)

Query: 85  KVIGEGGYGIVYYG---LLEDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRL 140
             IG G +G V  G        ++V VK L  +    E+  F  EV+    + H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTW-EIRMNIILGTAKGLSYLHEGL 199
           LG C E    +LV E+   G+L+ +L  + G  + +   ++   +    A GL +LH+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGYVAPEYAS-- 256
               +H D+   N  +    + K+ D+GLA     E  YIT         ++APE     
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 257 -----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                     ++S+++S G+ + E+ +        +P  +++  + LK++V  +      
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQ------ 226

Query: 312 DPKLPEKP 319
           D KLP KP
Sbjct: 227 DIKLP-KP 233

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 52/278 (18%)

Query: 79  NGFSDDKVIGEGGYGIVYYGLL---EDNSKVAVKNL----LNNRGQAEREFKVEVEAIGR 131
             F   K+I  G YG VY  L+   E   + A+K +    L  R Q ++ F VE + +  
Sbjct: 1   EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTF 57

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
             +  +V +        H  +V EYV  G+    L  ++G    L  ++       T   
Sbjct: 58  AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGA---LPVDMARMYFAETVLA 113

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL-LGSESS------------- 237
           L YLH      +VHRD+K  N+LI    + K++DFGL+K+ L S ++             
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV----- 292
           ++  +V GT  Y+APE        +  D ++ GI++ E + G +P  +   PEE+     
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDTPEELFGQVI 229

Query: 293 -NLIEWLKKMVTNRNPEGVLDPKLPEKP---TSRLLKR 326
            + IEW         PEG  D  LP       SRLL++
Sbjct: 230 SDDIEW---------PEG--DEALPADAQDLISRLLRQ 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 28/208 (13%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K +G G YG V   +      KVA+K L     +   A+R ++ E+  +  ++H+N++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL 79

Query: 141 LGY--CAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           L     A          LV  Y+   +L++ +        PL+ +    ++     GL Y
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKY 132

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPE 253
           +H      ++HRD+K  N+ +++    K+ DFGLA+   +E + Y+ TR      Y APE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPE 184

Query: 254 YASTGM-LNERSDVYSFGILIMEVISGR 280
                M  N+  D++S G ++ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA--IGRVRHKNLVRLLGYC 144
           +GEG Y  VY G  + N K+    ++  + +    F    EA  +  ++H N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  LV+EYV+  +L Q++    G   P   ++ +  +L   +GLSY+H+     ++
Sbjct: 73  HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNER 263
           HRD+K  N+LI      K++DFGLA+     S   +  V+ T  Y  P+    +   +  
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184

Query: 264 SDVYSFGILIMEVISG 279
            D++  G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 28/220 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL-----LNNRGQ----AEREFKVEVEAIGRVRH 134
           KVIG+G +G V     + + K  AVK L     LN + Q    AER   ++      V+H
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-----NVKH 55

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI-ILGTAKGL 192
             LV L  Y  +   ++  V ++VN G L  + H       P   E R        A  L
Sbjct: 56  PFLVGL-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYAAEIASAL 109

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            YLH      +V+RD+K  NIL+D   +  ++DFGL K  G   S  TT   GT  Y+AP
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAP 165

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           E       +   D +  G ++ E++ G +P  Y R   E+
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG-LPPFYCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D + + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168

Query: 251 APEYASTGMLNER----SDVYSFGILIMEVISGRIP 282
           APE       NER     D +  G LI E+I G+ P
Sbjct: 169 APEVVK----NERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 28/253 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRL 140
           +V+G+G +G V    L+++ ++ AVK L  +    + + +    E   +   R+   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 141 LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHEG 198
           L  C +   R+  V E+VN G+L    H  +        E R           L +LH+ 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFH--IQKSRRFD-EARARFYAAEITSALMFLHD- 114

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               +++RD+K  N+L+D   + K++DFG+ K  G  +   T+   GT  Y+APE     
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPE--------EVNLIEWLKKMVTNRNPEGV 310
           +     D ++ G+L+ E++ G  P +     +        EV    WL +     +   +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ-----DAVDI 226

Query: 311 LDPKLPEKPTSRL 323
           L   + + PT RL
Sbjct: 227 LKAFMTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 39/218 (17%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
           + D K +G G YG V   L     +KVA+K L     +   A+R ++ E+  +  ++H+N
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQW---------LHGDVGPC---SPLTWEIRMNI 184
           ++ LL              +  + +L+++         +  D+G       L+ +    +
Sbjct: 76  VIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRV 243
           +    KGL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE + Y+ TR 
Sbjct: 124 VYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR- 179

Query: 244 MGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 280
                Y APE     M   +  D++S G ++ E+++G+
Sbjct: 180 ----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 13/205 (6%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV----AVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           +VIG G Y  V    L+   ++     VK  L N  +     + E     +  +   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 141 LGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  C +   R+  V EYVN G+L   +         L  E         +  L+YLHE  
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE-- 114

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 260 LNERSDVYSFGILIMEVISGRIPVD 284
                D ++ G+L+ E+++GR P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 66/266 (24%), Positives = 118/266 (44%), Gaps = 45/266 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA 145
           IG G YG VY    +      A+K +    G+     + E+  +   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH 205
                 +  E+   G+L+   H   GP S         +   T +GL YLH   +   +H
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY---VSRETLQGLYYLHSKGK---MH 129

Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYAST---GML 260
           RDIK +NIL+  + + K++DFG++  +   ++ I  R   +GT  ++APE A+    G  
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 261 NERSDVYSFGILIMEVISGRIPV--------------DYSRPPEEVNLIEW------LKK 300
           N+  D+++ GI  +E+   + P+                 +PP+  + ++W        K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 301 MVTNRNPEGVLDPKLPEKPTS-RLLK 325
           M   +NP+        ++PT+ +LL+
Sbjct: 247 MALTKNPK--------KRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 24/224 (10%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEV 126
           +R+L++    +   KVIG G +G V     + + KV    LL+     +R     F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWE--IRMN 183
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAKFYTAE 150

Query: 184 IILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           ++L     L  +H  GL    +HRD+K  N+L+DKH + K++DFG    +          
Sbjct: 151 VVLA----LDAIHSMGL----IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 243 VMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIP 282
            +GT  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +G G YG V          KVAVK L     +   A R ++ E+  +  ++H+N++ LL 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                       E     NL      ++  C  L+ E    +I    +GL Y+H      
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---G 138

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-L 260
           ++HRD+K SN+ +++    ++ DFGLA+    E + Y+ TR      Y APE     M  
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHY 193

Query: 261 NERSDVYSFGILIMEVISGRI 281
           N+  D++S G ++ E++ G+ 
Sbjct: 194 NQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 49/232 (21%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE------------------REFKV 124
              +GEG YG V           VA+K +       +                  RE K+
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
             E    ++H+N++ L+    EG    LV + +   +L++ +   +     LT      I
Sbjct: 74  MNE----IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCI 124

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--------SES 236
           +L    GL+ LH+      +HRD+  +NI I+     K++DFGLA+  G        S+ 
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 237 SY------ITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 280
                   +T++V+ T  Y APE    +    +   D++S G +  E+++G+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 79  NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE-REFKV-EVEAIGRVRHK 135
           N F    V+GEG YG+V      E    VA+K   ++    E +E  + E++ +  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N+V L           LV+EYV    LE     +  P      ++R + I    K + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKAIHWC 116

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPE 253
           H+     +VHRDIK  N+LI  +   K+ DFG A+ L  GS ++Y  T  + T  Y +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRSPE 171

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
                   +  D++S G ++ E+  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 37/291 (12%)

Query: 81  FSDDKVIGEGGYGIVYYGLL--EDNS--KVAVKNL---LNNRGQAEREFKVEVEAIGRVR 133
           F+  +++G+G +G V    L  ED S  KVAVK L   + +    E EF  E   +    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 134 HKNLVRLLGYCAEGAHR------MLVYEYVNNGNLEQWLHGDVGPCSPLTW--EIRMNII 185
           H N+++L+G       +      M++  ++ +G+L  +L        P T   +  +  +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
           +  A G+ YL        +HRD+ + N +++++    V+DFGL+K + S   Y       
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 246 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT 303
               ++A E  +  +    SDV++FG+ + E+++ G+ P  Y+   E   +  +L K   
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YA-GVENSEIYNYLIKGNR 233

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            + P     P   E         +  +  +C  P  + RP   H+   LE 
Sbjct: 234 LKQP-----PDCLED--------VYELMCQCWSPEPKCRPSFQHLRDQLEL 271

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 7/93 (7%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIP 282
           APE    G   + S D +S G ++ +++ G  P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 38/268 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KV+G G YG V+  L+   +          KV  K  L  + +     + E   +  VR 
Sbjct: 6   KVLGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAK 190
              +  L Y  +   ++ L+ +YV+ G +   L+           E+R     IIL    
Sbjct: 64  SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA--- 117

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH+     +V+RDIK  NIL+D   +  ++DFGL+K   SE    T    GT  Y+
Sbjct: 118 -LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 251 APEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           APE     G   +  D +S GILI E+++G  P  ++   E     E  ++++       
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGERNTQSEVSRRILK------ 225

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDP 337
             DP  P         + LL  L   DP
Sbjct: 226 -CDPPFP--SFIGPEAQDLLHKLLRKDP 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 8/94 (8%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFG 248
           GL +LH+     +++RD+K  N+L+DK  + K++DFG+ K  + G       +   GT  
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPD 161

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y+APE       NE  D +SFG+L+ E++ G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 21/226 (9%)

Query: 87  IGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLG 142
           +G+GG+G V    +    K+ A K L   R +  + ++   VE   + +V  + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK---GLSYLHEGL 199
                    LV   +N G+L   ++ +V   +P   E R      TA+   GL +LH+  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR- 116

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++++RD+K  N+L+D   N ++SD GLA  L    S  T    GT G++APE      
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR 305
            +   D ++ G+ + E+I+ R P  +    E+V       K +  R
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP--FRARGEKVE-----NKELKQR 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.0 bits (142), Expect = 3e-09
 Identities = 78/301 (25%), Positives = 137/301 (45%), Gaps = 54/301 (17%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGR 131
           E   N +   K IG G +G V+    +   +      ++ RG  ERE     +EV  +  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 132 VRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           ++HKN+VR +      A++ L  + E+ + G+L +    ++  C  +  +I  + I+   
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR----NIQKCYKMFGKIEEHAIVDIT 124

Query: 190 K----GLSYLHEGLE----PKVVHRDIKSSNILID---KHWN--------------PKVS 224
           +     L+Y H   +     +V+HRD+K  NI +    +H                 K+ 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+K +G ES  +    +GT  Y +PE     T   +++SD+++ G +I E+ SG+ P
Sbjct: 185 DFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             + +      LI  LK+            P LP K  S+ L  IL+  L  ++ +A++R
Sbjct: 243 --FHKANNFSQLISELKR-----------GPDLPIKGKSKELN-ILIKNL--LNLSAKER 286

Query: 343 P 343
           P
Sbjct: 287 P 287

Length = 1021

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 31/227 (13%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNL-------LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +G+GGYG V+    +D  + VA+K +       LN      R    E + +   + + LV
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV----RHVLTERDILTTTKSEWLV 64

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +LL    +  +  L  EYV  G+    L+  G +       +   M       + +  LH
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM------FEAVDALH 118

Query: 197 E-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           E G     +HRD+K  N LID   + K++DFGL+K            V+G+  Y+APE  
Sbjct: 119 ELG----YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE-VNLIEWLKKM 301
                +   D +S G ++ E + G  P   S P E   NL  W K+ 
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KET 216

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 19/150 (12%)

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           L  C +   R+  V EYVN G+L   +   G       + +   +++      GL +LH 
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR 119

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVAPEY 254
                +++RD+K  N+++D   + K++DFG+ K    E     +TTR   GT  Y+APE 
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +     +  D +++G+L+ E+++G+ P D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)

Query: 87  IGEGGYGIVYYGL--LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +GEG Y  VY G   L DN  VA+K + L +   A      EV  +  ++H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                   LV+EY++  +L+Q+L  D G    +   +++  +    +GL+Y H     KV
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLD-DCGNSINMH-NVKL-FLFQLLRGLNYCHR---RKV 125

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--YASTGMLN 261
           +HRD+K  N+LI++    K++DFGLA+     +   +  V+ T  Y  P+    ST   +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            + D++  G +  E+ +GR     S   E+++ I
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 6/85 (7%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST------ 257
           VHRDIK  N+LID+  + K++DFG A  L +     +   +GT  Y+APE  +T      
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
           G      D +S G++  E+I GR P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 69/288 (23%)

Query: 21  SPTGY-NKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTN 79
           +  G   K  ++  K +      N + G   D+   +  +++                  
Sbjct: 20  ANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDIN-------------RSPNK 66

Query: 80  GFSDDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            +    +IG G +G+VY  +  D S KVA+K +L +     RE  +    +  + H N++
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINII 122

Query: 139 RL---------------------LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
            L                     + +  +  H+ + +   NN  L  +L          +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL------VKLYS 176

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAK-LLGSE 235
           +++         + L+Y+H      + HRD+K  N+LID + +  K+ DFG AK LL  +
Sbjct: 177 YQL--------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225

Query: 236 S--SYITTRVMGTFGYVAPEYASTGMLNERS--DVYSFGILIMEVISG 279
              SYI +R      Y APE    G  N  +  D++S G +I E+I G
Sbjct: 226 RSVSYICSRF-----YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 18/97 (18%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFG 248
           +GL Y+H      ++HRD+K SNI +++    K+ DFGLA+    E + Y+ TR      
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           Y APE     MLN        D++S G ++ E+++G+
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 10/99 (10%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-G 245
           A GL +LH      +++RD+K  N+++D   + K++DFG+ K    E+ +   TTR   G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCG 163

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           T  Y+APE  +     +  D ++FG+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH       V+RD+K  NIL+D + + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRV-GTVGYM 168

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE  +        D +  G LI E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEA--IGRVRHKNLVRLLG 142
           + +GEG Y  VY G+   N ++    +++ + +    F    EA  +  ++H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                     V+EY++  +L Q++    G   P    + M  +L   +GL+Y+H      
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHG---QH 123

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           ++HRD+K  N+LI      K++DFGLA+     S   ++ V+ T  Y  P+    G  + 
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDY 181

Query: 263 RS--DVYSFGILIMEVISGR 280
            S  D++  G + +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 85/277 (30%)

Query: 85  KVIGEGGYGIVY----YGLLEDNS--KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKN 136
           K +G G +G V     +GL ++++  +VAVK L  +    ERE    E++ +  + +HKN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103

Query: 137 LVRLLG-------------YCAEG---------AHRMLVY------------EYVNNGNL 162
           +V LLG             YC  G         A   L +            +Y N    
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163

Query: 163 EQWLHGDVG-------------PCS-------------------PLTWEIRMNIILGTAK 190
           ++++  D G             P S                   PL  +  +      A+
Sbjct: 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQ 223

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---- 246
           G+ +L        +HRD+ + N+L+      K+ DFGLA+ + ++S+Y+   V G     
Sbjct: 224 GMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLP 277

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
             ++APE     +   +SDV+S+GIL+ E+ S G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YLH      +++RD+K  N+L+D   + KV+DFG AK +       T  + GT  Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPE 185

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
              +    +  D ++ G+L+ E I+G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNS--------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
           KV+G+GGYG V+       +        KV  K  +    +     K E   +  V+H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNL------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           +V L+     G    L+ EY++ G L      E     D   C  L+ EI +        
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-CFYLS-EISL-------- 111

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH+     +++RD+K  NIL+D   + K++DFGL K    E + +T    GT  Y+
Sbjct: 112 ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYM 167

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE        +  D +S G L+ ++++G  P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 57/238 (23%), Positives = 110/238 (46%), Gaps = 36/238 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + D + +G G  G+V+  +  D + +VAVK ++    Q+ +    E++ I R+ H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 140 LLGYCAEGAHRM--------------LVYEYVNNG---NLEQWLHGDVGPCSPLTWEIRM 182
           +          +              +V EY+       LEQ      GP S     + M
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ------GPLSEEHARLFM 120

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESS---Y 238
             +L   +GL Y+H      V+HRD+K +N+ I+ +    K+ DFGLA+++    S   Y
Sbjct: 121 YQLL---RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 239 ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           ++  ++  + Y +P    S     +  D+++ G +  E+++G+     +   E++ LI
Sbjct: 175 LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 30/174 (17%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-- 246
           AKG+S+L        +HRD+ + NIL+      K+ DFGLA+ + ++S+Y+   V G   
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277

Query: 247 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT 303
               ++APE     +    SDV+S+GIL+ E+ S G  P  Y   P +    + +K    
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIK---- 331

Query: 304 NRNPEG--VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ 355
               EG  +L P+        ++K        C D +  KRP    +V ++E Q
Sbjct: 332 ----EGYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIEQQ 374

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 28/226 (12%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---FKVEVE 127
           + +L +    F   KVIG G +G V     + + +V    LL+     +R    F  E  
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 128 AIGRVRHKN---LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWEI--R 181
            I  + H N   +V+L     +  +  +V EY+  G+L   +   D+    P  W     
Sbjct: 95  DI--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI----PEKWARFYT 148

Query: 182 MNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
             ++L     L  +H  G     +HRD+K  N+L+DK  + K++DFG    + +      
Sbjct: 149 AEVVLA----LDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200

Query: 241 TRVMGTFGYVAPEY----ASTGMLNERSDVYSFGILIMEVISGRIP 282
              +GT  Y++PE        G      D +S G+ + E++ G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 24/183 (13%)

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
           SPLT E  +      A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ + 
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225

Query: 234 SESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP 289
            +  Y+   + R+     ++APE     +   +SDV+SFG+L+ E+ S G  P    +  
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           EE    + LK     R PE            +  + RI+   L C   + ++RP    +V
Sbjct: 284 EE--FCQRLKDGTRMRAPEN----------ATPEIYRIM---LACWQGDPKERPTFSALV 328

Query: 350 HML 352
            +L
Sbjct: 329 EIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE           D +  G+++ E++ GR+P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 25/153 (16%)

Query: 141 LGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVG----PCSPL-TWEIRMNIILGTAKGLSY 194
           L  C +   R+  V EYVN G+L   +   VG    P +     EI + +    +KG   
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVA 251
                   +++RD+K  N+++D   + K++DFG+ K    E+ +  +TT+   GT  Y+A
Sbjct: 122 --------IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIA 169

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           PE  +     +  D ++FG+L+ E+++G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 24/169 (14%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF- 247
           A G+ +L        VHRD+ + N+LI +    K+ DFGLA+ +  +S+YI+     TF 
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303

Query: 248 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN 304
              ++APE     +    SDV+SFGIL+ E+ + G  P  Y   P        +K+    
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP--YPELPMNEQFYNAIKRGYRM 361

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P    D              I  +  +C +   + RP    +VH++ 
Sbjct: 362 AKPAHASD-------------EIYEIMQKCWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 42/272 (15%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLL--EDNSKVAVKNL----LNNRGQAEREFK 123
             R+ ++    F+  + +G G +G V       ED   VA+K      +  + Q +  F 
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------GDVGPCSPLT 177
            E + +  + H   V L G   + ++  LV E+V  G    +L        DVG      
Sbjct: 81  -ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG----CF 135

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
           +  ++ +I    + L+         +V+RD+K  N+L+DK    K++DFG AK++ +   
Sbjct: 136 YAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
             T  + GT  Y+APE        + +D ++ GI I E++ G  P  Y+  P        
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEP-------- 233

Query: 298 LKKMVTNRNPEGVLD-PKLPEKPTSRLLKRIL 328
              ++  +  EG++  PK  +     L+K++L
Sbjct: 234 --LLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 70/250 (28%), Positives = 112/250 (44%), Gaps = 22/250 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG----QAEREFKVEVEAIGR-VRHKNLVR 139
           KVIG+G +G V     +   K     +L  +     + E+    E   + + V+H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           L  +  + A ++  V +Y+N G L   L  +     P        I    A  L YLH  
Sbjct: 61  L-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS- 114

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               +V+RD+K  NIL+D   +  ++DFGL K    E +  T+   GT  Y+APE     
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIE---WLKKMVTNRNPEGVLDP 313
             +   D +  G ++ E++ G +P  YSR   E+  N++     LK  +TN +   +L+ 
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG-LPPFYSRNTAEMYDNILNKPLQLKPNITN-SARHLLEG 229

Query: 314 KLPEKPTSRL 323
            L +  T RL
Sbjct: 230 LLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 87  IGEGGYGIVYYGLLEDNSKVA---VKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           IG G +G V    +  ++ VA   VK L  N    E+ EF  + +    ++H N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 143 YCAEGAHRMLVYEYVNNGNL------EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            C E    +LV+EY   G+L      EQW   +    S L    RM   +  A G++++H
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT--RVMGTFGYVAPEY 254
              +   +H D+   N  +      KV D+G+      E  YI T         ++APE 
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172

Query: 255 AST---GML----NERSDVYSFGILIMEV 276
                 G++     + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  L      ++V+RD+K  NIL+D   + ++SD GLA  +  E   +  RV GT GY+
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYM 168

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           APE  +        D +  G LI E+I G+ P
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 22/223 (9%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEV 126
           +R+L +    +   KVIG G +G V     +   KV    LL+     +R     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-DVGPCSPLTWE--IRMN 183
           + +       +V+L     +  +  +V EY+  G+L   +   DV    P  W       
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFYTAE 150

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           ++L     L  +H       +HRD+K  N+L+DK  + K++DFG    +  E        
Sbjct: 151 VVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203

Query: 244 MGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIP 282
           +GT  Y++PE   +    G      D +S G+ + E++ G  P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNS----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
           KV+G G YG V+  L+   S          KV  K  +  + +     + E + +  +R 
Sbjct: 6   KVLGTGAYGKVF--LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG-TAKGL 192
              +  L Y  +   ++ L+ +Y+N G L   L            E  + I  G     L
Sbjct: 64  SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLAL 118

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
            +LH+     +++RDIK  NIL+D + +  ++DFGL+K    +         GT  Y+AP
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 253 EYASTGML--NERSDVYSFGILIMEVISGRIP 282
           +    G    ++  D +S G+L+ E+++G  P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 7/135 (5%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T   GT  Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLKKMVTNRNPE 308
           PE           D +  G+++ E++ GR+P    D+ R  E + + E       +   +
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223

Query: 309 GVLDPKLPEKPTSRL 323
            +L   L + P  RL
Sbjct: 224 SLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 51/198 (25%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE-------------AIGR-V 132
           IG G YG VY        K   KN  + +  A ++FK + E             A+ R +
Sbjct: 8   IGRGTYGRVY--------KAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL 59

Query: 133 RHKNLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLH----GDVGPCSP-----LTWEIR 181
           +H+N+V L+    E A +   L+++Y  + +L Q +            P     L W+I 
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGS--E 235
           +N       G+ YLH      V+HRD+K +NIL+     +    K+ D GLA+L  +  +
Sbjct: 118 LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 236 SSYITTRVMGTFGYVAPE 253
                  V+ T  Y APE
Sbjct: 168 PLADLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 16/144 (11%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L++LHE     +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SRPPEEVNLIEWLKKMVTNR---- 305
           PE           D ++ G+L+ E+++GR P D        + N  ++L +++  +    
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224

Query: 306 ------NPEGVLDPKLPEKPTSRL 323
                     VL   L + P  RL
Sbjct: 225 PRSLSVKASSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 8/108 (7%)

Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
            PLT E  ++     A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ + 
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 234 SESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
            +  Y+     R+     ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L  LH+     V++RD+K  NIL+D   +  + DFGL KL   +     T   GT  Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN--RNPEG 309
           PE        +  D ++ G+L+ E+++G +P  Y    E VN  E  +K++    R P+G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFYD---ENVN--EMYRKILQEPLRFPDG 215

Query: 310 V-------LDPKLPEKPTSRL 323
                   L   L   PT RL
Sbjct: 216 FDRDAKDLLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 36/211 (17%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           I EG YG+VY     +    VA+K L   +   E+E F +    E+  + +++H N+V +
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIVTV 69

Query: 141 ----LGYCAEGAHRMLVYEYVNNGNLEQWLHG--DVGPCSPLTWEIRMNIILGTAKGLSY 194
               +G  +      +V EYV     E  L    +      L  E++  ++L    G+++
Sbjct: 70  KEVVVG--SNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVK-CLMLQLLSGVAH 121

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH+     ++HRD+K+SN+L++     K+ DFGLA+  GS     T  V+ T  Y APE 
Sbjct: 122 LHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPEL 177

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGR 280
               +L  +      D++S G +  E+++ +
Sbjct: 178 ----LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 53/256 (20%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLL------------NNRGQAEREFKVEVEAIGRVRH 134
           +G+G +G VY  L++D   VA + L             N   QA      E + + ++ H
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLDH 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNL----EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             +V+      E     ++ EY    +L    E+  H           E  + ++LG   
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG--- 118

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            + Y+H+    +++HRD+K+ NI +  +   K+ DFG+++LL       TT   GT  Y+
Sbjct: 119 -VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYM 172

Query: 251 APEYASTGMLNERSDVYSFGILIME-------------------VISGRIPVDYSRPPEE 291
           +PE       + +SD++S G ++ E                   ++ G  P        +
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232

Query: 292 VNLIEWLKKMVTNRNP 307
           +N I  ++ M+ N++P
Sbjct: 233 LNSI--MQSML-NKDP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 24/160 (15%)

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ HK+LV   G C  G   ++V EYV  G+L+ +L  +      ++W+      L  AK
Sbjct: 55  QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAK 107

Query: 191 GLSYLHEGLEPK-VVHRDIKSSNILI-----DKHWNP---KVSDFGLA-KLLGSESSYIT 240
            L++    LE K + H ++ + N+L+      K  NP   K+SD G++  +L  E   + 
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE--ILL 165

Query: 241 TRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
            R+     +V PE       L+  +D +SFG  + E+ SG
Sbjct: 166 ERI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 29/157 (18%)

Query: 86  VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE------AIGRV------R 133
            +GEG Y  VY G          ++ L  +  A +E ++E E      AI         +
Sbjct: 12  KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           H N+V L           LV+EY++  +L+Q++    G  S     + +  +L   +GL+
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
           Y H+    +V+HRD+K  N+LI +    K++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 8/107 (7%)

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            LT E  +      AKG+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ +  
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 235 ESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           +  Y+     R+     ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTFG 248
           GL +LH      +++RD+K  N+++D+  + K++DFG+ K  + G   +   +   GT  
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161

Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y+APE           D +SFG+L+ E++ G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH      V++RD+K  NIL+D   + K++DFG+ K  G  +   TT   GT  Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIA 164

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           PE           D ++ G+L+ E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 9/98 (9%)

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF- 247
           A+G+ +L        VHRD+ + N+L+ +    K+ DFGLA+ +  +S+Y++     TF 
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301

Query: 248 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
              ++APE     +    SDV+S+GIL+ E+ S G  P
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 21/210 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKNLVRL 140
           KVIG G +G V    L++  KV    +LN     +R     F+ E + +    ++ +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHG--DVGPCSPLTWEI-RMNIILGTAKGLSYLHE 197
                +  +  LV +Y   G+L   L    D  P     + +  M I + +   L Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                 VHRDIK  NIL+D + + +++DFG    L  + +  ++  +GT  Y++PE    
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 258 -----GMLNERSDVYSFGILIMEVISGRIP 282
                G      D +S G+ + E++ G  P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 5e-07
 Identities = 59/235 (25%), Positives = 91/235 (38%), Gaps = 47/235 (20%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G  G V+   L+        KV  K  +  R + +R    E E +  + H  L  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATLDHPFLPT 65

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---NIILGTAKGLSYLH 196
           L        +  LV +Y   G L + L    G C       R     ++L     L YLH
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAAEVLLA----LEYLH 120

Query: 197 -EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS--------------------- 234
             G    +V+RD+K  NIL+ +  +  +SDF L+K                         
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 235 -------ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                  E S+ +   +GT  Y+APE  S        D ++ GIL+ E++ G  P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 16/184 (8%)

Query: 101 EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL-GYCAEGAHRMLVYEYVNN 159
           E   KV VK          +    E++ +  + H+ ++ L+  Y  +    M++ +Y  +
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                 L   V    PL  E  + I     + L+YLH      ++HRD+K+ NI +D+  
Sbjct: 172 ------LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPE 222

Query: 220 NPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           N  + DFG A KL     +       GT    +PE  +      ++D++S G+++ E+  
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282

Query: 279 GRIP 282
             + 
Sbjct: 283 KNVT 286

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 43/224 (19%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIG---------------- 130
           +G G    +Y G+L            ++    E+E KV ++ +                 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57

Query: 131 --RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
             +V HK++V L G C      ++V E+V  G L+ ++H        LT   +  +    
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNIL-----IDKHWNP--KVSDFGLAKLLGSESSYITT 241
           A  LSYL    +  +VH ++ + NIL     ID    P  K+SD G+   + S    +  
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE- 170

Query: 242 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRIPV 283
                  ++APE    +  L+  +D +SFG  + E+  +G IP+
Sbjct: 171 ----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 20/172 (11%)

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           + +V H +L  + G C  G+  ++V E+V +G L+  L  + G   P+ W+I +   L +
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKITVAQQLAS 128

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNP--KVSDFGLAKLLGSESSYITT 241
           A  LSYL    +  +VH ++ + NIL+ +       +P  K+SD G++    S    +  
Sbjct: 129 A--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182

Query: 242 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRIPVDYSRPPEE 291
                  ++APE       L+  +D +SFG  ++E+   G +P+    P E+
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 68/290 (23%), Positives = 116/290 (40%), Gaps = 61/290 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-KVAVKN---------LLNNRGQAEREFKVEVEAIGRVRH 134
           ++IG+GG G VY       S +VA+K          LL  R    RE K+  + I    H
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR--FLREAKIAADLI----H 61

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR--------MNIIL 186
             +V +   C++G        Y+    L+  L   V     L+ E+         ++I  
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------------- 232
                + Y+H      V+HRD+K  NIL+       + D+G A                 
Sbjct: 121 KICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 233 -GSESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
                S +T   +++GT  Y+APE       +E +D+Y+ G+++ ++++   P  Y R  
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRR-- 233

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPK--LPEKPTSRLLKRILLVALRCVDP 337
                 +  +K+      + +L P    P +     L +I + AL  VDP
Sbjct: 234 ------KKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKAL-AVDP 273

Length = 932

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/117 (33%), Positives = 55/117 (47%), Gaps = 29/117 (24%)

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
           NI+ G  +GL+YLH+      +HR+IK+S+ILI        S  GL  L G    Y   R
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILI--------SGDGLVSLSGLSHLYSLVR 153

Query: 243 --VMGTFGYVAPEYASTGML---------------NERSDVYSFGILIMEVISGRIP 282
                   Y  P++ ST +L               N +SD+YS GI   E+ +GR+P
Sbjct: 154 NGQKAKVVYDFPQF-STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.3 bits (116), Expect = 3e-06
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 12/114 (10%)

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITT 241
            II    + L+ LH+     ++H DIK  N+L D+      + D+GL K++G+ S Y   
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166

Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
              GT  Y +PE    G   + S D ++ G+L  E+++G+ P       EE++L
Sbjct: 167 --DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDL 216

Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 22/201 (10%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVR-HKNLVRLLG- 142
           IGEG +  V      +     A+K +  +    E+   + E++A+ R+  H N++RL+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 143 -YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            +  +     LV+E ++  NL + + G   P      +  M  +L   K L ++H     
Sbjct: 67  LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRN--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPE-YAST 257
            + HRDIK  NILI      K++DFG  + + S+   + YI+TR      Y APE   + 
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLLTD 173

Query: 258 GMLNERSDVYSFGILIMEVIS 278
           G    + D+++ G +  E++S
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 38/183 (20%), Positives = 80/183 (43%), Gaps = 19/183 (10%)

Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL--------LGYCAEGAHRMLVYE 155
            +  +   +    +A  + + E+ A+GR+ H+N++++          Y     +   +Y 
Sbjct: 192 CERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYS 251

Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++ +     W         PL  + R  I+      + Y+H+    K++HRDIK  NI +
Sbjct: 252 FMYDEAF-DWKD------RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300

Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           +      + DFG A     E        +GT    +PE  +     E +D++S G+++++
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360

Query: 276 VIS 278
           ++S
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 66/287 (22%), Positives = 110/287 (38%), Gaps = 55/287 (19%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKN 136
           F   KVIG G +G V     +D   V    +L      E+E     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V++     +  +  L+ E++  G++   L         LT E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL---------------------------- 228
           +      +HRDIK  N+L+D   + K+SDFGL                            
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 229 ------AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                 A+        +    +GT  Y+APE       N+  D +S G+++ E++ G  P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              S  P+E       KK++  +  E ++ P  PE P S   K ++L
Sbjct: 236 F-CSETPQET-----YKKVMNWK--ETLIFP--PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 13/96 (13%)

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH+     +V+RD+K  NIL+D   +  + DFGL+K   +++   T    GT  Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLA 164

Query: 252 PEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           PE     +L+E+      D +S G+L+ E+  G  P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-----ASTG 258
           VHRDIK  N+L+DK+ + +++DFG    L ++ +  +   +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
                 D +S G+ + E++ G  P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 37/215 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKN-LVR 139
           IGEG YG VY    ++  K VA+K     R + + E        E+  +  +     +VR
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 140 LLGYCAEGAHR-------MLVYEYVNNGNLEQWLHGDV-GPCSPLTWEIRMNIILGTAKG 191
           LL    E            LV+EY+++ +L++++  +  GP  PL  +   + +    KG
Sbjct: 66  LL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           +++ H   +  V+HRD+K  N+L+DK     K++D GL +         T  ++ T  Y 
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178

Query: 251 APE------YASTGMLNERSDVYSFGILIMEVISG 279
           APE      + ST +     D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPV-----DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 35/138 (25%), Positives = 69/138 (50%), Gaps = 15/138 (10%)

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGML 260
           K++HRD+KS+NI +      K+ DFG +K      S  + +   GT  Y+APE       
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---------EGVL 311
           ++++D++S G+++ E+++   P    + P +  +++  + +    +P         + +L
Sbjct: 249 SKKADMWSLGVILYELLTLHRPF---KGPSQREIMQ--QVLYGKYDPFPCPVSSGMKALL 303

Query: 312 DPKLPEKPTSRLLKRILL 329
           DP L + P  R   + LL
Sbjct: 304 DPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 59/275 (21%), Positives = 100/275 (36%), Gaps = 76/275 (27%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHK 135
           F   K IG G +G V      D + + A+K L    +  R QA    K E + +    ++
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-HVKAERDILAEADNE 61

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI---------IL 186
            +V+L     +  +   V +Y+  G++   L             IR+ I         I 
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEEDLARFYIA 108

Query: 187 GTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA---------------- 229
                +  +H+ G     +HRDIK  NILID+  + K++DFGL                 
Sbjct: 109 ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 230 ----------KLLGSESSYITTRV----------------MGTFGYVAPEYASTGMLNER 263
                     +            +                +GT  Y+APE        + 
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224

Query: 264 SDVYSFGILIMEVISGRIPVDYSRPPE-EVNLIEW 297
            D +S G+++ E++ G+ P     P E ++ +I W
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
                 D +S G+ + E++ G  P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 25/162 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKV-AVK-----NLLN----NRGQAEREFKVEVEAIG 130
           F   K I  G +G VY G  ++NSK+ AVK     +++N    ++ QAER+      A+ 
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERD------ALA 59

Query: 131 RVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
             +   +V L  Y  + A+ + LV EY+  G+++  LH           E+ +  I   A
Sbjct: 60  LSKSPFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVA 114

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L YLH      ++HRD+K  N+LI    + K++DFGL+K+
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 61/290 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE----FKVEVEAIGRVRHKN 136
           F   KVIG G +G V     +D   +    +L      E+E     + E + +       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V++     +  +  L+ E++  G++   L         L+ E     I  T   +  +H
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH 118

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG----------------SESSY-- 238
           +      +HRDIK  N+L+D   + K+SDFGL   L                 S+ S+  
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 239 ----------------ITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRI 281
                           +    +GT  Y+APE +  TG  N+  D +S G+++ E++ G  
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234

Query: 282 PVDYSRPPEEV--NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
           P   S  P+E    ++ W + +V             PE P S   K ++L
Sbjct: 235 PF-CSETPQETYRKVMNWKETLVFP-----------PEVPISEKAKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 57/253 (22%), Positives = 105/253 (41%), Gaps = 30/253 (11%)

Query: 66  GHWYTL--RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFK 123
           GH+Y +   +++VST  F    ++GEG +G V         +     ++ N  +  R+ K
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 124 VEVEAIGRVRHKN------LVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSP 175
           +E++ + +VR  +      L+++  Y       M +        L  W+  HG      P
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG------P 227

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-----------KHWNPKVS 224
            +      II  T   L Y H   E  ++H D+K  NIL++           +   P   
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285

Query: 225 DFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              +  L G  +  +  T ++ T  Y +PE          +D++S G +I E+ +G++  
Sbjct: 286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345

Query: 284 DYSRPPEEVNLIE 296
           D     E ++L+E
Sbjct: 346 DTHDNLEHLHLME 358

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           + + YLHE    +++HRDIK+ NI I+   +  + DFG A      ++       GT   
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            APE  +        D++S GI++ E+ +  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 192 LSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-GSESSYITTRVMGTFGY 249
           + Y+H EG    ++HRDIK+ N+L++   +  + DFG A    GS S+     + GT   
Sbjct: 273 IDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 250 VAPEYASTGMLNERSDVYSFGILIME 275
            APE  +        D++S G++I E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 38/172 (22%), Positives = 54/172 (31%), Gaps = 34/172 (19%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           + L     L  LH         R  KS NIL+   W+  +   G       E S      
Sbjct: 22  VCLQCLGALRELH---------RQAKSGNILLT--WDGLLKLDGSVAFKTPEQSRPDPYF 70

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           M      APE        E++D+YS GI + E +   +P  Y+   E   ++E L   + 
Sbjct: 71  M------APEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEERELSAILEILLNGMP 122

Query: 304 NR------NPEGVLDPK---------LPEKPTSRLLKRILLVALRCVDPNAQ 340
                   N EGV   +             P  R      L   R +     
Sbjct: 123 ADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETL 174

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 84  DKVIGEG--GYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKV---EVEAIGRVRHKNL 137
             +IG+      IV+    +  +  VAVK + N    ++ + K+   E+    +++H N+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +  +      +   +V   +  G+ E  L  H   G    L       I+      L Y+
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG----LPELAIAFILKDVLNALDYI 117

Query: 196 H-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------ 248
           H +G     +HR +K+S+IL+    + KV   GL   +         RV+  F       
Sbjct: 118 HSKGF----IHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 249 --YVAPEYASTGML--NERSDVYSFGILIMEVISGRIP 282
             +++PE     +   NE+SD+YS GI   E+ +G +P
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 16/26 (61%), Positives = 21/26 (80%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLA 229
           +HRDIK  NILID+  + K+SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 35/126 (27%), Positives = 53/126 (42%), Gaps = 40/126 (31%)

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGL----------------AKLLGSESSYITTRVM--- 244
           +HRDIK  N+L+D   + K+SDFGL                +  L S      ++ M   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 245 ------------------GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDY 285
                             GT  Y+APE +  TG  N+  D +S G+++ E++ G  P   
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF-C 240

Query: 286 SRPPEE 291
           S  P+E
Sbjct: 241 SDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 15/109 (13%)

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I+ G  K L Y+H       VHR +K+S+ILI    + KV   GL   L   +     RV
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHGQRLRV 160

Query: 244 MGTFG--------YVAPEYASTGM--LNERSDVYSFGILIMEVISGRIP 282
           +  F         +++PE     +   + +SD+YS GI   E+ +G +P
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 9e-04
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 8/100 (8%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVY----YGLLEDNSK--VAVKNLLNNRGQAERE-FKVEVE 127
           E   N  S  K +G G +G V     YGL + ++   VAVK L  +    ERE    E++
Sbjct: 31  EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90

Query: 128 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL 166
            +  +  H N+V LLG C  G   +++ EY   G+L  +L
Sbjct: 91  VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	413
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.31
COG4248	637	Uncharacterized protein with protein kinase and he	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.86
PRK09902	216	hypothetical protein; Provisional	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.82
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.62
PF01636	239	APH: Phosphotransferase enzyme family This family	98.58
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.53
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.39
PLN02876	822	acyl-CoA dehydrogenase	98.34
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.15
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.13
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.1
PRK10593	297	hypothetical protein; Provisional	98.08
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.99
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.82
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.82
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.77
PRK05231	319	homoserine kinase; Provisional	97.75
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
KOG2270	520	consensus Serine/threonine protein kinase involved	97.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.55
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.46
PLN02236	344	choline kinase	97.33
COG2334	331	Putative homoserine kinase type II (protein kinase	97.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.09
PLN02756	418	S-methyl-5-thioribose kinase	96.97
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.96
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.95
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.93
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.83
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.75
PRK11768	325	serine/threonine protein kinase; Provisional	96.66
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.6
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.59
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	96.56
PRK12396	409	5-methylribose kinase; Reviewed	96.36
PRK06148	1013	hypothetical protein; Provisional	96.27
PTZ00384	383	choline kinase; Provisional	96.15
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.23

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-53  Score=406.28  Aligned_cols=289  Identities=53%  Similarity=0.918  Sum_probs=254.6

Q ss_pred             CCccccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccccccee
Q 015076           65 WGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (413)
Q Consensus        65 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~  144 (413)
                      ....|++.++..++++|....+||+|+||.||+|...++..||||++.........+|..|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45779999999999999999999999999999999998899999987655433155699999999999999999999999


Q ss_pred             eeCC-eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          145 AEGA-HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       145 ~~~~-~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      .+.+ ..+||+||+++|+|.++|+.....  +++|..+++|+.++|+||+|||..+.+.|||||||++|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 599999999999999999886532  8999999999999999999999987778999999999999999999999


Q ss_pred             EecccceecCC-CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          224 SDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       224 ~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      +|||+|+.... ........ .||.+|+|||++..+..+.|+||||||++|.||+||+.|.+...+.....+..|....+
T Consensus       219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999976654 22221111 79999999999999999999999999999999999999988766666667899999999


Q ss_pred             hcCCCCCcCCCCCC-CCCcH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          303 TNRNPEGVLDPKLP-EKPTS-RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       303 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .......++|+.+. ..... .....+..++.+|++.+|.+||+|.+|+++|+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99899999999986 44443 67788999999999999999999999999996554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-53  Score=383.65  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=219.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeeeCC-eeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~i  152 (413)
                      +..++++..+.||+|..|+||+++++ ++..+|+|.+... .....+++.+|+++++..+||+||.+|+.|..+. .+.|
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            34456778889999999999999977 5677999998544 4556678999999999999999999999999998 5999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||++|+|+.++...    +.+++...-.|+.++++||.|||. .   +||||||||+|||++..|.+||||||.+..
T Consensus       156 ~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             ehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            99999999999999876    579999999999999999999996 6   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      +...   ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||.... .......+.+..++..       
T Consensus       229 lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~-------  297 (364)
T KOG0581|consen  229 LVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDE-------  297 (364)
T ss_pred             hhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcC-------
Confidence            7543   5677899999999999999999999999999999999999999997641 1122333334433332       


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                        ..+..+...++.++..++..||++||.+|||+.++++|-.-.
T Consensus       298 --ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  298 --PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             --CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence              222222235888999999999999999999999999986543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-53  Score=373.85  Aligned_cols=260  Identities=24%  Similarity=0.358  Sum_probs=216.5

Q ss_pred             CCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccc-eeeeC-CeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLG-YCAEG-AHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~-~~~~~-~~~~iv  153 (413)
                      .+|++++.||+|.||.||++. ..+|..+|.|.+.-.  .......+..|+.+|++|+|||||++++ .|.++ ..++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458899999999999999999 557889999988644  3445567889999999999999999998 44444 448999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCC-ceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-KVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||.+|+|.++++..+.....+++..+|+++.|++.||.++|++.+. -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999987666667899999999999999999999984221 2899999999999999999999999999998


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... ...+.+|||.||+||.+.+..|+.||||||+||++|||+.-+.||.+.+      ......++ .+.       
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI-~qg-------  243 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKI-EQG-------  243 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHH-HcC-------
Confidence            76544 3566889999999999999999999999999999999999999998763      22222222 222       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       .++.-+...++.++..||..|+..||+.||+...++..+..
T Consensus       244 -d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 -DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence             23334457789999999999999999999986666655543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-52  Score=398.59  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=218.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .+|...++||+|||+.||.+++ ..|..||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999997 78999999998763   3455677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |+|..++|..+++++    .++++.+++.+++||+.||.|||++   +|+|||||..|+||+++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999866    6899999999999999999999999   999999999999999999999999999998864


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .. ....+.||||.|.|||++....++..+||||+|||||.||+|++||+.....+....+.      .+.       - 
T Consensus       171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------~~~-------Y-  235 (592)
T KOG0575|consen  171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------LNE-------Y-  235 (592)
T ss_pred             cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------hcC-------c-
Confidence            32 23566899999999999999999999999999999999999999998665444443332      111       1 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                         ..+..++.+..+||.++|+.||.+|||+++|+.+--
T Consensus       236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF  271 (592)
T ss_pred             ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence               112246677889999999999999999999998743

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=379.44  Aligned_cols=251  Identities=23%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..+|.+.+.||.|+||+||+|+++ ++..||||.+...  .....+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457899999999999999999965 5788999999776  4566677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC------CCceEEeccc
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH------WNPKVSDFGL  228 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfG~  228 (413)
                      |||+||+|.+||+..    +.+++..+..++.||+.||++||++   +||||||||.||||+..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999987    5899999999999999999999999   99999999999999765      3589999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      |+.+...  ....+.+|++-|||||++..+.|+.|+|+||+|++||++++|+.||+..+..+...      .+-....  
T Consensus       162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~------~~~k~~~--  231 (429)
T KOG0595|consen  162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL------YIKKGNE--  231 (429)
T ss_pred             hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhcccc--
Confidence            9998743  34667899999999999999999999999999999999999999998665443222      2211111  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                            .........+..+.+|+...+..+|..|-++.+-..+
T Consensus       232 ------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  232 ------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             ------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                  1112223333345566666667777777666655443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-52  Score=382.35  Aligned_cols=261  Identities=23%  Similarity=0.376  Sum_probs=215.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCch-------hHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ-------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      ..+.|.+.+.||+|+||.|-+|. .++++.||||++.+....       ....+.+|+++|++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678999999999999999999 557999999998654311       1234578999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEe
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSD  225 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D  225 (413)
                      ..|+||||+.||+|.+.+-.+    ..+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999877    5688888899999999999999999   99999999999999766   6799999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      ||+|+..+.  .....++|||+.|.|||++.++.   +..++|+|||||+||-+++|.+||........  +.    ..+
T Consensus       323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI  394 (475)
T KOG0615|consen  323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQI  394 (475)
T ss_pred             cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHH
Confidence            999999873  33467789999999999997765   33488999999999999999999975443221  11    111


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                      ..+..      .+-...+.+++++.++||.+||..||++|||+.|+|++.+....+
T Consensus       395 ~~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  395 LKGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hcCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            11110      112234667889999999999999999999999999997765443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=388.92  Aligned_cols=263  Identities=32%  Similarity=0.541  Sum_probs=217.1

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchh--HHHHHHHHHHHhcCCCCCcccccceeeeCC-ee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA--EREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HR  150 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~  150 (413)
                      +.+...++.+.+.||.|+||+||+|.++....||||++.......  ...|.+|+.+|.+++|||||++++++.+.. .+
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            445556667777899999999999999855559999987654322  568999999999999999999999999987 79


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc-eeeccCCCCcEEEcCCC-CceEEeccc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHW-NPKVSDFGL  228 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfG~  228 (413)
                      +|||||+++|+|..+++..  ....+++..++.|+.||++||.|||++   + ||||||||+|||++.++ ++||+|||+
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            9999999999999999874  126899999999999999999999999   8 99999999999999998 999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++...... ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.....      .+.+........
T Consensus       191 sr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~  263 (362)
T KOG0192|consen  191 SREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL  263 (362)
T ss_pred             ceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC
Confidence            98775432 1223367999999999999  56899999999999999999999999986554      122222222211


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                           .+.++    ..+...+..++.+||..||+.||++.+|+..|+.+..
T Consensus       264 -----Rp~~p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 -----RPPIP----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -----CCCCC----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                 12222    2266778999999999999999999999999987644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-51  Score=370.31  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=212.7

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +..++|++.++||+|+||+||+++.+ +++.+|+|.+.+..   ....+....|..+|..++||+||+++..|++...+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34678999999999999999999955 57779999886653   234567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +|+||+.||.|...|.+.    +.+++..+..++.+|+.||.|||++   |||||||||+|||||.+|.++|+|||+|+.
T Consensus       102 lVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            999999999999999877    6899999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ..... ..+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+..      .+..++.....     
T Consensus       175 ~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~-----  242 (357)
T KOG0598|consen  175 DLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKL-----  242 (357)
T ss_pred             cccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcC-----
Confidence            54332 2355689999999999999999999999999999999999999999865533      33333333220     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHH
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP----KMGHVVHM  351 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~  351 (413)
                           ..++.-++.+.++++.++|..||++|.    .+.+|-+|
T Consensus       243 -----~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  243 -----PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                 122233566788999999999999995    56665554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=381.89  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=222.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .+++....+..++.||+|.||.||.|.++...+||+|.+... ......|.+|+++|++|+|+|||+++++|..+..++|
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            344555567778899999999999999998889999988765 3456778899999999999999999999999889999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      |||||+.|+|.++|....+  ..+.....+.++.|||+|++||+++   ++|||||..+|||++++..+||+|||+|+..
T Consensus       279 VtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence            9999999999999987322  6789999999999999999999999   9999999999999999999999999999966


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .++.........-+..|.|||.+..+.++.||||||||++||||+| |+.||.+....+....++               
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---------------  418 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---------------  418 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---------------
Confidence            5544434444445778999999999999999999999999999999 999998776554433332               


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                       .......+..++..+.+||..||..+|++|||+..+...|+...
T Consensus       419 -~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  419 -RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             -ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence             22222334457788999999999999999999999999988764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-49  Score=372.65  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=214.0

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .-..++|..++.||.|+|++|++|+.+ .++.||||++.+..   .....-+..|-.+|.+| .||.|++++.-|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            446789999999999999999999954 68889999885442   22233466788889999 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+|+||+++|+|.++|++.    +.+++..+..++.+|+.||+|||++   |||||||||+|||||++++++|+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999987    6899999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc----------e--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 015076          230 KLLGSESSY----------I--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW  297 (413)
Q Consensus       230 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~  297 (413)
                      +.+.+....          .  ...++||..|.+||++.+...++.+|||+||||||+|+.|.+||.+.+.......+..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            987532211          1  1458999999999999999999999999999999999999999987765433222211


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +             +-.+    +..++....+||.+.|..||.+|+|..+|-+|.
T Consensus       302 l-------------~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  302 L-------------DYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             h-------------cccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            1             1112    222346688999999999999999999999873

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-48  Score=346.02  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=213.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +.|+...++|+|+||.||+|+++ +|+.||||++....  ....+-..+|+++|++|+|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56888999999999999999966 58889999997654  3445677899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ||+. ++.+-|....   ..++...+..++.|+++|+.|+|++   ++|||||||+||||+.+|.+||||||+|+.+...
T Consensus        82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9976 5555555443   5789999999999999999999999   9999999999999999999999999999988743


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------HHh-hcC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------KMV-TNR  305 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~-~~~  305 (413)
                      .. ..+..+.|.+|+|||++.+ -+|+..+|||++||++.||++|.+-|.+....+....+....        .++ .+.
T Consensus       155 gd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  155 GD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             cc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            32 2344678999999998877 679999999999999999999999998887666555443211        111 122


Q ss_pred             CCCCcCCCCCCCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 NPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .+..+.-|.....     ....++.-+++++..||+.||.+|++.++++.+
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            2222222222111     122345568899999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=372.62  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=221.1

Q ss_pred             CCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      ..|.....||+|+.|.||.|. ..++..||||++........+.+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            458888999999999999998 4568889999998888888889999999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      +||+|.+.+...     .+++.++..|+++++.||+|||.+   ||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus       353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999999765     599999999999999999999999   999999999999999999999999999998876554


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       ...+.+||+.|||||++....|++|.||||||+|++||+-|++||-..++...      +..+..++.        +..
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng~--------P~l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT--------PKL  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcCC--------CCc
Confidence             45667899999999999999999999999999999999999999976444332      222233322        222


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .....++..+.+++.+||+.|+++|+++.|+|+|--
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF  525 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF  525 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence            334567788999999999999999999999999843

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=352.13  Aligned_cols=265  Identities=24%  Similarity=0.357  Sum_probs=218.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ...+.|++.++||.|..++||+|+ ...+..||||++..+. ......+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            456789999999999999999999 4568999999996553 34458899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |.||.+|++.+++.....  ..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.+||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999976543  4599999999999999999999999   99999999999999999999999999886654


Q ss_pred             CCCcc---eeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          234 SESSY---ITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       234 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .....   ....++||++|||||++..  ..|+.|+||||||++..||.+|..||....+.      +.+...+.+..+ 
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp-  250 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPP-  250 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCC-
Confidence            32221   1156789999999999533  45999999999999999999999999755432      222222333322 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ...-..++.+....+.+.+..++..||+.||.+|||+++++++-
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence            12223344455566788999999999999999999999999863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.8e-48  Score=365.60  Aligned_cols=261  Identities=24%  Similarity=0.295  Sum_probs=216.7

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ++...+..++|+++++||+|+||.||+|+.+ +|..+|+|++.+..   ......++.|-.+|....+|+||+++..|++
T Consensus       133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            3334567889999999999999999999955 68889999987653   3345678889999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      .+.+||||||++||++..+|.+.    ..|++..+..++.+++.|+..||+.   |+|||||||+|+|||..|++||+||
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence            99999999999999999999877    6899999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCC-----------------------CCc-----------------------ceeeccccccCccCccccccCCC
Q 015076          227 GLAKLLGS-----------------------ESS-----------------------YITTRVMGTFGYVAPEYASTGML  260 (413)
Q Consensus       227 G~a~~~~~-----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~  260 (413)
                      |||.-+..                       ...                       ......+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            99853210                       000                       00112579999999999999999


Q ss_pred             CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCC
Q 015076          261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ  340 (413)
Q Consensus       261 ~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  340 (413)
                      +..+|+|||||||||||.|.+||...++.+....+..++..+.             ......++.+..+||.+||. ||+
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHH
Confidence            9999999999999999999999998887766555433332221             11122344678899999999 999


Q ss_pred             CCC---CHHHHHHHH
Q 015076          341 KRP---KMGHVVHML  352 (413)
Q Consensus       341 ~RP---s~~eil~~l  352 (413)
                      +|.   .+.||-+|.
T Consensus       432 ~RLG~~G~~EIK~HP  446 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKHP  446 (550)
T ss_pred             HhcCcccHHHHhcCC
Confidence            997   477887764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=365.61  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=213.7

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecC----Cc-hhHHHHHHHHHHHhcCC-CCCcccccceeeeCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN----RG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  148 (413)
                      ...+.|.+++.||+|+||+|++|.+ .++..||+|.+...    .. .....+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999985 46899999966443    11 33456778999999998 999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFG  227 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG  227 (413)
                      .+++||||+.||+|.+++...    .++.+..+..++.|++.|++|||++   ||+||||||+|||++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999999884    6899999999999999999999999   99999999999999999 999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+..      ....++....
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~  239 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGE  239 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCC
Confidence            999874 2233456689999999999999877 76 7899999999999999999999863322      2222222111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                             -.++....   +.++..|+.+||..||.+|+|+.+|+.+-+...
T Consensus       240 -------~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  240 -------FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                   11111111   677899999999999999999999998766654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-47  Score=359.27  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=216.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~i  152 (413)
                      .+.|+.++.||+|.||.||+|+ ..+|+.||+|++..+.  .....-..+||.+|++|+||||+++.++..+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4568999999999999999999 5578899999997765  34445667899999999999999999998876  78999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      |+|||+. +|.-++....   -.+++.++..++.||+.||+|||++   ||+|||||.+|||||.+|.+||+|||||+++
T Consensus       196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999965 8888887643   4799999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ........+..+-|.+|+|||++.+. .|+.++|+||.||||.||++|++.|.+.+..+....+-   ++.........-
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf---klcGSP~e~~W~  345 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF---KLCGSPTEDYWP  345 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH---HHhCCCChhccc
Confidence            76665545556779999999988775 59999999999999999999999999887665555443   222221111111


Q ss_pred             CCCCC--------CCC-------cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 DPKLP--------EKP-------TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ~~~~~--------~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...++        ...       ...++...++|+..+|..||.+|.|+.++|..=..
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            01111        000       12234567899999999999999999999987444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=352.73  Aligned_cols=259  Identities=26%  Similarity=0.401  Sum_probs=209.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC--eeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~iv~  154 (413)
                      ..+|...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|++++|||||++++......  .++|+|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345778899999999999999965 48889999886654333667889999999999999999999754443  689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecccceecC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLG  233 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~  233 (413)
                      ||+++|+|.+++.+..   ..+++..+..+..||++||+|||++   |||||||||+|||++. ++.+||+|||++....
T Consensus        96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999998874   2699999999999999999999999   9999999999999999 7999999999998776


Q ss_pred             C--CCcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          234 S--ESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       234 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .  ........+.||+.|||||++..+. ...++|||||||++.||+||+.||...     .....++..+......   
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~---  241 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL---  241 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC---
Confidence            3  2222234578999999999998543 345999999999999999999999743     1112222222222111   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                        +    ..+..++.+..+++.+|+..||++|||+.++|.+.-...
T Consensus       242 --P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  242 --P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             --C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence              1    223336777899999999999999999999999976543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=358.30  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=217.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCCcccccceeeeCC-eeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA-HRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~-~~~  151 (413)
                      ...++|.+++.||.|.||.||+|+ ...+..||||+++.+-. .....=.+|+..|++|+ ||||+++.+++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            456789999999999999999999 45688899999876543 33334467999999999 999999999999888 999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||| ..+|.++++.+.   ..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+.
T Consensus        87 fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            999999 569999998774   6899999999999999999999999   999999999999999888999999999998


Q ss_pred             cCCCCcceeeccccccCccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC--
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE--  308 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--  308 (413)
                      ......+  +..+.|.+|+|||++ +.+.|+.+.|||++|||++|+.+-++-|.+.+..+.+..+.   .++......  
T Consensus       160 v~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EVLGTPDKDSW  234 (538)
T ss_pred             cccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HHhCCCccccc
Confidence            7655443  446789999999976 56779999999999999999999999999877655554442   222221111  


Q ss_pred             -------CcCCCCCCCCC-------cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 -------GVLDPKLPEKP-------TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 -------~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                             ..++-.++...       ....+.+..++|.+||..||.+|||+.+.+++.-.+
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence                   11111221111       122667889999999999999999999999986544

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-46  Score=326.34  Aligned_cols=275  Identities=23%  Similarity=0.321  Sum_probs=218.3

Q ss_pred             CCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .+|...+.||+|.||.||+|+ ..+|+.||||++.....  .......+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468889999999999999999 55799999999976543  234567789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++ .+|+..++...   -.++...+..++.++++||+|||++   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        82 fm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            995 59999998765   5799999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC--
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--  312 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  312 (413)
                      ...... .+-|.+|+|||++.| ..|+..+||||.||++.||+-|.+-|.+.+.-+...   .+...+........-+  
T Consensus       155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~---~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS---KIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH---HHHHHcCCCCcccCcccc
Confidence            543333 267999999998766 569999999999999999999887777665443333   2333333322211110  


Q ss_pred             -----------CC-CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 015076          313 -----------PK-LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSN  364 (413)
Q Consensus       313 -----------~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~~~~~  364 (413)
                                 +. .....-...+.+.++|+..||..||.+|+|+.+++++-.....+...+..
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS  294 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence                       00 00112223456679999999999999999999999987665544444443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.5e-47  Score=360.04  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=214.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..  ......+.+|+++++.++|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            67999999999999999999955 57779999886543  3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+.| +|+.+|...    +.++++.+..++.+++.||.|||+.   +|+|||+||.|||++..|.+||||||+|+.+...
T Consensus        82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9966 999999877    6899999999999999999999999   9999999999999999999999999999988764


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      . .......|||.|||||+..+.+|+..+|+|||||++||+++|++||...      ...+.++.+..+.          
T Consensus       154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~----------  216 (808)
T KOG0597|consen  154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP----------  216 (808)
T ss_pred             c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC----------
Confidence            3 3456678999999999999999999999999999999999999999633      2233333333221          


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ..++...+..+..++...|.+||..|.|..+++.|
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence             12233667789999999999999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=332.18  Aligned_cols=239  Identities=26%  Similarity=0.349  Sum_probs=206.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ...++|+..+.||.|+||.|.+++.+ ++..+|+|.+.+..   ....+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            34567999999999999999999965 57789999886553   234456778999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||++||.|..++++.    +++++..++.++.||+.||+|||+.   +|++|||||+|||||.+|.+||+|||+|+.
T Consensus       121 mvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999876    6899999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ....    +-+.||||.|+|||++..+.|..++|+|+||+++|||+.|.+||...++..      ...+++....     
T Consensus       194 v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~v-----  258 (355)
T KOG0616|consen  194 VSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGKV-----  258 (355)
T ss_pred             ecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCcc-----
Confidence            7543    556899999999999999999999999999999999999999998776533      2333333221     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKR  342 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  342 (413)
                            ..+..++.++.+|+...|+.|-.+|
T Consensus       259 ------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                  1223355678899999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-46  Score=363.97  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=214.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +-|++++.||.|+.|.|-+|++ .+|+.+|||++.+..   ......+.+|+.+|+.+.||||+.+|+++++..++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4588999999999999999995 579999999986652   233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||++||.|++++-..    +++++.++.+++.||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-..
T Consensus        92 Eyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999999877    6899999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCcceeeccccccCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      +  ....+.||++.|.|||++.+.+|+ .++||||+|+|||.||||++||+.++..      ..+.+. ..+.+      
T Consensus       165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir------~LLlKV-~~G~f------  229 (786)
T KOG0588|consen  165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR------VLLLKV-QRGVF------  229 (786)
T ss_pred             C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH------HHHHHH-HcCcc------
Confidence            3  345667999999999999999985 7899999999999999999999844422      222222 21211      


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .-+..++.+..+|+.+|+..||++|.|+++|++|..-.
T Consensus       230 ----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  230 ----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             ----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence                11244667789999999999999999999999997554

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=356.85  Aligned_cols=270  Identities=27%  Similarity=0.434  Sum_probs=222.7

Q ss_pred             ccccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCccccccee
Q 015076           67 HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (413)
Q Consensus        67 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~  144 (413)
                      ......+|++..+.+.+...||+|.||+||+|+|.  ..||||.+..+..  ...+.|++|+.++++-+|.||+-+.|+|
T Consensus       380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CCccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            34456888999999999999999999999999984  4699999876643  4567899999999999999999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                      ..+.. .||+.+|+|.+|..+|+-..   ..+.....+.|+.||++|+.|||.+   +|||||||..||+|.++++|||+
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEe
Confidence            99887 99999999999999998765   5789999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCC-cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          225 DFGLAKLLGSES-SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       225 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      |||++..-..-. ........|...|||||++.   ..+|++.+||||||||+|||+||.+||........+..+.    
T Consensus       531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG----  606 (678)
T KOG0193|consen  531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG----  606 (678)
T ss_pred             cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec----
Confidence            999997542210 01112234778999999884   3569999999999999999999999998544444433332    


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                         .    ..+.+ ........+.++|.+|+..||.+++++||.+.+|+..|+.+..
T Consensus       607 ---r----G~l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 ---R----GYLMP-DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---c----cccCc-cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               1    11111 1223455678899999999999999999999999998888755

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-47  Score=351.06  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=216.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..|...+.||+|.||.||+|.+. .++.||+|++.... ......+.+|+.+|..++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777899999999999999955 67789999986654 34457888999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      |.||++.+.+...    ..+.+..+..++++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||++.......
T Consensus        93 ~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999999876    4568888999999999999999999   99999999999999999999999999999886544


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. ..+++||+.|||||++....|+.|+||||||++++||++|.+|+....+.....++                ....+
T Consensus       166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~P  228 (467)
T KOG0201|consen  166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAP  228 (467)
T ss_pred             hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCC
Confidence            43 47789999999999999889999999999999999999999999877765444332                12222


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ......+++.+.+++..||+.||+.||++.+++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            23334678889999999999999999999999987

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-46  Score=359.85  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=211.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCC-CCCcccccceeeeCC
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA  148 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  148 (413)
                      ..+..++|.+.++||+|.||+|+++..+ +++.+|||.+.+..   ....+..+.|.+++.... ||.++.++..|+..+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4567789999999999999999999966 57789999987764   344556777888888775 999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ++|+||||+.||++..+.+.     ..+++..+..++.+|+.||.|||++   ||||||||.+|||||.+|.+||+|||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence            99999999999996666654     4799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      |+..-... ..+.+++||+.|||||++.+..|+.++|+|||||+||||+.|..||.+.+.++....+      +...   
T Consensus       515 cKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d~---  584 (694)
T KOG0694|consen  515 CKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VNDE---  584 (694)
T ss_pred             ccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcCC---
Confidence            98654222 2467899999999999999999999999999999999999999999987765432222      2111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  351 (413)
                          .    .++..++.+.+.++.++|..+|++|.-+     .+|.++
T Consensus       585 ----~----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  585 ----V----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ----C----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence                1    2234467788999999999999999855     455544

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-46  Score=356.58  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=206.7

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceeee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  146 (413)
                      ++..++|++.+.||+|+||.||+|.+.      .+..||||.+..... .....+..|+.+++.+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            456678999999999999999999742      245799998865432 3345788899999999 89999999998875


Q ss_pred             C-CeeEEEEEeccCCChhhhccCCCC------------------------------------------------------
Q 015076          147 G-AHRMLVYEYVNNGNLEQWLHGDVG------------------------------------------------------  171 (413)
Q Consensus       147 ~-~~~~iv~e~~~~gsL~~~l~~~~~------------------------------------------------------  171 (413)
                      . ..+++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 468999999999999998864321                                                      


Q ss_pred             ----CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce-eeccccc
Q 015076          172 ----PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGT  246 (413)
Q Consensus       172 ----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt  246 (413)
                          ...++++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......... .....++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                013578889999999999999999999   99999999999999999999999999998654322211 2233457


Q ss_pred             cCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHH
Q 015076          247 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK  325 (413)
Q Consensus       247 ~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (413)
                      ..|+|||++.+..++.++|||||||+||||++ |..||........      +...+.....     ..    ....++.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~----~~~~~~~  304 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MR----APENATP  304 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CC----CCCCCCH
Confidence            78999999999999999999999999999997 9999976443211      1111111111     01    1123455


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          326 RILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       326 ~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+.+++.+||+.||++|||+.+|++.|+..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=368.97  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=217.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCC-CEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccce-eee----
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDN-SKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGY-CAE----  146 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~-~~~----  146 (413)
                      +.+...++++.+.|.+|||+.||+|.+..+ .+||+|++...+....+.+.+|+++|+.|+ |+|||.+++. ...    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            456677899999999999999999997765 999999999888888999999999999996 9999999993 221    


Q ss_pred             --CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          147 --GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       147 --~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                        .-.++|.||||.||.|-++++.+..  ..|++.++++|++|+++|+++||.. ++.|||||||-+||||+.+|++|||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence              1356899999999999999986544  4599999999999999999999987 5679999999999999999999999


Q ss_pred             ecccceecCCCCc--cee------eccccccCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 015076          225 DFGLAKLLGSESS--YIT------TRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (413)
Q Consensus       225 DfG~a~~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~  293 (413)
                      |||.+...-....  ...      -...-|+.|+|||++   .+..++.|+|||+|||+||-|+....||+.....    
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence            9999864322111  000      012358999999976   5678999999999999999999999999854321    


Q ss_pred             HHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                                     .+++..+...+...++..|.+||..||+.||++||++-+++..+-.+.
T Consensus       265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                           234444444555789999999999999999999999999999876653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-46  Score=340.56  Aligned_cols=250  Identities=20%  Similarity=0.389  Sum_probs=214.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ..+|++.+.||+|.||+|-+|+ +..|+.||||.+.++...   +.-.+.+|+++|..|+||||+.+|.+|++.+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4579999999999999999999 578999999999776544   344678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||..+|.|.+|+...    +.|++.++..+++||..|+.|+|.+   +++|||||.+|||||.++++||+|||++..+.
T Consensus       132 MEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999877    6899999999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ...  ...++||++-|.+||++.+.+| ++.+|-||||++||.|+.|..||++.+-.      ..++. +..+.   ...
T Consensus       205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ-Is~Ga---YrE  272 (668)
T KOG0611|consen  205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ-ISRGA---YRE  272 (668)
T ss_pred             ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH-hhccc---ccC
Confidence            544  3577899999999999999998 47899999999999999999999866522      11222 22221   111


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +.-+        ....-||++||..||++|.|+.+|..|.+-
T Consensus       273 P~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  273 PETP--------SDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             CCCC--------chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            2211        234568999999999999999999999754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-46  Score=352.08  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=217.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe-eEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-RMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~iv  153 (413)
                      .++|.+++++|+|+||.+++++++ ++..+++|++....  ....+...+|+.++++++|||||.+.+.|.+++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            467999999999999999999965 57789999886554  2334467889999999999999999999998887 9999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |+||+||+|.+.|.+..+  ..+++..++.|+.|++.|+.|||++   +|+|||||+.|||++.++.++|+|||+|+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999999999999987653  5799999999999999999999998   99999999999999999999999999999987


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ...+.+||+.||+||++.+.+|..|+|||||||++|||++-+++|...+...      .+.++....        
T Consensus       158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~--------  222 (426)
T KOG0589|consen  158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGL--------  222 (426)
T ss_pred             Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhcc--------
Confidence            6652 3566789999999999999999999999999999999999999998655433      233332211        


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        ....+..++.++..+|..|+..+|+.||++.++|.+
T Consensus       223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              223455678889999999999999999999999987

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=341.31  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=208.9

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--------------chhHHHHHHHHHHHhcCCCCCccc
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--------------GQAEREFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~hpniv~  139 (413)
                      ....++|++++.||+|.||.|-+|+.. +++.||||++.+..              ....+.+.+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            356788999999999999999999954 68889999885432              112357889999999999999999


Q ss_pred             ccceeeeC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC
Q 015076          140 LLGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (413)
Q Consensus       140 ~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~  217 (413)
                      ++.+..+.  +.+|||+|||..|.+...-...    ..+.+.+++.++++++.||+|||.+   |||||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            99998765  6889999999888876543322    2399999999999999999999999   9999999999999999


Q ss_pred             CCCceEEecccceecCCCC----cceeeccccccCccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 015076          218 HWNPKVSDFGLAKLLGSES----SYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (413)
Q Consensus       218 ~~~~kl~DfG~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~~l~elltg~~Pf~~~~~~  289 (413)
                      +|++||+|||.+..+....    .......+|||.|+|||...++.    .+.+.||||+|++||.|+.|++||.+..  
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--  323 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--  323 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence            9999999999998773221    11123367999999999886633    3567899999999999999999997443  


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                          ..+...+++..         .+......++..++.+||.++|++||+.|.+..+|..|......
T Consensus       324 ----~~~l~~KIvn~---------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  324 ----ELELFDKIVND---------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----HHHHHHHHhcC---------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                23334444332         22222233567789999999999999999999999999876543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=344.25  Aligned_cols=248  Identities=25%  Similarity=0.308  Sum_probs=206.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46899999999999999999965 68889999886432   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999765    4789999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .........       ..
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~-------~~  216 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILAGK-------LE  216 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------cC
Confidence            2    223468999999999999899999999999999999999999997544321      112222111       01


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le~  354 (413)
                      ++    ..+...+.+++.+||+.||.+||+     +.+++++...
T Consensus       217 ~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         217 FP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             CC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence            11    123456889999999999999995     8999887543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=317.66  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=216.0

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeC-----
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----  147 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  147 (413)
                      +.+..++|++.+.||+|||+.||++. ..++..+|+|++........+...+|++..++++||||++++++...+     
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34677899999999999999999999 567888999999888878888999999999999999999999987543     


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...||+++|...|+|.+.+.........+++.+++.|+.+|++||.+||+. .+.++||||||.|||+.+.+.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            348999999999999999987655556899999999999999999999998 2249999999999999999999999999


Q ss_pred             cceecCCCCcc--------eeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 015076          228 LAKLLGSESSY--------ITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       228 ~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~  296 (413)
                      .+....-.-..        .......|..|+|||++.-   ...+.++|||||||+||+|+.|..||+..-..       
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------  247 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------  247 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence            98765311100        0111246899999998854   45789999999999999999999999632111       


Q ss_pred             HHHHHhhcCCC-CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          297 WLKKMVTNRNP-EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       297 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                             .... -.+....+.......+++.+.++|.+||+.||.+||++.+++..++.+
T Consensus       248 -------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 -------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                   0000 112222222223334888999999999999999999999999998865

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-44  Score=339.95  Aligned_cols=266  Identities=23%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||.||+|+++ ++..||+|++....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999976 57789999886542  2334567789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++++.+..+....    ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99887776554332    4689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH---------HHHhhcCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL---------KKMVTNRN  306 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~  306 (413)
                      .........|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...         ........
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            332233456899999999999888999999999999999999999999865432221111110         00000100


Q ss_pred             CCCcCCCCCCC------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 PEGVLDPKLPE------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ......+....      .....++..+.+|+.+||+.||++|||++++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000      0111245679999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-45  Score=349.38  Aligned_cols=248  Identities=22%  Similarity=0.314  Sum_probs=206.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.++ +++.||+|.+....   ......+..|+.+++.++||||+++++++..++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467999999999999999999965 57889999886532   23345688899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            9999999999999765    4789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ...    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ..........       .
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~-------~  232 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGR-------L  232 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCC-------c
Confidence            332    2356899999999999999999999999999999999999999754322      1112222111       0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                      .++    ..+...+.+|+.+||+.||.+||+     +.+++.|..
T Consensus       233 ~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        233 KFP----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             CCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence            111    113456889999999999999997     788888744

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-44  Score=337.71  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=205.4

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|++.+.||+|+||.||+|.. .++..||+|.+....   ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            378889999999999999995 468899999886543   2233457789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++|+|..++.....  ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999988754321  3689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........   +...+....         
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~---------  221 (285)
T cd05631         156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ---------  221 (285)
T ss_pred             Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc---------
Confidence            22  2345689999999999999999999999999999999999999986543221111   111111100         


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                       ......++..+.+|+.+||+.||++||+     +++++++..
T Consensus       222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence             1112234567889999999999999997     888888743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-44  Score=338.20  Aligned_cols=246  Identities=20%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchh---HHHHHHHHHHHhcCCCCCcccccceeee----CCeeEEEEEec
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA---EREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVYEYV  157 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~iv~e~~  157 (413)
                      ..||+|++|.||+|.+ +|+.||||.+.......   ...+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6899999999999998 48899999886543322   4667899999999999999999999876    35789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++|+|.+++...    ..+++...+.++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999765    46899999999999999999999732  78999999999999999999999999998654321 


Q ss_pred             ceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...+..+      ...........     ..+
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~~-----~~~  243 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNNS-----LKL  243 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCC-----CCC
Confidence               23457899999999976  679999999999999999999999997554221      11122111110     111


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      +    ..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       244 ~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        244 P----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             C----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1    134567899999999999999999999999998653

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-45  Score=348.66  Aligned_cols=255  Identities=23%  Similarity=0.311  Sum_probs=208.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|.+. ++..||||++....   ......+..|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46999999999999999999966 57899999886542   233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999765    4789999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.   ..   .   ..+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~---~---~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---YW---K---ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---hc---c---ccccCC
Confidence                2334568999999999999999999999999999999999999997654332211111   10   0   001111


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ........++.++.+++.+||..+|.+||++.+++++..
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            111111245667889999999999999999999998843

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.1e-45  Score=347.07  Aligned_cols=243  Identities=22%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      ++||+|+||.||+|..+ +++.||||.+....   ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999964 68889999886532   223356778999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  240 (413)
                      +|.+++...    ..+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  152 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence            999998765    5789999999999999999999999   999999999999999999999999999875422211 13


Q ss_pred             eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCc
Q 015076          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (413)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (413)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...      ....... ..      ..+    +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~-~~------~~~----p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-EE------IRF----P  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC------CCC----C
Confidence            34579999999999999999999999999999999999999997543211      1111111 11      111    1


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      ..++..+.+++.+||..||++||     ++.+++++-
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~  252 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR  252 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence            23456788999999999999999     899998873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-46  Score=351.82  Aligned_cols=251  Identities=28%  Similarity=0.495  Sum_probs=210.7

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      |++.++....++-||.|+.|.||+|+.+ ++.||||++..-.       ..+|+-|++|+||||+.|.++|.....+|||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            4455566666788999999999999987 7889999874332       2367779999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||||..|-|.++|+..    .++.......|..+||.|+.|||.+   .|||||||.-||||..+..+||+|||.++...
T Consensus       191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            9999999999999887    5789999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      +...  ...++||..|||||++.+.+.+.|+|||||||||||||||..||..-+....+      +         .+=..
T Consensus       264 ~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------w---------GVGsN  326 (904)
T KOG4721|consen  264 DKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------W---------GVGSN  326 (904)
T ss_pred             hhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------E---------eccCC
Confidence            5422  34588999999999999999999999999999999999999999643322111      1         11111


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .+....+..+++.+.-|+.+||+..|..||++.+|+.||+-..
T Consensus       327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            2222334556778899999999999999999999999998653

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-44  Score=334.58  Aligned_cols=256  Identities=26%  Similarity=0.412  Sum_probs=206.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||.||+|.++    .+..||+|.+..... .....+..|+.+++.++||||+++++++..+...+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            4567999999999999999999753    355799998865532 33457889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            9999999999999997643   4689999999999999999999999   999999999999999999999999998765


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .   +... .....   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~-~~~~~---  226 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V---IKAV-EDGFR---  226 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHHH-HCCCC---
Confidence            43222211222335678999999999999999999999999999775 999997544321   1   1111 11110   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        .    .....++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       227 --~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         227 --L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence              0    1122355678899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-44  Score=343.93  Aligned_cols=266  Identities=21%  Similarity=0.326  Sum_probs=209.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3578999999999999999999965 57788999886543 234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999999765    46899999999999999999999851  699999999999999999999999999876533


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc---CCCC---
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN---RNPE---  308 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~---  308 (413)
                      ..   .....||..|+|||++.+..++.++|||||||++|+|++|+.||......+.   ...+......   ....   
T Consensus       157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccC
Confidence            21   2345689999999999999999999999999999999999999965432211   1100000000   0000   


Q ss_pred             ----------------------------CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          309 ----------------------------GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       309 ----------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                                  .+.....+......++.++.+|+.+||..||++|||+.+|+++..-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                        0000001111122356779999999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-43  Score=343.95  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|+..+.||+|+||.||+|.+. +++.||||.+..... .....+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            456778899999999999999965 688999998865433 344678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|....        ...+..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||++......
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999986532        356778889999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .. ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+....   ........     
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~-----  292 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMSQ-----  292 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhccC-----
Confidence            21 1234568999999998743     2345689999999999999999999974332221111   11111100     


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .......++..+.+||.+||..||++|||+.|++++-.-.
T Consensus       293 -----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        293 -----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             -----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence                 0111223556789999999999999999999999985433

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.4e-44  Score=338.76  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=205.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-----------------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccc
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-----------------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~  139 (413)
                      .++|++.+.||+|+||.||+|.+++                 +..||+|.+.... ......+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4679999999999999999998532                 2369999886543 334557889999999999999999


Q ss_pred             ccceeeeCCeeEEEEEeccCCChhhhccCCCC---------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCcee
Q 015076          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVG---------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV  204 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv  204 (413)
                      +++++......++||||+++++|.+++.....               ....+++..++.++.||+.||+|||+.   ||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999998854311               113478889999999999999999999   999


Q ss_pred             eccCCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh--CCC
Q 015076          205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRI  281 (413)
Q Consensus       205 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt--g~~  281 (413)
                      ||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865433221 1223445788999999988899999999999999999987  567


Q ss_pred             CCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       282 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ||.......   ............... .. .    .....++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQGRQ-VY-L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhcccc-cc-c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776543222   222222222111100 00 0    011124567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-44  Score=332.61  Aligned_cols=257  Identities=24%  Similarity=0.442  Sum_probs=210.2

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +..++|++.+.||+|+||.||+|...++..||+|.+.... .....+..|+.+++.++|+||+++++++......+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            4567899999999999999999998888889999876433 345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999975422  4688899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .........++..|+|||++....++.++|||||||++|+|++ |..||.......   .   .... .....     . 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~---~~~~-~~~~~-----~-  223 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---V---MSAL-QRGYR-----M-  223 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---H---HHHH-HcCCC-----C-
Confidence            3222223345678999999988889999999999999999998 999997543221   1   1111 11110     0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .....++..+.+++.+||..+|++||+++++++.|+.
T Consensus       224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               1111245678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=324.72  Aligned_cols=277  Identities=23%  Similarity=0.283  Sum_probs=215.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchh--HHHHHHHHHHHhcCCCCCcccccceeee--CCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA--EREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~  151 (413)
                      +.+.|+.+..|++|.||.||+|+++ +++.||+|++.......  .-...+|+.+|.+++|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            3456889999999999999999955 68889999997654221  2245679999999999999999888754  36799


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||||+. +|..++....   +++...++..++.|+++||+|||.+   .|+||||||+|+|++..|.+||+|||+|+.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence            99999965 9999998775   6899999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ++..... .+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++-|.+....+....+-.+...........+
T Consensus       227 ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  227 YGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            8765333 3345679999999988775 5999999999999999999999999888766555444322222111111111


Q ss_pred             CC------CCCCCCCcHH---------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCCC
Q 015076          311 LD------PKLPEKPTSR---------LLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKE  361 (413)
Q Consensus       311 ~~------~~~~~~~~~~---------~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~~  361 (413)
                      ..      -.++..+...         ++..-.+|+..+|..||.+|.|+++.|++=.....+...
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence            10      0111111111         446678899999999999999999999986665544433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-45  Score=313.52  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=216.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ...++|++++.||+|.||.||+|+. +++..||+|++.+..   ......+.+|+++-..|+||||+++|++|.+....|
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence            3567899999999999999999994 467779999887653   334567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +++||.++|+|...|.....  ..+++...+.++.|+|.||.|+|..   +||||||||+|+|++..+.+||+|||-+..
T Consensus        99 LilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999999985433  5799999999999999999999999   999999999999999999999999999887


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .+   .....+.|||..|++||...+..++..+|+|++|++.||++.|.+||......+....+.   +          +
T Consensus       174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---k----------~  237 (281)
T KOG0580|consen  174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---K----------V  237 (281)
T ss_pred             cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---H----------c
Confidence            64   223566899999999999999999999999999999999999999998555333222221   1          1


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +-    ..+..++....++|.+|+..+|.+|.+..+++.+..-
T Consensus       238 ~~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  238 DL----KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             cc----cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence            11    2224466778999999999999999999999998653

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.7e-44  Score=358.57  Aligned_cols=254  Identities=19%  Similarity=0.285  Sum_probs=208.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-C-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-D-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++..++..||||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34999999999999999999854 3 577899977665555556778899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++|+|.+++........++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999998865333335789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             c-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 S-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..+........     .   
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~-----~---  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKY-----D---  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-----C---
Confidence            2 1234467999999999999999999999999999999999999999754321      12222222111     0   


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        .....++..+.++|.+||..||++||++.+++.+
T Consensus       290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              0112345678999999999999999999998764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-43  Score=334.42  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=203.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||.|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            467999999999999999999965 67889999886443 2234567789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++ +|.+++....   ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9964 8998886542   3578999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC---------
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---------  305 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  305 (413)
                      ... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+   .......         
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  232 (288)
T cd07871         157 TKT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGIT  232 (288)
T ss_pred             Ccc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhccc
Confidence            221 233467999999998865 56899999999999999999999999766543322221   1111100         


Q ss_pred             ---CCCCcCCCCCCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 ---NPEGVLDPKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ---~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         .......+.....    .......++.+|+.+||..||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               0000000110000    011234568899999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-44  Score=345.45  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=206.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC--CCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      +..++|.+.+.||+|+||.||+|.++.  +..||+|.+....   ......+..|+.+++.++||||+++++++.+....
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            345679999999999999999998543  3579999886432   23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++.
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            9999999999999999765    4789999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...      .........     
T Consensus       180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~-----  244 (340)
T PTZ00426        180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGI-----  244 (340)
T ss_pred             ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCC-----
Confidence            76432    233568999999999999889999999999999999999999997544321      112221111     


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                        ..++    ..++..+.+++.+||+.||++|+     ++++++++..
T Consensus       245 --~~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        245 --IYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             --CCCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence              0111    12345678999999999999995     8999998744

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.5e-44  Score=329.62  Aligned_cols=252  Identities=23%  Similarity=0.432  Sum_probs=204.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .++|++.+.||+|+||.||++.++++..+|+|.+.... .....+..|+.++++++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            35688999999999999999998878889999875433 33467888999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            9999999987543   3689999999999999999999999   999999999999999999999999999886543222


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+.      +........   ...+   
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~~---~~~~---  223 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGFR---LYRP---  223 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCC---CCCC---
Confidence            21222335668999999988889999999999999999999 8999975443221      111111111   0011   


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          ...+..+.+++.+||..+|++||++.++++.|
T Consensus       224 ----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 ----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                11235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-43  Score=345.92  Aligned_cols=265  Identities=18%  Similarity=0.232  Sum_probs=203.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|...      ...+.+|+++++.++||||+++++++......++|||
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            4578999999999999999999964 67889999642      2346789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ++ +++|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       164 ~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        164 RY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             cC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            99 56888888655    4689999999999999999999999   9999999999999999999999999999764332


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccc----ccHHHHHHHHhhcCCC----
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE----VNLIEWLKKMVTNRNP----  307 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~----  307 (413)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|..||........    ...+..+.........    
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            22223446799999999999999999999999999999999999988754322110    0011111110000000    


Q ss_pred             ---------------CCcCCCC-CCC-CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 ---------------EGVLDPK-LPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ---------------~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                                     .....+. .+. .....++.++.+|+.+||+.||++|||+.|++++-...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                           0000000 000 01123456789999999999999999999999876543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-44  Score=328.82  Aligned_cols=257  Identities=24%  Similarity=0.282  Sum_probs=215.3

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .+..+.|++++.||+|.-|+||+|..++ +..+|+|++.+..-   ....++..|.+||+.++||.++.+|..|+.+...
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            4566779999999999999999999764 57899999866542   2334567799999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      |++||||+||+|..++++..+  ..+++..+..++.+++-||+|||-.   |||+|||||+||||.++|.+.|+||.|+.
T Consensus       153 cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999999987654  5799999999999999999999999   99999999999999999999999999875


Q ss_pred             ecCC---------------------------------C-C---------------------cceeeccccccCccCcccc
Q 015076          231 LLGS---------------------------------E-S---------------------SYITTRVMGTFGYVAPEYA  255 (413)
Q Consensus       231 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~  255 (413)
                      .+..                                 . .                     ......++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3310                                 0 0                     0112346899999999999


Q ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcC
Q 015076          256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCV  335 (413)
Q Consensus       256 ~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  335 (413)
                      .+...+.++|+|+||++||||+.|..||.+.+..+....+      +..       +..++..+  ..+..+.+||++.|
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI------v~~-------~l~Fp~~~--~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI------VGQ-------PLKFPEEP--EVSSAAKDLIRKLL  372 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH------hcC-------CCcCCCCC--cchhHHHHHHHHHh
Confidence            9999999999999999999999999999988876554333      111       12333333  56778999999999


Q ss_pred             CCCCCCCCC----HHHHHHH
Q 015076          336 DPNAQKRPK----MGHVVHM  351 (413)
Q Consensus       336 ~~dp~~RPs----~~eil~~  351 (413)
                      .+||.+|..    +.||-+|
T Consensus       373 vKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ccChhhhhccccchHHhhcC
Confidence            999999998    8888876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-43  Score=343.31  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=198.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||+||+|... +++.||||++....   ......+..|+.++..++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999865 57889999886532   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999765    5799999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 015076          235 ESS----------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (413)
Q Consensus       235 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~  280 (413)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Q 015076          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD--PNAQKRPKMGHVVHM  351 (413)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~eil~~  351 (413)
                      .||......+.      ...+..... ..    .++.  ...++.++.+++.+++.  .++..||++.+|+++
T Consensus       234 ~Pf~~~~~~~~------~~~i~~~~~-~~----~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQET------YKKVMNWKE-TL----IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHH------HHHHHcCcC-cc----cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99975543221      111111100 00    0111  11134456667766443  334457899999988

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.5e-44  Score=347.43  Aligned_cols=264  Identities=27%  Similarity=0.421  Sum_probs=207.2

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEE------cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +.+..++|++.+.||+|+||.||+|.+      .++..||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            345566899999999999999999973      235579999886443 33445788899999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCC------------------------------------------------------
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVG------------------------------------------------------  171 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~------------------------------------------------------  171 (413)
                      .....++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999998864321                                                      


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          172 -----------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       172 -----------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                                       ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             012578899999999999999999999   999999999999999999999999999987644


Q ss_pred             CCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          235 ESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       235 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......  ....    .+.....     
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~-----  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEGYR-----  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhCcc-----
Confidence            32211 122334667999999999999999999999999999998 899986543221  1111    1111110     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+    ...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       336 ~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0011    11245788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.7e-44  Score=341.75  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      +.||+|+||.||++... ++..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68899999886542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  240 (413)
                      +|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence            999988765    4789999999999999999999999   999999999999999999999999999875432211 22


Q ss_pred             eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCc
Q 015076          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (413)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (413)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...      ....... ..      ..++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~-~~------~~~p----  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-ED------IKFP----  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhcc-CC------ccCC----
Confidence            34578999999999999999999999999999999999999997543221      1111111 10      1111    


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      ..++.++.+++.+||..||++||     ++.+++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence            23456788999999999999997     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-43  Score=328.02  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=209.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +..++|++.+.||+|+||.||+|.+.++..||+|.+.... .....+.+|+.++++++||||+++++++......+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            4567799999999999999999998777889999886543 335668889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999997643  14689999999999999999999999   9999999999999999999999999999877533


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ..........+..|+|||++.+..++.++||||||+++|+|++ |+.||.......      ....+.....        
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~--------  222 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYR--------  222 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC--------
Confidence            2211122223457999999998899999999999999999999 999997543211      1111111110        


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .  .....++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       223 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 M--PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             C--CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0  1112345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.6e-44  Score=341.09  Aligned_cols=243  Identities=24%  Similarity=0.296  Sum_probs=199.0

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      +.||+|+||.||++... ++..||+|.+....   ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999964 68899999886532   233456678999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  240 (413)
                      +|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  152 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence            999988765    4789999999999999999999999   999999999999999999999999999875422211 12


Q ss_pred             eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCc
Q 015076          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (413)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (413)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....      ........       ..++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~~-------~~~p----  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEE-------IRFP----  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCC-------CCCC----
Confidence            345689999999999999999999999999999999999999975432211      11111111       1111    


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          321 SRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      ..++..+.+++.+||+.||++||     ++.+++++-
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            23456788999999999999998     899998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=327.67  Aligned_cols=266  Identities=23%  Similarity=0.344  Sum_probs=208.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEee--cCCchhHHHHHHHHHHHhcCCCCCcccccceeee-----CC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----GA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~  148 (413)
                      ....|...+.||+|+||.|+.+.++ +|..||||++.  -......++..+|+++|+.++|+||+.+++++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456777899999999999999954 68999999997  3455666778889999999999999999999865     35


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      .+|+|+|+| +.+|...++..    ..++...+..+++||++||.|+|+.   +|+||||||.|+|++.+..+||||||+
T Consensus       100 DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            689999999 77999999876    4699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCC-cceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          229 AKLLGSES-SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       229 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |+...... ....+..+.|.+|.|||++.. ..|+.+.||||+||++.||++|+.-|.+.+......++.   ..+....
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~---~~lGtP~  248 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL---ELLGTPS  248 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH---HhcCCCC
Confidence            99885421 111244567999999997754 569999999999999999999999998876544433321   1111100


Q ss_pred             CC-----------CcC--CCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PE-----------GVL--DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~-----------~~~--~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..           ..+  .+..+..+    ........++|+.+||..||.+|+|++|.|+|.-
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence            00           000  00111111    1123455789999999999999999999999853

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-43  Score=340.62  Aligned_cols=254  Identities=25%  Similarity=0.287  Sum_probs=203.6

Q ss_pred             CCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCee
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  150 (413)
                      +|++.+.||+|+||.||+++..    ++..||+|.+....    ......+..|+.+++.+ +||||+.+++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999853    57889999886432    23345677899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999998765    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..............||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+  .......     
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~-----  226 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC-----  226 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcC-----
Confidence            6543333333446799999999998765 4789999999999999999999999754332221111  1111111     


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                        ++.++    ..++..+.+++.+||..||++||     ++.+++++..
T Consensus       227 --~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         227 --DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             --CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence              11111    22455688999999999999999     7888888743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.8e-45  Score=363.45  Aligned_cols=268  Identities=29%  Similarity=0.498  Sum_probs=223.7

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccce
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGY  143 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~  143 (413)
                      ....++...+.+..+.||+|+||+||+|...      +...||||.++..... ...+|.+|++++..|+|||||+++|+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3445667777888899999999999999843      2345999999877665 77899999999999999999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCC------C----CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcE
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------P----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI  213 (413)
                      |.+++.+++|+|||..|+|.++|.....      .    ..+|+..+.+.|+.|||.|+.||-++   .+|||||-.+|+
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC  634 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC  634 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence            9999999999999999999999954221      1    23489999999999999999999999   999999999999


Q ss_pred             EEcCCCCceEEecccceecCCCCcceee-ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCccc
Q 015076          214 LIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE  291 (413)
Q Consensus       214 ll~~~~~~kl~DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~  291 (413)
                      ||.++..|||+|||+++..-....+... ...-..+||+||.|..+.||.+||||||||+|||+++ |+.||.+....+.
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence            9999999999999999865433333322 3344789999999999999999999999999999998 9999987776554


Q ss_pred             ccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      +..+       +++.        + ...+..++.++..||..||+.+|.+||+++||-..|+....
T Consensus       715 Ie~i-------~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECI-------RAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHH-------HcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            4333       2222        1 23445678889999999999999999999999999987543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-44  Score=347.18  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=204.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+..|+.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999965 58889999986532   233456778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999999765    4699999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc-------------------------------------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHH
Q 015076          235 ESSY-------------------------------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (413)
Q Consensus       235 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ell  277 (413)
                      ....                                     .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH
Q 015076          278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVHML  352 (413)
Q Consensus       278 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~l  352 (413)
                      +|..||.......      ..........       .+.......++..+.+++.+|+. +|.+|++   +.+++++.
T Consensus       234 ~G~~Pf~~~~~~~------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         234 VGYPPFCSDNPQE------TYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             cCCCCCCCCCHHH------HHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            9999997554321      1122221110       11111111345678889999996 9999998   99998874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8e-44  Score=329.75  Aligned_cols=256  Identities=28%  Similarity=0.517  Sum_probs=212.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34579999999999999999999888889999998776655667888999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..++.++.||+.||.|||++   |++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999976432  4689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .. .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+   .   +........      .  
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~------~--  223 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V---YDQITAGYR------M--  223 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H---HHHHHhCCc------C--
Confidence            21 223345778999999988899999999999999999998 899997544221   1   111111100      0  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        .....++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              1112345678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.9e-44  Score=342.04  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=206.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+....   ......+..|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46999999999999999999965 68889999886542   234456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++....   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999997653   4699999999999999999999999   999999999999999999999999999987755


Q ss_pred             CCcceeeccccccCccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ..........||+.|+|||++.      ...++.++|||||||++|+|++|+.||.......      .+..+.......
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~  228 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL  228 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence            4433334457899999999986      4567899999999999999999999997544322      122222211100


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                           .++.  ...++..+.+|+..||. +|.+|||+.+++++-
T Consensus       229 -----~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         229 -----KFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             -----CCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence                 1111  12245668889999998 999999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-44  Score=345.55  Aligned_cols=254  Identities=23%  Similarity=0.307  Sum_probs=208.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ......+..|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999965 68899999886532   234456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999765    5799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CC----------------------------cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015076          235 ES----------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS  286 (413)
Q Consensus       235 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~  286 (413)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11223456899999999999999999999999999999999999999765


Q ss_pred             CCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHh
Q 015076          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHMLE  353 (413)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~le  353 (413)
                      ....      ....+.....  .   ..++..  ..++..+.++|.+||. ||.+||+ +.+++++..
T Consensus       234 ~~~~------~~~~i~~~~~--~---~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         234 TLQE------TYNKIINWKE--S---LRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CHHH------HHHHHhccCC--c---ccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            4221      1122211000  0   011111  1156678899999997 9999999 999999843

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-43  Score=346.41  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=201.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|++++.||+|+||+||+|++. ++..||||++....   ......+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999954 57889999986542   2334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999999765    4689999999999999999999999   9999999999999999999999999997543110


Q ss_pred             C----------------------------------------------cceeeccccccCccCccccccCCCCccchhHHH
Q 015076          236 S----------------------------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSF  269 (413)
Q Consensus       236 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl  269 (413)
                      .                                              .......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            0                                              000123579999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHh--cCCCCCCCCCCHHH
Q 015076          270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALR--CVDPNAQKRPKMGH  347 (413)
Q Consensus       270 G~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~e  347 (413)
                      ||++|||++|..||.........      ........       .+.......++.++.+++.+  |+..++..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            99999999999999765432211      11111100       00111112245567788877  55666777999999


Q ss_pred             HHHHHh
Q 015076          348 VVHMLE  353 (413)
Q Consensus       348 il~~le  353 (413)
                      ++++-.
T Consensus       302 ~l~hp~  307 (381)
T cd05626         302 IKAHPF  307 (381)
T ss_pred             HhcCcc
Confidence            999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.4e-44  Score=346.86  Aligned_cols=258  Identities=19%  Similarity=0.251  Sum_probs=208.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ....++|++.+.||+|+||.||+|... ++..||+|.+....   ......+..|+.+++.++||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            445678999999999999999999965 57889999886432   22334577899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++|+|.+++...     .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999998653     588889999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .............+||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......      ....+.....
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC
Confidence            7654332223445799999999998653    47899999999999999999999997554321      1222222111


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~le  353 (413)
                      .       +.......++..+.+++.+||..+|.+  |+|+.+++++..
T Consensus       265 ~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         265 S-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             c-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            0       111111235667889999999999988  999999998854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-44  Score=338.50  Aligned_cols=241  Identities=21%  Similarity=0.258  Sum_probs=197.3

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||+|+||.||+|.+. ++..||+|.+...   .......+..|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 5778999988643   223345677899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++...    ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.++|+|||+++....... ....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence            9999765    4789999999999999999999999   999999999999999999999999999986432222 2334


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..........       ..+    +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~-------~~~----~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP-------LRF----PDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC-------CCC----CCc
Confidence            57899999999999999999999999999999999999999754321      2222222211       011    123


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRPK---MGHVVHML  352 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs---~~eil~~l  352 (413)
                      ++..+.+++.+||..||++||+   +.+++.+.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp  248 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP  248 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence            4567889999999999999975   67777663

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-43  Score=327.30  Aligned_cols=258  Identities=23%  Similarity=0.392  Sum_probs=208.2

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +...+|.+.+.||+|+||.||+|.++ .+..||+|.+... ......+..|+++++.++||||+++++++......+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            34556889999999999999999965 5778999987643 334567888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          82 EFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999865421  4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+      ..... ....     ..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~-~~~~-----~~  224 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL-EKGY-----RM  224 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH-HCCC-----CC
Confidence            32221222234668999999999999999999999999999998 999987543221      11111 1110     01


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .....++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       225 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                11122456789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-43  Score=346.73  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46999999999999999999955 58889999885432   223456778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+|..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999753210


Q ss_pred             C------------------------------------------CcceeeccccccCccCccccccCCCCccchhHHHHHH
Q 015076          235 E------------------------------------------SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL  272 (413)
Q Consensus       235 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~  272 (413)
                      .                                          ........+||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                          0000123579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC---CHHHHH
Q 015076          273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP---KMGHVV  349 (413)
Q Consensus       273 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~eil  349 (413)
                      +|+|++|+.||......+...      ......       ..+.......++..+.+++.+|+ .+|.+|+   ++.+++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQL------KVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHH------HHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999997655332211      111100       01111111234556777888876 5999999   899999


Q ss_pred             HHHh
Q 015076          350 HMLE  353 (413)
Q Consensus       350 ~~le  353 (413)
                      ++..
T Consensus       300 ~h~~  303 (376)
T cd05598         300 AHPF  303 (376)
T ss_pred             CCCC
Confidence            8843

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-43  Score=337.56  Aligned_cols=246  Identities=26%  Similarity=0.355  Sum_probs=198.0

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHH---hcCCCCCcccccceeeeCCeeEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAI---GRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      |++.+.||+|+||.||+|.+. ++..||||.+....   ......+..|++++   +.++||||+++++++......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999965 68889999986432   22334566666554   566899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|..++..     ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988864     3689999999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......      .........       .
T Consensus       153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~-------~  218 (324)
T cd05589         153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDE-------V  218 (324)
T ss_pred             CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------C
Confidence            2221 2334678999999999999999999999999999999999999997554321      112222111       1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      .++    ..++..+.+++.+||..||.+||     ++.+++++.
T Consensus       219 ~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         219 RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            111    12456688999999999999999     577777764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-43  Score=326.08  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            35688999999999999999998777779999876443 33467888999999999999999999999988999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      .+++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            9999999987643   3689999999999999999999999   999999999999999999999999999886644322


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......      ...........      .. 
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~------~~-  222 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRL------YR-  222 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCC------CC-
Confidence            21222335678999999988889999999999999999998 999996444221      11111111110      00 


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                         ....+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       223 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 ---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               1113467899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.4e-43  Score=336.82  Aligned_cols=265  Identities=21%  Similarity=0.333  Sum_probs=206.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999966 57778888776543 234467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999765    46899999999999999999999741  799999999999999999999999999876532


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC------
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE------  308 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------  308 (413)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........   + .........      
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~  229 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM---F-GCPVEGDPAESETSP  229 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH---h-cCcccCCccccccCc
Confidence            2   12334689999999999988899999999999999999999999975432111000   0 000000000      


Q ss_pred             ---------------------------CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          309 ---------------------------GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       309 ---------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                                 .+.....+......+..++.+|+.+||+.||++|||+.+++.+-.-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence                                       0000000011111234668899999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-43  Score=337.38  Aligned_cols=243  Identities=25%  Similarity=0.362  Sum_probs=198.7

Q ss_pred             cEEeeeCceEEEEEEE----cCCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +.||+|+||.||++..    ..++.||+|.+....    ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999985    257789999886432    22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...    ..+.+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999765    4688899999999999999999999   99999999999999999999999999987543222


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..+.......       ..++
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~-------~~~~  220 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGK-------LNLP  220 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------CCCC
Confidence            2 233456899999999999888999999999999999999999999754422      1122222111       0111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                          ..++..+.+++.+||..||++||     ++.+++++.
T Consensus       221 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         221 ----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             ----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence                12345688999999999999999     899988864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-43  Score=345.28  Aligned_cols=264  Identities=25%  Similarity=0.430  Sum_probs=207.4

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +....++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+..|+.+++.+ +|+||+++++++.
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3455678999999999999999999842      23469999886543 33345688899999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCC-------------------------------------------------------
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDV-------------------------------------------------------  170 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~-------------------------------------------------------  170 (413)
                      .....++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999885321                                                       


Q ss_pred             -----------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc-
Q 015076          171 -----------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-  238 (413)
Q Consensus       171 -----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  238 (413)
                                 ....++++..++.++.||+.||+|||++   ||+||||||+|||+++++.+||+|||+++........ 
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                       0113578899999999999999999999   9999999999999999999999999999865433221 


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||........      +........     ....+ 
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~-----~~~~~-  337 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY-----QMSRP-  337 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc-----CccCC-
Confidence            1122335678999999988999999999999999999997 9999975432211      111111111     01111 


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         ..++.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus       338 ---~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 ---DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-43  Score=344.36  Aligned_cols=261  Identities=19%  Similarity=0.266  Sum_probs=207.5

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      .+....++|++.+.||+|+||.||+|.+. +++.+|+|.+...   .......+..|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34456678999999999999999999965 5778999988542   1223456778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999653     588899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      +..............+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.......      ....+...
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~  262 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH  262 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence            987654333333456799999999998654    37889999999999999999999997554321      12222221


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHhc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLEA  354 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~le~  354 (413)
                      ...     ..+  .....++..+.+++..||..++.+  |+++.+++++...
T Consensus       263 ~~~-----~~~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         263 KNS-----LNF--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             Ccc-----cCC--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            110     011  111234566788899999865544  8999999998543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.9e-43  Score=331.55  Aligned_cols=267  Identities=21%  Similarity=0.284  Sum_probs=202.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|... ++..||||.+..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999965 688899998864432 223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+. ++|.+++....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            995 68888776543   4688999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC-----
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG-----  309 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  309 (413)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......  ......+...........     
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence            21 1233467999999998865 45889999999999999999999999754321  111111111111100000     


Q ss_pred             ---cCC-CCC----CCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          310 ---VLD-PKL----PEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       310 ---~~~-~~~----~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ... ..+    +...     ...++..+.+++.+||+.||++|||+.++++|-..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f  291 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF  291 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence               000 000    0000     00123567899999999999999999999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=347.16  Aligned_cols=270  Identities=29%  Similarity=0.423  Sum_probs=219.6

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcC--C---CEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCccccc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED--N---SKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLL  141 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~  141 (413)
                      ....|++..++..+.++||+|+||.||+|..+.  +   ..||+|.....   ......++..|+++|+.++|||||++|
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            445677788888899999999999999999542  2   22899988742   345667899999999999999999999


Q ss_pred             ceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       142 ~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      |++.....++||||+|+||+|.++|.+..   ..++..+...++.+.+.||+|||++   ++|||||-.+|+|++.++.+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence            99999999999999999999999998874   3699999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||+++........ .....-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+      ...+
T Consensus       302 KISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~k  374 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAK  374 (474)
T ss_pred             EeCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHH
Confidence            99999998865421111 111234679999999999999999999999999999999 888997655432      2222


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCCC
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKE  361 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~~  361 (413)
                      +..+...         ...+...+..+..++.+||..+|++||||.++.+.++........
T Consensus       375 I~~~~~r---------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  375 IVKNGYR---------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHhcCcc---------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            2232221         111224456788888999999999999999999999987665544

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-43  Score=331.18  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc--CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCCcccccceee-----e
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCA-----E  146 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~-----~  146 (413)
                      ++|++.+.||+|+||.||+|.+.  ++..||+|.+.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999863  467799998864332  2233455677666655   6999999999875     3


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ....++||||++ ++|.+++.....  ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999995 699998865422  4589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....   +........
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPG  229 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCC
Confidence            999876433  123345689999999999888999999999999999999999999986554322211   111111000


Q ss_pred             C----------CCcCCCCCCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 P----------EGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 ~----------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .          ...+......   .....+...+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0          0000000000   0011244567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=341.21  Aligned_cols=263  Identities=22%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC-----CeeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~  151 (413)
                      +|++.+.||+|+||.||+|... ++..||||++...  .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999965 6889999988643  223345678899999999999999999987543     3579


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+ +++|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            999999 56899988755    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCc--ceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC-
Q 015076          232 LGSESS--YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (413)
Q Consensus       232 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (413)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...........   +........ 
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~  229 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL---ITDLLGTPSP  229 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH---HHHHhCCCCH
Confidence            432211  11234568999999999866  6789999999999999999999999976543221111   110000000 


Q ss_pred             ----------CC---CcCCCCCCCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 ----------PE---GVLDPKLPEKP---TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ----------~~---~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                                ..   ..+....+...   ...+...+.+++.+||+.||++|||+.+++++-.
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence                      00   00000000000   0113456789999999999999999999998743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-43  Score=335.54  Aligned_cols=242  Identities=25%  Similarity=0.362  Sum_probs=193.4

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhc-CCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|... ++..||+|.+....   ......+..|..++.. .+||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 57789999886532   2223344556666664 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            9999998765    4789999999999999999999999   99999999999999999999999999998653322 22


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...      ....+... .      +.+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~-~------~~~----  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND-R------PHF----  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-C------CCC----
Confidence            344578999999999999999999999999999999999999997554321      11111111 0      111    


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  351 (413)
                      +..++..+.+++.+||+.||++||++. +++++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            122455678999999999999999875 56554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.8e-44  Score=340.27  Aligned_cols=243  Identities=22%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      +.||+|+||.||++... ++..||+|.+....   ......+..|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999964 68889999886532   223456678999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      +|..++...    ..+++..+..++.||+.||+|||+ .   ||+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            999988765    478999999999999999999997 7   999999999999999999999999999875432222 1


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........      ...... ..      ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~-~~------~~~p---  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILM-EE------IRFP---  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhc-CC------CCCC---
Confidence            2345689999999999999999999999999999999999999975443211      111111 11      1111   


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                       ..++..+.+++.+||+.||++|+     ++.+++++.
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         217 -RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence             12456788999999999999996     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.5e-43  Score=328.71  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=207.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-C-----CEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-N-----SKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.... +     ..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3578999999999999999998543 2     4689998864432 3445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          151 MLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      +++|||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            999999999999999865321            114588899999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~  296 (413)
                      +.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+   .. 
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~-  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VI-  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-
Confidence            9999999999986543221 12233456788999999988899999999999999999998 999997554322   11 


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ..+.....         ......++.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus       237 ---~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 ---EMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               11111111         11123456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-43  Score=328.33  Aligned_cols=257  Identities=26%  Similarity=0.471  Sum_probs=207.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..+|.+.+.||+|+||.||+|...+      +..||+|.+...... ....+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4568899999999999999998543      467999988655443 456889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCC----------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC
Q 015076          151 MLVYEYVNNGNLEQWLHGDV----------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~  220 (413)
                      ++||||+++++|.+++....          .....+++..+..++.|++.||+|||++   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999996542          1224588999999999999999999999   9999999999999999999


Q ss_pred             ceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 015076          221 PKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       221 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (413)
                      ++|+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........   .   
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~---  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---I---  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H---
Confidence            999999999765332211 1223345788999999999999999999999999999998 9999975443221   1   


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ... .....         ......++..+.+++.+||..||++||++.||++.|+
T Consensus       235 ~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECI-TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHH-HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111 11111         0111234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2e-43  Score=345.54  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|++++.||+|+||.||+|+.. ++..||+|.+....   ......+..|+.+++.++||||+++++.+.++...++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999964 57889999886532   2334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999998765    4689999999999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------cceeeccccccCccCccccccCCCCccchhHHH
Q 015076          236 S----------------------------------------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSF  269 (413)
Q Consensus       236 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl  269 (413)
                      .                                              .......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HH
Q 015076          270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MG  346 (413)
Q Consensus       270 G~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~  346 (413)
                      ||+||||++|+.||...+..+.      ........       ..+.......++..+.+++.+|+ .+|++|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999976543221      11111110       01111112234556777787765 49999997   88


Q ss_pred             HHHHHH
Q 015076          347 HVVHML  352 (413)
Q Consensus       347 eil~~l  352 (413)
                      ++++|-
T Consensus       301 ei~~hp  306 (382)
T cd05625         301 EIKAHP  306 (382)
T ss_pred             HHhcCC
Confidence            888763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-43  Score=336.62  Aligned_cols=247  Identities=22%  Similarity=0.297  Sum_probs=199.6

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCC-CCcccccceeeeCCeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~iv~  154 (413)
                      +|++.+.||+|+||.||+|... ++..||||.+....   ......+..|++++..++| ++|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999965 56789999886532   2334567789999999976 46888999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999998765    4689999999999999999999999   999999999999999999999999999875422


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .........       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~-------~~  219 (324)
T cd05587         154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN-------VS  219 (324)
T ss_pred             CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-------CC
Confidence            211 1334568999999999999999999999999999999999999997544221      111221111       11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHM  351 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  351 (413)
                      +    +..++..+.+++.+||..||.+|++.     .+++++
T Consensus       220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         220 Y----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1    12245678899999999999999986     667665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-43  Score=352.32  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=207.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC----
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----  148 (413)
                      ...++|.+.+.||+|+||+||+|.. .++..||||.+....  ......+..|+.++..++|+||+++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4457899999999999999999985 468899999886543  334456788999999999999999988764332    


Q ss_pred             ----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          149 ----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       149 ----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                          .+++||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                36899999999999999976443345799999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          225 DFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       225 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ..+.....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~~  259 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTLA  259 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc
Confidence            9999987643221 1233457999999999999999999999999999999999999999754321      12222221


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ...     . .    .+..++..+.+++.+||..||.+||++.+++++
T Consensus       260 ~~~-----~-~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRY-----D-P----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC-----C-C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110     1 1    112345678999999999999999999999876

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-42  Score=340.84  Aligned_cols=263  Identities=19%  Similarity=0.274  Sum_probs=198.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|+++|++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999965 577899995422      2346799999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      + .++|..++....   ..+++..++.|+.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 Y-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9 568888886543   4699999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC-Cccc----ccHHHHHHHHhh--cCCCC
Q 015076          237 SY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEE----VNLIEWLKKMVT--NRNPE  308 (413)
Q Consensus       237 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~-~~~~----~~~~~~~~~~~~--~~~~~  308 (413)
                      .. ......||..|+|||++.+..++.++|||||||+||||++|..|+.... ....    ......+.....  .....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21 1234569999999999999999999999999999999999887653222 1111    111111111000  00000


Q ss_pred             C---------------cCCCCCCCCCcH---HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          309 G---------------VLDPKLPEKPTS---RLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       309 ~---------------~~~~~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .               ...+........   .....+.+||.+||+.||.+|||+.|+|++-.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence            0               000000000011   22346789999999999999999999998743

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.4e-43  Score=323.73  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=206.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +..++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+||+++++++.. ...+++||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            34567999999999999999999988888899998865433 34568899999999999999999998754 56799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          81 YMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             ecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999875422  4689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .........++..|+|||++.+..++.++||||||+++|+|++ |..||......+      ..........      . 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~------~-  222 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYR------M-  222 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC------C-
Confidence            2222222335678999999988889999999999999999999 899996543221      1111111100      0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ......+..+.+++.+||..+|++|||+.++++.|+.
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 ---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               1112345678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.8e-43  Score=324.60  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=206.6

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..++|++.+.||+|+||.||+|.+.++..||+|.+.... .....+..|+++++.++||||+++++++.. ...++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            456799999999999999999998777789999886433 234578889999999999999999998754 557999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999975422  3578999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ........++..|+|||++.+..++.++|||||||++|+|++ |..||........      ...... ...        
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~~~-~~~--------  221 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVER-GYR--------  221 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHHhc-CCC--------
Confidence            222223345678999999988899999999999999999999 8889875432211      111111 100        


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       ......++..+.+++.+||+.||++||++.++++.|+..
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             011234566789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-43  Score=320.33  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=209.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCC-cccccceeeeCC-----
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGA-----  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~-----  148 (413)
                      ...|...+.||+|+||+||+|+. .+|..||+|++.....  .......+|+.+|++++|+| |+.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34577778899999999999994 4788999999976543  24455678999999999999 999999998776     


Q ss_pred             -eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          149 -HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       149 -~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                       .+++|+||+ .-+|..++.........++...+..++.||+.||+|||++   +|+||||||.||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             889999999 5699999977542223577789999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC-
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR-  305 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-  305 (413)
                      +|+...-.... ....++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+....+....+   ...+... 
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I---f~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI---FRLLGTPN  241 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH---HHHcCCCC
Confidence            99976533222 3345689999999999887 6999999999999999999999999887764333332   3332221 


Q ss_pred             --CCCCcC---C--CCCCCCC-cHHHH-------HHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          306 --NPEGVL---D--PKLPEKP-TSRLL-------KRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       306 --~~~~~~---~--~~~~~~~-~~~~~-------~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ....+.   +  ..++... ...+.       ....+++.+||+.+|.+|.|+..++.|-.
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence              111111   1  1111111 11121       36789999999999999999999999843

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=344.69  Aligned_cols=254  Identities=23%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... ++..||||.+....   ......+..|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999854 68889999886532   223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999765    4789999999999999999999999   999999999999999999999999999863321


Q ss_pred             CCc----------------------------------------------ceeeccccccCccCccccccCCCCccchhHH
Q 015076          235 ESS----------------------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYS  268 (413)
Q Consensus       235 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvws  268 (413)
                      ...                                              ......+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000                                              0001246899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC---CCH
Q 015076          269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR---PKM  345 (413)
Q Consensus       269 lG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~  345 (413)
                      |||++|||++|..||......+.      ...+......     ..++  ....++..+.+++.+||. +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~-----~~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHET------YRKIINWRET-----LYFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCc-----cCCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            99999999999999975543221      1111111100     0111  111245668899999997 66665   599


Q ss_pred             HHHHHHHh
Q 015076          346 GHVVHMLE  353 (413)
Q Consensus       346 ~eil~~le  353 (413)
                      .+++.+..
T Consensus       300 ~~~l~hp~  307 (377)
T cd05629         300 HEIKSHPF  307 (377)
T ss_pred             HHHhcCCC
Confidence            99998853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.7e-43  Score=335.50  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=199.3

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|.++ ++..||+|.+....   ......+..|..+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999965 57889999987542   23345677899999888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence            9999988655    4799999999999999999999999   99999999999999999999999999987532211 12


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--EVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+....+.....      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p-  225 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC-
Confidence            334578999999999999999999999999999999999999997433221  11112222222222111      111 


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHH
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPK------MGHVVHML  352 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~l  352 (413)
                         ..++..+.+++.+||..||.+|++      +.+++++-
T Consensus       226 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05588         226 ---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP  263 (329)
T ss_pred             ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence               124556889999999999999997      67888763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.7e-43  Score=323.18  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=208.5

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++..++|++.++||+|+||.||+|..+++..||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++|
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            355678999999999999999999988889999998865443 3457888999999999999999999874 45689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+.+++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999865432  4689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........++..|+|||++....++.++||||||+++|+|++ |+.||........   .   ..+. ....     .
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~~~-~~~~-----~  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I---QNLE-RGYR-----M  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H---HHHH-cCCC-----C
Confidence            32222223345678999999988889999999999999999999 9999975443221   1   1111 1100     0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          ......+.++.+++.+||..+|++|||+++++..|+.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                1112244579999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-44  Score=327.01  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=203.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeC-----CeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~iv  153 (413)
                      .|...+++|.|+||.||+|... ++..||||++..+..-    -.+|+++|+.+.|||||++.-+|...     -...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4778899999999999999954 5688999999766542    23589999999999999998887532     245789


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~  232 (413)
                      |||++. +|.++++........++...+.-+..||++||+|||+.   ||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999965 99999875433346789999999999999999999998   99999999999999976 89999999999998


Q ss_pred             CCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC---
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---  308 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---  308 (413)
                      ..+...  .....|..|+|||++.+. .|+.+.||||.|||+.||+-|++-|.+.+..+....+-.+........+.   
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            766553  334568899999988764 59999999999999999999999999876554443332221111110000   


Q ss_pred             ----CcCCCCCCC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 ----GVLDPKLPE-----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ----~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          ....+.+..     ........+..+|+.++|..+|.+|.++.+++.+-
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence                011111111     12334567789999999999999999999999873

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-43  Score=323.47  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      .+|++.+.||+|+||.||+|.++.+..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4588999999999999999998777789999875433 234567789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999987543   3689999999999999999999999   9999999999999999999999999999866432221


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.   .   ..... ..     ....  
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~~~~~-~~-----~~~~--  222 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V---ESVSA-GY-----RLYR--  222 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H---HHHHc-CC-----cCCC--
Confidence            1111223457999999998899999999999999999999 8999975433221   1   11111 10     0111  


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        ...++..+.+++.+||..+|++|||+.++++.|
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              112456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-43  Score=335.38  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|..+ +++.||||.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 57889999886432   23345566788888776 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~  152 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T  152 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence            9999988765    4789999999999999999999999   999999999999999999999999999876432221 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...      ....+.....       .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~-------~~----  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEV-------VY----  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCC-------CC----
Confidence            334578999999999999999999999999999999999999997544221      1222221110       11    


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKM------GHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~l  352 (413)
                      +..++..+.+++.+||+.||++||++      .+++.+-
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~  254 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP  254 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence            11245678899999999999999998      6777663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.4e-43  Score=341.41  Aligned_cols=263  Identities=20%  Similarity=0.267  Sum_probs=208.9

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ++.+....++|++.+.||+|+||.||+|.++ ++..+|+|.+....   ......+..|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455667789999999999999999999966 57789999885422   2234457789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      +...++||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     588899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |++..............+||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+..      .....+.
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~  260 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM  260 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence            99987654333333456799999999998654    3789999999999999999999999754422      1222222


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHhc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLEA  354 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~le~  354 (413)
                      .....       +.......++..+.++|..||..++.+  |+++.+|+++...
T Consensus       261 ~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         261 NHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             cCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            21111       111112245667889999999844433  7899999998643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=322.90  Aligned_cols=256  Identities=29%  Similarity=0.473  Sum_probs=206.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++|++.+.||+|+||.||+|.++.    ...||+|.+.... ......+..|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4579999999999999999998642    3468999876543 3344578889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+|+||||+|||+++++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999997643   4689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          233 GSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       233 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~~---  227 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V---IKAVEDGYRL---  227 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H---HHHHHcCCCC---
Confidence            52221 12222335678999999998899999999999999999998 999986433211   1   1111111000   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                             .....++..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   11123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-42  Score=328.94  Aligned_cols=257  Identities=21%  Similarity=0.263  Sum_probs=201.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||++... ++..||+|.+...   .......+..|+.++..++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999965 5888999988642   1223456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999997532   4689999999999999999999999   999999999999999999999999999977654


Q ss_pred             CCcceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..........||+.|+|||++..     ..++.++|||||||++|+|++|+.||......      ............. 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~-  227 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHF-  227 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcc-
Confidence            33322333468999999999863     45788999999999999999999999754322      1122222111100 


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCC--CCCCHHHHHHHHh
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQ--KRPKMGHVVHMLE  353 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~eil~~le  353 (413)
                          .++.. ...++..+.+++.+||..+++  .|+++.+++++-.
T Consensus       228 ----~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         228 ----QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ----cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence                01111 112456678888887755443  4889999999843

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-42  Score=339.30  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=203.6

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCC-----eeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~  151 (413)
                      +|++.+.||+|+||.||+|.+. ++..||||++...  .......+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4889999999999999999964 6889999988543  2233457788999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+. ++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999995 5888887654    4799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHH-------------
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW-------------  297 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~-------------  297 (413)
                      .............++..|+|||++.+. .++.++|||||||++|||++|+.||...+.......+..             
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            654333223344678999999998774 479999999999999999999999986654332221110             


Q ss_pred             ---HHHHh-hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          298 ---LKKMV-TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       298 ---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ....+ ............  .......+..+.+|+.+||+.||++|||+.+++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence               00000 000000000000  00111235678899999999999999999999988543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-42  Score=320.72  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=210.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... ++..||||.+...   .......+..|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999954 6889999987542   2333456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.........+++..++.++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864332235689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......    ........ ...        .
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-~~~--------~  224 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-EQC--------D  224 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-hcC--------C
Confidence            3221 22345788999999998888999999999999999999999998643221    11112211 111        1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+......++..+.+++.+||..+|++||++.+|++.++..
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11122334567799999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=334.05  Aligned_cols=255  Identities=23%  Similarity=0.315  Sum_probs=219.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCch---hHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~  151 (413)
                      ....|++.+.||+|.||.||+|..+. |..+|+|.+.+....   ....+.+|+.+|+++. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34568999999999999999999664 899999999766433   3468899999999998 999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC----CCceEEecc
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVSDFG  227 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG  227 (413)
                      +|||+|.||.|.+.+...     .+++..+..++.|++.+++|||+.   ||+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999765     299999999999999999999999   99999999999999543    579999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......      +.. .  
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~------i~~-~--  253 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA------ILR-G--  253 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH------HHc-C--
Confidence            9998876  3446668899999999999999999999999999999999999999987664433221      111 1  


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          +..+.......++..+.++|..|+..||.+|+|+.++|+|.+-
T Consensus       254 ----~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi  296 (382)
T KOG0032|consen  254 ----DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI  296 (382)
T ss_pred             ----CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence                1244556667788889999999999999999999999998653

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-42  Score=332.75  Aligned_cols=256  Identities=20%  Similarity=0.260  Sum_probs=202.4

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....   ......+..|+.++..++|+||+.+++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999965 57789999886422   223345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999997632   4689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..........||+.|+|||++.+     +.++.++|||||||++|+|++|+.||......+      ....+......  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~--  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEER--  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCc--
Confidence            43333334579999999999865     568899999999999999999999997543221      12222211100  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~l  352 (413)
                         ..++. ....++..+.+++.+||..++.+  |+++.+++++.
T Consensus       227 ---~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         227 ---FQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             ---ccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence               01111 11234567888999998866544  46899998873

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-42  Score=332.93  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|... ++..||+|.+...   .......+..|+.++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999965 5788999988754   223345577888888776 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence            9999888655    4799999999999999999999999   999999999999999999999999999875422211 1


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE--EVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......++...+.....      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p-  225 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCC-
Confidence            234578999999999999999999999999999999999999996322211  11112222222221111      111 


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHH
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPK------MGHVVHM  351 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~  351 (413)
                         ..++..+.+++.+||..||++||+      +.+++++
T Consensus       226 ---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         226 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               224456889999999999999998      4677766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.9e-43  Score=334.58  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=199.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +|++.+.||+|+||.||+|... ++..||||.+....   ......+..|..++..+ +|++|+.+++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999966 56789999886542   22234566677888777 5899999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999998765    4689999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ....+....       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~-------~~  219 (323)
T cd05616         154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-------VA  219 (323)
T ss_pred             CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            221 2334578999999999999999999999999999999999999997544321      112222111       11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHM  351 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  351 (413)
                      +    +..++.++.+++.+||+.||++|++.     .+++++
T Consensus       220 ~----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         220 Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             C----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            1    12345678899999999999999984     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.6e-43  Score=347.67  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=197.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeC--------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--------  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--------  147 (413)
                      ...+|++.+.||+|+||.||+|... ++..||||++.....    ...+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999964 678899998864432    234699999999999999998876432        


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEec
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDF  226 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  226 (413)
                      ..+++||||++ ++|.+++.........+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            24679999996 477777654322235799999999999999999999999   999999999999998665 6999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      |+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+   ...+...
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI---IQVLGTP  290 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCC
Confidence            99987643322  2335689999999988664 6899999999999999999999999866543322111   1111000


Q ss_pred             CC-------CCcCCCCCCC--------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          306 NP-------EGVLDPKLPE--------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       306 ~~-------~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..       ....+-.++.        ..+...+.++.+|+.+||..||.+|||+.+++++..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            00       0000000110        011123467899999999999999999999998854

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-43  Score=334.96  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=197.7

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|... ++..||+|.+....   ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57889999886532   23344566788888866 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            9999988765    4689999999999999999999999   999999999999999999999999999876432222 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...      ..........       ..+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~-------~~p---  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDV-------LYP---  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC-------CCC---
Confidence            334568999999999999999999999999999999999999997554322      1222221110       111   


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRP-------KMGHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RP-------s~~eil~~l  352 (413)
                       ..++..+.+++.+||..||++||       ++.+++++.
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence             12346788999999999999999       888888774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-42  Score=333.31  Aligned_cols=262  Identities=21%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +...+|++.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            45568999999999999999999965 4677999964322      2245899999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |++ .++|.+++....   ..+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             Ecc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            999 568888886543   5789999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH----HHHHHHHhhc-C-CCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL----IEWLKKMVTN-R-NPE  308 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~-~-~~~  308 (413)
                      ...  .....||..|+|||++.+..++.++|||||||++|||+++..|+...........    ...+...+.. . .+.
T Consensus       210 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 APA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             Ccc--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            211  2345689999999999999999999999999999999986555432222111000    0011111110 0 000


Q ss_pred             CcC------------------CCCCC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVL------------------DPKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~------------------~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ...                  .....   ......++..+.++|.+||+.||++|||+.|+++|-
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp  352 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP  352 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence            000                  00000   000012234566799999999999999999999874

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=325.43  Aligned_cols=253  Identities=23%  Similarity=0.290  Sum_probs=204.6

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|++.++||+|+||.||++... ++..||+|.+.....   .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4888999999999999999964 688899998865332   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999988854321  4689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........   ..+...+...          
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------  220 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------  220 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------
Confidence            22  23346899999999999889999999999999999999999999764432211   1111111111          


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      .......++..+.+|+.+||..||++||     ++.+++++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP  262 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence            0111233566788999999999999999     888998774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-42  Score=340.62  Aligned_cols=265  Identities=25%  Similarity=0.418  Sum_probs=209.5

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCCccccccee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYC  144 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~  144 (413)
                      .++...++|++.++||+|+||.||+|.+..      +..||||.+..... .....+.+|+.+++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            345667899999999999999999998531      24699998865433 33467889999999996 99999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC-----------------------------------------------------
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG-----------------------------------------------------  171 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  171 (413)
                      ......++|||||++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999998854210                                                     


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          172 ---------------------------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       172 ---------------------------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                                                             ....+++..++.++.||+.||+|||+.   +|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence                                                   012478888999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            999999999999999998664332211 222346788999999999999999999999999999997 999987543221


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .      +...+.....         ......++..+.+++.+||..||++|||+.+|++.|+..
T Consensus       348 ~------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         348 T------FYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             H------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            1      1111111110         011223556789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-42  Score=324.93  Aligned_cols=250  Identities=22%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||+|+||+||++.+. +++.||+|.+......   ....+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 6788999988654322   234567899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      ..++.........+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988754332335799999999999999999999999   999999999999999999999999999987644322 1234


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  .........         ..  ......
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~---------~~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILN---------DS--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcc---------cC--CCCccc
Confidence            56899999999999999999999999999999999999999754322111  111111111         00  011223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          323 LLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                      ++..+.+++.+||+.||++||     ++++++++-.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            566788999999999999999     7788887743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=313.99  Aligned_cols=256  Identities=19%  Similarity=0.280  Sum_probs=212.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .+.|++-++||+|.|+.||++.+. +|+.+|+|++...  .....+.+.+|+++.+.|+|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456888899999999999999854 6888999977433  3346678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~  231 (413)
                      |++.|++|..-|-.+    .-+++..+-.++.||++||.|+|.+   +|||||+||+|+|+-..   .-+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999997766544    3588899999999999999999999   99999999999999533   3489999999998


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ++.  ......++|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+.....      ..+.. +.     
T Consensus       163 l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly------e~I~~-g~-----  228 (355)
T KOG0033|consen  163 VND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------EQIKA-GA-----  228 (355)
T ss_pred             eCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH------HHHhc-cc-----
Confidence            873  33466788999999999999999999999999999999999999999864432221      11111 11     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       -..+......++.+..+|+.+||..||.+|.|+.|.|+|-.-.
T Consensus       229 -yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  229 -YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             -cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence             1223334455777889999999999999999999999986543

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-42  Score=320.10  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..++|++.+.||+|+||.||+|.+..+..+|+|.+.... .....+.+|+++++.++|||++++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            345699999999999999999998777789999875443 334668889999999999999999988754 567999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..+..++.|++.||+|||+.   |++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999976432  3588999999999999999999999   99999999999999999999999999998764332


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+   .   ..... ....     .  
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~-~~~~-----~--  222 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V---LEQVE-RGYR-----M--  222 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHH-cCCC-----C--
Confidence            222222345678999999988889999999999999999999 999997543221   1   11111 1110     0  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        ......+..+.+++.+||..||++||++.+|++.|+.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              1112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-42  Score=330.74  Aligned_cols=258  Identities=26%  Similarity=0.466  Sum_probs=205.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ...+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            3467999999999999999999854 333    38999886443 34456788899999999999999999998765 46


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++++||+++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            89999999999999997653   4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+       +........  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~--  228 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE--  228 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCC--
Confidence            765433221 122234678999999999999999999999999999998 999997543211       111111111  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                           .++.  ...+...+.+++.+||..+|++||++.+++..+.....
T Consensus       229 -----~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 -----RLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             -----CCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                 0110  11234568899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-42  Score=326.58  Aligned_cols=261  Identities=24%  Similarity=0.429  Sum_probs=208.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|.+.+.||+|+||.||++...      ++..+|+|.+..........+..|+.++++++||||+++++++......
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3467999999999999999999842      2345889988766555567789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          151 MLVYEYVNNGNLEQWLHGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      ++||||+++++|.+++....         .....+++..++.++.|++.||+|||++   |++||||||+|||+++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999986432         1123589999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      +|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......      ...
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~  233 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE  233 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            99999999865432211 1122345778999999998899999999999999999998 999986543221      111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .... ....     ..    ...++..+.+++.+||+.||.+|||+.++++.|+...
T Consensus       234 ~i~~-~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         234 CITQ-GRVL-----QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHc-CCcC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            2111 1110     01    1123456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-42  Score=325.09  Aligned_cols=259  Identities=21%  Similarity=0.417  Sum_probs=204.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      +..++|++.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999753      24569999875432 233456888999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCC------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGP------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ..++||||+++++|.+++......      ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998653211      13467888999999999999999999   999999999999999999999


Q ss_pred             EEecccceecCCCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 015076          223 VSDFGLAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      |+|||++........... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.......      ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence            999999876543222111 12345778999999998899999999999999999999 788987543221      1111


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .. .....     ..    ...++..+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~~-~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VM-EGGLL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HH-cCCcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11 11110     11    1123457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=320.25  Aligned_cols=258  Identities=28%  Similarity=0.495  Sum_probs=210.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++..++|++.+.||+|+||.||+|..+++..+|||.+.... .....+..|+.+++.++|+||+++++++......++||
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            35678899999999999999999998878889999876443 34567888999999999999999999999888999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.....  ..+++..+..++.+++.||.|||++   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999976432  4689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......      ..........      .
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~------~  223 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVERGYR------M  223 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC------C
Confidence            22211222234678999999998889999999999999999998 999996543211      1112111100      0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .    .....+..+.+++.+||..+|++||++.++++.|+.
T Consensus       224 ~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 P----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0    111224578999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-42  Score=326.38  Aligned_cols=261  Identities=25%  Similarity=0.428  Sum_probs=210.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..+|.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            356888999999999999999843      24458889886665555677889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          152 LVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      +||||+++++|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999965321            123589999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 015076          220 NPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW  297 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~  297 (413)
                      .++|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .   
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---  234 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V---  234 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---
Confidence            999999999976543221 11223456788999999999999999999999999999999 999986543321   1   


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      +.. .......         .....++..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus       235 ~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IEC-ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHH-HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111 1111111         1112245678999999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=362.56  Aligned_cols=262  Identities=28%  Similarity=0.468  Sum_probs=215.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc--CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE--DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      .....+..+.||+|.||.||.|...  .+.    .||||.+.+.. .....+|.+|+.+|+.++|||||+++|++.+...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3566778899999999999999854  343    38999887654 4556789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      .+|++|||+||+|..+|.+.+.   ....++..+.+.++.|||+|+.||+++   ++|||||..+|+||+....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999977521   125689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeecc-ccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          227 GLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      |+|+.......+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+..      ......
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------~~~~~g  920 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEG  920 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhC
Confidence            99995443333322222 33568999999999999999999999999999999 89999765543322      112222


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      +          ...++..++..+.+||..||+.+|++||++..|++.++.+..
T Consensus       921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1          223455677789999999999999999999999998877644

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-42  Score=319.43  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=211.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|.. .++..+|||.+....   ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5688999999999999999995 478899999876432   233457888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.........+++..++.++.||+.||+|||++   |++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998865333335789999999999999999999999   999999999999999999999999999887644


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ..........         ..
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~---------~~  224 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ---------CD  224 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhc---------CC
Confidence            3221 22346889999999998888999999999999999999999999643321    1111111111         11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+......++..+.+++.+||..||++|||+.+|++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11122234667899999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.4e-42  Score=321.10  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=205.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.. .++..||+|++..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            46799999999999999999996 46788999988765555556788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999998754    4789999999999999999999999   99999999999999999999999999998664322


Q ss_pred             cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      . ......++..|+|||.+.   ...++.++|||||||++|+|++|+.||....+.......      . ..   ....+
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~-~~---~~~~~  229 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------S-KS---NFQPP  229 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------e-cC---CCCCC
Confidence            1 122346789999999874   345788999999999999999999998644322111100      0 00   00001


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ..  .....++..+.+++.+||..+|++|||+++|+++|
T Consensus       230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11  11123556789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.1e-43  Score=332.21  Aligned_cols=242  Identities=23%  Similarity=0.335  Sum_probs=194.2

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|.++ ++..||+|.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999965 57889999886532   22334556677777654 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.++|+|||+++....... .
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence            9999998764    4689999999999999999999999   999999999999999999999999999875322211 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .   .... ....      +.++.  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~~-~~~~------~~~~~--  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FESI-RVDT------PHYPR--  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHH-HhCC------CCCCC--
Confidence            334678999999999999999999999999999999999999997544221   1   1111 1110      11111  


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  351 (413)
                        .++.++.+++.+||+.||++||++. +++++
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence              2455688999999999999999984 66655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-42  Score=330.86  Aligned_cols=242  Identities=25%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhc-CCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|.+. ++..||||.+....   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57789999886542   2233445667777775 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            9999998764    4689999999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||...+...   .   ...... ..      +.++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~i~~-~~------~~~~---  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQSIRM-DN------PCYP---  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh-CC------CCCC---
Confidence            334568999999999999999999999999999999999999997544221   1   111111 10      1111   


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG-HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  351 (413)
                       ..+...+.+++.+||+.||++||++. +++++
T Consensus       217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         217 -RWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence             12455688999999999999999997 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=318.43  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-----hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-----QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ++|.+.+.||+|++|.||+|... ++..+|+|.+.....     .....+.+|++++++++||||+++++++..+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56899999999999999999854 688999998864421     123467889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999998765    4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          233 GSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       233 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ........  ....++..|+|||++.+..++.++||||||+++|+|++|+.||........      .........    
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~----  224 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPT----  224 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCC----
Confidence            43222111  234578899999999998899999999999999999999999964332211      111111111    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                       ...    ....+...+.+++.+||..+|++|||+.+++++.
T Consensus       225 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         225 -NPQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -CCC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence             011    1223455688999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.2e-42  Score=331.14  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=199.4

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|... ++..||+|.+....   ......+..|+.++.++ +||||+.+++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999965 57789999987542   23345677899998888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  152 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T  152 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence            9999988655    4799999999999999999999999   999999999999999999999999999875322211 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..............+.........      .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~----  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI----  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----
Confidence            33467899999999999999999999999999999999999999754333222222222322222111      11    


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKM------GHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~l  352 (413)
                      +..++..+.+++.+||..||++|+++      .+++++-
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            11244567899999999999999984      5777663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-42  Score=331.66  Aligned_cols=243  Identities=24%  Similarity=0.327  Sum_probs=197.6

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||+||+|.++ ++..||||.+....   ......+..|+.+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 57789999886542   23345567788888877 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++........ .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  152 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T  152 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence            9999988765    4799999999999999999999999   999999999999999999999999999875322221 1


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ........ ..      ..+    
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~-~~------~~~----  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILE-DE------VRY----  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHc-CC------CCC----
Confidence            23356899999999999999999999999999999999999999754321      11111111 11      011    


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~l  352 (413)
                      +..++..+.+++.+||..||++||++     .+++++-
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence            12245678899999999999999999     8888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2e-42  Score=330.92  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=192.9

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHH-HHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||+||+|.+. +++.||+|.+....   ......+..|.. +++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999965 68889999886432   122233444444 56789999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence            9999998765    4789999999999999999999999   999999999999999999999999999875422221 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      .......... .      .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-~------~~----  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP-L------RL----  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC-C------CC----
Confidence            33456899999999999999999999999999999999999999754321      1122222111 0      11    


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG----HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~----eil~~  351 (413)
                      ...++..+.+++.+||+.||.+||++.    +++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            112356688999999999999999884    66654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-43  Score=335.42  Aligned_cols=238  Identities=24%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             cEEeeeCceEEEEEEE----cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           85 KVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      +.||+|+||.||++..    .++..||+|++.....  .....+..|++++++++||||+++++++......|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999974    3578899998865322  233456779999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999998765    4689999999999999999999999   999999999999999999999999999886543322 


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .........       ..+   
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~~-------~~~---  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKAK-------LGM---  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcCC-------CCC---
Confidence            2334578999999999998889999999999999999999999997543221      112221111       011   


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKMGH  347 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~~e  347 (413)
                       +..++..+.+++.+||+.||++||++.+
T Consensus       218 -p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 -PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             1224566889999999999999999444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-42  Score=333.11  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=205.5

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceeee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  146 (413)
                      .+..++|++.+.||+|+||.||+|...      +++.||+|++..... .....+..|+.++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            345668999999999999999999732      246799998864432 2335677899999999 79999999998764


Q ss_pred             -CCeeEEEEEeccCCChhhhccCCCCC-----------------------------------------------------
Q 015076          147 -GAHRMLVYEYVNNGNLEQWLHGDVGP-----------------------------------------------------  172 (413)
Q Consensus       147 -~~~~~iv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  172 (413)
                       +..++++|||+++++|.+++......                                                     
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             46788999999999999988542210                                                     


Q ss_pred             ----CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce-eecccccc
Q 015076          173 ----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTF  247 (413)
Q Consensus       173 ----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~  247 (413)
                          ..++++..+..++.||+.||+|||++   +|+||||||+|||+++++.++|+|||++.......... .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                13689999999999999999999999   99999999999999999999999999998764332221 22234567


Q ss_pred             CccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHH
Q 015076          248 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR  326 (413)
Q Consensus       248 ~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (413)
                      .|+|||++.+..++.++|||||||++|+|++ |..||......+.      +...+......         ........+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~  304 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPE  304 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHH
Confidence            8999999999999999999999999999998 9999975432211      11222211110         011224467


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          327 ILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       327 l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      +.+++.+||+.+|++||++.+|+++|+..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            89999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.9e-42  Score=322.57  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .++|++.+.||+|+||.||+|..     ..+..+++|.+.... ......+.+|+.+++.++||||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            46789999999999999999984     235679999886433 233467888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCC-------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          152 LVYEYVNNGNLEQWLHGDVG-------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      +||||+++++|.+++.....             ....+++..++.++.|++.||+|||++   +++||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence            99999999999999853211             123578899999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~  296 (413)
                      +.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||........     
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-----  235 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-----  235 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            99999999999865432211 1223345778999999988889999999999999999998 9999965432111     


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        ...+......         .....++..+.+++.+||+.||++||++.+|+++|..
T Consensus       236 --~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 --IEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              1111111110         1112245678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.9e-43  Score=322.89  Aligned_cols=249  Identities=33%  Similarity=0.562  Sum_probs=194.8

Q ss_pred             cccEEeeeCceEEEEEEEc-----CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           83 DDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +.+.||.|.||.||+|.+.     .+..|+||.+..... .....+.+|++.+++++||||+++++++......++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999966     255799998855433 3467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++|+|.++|....  ...+++..++.|+.||+.||+|||+.   +++|+||+++|||++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999998762  15799999999999999999999999   99999999999999999999999999998773222


Q ss_pred             c-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          237 S-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      . ...........|+|||.+....++.++||||||+++|||++ |+.||......      ...........        
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~~~~~~--------  223 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKLKQGQR--------  223 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccc--------
Confidence            2 12223446788999999999999999999999999999999 78888644221      11222211111        


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        ......++..+.+++..||..||++|||+.+|++.|
T Consensus       224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              112223456788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.4e-41  Score=313.96  Aligned_cols=260  Identities=23%  Similarity=0.401  Sum_probs=211.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... ++..||+|.+....   ......+.+|++++++++|+||+++++++......++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999966 78899999875422   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|..++.........+++..++.++.+++.||+|||+.   ||+|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999865433335689999999999999999999999   999999999999999999999999999886643


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....    ........... .        .
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~--------~  224 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-C--------D  224 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc-C--------C
Confidence            3221 2234578899999999888899999999999999999999999964431    11111111111 1        1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+..+...+...+.+++.+||..+|++|||+.+|++.|+..
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11122234566789999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.6e-42  Score=317.50  Aligned_cols=257  Identities=25%  Similarity=0.462  Sum_probs=208.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++..++|++.+.||+|+||.||++....+..+|+|.+.... .....+.+|+++++.++|+||+++++++.. ...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            45567899999999999999999998778889999876432 345678889999999999999999999887 7789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999976432  4678899999999999999999998   999999999999999999999999999987644


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........++..|+|||++....++.++|+|||||++|+|++ |+.||........   ..    .+.....      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~----~~~~~~~------  221 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IR----ALERGYR------  221 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHhCCCC------
Confidence            32222222345678999999988889999999999999999999 9999975432211   11    1111111      


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               01112345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.5e-43  Score=338.12  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=201.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|..+ ++..||||.+....   ......+..|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999965 58889999886432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999765    4789999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 015076          235 ESS----------------------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (413)
Q Consensus       235 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~  280 (413)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0012357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH
Q 015076          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVHML  352 (413)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~l  352 (413)
                      .||........      ......... . +   .++.  ...++..+.++|.+|+ .||.+|++   +.++++|-
T Consensus       234 ~Pf~~~~~~~~------~~~i~~~~~-~-~---~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp  294 (360)
T cd05627         234 PPFCSETPQET------YRKVMNWKE-T-L---VFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP  294 (360)
T ss_pred             CCCCCCCHHHH------HHHHHcCCC-c-e---ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence            99976543321      111111100 0 0   0111  1124456778888876 49999984   77888774

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.9e-42  Score=314.75  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=199.9

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChh
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~  163 (413)
                      ++||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988888999998765432 33456888999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeecc
Q 015076          164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV  243 (413)
Q Consensus       164 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  243 (413)
                      +++....   ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9986543   4588999999999999999999999   999999999999999999999999999976543322111222


Q ss_pred             ccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       244 ~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      .++..|+|||++.+..++.++||||||+++|+|++ |..||........   .   .. ......     .    .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~---~~-~~~~~~-----~----~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R---EQ-VEKGYR-----M----SCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H---HH-HHcCCC-----C----CCCCC
Confidence            34667999999988899999999999999999998 9999975432211   1   11 111110     0    11112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          323 LLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ++..+.+++.+||..+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.2e-42  Score=314.76  Aligned_cols=250  Identities=25%  Similarity=0.448  Sum_probs=206.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|.+.+.||+|++|.||+|..+ ++..|++|.+...  .......+..|+.+++.++||||+++++++......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999965 6888999988643  234456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999976422  5789999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||......      ......... .        .+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~--------~~  219 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRG-V--------FP  219 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-C--------CC
Confidence            22 23346789999999999999999999999999999999999999754421      111222111 1        11


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       .....+...+.+++.+||+.+|++||++.+++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             1112456678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.6e-42  Score=335.47  Aligned_cols=268  Identities=21%  Similarity=0.260  Sum_probs=207.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-C-----CCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-H-----KNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~~~~~~~~~~~  149 (413)
                      ...+|.+.++||+|.||.|.+|.+ ++++.||||++++.. .-..+...|+.+|..|+ |     -|||+++++|...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            334789999999999999999995 468999999886554 33455567999999996 3     489999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC--CceEEecc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW--NPKVSDFG  227 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG  227 (413)
                      +|||+|.+ ..+|.++|+.+.-  ..++...+..|+.||+.||.+||+.   +|||+||||+||||.+.+  .+||+|||
T Consensus       263 lciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999 6799999987643  5799999999999999999999999   999999999999997543  69999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-------
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-------  300 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-------  300 (413)
                      .++.......    +.+.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.+..+....+.-+..       
T Consensus       337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9997654321    45668899999999999999999999999999999999888888776554333211100       


Q ss_pred             --------Hhhc-CCCC------C-----------------cCCCCCC-CC------CcHHHHHHHHHHHHhcCCCCCCC
Q 015076          301 --------MVTN-RNPE------G-----------------VLDPKLP-EK------PTSRLLKRILLVALRCVDPNAQK  341 (413)
Q Consensus       301 --------~~~~-~~~~------~-----------------~~~~~~~-~~------~~~~~~~~l~~li~~cl~~dp~~  341 (413)
                              .+.. ....      .                 ..+...+ ..      .....-..+++++.+||+.||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                    0000 0000      0                 0000111 00      01112346799999999999999


Q ss_pred             CCCHHHHHHHHhcc
Q 015076          342 RPKMGHVVHMLEAQ  355 (413)
Q Consensus       342 RPs~~eil~~le~~  355 (413)
                      |+|..++++|-...
T Consensus       493 R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  493 RITPAQALNHPFLT  506 (586)
T ss_pred             cCCHHHHhcCcccc
Confidence            99999999985443

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-42  Score=328.92  Aligned_cols=242  Identities=23%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHH-HHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|.+. ++..||+|.+....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999965 57889999886432   12233444454 467889999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence            9999888654    4688999999999999999999999   999999999999999999999999999875322211 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      ..........       ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~-------~~~~---  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP-------LQLP---  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC-------CCCC---
Confidence            33457899999999999889999999999999999999999999754321      1122222111       0111   


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG----HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~----eil~~  351 (413)
                       ......+.+++.+||+.||.+||++.    +++++
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence             12345688999999999999999764    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4e-42  Score=344.77  Aligned_cols=269  Identities=22%  Similarity=0.292  Sum_probs=197.1

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC------CCCcccccceeee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR------HKNLVRLLGYCAE  146 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~  146 (413)
                      +....++|++.++||+|+||+||+|.+. .+..||||++.... .....+..|+.+++.++      |.+++.+++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4456688999999999999999999965 57789999885432 22334555666666664      4568888888875


Q ss_pred             C-CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCC-----
Q 015076          147 G-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHW-----  219 (413)
Q Consensus       147 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~-----  219 (413)
                      . .+.++|||++ +++|.+++...    ..+++..+..|+.||+.||+|||+ .   |||||||||+|||++.++     
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence            4 5789999998 77898888765    479999999999999999999997 6   999999999999998765     


Q ss_pred             -----------CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          220 -----------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       220 -----------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                                 .+||+|||++......    ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                       4899999988643221    2346789999999999999999999999999999999999999986654


Q ss_pred             cccccHHHHHHH-----------------Hhhc-CCCCCcCCCC----C-CCC--CcHHHHHHHHHHHHhcCCCCCCCCC
Q 015076          289 PEEVNLIEWLKK-----------------MVTN-RNPEGVLDPK----L-PEK--PTSRLLKRILLVALRCVDPNAQKRP  343 (413)
Q Consensus       289 ~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~----~-~~~--~~~~~~~~l~~li~~cl~~dp~~RP  343 (413)
                      .+....+.....                 .... .......++.    + ...  ........+.+||.+||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            332222211100                 0000 0000000000    0 000  0000134577999999999999999


Q ss_pred             CHHHHHHHHhcc
Q 015076          344 KMGHVVHMLEAQ  355 (413)
Q Consensus       344 s~~eil~~le~~  355 (413)
                      |+.|+++|-...
T Consensus       431 ta~e~L~Hp~~~  442 (467)
T PTZ00284        431 NARQMTTHPYVL  442 (467)
T ss_pred             CHHHHhcCcccc
Confidence            999999986544

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.9e-42  Score=315.69  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=197.6

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      +.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 68889999875443 34456788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee-e
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-T  241 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~  241 (413)
                      .+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99986542   4689999999999999999999999   999999999999999999999999999876543211111 1


Q ss_pred             ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCc
Q 015076          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (413)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (413)
                      ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.......       ..........     .    ...
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~-----~----~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVR-----L----PCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC-----C----CCc
Confidence            1123457999999999999999999999999999998 888986433211       1111111100     0    111


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          321 SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..++..+.+++.+||..+|++|||+.++++.|.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-42  Score=323.94  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=204.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..+|++.+.||+|+||.||+|...+      +..||+|.+..... .....+..|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            3458888999999999999998532      46799998865443 2345688899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          151 MLVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      ++++||+.+++|.+++....            .....+++..++.++.|++.||+|||+.   ||+||||||+|||++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999985321            1123588899999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~  296 (413)
                      +.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....      .
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~  234 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D  234 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence            99999999998865432221 1223345789999999988889999999999999999998 88888754322      1


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...... .....         .....++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       235 ~~~~i~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIR-NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHH-cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            122221 11110         1122355668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.6e-42  Score=322.90  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=207.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..+|++.+.||+|+||.||+|... ++..|++|.+..........+..|+.+++.+.||||+++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            457999999999999999999954 6888999998776655667788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...     .+++..+..++.|++.||+|||+.   ||+|+||||+|||++.++.++|+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999998643     578999999999999999999999   99999999999999999999999999987654332


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........      .........        ..
T Consensus       171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~--------~~  235 (296)
T cd06654         171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--------PE  235 (296)
T ss_pred             cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCC--------CC
Confidence            21 2234688999999999888899999999999999999999999975443211      111111110        01


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ......+...+.+++.+||..+|++|||+.+|+.+-
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence            111234556788999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-42  Score=324.75  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=209.2

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      ++++..++|++.+.||+|+||.||++.+..      ...+|+|.+.... ......+..|+.+++++ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            355667889999999999999999998642      3568999876542 23345688899999999 799999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      ..+...+++|||+++++|..++....            .....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence            99999999999999999999986431            1235689999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999998764332211 112234678999999988999999999999999999997 999986543221


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .      ... ......     .    .....+...+.+|+.+||..||++|||+.++++.|+.+
T Consensus       243 ~------~~~-~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 L------FKL-LKEGYR-----M----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H------HHH-HHcCCc-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1      111 111110     0    11122355788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.3e-42  Score=329.33  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +|+..+.||+|+||.||+|... ++..||+|.+....   ......+..|+.+++.+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788899999999999999965 68889999886532   233445677888888885 577888999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999998765    4799999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .........       ..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~-------~~  219 (323)
T cd05615         154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN-------VS  219 (323)
T ss_pred             CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            221 1234568999999999999999999999999999999999999997554221      122222111       01


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHM  351 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~  351 (413)
                      +    +..++..+.+++.+||+.+|.+|++.     .+++++
T Consensus       220 ~----p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         220 Y----PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             C----CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            1    12245568899999999999999974     455554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=321.89  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=207.0

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      +..++|++.+.||+|+||.||+|..+.      +..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            456789999999999999999998642      3579999876443 233457888999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVG------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ..++||||+++++|.+++.....      ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999999865321      113478899999999999999999999   999999999999999999999


Q ss_pred             EEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 015076          223 VSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      |+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   .   ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~---~~  233 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---L---KF  233 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---H---HH
Confidence            9999998765433221 1223446788999999988889999999999999999998 9999975443221   1   11


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      . .....     ...+    ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       234 ~-~~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 V-IDGGH-----LDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             H-hcCCC-----CCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1 11111     1111    123567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.8e-42  Score=320.04  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=201.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .++|++.+.||+|+||.||+|.+. ++.    ++++|.+..... ....++..|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            457899999999999999999964 343    477787654332 234567788889999999999999998764 4578


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +++||+++|+|.+++....   ..+++..++.++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.
T Consensus        85 ~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            9999999999999997643   4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          232 LGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......       ....+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~  231 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA  231 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC
Confidence            643322 11233456778999999988899999999999999999998 999997554321       111222211100


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                           .+    ..+...+..++.+||..||++|||+.++++.|....
T Consensus       232 -----~~----~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         232 -----QP----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             -----CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 01    112345788999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-41  Score=316.75  Aligned_cols=253  Identities=23%  Similarity=0.396  Sum_probs=203.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.++||+|+||.||+|.+ .++..||+|.+.... ......+..|+.++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4688999999999999999995 467889999886543 33446788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|..+        ..+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            999998654        2478888999999999999999999   99999999999999999999999999998654321


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... .......... ....        
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------  217 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDP--------  217 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCC--------
Confidence               23356899999999999989999999999999999999999999653322111 1111111111 1111        


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +......++.++.+++.+||+.+|++||++.+++++...
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence            111122245578899999999999999999999987544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-42  Score=323.51  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-----CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee--CCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  150 (413)
                      ..+|++.+.||+|+||.||+|..+     ++..||+|.+..........+..|+++++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357899999999999999999742     477899999876665666788999999999999999999997643  3568


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+||++++++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            99999999999999997543   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccc---------ccHHHHHH
Q 015076          231 LLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE---------VNLIEWLK  299 (413)
Q Consensus       231 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~---------~~~~~~~~  299 (413)
                      ..........  ....++..|+|||++.+..++.++|||||||++|||++|..|+........         ......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            7654332211  112234569999999888899999999999999999998777542211000         00000011


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......         ........++..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111         00011223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-41  Score=318.91  Aligned_cols=247  Identities=23%  Similarity=0.283  Sum_probs=196.1

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||+|+||.||++..+ ++..||+|.+....   ......+..|+++++.++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999955 58899999885432   12234556699999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++.....  ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~  153 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ  153 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence            988854321  4588999999999999999999999   999999999999999999999999999987654322  233


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...........         ... .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~---------~~~-~~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED---------EVK-FEHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc---------ccc-ccccc
Confidence            4689999999999988899999999999999999999999975432111  11111211111         110 11123


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ++.++.+++.+||+.||++||++.|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            566789999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-41  Score=325.99  Aligned_cols=256  Identities=21%  Similarity=0.270  Sum_probs=201.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||++..+ ++..+|+|.+.+..   ......+..|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999965 46779999885422   223345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++|+|.+++....   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999997632   4689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||......      .....+......  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~--  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKER--  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcc--
Confidence            3333333457999999999886     346889999999999999999999999754322      222222221110  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~l  352 (413)
                         ..++. ....++..+.+++.+|+..++.+  |+++.+++++-
T Consensus       227 ---~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         227 ---FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             ---ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence               01111 11234567888888888654444  78999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-42  Score=331.11  Aligned_cols=238  Identities=24%  Similarity=0.299  Sum_probs=189.7

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHH-HHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|.+. ++..||+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999966 56789999886432   12223333343 456788999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++...    ..+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~  152 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T  152 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence            9999999765    4688899999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...      ......... .          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~-~----------~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKP-L----------QL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-c----------CC
Confidence            334579999999999999999999999999999999999999997544221      122222111 0          11


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGH  347 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~e  347 (413)
                      ...++..+.+++.+||+.||.+||++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            1234566889999999999999998774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-41  Score=314.67  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=204.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +|++.+.||.|+||.||++.+. ++..+|+|.+... .......+..|+.+++.++|+||+++++.+..+...+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5888999999999999999965 6888999988543 2344567788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||++   +|+|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999998865322  4688999999999999999999999   999999999999999999999999999987643322


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+...      ...... .....         
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~---------  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVC-QGSYK---------  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHh-cCCCC---------
Confidence             1233568899999999998889999999999999999999999997543211      111111 11110         


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .....++..+.+++.+||+.||++|||+.+|+..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1112345568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-42  Score=326.38  Aligned_cols=269  Identities=23%  Similarity=0.313  Sum_probs=204.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|.+.+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            367999999999999999999965 57789999886443 2233456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++ +|.+++....   ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++......
T Consensus        85 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          85 YLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9964 8888876542   4588999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH---------HHhhcC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK---------KMVTNR  305 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~  305 (413)
                      ... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....         ......
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         158 TKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             ccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            221 223457899999998865 468999999999999999999999997665433222221100         000000


Q ss_pred             CCCCcCCCCCC----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          306 NPEGVLDPKLP----EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       306 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .......+...    ......++.++.+++.+||..||.+|||+.+++++..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence            00000000000    00112245678899999999999999999999987544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-42  Score=334.65  Aligned_cols=267  Identities=18%  Similarity=0.248  Sum_probs=205.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      +...+|++.+.||+|+||.||+|...   .+.+||+|.+...     ....+|+++++.++||||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            34567999999999999999999753   3567999977543     234579999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +||++ +++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.++|+|||++...
T Consensus       164 v~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             Eehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999 46888888543    5799999999999999999999999   9999999999999999999999999999766


Q ss_pred             CCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC---
Q 015076          233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---  308 (413)
Q Consensus       233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---  308 (413)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..+.+.+......   
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            443221 1234578999999999999999999999999999999999999997665443222222221111110000   


Q ss_pred             --------------CcCCCCCCCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 --------------GVLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 --------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                                    ....+.....   ....+..++.++|.+||..||++|||+.+++.+-...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                          0000000000   0012345678899999999999999999999986543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=324.74  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=215.4

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      =|.+.+.||+|.|+.|-+|++ -+|.+||||++.+..-  .....+.+|++.|+.++|||||++|++......+|+|+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            378889999999999999984 4899999999976543  3345788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-CCCCceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~  235 (413)
                      -++|+|++||.+..   ..+.+..+.+++.||+.|+.|+|+.   .+|||||||+||.+- +-|-+||+|||++..+.++
T Consensus        99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999997765   5799999999999999999999999   999999999999775 5688999999999887655


Q ss_pred             CcceeeccccccCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ..  ..+.||+..|-|||++.+..|+ +++||||||+|||.|++|+.||+..+..+.+.++               +|-+
T Consensus       173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDCK  235 (864)
T KOG4717|consen  173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDCK  235 (864)
T ss_pred             ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hccc
Confidence            43  5667999999999999999887 5789999999999999999999876665554433               2222


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +  ..+...++++.+||..||..||.+|.+.+||+..-+-
T Consensus       236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            2  3456788999999999999999999999999987543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=314.75  Aligned_cols=251  Identities=29%  Similarity=0.456  Sum_probs=207.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..++|++.+.||.|+||.||+|... ++.||+|.+..... ....+..|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            4567999999999999999999876 78899998865544 466788899999999999999999999989999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            999999999976421  3689999999999999999999999   99999999999999999999999999998763322


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .    ....+..|+|||.+....++.++||||||+++|+|++ |..||.......       +...+.....     .  
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-----~--  218 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYR-----M--  218 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC-----C--
Confidence            1    2234668999999988889999999999999999997 999986443211       1111111110     1  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        .....++..+.+++.+||..+|++|||+.++++.|+.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              1112345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-41  Score=323.15  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=205.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+..|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46999999999999999999965 56778888776442 23345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ .   +++|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999765    578999999999999999999997 5   8999999999999999999999999998755322


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC--------
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP--------  307 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  307 (413)
                      .   .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+....................        
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            1   23456899999999998888999999999999999999999999654322111100000000000000        


Q ss_pred             -------------CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          308 -------------EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       308 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                   ..+.....+..+...++..+.+++.+||..+|++|||+.+|+++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                         00000000111112255678999999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.9e-42  Score=317.54  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      +..++|.+.+.||+|+||.||+|.+.+    ...|+||...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            345679999999999999999998543    2468999876554 3455678899999999999999999998876 457


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.++|+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence            89999999999999997643   3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..............++..|+|||.+....++.++|||||||++|+|++ |..||......+.      ..........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~--  227 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL--  227 (270)
T ss_pred             ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC--
Confidence            765443322222334568999999988889999999999999999986 9999975543221      1111111100  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                              .....++..+.+++.+||..+|++|||+.+++..|+...
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    111234567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-42  Score=320.29  Aligned_cols=267  Identities=24%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             CC-CcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeC--Cee
Q 015076           80 GF-SDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (413)
Q Consensus        80 ~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  150 (413)
                      +| ++.+.||+|+||+||++..     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 8899999999999988753     3467899998865432 3456778899999999999999999987653  468


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++++|.+++...     .+++..++.++.|++.||+|||++   +|+||||||+|||+++++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence            9999999999999999653     589999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcce--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .........  .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... .................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence            765432211  122235667999999988889999999999999999999999986432210 00000000000000000


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+..........++..+.+++.+||+.+|++|||+++|++.|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00001111111223456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.6e-42  Score=320.64  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=206.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..+|++.+.||+|+||.||++...      ++..+|+|.+..........+..|+++++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            467888999999999999999732      34568899877666666678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC
Q 015076          152 LVYEYVNNGNLEQWLHGDVG-----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN  220 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~  220 (413)
                      ++|||+++++|.+++.....           ....+++..++.++.||+.||+|||+.   +++|+||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999865421           113588999999999999999999999   9999999999999999999


Q ss_pred             ceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 015076          221 PKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       221 ~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (413)
                      ++|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||........      .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence            9999999997654322211 122335678999999999999999999999999999998 9999864332211      1


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .........          .....++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       235 ~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111111100          1112244568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-41  Score=329.91  Aligned_cols=266  Identities=24%  Similarity=0.294  Sum_probs=200.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCC-----
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----  148 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999964 5888999988643  2334456778999999999999999999886443     


Q ss_pred             -eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          149 -HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       149 -~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                       ..++||||+++ +|.+.+.      ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             57999999965 6666664      2478899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH------------
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------  295 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~------------  295 (413)
                      +++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........            
T Consensus       169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            997653322  123356899999999999999999999999999999999999999865432111000            


Q ss_pred             ----HHHHHHhhcCC-CCC-cCCCCCC-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          296 ----EWLKKMVTNRN-PEG-VLDPKLP-------EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       296 ----~~~~~~~~~~~-~~~-~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          ........... ... .+....+       ..........+.+|+.+||..||++|||+.|++++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                00011111000 000 0000000       00111234568899999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.1e-42  Score=329.91  Aligned_cols=242  Identities=25%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHH-HHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|... ++..||+|.+....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 68899999886532   222334444544 56779999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence            9999988765    5799999999999999999999999   999999999999999999999999999875422211 1


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...      ......... .  .+.       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~-~--~~~-------  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKP-L--VLR-------  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCC-c--cCC-------
Confidence            234568999999999999999999999999999999999999997543221      122222111 0  011       


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG----HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~----eil~~  351 (413)
                       ...+..+.+++.+||..+|.+||++.    +++++
T Consensus       217 -~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         217 -PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             -CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence             12345678899999999999999875    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-42  Score=317.55  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=202.9

Q ss_pred             CCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHH--HHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      |++.+.||+|+||+||++.... +..+|+|.+.........  ....|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999764 568999998776544333  3355999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++...    ..+++..++.++.||++||++||+.   +|+|+||||+||+++.++.++|+|||.+..... ..
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred             cccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            999999999833    5789999999999999999999999   999999999999999999999999999986522 22


Q ss_pred             ceeeccccccCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-HhhcCCCCCcCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-MVTNRNPEGVLDPKL  315 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  315 (413)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||................. ......         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS---------  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------
Confidence            2344567899999999998 88899999999999999999999999985522222222211111 000000         


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        .........+.+++.+||+.||++|||+.+++++
T Consensus       224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0000012679999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-41  Score=321.73  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcC-CC--EEEEEEeecC-CchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLED-NS--KVAVKNLLNN-RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ++|++.++||+|+||.||+|..+. +.  .+++|.+... .......+..|+.+++++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            679999999999999999998653 32  4688877542 233456788899999999 799999999999999999999


Q ss_pred             EEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          154 YEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      |||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   ||+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999865321            113588999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||++........  ......+..|+|||++.+..++.++|||||||++|+|++ |..||.......      ....
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK  230 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence            9999999864321111  111223557999999988899999999999999999997 999997544322      1111


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .....      ..    .....++..+.+++.+||+.+|.+|||+.++++.|+....
T Consensus       231 ~~~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         231 LPQGY------RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HhcCC------CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11110      01    1112245678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-41  Score=320.18  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+..|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788999999999999999853      124588887765433 334578889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCC--------------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          153 VYEYVNNGNLEQWLHGDV--------------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      +|||+.+++|.+++....                    .....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999886421                    1123588999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998654332211 122345678999999988889999999999999999998 999997544221


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         ...    ......     ..    .....++..+.+++.+||+.+|++||++.++++.|+..
T Consensus       238 ---~~~----~~~~~~-----~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 ---LFN----LLKTGY-----RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ---HHH----HHhCCC-----CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence               111    111110     01    11223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.3e-42  Score=325.09  Aligned_cols=263  Identities=27%  Similarity=0.438  Sum_probs=207.0

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      ++..++|.+.+.||+|+||.||+|.+..        ...+|+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4445789999999999999999998531        2469999886543 33445688899999999 799999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      ......++||||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   |++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999975421            123588999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||++.++.++|+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            999999999999999987654322111 111224568999999988889999999999999999998 888986433211


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                             +...+.....         ......++..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       251 -------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 -------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -------HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                   1111111111         0111234567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.7e-43  Score=304.35  Aligned_cols=256  Identities=21%  Similarity=0.320  Sum_probs=213.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----c---hhHHHHHHHHHHHhcC-CCCCcccccceeee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----G---QAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  146 (413)
                      ..+.|...+.||.|..+.|-++.++ ++..+|+|++....     .   ...++-..|+.+|+++ .||+|+.+.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4567888899999999999988855 67789999885322     1   1223456799999998 59999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      +..+++|+|.|+.|.|+++|...    -.+++.....|++|+.+|+.|||..   +||||||||+|||++++.++||+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999877    5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      |+++.+..+..  ....||||+|+|||.+..      ..|+..+|+|++|++||.|+.|.+||....       .-.+.+
T Consensus       168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR  238 (411)
T KOG0599|consen  168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLR  238 (411)
T ss_pred             ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHH
Confidence            99998876543  455789999999998854      347888999999999999999999996332       111223


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ++..+.      -.+.+....+++....+||.+||+.||.+|.|++|.|+|.-.
T Consensus       239 ~ImeGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  239 MIMEGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             HHHhcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            333332      133445567788899999999999999999999999998544

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.7e-42  Score=319.63  Aligned_cols=258  Identities=27%  Similarity=0.456  Sum_probs=203.4

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..++|.+.+.||+|+||.||+|.+..      +..|++|.+.... ......+..|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35679999999999999999999653      4568899776443 3334568889999999999999999999998889


Q ss_pred             eEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---CceE
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKV  223 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  223 (413)
                      .++||||+++++|.+++.....   ....+++..++.++.||+.||+|||+.   +++|+||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999865421   123589999999999999999999999   999999999999998765   5899


Q ss_pred             EecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 015076          224 SDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||........      ....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~------~~~~  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------MEFV  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHH
Confidence            9999998663222111 111223568999999998999999999999999999997 9999975443221      1111


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ......          .....++..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111110          111224567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=334.64  Aligned_cols=246  Identities=31%  Similarity=0.493  Sum_probs=208.7

Q ss_pred             EEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhh
Q 015076           86 VIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ  164 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~  164 (413)
                      +||+|.||+||.|++.+ ...+|||.+........+.+..|+.+.+.|+|.|||+++|.+.+++++-|.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999764 55689999988877777888999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCC--CHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-CCCCceEEecccceecCCCCcceee
Q 015076          165 WLHGDVGPCSPL--TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITT  241 (413)
Q Consensus       165 ~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~  241 (413)
                      +|....   +++  .+...-.+.+||++||.|||.+   .|||||||-+|||++ -.|.+||+|||.++.+..-+.. +.
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TE  734 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TE  734 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-cc
Confidence            998776   456  7888899999999999999999   999999999999996 4688999999999988655443 56


Q ss_pred             ccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          242 RVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ++.||..|||||++..++  |+.++|||||||++.||.||++||-....+...     +.+.       ..+  +.-...
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkV-------Gmy--KvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKV-------GMY--KVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhh-------cce--ecCCCC
Confidence            788999999999997765  889999999999999999999999644332211     1110       000  111234


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +..++.+...+|++|+.+||.+||+++++|...
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            567888999999999999999999999999753

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.7e-42  Score=323.33  Aligned_cols=265  Identities=26%  Similarity=0.430  Sum_probs=209.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccce
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~  143 (413)
                      +.+..++|.+.+.||+|+||.||+|.+.        ++..||+|.+.... ......+..|+.+++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3466778999999999999999999742        23468999876432 33456788999999999 79999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      +......+++|||+++++|.+++.....            ....+++..++.++.||+.||.|||++   ||+||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence            9999999999999999999999975421            123578889999999999999999999   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999998765432221 122345678999999988889999999999999999998 88888644321


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                            ..... +......         .....++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       247 ------~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         247 ------ELFKL-LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ------HHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                  11111 1111110         1112355678899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.8e-42  Score=319.27  Aligned_cols=262  Identities=24%  Similarity=0.383  Sum_probs=208.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC-----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeee-CC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~  148 (413)
                      +..++|++.++||+|+||.||+|.+..     +..|++|.+.... ......+.+|+.+++.++||||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456789999999999999999999765     6778999876442 3445678889999999999999999998765 57


Q ss_pred             eeEEEEEeccCCChhhhccCCCCC----CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                      ..+++++|+++++|.+++......    ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998654221    14689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 015076          225 DFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       225 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |||+++.+....... .....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+   .   ... .
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---~~~-~  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M---AAY-L  232 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H---HHH-H
Confidence            999998654332211 122345678999999988889999999999999999999 999997543321   1   111 1


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .....       +  .....++..+.+++.+||..||++|||+.++++.|+...
T Consensus       233 ~~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 KDGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HcCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11110       0  011224567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-41  Score=317.47  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|++.+.||+|+||+||+|.+. ++.    +||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            3567999999999999999999854 343    48999886543 33456788899999999999999999998754 47


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++|+|.+++....   ..+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            89999999999999997643   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..    ..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~  230 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGERL  230 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcC
Confidence            765332211 112234678999999988899999999999999999998 899986433211   11    111111100


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                               .....++..+.+++.+||..||+.||++.+++..|+....
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     1112345678899999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-41  Score=318.90  Aligned_cols=254  Identities=22%  Similarity=0.291  Sum_probs=203.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|+..+.||+|+||.||++.+. +++.||+|.+.....   .....+..|+.+++.++|+||+.+++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3778899999999999999965 678899998865432   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999998854321  4689999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............   .......          
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~~----------  220 (285)
T cd05630         156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV----------  220 (285)
T ss_pred             cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhhh----------
Confidence            22  22346899999999999999999999999999999999999999754322111111   1111100          


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                      .......+...+.+|+.+||+.||++|||     +.+++++-.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence            00111224556889999999999999999     889988644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-41  Score=320.68  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=209.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..+|.+.+.||+|+||.||+|.. .++..||+|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            46799999999999999999995 46889999998766655667788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999998643     588999999999999999999999   99999999999999999999999999998764432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+........      ...        ....
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~--------~~~~  234 (297)
T cd06656         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN--------GTPE  234 (297)
T ss_pred             cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccC--------CCCC
Confidence            21 22346789999999999888999999999999999999999999754432211100      000        0111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ......+...+.+++.+||..+|++||++.+++++-.
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence            1122345566889999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=321.77  Aligned_cols=264  Identities=26%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC---------------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccccc
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED---------------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLL  141 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~  141 (413)
                      .++|++.+.||+|+||.||+|....               ...||+|.+.... ......+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999987542               1248999886543 33445788999999999999999999


Q ss_pred             ceeeeCCeeEEEEEeccCCChhhhccCCCC--------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcE
Q 015076          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVG--------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (413)
Q Consensus       142 ~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI  213 (413)
                      +++......++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999854321        112478899999999999999999999   999999999999


Q ss_pred             EEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCcc
Q 015076          214 LIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPE  290 (413)
Q Consensus       214 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt--g~~Pf~~~~~~~  290 (413)
                      ++++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++  +..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999765432221 1222345778999999988889999999999999999998  667876443322


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                         .+............. ...     .....++..+.+|+.+||+.||++|||+.+|++.|.
T Consensus       241 ---~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIENTGEFFRNQGRQ-IYL-----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHhhhhcccc-ccC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               111111111111000 000     011123457999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=354.54  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=202.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee--CC
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GA  148 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~  148 (413)
                      .....++|++.+.||+|+||+||+|.+. .+..||+|.+....  ......+..|+.+++.|+|||||+++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            4556789999999999999999999965 46678899876432  2345678889999999999999999998854  46


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc----CCceeeccCCCCcEEEcC-------
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL----EPKVVHRDIKSSNILIDK-------  217 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~----~~~ivH~Dlkp~NIll~~-------  217 (413)
                      .+||||||+++++|.++|.........+++..++.|+.||+.||+|||+..    ..+||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            789999999999999999754333357999999999999999999999851    015999999999999964       


Q ss_pred             ----------CCCceEEecccceecCCCCcceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015076          218 ----------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDY  285 (413)
Q Consensus       218 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~  285 (413)
                                .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||+|++|..||..
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      2348999999998664322  1234578999999999854  4588999999999999999999999975


Q ss_pred             CCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .....     ..+.. +...       +.+   +...++..+.+||..||..+|.+||++.++|.+
T Consensus       246 ~~~~~-----qli~~-lk~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANNFS-----QLISE-LKRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcHH-----HHHHH-HhcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            43211     11111 1111       111   111235678899999999999999999999965

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-41  Score=319.84  Aligned_cols=265  Identities=25%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeC
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  147 (413)
                      ++..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456678999999999999999999753      244799998754432 2334677899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVG------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      ...++||||+++|+|.+++.....      ....+++..+..++.|++.||.|||++   +|+||||||+|||+++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999964321      123457788899999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      +|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+      ...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~  232 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLK  232 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            999999988653322211 122235678999999998899999999999999999998 788986543221      111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                      ........      ..    ...++..+.+++.+||+.||++|||+.++++.|.....+
T Consensus       233 ~~~~~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         233 FVMDGGYL------DQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             HHHcCCCC------CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence            11111111      01    112346789999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-41  Score=320.28  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=196.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCCcccccceeee-----CC
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCAE-----GA  148 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~-----~~  148 (413)
                      +|++.+.||+|+||.||+|.+. +++.||+|.+.....  .....+..|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999965 578899998864321  2223455677766655   79999999998754     34


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..+++|||+. ++|.+++.....  ..+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            6799999996 588888865422  4589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC---
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---  305 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---  305 (413)
                      +........  .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........   +.......   
T Consensus       155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLIGLPPED  229 (288)
T ss_pred             cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH---HHHHhCCCChh
Confidence            987643221  2334679999999999888999999999999999999999999975543222111   11111100   


Q ss_pred             -CC------CCcCCCCCC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 -NP------EGVLDPKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 -~~------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ..      ...+.+...   ......+...+.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00      000000000   00112345678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-41  Score=314.69  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=198.0

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCC---EEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC------Ce
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------AH  149 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~  149 (413)
                      |.+.+.||+|+||.||+|.+..+.   .+|+|.+...  .......+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            457789999999999999965432   5899987543  233456788899999999999999999876432      34


Q ss_pred             eEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      .+++|||+++++|.+++....  .....+++..++.++.|++.||+|||++   +|+||||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874321  1124589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          228 LAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       228 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ++........... ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.......      ... .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~-~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYD-YLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH-HHHcC
Confidence            9987654322111 12245678999999999999999999999999999999 899997533211      111 12211


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...     .    ....++..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       231 ~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRL-----K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCC-----C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            110     0    111244568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-41  Score=316.19  Aligned_cols=256  Identities=29%  Similarity=0.462  Sum_probs=205.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-C---CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-D---NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... ......+..|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357889999999999999999854 2   3368999876543 2334678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            999999999999997653   4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceee--ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      .........  ...++..|+|||.+.+..++.++|+|||||++|++++ |..||......+   ..   ........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~~~~~~---  227 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI---KAIEEGYR---  227 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH---HHHhCCCc---
Confidence            543222111  1223568999999998899999999999999999886 999997544322   11   11111100   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .  .....++..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       228 -----~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -----L--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----C--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 0  11122456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-41  Score=323.13  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC--EEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS--KVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||.||+|.++ ++.  .+++|.+.... ......+.+|+.++.++ +||||+++++++......+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            4568999999999999999999965 344  35777665432 33456788899999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          152 LVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      +||||+++++|.+++.....            ....+++..++.++.||+.||+|||+.   ||+||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999865321            113588999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (413)
                      .+||+|||++........  .....++..|+|||++.+..++.++|||||||++|+|+| |..||......+      ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~  233 (303)
T cd05088         162 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY  233 (303)
T ss_pred             cEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH
Confidence            999999999864321111  111224667999999988889999999999999999998 999997544321      11


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ... ....     ..    ......+..+.+++.+||+.+|++||++.+++..|+...
T Consensus       234 ~~~-~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         234 EKL-PQGY-----RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HHH-hcCC-----cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111 1110     00    011123456889999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-41  Score=328.95  Aligned_cols=266  Identities=24%  Similarity=0.287  Sum_probs=201.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC-----
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----  147 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----  147 (413)
                      ...++|++.+.||+|+||.||+|.+. .+..||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35678999999999999999999854 58889999886532  23345677899999999999999999988543     


Q ss_pred             -CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          148 -AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       148 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                       ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             357999999965 67776642      478899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH-----------
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI-----------  295 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~-----------  295 (413)
                      |+++......  ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+..........           
T Consensus       164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998654322  223456899999999999999999999999999999999999999765422211100           


Q ss_pred             -----HHHHHHhhcCC-CCCcC------CCCCC--CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          296 -----EWLKKMVTNRN-PEGVL------DPKLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       296 -----~~~~~~~~~~~-~~~~~------~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           ........... .....      +...+  ..........+.+|+.+||..||++|||+.+++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence                 00011111100 00000      00000  0111223456889999999999999999999999843

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-41  Score=316.22  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            457889999999999999999854 5888999988766555556678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999998765    5789999999999999999999999   99999999999999999999999999987664322


Q ss_pred             cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      . ......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+....      .........    .+
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~----~~  229 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQ----PP  229 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCC----CC
Confidence            1 123356899999999874   456889999999999999999999998644322111      111111100    01


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ....  ...++..+.+++.+||..+|++|||+.+|+++
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            1111  11244568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-41  Score=313.69  Aligned_cols=250  Identities=29%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccccccee-eeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~iv~e  155 (413)
                      ...+|++.+.||+|+||.||++... +..+|+|.+....  ....+..|+.++++++|+|++++++++ ......+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            3467999999999999999999865 7789999875432  345688899999999999999999975 45567899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..++.++.|++.||+|||++   |++||||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            9999999999876432  3588999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .    ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......      .... +.....     . 
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~-~~~~~~-----~-  218 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR-VEKGYK-----M-  218 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HhcCCC-----C-
Confidence            2    22234668999999988889999999999999999997 999986433211      1111 111111     1 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .....++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 ---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               1112345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-41  Score=314.36  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=201.5

Q ss_pred             CCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe-----
Q 015076           81 FSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  149 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-----  149 (413)
                      |.+.+.||+|+||.||+|....    +..||+|.+....  ......+..|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998542    3679999886543  2334578889999999999999999998765543     


Q ss_pred             -eEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          150 -RMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       150 -~~iv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                       .+++|||+++++|..++....  .....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             799999999999999885432  1224689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          227 GLAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       227 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      |+++.......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.......      ........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcC
Confidence            99987643322211 11234678999999988899999999999999999999 889986543221      11111111


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      . .     ..    ....++..+.+++.+||..||++|||+.++++.|+..
T Consensus       232 ~-~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 N-R-----LK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C-C-----CC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1 1     01    1123456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-41  Score=313.00  Aligned_cols=252  Identities=26%  Similarity=0.493  Sum_probs=203.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      ..+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|+++++.++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            35688899999999999999998778889999875433 33456888999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++....   ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            9999999987543   4688999999999999999999999   999999999999999999999999999886643322


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||......      ..........   ....+   
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~---~~~~~---  223 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINAGF---RLYKP---  223 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhCCC---CCCCC---
Confidence            11222234678999999988889999999999999999998 99999643321      1111111110   00111   


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          ...+..+.+++.+||..+|++|||+.+++++|
T Consensus       224 ----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 ----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                11346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-41  Score=319.66  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=209.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .+|++.+.||.|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4699999999999999999985 468899999987665556677889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|..++...     .+++..+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999988643     589999999999999999999999   999999999999999999999999999886644322


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      . .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....      ..........        ..
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~~~--------~~  235 (296)
T cd06655         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTP--------EL  235 (296)
T ss_pred             c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCc--------cc
Confidence            1 2234678899999999988899999999999999999999999975543221      1111111100        01


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....++..+.++|.+||..||++|||+.+|+.+-...
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            11223456788999999999999999999999875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=326.05  Aligned_cols=267  Identities=27%  Similarity=0.430  Sum_probs=219.5

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +...+...+.+.||+|-||.|.+|......+||+|++....... ..+|..|+++|.+|+||||+.++++|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            45667788999999999999999998888999999998776544 47999999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      +||+++|+|.+++..+..+  .+.......|+.||+.||+||.+.   ++|||||.+.|+|++.++++||+|||+++-+-
T Consensus       614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999876432  245566778999999999999999   99999999999999999999999999999665


Q ss_pred             CCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          234 SESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       234 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .+..+.. ...+-..+|||+|.+.-++++.+||+|+||++|||+++  ...||.....+..   ++-...++.......+
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV  765 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee
Confidence            5444433 34566889999999999999999999999999999875  7888875443322   2222333333222221


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      +      ..+.-++..+.++|++||..|-++||+++++..+|...
T Consensus       766 l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 L------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1      22334667788999999999999999999999988754

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-41  Score=314.94  Aligned_cols=256  Identities=29%  Similarity=0.489  Sum_probs=204.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCC---EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++|+..+.||+|+||.||+|... ++.   .+|+|.+.... ......+..|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999965 232   68999876543 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999987543   4689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceee--ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      .........  ....+..|+|||++.+..++.++|||||||++|+|++ |+.||......      .....+ ....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-~~~~---  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-NDGF---  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-hcCC---
Confidence            432221111  1123457999999988889999999999999999997 99999654321      111111 1110   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          ..  .....++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       228 ----~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RL--PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                00  11122456788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=321.53  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=208.2

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +.+..++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+..|+.+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3456678999999999999999999742      24468999876543 33345788999999999 7999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      ..+..+++|||+++++|.+++.....  ..+++..++.++.|++.||+|||++   +|+|+||||+|||++.++.++|+|
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            99999999999999999999975432  3489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhh
Q 015076          226 FGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       226 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      ||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........      +.....
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~  258 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIK  258 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHH
Confidence            9999866433221 1222345778999999999999999999999999999998 9999875432211      111111


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ....     .    ......+..+.+++.+||..+|++|||+.++++.|+..
T Consensus       259 ~~~~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGYR-----M----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCc-----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1110     0    01112345789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-41  Score=318.46  Aligned_cols=264  Identities=25%  Similarity=0.422  Sum_probs=203.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-----------------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccc
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-----------------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~  139 (413)
                      .++|++.+.||+|+||.||++.+.                 +...+|+|.+.... ......+..|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457999999999999999998643                 13358999886543 334567889999999999999999


Q ss_pred             ccceeeeCCeeEEEEEeccCCChhhhccCCCCC-------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      +++++......+++|||+++++|.+++......       ...+++..++.++.|++.||+|||+.   |++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       12477889999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPP  289 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt--g~~Pf~~~~~~  289 (413)
                      ||++.++.++|+|||++......... ......++..|++||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999865432211 1222334678999999888889999999999999999998  77888654332


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ...   ............. ...+     ....++..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 ~~~---~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVI---ENTGEFFRDQGRQ-VYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH---HHHHHHHhhcccc-ccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211   1111111111000 0001     11124467889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-41  Score=333.00  Aligned_cols=264  Identities=25%  Similarity=0.427  Sum_probs=208.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~  145 (413)
                      +++..++|.+.+.||+|+||.||+|.+.      .+..||+|++..... .....+..|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            5566778999999999999999999854      245799999865432 33456888999999997 999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCC------------------------------------------------------
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVG------------------------------------------------------  171 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~------------------------------------------------------  171 (413)
                      .....++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          172 ----------------------------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       172 ----------------------------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                                                              ....+++..++.++.||+.||+|||+.   +|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    112467788899999999999999998   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||+++++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            999999999999999999865332211 1222356788999999988889999999999999999998 89998644322


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      +.      ....+.....     .    ..+..++..+.+++.+||..+|.+||++.+|++.|+..
T Consensus       349 ~~------~~~~~~~~~~-----~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQ------FYNAIKRGYR-----M----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH------HHHHHHcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11      1111111110     0    11122456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-41  Score=313.34  Aligned_cols=249  Identities=25%  Similarity=0.442  Sum_probs=202.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch---------hHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      +|.+.+.||+|+||.||+|... ++..+|+|.+......         ....+..|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 5788999988654321         22467889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+++|||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999765    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc-----eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          230 KLLGSESSY-----ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       230 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      +........     ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......      .+..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-  226 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGE-  226 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhc-
Confidence            876422111     1122457889999999988889999999999999999999999997543211      1111111 


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                           ...+.+    ...++..+.+++.+||+.||.+||++.+|+++
T Consensus       227 -----~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 -----NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                 011111    12345678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-41  Score=312.44  Aligned_cols=245  Identities=28%  Similarity=0.464  Sum_probs=195.8

Q ss_pred             EEeeeCceEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           86 VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      .||+|+||.||+|.++   ++..+|+|++....  ......+..|+.+++.++||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999743   46789999875443  2345678889999999999999999998754 5678999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  240 (413)
                      +|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999754    4689999999999999999999999   999999999999999999999999999987654332211


Q ss_pred             --eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          241 --TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       241 --~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                        ....++..|+|||.+....++.++|||||||++|||++ |..||.......   ..   . .+.....     ...+ 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~---~-~i~~~~~-----~~~~-  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VT---Q-MIESGER-----MECP-  220 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---H-HHHCCCC-----CCCC-
Confidence              11234578999999988889999999999999999998 999997543221   11   1 1221111     1111 


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ..++..+.++|.+||+.||++||++.+|...|+.
T Consensus       221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence               1245678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=313.73  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=215.2

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      |.+++.||+|+||.||+|.++ .|..+|||.+..+  .+.+++..|+.++++.+.|+||++|+.+.....++||||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            778889999999999999966 5888999988544  5677888999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      |++.+++..+.   .+|.+.++..++...++||+|||..   .-||||||..||||+-+|.+||+|||.|-.+.+... .
T Consensus       113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K  185 (502)
T KOG0574|consen  113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K  185 (502)
T ss_pred             CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence            99999997665   6899999999999999999999998   889999999999999999999999999987755433 3


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      ..++.||+.|||||++..-.|+.++||||||++..||..|++||..-.+....+++       .       -++......
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------P-------T~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------P-------TKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------c-------CCCCCCCCC
Confidence            56688999999999999999999999999999999999999999755554443332       0       112222234


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +...+.++.+++..||-.+|++|-|+..+++|-
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            567888999999999999999999999998873

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=311.61  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=208.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357999999999999999999964 5778999988766655667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999987642   4689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeeccccccCccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      . ......++..|+|||.+.+.   .++.++|||||||++|+|++|+.||..........      .......     .+
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~~~~~~-----~~  223 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSNF-----PP  223 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhccC-----CC
Confidence            1 12335678899999998776   78999999999999999999999997544322111      1111100     00


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ........++..+.+++.+||..+|..|||+.+|+.+
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 -PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0011233466789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.3e-41  Score=316.75  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=201.9

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|+..+.||+|+||+||+|.+. +++.||+|.+.....   .....+..|+++++.++|+||+.+++.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3778899999999999999964 678899998865432   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999988864321  4699999999999999999999999   9999999999999999999999999999765433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........   +........      .  
T Consensus       156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~------~--  222 (285)
T cd05632         156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE------E--  222 (285)
T ss_pred             Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc------c--
Confidence            22  2334689999999999888999999999999999999999999975433221111   111111110      0  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  351 (413)
                        .....++..+.+|+..||+.||++||+     +.+++.+
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              111234556789999999999999999     6777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-41  Score=321.66  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=204.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||.|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            467999999999999999999965 57889999886443 2334467789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++ ++|.+++....   ..+++..++.++.||+.||+|||+.   +|+|+||||+|||++.++.++|+|||++......
T Consensus        85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            996 58988886543   4688999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC---CCCCcC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR---NPEGVL  311 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  311 (413)
                      ... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+...   .+...+...   .....+
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhh
Confidence            221 2223568899999988654 57889999999999999999999997654332211   111111100   000000


Q ss_pred             ------CCCCCC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 ------DPKLPE-------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ------~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                            ....+.       .....++..+.+||.+||+.||.+|||+.+++++-..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                  000000       0112345678899999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.9e-41  Score=315.43  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=203.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcC-C---CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLED-N---SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .+|++.+.||+|+||.||+|.... +   ..||||.+.... ......+..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            458899999999999999999653 3   359999886542 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++....   ..+++..++.++.|++.||+|||++   |++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999987643   4689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcce--eeccc--cccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          234 SESSYI--TTRVM--GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       234 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......  .....  .+..|+|||.+.+..++.++|||||||++|||++ |..||......+   ...   .......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~---~i~~~~~--  229 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN---AIEQDYR--  229 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH---HHHcCCc--
Confidence            322211  11111  2457999999998999999999999999999886 999996543221   111   1111100  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                            .  .....++..+.+++.+||..+|.+||++.+|+..|+..
T Consensus       230 ------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ------L--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0  11123445688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4e-41  Score=317.20  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=205.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .+.|++.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            466999999999999999999965 4788999988766656667788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|..++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            99999988875532   4689999999999999999999999   99999999999999999999999999987643322


Q ss_pred             cceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          237 SYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      . ......++..|+|||++.     ...++.++|||||||++|+|++|..||......      ...........     
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-----  232 (292)
T cd06644         165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP-----  232 (292)
T ss_pred             c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCC-----
Confidence            1 123345788999999884     345788999999999999999999999654321      11111111111     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                       +..  .....++..+.+++.+||..+|++||++.+++++-
T Consensus       233 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  270 (292)
T cd06644         233 -PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP  270 (292)
T ss_pred             -ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             000  11223456788999999999999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-41  Score=324.58  Aligned_cols=267  Identities=26%  Similarity=0.427  Sum_probs=209.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccc
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLG  142 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~  142 (413)
                      ++++...+|++.+.||+|+||.||+|.+..        ...||+|.+.... ......+..|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            456666789999999999999999997421        2358999776432 23456788999999999 7999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCC
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp  210 (413)
                      ++......+++|||+++++|.+++.....            ....+++..++.++.|++.||+|||++   |++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence            99999999999999999999999865321            123588899999999999999999999   999999999


Q ss_pred             CcEEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 015076          211 SNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (413)
Q Consensus       211 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~  288 (413)
                      +|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999998764332211 111234567999999999999999999999999999998 8899865432


Q ss_pred             cccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                      .+      ..... ......         .....++..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       243 ~~------~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 EE------LFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HH------HHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            21      11111 111110         11123455788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-41  Score=316.38  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||+||++... ++..||+|.+.... ......+.+|+++++.++||||+++++++......++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            3567999999999999999999965 57889999876543 344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.+++.||.|||+..  +++|+||||+||++++++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999999998764    47899999999999999999999632  899999999999999999999999999865422


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc-----cccHHHHHHHHhhcCCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE-----EVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..   .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......     ...............    
T Consensus       157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            21   223568999999999988899999999999999999999999997544321     111122222222211    


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                           .+......++..+.+++.+||+.||++|||+.|++++...+.
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                 111112235567899999999999999999999999865543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.8e-41  Score=312.65  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +|++.+.||+|+||.||+|...++..+|+|.+.....      .....+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            5889999999999999999987889999998864421      1234678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999765    4689999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCC-----cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          234 SES-----SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       234 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ...     ........++..|+|||++.+..++.++|||||||++|+|++|..||...+.....      ......... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCC-
Confidence            211     11122346889999999999888999999999999999999999999754322111      111111000 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         .+.+    ...+...+.+++.+||..+|++||++.+++.+
T Consensus       227 ---~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 ---MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               0111    12355678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.9e-41  Score=316.44  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=203.4

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+..|+++++.++||||+++++++..+...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            678889999999999999966 4667888888665555567788899999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++.+..   .++++..+..++.|++.||.|||+.   |++||||||+|||++.++.++|+|||++........ .
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            99999876532   4789999999999999999999999   999999999999999999999999999876543221 1


Q ss_pred             eeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          240 TTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .....++..|+|||++.     +..++.++|||||||++|+|++|+.||.......      ...........      .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~------~  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPP------T  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCC------C
Confidence            23346899999999873     4557889999999999999999999996433211      11111111110      0


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .  ..+..++..+.+++.+||..||.+||++.+++++...
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  265 (282)
T cd06643         228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV  265 (282)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence            0  1112345678999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.7e-41  Score=310.68  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.... +..+++|.+.....  ...+.+|+++++.++||||+++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3679999999999999999999764 78899998864432  67889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999986543   5789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......++..|+|||++.+..++.++||||||+++|+|++|+.||..........       ......     ..  .
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~-----~~--~  218 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKP-----PP--T  218 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCC-----CC--C
Confidence            2 1233457889999999998899999999999999999999999997543321110       000000     00  1


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ......+...+.+++.+||+.||++|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            11223456678999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-41  Score=326.45  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  147 (413)
                      ..++|++.+.||+|+||.||+|.+. .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 57889999886532  33445677899999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...|+||||++ ++|.+++..      .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            35799999995 477777642      478899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH-----------
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE-----------  296 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~-----------  296 (413)
                      +++......  ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+-           
T Consensus       172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998654322  2234568999999999999999999999999999999999999997654322111110           


Q ss_pred             -----HHHHHhhcCCC-C-----CcCCCC-C--CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          297 -----WLKKMVTNRNP-E-----GVLDPK-L--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       297 -----~~~~~~~~~~~-~-----~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           .+.....+... .     ...... .  ...........+.+++.+||+.||.+|||+.+++++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence                 00000000000 0     000000 0  00011112456889999999999999999999999844

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.4e-41  Score=311.15  Aligned_cols=247  Identities=27%  Similarity=0.464  Sum_probs=195.8

Q ss_pred             EEeeeCceEEEEEEEc---CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           86 VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .||+|+||.||+|.+.   .+..||+|.+..... .....+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999754   345689998865533 334578899999999999999999998864 56899999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceee
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT  241 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  241 (413)
                      |.+++....   ..+++..++.++.|++.||+|||++   |++||||||+|||++.++.+||+|||++............
T Consensus        81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999987543   4789999999999999999999999   9999999999999999999999999999865443322111


Q ss_pred             c--cccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          242 R--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       242 ~--~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                      .  ..++..|+|||.+....++.++|||||||++|+|++ |..||......+      ... .+.....     .    .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~~-----~----~  218 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQGKR-----L----D  218 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCCCC-----C----C
Confidence            1  223578999999988889999999999999999996 999997543221      111 1111110     1    1


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+..++.++.+++.+||..+|++||++.+|.+.|+..
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1122456788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=309.90  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=204.1

Q ss_pred             cEEeeeCceEEEEEEEcC----CCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|....    +..|++|.+....... ...+..|+.+++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    7789999887654433 67888999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCC-----CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          160 GNLEQWLHGDVGP-----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       160 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ++|.+++......     ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999775211     25799999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          235 ESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ... .......++..|+|||.+....++.++|||||||++|+|++ |..||.......      ....... ...     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~-~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRK-GYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CCC-----
Confidence            332 11233457889999999988889999999999999999999 699997653221      1122211 110     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .    .....++.++.+++.+||..+|++|||+.+++++|+
T Consensus       226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 L----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0    111223567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-41  Score=325.52  Aligned_cols=264  Identities=27%  Similarity=0.419  Sum_probs=203.7

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEE------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceeee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  146 (413)
                      ....++|++.+.||+|+||.||+|.+      .+++.||||.+..... .....+..|+.++.++ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            34557899999999999999999974      2467899998865432 3345688899999999 68999999998765


Q ss_pred             C-CeeEEEEEeccCCChhhhccCCCC------------------------------------------------------
Q 015076          147 G-AHRMLVYEYVNNGNLEQWLHGDVG------------------------------------------------------  171 (413)
Q Consensus       147 ~-~~~~iv~e~~~~gsL~~~l~~~~~------------------------------------------------------  171 (413)
                      . ...+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 567999999999999999864321                                                      


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce-ee
Q 015076          172 ---------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TT  241 (413)
Q Consensus       172 ---------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~  241 (413)
                               ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......... ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                     012468888999999999999999999   99999999999999999999999999998653322211 12


Q ss_pred             ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCc
Q 015076          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT  320 (413)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (413)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||........      +...+.....     ...+.   
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~-----~~~~~---  305 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR-----MRAPD---  305 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCC-----CCCCC---
Confidence            2335678999999988899999999999999999997 9999865432211      1111111111     01111   


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          321 SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       321 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                       ..+..+.+++..||+.||++|||+.+|+++|+...
T Consensus       306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             12346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-41  Score=315.33  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeC------C
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG------A  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~------~  148 (413)
                      ..+.|++.+.||+|+||.||+|... ++..||+|.+.... .....+..|+.+++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            3467889999999999999999965 57789999886543 3445778899999998 699999999998653      4


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..+++|||+++++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence            68999999999999999876422  4689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      +........ ......|+..|+|||++.     +..++.++|||||||++|+|++|..||.........      .....
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~~  230 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR  230 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHhc
Confidence            986543221 223456899999999885     345888999999999999999999999643321111      11111


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ....     .   .....++..+.+++.+||..+|.+|||+.+++++
T Consensus       231 -~~~~-----~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         231 -NPAP-----R---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -CCCC-----C---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence             1100     1   1112345678999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=332.35  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=204.8

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchh---HHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA---EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      |.-++.||.|+||.||.|++. +...||||++.-.....   -..+..|+..|+.++|||++.+.++|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            677788999999999999954 67789999986554332   35788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      | -|+-.+++.-..   .++.+..+..|+.+.+.||+|||+.   +.||||||..||||++.|.|||+|||.|....+. 
T Consensus       108 C-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 C-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             H-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            9 568777775443   5899999999999999999999999   9999999999999999999999999999877553 


Q ss_pred             cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                          ..++|||.|||||++.   .+.|+-++||||||++..||...++|+...+....      +-.+..+..       
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYHIAQNes-------  242 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES-------  242 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHHHHhcCC-------
Confidence                4479999999999874   57899999999999999999999999764443222      222222221       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        |.....+.+..+..++..||+.-|.+|||.++++.|
T Consensus       243 --PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 --PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              222345677889999999999999999999999886

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.7e-41  Score=318.70  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-----------------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-----------------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~  139 (413)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+..... .....+..|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999998542                 23589998865532 34567889999999999999999


Q ss_pred             ccceeeeCCeeEEEEEeccCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVG-------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      +++++..+...+++|||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999876431       112689999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRIPVDYSRPP  289 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt--g~~Pf~~~~~~  289 (413)
                      |+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++  +..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543221 11233456788999999988889999999999999999998  77788643321


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .   .+...............      ......++.++.+++.+||+.||++|||+.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1   12211111111110000      0111224467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.8e-41  Score=308.81  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.++||.|+||.||.++. .++..+++|.+....  ......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999999984 468889999876543  34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999976432  4689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+      ......... .        .
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~-~--------~  219 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGN-Y--------T  219 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-C--------C
Confidence            2 2334568999999999988889999999999999999999999997543221      122222111 1        1


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                       .....++..+.+++.+||..+|++||++.++++++
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             11133456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-41  Score=341.17  Aligned_cols=275  Identities=16%  Similarity=0.235  Sum_probs=193.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC--CCEEEEEE--------------ee---cCCchhHHHHHHHHHHHhcCCCCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKN--------------LL---NNRGQAEREFKVEVEAIGRVRHKN  136 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~e~~~l~~l~hpn  136 (413)
                      ...++|++++.||+|+||+||+|..+.  +..+++|.              +.   .........+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987542  21122221              10   111223456788999999999999


Q ss_pred             cccccceeeeCCeeEEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE
Q 015076          137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI  215 (413)
Q Consensus       137 iv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll  215 (413)
                      |+++++++...+..|+|++++ +++|..++..... .........+..++.||+.||+|||++   ||+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999999999999999999999 4577777644321 112334567788999999999999999   99999999999999


Q ss_pred             cCCCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCCCcccccH
Q 015076          216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPPEEVNL  294 (413)
Q Consensus       216 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~P-f~~~~~~~~~~~  294 (413)
                      +.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ |...........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987755443334456799999999999999999999999999999999998764 432222211111


Q ss_pred             HHHHHHHh--hcCCCCC------cCC----CCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          295 IEWLKKMV--TNRNPEG------VLD----PKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       295 ~~~~~~~~--~~~~~~~------~~~----~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...+....  ....+..      .+.    ...+...     ...+...+.+++.+||..||.+|||+.|++.+...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            11111100  0000000      000    0000000     01123456788999999999999999999987543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-41  Score=309.91  Aligned_cols=247  Identities=27%  Similarity=0.453  Sum_probs=197.5

Q ss_pred             cEEeeeCceEEEEEEEc-CC---CEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DN---SKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|.+. .+   ..+|+|.+..... .....+..|+.+++.+.||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999843 22   5799998865543 345678889999999999999999998764 467999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++...    ..+++..++.++.|++.||+|||..   +++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999765    3689999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             eec--cccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          240 TTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       240 ~~~--~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      ...  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||...+...   ....    +......        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~----~~~~~~~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM----LESGERL--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHcCCcC--------
Confidence            111  123467999999998899999999999999999998 999997543211   1111    1111110        


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       .....++..+.+++.+||..+|++||++.+|++.|+..
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             11122446788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-41  Score=314.39  Aligned_cols=258  Identities=27%  Similarity=0.462  Sum_probs=205.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|+.+.      ...+++|.+...... ....+..|++++++++|+||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            4679999999999999999999542      356889977654433 456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCC-----CCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPC-----SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      ++||||+++++|.+++.......     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999997653211     2689999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      ||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ...... .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~-~  233 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQ-A  233 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHH-c
Confidence            99987553332222333456778999999988889999999999999999998 888986433211      111111 1


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ....        ......++..+.+++.+||..+|++|||+.++++.|.
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1110        0111224457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.2e-41  Score=309.12  Aligned_cols=250  Identities=21%  Similarity=0.352  Sum_probs=203.1

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee-CCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~iv~e  155 (413)
                      +|++.+.||+|++|.||++..+ ++..||+|.+....  ......+..|++++++++|+|++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999965 57789999886543  2344568889999999999999999988764 456899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++.....  ..+++..++.++.+++.||++||+.   |++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999875322  4689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..      ......... ..        
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~-~~--------  219 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG-KL--------  219 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc-CC--------
Confidence            22 223456889999999999999999999999999999999999999744321      111111111 11        


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      + .....++..+.+++.+||+.+|++|||+.+++++
T Consensus       220 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 P-PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             C-CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0 1123355678999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=313.22  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||.|+||.||+|... ++..||+|.+.... ......+..|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46889999999999999999965 57889999886543 33445788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...     ++++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998753     689999999999999999999999   99999999999999999999999999998775432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......++..|+|||++.+..++.++|||||||++|+|++|..||...+...      ..... .....     +.+.
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~-~~~~~-----~~~~  219 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLI-PKNNP-----PSLE  219 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHh-hhcCC-----CCCc
Confidence            2 1233467889999999988889999999999999999999999997544211      11111 11111     1111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         ...++..+.+++.+||..+|++|||+++++++-.-
T Consensus       220 ---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~  254 (274)
T cd06609         220 ---GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI  254 (274)
T ss_pred             ---ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence               11155678899999999999999999999987443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-41  Score=320.00  Aligned_cols=262  Identities=18%  Similarity=0.277  Sum_probs=188.6

Q ss_pred             ccEEeeeCceEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee--CCeeEEEEEecc
Q 015076           84 DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYVN  158 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~iv~e~~~  158 (413)
                      ++.||+|+||.||+|..+   ++..||+|.+....  ....+.+|+.+++.++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   45789999885432  23456789999999999999999998854  466899999994


Q ss_pred             CCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE----cCCCCceEEecccc
Q 015076          159 NGNLEQWLHGDV-----GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (413)
Q Consensus       159 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a  229 (413)
                       ++|.+++....     .....+++..+..++.||+.||+|||++   ||+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888764321     1123589999999999999999999999   99999999999999    45678999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCccc------ccHHHHHHH
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEE------VNLIEWLKK  300 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~------~~~~~~~~~  300 (413)
                      +........  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........      ......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            876432211  12345789999999998764 589999999999999999999999975432111      001111111


Q ss_pred             HhhcCCC------------CCcC---CC-CCCC--------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          301 MVTNRNP------------EGVL---DP-KLPE--------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       301 ~~~~~~~------------~~~~---~~-~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .......            ....   .. ....        .........+.+|+.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000            0000   00 0000        0000112357889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.9e-41  Score=348.22  Aligned_cols=260  Identities=20%  Similarity=0.337  Sum_probs=204.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.++||+|+||.||+|.+. +++.||||++....   ......+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            67999999999999999999965 58899999886532   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          155 EYVNNGNLEQWLHGDVG-------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ||++|++|.+++.....       ....+++..++.++.||+.||+|||++   ||+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211       113456778899999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCc-----------------ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 015076          228 LAKLLGSESS-----------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (413)
Q Consensus       228 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~  290 (413)
                      ++........                 ......+||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01123569999999999999999999999999999999999999997533211


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQ  355 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~le~~  355 (413)
                      ..     ......         ......+...++..+.+++.+||..||++|| ++.++++.|+..
T Consensus       239 i~-----~~~~i~---------~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 IS-----YRDVIL---------SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hh-----hhhhcc---------ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            10     000000         0000111224556788999999999999996 566677766654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=307.77  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=200.3

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChh
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE  163 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~  163 (413)
                      ++||+|+||.||+|.+.++..|++|.+...... ....+..|+++++.++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999766899999988655433 4567889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee-ec
Q 015076          164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-TR  242 (413)
Q Consensus       164 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~  242 (413)
                      +++....   ..+++..++.++.+++.||+|||++   +++||||||+|||++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9986543   4688999999999999999999999   999999999999999999999999999986543221111 11


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS  321 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (413)
                      ..++..|+|||.+.+..++.++|||||||++|+|++ |..||.........       ..+....         ......
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGY---------RMPAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCC---------CCCCCc
Confidence            223567999999988899999999999999999999 88888654422111       1111110         001122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       322 ~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            34567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.6e-41  Score=316.82  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+..|+.+++.++||||+++++++..+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4567999999999999999999864      35679999886543 2345678889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCC------------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          150 RMLVYEYVNNGNLEQWLHGDV------------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      .+++|||+++++|.+++....                  .....+++..++.++.|++.||+|||++   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999986421                  1113578899999999999999999999   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||+++++.++|+|||++.......... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987653322111 112234667999999988899999999999999999997 88888644322


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      +      .... +......         .....++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 ~------~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 E------VIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H------HHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1      1111 1111110         011124567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.3e-41  Score=320.42  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=206.3

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      ....++|.+.+.||+|+||.||+|...        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            445567999999999999999999742        23458999876443 23445688899999999 699999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      ......+++|||+++++|.+++.....            ....+++..+..++.||+.||.|||++   |++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            999999999999999999999965321            124588999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998664322211 111224567999999988899999999999999999999 899986543222


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ..      . .......     .    .....++..+.+++.+||..+|++|||+.++++.|+...
T Consensus       245 ~~------~-~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 LF------K-LLREGHR-----M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HH------H-HHHcCCC-----C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11      1 1111111     0    111234457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-41  Score=311.19  Aligned_cols=240  Identities=24%  Similarity=0.398  Sum_probs=190.3

Q ss_pred             cEEeeeCceEEEEEEEcC-------------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           85 KVIGEGGYGIVYYGLLED-------------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +.||+|+||.||+|....             ..+|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998432             2258888776555555567888999999999999999999999988999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC-------ceEE
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-------PKVS  224 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~  224 (413)
                      +||||+++++|..++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999999886543   4689999999999999999999999   9999999999999987664       8999


Q ss_pred             ecccceecCCCCcceeeccccccCccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCcccccHHHHHHHHh
Q 015076          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI-SGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       225 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~~l~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |||++......     ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.       ....
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~  222 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY  222 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence            99998755322     2245788999999886 466899999999999999997 58888864332211       1111


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      . ...      ..    .......+.+||.+||+.||++||++.+|++.|+
T Consensus       223 ~-~~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E-GQC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-cCc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1 100      00    0112356889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=315.85  Aligned_cols=255  Identities=22%  Similarity=0.320  Sum_probs=207.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||.|+||.||+|.+. ++..+|+|.+..........+..|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356999999999999999999965 5788999988766656667788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999987643   4699999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          237 SYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      . ......+++.|+|||++.     ...++.++|||||||++|+|++|+.||.......      .+........     
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-----  225 (280)
T cd06611         158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSEP-----  225 (280)
T ss_pred             c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCCC-----
Confidence            2 123346899999999874     3457789999999999999999999997543221      1112111110     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                       +.+  .....++..+.+++.+||+.+|.+||++.+++++-.
T Consensus       226 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         226 -PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             -CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence             011  112234567889999999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=306.22  Aligned_cols=252  Identities=25%  Similarity=0.280  Sum_probs=208.8

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchh---HHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQA---EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .+..++|..+++||+|.||+|.+++- ..++.+|||++.+.-...   ...-..|-++|+..+||.+..+...|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            45678899999999999999999994 468889999887654332   33456689999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      |+||||.+||.|.-.|.+.    ..+++.....+..+|+.||.|||++   +||+||||.+|+|+|.+|.+||+|||+|+
T Consensus       244 CFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence            9999999999999999876    5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .--.. .....++||||.|+|||++....|+.++|+|.+|++||||++|++||...+......++      +. .     
T Consensus       317 E~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~-e-----  383 (516)
T KOG0690|consen  317 EEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LM-E-----  383 (516)
T ss_pred             hcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------Hh-h-----
Confidence            54322 22356789999999999999999999999999999999999999999865543322222      11 0     


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  351 (413)
                       +-+    .+..++.+...|+...|..||.+|.     .+.||.++
T Consensus       384 -d~k----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 -DLK----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -hcc----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence             011    2233555678888999999999996     46666655

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-41  Score=327.50  Aligned_cols=262  Identities=23%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeC------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  147 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+.....  .....+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999954 678899998864322  2334577899999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...+++|+++ +++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3568999998 7899888754     3699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++......    .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+......   .+........
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~  236 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK---RIMEVVGTPS  236 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCC
Confidence            99876432    233568999999999876 568999999999999999999999997544322111   1111000000


Q ss_pred             CC---Cc-------CCCCCCCCCc-------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PE---GV-------LDPKLPEKPT-------SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~---~~-------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ..   .+       ....++..+.       ......+.+|+.+||..||++|||+.+++++-..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            00   00       0000000000       0123347899999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=330.58  Aligned_cols=261  Identities=21%  Similarity=0.318  Sum_probs=214.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCE-EEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +-|.++..||.|+||.||+|..++... .|.|.+.-........|..|+.||..+.||+||++++.|..++.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            346778889999999999999765443 5677776667777888999999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      .||-+..++-.-.   ..|.+.++..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+...... .
T Consensus       112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            9999998876543   5799999999999999999999999   9999999999999999999999999998754332 2


Q ss_pred             ceeeccccccCccCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          238 YITTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      .....++|||+|||||+.     .+.+|+.++||||||++|.||..+.+|....      +....+.++..... ..   
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSeP-PT---  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEP-PT---  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcCC-Cc---
Confidence            335668999999999976     4578999999999999999999999997533      33333333322221 11   


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCC
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~  360 (413)
                          ...+..++..+.+++.+||..||..||+++++++|......++.
T Consensus       255 ----LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  255 ----LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ----ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                12345677889999999999999999999999998665544433

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=324.81  Aligned_cols=242  Identities=23%  Similarity=0.262  Sum_probs=190.1

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcC---CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ||+|+||+||+|... ++..||+|.+.....   .....+..|..++..+   +||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 588999998864321   1223344566666555   699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.++|+|||++........ .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            9999988765    5789999999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                      ....+||..|+|||++.+. .++.++|||||||++|+|++|+.||.......      ....... ..      ..++  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~------~~~~--  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAF-GK------VRFP--  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHc-CC------CCCC--
Confidence            3345789999999998765 48999999999999999999999997543221      1122111 11      0111  


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHH
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRP----KMGHVVHML  352 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~l  352 (413)
                       ...++..+.+++.+||..||.+||    ++.+++++.
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~  254 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP  254 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence             112456688999999999999998    677887763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=317.32  Aligned_cols=254  Identities=23%  Similarity=0.279  Sum_probs=205.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||+|... ++..||+|.+......   ....+..|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999965 4889999988765432   3456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+.+++|.+++.....  ..+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999875422  4689999999999999999999999   999999999999999999999999999875532


Q ss_pred             CCcc----------------------------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015076          235 ESSY----------------------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS  286 (413)
Q Consensus       235 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~  286 (413)
                      ....                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            112346788999999999888999999999999999999999999755


Q ss_pred             CCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHH
Q 015076          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK----MGHVVHML  352 (413)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~eil~~l  352 (413)
                      +....      +.......         ........++..+.+++.+||..||++|||    +.+++.+-
T Consensus       236 ~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         236 NRDET------FSNILKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             chHHH------HHHHhcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            43211      11111111         111111125678999999999999999999    88888763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.6e-41  Score=314.28  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|++|.||+|... ++..||+|.+....  ......+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4888999999999999999965 68889999885432  22345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      ++ ++|.+++..... ...+++..++.++.||+.||+|||+.   +++|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            96 688888765321 24689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh--c---------
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT--N---------  304 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~---------  304 (413)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||............  ......  .         
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI--FRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhCCCChhhhhcchhh
Confidence            1 12233568899999988654 4789999999999999999999999755432111100  000000  0         


Q ss_pred             ----CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          305 ----RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       305 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                          ........ .........++.++.++|.+||+.||++|||+.+|+.+
T Consensus       233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCc-chhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                00000000 00001112245678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-40  Score=309.40  Aligned_cols=256  Identities=27%  Similarity=0.449  Sum_probs=203.6

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +...+.+.....||+|+||.||+|.+. ++..|++|.+..........+.+|+.+++.++|+||+++++++..+...++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            445666777789999999999999954 5778999988776666677889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCC--CHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPL--TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~  230 (413)
                      |||+++++|.+++....   ..+  ++..+..++.||+.||+|||+.   +|+||||||+||+++. ++.++|+|||++.
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999997543   234  7888899999999999999999   9999999999999976 6789999999987


Q ss_pred             ecCCCCcceeeccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........ .....++..|+|||++.+..  ++.++||||||+++|+|++|..||..........   +......     
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~-----  228 (268)
T cd06624         158 RLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFK-----  228 (268)
T ss_pred             ecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhc-----
Confidence            65432221 22345789999999986644  7889999999999999999999996432211110   0000000     


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        ..+.    .+..+...+.+++.+||+.+|.+|||+.+++.+
T Consensus       229 --~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 --IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              0011    122345678899999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=340.08  Aligned_cols=260  Identities=29%  Similarity=0.472  Sum_probs=221.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC-C---CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-N---SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ++......+.++||.|.||.||+|+.+. +   ..||||.++... ......|+.|+.||-+++||||+++.++......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            3455668899999999999999999653 3   359999997764 4556789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+||+|||++|+|+.+|..+.   +.+.+.++..+++.|+.|+.||-+.   ++|||||..+|||++.+..+|++|||++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999998876   5699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeecc--ccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          230 KLLGSESSYITTRV--MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       230 ~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      +.+.++......+.  .-..+|.|||.+...+++.+|||||||++|||.++ |..||-...+.+-...+           
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-----------  847 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-----------  847 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-----------
Confidence            98865442222222  23579999999999999999999999999999876 99998755544332222           


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                           ...+...++.+++..|.+||+.||++|-.+||.+.+|+..|++..
T Consensus       848 -----e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  848 -----EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             -----HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                 123444566778899999999999999999999999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-40  Score=312.05  Aligned_cols=261  Identities=22%  Similarity=0.392  Sum_probs=203.0

Q ss_pred             CCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~  151 (413)
                      -|++.+.||+|+||.||+|..     .++..||+|.+.... ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478899999999999999974     246789999886443 33446788999999999999999999988765  5689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||++   |++||||||+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999986542   3689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC--------cccccHHHHHHHH
Q 015076          232 LGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP--------PEEVNLIEWLKKM  301 (413)
Q Consensus       232 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~--------~~~~~~~~~~~~~  301 (413)
                      .......  ......++..|+|||++.+..++.++|||||||++|+|+++..|+.....        .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221  11234567789999999888899999999999999999998776432110        0000011111111


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......         ......++..+.+|+.+||+.+|++|||+.++++.++.+
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111110         011123566799999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-40  Score=307.36  Aligned_cols=253  Identities=24%  Similarity=0.452  Sum_probs=204.3

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      +|+..+.||+|+||.||+|.. .++..||+|.+.....      .....+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 5688899998864331      234678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEeccccee
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKL  231 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~  231 (413)
                      ||||+++++|.+++...    .++++..++.++.|++.||+|||++   |++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999999764    4789999999999999999999999   999999999999998776 599999999877


Q ss_pred             cCCCCcc---eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||...........   +......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~----  226 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASA----  226 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhcc----
Confidence            6432111   12234678899999999888899999999999999999999999964433221111   1111110    


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                           .........+...+.+++.+||..+|++||++.+++++
T Consensus       227 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 -----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                 01112233466778999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-40  Score=307.74  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=200.4

Q ss_pred             cEEeeeCceEEEEEEEcC--CC--EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLED--NS--KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|++|.||+|.+..  +.  .||||.+..... .....+..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  22  589998876655 556788999999999999999999999988 889999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976532  4689999999999999999999999   99999999999999999999999999998765422211


Q ss_pred             --eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          240 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       240 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                        .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+      ...........       + 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~-------~-  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER-------L-  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc-------C-
Confidence              112346788999999999899999999999999999998 999996443222      11111111100       0 


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                       .....++..+.+++.+||..+|++|||+.++++.|.
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             011224567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-40  Score=310.53  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=203.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.++++++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999965 68889999886542 33346788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|..++.... ....+++..+..++.|++.||.|||++.  +|+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999887532 1247899999999999999999999632  89999999999999999999999999987653221


Q ss_pred             cceeeccccccCccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          237 SYITTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                         .....++..|+|||.+.+.      .++.++|||||||++|+|++|+.||........   ...+..... ..    
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~-~~----  226 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVD-GD----  226 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhh-cC----
Confidence               2234578899999988554      358899999999999999999999965432211   111111111 11    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           +......+..++.+++.+||..+|++||++.+++.+..
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence                 11122236777899999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-40  Score=312.97  Aligned_cols=265  Identities=22%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||.||+|.++ ++..||+|++....  ......+..|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46899999999999999999976 58889999886443  2234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|..++...    ..+++..++.++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99998888877554    4689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH--------HhhcCC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK--------MVTNRN  306 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~  306 (413)
                      .. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+.....        ......
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            32 1223457889999998866 5588999999999999999999999986554332221110000        000000


Q ss_pred             -CCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 -PEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 -~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ......+......     ...++..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence             0000000000000     11235678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=325.96  Aligned_cols=263  Identities=25%  Similarity=0.411  Sum_probs=220.6

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc---CCC--EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccce
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE---DNS--KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGY  143 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~  143 (413)
                      +.+.+++........++||.|.||.||+|.+.   .|.  .||||..+.+. ....+.|..|+.+|+.++||||++++|+
T Consensus       380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence            33456667777888899999999999999843   233  48999887754 4556789999999999999999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      |.+. ..+||||.++-|.|..||..+.   ..++......++.||+.||+|||+.   ++|||||..+|||+.....+||
T Consensus       460 ~~e~-P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL  532 (974)
T KOG4257|consen  460 CVEQ-PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL  532 (974)
T ss_pred             eecc-ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence            9774 5899999999999999998765   5799999999999999999999999   9999999999999999999999


Q ss_pred             EecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 015076          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      +|||+++...+...+......-...|||||.+.-..++.+||||-||++|||++. |..||.+-...+....+       
T Consensus       533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------  605 (974)
T KOG4257|consen  533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------  605 (974)
T ss_pred             cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------
Confidence            9999999998877766665556789999999999999999999999999999886 99999876654433222       


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                               ...-....+..++..+..|+.+||.++|.+||++.+|...|+.+
T Consensus       606 ---------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  606 ---------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ---------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                     11111122345677788999999999999999999998877553

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-40  Score=311.97  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4677788999999999999865 57789999876443 334467889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++..     ..+++..++.++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999998864     3689999999999999999999999   999999999999999999999999999976643321


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       ......++..|+|||++.+..++.++|||||||++|+|++|+.||.........      .. ....         ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~---------~~~  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPKN---------SPP  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhcC---------CCC
Confidence             122345788999999999988999999999999999999999998643322111      00 1111         011


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .....++..+.+++.+||+.+|++||++.+++++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            112235567889999999999999999999999744

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-40  Score=306.12  Aligned_cols=251  Identities=29%  Similarity=0.507  Sum_probs=203.0

Q ss_pred             CCcccEEeeeCceEEEEEEEcC-----CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      |++.+.||.|+||.||++.+..     +..||+|.+...... ....+..|+.+++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4677899999999999999653     377999988655433 5678889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999976531  1289999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........++..|+|||.+.+..++.++|||||||++|+|++ |..||......      .......... .     .
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~~~~-~-----~  223 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYLKKGY-R-----L  223 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCC-C-----C
Confidence            43322222336789999999988889999999999999999998 78888653221      1111111111 1     0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          .....++.++.+++.+||..||++|||+.++++.|
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                11122566789999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3e-40  Score=308.86  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=207.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..|+..+.||.|+||.||+|.+. .+..||+|.+.... ......+..|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999965 57889999876543 34456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++..     .++++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999999864     3688999999999999999999999   99999999999999999999999999997764432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....++..|+|||++.+..++.++|+|||||++|+|++|..||..........      . ..         ...+
T Consensus       156 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~---------~~~~  218 (277)
T cd06640         156 IK-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L-IP---------KNNP  218 (277)
T ss_pred             cc-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h-hh---------cCCC
Confidence            21 223457889999999988889999999999999999999999997544321111      0 00         1111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......++..+.+++.+||+.+|++||++.+++++....
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence            223345677889999999999999999999999885543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-40  Score=309.02  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEcC--CCEEEEEEeecCC----------chhHHHHHHHHHHHhc-CCCCCcccccceeee
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNR----------GQAEREFKVEVEAIGR-VRHKNLVRLLGYCAE  146 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~  146 (413)
                      +|++.+.||+|+||.||+|.+..  +..+|+|.+....          ......+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999664  6779999875321          2233456678887765 799999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+|||++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999885432223578999999999999999999996 5   899999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ||++.......  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ....... .
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~-~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIVE-A  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHhh-c
Confidence            99998765433  2334568899999999998889999999999999999999999996433211      1111111 1


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..        .......++..+.+++.+||+.||++||++.|+.++++
T Consensus       229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11        01111234567889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-40  Score=305.86  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=203.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +|+..+.||+|+||.||+|... ++..|++|.+....     ......+..|+.+++.++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4788899999999999999966 78899999886543     23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999765    4688999999999999999999999   99999999999999999999999999988764


Q ss_pred             CCCcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ...  ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||......      ............     
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-----  220 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL-----  220 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC-----
Confidence            432  123456889999999987776 899999999999999999999999744311      111111110110     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +.    ....+...+.+++.+||+.+|++||++.+++.+
T Consensus       221 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            11    112345678899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-40  Score=317.14  Aligned_cols=264  Identities=18%  Similarity=0.221  Sum_probs=196.9

Q ss_pred             cccEEeee--CceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           83 DDKVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        83 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      ++++||+|  +|++||++..+ ++..||+|++....  ......+..|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  78999999854 68889999886542  233456778999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++.....  ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999865321  3589999999999999999999999   999999999999999999999999987544321111


Q ss_pred             c------eeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-----
Q 015076          238 Y------ITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-----  304 (413)
Q Consensus       238 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----  304 (413)
                      .      ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||........  ...........     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCcccccccc
Confidence            0      0112346778999999876  4589999999999999999999999974332110  00000000000     


Q ss_pred             ---------CCCCCcCC-----------------CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          305 ---------RNPEGVLD-----------------PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       305 ---------~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                               .......+                 ..........+...+.+++.+||+.||++|||+.+++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                     00000000                 00000112234567899999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=309.77  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=195.4

Q ss_pred             cEEeeeCceEEEEEEEcC-CC--EEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLED-NS--KVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ++||+|+||.||+|...+ +.  .+++|.+.... ......+..|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999653 43  46888776432 34456788899999999 799999999999999999999999999


Q ss_pred             CChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          160 GNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       160 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ++|.+++.....            ....+++..++.++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            123588999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++........  ......+..|+|||++....++.++|||||||++|+|++ |..||......+      ..........
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~  229 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGYR  229 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhCCCC
Confidence            9863321111  111223567999999988889999999999999999997 999996543221      1111111100


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                            ..    ....+...+.+++.+||..+|.+|||+.++++.|+.+
T Consensus       230 ------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         230 ------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ------CC----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                  01    1112345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.8e-41  Score=313.36  Aligned_cols=262  Identities=26%  Similarity=0.389  Sum_probs=203.5

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceee----
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCA----  145 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~----  145 (413)
                      +.+....++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+..|+.+++.+ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            344556789999999999999999999865 57789999765432 3345677899999999 6999999999873    


Q ss_pred             -eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          146 -EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       146 -~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                       .+...++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEc
Confidence             44678999999999999998764322235789999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCcceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       225 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      |||++........ ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||........      +.
T Consensus       167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~  239 (286)
T cd06638         167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LF  239 (286)
T ss_pred             cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hh
Confidence            9999987643221 1233468999999998753     4578899999999999999999999975432211      11


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ..... .....       .....+...+.+++.+||+.||++|||+.+|++++
T Consensus       240 ~~~~~-~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIPRN-PPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hcccc-CCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            11110 00000       01112345688999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1e-40  Score=314.56  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=202.5

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      |.....||+|+||.||++... ++..||||.+..........+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999864 5888999988665555566788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++..     ..+++..++.++.||+.||+|||+.   +|+||||||+||++++++.++|+|||++......... 
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-  174 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-  174 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence            999998854     3588999999999999999999999   9999999999999999999999999998765432221 


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........   .   ... ...     +...+.  .
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~---~~~-~~~-----~~~~~~--~  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M---RRI-RDN-----LPPRVK--D  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHH-Hhc-----CCCccc--c
Confidence            2334688999999999888899999999999999999999999975432211   1   111 110     011111  1


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ...++..+.+++.+||..||.+|||+.+++++-.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  274 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF  274 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            1124556888999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-41  Score=312.27  Aligned_cols=239  Identities=24%  Similarity=0.414  Sum_probs=188.7

Q ss_pred             EEeeeCceEEEEEEEcC-------------------------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccc
Q 015076           86 VIGEGGYGIVYYGLLED-------------------------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRL  140 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~  140 (413)
                      +||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13488888765544455678889999999999999999


Q ss_pred             cceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-
Q 015076          141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-  219 (413)
Q Consensus       141 ~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-  219 (413)
                      ++++......++||||+++++|..++....   ..+++..+..++.||++||+|||++   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            999999999999999999999999986543   4689999999999999999999999   999999999999997654 


Q ss_pred             ------CceEEecccceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCCccc
Q 015076          220 ------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVI-SGRIPVDYSRPPEE  291 (413)
Q Consensus       220 ------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~ell-tg~~Pf~~~~~~~~  291 (413)
                            .++++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  3799999987644221     12346788999998865 56899999999999999985 69999975543221


Q ss_pred             ccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .   ...    ...       ...+..    ....+.++|.+||+.+|++|||+.+|++.|.
T Consensus       231 ~---~~~----~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 E---RFY----EKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---HHH----Hhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1   111    100       011111    2346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-40  Score=306.68  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceee--eCCeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~iv~  154 (413)
                      +|++.+.||.|+||.||++... ++..+|+|.+....  ......+..|+.+++.++||||+++++++.  .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4888999999999999999854 67889999886432  334456888999999999999999999775  345689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh-----hccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH-----EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      ||+++++|.+++........++++..++.++.||+.||+|||     +.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999764333367999999999999999999999     77   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ......... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||......   ...    ........  
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~--  227 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGKF--  227 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCCC--
Confidence            877544321 23346899999999998888999999999999999999999999754421   111    11111111  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         +    .....++..+.+++.+||..+|++||++.+|+++
T Consensus       228 ---~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ---R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               1    1223456778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-40  Score=304.61  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=203.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||+|... ++..+|+|.+....  ......+..|+.+++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4888999999999999999954 67889999886542  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++.....  ..+++..++.++.+++.||+|||++   +++|+||+|+||++++++ .++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999976432  4589999999999999999999999   999999999999998654 5799999999877543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....      ........ .     .  
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~-~-----~--  219 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSGT-F-----A--  219 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhcC-C-----C--
Confidence            22  2234678899999999988899999999999999999999999975543221      11111111 0     0  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        .....++..+.+++.+||..+|++|||+.+++++
T Consensus       220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              1112245678899999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2e-40  Score=306.06  Aligned_cols=250  Identities=22%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||++... +++.||+|.+....  ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5889999999999999999954 68889999886432  33445788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +.+++|.+++.....  ..+++..++.++.|++.||+|||++   +++|+||+|+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            999999998865422  3578999999999999999999999   99999999999999999999999999998764432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||......      ...........      +   
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~------~---  219 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSY------P---  219 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCC------C---
Confidence            2 122345788999999999889999999999999999999999999744322      11222221111      0   


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       .....+...+.++|.+||+.+|++||++.+|+++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             1122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-40  Score=313.17  Aligned_cols=265  Identities=23%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||.||+|.++ ++..||+|.+.....  .....+..|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999975 578899998754332  234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|..+....    ..+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999988877554    3589999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------HHhhcCC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------KMVTNRN  306 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~  306 (413)
                      .. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....        .......
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            32 1233457889999998865 457889999999999999999999997544321111110000        0000000


Q ss_pred             -CCCcCCCCCCCC-----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 -PEGVLDPKLPEK-----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 -~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ......+.....     ....++..+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             000000000000     012345678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=312.77  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+....  ......+..|+++++.++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46899999999999999999966 57789999875432  2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++++.+..++...    ..+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99887776665443    4689999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC-------
Q 015076          236 SSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP-------  307 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------  307 (413)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.....   .........       
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI---QKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHhhhcc
Confidence            32223345678899999999888 7899999999999999999999999755432211111   111100000       


Q ss_pred             -CCcCCC-CCCC---------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          308 -EGVLDP-KLPE---------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       308 -~~~~~~-~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       ...... .++.         .....++..+.++|.+||..+|++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             000000 0000         0111236779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-40  Score=304.44  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=209.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|++|.||+|... ++..|++|++..... .....+..|+..+..++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999966 588899998866544 4457788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++...    ..+++..++.++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999765    578999999999999999999999 8   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........   ...........         .
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~---------~  220 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAICDGP---------P  220 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHhcCC---------C
Confidence            322 2234578899999999998999999999999999999999999975543121   12122222111         1


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +......++..+.+++.+||..+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111111156779999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=299.05  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=203.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~i  152 (413)
                      ...++.+.+..||.|..|.||+++.+ .|..+|||.+.... .....+++..+.++...+ +|.||+.+++|..+..++|
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            34556777889999999999999966 57789999997654 344456677777766654 8999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      .||.| ..-++.++.+..   +++++..+-++...+++||.||..++  +|+|||+||+|||+|+.|++||||||++-.+
T Consensus       169 cMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  169 CMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            99998 445666665544   57999999999999999999998876  9999999999999999999999999999877


Q ss_pred             CCCCcceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      -+...  .....|-+.|||||.+.-   ..|+.++||||||++|+||.||..||.+.+.+..     .+.+++.+. +  
T Consensus       243 vdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----~ltkvln~e-P--  312 (391)
T KOG0983|consen  243 VDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----VLTKVLNEE-P--  312 (391)
T ss_pred             ecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----HHHHHHhcC-C--
Confidence            54333  344568899999998854   3589999999999999999999999987654422     222333321 1  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         +.++  ....++..+.+++..||..|+.+||...+++++-
T Consensus       313 ---P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  313 ---PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             ---CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence               1121  1222777899999999999999999999999873

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-40  Score=312.42  Aligned_cols=246  Identities=25%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+....   ......+..|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46899999999999999999965 57889999886432   233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.||+.||.|||+.   |++|+||+|+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999765    5789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......      ........ ..      ..
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~------~~  216 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILE-GK------VR  216 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CC------cc
Confidence            3    23346889999999998888999999999999999999999999754411      11111111 11      11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      ++    ..+...+.+++.+||..||.+|+     ++++++++-
T Consensus       217 ~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         217 FP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             CC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence            11    12356788999999999999999     788887763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-41  Score=319.02  Aligned_cols=258  Identities=21%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~  151 (413)
                      .+....|++++.||+||.+.||++...+.+.||+|++...  +.....-|..|+..|.+|+ |.+||++++|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            3566779999999999999999999888888999877543  3455678999999999995 899999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||- ..+|..+|....   ..++.-.+..+..|++.|+.++|.+   ||||.||||.|+|+-+. .+||+|||+|..
T Consensus       437 mvmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANA  508 (677)
T ss_pred             EEeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcc
Confidence            999976 569999998765   2344348889999999999999999   99999999999999764 999999999998


Q ss_pred             cCCCCcc-eeeccccccCccCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          232 LGSESSY-ITTRVMGTFGYVAPEYASTGM-----------LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ...+... .....+||+.||+||.+....           .++++||||||||||+|+.|+.||.     ...+.+..+.
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aKl~  583 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAKLH  583 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHHHH
Confidence            8655443 345678999999999884422           5678999999999999999999996     2222333222


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .+....  .++   .++.-+..   .++++++..||..||++|||+.|+|++--
T Consensus       584 aI~~P~--~~I---efp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  584 AITDPN--HEI---EFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             hhcCCC--ccc---cccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence            222111  111   11111111   12889999999999999999999998743

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.3e-40  Score=307.89  Aligned_cols=265  Identities=24%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeee--CCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~iv~  154 (413)
                      ++|+..+.||.|++|.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++..  ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46889999999999999999975 577899998865433 345678889999999999999999998854  34789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.........+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988764332335689999999999999999999999   999999999999999999999999999875532


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ..   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ............... ... +...
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~-~~~~  231 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMP-NPE-LKDE  231 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCC-chh-hccC
Confidence            21   12345788999999999899999999999999999999999999865331 111222222222111 111 1111


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .  .....++..+.+++.+||..+|++|||+.|++.+-.-
T Consensus       232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            0  1112356778999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-40  Score=306.10  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||.|+||.||+|.++ ++..+|+|.+.... ......+.+|+++++.++||||+++++++......+++|||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999966 58889999887653 34456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999997653   478999999999999999999999 8   9999999999999999999999999998765322


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..   ....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+.......         .
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~---------~  221 (265)
T cd06605         155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP---------P  221 (265)
T ss_pred             Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC---------C
Confidence            21   1256788999999999999999999999999999999999999654321 111222222222211         1


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +......++..+.++|.+||..||++|||+.+++.+-
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  258 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP  258 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence            1111222667789999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-40  Score=310.90  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeee-
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE-  146 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~-  146 (413)
                      ++.++....+.|++.+.||.|+||.||+|.+. ++..+|+|.+.... .....+..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34445556688999999999999999999964 57889999875543 3345678899999998 69999999998853 


Q ss_pred             -----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          147 -----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       147 -----~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                           ....+++|||+++++|.+++.....  ..+++..++.++.||+.||+|||+.   +|+|+||||+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence                 4678999999999999999865432  4588899999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~  296 (413)
                      +|+|||++........ ......|+..|+|||++.     ...++.++|||||||++|+|++|..||...........  
T Consensus       161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            9999999876532211 123356889999999875     34688899999999999999999999964432211110  


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                          .. .        ..........++..+.++|.+||..||.+|||+.+|+++
T Consensus       238 ----~~-~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 ----IP-R--------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ----Hh-h--------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                00 0        011111122356679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-40  Score=306.87  Aligned_cols=248  Identities=30%  Similarity=0.459  Sum_probs=200.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .++|++.+.||+|+||.||++.. .+..||+|.+....  ....+.+|+.+++.++||||+++++++.... .+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            45689999999999999999875 47789999875432  3457888999999999999999999987654 79999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++++|.+++.....  ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999975432  4689999999999999999999999   99999999999999999999999999987653321 


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                         .....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......+.      .. ......         .
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~-~~~~~~---------~  215 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------KE-CVEKGY---------R  215 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------HH-HHhCCC---------C
Confidence               11234568999999988899999999999999999997 9999975443221      11 111111         0


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ......++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            01122345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-40  Score=312.16  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=202.7

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeC---
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG---  147 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~---  147 (413)
                      ++....++|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+..|+.+++++ +||||+++++++...   
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            34445788999999999999999999964 67889999875432 2345677899999998 799999999998653   


Q ss_pred             --CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          148 --AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       148 --~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                        ...++||||+++++|.++++........+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence              358999999999999998864332235789999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||++......... .....|+..|+|||++...     .++.++|||||||++|+|++|+.||........      +..
T Consensus       172 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~  244 (291)
T cd06639         172 FGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFK  244 (291)
T ss_pred             cccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHH
Confidence            9998865432211 2234678999999987543     368899999999999999999999975432211      111


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .... ....+       .....+...+.++|.+||+.+|++||++.+++++
T Consensus       245 ~~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 IPRN-PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HhcC-CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111 11111       1112344578999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.7e-40  Score=310.89  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=208.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|.+.+.||+|+||.||++... ++..||+|.+..........+..|+.+++.++||||+++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367999999999999999999854 6788999988655555567788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...     .+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999998653     578899999999999999999999   99999999999999999999999999987664432


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+      ...        ....
T Consensus       170 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~--------~~~~  234 (293)
T cd06647         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN--------GTPE  234 (293)
T ss_pred             cc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcC--------CCCC
Confidence            22 23346888999999998888999999999999999999999999754432211110      000        0111


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ......+...+.+++.+||..+|++||++.+++.+--
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            1122335567889999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=314.82  Aligned_cols=265  Identities=24%  Similarity=0.313  Sum_probs=217.9

Q ss_pred             ccccHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccc
Q 015076           67 HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        67 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      +|.++.-.-+..+.|+.-++||+||||.||-++.+ +|+-+|.|.+.+++   .......++|..+|.+++.+.||.+-.
T Consensus       173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            44455555678899999999999999999999855 67779999875543   234456778999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      .|+..+.+|+||..|+||+|.-.|.+...  ..+++..+..++.+|+-||++||+.   +||+|||||+|||||+.|+++
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence            99999999999999999999999977643  5799999999999999999999999   999999999999999999999


Q ss_pred             EEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |+|+|+|..+.....  ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........   -+.+.+
T Consensus       328 ISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~  402 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRT  402 (591)
T ss_pred             eeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHH
Confidence            999999998876554  233489999999999999999999999999999999999999997544322111   122222


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHM  351 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~  351 (413)
                      ..          .+...+..++++...++...|..||++|.-     +.+|-+|
T Consensus       403 ~~----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  403 LE----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             hc----------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            11          122344567788899999999999999974     4566655

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3e-40  Score=306.01  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=192.6

Q ss_pred             cEEeeeCceEEEEEEEcC----CCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceee-eCCeeEEEEEecc
Q 015076           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEYVN  158 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~iv~e~~~  158 (413)
                      +.||+|+||.||+|.+.+    ...+|+|.+... .......+..|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    346899987543 2344567888999999999999999999765 4566899999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++....   ..+.+..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999997643   3467788899999999999999999   9999999999999999999999999999765332111


Q ss_pred             ---eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          239 ---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       239 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                         ......++..|+|||.+.+..++.++|||||||++|||++| ..||.....      ............      . 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~------~-  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRR------L-  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCC------C-
Confidence               11123457789999999888999999999999999999995 556653321      111111111110      0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         .....++..+.+++.+||..+|++||++.+|++.|+..
T Consensus       222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               01112345788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.2e-40  Score=305.95  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=198.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCCcccccceeee--CCee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  150 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  150 (413)
                      .+|++.+.||+|+||.||+|... .+..|++|.+....     ......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999964 58889999875432     1233567889999999999999999998865  3678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++++|.+++...    ..+++...+.++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            9999999999999999765    4689999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCc--ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .......  .......++..|+|||++.+..++.++|||||||++|+|++|+.||......      ..+.......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC---
Confidence            6532111  1112245788999999999888999999999999999999999999743221      1111111111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        ..+.+    ...+...+..++ .||..+|++||++++|+++-
T Consensus       226 --~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         226 --TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             --CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence              01111    223445566666 68889999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=308.37  Aligned_cols=256  Identities=32%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCC------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~------  148 (413)
                      ..++|++.+.||+|+||.||+|..+ ++..+++|.+..... ....+..|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3578999999999999999999975 577899998765543 346788999999999 6999999999986544      


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            58999999999999999865432235789999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      +........ ......++..|+|||++..     ..++.++|||||||+||+|++|+.||.......      .......
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~  232 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPR  232 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhc
Confidence            886643322 1233458899999998753     347789999999999999999999996432211      1111111


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .. .     +.  ......++..+.+++.+||..||++|||+.+++++
T Consensus       233 ~~-~-----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 NP-P-----PT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             cC-C-----CC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11 0     01  11123366788999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-40  Score=308.29  Aligned_cols=262  Identities=24%  Similarity=0.400  Sum_probs=206.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-----CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeee--CCee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR  150 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~  150 (413)
                      ..|++.+.||+|+||.||+|.+.     .+..+|+|.+...... ....+..|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46888899999999999999853     3577999988755443 46688999999999999999999999877  5678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++++|.+++....   ..+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999997653   3699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc--------cHHHHHHH
Q 015076          231 LLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--------NLIEWLKK  300 (413)
Q Consensus       231 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~--------~~~~~~~~  300 (413)
                      ..........  ....++..|+|||.+.+..++.++|||||||++|+|++|..||.........        .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            7753322211  1223456799999998889999999999999999999999998643321100        01111111


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+.....         ......++..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus       238 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111110         011122346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-40  Score=307.44  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=192.2

Q ss_pred             cEEeeeCceEEEEEEEcC---CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           85 KVIGEGGYGIVYYGLLED---NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      +.||+|+||.||+|.+.+   +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   45689998765442 33457888999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCC-CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          161 NLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       161 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999965321 123467778889999999999999999   99999999999999999999999999987544332221


Q ss_pred             -eeccccccCccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          240 -TTRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       240 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                       .....++..|+|||++.+.       .++.++|||||||++|||++ |..||......+...      .... ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~------~~~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT------YTVR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH------HHhh-cccCCC
Confidence             1234567889999988542       35789999999999999996 999997544322111      1111 111111


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+.+.    ......+.+++..|| .+|++|||+.+|+..|+
T Consensus       231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111    123445778899999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-40  Score=310.69  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||+|.+. ++..||+|++....  ......+..|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999964 68889999886554  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      + +++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999986543   5699999999999999999999999   99999999999999999999999999998775443


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC--------
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP--------  307 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  307 (413)
                      ........++..|+|||++.+. .++.++|||||||++|+|++|.+||........   .............        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence            2222334689999999988654 468999999999999999999888865443211   1111111110000        


Q ss_pred             ----CCcCCCCCCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          308 ----EGVLDPKLPE----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       308 ----~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          ..+..+....    .........+.+++.+||..+|++|||+++++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                0000000000    00112347789999999999999999999999873

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-40  Score=312.89  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      |.....||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++..+...+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            444567999999999999864 6889999988665555566788899999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|..++..     ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........ .
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence            999998754     3589999999999999999999999   999999999999999999999999999876543322 1


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........      +... .......       ...
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~-------~~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRL-RDSPPPK-------LKN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hccCCCC-------ccc
Confidence            2335689999999999888899999999999999999999999975432211      1111 1111000       011


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+...+.+++.+||+.+|++||++.+++++....
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence            122345688999999999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.7e-40  Score=303.73  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=204.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|.+.+.||+|+||.||+|... ++..|++|.+......  ....+..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999954 6888999988765443  567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...    ..+++..+..++.+++.||.|||+.   +|+|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999765    4688999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceee---ccccccCccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          237 SYITT---RVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       237 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .....   ...++..|+|||++.+..   ++.++||||||+++|+|++|..||.......     ........ ..    
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~----  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA-GH----  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc-CC----
Confidence            22111   345788999999998766   8899999999999999999999997443211     11111111 10    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       .+.++.  ...+...+.+++.+||+.+|++|||+.+++.+
T Consensus       224 -~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 -KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             111111  12235667899999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-40  Score=311.29  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||+|.+. +|..||+|.+....  ......+..|+.+++.++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888999999999999999965 68889999886432  22234567799999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      ++ ++|.+++....   ..+++..++.++.||++||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            96 58888776532   4689999999999999999999999   99999999999999999999999999998664332


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC------CC
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP------EG  309 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~  309 (413)
                      .. .....++..|+|||++.+. .++.++|||||||++|+|++|..||.......  .....+.........      ..
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence            21 2234578899999988664 47899999999999999999999864333211  111111111110000      00


Q ss_pred             cCC----CCCCC-----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          310 VLD----PKLPE-----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       310 ~~~----~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ..+    +....     .....++..+.+++.+||+.||.+|||+.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000    00000     0112345678899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-41  Score=310.18  Aligned_cols=240  Identities=21%  Similarity=0.405  Sum_probs=190.1

Q ss_pred             cEEeeeCceEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +.||+|+||.||+|..+.        ..++++|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998542        224788877555445556788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC--------ceEEeccc
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--------PKVSDFGL  228 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG~  228 (413)
                      +++|+|..++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999997653   3689999999999999999999999   9999999999999987765        58999998


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCC-CCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGR-IPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      +......     ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||........   .   . ..... 
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~---~-~~~~~-  221 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L---Q-FYEDR-  221 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H---H-HHHcc-
Confidence            8654322     22457889999999876 45899999999999999999984 66653322111   1   0 11110 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                            ..++.    ....++.+++.+||+.||++|||+.+|++.|+
T Consensus       222 ------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  11111    12356889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=340.10  Aligned_cols=263  Identities=22%  Similarity=0.274  Sum_probs=218.9

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceee
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~  145 (413)
                      .++++++..++|+++++||+|+||.|.+++.+ ++..||+|++.+.   ......-|..|-.+|..-+.+.|+.++-.|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            35667788899999999999999999999966 5677899988653   2344567888999999999999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      ++.++|+||||++||+|-.++.+.    .++++..+..++..|+.||..||+.   |+|||||||+|||||..|++||+|
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence            999999999999999999999877    4799999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccc----c-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS----T-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||.|-.+..+........+|||-|.+||++.    + +.|+..+|+||+||++|||+.|..||......+.      ..+
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT------Y~K  292 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET------YGK  292 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH------HHH
Confidence            9999998877666677778999999999884    2 5699999999999999999999999985543333      333


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHh
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK---MGHVVHMLE  353 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~le  353 (413)
                      ++.....-     .+|  ....++....+||.+.+. +|+.|..   +.++-.|.-
T Consensus       293 Im~hk~~l-----~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  293 IMNHKESL-----SFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             Hhchhhhc-----CCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence            33322111     122  223367778888877665 6888887   999988753

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.4e-40  Score=304.50  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=199.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCCcccccceeeeC--Cee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  150 (413)
                      .+|++.+.||+|+||.||+|... ++..||||.+....     ......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999964 58889999875332     12345778899999999999999999988763  567


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++++|.+++...    ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999998754    4688899999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........  ......++..|+|||++.+..++.++|||||||++|+|++|+.||.......      .+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~--  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPT--  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHHHhcCCC--
Confidence            65321111  1123457889999999988889999999999999999999999996432111      1111111110  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         .+    ..+..+...+.+++.+||. +|+.||++++|+++.
T Consensus       227 ---~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         227 ---NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             ---CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence               11    1233456678888999985 999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-40  Score=307.05  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc----------hhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG----------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      +|.+.+.||.|+||.||+|... ++..+|+|.+.....          ...+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4788899999999999999854 688899998753211          11246778999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+++++|.+++...    ..+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999765    4789999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcc-eeeccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          229 AKLLGSESSY-ITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       229 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      +......... ......++..|+|||++....  ++.++|+||||+++|+|++|..||......      ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc
Confidence            9765432111 122345788999999987654  889999999999999999999999633221      1111111111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                           ....++......++..+.+++.+||..+|++|||+.+|+++
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 -----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 11111222223456788999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=308.60  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=203.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-CC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-NS----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..+|++.+.||+|+||.||+|.++. +.    .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4678999999999999999998542 33    588997765543 345678889999999999999999999887 7889


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+|||++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            9999999999999997653   4689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          232 LGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       232 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ......... ....++..|+|||.+....++.++|||||||++|||++ |+.||......+      . ...+.....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~--  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------I-PDLLEKGER--  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhCCCC--
Confidence            653332211 11223568999999988889999999999999999998 999997544321      1 111111110  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .  ..+..+...+.+++.+||..||++||++.++++.|...
T Consensus       230 -----~--~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 -----L--PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -----C--CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 0  00111334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.6e-40  Score=313.47  Aligned_cols=262  Identities=19%  Similarity=0.291  Sum_probs=187.8

Q ss_pred             ccEEeeeCceEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee--eCCeeEEEEEecc
Q 015076           84 DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYVN  158 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~iv~e~~~  158 (413)
                      ...||+|+||.||+|..+   ++..||+|.+....  ....+.+|+.+++.++||||+++++++.  .+...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            358999999999999965   34679999875432  2345678999999999999999999885  3567899999995


Q ss_pred             CCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE----cCCCCceEEecccc
Q 015076          159 NGNLEQWLHGDV-----GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (413)
Q Consensus       159 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a  229 (413)
                       ++|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57877764221     1123588999999999999999999999   99999999999999    56678999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc------cHHHHHHH
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV------NLIEWLKK  300 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~------~~~~~~~~  300 (413)
                      +........  ......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||.........      .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876433221  1233568999999999876 45899999999999999999999999754321110      00000000


Q ss_pred             HhhcCCC------------CCc---C-CCCCCC--------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          301 MVTNRNP------------EGV---L-DPKLPE--------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       301 ~~~~~~~------------~~~---~-~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .+.....            ...   . ......        .........+.+|+.+||..||.+|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000000            000   0 000000        0000123457789999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.3e-40  Score=304.29  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||.|+||+||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999954 57789999886443 23556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++..... ...+++..+..++.|++.||+|||+.   |++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999975421 14689999999999999999999999   99999999999999999999999999987665432


Q ss_pred             cc---eeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          237 SY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       237 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..   ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........      .........      
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~------  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDP------  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCC------
Confidence            22   12334688999999998777 789999999999999999999999975443211      111111111      


Q ss_pred             CCCCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          313 PKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       313 ~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +.+... ....++..+.+++.+||..||++||++.+|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111111 123456778999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-40  Score=313.34  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=202.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|+..+.||+|+||.||+|.+. ++.    .+|+|.+..... .....+..|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3467889999999999999999854 343    478887765432 3334678899999999999999999998754 46


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++++||+++|+|.+++....   ..+++..++.++.|++.||+|||++   +|+|+||||+|||++.++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            79999999999999987643   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......       ....+..... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-  229 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGER-  229 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC-
Confidence            76433221 1122345678999999998899999999999999999997 999996543211       1111211110 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                            ++.  ...+...+.+++..||..+|++||++.++++.|....
T Consensus       230 ------~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         230 ------LPQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ------CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  100  1123456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-39  Score=308.19  Aligned_cols=265  Identities=23%  Similarity=0.292  Sum_probs=203.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +|++.+.||+|+||.||+|... ++..||||.+......     ....+..|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999965 6889999998655322     344567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+ +++|.+++....   ..+++..++.++.||++||+|||++   ||+|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999997652   3699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC-------
Q 015076          234 SESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR-------  305 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-------  305 (413)
                      ..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........   ..........       
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhh
Confidence            43221 222346788999998855 45789999999999999999998888654432211   1111111000       


Q ss_pred             --CCCCcCCCC-CC----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          306 --NPEGVLDPK-LP----EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       306 --~~~~~~~~~-~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                        ......... ..    .......+..+.++|.+||..||++|||+.+++.+-.-.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence              000000000 00    001123457789999999999999999999999974433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.3e-40  Score=312.20  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||.||++... .++.|++|.+.....   .....+..|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46899999999999999999965 577899998865432   23456778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999864211


Q ss_pred             CC--------------cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          235 ES--------------SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       235 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ..              ........++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+      ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence            00              001112457889999999988889999999999999999999999997543221      1222


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ......       ..+.. ...++..+.+++.+||+.||++||++.++.+.|+.
T Consensus       228 ~~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 VISDDI-------EWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHhccc-------CCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111110       00111 11355678999999999999999996555555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-40  Score=304.68  Aligned_cols=238  Identities=26%  Similarity=0.455  Sum_probs=190.3

Q ss_pred             cEEeeeCceEEEEEEEcCCC-----------EEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           85 KVIGEGGYGIVYYGLLEDNS-----------KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +.||+|+||.||+|.+....           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976433           4777866544333 6778889999999999999999999887 778999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-------CceEEec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-------NPKVSDF  226 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df  226 (413)
                      |||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++       .++|+||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999997653   2689999999999999999999999   999999999999999887       7999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhh
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      |++.....     .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.........   .+..    
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~----  220 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ----  220 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh----
Confidence            99986543     1223467789999998776  78999999999999999999 57787654322111   1111    


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ...       ..+...    ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       221 ~~~-------~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-------RLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-------CCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000       011111    157889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.3e-40  Score=306.92  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=197.2

Q ss_pred             cEEeeeCceEEEEEEEcC-------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +.||+|+||.||+|...+       +..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       2468999775443 23456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-----CceEEeccc
Q 015076          157 VNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-----NPKVSDFGL  228 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~  228 (413)
                      +++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999965321   124578999999999999999999998   999999999999999887     899999999


Q ss_pred             ceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          229 AKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       229 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      +......... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||......+      ......... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~-  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHVTAGG-  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHHHhcCC-
Confidence            8765332211 1122345778999999999999999999999999999998 999996443211      111111110 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                               .......++..+.+++.+||..+|.+||++.+|++.|+
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                     00112235667899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.7e-40  Score=303.98  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=190.6

Q ss_pred             EEeeeCceEEEEEEEcCCC---EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           86 VIGEGGYGIVYYGLLEDNS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .||+|+||.||+|...++.   .+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999754332   45667665433 3345678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC-ccee
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-SYIT  240 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~  240 (413)
                      |.+++..........++..++.++.||+.||+|||+.   +++||||||+|||++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976433234567788899999999999999999   99999999999999999999999999986432211 1112


Q ss_pred             eccccccCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          241 TRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       241 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......      ..+...... ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCC
Confidence            33467889999998743       245789999999999999997 57787543321      122222221 1122223


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      +.+...    +...+.+++..|| .+|++||++.+|++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            332222    4456788889999 67999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6e-40  Score=307.43  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=198.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHH-HhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||.||+|.++ ++..||+|.+.... ......+..|+.+ ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46899999999999999999965 68899999886543 2233445556554 666789999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++ ++|.+++.........+++..++.++.||+.||+|||++.  +++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            995 6888887654333357999999999999999999999743  8999999999999999999999999998865432


Q ss_pred             CcceeeccccccCccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ..  .....++..|+|||++.+    ..++.++|+|||||++|+|++|+.||......     ...+.......      
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~------  224 (283)
T cd06617         158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP------  224 (283)
T ss_pred             cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC------
Confidence            21  222457889999998865    45688999999999999999999999643211     11111111111      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                         .+..+...++..+.+++.+||..+|++||++.+++++-.
T Consensus       225 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  263 (283)
T cd06617         225 ---SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF  263 (283)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence               111112235677999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.3e-40  Score=304.79  Aligned_cols=253  Identities=24%  Similarity=0.388  Sum_probs=190.1

Q ss_pred             EEeeeCceEEEEEEEcC---CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           86 VIGEGGYGIVYYGLLED---NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .||+|+||.||+|....   ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997433   3468888765433 2334567889999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCC-CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce-
Q 015076          162 LEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-  239 (413)
Q Consensus       162 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-  239 (413)
                      |.+++...... ....++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999764321 13456788899999999999999999   99999999999999999999999999987543322111 


Q ss_pred             eeccccccCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          240 TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .....++..|+|||++..       ..++.++|||||||++|+|++ |..||......+      .......... ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccCC
Confidence            122345678999998643       456889999999999999999 788886443221      1112121111 1111


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .+.    ....++..+..++..|| .||++|||+++|++.|.
T Consensus       232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111    12234556777888898 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-40  Score=304.58  Aligned_cols=249  Identities=23%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +|++.+.||.|+||.||+|.+. ++..||+|.+....   ......+.+|++++++++||||+++++++..+...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999965 58889999886543   2345678889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+.+++|.+++...    .++++..+..++.||++||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999765    4789999999999999999999999   9999999999999999999999999998876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ..  .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.........    .+.......      ..  
T Consensus       154 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~------~~--  219 (258)
T cd05578         154 TL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQETA------DV--  219 (258)
T ss_pred             cc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhccc------cc--
Confidence            21  23345788999999998888999999999999999999999999865542111    111111100      01  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKM--GHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~eil~~  351 (413)
                        ..+...+..+.+++.+||..||.+||++  .+++++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence              1112244778899999999999999999  776653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-39  Score=303.39  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=202.6

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      |++.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            778899999999999999864 67889999875433 2334578889999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            9999999864     3689999999999999999999999   9999999999999999999999999998766433221


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.......      ..... .....     +    .
T Consensus       158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~-----~----~  220 (277)
T cd06641         158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKNNP-----P----T  220 (277)
T ss_pred             -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcCCC-----C----C
Confidence             223457889999999988889999999999999999999999996433211      11111 11110     1    1


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ....++..+.+++.+||+.+|.+||++.+++++.-
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  255 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  255 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            12234567889999999999999999999999743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=304.18  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=201.9

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC---CCCcccccceeeeCCeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+..|+.+++.++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            478889999999999999996 468889999876542 334456788999999986   999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999998653     689999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... .....|+..|+|||.+.++ .++.++|+|||||++|+|++|..||........      ... .....     .+
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~~~~~-----~~  220 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-IPKSK-----PP  220 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-cccCC-----CC
Confidence            4322 2334688999999988654 478999999999999999999999975432211      110 00000     01


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .+.   ...++..+.+++.+||+.||++||++.+++.+-.
T Consensus       221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~  257 (277)
T cd06917         221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSKW  257 (277)
T ss_pred             CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence            111   1125567899999999999999999999998643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-39  Score=306.16  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||.|++|.||+|... ++..||||.+....  ......+..|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999965 68889999886443  22335688899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +. ++|..++.....  ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            95 689888865432  5689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC----------
Q 015076          237 SYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR----------  305 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----------  305 (413)
                      .. .....++..|+|||++.+.. ++.++|||||||++|+|+||+.||.........  ..... .....          
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFR-TLGTPDEVVWPGVTS  230 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHH-HhCCCChhhhhhhhH
Confidence            11 12234688999999886644 688999999999999999999999755432211  11111 00000          


Q ss_pred             ------CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 ------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                            .........+ ......+...+.++|.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                  0000000000 00011234567899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.9e-39  Score=296.50  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=207.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      +|.+.+.||+|++|.||++... ++..+++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999975 688899998876655566788899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++....   ..+++..++.++.|++.||++||+.   +++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999987653   4789999999999999999999998   999999999999999999999999999987755432 


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.....      ..... ...     +.+.  
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~-----~~~~--  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NGP-----PGLR--  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cCC-----CCcC--
Confidence             23456789999999998888999999999999999999999999754322111      11111 111     1111  


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ....++..+.+++.+||+.||++|||+.+++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111135678999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=318.99  Aligned_cols=262  Identities=23%  Similarity=0.398  Sum_probs=220.5

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      +.|+....+.....+||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|+.+|+.++|||+|+++++|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            5677777778888999999999999999875 556999987654 45678899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      |||+|||..|+|.+||....  ...++....+.++.||..|+.||..+   ++|||||..+|+|+.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999997642  25688888999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ++..+.........-...|.|||-+.-..++.|+|||+||++|||+.| |-.||.+-+......+       +       
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-------L-------  479 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-------L-------  479 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-------H-------
Confidence            987665444444445788999999999999999999999999999998 8888865442222111       1       


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                        ...+.-..+..|+....+||+.||+.+|.+||++.||-+.+|..
T Consensus       480 --EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  480 --EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             --hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence              12233344556777899999999999999999999999888764

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=310.24  Aligned_cols=268  Identities=19%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEc---CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~  151 (413)
                      +|++.+.||+|+||.||+|...   .+..||+|.+....   ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4888999999999999999965   47889999887633   33345677899999999999999999999888  8899


Q ss_pred             EEEEeccCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC----CCCceEEec
Q 015076          152 LVYEYVNNGNLEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK----HWNPKVSDF  226 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  226 (413)
                      +||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 777766433221 13789999999999999999999999   9999999999999999    899999999


Q ss_pred             ccceecCCCCc--ceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc------cHHHH
Q 015076          227 GLAKLLGSESS--YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV------NLIEW  297 (413)
Q Consensus       227 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~------~~~~~  297 (413)
                      |++........  .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........      .....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322  11233467889999998766 45889999999999999999999999765443200      00011


Q ss_pred             HHHHhhcC------------CCC----CcCCCCCCC-CCcH------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          298 LKKMVTNR------------NPE----GVLDPKLPE-KPTS------RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       298 ~~~~~~~~------------~~~----~~~~~~~~~-~~~~------~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +...+...            ...    .......+. ....      .....+.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11111000            000    000001110 0001      234568899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-39  Score=307.21  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=202.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ...|++.+.||+|+||.||+|... ++..||+|.+....   ......+..|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356899999999999999999965 68889999886432   23335688899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+. |+|.+++....   ..+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++....
T Consensus        94 ~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            99996 57777765432   4689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          234 SESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ..     ....++..|+|||++.   ...++.++||||||+++|+|++|..||........      .......      
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~------  229 (307)
T cd06607         167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN------  229 (307)
T ss_pred             CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC------
Confidence            32     2345788999999874   45688999999999999999999999964432211      1111111      


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         ..+......++..+.+++.+||..+|++||++.+|+.+....
T Consensus       230 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         230 ---DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence               111122234667799999999999999999999999875543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=306.28  Aligned_cols=264  Identities=22%  Similarity=0.318  Sum_probs=198.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|..+ ++..||||.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            467999999999999999999965 678899998865432 223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+.+ +|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9974 9999886543   3689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC------
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE------  308 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------  308 (413)
                      ... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||........  ....+..........      
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhh
Confidence            111 122346889999998865 4588999999999999999999999975442111  111111111000000      


Q ss_pred             ---CcCCCCCCC---C------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 ---GVLDPKLPE---K------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ---~~~~~~~~~---~------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         .........   .      ........+.+++.+||+.+|++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               000000000   0      000112567899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.7e-39  Score=297.97  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||.|+||.||++.+. ++..+++|.+.....  .....+..|+++++.++|||++++++.+......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999965 688899998866533  4556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.........+++..++.++.+++.||.|||+.   |++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999976532235799999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                       .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .......... .     ..+ 
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~~-  223 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQ-Y-----PPI-  223 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCC-C-----CCC-
Confidence             2233456889999999998888999999999999999999999999654421      1122221111 1     111 


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         ...+...+.+++.+||..+|++|||+.+++++
T Consensus       224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               11345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.9e-39  Score=307.37  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=201.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|...+.||+|+||.||+|... ++..+|+|.+....   ......+..|+++++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3788899999999999999954 67889999886432   2334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+. |+|.+++....   .++++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            996 47777775432   4689999999999999999999999   9999999999999999999999999998755432


Q ss_pred             CcceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          236 SSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                           ....++..|+|||++.   .+.++.++|||||||++|+|++|+.||........      .........      
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~------  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES------  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhccC------
Confidence                 2345788999999873   45688999999999999999999999864322111      111111111      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                         +......++..+.+++.+||+.+|.+||++.+|++++.....
T Consensus       242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence               111222355678999999999999999999999998776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.4e-39  Score=304.15  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      .|...+.||+|++|.||++... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999954 688899998865555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++...     .+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.........
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            99999998762     588999999999999999999999   9999999999999999999999999988755433221


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                       .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..      ......... ...     ...  
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~~~-----~~~--  236 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-LPP-----KLK--  236 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-CCC-----CCc--
Confidence             23346889999999998888999999999999999999999999754321      111211111 110     100  


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ....++..+.+++.+||..+|++|||+.+++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            111244678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-39  Score=314.27  Aligned_cols=265  Identities=25%  Similarity=0.294  Sum_probs=201.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  147 (413)
                      ..++|++.+.||+|+||.||+|... ++..||||.+...  .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4678999999999999999999954 6889999987543  223345677899999999999999999987643      


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999995 588887753      388899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH------------
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------  295 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~------------  295 (413)
                      ++........  .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+            
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9987654322  23345789999999999999999999999999999999999999755432111100            


Q ss_pred             HH----HHHHhhcCC------CCCcCC----CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          296 EW----LKKMVTNRN------PEGVLD----PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       296 ~~----~~~~~~~~~------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..    .........      ......    +.............+.+++.+||+.||++|||+.+++.+-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~  313 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY  313 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence            00    000000000      000000    00001112234667889999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-39  Score=298.88  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||++... ++..+++|.+....  ......+..|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4888999999999999999855 67889999886542  23445677899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++.........+++..++.++.|++.||+|||+.   |++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876433335789999999999999999999999   9999999999999999999999999999876543 


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+...       +........        .+
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~--------~~  219 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGK--------YP  219 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC--------CC
Confidence              1223457899999999999899999999999999999999999997554321       111111111        11


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       .....+..++.+++.+||..+|++|||+.+++++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             1122566779999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.9e-39  Score=299.47  Aligned_cols=250  Identities=22%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|+||.||+|..+ ++..+|+|.+....  ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4888999999999999999965 57889999886542  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC-ceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++. ++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            999999999876432  3579999999999999999999999   9999999999999998864 699999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      ... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ........... .    .   
T Consensus       156 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~----~---  220 (257)
T cd08225         156 MEL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQGY-F----A---  220 (257)
T ss_pred             ccc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccc-C----C---
Confidence            221 2234588999999999888899999999999999999999999964432      11222222111 1    1   


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        .....++..+.+++.+||..+|++|||+.+++++
T Consensus       221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              0111244578999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-39  Score=307.73  Aligned_cols=267  Identities=25%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~i  152 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+......  ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            567999999999999999999965 5889999988644322  223456799999999999999999998754  56899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+. ++|.+++....   ..+++..++.++.||+.||+|||+.   |++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999995 58888886543   5789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC---
Q 015076          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---  308 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---  308 (413)
                      ...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+   ..........   
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~  234 (309)
T cd07845         159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWP  234 (309)
T ss_pred             CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhch
Confidence            543221 122345788999998865 55889999999999999999999999765443222111   1111100000   


Q ss_pred             --------CcCC-CCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 --------GVLD-PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 --------~~~~-~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                              .... +..+...    ....+..+.++|.+||+.||++|||+.+++.+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                    0000 0000000    011356778999999999999999999999886554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-39  Score=301.79  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=198.8

Q ss_pred             CCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC------
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  148 (413)
                      |.+.+.||+|+||.||+|.+.    .+..||||.+....  ......+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999853    35789999886542  334567888999999999999999999875432      


Q ss_pred             eeEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ..+++++|+.+++|..++....  .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999988874321  1123588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          227 GLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       227 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      |+++......... .....+++.|++||.+....++.++|||||||++|+|++ |+.||......+      ........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHHHHcC
Confidence            9998664332211 122345678999999988889999999999999999999 889986543221      11111111


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...      .    ....++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       232 ~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110      0    0112445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-39  Score=306.30  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=197.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCC-CCCcccccceeeeCCe-----
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAH-----  149 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~-----  149 (413)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+.....  .....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999965 688899998754432  23356778999999995 6999999999876655     


Q ss_pred             eEEEEEeccCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGP-CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFG  227 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG  227 (413)
                      .++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 888887653221 24689999999999999999999999   9999999999999998 8899999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+   ........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---FKLLGTPT  232 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHhCCCC
Confidence            98865432211 122346888999998765 45789999999999999999999999765432221111   11110000


Q ss_pred             C---CCc--------C---CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 P---EGV--------L---DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 ~---~~~--------~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .   ...        .   .+.........++..+.++|.+||..||.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0   000        0   0000000112356678999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-40  Score=319.35  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             CcccEEeeeCceEEEEEEEc-CCCEEEEEEe--ec--CCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCe--eEEEE
Q 015076           82 SDDKVIGEGGYGIVYYGLLE-DNSKVAVKNL--LN--NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVY  154 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--~~iv~  154 (413)
                      +...+||+|+|-+||+|.+. +|..||--.+  ..  .......+|..|+.+|+.|+||||+++|+++.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999965 4666663222  11  233445789999999999999999999999987654  78999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecccceecC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLG  233 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~  233 (413)
                      |.+..|+|..|+.+.    ..+....+..|++||++||.|||++ .+.|||||||.+||+|+.+ |.|||+|+|||....
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999887    5789999999999999999999998 5689999999999999865 889999999999875


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ...   ...++|||.|||||+.. ..|+..+||||||++|+||+|+.+||...     .+..+..++......+..+-.-
T Consensus       198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHhhcc
Confidence            432   33478999999999886 88999999999999999999999999743     3344445555444333222111


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +         ..+++++|.+|+.. .++|||+.|+|.+-
T Consensus       269 ~---------dPevr~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  269 K---------DPEVREFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             C---------CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence            1         23578999999999 99999999999863

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=321.35  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=211.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC--CC--EEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED--NS--KVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++..+.++||+|.||.|++|.|..  |.  .||||.+..+... ....|.+|+.+|.+|+|||++++|++..+ ....+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3456677899999999999999763  33  4899998776544 66789999999999999999999999988 67889


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      |||.++.|+|.+.|++.  ....|.......++.||+.||.||.++   ++|||||..+|+||-....+||+||||.+.+
T Consensus       188 V~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             HhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence            99999999999999872  336788999999999999999999999   9999999999999999889999999999988


Q ss_pred             CCCCcceee--ccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSYITT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      +....+...  ...-...|+|||.+....++.++|||+|||+||||+| |+.||-+......+..++             
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------------  329 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------------  329 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------------
Confidence            766554332  2334678999999999999999999999999999998 899998766543332221             


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         ..-....+..+++++.+++..||..+|.+||||..|.+.+
T Consensus       330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence               1111233445788999999999999999999999997443

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-39  Score=303.34  Aligned_cols=256  Identities=26%  Similarity=0.372  Sum_probs=209.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..+.|++.+.||+|+||.||+|.+. ++..+++|.+..... ....+..|+.+++.++|+||+++++++......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3566889999999999999999976 688899998876544 55678889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999998753   3799999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .. ......++..|++||++.+..++.++|+||||+++|+|++|+.||........      ...... ....       
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~-------  234 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT-KGIP-------  234 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-cCCC-------
Confidence            21 12234578899999999888899999999999999999999999974433211      111111 1100       


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .......++..+.+++.+||+.+|.+|||+.+|+.+..-
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  273 (286)
T cd06614         235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL  273 (286)
T ss_pred             CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence            011122255678999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.9e-39  Score=304.30  Aligned_cols=264  Identities=19%  Similarity=0.241  Sum_probs=197.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467999999999999999999854 688999998865432 223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+. ++|.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            995 67777765432   4578888999999999999999999   9999999999999999999999999998764332


Q ss_pred             CcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc----------
Q 015076          236 SSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN----------  304 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----------  304 (413)
                      ... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.......  ..+.........          
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence            211 2234578899999988654 57889999999999999999999997544321  111111100000          


Q ss_pred             --C-CCCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          305 --R-NPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       305 --~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        . ..........+...     .......+.+++.+|+..||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              0 00000000000000     00113467889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=303.46  Aligned_cols=261  Identities=26%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeEEEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYE  155 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~iv~e  155 (413)
                      |++.+.||.|+||.||+|... ++..+|+|.+....  ......+..|+.+++.++|||++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999966 47889999987653  33345678899999999999999999999888  89999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++ ++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            996 48888886542   4789999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC---CCc-
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGV-  310 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-  310 (413)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........   +.........   ... 
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVS  230 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhccccc
Confidence            3222233456888999997765 4578999999999999999999999976553322111   1111110000   000 


Q ss_pred             -------CCC--C----CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          311 -------LDP--K----LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       311 -------~~~--~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                             ...  .    +.......++..+.+++.+||..+|.+||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   000  0    0000001126678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=291.69  Aligned_cols=259  Identities=21%  Similarity=0.270  Sum_probs=205.8

Q ss_pred             hcCCCCcc-cEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeee----CCe
Q 015076           77 STNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE----GAH  149 (413)
Q Consensus        77 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~  149 (413)
                      .+++|.+. ++||-|-.|.|..+.++ ++.++|+|.+...     ...++|+++.-.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556553 57999999999999855 7889999976422     2334566655444 59999999999865    356


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEec
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDF  226 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  226 (413)
                      +.+|||+++||.|+..+.....  ..+++.++..|+.||+.|+.|||+.   +|.||||||+|+|....   ..+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999987643  5799999999999999999999999   99999999999999654   45899999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |+|+.......  ..+.+-|+.|.|||++....|+..+|+||+|++||-|++|.+||......   ...--++..+..+.
T Consensus       209 GFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq  283 (400)
T KOG0604|consen  209 GFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC
Confidence            99997654333  34456799999999999999999999999999999999999999644321   11111222233222


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                            -.++...+...++...++|+.+|..+|.+|.|+.+++.+-.-..
T Consensus       284 ------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  284 ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             ------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence                  25667778889999999999999999999999999999865443

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=313.24  Aligned_cols=262  Identities=23%  Similarity=0.344  Sum_probs=197.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Cee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            367999999999999999999854 68899999885432 23345677899999999999999999987544     357


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+. ++|..++..     ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            99999995 588887754     3699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc--eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          231 LLGSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ........  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...   ....+...+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence            66432211  1123467899999998654 568999999999999999999999997543211   11111111111000


Q ss_pred             C-----------Cc---CC--CCCC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          308 E-----------GV---LD--PKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       308 ~-----------~~---~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .           ..   ..  ...+ .......+..+.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0           00   00  0000 00011235678899999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.5e-39  Score=305.00  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=200.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~iv  153 (413)
                      ++|++.+.||.|+||.||+|.++ ++..+++|.+......  ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57999999999999999999976 5788999988654322  223566799999999999999999998877  889999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+. ++|.+++....   ..+++..++.++.||+.||+|||+.   +++|+||||+|||++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99996 59998887643   3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc--------
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN--------  304 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--------  304 (413)
                      ..... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+   ......        
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI---FKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCchHHHHH
Confidence            43211 2234578899999988654 4689999999999999999999999765432221111   110000        


Q ss_pred             ---------CCCCCcCCCCCCCCCcHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          305 ---------RNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       305 ---------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                               ..........+....... +...+.++|.+||+.||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     000000000000111111 35678899999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=302.00  Aligned_cols=262  Identities=23%  Similarity=0.323  Sum_probs=199.1

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      |++.+.||.|++|.||+|.+. ++..||+|++....  ......+..|+.+++.++||||+++++++.++...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999965 68899999886543  223356778999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                       +++|.+++.....  ..+++..++.++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 -DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             -CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence             4689998876532  3689999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-----------C
Q 015076          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-----------R  305 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----------~  305 (413)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|+.||.........  ..........           .
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhch
Confidence            1 1223468899999987664 5789999999999999999999999755432211  1111100000           0


Q ss_pred             CCCCcCC---CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 NPEGVLD---PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .....+.   ..........++..+.+++.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000   000001112344678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-39  Score=311.81  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Ce
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  149 (413)
                      .++|.+.+.||+|+||+||+|... ++..||||.+...  .......+..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357999999999999999999954 6888999988643  223345667899999999999999999987644     35


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+. ++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 6898888765    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC-
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP-  307 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  307 (413)
                      ........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+......   .+......... 
T Consensus       156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~  231 (337)
T cd07858         156 RTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEE  231 (337)
T ss_pred             cccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChH
Confidence            87643321 2233457889999998765 468999999999999999999999997554221111   11111100000 


Q ss_pred             -----------------CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          308 -----------------EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       308 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                                       ....+..+. .....++..+.+++.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                             000000000 0012356678999999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.7e-39  Score=302.49  Aligned_cols=258  Identities=17%  Similarity=0.230  Sum_probs=188.0

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCC----CEEEEEEeecCCchhH-----------HHHHHHHHHHhcCCCCCcccc
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDN----SKVAVKNLLNNRGQAE-----------REFKVEVEAIGRVRHKNLVRL  140 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~hpniv~~  140 (413)
                      +..++|++.++||+|+||+||+|.+.++    ..+|+|..........           .....+...+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4557899999999999999999996543    4456664332221111           112233445667789999999


Q ss_pred             cceeeeCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc
Q 015076          141 LGYCAEGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (413)
Q Consensus       141 ~~~~~~~~----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~  216 (413)
                      ++++....    ..+++|+++ ..++.+.+...    ...++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            98765443    347888887 44676666543    3467888999999999999999999   999999999999999


Q ss_pred             CCCCceEEecccceecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 015076          217 KHWNPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE  290 (413)
Q Consensus       217 ~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~  290 (413)
                      .++.++|+|||+|+........      ......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999876432111      1122468999999999999999999999999999999999999998653322


Q ss_pred             cccH---HHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          291 EVNL---IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       291 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ....   ...+.....         ....   ....++.+.+++..||..+|++||++.+|++.++
T Consensus       241 ~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111   111111111         1110   1123467889999999999999999999998763

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.7e-39  Score=301.07  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCCcccccceeeeC--CeeEEEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVYE  155 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~~~iv~e  155 (413)
                      |++.+.||+|+||.||+|... ++..||+|.+.... .........|+.+++++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999954 67889999886542 222234456888888885 99999999999887  88999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |++ ++|.+++....   ..+++..++.++.|++.||+|||+.   +++||||||+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 58888776532   4689999999999999999999999   9999999999999999 99999999999876433


Q ss_pred             CcceeeccccccCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC--------
Q 015076          236 SSYITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--------  306 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------  306 (413)
                      ..  .....++..|+|||++. +..++.++|||||||++|+|++|..||...+..+.   ............        
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence            22  12345788999999764 45678999999999999999999999976543221   111111110000        


Q ss_pred             CCCcCCCCCCCC-------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 PEGVLDPKLPEK-------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .....+...+..       ....++..+.++|.+||..+|++||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000011100       012356789999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-38  Score=293.07  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=207.1

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY  154 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~iv~  154 (413)
                      +|++.+.||+|++|.||+|... ++..|++|.+.....  .....+..|+.++++++||||+++++.+...  ...+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999976 688899998865542  4567788999999999999999999999888  8899999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999765    3799999999999999999999998   999999999999999999999999999987765


Q ss_pred             CCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ..........         .
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------S  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------c
Confidence            4321 12334678999999999888899999999999999999999999975541     1111111110         0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .........++..+.+++.+||..+|++||++.+++.+
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            11111222346779999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-39  Score=304.44  Aligned_cols=267  Identities=24%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC---
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA---  148 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---  148 (413)
                      +...++|++.+.||+|+||.||+|..+ ++..||+|.+....  ......+..|+.+++.++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            355678999999999999999999975 57889999886543  233356778999999999999999999887654   


Q ss_pred             -------eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          149 -------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       149 -------~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                             ..++||||+++ +|..++....   ..+++..++.++.||+.||+|||+.   +|+|+||||+||++++++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                   78999999975 7777765542   4789999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ...+..
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~  232 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISR  232 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHH
Confidence            999999998765433221222345788999998765 4578999999999999999999999975443221   212222


Q ss_pred             HhhcCCCCC---c--------CCCCCC-----CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          301 MVTNRNPEG---V--------LDPKLP-----EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       301 ~~~~~~~~~---~--------~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .........   +        .+....     ......++..+.+++.+||..||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            211111000   0        000000     00011235678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-39  Score=294.08  Aligned_cols=248  Identities=27%  Similarity=0.467  Sum_probs=205.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|++.+.||+|++|.||++... .+..|++|.+.....  .....+..|++++++++|||++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4888999999999999999865 577899998876543  4556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...    ..+++..++.++.|++.||.|||+.   ||+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998765    5799999999999999999999999   99999999999999999999999999998776543


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|..||......      ...........      +.+ 
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~~~-  219 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQDDH------PPL-  219 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhccCC------CCC-
Confidence            32 23346788999999998888899999999999999999999999743311      11111111110      111 


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         ...+...+.+++.+||..+|++|||+.+++.+
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence               12235678899999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.7e-39  Score=297.49  Aligned_cols=245  Identities=23%  Similarity=0.293  Sum_probs=199.7

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||.|+||.||+|... .+..+|+|.+.....   .....+..|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 488899998865432   3446788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++.+.    ..+++..+..++.||+.||+|||++   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999765    4689999999999999999999999   99999999999999999999999999998765432  1233


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|..||......    .............     ....    +..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~-----~~~~----~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG-----KLEF----PNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC-----CCCC----Ccc
Confidence            46789999999998888999999999999999999999999755421    1122222221010     0111    112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          323 LLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                      ....+.+++.+||..+|++||+     +.|++++-.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence            2567899999999999999999     888887643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.3e-39  Score=300.38  Aligned_cols=245  Identities=22%  Similarity=0.287  Sum_probs=190.6

Q ss_pred             EEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHH---HhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           86 VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEA---IGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      +||+|+||.||++... ++..+|+|.+.....   .....+..|..+   +...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 578899998865421   112233344433   334479999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||||+|||+++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            99999988755    4799999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........    +......      ...    
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~----  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNV----  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCc----
Confidence             223468999999998864 568999999999999999999999997544322111    1111100      011    


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEA  354 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le~  354 (413)
                      ..+..++.++.+++.+||..||.+||     ++.+++++...
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            11223556788999999999999999     69999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=296.04  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCCcccccceeeeC--Cee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR  150 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~  150 (413)
                      .+|++.+.||+|+||.||+|... ++..||+|.+....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999954 58889999875321     23345788899999999999999999998664  568


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999998754    4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCc--ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .......  .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.......      .+.......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~---  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQP---  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCC---
Confidence            6532111  11123458899999999988889999999999999999999999997432211      111111111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        ..+    ..+..+...+.+++.+||. +|..||++.+++.+.
T Consensus       226 --~~~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         226 --TKP----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             --CCC----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence              011    1223456678999999999 579999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-39  Score=309.50  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=203.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC-----eeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~  151 (413)
                      +|++.+.||.|+||.||+|... .+..||||.+....  ......+..|+.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999965 58899999886543  344567888999999999999999999988765     789


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ++|||++ ++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999996 5899888765    4799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc--ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESS--YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......  .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....   +..........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChh
Confidence            754321  112334578899999999887 789999999999999999999999976553221111   11110000000


Q ss_pred             -----------CcCC---CCCC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          309 -----------GVLD---PKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       309 -----------~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                                 ..+.   ....   ......++..+.+++.+||+.+|++|||+.+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  290 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP  290 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence                       0000   0000   000112456788999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=299.92  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=202.6

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      |++.+.||+|++|.||+|... ++..+++|.+.....  .....+..|+.+++.++|+||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677889999999999999965 688899998865432  24567788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++ +|.+++....   ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            65 8888876643   4789999999999999999999999   999999999999999999999999999987755431


Q ss_pred             ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC---CCcCC-
Q 015076          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGVLD-  312 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  312 (413)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+   .........   ..... 
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhh
Confidence             12224578899999998776 7899999999999999999999999765432221111   111000000   00000 


Q ss_pred             --------CCC----CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          313 --------PKL----PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       313 --------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                              +..    .......++..+.++|.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    000    001123456789999999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.4e-39  Score=302.55  Aligned_cols=259  Identities=27%  Similarity=0.390  Sum_probs=198.4

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|...+.||+|+||.||++.+. ++..+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35667789999999999999965 57889999886543 334557888999999996 9999999999999999999999


Q ss_pred             eccCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          156 YVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       156 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |+. ++|.++.... ......+++..+..++.+++.||+|||+..  +++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            985 4655543210 001157899999999999999999999632  899999999999999999999999999976543


Q ss_pred             CCcceeeccccccCccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...  .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     .....+.......      
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------  227 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------  227 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------
Confidence            221  1223578899999998776   68999999999999999999999997443     1111112111111      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .+.+.......++..+.+|+.+||+.||++|||+.+|+++-.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            111222222346678999999999999999999999998744

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.5e-39  Score=309.92  Aligned_cols=265  Identities=21%  Similarity=0.348  Sum_probs=202.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee----CCeeE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM  151 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~  151 (413)
                      ++|++.+.||+|+||.||+|... ++..||+|++....  ......+..|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67999999999999999999954 68899999886542  2334567789999999999999999998753    35689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+. ++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 6899988765    4699999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCc---ceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC-
Q 015076          232 LGSESS---YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (413)
Q Consensus       232 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (413)
                      ......   .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........   +........ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~---~~~~~g~~~~  233 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL---ILSVLGSPSE  233 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH---HHHHhCCChh
Confidence            543221   11223468899999998765 4588999999999999999999999976543221111   111110000 


Q ss_pred             ----------CCCcCC--CCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 ----------PEGVLD--PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ----------~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                ......  +......    ....+..+.+++.+||+.+|++|||+.+++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence                      000000  0000000    12246778999999999999999999999998554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.3e-39  Score=300.80  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv  153 (413)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+...   .......+..|+.++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999965 6889999987653   2233466788999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999765    4799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCc-------------------ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH
Q 015076          234 SESS-------------------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL  294 (413)
Q Consensus       234 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~  294 (413)
                      ....                   .......++..|+|||++.+..++.++||||||+++|+|++|..||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            4321                   1223346789999999998888999999999999999999999999755421     


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHH
Q 015076          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM----GHVVHM  351 (413)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~eil~~  351 (413)
                       ..........       ..    ....++..+.+++.+||+.+|++||++    .+++++
T Consensus       229 -~~~~~~~~~~-------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 -LTFQKILKLE-------YS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHHHHHhcC-------CC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             1111111110       11    112235678999999999999999999    888875

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=344.27  Aligned_cols=262  Identities=27%  Similarity=0.533  Sum_probs=207.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ...|...++||+|+||.||+|.. .++..||||++.......    ..|++++++++|||||++++++.++...++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35678888999999999999996 478899999885433221    2468889999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++|+|.++++       .++|..+..++.|+++||+|||..+..+|+||||||+||+++.++..++. ||........ 
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            99999999994       37899999999999999999995444599999999999999998887775 6655433211 


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                          ....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... .......|.............+++.+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence                123578999999999999999999999999999999999999954322 233445555444333333334444432


Q ss_pred             C--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          317 E--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       317 ~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .  ........++.+++.+||+.||++||||.+|++.|+....
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            2  2234566678899999999999999999999999997643

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=311.94  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=211.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ....|.+.+.||+|.|+.|.+|++. ++..||||.+.+...  .....+.+|+++|+.++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567999999999999999999955 688999998876543  3334578899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+.+|.+++++.+.    +.+.+..+..++.|++.|++|||++   +|||||||++||||+.+.++||+|||++..+.
T Consensus       134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999887    5777799999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..  ....+++|++.|.|||++.+..| ++.+|+||+|++||.|+.|.+||++....+.....               +.
T Consensus       207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~  269 (596)
T KOG0586|consen  207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LR  269 (596)
T ss_pred             cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------ee
Confidence            43  34667899999999999999876 57999999999999999999999976644322111               11


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .++.  .+--++.++.++++++|-.+|.+|+++++|..+-.
T Consensus       270 gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  270 GKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             eeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            1111  11123456778999999999999999999987643

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6e-39  Score=304.50  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=197.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCC------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  148 (413)
                      .++|++.+.||+|+||.||+|... ++..||||.+.....  .....+.+|+.+++.++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999965 588899998865432  22335567999999999999999999876543      


Q ss_pred             --eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          149 --HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       149 --~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                        ..++||||+. ++|.+++....   ..+++..++.++.||+.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              4599999995 58888776542   3689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcc---eeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          227 GLAKLLGSESSY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       227 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+..+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866432211   11234568899999987664 47889999999999999999999997655432222222111100


Q ss_pred             hcCCCCCc-----CC-CCCCCCCcH---------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          303 TNRNPEGV-----LD-PKLPEKPTS---------RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       303 ~~~~~~~~-----~~-~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ........     .+ -.++.....         .....+.++|.+||..||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000000     00 000000000         013456789999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-38  Score=299.08  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +|++.+.||.|++|.||+|... ++..||||.+..... .....+..|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4889999999999999999975 578899998865432 23456678999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            75 88888765421 24689999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC--------CC
Q 015076          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--------PE  308 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~  308 (413)
                      . .....++..|++||++.+. .++.++|||||||++|+|++|+.||...+..+....+   ........        ..
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI---FRIMGTPTESTWPGISQL  231 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhCCCChhhHHHHhcC
Confidence            1 1223568899999987654 5788999999999999999999999866543221111   00000000        00


Q ss_pred             CcCCCCCCCC-------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          309 GVLDPKLPEK-------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ..+....+..       ....++..+.+++.+||+.||.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000111100       011235678899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-38  Score=300.78  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             ccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ...||+|+||.||++..+ ++..||||++..........+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999864 6888999988655555566788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++..     ..+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++......... ...
T Consensus       105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~  175 (292)
T cd06657         105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKS  175 (292)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc-ccc
Confidence            998754     3588999999999999999999999   9999999999999999999999999998765433211 233


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||........   ...+..    ..     ...+.  ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~----~~-----~~~~~--~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD----NL-----PPKLK--NLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----hC-----CcccC--Cccc
Confidence            4678999999999888899999999999999999999999975432211   111111    10     01111  1122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ++..+.+++.+||+.+|.+||++.+++.+-
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~~  271 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKHP  271 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence            345678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-38  Score=298.19  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=195.5

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||+|+||+||+|... ++..||+|.+....   ......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999855 58889999886432   22344567799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........  ...
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence            999876432  3689999999999999999999999   999999999999999999999999999876543221  223


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..++..|+|||++.+..++.++|||||||++|+|++|+.||...........+   ......          .+......
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~----------~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLE----------MAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcccc----------ccccCCcc
Confidence            45788999999998888999999999999999999999999755432111111   111000          01111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      ++..+.+++.+||+.||++||     ++.+++.+.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence            456788999999999999999     777787653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-38  Score=295.48  Aligned_cols=245  Identities=23%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||.|+||.||++.+. ++..+++|.+.....   .....+..|++++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 488999998865433   3456788899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc-----
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-----  237 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----  237 (413)
                      .+++...    ..+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999765    4789999999999999999999999   999999999999999999999999999876533211     


Q ss_pred             --ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          238 --YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       238 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                        .......++..|+|||.+....++.++||||||+++|+|++|..||.......      ....... ...      ..
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~------~~  220 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-GKI------EW  220 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CCc------CC
Confidence              01223457889999999988889999999999999999999999997544221      1111111 110      00


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      +  ....++..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       221 ~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 P--EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             C--ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1  11113567899999999999999999944444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-38  Score=304.09  Aligned_cols=262  Identities=21%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             cEEeee--CceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      ..||+|  +||+||++.+. .++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999964 68999999886543  23346788899999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999876432  3589999999999999999999999   99999999999999999999999998654332111100


Q ss_pred             ------eeccccccCccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----------
Q 015076          240 ------TTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK-----------  300 (413)
Q Consensus       240 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~-----------  300 (413)
                            .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||........  ....+..           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence                  0112345679999998764  478999999999999999999999975432111  0000000           


Q ss_pred             -----H----------------hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          301 -----M----------------VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       301 -----~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           .                .............+.......+...+.+|+.+||+.||++|||+.+++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                 0                0000000011111112223446778999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-38  Score=297.75  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=199.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCee
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  150 (413)
                      +|++.+.||.|+||.||+|...    ++..||+|.+....    ......+..|+.+++.+ +|+||+.+++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999853    57889999886432    23345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999998765    4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ..............|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.........  ...........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~---  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE---  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhccC---
Confidence            7644332223345688999999988653  4778999999999999999999999743322111  11111111111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHM  351 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~  351 (413)
                          +..    ...+...+.+++.+||..||++||     ++.+++.+
T Consensus       229 ----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                111    122455688999999999999997     67777766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=300.87  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|++|.||+|.+. ++..||+|.+.....  .....+..|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999965 688899998754322  234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecccceecCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~  234 (413)
                      |++ ++|.+++.....  ..+++..++.++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            995 588887754321  3468888899999999999999999   9999999999999985 45689999999976543


Q ss_pred             CCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC-
Q 015076          235 ESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-  312 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  312 (413)
                      .... .....+++.|+|||++.+ ..++.++|||||||++|+|+||..||......+.....   ....... ....++ 
T Consensus       156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~-~~~~~~~  230 (294)
T PLN00009        156 PVRT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTP-NEETWPG  230 (294)
T ss_pred             Cccc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCC-Chhhccc
Confidence            2211 123356889999998866 45789999999999999999999999765432221111   1111000 000000 


Q ss_pred             -----------CCCCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          313 -----------PKLPE----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       313 -----------~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                                 +....    .....++..+.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000    0011235568899999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.3e-38  Score=292.23  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=192.9

Q ss_pred             HhcCCCCcccEE--eeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVI--GEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (413)
                      ...+.|++.+.+  |+|+||.||++..+ ++..+|+|.+........     |+.....+ +||||+++++.+...+..+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            344677777776  99999999999954 677889998754322211     22222212 6999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~  230 (413)
                      +||||+++++|.+++...    ..+++..++.++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++.
T Consensus        86 iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            999999999999999765    3799999999999999999999999   999999999999999998 99999999988


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ......     ...++..|+|||++.+..++.++||||||+++|+|++|..||...... ......+.... . .     
T Consensus       159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~-~-----  225 (267)
T PHA03390        159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q-K-----  225 (267)
T ss_pred             ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c-c-----
Confidence            764322     235789999999999989999999999999999999999999744322 11111111111 1 0     


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHM  351 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~  351 (413)
                         ..  .....++..+.+++.+||+.+|.+||+ +++++++
T Consensus       226 ---~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 ---KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ---cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence               00  111245667899999999999999995 6999875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.9e-38  Score=298.62  Aligned_cols=265  Identities=17%  Similarity=0.201  Sum_probs=196.0

Q ss_pred             CcccEEeeeCceEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      .+.+.+|.|+++.||++.. ++..||||++...  .......+..|+.+++.++||||+++++++......+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3444555555555555444 5889999998654  334556788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc--
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS--  237 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  237 (413)
                      ++|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||.+........  
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          84 GSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999976432  3588999999999999999999999   999999999999999999999999999875532211  


Q ss_pred             ----ceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh----cC--
Q 015076          238 ----YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT----NR--  305 (413)
Q Consensus       238 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----~~--  305 (413)
                          .......++..|+|||++..  ..++.++|||||||++|+|++|+.||.......  ...........    ..  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence                11122456788999999866  358899999999999999999999997543211  11111100000    00  


Q ss_pred             -----CCCC----cCC----CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          306 -----NPEG----VLD----PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       306 -----~~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                           ....    ...    ..........+..++.+++.+||..||++|||+.+++++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence                 0000    000    001112233456778999999999999999999999987553

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=293.03  Aligned_cols=242  Identities=24%  Similarity=0.296  Sum_probs=189.5

Q ss_pred             cEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch---hHHHHHHHHHH-HhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ---AEREFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|... +++.||+|.+......   ....+..|..+ ....+|+||+++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999964 5788999988644321   12233445444 4455899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999999765    4689999999999999999999999   999999999999999999999999999876533     


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+...      ......... .      ..+...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~------~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRR-I------NWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc-c------CCCCcc
Confidence            223457889999999988889999999999999999999999997543321      111111111 0      111112


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMG---HVVHM  351 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~---eil~~  351 (413)
                      ...++..+.+++.+||..+|++||++.   +++.+
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            223567789999999999999999664   55554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.6e-38  Score=296.43  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=200.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCee
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  150 (413)
                      +|++.+.||+|+||.||++...    ++..||||.+....    ......+..|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999843    46789999886432    22345677899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998754    4689999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCCcceeeccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ..............|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.........  ...........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~---  228 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKSK---  228 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHccC---
Confidence            65443322233346889999999987665  788999999999999999999999643322111  11112221111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          ...    ...+...+.+++.+||+.||++|||+.++...|+.
T Consensus       229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                111    11244568899999999999999998877666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-38  Score=296.82  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=199.3

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~  151 (413)
                      .+..++|++.+.||+|+||.||+|.++. +..||||.+..... .....+..|+.++.+.. ||||+++++++......+
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            3456789999999999999999999764 88899998865432 23445666777666664 999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++|||+ +++|.+++....   ..+++..+..++.|++.||+|||+ .   +|+||||+|+||++++++.++|+|||++.
T Consensus        91 ~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          91 ICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            999998 457777765532   478999999999999999999997 5   89999999999999999999999999987


Q ss_pred             ecCCCCcceeeccccccCccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .......  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+.+........
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~  236 (296)
T cd06618         164 RLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP  236 (296)
T ss_pred             hccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC
Confidence            6543222  12234788999999987554    789999999999999999999999643211     111222222111


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .      ..+  ....+..++.+++.+||..||++||++.+++.+..
T Consensus       237 ~------~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         237 P------SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             C------CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            0      111  11134567899999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-38  Score=302.61  Aligned_cols=264  Identities=23%  Similarity=0.307  Sum_probs=196.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeC-------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------  147 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-------  147 (413)
                      .++|++.+.||+|+||.||+|.++ ++..+|+|.+......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 5788999988654322  234567899999999999999999987443       


Q ss_pred             -CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          148 -AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       148 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                       ..+++||||+. ++|...+....   ..+++..+..++.|+++||+|||+.   ||+|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence             35699999995 47777765432   4799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcc----------eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH
Q 015076          227 GLAKLLGSESSY----------ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       227 G~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~  295 (413)
                      |++.........          ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211          1122356888999998765 45889999999999999999999999765543222111


Q ss_pred             HHHHHHhhcCCC---------CC----cCCCCCCCCC---cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          296 EWLKKMVTNRNP---------EG----VLDPKLPEKP---TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       296 ~~~~~~~~~~~~---------~~----~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .   ........         ..    ......+...   ...+...+.+++.+||..||++|||+.+++.+
T Consensus       240 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 F---KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             H---HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1   11000000         00    0000011000   11233568899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.1e-38  Score=292.28  Aligned_cols=251  Identities=18%  Similarity=0.308  Sum_probs=197.7

Q ss_pred             CCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +|.+.+.||+|+||.||++.+.. +..+++|.+...     .......+..|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998653 344555544321     122334566789999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   |++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865333335799999999999999999999999   9999999999999976 579999999987764


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...........        
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~~~--------  221 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVEGP--------  221 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHcCC--------
Confidence            3322 23335678899999999888899999999999999999999999964321      11122221111        


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                       .+ .....++..+.++|.+||..+|++||++.+++++
T Consensus       222 -~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         222 -TP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -CC-CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             11 1123456788999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=294.70  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCCcccccceeeeCCe-----
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAH-----  149 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~-----  149 (413)
                      |++.+.||+|+||.||+|.++ ++..||+|.+.....  .....+..|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999976 488999998864322  2234555677776655   69999999999987776     


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+++|||++ ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 589888865432  3689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC----
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR----  305 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----  305 (413)
                      ........  .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....   +.......    
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK---IFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH---HHHHcCCCChHh
Confidence            87643322  2233478899999999999999999999999999999999999975543221111   11110000    


Q ss_pred             CCC------CcCCCCCC---CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 NPE------GVLDPKLP---EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ~~~------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ...      ........   ..........+.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            000      00000000   11122445778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.6e-38  Score=303.26  Aligned_cols=266  Identities=23%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCCcccccceeeeC--Cee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEG--AHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..+|+|++...  .......+..|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567999999999999999999965 5788999988543  223344567899999999 999999999988643  468


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||++ ++|..++...     .+++..++.++.||+.||+|||+.   ||+|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999996 5999888653     578899999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc----eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH-------
Q 015076          231 LLGSESSY----ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL-------  298 (413)
Q Consensus       231 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~-------  298 (413)
                      ........    ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+...       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66433221    1233468899999998755 55789999999999999999999999754432211111000       


Q ss_pred             -----HHHhhcCCCCCcCCCC--CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          299 -----KKMVTNRNPEGVLDPK--LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       299 -----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                           ...........+....  ........++..+.++|.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 0000000000000000  0001111245678999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.5e-38  Score=294.42  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=190.3

Q ss_pred             EEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHH---HHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           86 VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEV---EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|.   ..++...||||+.+++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 578999998865432   1122233333   34455679999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      |++|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999988654    4799999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             eeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       .....|+..|+|||++.++ .++.++|||||||++|+|++|+.||...........    ......      ....++ 
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~-  219 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELP-  219 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCC-
Confidence             2234689999999998754 689999999999999999999999975533221111    111110      011111 


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                         ..++..+.+++.+||..+|.+||     ++.+++++..
T Consensus       220 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~  257 (278)
T cd05606         220 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF  257 (278)
T ss_pred             ---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence               12356789999999999999999     9999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=292.45  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      |++.+.||+|+||.||+|... ++..|+||.+..... .......+|+..+++++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999975 477899998765432 22334456899999999 999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                       +++|.+++.....  ..+++..+..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             7899988876431  4689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             ceeeccccccCccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH----------HHHHHhhcCC
Q 015076          238 YITTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE----------WLKKMVTNRN  306 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~  306 (413)
                        .....++..|+|||++. ...++.++|+||||+++|+|++|+.||......+......          |.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              22345788999999874 4457899999999999999999999997654432211110          0000000000


Q ss_pred             CCCcCCCCCCCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 PEGVLDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ....+.......   ........+.+++.+||+.+|++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000000   001114678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-38  Score=297.55  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      |...+.||+|+||.||+|... ++..|++|.+.....   .....+..|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            667788999999999999964 578899998864322   2335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +. ++|.+++....   .++++..++.++.||+.||.|||+.   |++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            95 57777775432   4689999999999999999999999   999999999999999999999999999865432  


Q ss_pred             cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                         .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+....      .........       
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~-------  237 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNDS-------  237 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCC-------
Confidence               12346889999999874   45688999999999999999999999865432211      111111111       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        +......++..+.+++.+||+.+|.+||++.+++.+-.
T Consensus       238 --~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         238 --PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence              11112234456889999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.1e-38  Score=298.48  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..|...+.||+|+||.||+|+.. ++..+|+|.+...   .......+..|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999965 5778999988643   2233456778999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+. ++|.+++....   ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 58877765432   4689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .     ....++..|+|||.+.   ...++.++|||||||++|+|++|..||........      ........      
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~------  230 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------  230 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcC------
Confidence            2     2245788999999874   35688899999999999999999999864332111      11111111      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         .+......+...+.++|.+||..+|++||++.+++.+.....
T Consensus       231 ---~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ---CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence               111122345667899999999999999999999999865543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=289.78  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=211.3

Q ss_pred             ccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           84 DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .++||+|+|+.|-.+. ..++..||||++.+.......++.+|++++...+ |+||++++++|+++..+|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            4689999999999888 6789999999998888888889999999999985 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEecccceecCCCCcc
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~~~~~~~  238 (413)
                      |...|.+.    .-+++.++..+..+|+.||.|||.+   ||.||||||+|||-.....   +|||||.+..-.......
T Consensus       163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            99999877    5799999999999999999999999   9999999999999976655   799999987543221111


Q ss_pred             ------eeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccc--------ccHHHHHH
Q 015076          239 ------ITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--------VNLIEWLK  299 (413)
Q Consensus       239 ------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~--------~~~~~~~~  299 (413)
                            ...+.+|+..|||||+..     ...|+.++|.||||+|||-|+.|.+||.+.-..+.        ..-.+.+.
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                  122357889999999762     34589999999999999999999999975432221        11122233


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+..+.      -.+|+..+..++.+..+++...|..|+..|-++..++++..
T Consensus       316 esIQEGk------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  316 ESIQEGK------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             HHHhccC------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence            3333332      25677778889999999999999999999999999998643

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-38  Score=307.56  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=198.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeC---------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG---------  147 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---------  147 (413)
                      ..+|.+.+.||.|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999964 5888999998776666667788999999999999999999876543         


Q ss_pred             -----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCc
Q 015076          148 -----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNP  221 (413)
Q Consensus       148 -----~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~  221 (413)
                           ...++||||++ ++|.+++..     ..+++..++.++.||+.||.|||+.   ||+||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999996 589888754     3688999999999999999999999   9999999999999974 5578


Q ss_pred             eEEecccceecCCCCcce--eeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYI--TTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                      +|+|||++..........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||............  .
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~--~  232 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI--L  232 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H
Confidence            999999998654321111  122357889999997654 56888999999999999999999999755432211110  0


Q ss_pred             HHH----------hhcCCCCCcC-CCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          299 KKM----------VTNRNPEGVL-DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       299 ~~~----------~~~~~~~~~~-~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ...          .......... .......+    ...+..++.+++.+||..||++|||+.+++.+-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~  302 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY  302 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence            000          0000000000 00000000    1124567889999999999999999999998743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.4e-39  Score=329.78  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=190.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeee---------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE---------  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~---------  146 (413)
                      ..+|+.+++||+||||.||+++.+ +|+.||||++.... ......+.+|+.+|++|+|||||+++..+.+         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            467899999999999999999966 89999999997664 3344578889999999999999998733200         


Q ss_pred             ---------------------------------------------------------------------C----------
Q 015076          147 ---------------------------------------------------------------------G----------  147 (413)
Q Consensus       147 ---------------------------------------------------------------------~----------  147 (413)
                                                                                           +          
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                 0          


Q ss_pred             -------------------------------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh
Q 015076          148 -------------------------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH  196 (413)
Q Consensus       148 -------------------------------~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH  196 (413)
                                                     ..+||-||||+..+|.+++..+.-   .-.....|+++++|++||+|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~---~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF---NSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc---chhhHHHHHHHHHHHHHHHHHH
Confidence                                           125788999999888888876521   1147889999999999999999


Q ss_pred             hccCCceeeccCCCCcEEEcCCCCceEEecccceecC-----------------CCCcceeeccccccCccCccccccCC
Q 015076          197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG-----------------SESSYITTRVMGTFGYVAPEYASTGM  259 (413)
Q Consensus       197 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~  259 (413)
                      ++   |||||||||.||+|++++.|||+|||+|....                 .......+..+||.-|+|||++.+..
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998621                 01111234568999999999997654


Q ss_pred             ---CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC---CcHHHHHHHHHHHHh
Q 015076          260 ---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK---PTSRLLKRILLVALR  333 (413)
Q Consensus       260 ---~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~  333 (413)
                         |+.|+|+||||+|++||+.   ||...  .+....+..++    .        ..++..   ...... .-..+|.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR----~--------g~iP~~~~f~~~~~~-~e~slI~~  853 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR----K--------GSIPEPADFFDPEHP-EEASLIRW  853 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc----c--------CCCCCCcccccccch-HHHHHHHH
Confidence               9999999999999999986   66522  22222222111    1        222222   222222 34678999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 015076          334 CVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       334 cl~~dp~~RPs~~eil~~  351 (413)
                      |++.||.+|||+.|+|+.
T Consensus       854 Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HhcCCCccCCCHHHHhhc
Confidence            999999999999999974

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=302.62  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=200.3

Q ss_pred             CCCC-cccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchh--------------HHHHHHHHHHHhcCCCCCcccccc
Q 015076           79 NGFS-DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA--------------EREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        79 ~~y~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      ++|. +.+.||.|+||.||+|.+. .+..||||.+.......              ...+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4578999999999999965 68899999885442221              124678999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ++..+...++||||+. ++|.+++...    ..+++.....++.|++.||+|||+.   |++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 6899988654    4689999999999999999999999   999999999999999999999


Q ss_pred             EEecccceecCCCC-------------cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          223 VSDFGLAKLLGSES-------------SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       223 l~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                      |+|||++.......             ........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999998664110             0111223467889999988764 478999999999999999999999976553


Q ss_pred             cccccHHHHHHHHhhcCCCCCc-----------CCCCCCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          289 PEEVNLIEWLKKMVTNRNPEGV-----------LDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .+.   ...+............           .....+.   ......+..+.+++.+||+.+|++|||+.+++.+...
T Consensus       240 ~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        240 IDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            322   1111111111100000           0000000   0011235678899999999999999999999987554


Q ss_pred             c
Q 015076          355 Q  355 (413)
Q Consensus       355 ~  355 (413)
                      .
T Consensus       317 ~  317 (335)
T PTZ00024        317 K  317 (335)
T ss_pred             C
Confidence            3

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=336.89  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             CCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      -++.-...||.|.||.||.|. ..+|.-.|+|.+....  ......+.+|..++..|+|||+|+++++-...+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            356677899999999999999 5567889999875443  2334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ||.+|+|.+++...    ...++.....+..|++.|++|||++   |||||||||.||+|+.+|.+|++|||.|......
T Consensus      1315 yC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999999876    4677888888999999999999999   9999999999999999999999999999987654


Q ss_pred             Ccce---eeccccccCccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          236 SSYI---TTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       236 ~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ....   .....||+.|||||++.+..   ...+.||||||||+.||+||+.||...+..-     + +...+..+..  
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----a-IMy~V~~gh~-- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----A-IMYHVAAGHK-- 1459 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----H-HHhHHhccCC--
Confidence            3221   23457999999999996643   5678999999999999999999997444321     1 1112222211  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         |.    .+..++.+-.+++..||..||++|.++.+++++
T Consensus      1460 ---Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ---PQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---CC----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               22    223378888999999999999999999999887

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-38  Score=302.86  Aligned_cols=267  Identities=22%  Similarity=0.309  Sum_probs=202.0

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  147 (413)
                      ..++....++|.+.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            445556778999999999999999999985 468889999886532  22345677899999999999999999987543


Q ss_pred             ------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          148 ------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       148 ------~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                            ...+++++++ +++|.+++...     .+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  3468888887 78998887643     589999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+   ..
T Consensus       160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~  232 (345)
T cd07877         160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LR  232 (345)
T ss_pred             EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HH
Confidence            99999998765332    223467889999998866 56889999999999999999999999754432211111   00


Q ss_pred             HhhcCCCCCcCC--------------CCCCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          301 MVTNRNPEGVLD--------------PKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       301 ~~~~~~~~~~~~--------------~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .... ....+..              +..+..    ........+.++|.+||+.||.+||++.+++.+-.-
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f  303 (345)
T cd07877         233 LVGT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  303 (345)
T ss_pred             HhCC-CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence            0000 0000000              000000    001134568899999999999999999999988543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=314.80  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=216.2

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceee-----
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCA-----  145 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~-----  145 (413)
                      .+....+.|+++++||.|.+|.||+++ .++++.+|+|++..+. ...+++..|.++|+.+ .|||++.+++++.     
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            333456779999999999999999999 4568889999775554 4456677899999988 5999999999885     


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      .++.+|||||||.|||+.+++++-.+  ..+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.|||+|
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g--~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKG--NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcc--cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence            35789999999999999999987653  6899999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||++..+..... ...+++||+.|||||++...     .|+..+|+||||++..||.-|.+|+....+......+     
T Consensus       167 FGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-----  240 (953)
T KOG0587|consen  167 FGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-----  240 (953)
T ss_pred             eeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-----
Confidence            999998865433 35667899999999998543     4778999999999999999999999766654333222     


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                       .        .+|.+....+...++++.++|..||..|.++||++.++++|-
T Consensus       241 -p--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  241 -P--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             -C--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence             1        123333345677899999999999999999999999999873

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=310.12  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             CCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC------eeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------~~~  151 (413)
                      -|...+.||+|+||.||+++ ..+|+.||||.+.... ....+....|+++|++|+|+|||+++++-+...      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            35566789999999999999 4579999999886643 334556778999999999999999999865433      558


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc--CCCC--ceEEecc
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWN--PKVSDFG  227 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~DfG  227 (413)
                      +|||||.||+|..+|.... +...|++...+.++.+++.||.|||++   ||+||||||.||++-  .+|+  .||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999998643 446799999999999999999999999   999999999999993  3344  7999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .|+-+.++.  ....++||..|++||++.. +.|+..+|.|||||++|+.+||..||..........-+.|.- ...+..
T Consensus       170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp~  246 (732)
T KOG4250|consen  170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKPS  246 (732)
T ss_pred             ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCCC
Confidence            999887655  4677899999999999985 889999999999999999999999997554432221121111 111110


Q ss_pred             CC-----------CcCCCCC--CCCCcHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHH
Q 015076          307 PE-----------GVLDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRP--KMGHVVH  350 (413)
Q Consensus       307 ~~-----------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~eil~  350 (413)
                      ..           -.+...+  +......+...+-..+..+|..+|++|.  .+.+.-.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa  305 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFA  305 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHH
Confidence            00           0000111  2222334445556666778888888888  4444333

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.2e-38  Score=300.96  Aligned_cols=264  Identities=23%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee-CCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~  150 (413)
                      ....++|++.+.||.|+||.||+|... ++..||+|++....  ......+..|+.+++.++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346778999999999999999999855 68889999875432  2334567789999999999999999998865 5678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++|||+ +++|..++...     ++++..+..++.|++.||+|||+.   +|+|+||+|+|||+++++.++|+|||++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999999 66898888643     578888999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH---------HHHH
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---------WLKK  300 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~---------~~~~  300 (413)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.         +...
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            65332    123457889999998766 568999999999999999999999997554321111110         0000


Q ss_pred             HhhcCCCCCc---CCCCCCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          301 MVTNRNPEGV---LDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       301 ~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .... .....   +....+.   .....++..+.++|.+||+.+|++|||+.+++.+-
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         233 ICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             ccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            0000 00000   0000000   00112356789999999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-38  Score=303.98  Aligned_cols=260  Identities=22%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC------C
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~  148 (413)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|.+....  ......+..|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 68899999886432  22335677899999999999999999988654      3


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+. .+|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4699999995 47776652      3588999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK--------  299 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~--------  299 (413)
                      ++.....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....        
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8765322    123457889999998866 468899999999999999999999998654322111110000        


Q ss_pred             HHhhcCCCCCcCC--CCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          300 KMVTNRNPEGVLD--PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       300 ~~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .............  +..+...    .......+.+++.+||+.||++||++.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000000000  0000000    01234568899999999999999999999987

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-38  Score=292.10  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      |+..+.||+|+||.||+|... ++..+|+|.+....  ......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999965 58899999887653  333456778999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      + ++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            6 59999997653   3689999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC----------
Q 015076          238 YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN----------  306 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------  306 (413)
                      . .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...........   +........          
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK---IFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHHHhCCCcHHHHHhhccc
Confidence            1 2223457889999998776 789999999999999999999999976543222111   111110000          


Q ss_pred             --CCCcCCC---CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          307 --PEGVLDP---KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       307 --~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        ....+..   .............+.+++.+||..||++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence              0000000   00001111235678999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-38  Score=300.99  Aligned_cols=260  Identities=22%  Similarity=0.337  Sum_probs=199.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe----
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH----  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~----  149 (413)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+....  ......+..|+.+++.++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568999999999999999999965 57889999875432  2233566789999999999999999998866554    


Q ss_pred             --eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          150 --RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       150 --~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                        .++|+||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999999 6799998865     3689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........   +...... .
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~---i~~~~~~-~  235 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR---IMNLVGT-P  235 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHhcCC-C
Confidence            99866432    223457889999998765 3678999999999999999999999975543221111   1110000 0


Q ss_pred             CCCcC------------C--CCCCC----CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVL------------D--PKLPE----KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~------------~--~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .....            .  +....    .....++..+.+++.+||..||++|||+.+|+++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~  300 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY  300 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence            00000            0  00000    000123567899999999999999999999998743

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-37  Score=296.71  Aligned_cols=262  Identities=21%  Similarity=0.295  Sum_probs=197.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC-----
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----  148 (413)
                      ..++|++.+.||+|+||.||+|... ++..||||++....  ......+..|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999854 68889999885432  223456778999999999999999999886543     


Q ss_pred             -eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          149 -HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       149 -~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                       ..++||||+ +++|..++..     ..+++..++.++.||+.||+|||+.   ||+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             458999999 7799888864     3689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHH--------H
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW--------L  298 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~--------~  298 (413)
                      ++......    .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..        +
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99865432    223457889999998866 4588999999999999999999999975442211100000        0


Q ss_pred             HHHhhcCC-------CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          299 KKMVTNRN-------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       299 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ...+....       ........+ ......+...+.+++.+||..||++|||+.+++.+-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            00000000       000000000 000112345688999999999999999999999763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=292.52  Aligned_cols=274  Identities=20%  Similarity=0.278  Sum_probs=210.2

Q ss_pred             ccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCC--CC----Cccccc
Q 015076           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR--HK----NLVRLL  141 (413)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hp----niv~~~  141 (413)
                      +.+.......++|.+...+|+|.||.|-.+.+.. +..||||++..- ..-.++.+.|+++|.++.  .|    -+|.+.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            4444455568999999999999999999998654 678999977543 234456677999999994  23    378888


Q ss_pred             ceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC----
Q 015076          142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK----  217 (413)
Q Consensus       142 ~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~----  217 (413)
                      ++|.-.++.|||+|.+ |-|+.++|..+..  .+++...+..++.|++++++|||+.   +++|.||||+|||+.+    
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence            9999999999999999 7899999977532  6899999999999999999999999   9999999999999931    


Q ss_pred             ----------------CCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 015076          218 ----------------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI  281 (413)
Q Consensus       218 ----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~  281 (413)
                                      +..++|+|||.|.+.....    ...+.|..|.|||++.+-.++.++||||+||||+||.||..
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                            2348999999999876543    44667999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccHHHHHHHHhhc--------------CC---C--------CCcCCCCCC----CCCcHHHHHHHHHHHH
Q 015076          282 PVDYSRPPEEVNLIEWLKKMVTN--------------RN---P--------EGVLDPKLP----EKPTSRLLKRILLVAL  332 (413)
Q Consensus       282 Pf~~~~~~~~~~~~~~~~~~~~~--------------~~---~--------~~~~~~~~~----~~~~~~~~~~l~~li~  332 (413)
                      -|+..+..+.+.+.+.+...+..              +.   .        ..++++..+    .........+|.+|+.
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            99877754443333221110000              00   0        000000000    0112234556899999


Q ss_pred             hcCCCCCCCCCCHHHHHHHHh
Q 015076          333 RCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       333 ~cl~~dp~~RPs~~eil~~le  353 (413)
                      +||..||.+|+|+.|++.+--
T Consensus       388 ~mL~fDP~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSHPF  408 (415)
T ss_pred             HHHccCccccccHHHHhcCHH
Confidence            999999999999999998743

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=301.75  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=209.1

Q ss_pred             ccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      .++||+|.||+||-|.++ +|+.||||.+.+-+  ......+++|+.+|+.+.||.||.+...|+..+.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            678999999999999954 79999999986542  445578899999999999999999999999999999999999554


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEecccceecCCCCc
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~  237 (413)
                      -|+-+|....   ++|++.....++.||+.||.|||-+   +|+|+||||+|||+...   -++||||||+|+..++...
T Consensus       649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            4444444443   6899999999999999999999999   99999999999999654   4699999999999876533


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                        ...++||+.|+|||++.++.|...-|+||.|+++|--+.|..||..+..         +...+.+..      -.++.
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAa------FMyPp  785 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAA------FMYPP  785 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhccc------cccCC
Confidence              5667899999999999999999999999999999999999999974332         122222221      24567


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .++.+++...++||...|+..-.+|.|...-+.+..-
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence            8889999999999999999999999999988777543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=258.47  Aligned_cols=266  Identities=24%  Similarity=0.306  Sum_probs=207.4

Q ss_pred             CCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .|.-.+.||+|.||+||+|+ +.+++.||+|.+..+.  ........+|+.+|+.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667789999999999999 4567889999987654  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      | ..+|..+...-.   +.++...+..++.|+++||.|+|++   ++.||||||.|+||+.+|.+||+|||+++.++-..
T Consensus        83 c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             h-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9 568988886644   5789999999999999999999999   99999999999999999999999999999886544


Q ss_pred             cceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc---C
Q 015076          237 SYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV---L  311 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  311 (413)
                      ..... .+-|.+|.+|.++.+.. |+...|+||-||++.|+.. |++-|.+.+..+....+-+...........++   -
T Consensus       156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            33332 34699999999987754 8999999999999999997 66667776655555444444333333222221   1


Q ss_pred             CCC-CCCC----CcHH----HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPK-LPEK----PTSR----LLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~-~~~~----~~~~----~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      |-. ++..    ...+    +...-++++.+.|.-+|..|.++++.+++..
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence            111 1111    1122    2233468889999999999999999988743

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.8e-38  Score=280.16  Aligned_cols=278  Identities=20%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEE-EcC----CCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee-CC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGL-LED----NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~  148 (413)
                      ....|+..+.||+|.||.||+|. .++    +..+|||++....  ........+|+.+++.++||||+.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            34579999999999999999996 332    2258999886442  2233455679999999999999999999887 78


Q ss_pred             eeEEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC----CCceE
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKV  223 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl  223 (413)
                      .+++++||.+. +|..+|+..+. ....++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            89999999966 89998864332 224689999999999999999999999   89999999999999877    89999


Q ss_pred             EecccceecCCCCc--ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCccc------ccH
Q 015076          224 SDFGLAKLLGSESS--YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEE------VNL  294 (413)
Q Consensus       224 ~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~------~~~  294 (413)
                      +|||+++.+...-.  +....++-|.+|+|||++.+. .||.+.|||++|||+.||+|-++-|.+....-.      ...
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998864322  123456779999999988775 589999999999999999999988876543211      112


Q ss_pred             HHHHHHHhhcCCCCCcCC-CCCCCC----------C--c---HHH-------HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          295 IEWLKKMVTNRNPEGVLD-PKLPEK----------P--T---SRL-------LKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~-~~~~~~----------~--~---~~~-------~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +..+...+........-+ .+.+..          .  +   ..+       +..-.+|+.++|..||.+|.|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            222222222211110000 000000          0  0   000       1225689999999999999999999999


Q ss_pred             HhcccCC
Q 015076          352 LEAQESP  358 (413)
Q Consensus       352 le~~~~~  358 (413)
                      .-....+
T Consensus       338 ~yF~~d~  344 (438)
T KOG0666|consen  338 PYFTEDP  344 (438)
T ss_pred             cccccCC
Confidence            7666543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-37  Score=296.28  Aligned_cols=264  Identities=22%  Similarity=0.280  Sum_probs=194.5

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-C--CCEEEEEEeecC--CchhHHHHHHHHHHHhcC-CCCCcccccceeee----CCe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-D--NSKVAVKNLLNN--RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE----GAH  149 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~  149 (413)
                      +|++.+.||+|+||.||++... .  +..||+|.+...  .......+..|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4888999999999999999965 3  678999987643  222345677899999999 59999999986532    245


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+++++|+. ++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            789999984 6899988654    4789999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc---eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH---------
Q 015076          230 KLLGSESSY---ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---------  296 (413)
Q Consensus       230 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~---------  296 (413)
                      .........   ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.         
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            866432211   1223468999999998765 468999999999999999999999997644221110000         


Q ss_pred             HHHHHhhcC------CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          297 WLKKMVTNR------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       297 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .........      .....-...+. .....+...+.+++.+||+.||++|||+.+++.+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~  293 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP  293 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            000000000      00000000000 00111345788999999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.8e-37  Score=320.79  Aligned_cols=146  Identities=29%  Similarity=0.414  Sum_probs=131.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|.+.+.||+|+||.||+|.+. .++.||||++....   ......+..|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999966 68889999886532   22345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      |||+.+++|.+++...    ..+++..++.|+.||+.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999765    4688999999999999999999999   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=283.30  Aligned_cols=240  Identities=25%  Similarity=0.313  Sum_probs=195.9

Q ss_pred             EeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           87 IGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ||.|+||.||++... ++..+|+|.+.....   .....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 588899998865432   2445788899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeec
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR  242 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  242 (413)
                      .+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence            9999765    4689999999999999999999998   999999999999999999999999999987644321 2333


Q ss_pred             cccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       243 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      ..++..|++||.+.+...+.++|+||||+++|+|++|..||.....      ...........       ..+    +..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-------~~~----~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP-------LRF----PEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC-------CCC----CCC
Confidence            5678899999999888899999999999999999999999964432      11112221110       111    112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCH---HHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRPKM---GHVVHM  351 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~---~eil~~  351 (413)
                      .+..+.+++.+||..||++||++   .+++++
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            25668899999999999999999   566554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=300.06  Aligned_cols=255  Identities=23%  Similarity=0.274  Sum_probs=216.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCC-EEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNS-KVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +...+++.+..||-||||.|=++..+... .+|+|.+.+.   .....+.+..|-++|...+.|.||++|--|.+..++|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            34567788889999999999999866433 3788877554   3455667888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ++||-|-||.|+..|..+    +.+....+..++..+++|++|||++   |||+|||||+|++|+.+|.+||.|||+|+.
T Consensus       497 mLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999887    6899999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...+.  .+-+++||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.++....+.+-.--.++         
T Consensus       570 i~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------  638 (732)
T KOG0614|consen  570 IGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------  638 (732)
T ss_pred             hccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence            86543  3667899999999999999999999999999999999999999999888876666552111111         


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHhc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLEA  354 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le~  354 (413)
                            ..+..+.+...+||.+.+..+|.+|.-     +.+|-+|...
T Consensus       639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence                  223456677888999999999999975     7788777544

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=281.32  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=199.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ..++.+.+..||.|+||+|++-.++ .|+..|||++..... ....+++.|..+..+- ++||||++|+.+..++.+||.
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            3445566778999999999998866 688899999976654 4556777787766555 699999999999999999999


Q ss_pred             EEeccCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||.| ..||..+...- ......+++..+-.|...+++||.||-...  .|||||+||+|||++..|.+||||||++-.+
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999 55776655321 111256899999999999999999998775  8999999999999999999999999998766


Q ss_pred             CCCCcceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          233 GSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      -..-  ..+.-.|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+...+.     ..+.+.... .+.+..+
T Consensus       219 v~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l  290 (361)
T KOG1006|consen  219 VDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPIL  290 (361)
T ss_pred             HHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCee
Confidence            3321  1222356778999998854  3489999999999999999999999975443     222222222 2222111


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +    .......++..|..+|..||.+|-+.||...+++++
T Consensus       291 ~----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 L----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             c----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1    112234577889999999999999999999998875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=286.52  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .+...+|..+.+||+|+||+|.+|..+ +...+|||++.++-.   .+.+--..|-++|... +-|.+++++.+|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            345567999999999999999999865 455699998876532   2223334577777766 46899999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+||||+.||+|--.+...    +.+.+..+..++.+|+-||-+||++   |||+||||.+||||+.+|.+||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999888776    5788888999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      +.---. ...+.+++||+.|+|||++.-.+|+.++|+||+|++||||+.|+.||++.+..+....+      ....    
T Consensus       498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~ehn----  566 (683)
T KOG0696|consen  498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------MEHN----  566 (683)
T ss_pred             cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HHcc----
Confidence            743221 22356789999999999999999999999999999999999999999987654322221      1111    


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK  344 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  344 (413)
                             -..+..++++...++...|...|.+|..
T Consensus       567 -------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 -------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                   1344557788889999999999999963

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-38  Score=299.89  Aligned_cols=255  Identities=22%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             cccHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccce
Q 015076           68 WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGY  143 (413)
Q Consensus        68 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~  143 (413)
                      +..++.-.....-|..++.||-|+||.|.+++.. +...||+|.+.+.+   ......++.|..||..-..+.||+||..
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            3344444455666899999999999999999854 45568999886543   2334567889999999999999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      |++++.+|+||+|++||++-.+|-+.    +-+++..+..++.++..|+++.|..   |+|||||||+|||||.+|.+||
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence            99999999999999999999998776    6799999999999999999999998   9999999999999999999999


Q ss_pred             Eecccceec---------CCCCc--------------------------------ceeeccccccCccCccccccCCCCc
Q 015076          224 SDFGLAKLL---------GSESS--------------------------------YITTRVMGTFGYVAPEYASTGMLNE  262 (413)
Q Consensus       224 ~DfG~a~~~---------~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  262 (413)
                      +|||||.-+         ..+..                                ......+||+.|+|||++....|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            999998533         10000                                0012357999999999999999999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 015076          263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR  342 (413)
Q Consensus       263 ~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  342 (413)
                      .+|+||.|+|||||+.|+.||....+.+....+.-+..             .+...+..+++++..++|.+++ .++++|
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-------------~l~~~~~~~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-------------FLHIPYQGNLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-------------ccccccccccCHHHHHHHHHHh-cChhhh
Confidence            99999999999999999999998887665544321111             1222334455666666665433 245666


Q ss_pred             C
Q 015076          343 P  343 (413)
Q Consensus       343 P  343 (413)
                      .
T Consensus       917 L  917 (1034)
T KOG0608|consen  917 L  917 (1034)
T ss_pred             h
Confidence            5

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=283.88  Aligned_cols=268  Identities=28%  Similarity=0.426  Sum_probs=200.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCCcccccceeeeCC----eeEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEGA----HRML  152 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~~----~~~i  152 (413)
                      ....+.++||+|.||.||+|... ++.||||++.   ......+..|-++.+.  ++|+||+++++.-....    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            44567789999999999999986 5899999884   3445667777777766  47999999998865544    7899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc------cCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG------LEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      |++|.+.|+|.+||..+     .++|....+|+.-+++||+|||+.      .++.|+|||||..|||+..++++.|+||
T Consensus       286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999886     699999999999999999999965      3678999999999999999999999999


Q ss_pred             ccceecCCCCcc-eeeccccccCccCccccccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCCCCCccccc------
Q 015076          227 GLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGM-LN-----ERSDVYSFGILIMEVISGRIPVDYSRPPEEVN------  293 (413)
Q Consensus       227 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~------  293 (413)
                      |+|..+...... .....+||.+|||||++.+.. +.     .+.||||+|.|||||+++..-+......+-.-      
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999988644332 123368999999999997643 22     36799999999999999765543211111000      


Q ss_pred             ----HHHHHHHHhhcCCCCCcCCCCCCCCC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCC
Q 015076          294 ----LIEWLKKMVTNRNPEGVLDPKLPEKP-TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (413)
Q Consensus       294 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~  359 (413)
                          .++.++..+-    ....++.+++.- .-....-+.+.+..||+.||+.|.|+.=+-+++..+....
T Consensus       441 G~hPt~e~mq~~VV----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  441 GNHPTLEEMQELVV----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             cCCCCHHHHHHHHH----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence                0111111111    111223333221 1134566889999999999999999998888887765433

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=311.52  Aligned_cols=265  Identities=29%  Similarity=0.485  Sum_probs=214.2

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc----C----CCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccc
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE----D----NSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLG  142 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~  142 (413)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||.+..... .....+..|+.+|+.+ +|+||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            46667777788889999999999999833    1    34589998865543 4567889999999999 5999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCC---C-------CC--CCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCC
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV---G-------PC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp  210 (413)
                      ++...+..++|+||+..|+|..++...+   .       ..  ..++....+.++.||+.|++||++.   ++|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999997765   0       11  1389999999999999999999999   999999999


Q ss_pred             CcEEEcCCCCceEEecccceecCCCCcceeecccc--ccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 015076          211 SNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR  287 (413)
Q Consensus       211 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~  287 (413)
                      +|||+.++..+||+|||+|+.......+......+  ...|||||.+....|+.+|||||||++||||++ |..||.+-.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999765554444333332  456999999999999999999999999999999 899987522


Q ss_pred             CcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ....  +.+    .+..         ......+..+..++..+|+.||+.+|++||++.++++.++..
T Consensus       527 ~~~~--l~~----~l~~---------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEE--LLE----FLKE---------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHH--HHH----HHhc---------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1111  122    2222         122233444677899999999999999999999999999874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-36  Score=277.76  Aligned_cols=219  Identities=18%  Similarity=0.171  Sum_probs=176.4

Q ss_pred             eCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhhhccC
Q 015076           90 GGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (413)
Q Consensus        90 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~  168 (413)
                      |.+|.||++++. +++.||+|.+....     .+..|...+....||||+++++++......++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999965 67889999886543     223344555556799999999999999999999999999999999876


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccC
Q 015076          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG  248 (413)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~  248 (413)
                      .    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+......    .....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            5    4689999999999999999999999   9999999999999999999999999988665432    122345778


Q ss_pred             ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHH
Q 015076          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (413)
Q Consensus       249 y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (413)
                      |+|||.+.+..++.++|||||||++|+|++|..||.......            .     ......+    +..++..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~~~~----~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTTLNI----PEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccccCC----cccCCHHHH
Confidence            999999988889999999999999999999998875321100            0     0000011    123456788


Q ss_pred             HHHHhcCCCCCCCCCCH
Q 015076          329 LVALRCVDPNAQKRPKM  345 (413)
Q Consensus       329 ~li~~cl~~dp~~RPs~  345 (413)
                      +++.+||+.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=278.06  Aligned_cols=267  Identities=27%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCCcccccceeeeC----C
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEG----A  148 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~----~  148 (413)
                      +....+..+.+.||+|.||.||+|.|+ |..||||++....   +....+|.++.+.  |+|+||+.+++.-..+    .
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            445567889999999999999999998 8899999885433   3445556666654  5899999999875433    4


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc-----cCCceeeccCCCCcEEEcCCCCceE
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG-----LEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      .+++|++|.+.|||.+||.+.     .++....+++++-++.||++||..     .++.|.|||||..|||+.++|.+.|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            679999999999999999875     799999999999999999999954     3678999999999999999999999


Q ss_pred             EecccceecCCCCcce---eeccccccCccCccccccCC----C--CccchhHHHHHHHHHHHhC----------CCCCC
Q 015076          224 SDFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTGM----L--NERSDVYSFGILIMEVISG----------RIPVD  284 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwslG~~l~elltg----------~~Pf~  284 (413)
                      +|+|||..........   ....+||.+|||||++....    +  -..+||||||.|+||++.+          ++||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999998776543322   23468999999999985532    1  2368999999999999762          46775


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC-CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .-.+.+.. . +.+++.+=..    .++|.++. .........+.++|..||..+|.-|-|+-.|-+.|..+.
T Consensus       438 d~Vp~DPs-~-eeMrkVVCv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  438 DVVPSDPS-F-EEMRKVVCVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cCCCCCCC-H-HHHhcceeec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            43332211 1 1122221111    12222222 234567788999999999999999999999988887764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=272.07  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=200.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcC-CCCCcccccceeeeCC
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA  148 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~  148 (413)
                      +.+..++|.+.++||+|+|++|.+++++ +.+.+|+|++++.   ...+......|..+.... +||.+|.+..+|+.+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            4467789999999999999999999954 5777999987653   334455666677777665 6999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      .+++|.||++||+|--.+.+.    ..+++..+..+..+|+.||.|||++   |||+||||.+|||+|..|.+||+|+|+
T Consensus       325 rlffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence            999999999999998888766    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc-ccccHHHHHHHHhhcCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~  307 (413)
                      ++.--.. ...+.+++||+.|.|||++.+..|...+|+|+||++|+||+.|+.||+.-... ...+...++...+....+
T Consensus       398 cke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  398 CKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            9854322 23366789999999999999999999999999999999999999999743221 122223333333332221


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK  344 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  344 (413)
                            ++    +..++.+...++..-|+.||.+|..
T Consensus       477 ------ri----prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 ------RI----PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ------cc----cceeehhhHHHHHHhhcCCcHHhcC
Confidence                  11    1123333455667788899999853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=286.48  Aligned_cols=259  Identities=23%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchh-------HHHHHHHHHHHhcCCCCCcccccceee-eC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQA-------EREFKVEVEAIGRVRHKNLVRLLGYCA-EG  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~~~~~~~-~~  147 (413)
                      ..++|-++.+||+|||+.||+|. ....+.||+|+...+....       .....+|.++.+.|.||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            44568889999999999999999 4568889999764433221       234667999999999999999999986 55


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc---CCCCceEE
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVS  224 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~  224 (413)
                      +.+|-|+|||+|.+|.-||+..    ..+++.++..|+.||+.||.||... ++.|||-||||.||||.   ..|.+||+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            7789999999999999999887    5799999999999999999999986 67899999999999994   45789999


Q ss_pred             ecccceecCCCCc------ceeeccccccCccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH
Q 015076          225 DFGLAKLLGSESS------YITTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL  294 (413)
Q Consensus       225 DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~  294 (413)
                      |||+++.+..+..      ..+....||.+|++||.+.-+    .++.|+||||+|+++|+.+.|+.||...........
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            9999998864432      234456899999999976433    478899999999999999999999985543221111


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                         ...++....      -.++.  -...+.+..++|++||.+.-++|....++..+
T Consensus       696 ---eNTIlkAtE------VqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  696 ---ENTILKATE------VQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             ---hhchhccee------ccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence               111111111      11221  22345667889999999999999887776654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=294.18  Aligned_cols=244  Identities=23%  Similarity=0.275  Sum_probs=196.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..+.|.+...+|.|+|+.|-.+.+. +++..++|++......    ..+|+.++... +||||+++.+.+.++.+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567888889999999999988854 6778999988655222    22355444444 7999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE-cCCCCceEEecccceecC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~  233 (413)
                      |.+.|+-|.+.+...     +.....+..|+.+|+.|+.|||++   |||||||||+|||+ ++.++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999998888877654     223377788999999999999999   99999999999999 688999999999998775


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..    ..+.+-|..|.|||++....|+.++||||||++||+|++|+.||......     ++ +...+...        
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~e-i~~~i~~~--------  529 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IE-IHTRIQMP--------  529 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HH-HHHhhcCC--------
Confidence            54    22234588999999999999999999999999999999999999754432     11 12222211        


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          .....++...++|+.+||+.||.+||++.++..+-..
T Consensus       530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                1114567778999999999999999999999998665

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=300.12  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=208.9

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CC----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DN----SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .+..++||+|+||+||+|.|- ++    -+||||++.... .+...++..|+-+|.++.|||++++++++.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            456789999999999999853 33    358999886654 445678999999999999999999999998776 88999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      +|++.|+|.++++..+   ..+.....+.|..||++||.|||.+   +++||||-.+|||+.....+|+.|||+++.+..
T Consensus       777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            9999999999998765   5788899999999999999999999   999999999999999999999999999998865


Q ss_pred             CCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          235 ESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       235 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ...... ....-.+.|||-|.+....|++++|||||||++||++| |..|+.+....+...++       ..+.      
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~ge------  917 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGE------  917 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccc------
Confidence            443322 22334678999999999999999999999999999998 99999876654433322       2221      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       +  ...+..++.++..++.+||..|+..||+++++...+...
T Consensus       918 -R--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  918 -R--LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -c--CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence             1  223344667788999999999999999999998877553

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-38  Score=270.33  Aligned_cols=271  Identities=23%  Similarity=0.328  Sum_probs=205.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeee--------C
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------G  147 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------~  147 (413)
                      +.|+-..+||+|.||.||+|+. +++++||+|++.....  .-.....+|+.+|..|+|+|++.++++|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4577778899999999999995 4678899987754322  122345679999999999999999998743        3


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ..+|+||.+|+. +|.-+|....   ..++...+.+++.++..||.|+|+.   .|+|||+|+.|+||+.+|.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            457999999965 8988887654   5799999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcce---eeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          228 LAKLLGSESSYI---TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       228 ~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      +++.+.......   .+..+-|.+|++||.+.+. .|+++.|||.-||+|.||.||.+-|.+........++..+...+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            998764322111   1223459999999988764 599999999999999999999999988776555555544433333


Q ss_pred             cCCCCCcCC---------CCCCCCCc---HHHHH------HHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          304 NRNPEGVLD---------PKLPEKPT---SRLLK------RILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       304 ~~~~~~~~~---------~~~~~~~~---~~~~~------~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ......+.+         +.++....   .+..+      +..+|+..+|..||.+|+++.+++.+...-.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            322222211         00111111   11222      5678999999999999999999999865543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-35  Score=300.16  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=174.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-C----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccce------ee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-D----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY------CA  145 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~------~~  145 (413)
                      ..++|++.+.||+|+||.||+|.+. +    +..||+|++......  +....+  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            6788999999999999999999965 4    688999987543211  111111  1222223333333322      24


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCC----------------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCC
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGP----------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK  209 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk  209 (413)
                      .....++||||+++++|.+++......                ........+..++.||+.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            556789999999999999988653210                00112345668999999999999999   99999999


Q ss_pred             CCcEEEcC-CCCceEEecccceecCCCCcceeeccccccCccCccccccC----------------------CCCccchh
Q 015076          210 SSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG----------------------MLNERSDV  266 (413)
Q Consensus       210 p~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv  266 (413)
                      |+|||++. ++.+||+|||+++..............+|+.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999987654444445567789999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC-----CCcCCCCCCCC------CcHHHHHHHHHHHHhcC
Q 015076          267 YSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP-----EGVLDPKLPEK------PTSRLLKRILLVALRCV  335 (413)
Q Consensus       267 wslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~~l~~li~~cl  335 (413)
                      |||||+||||+++..|++..       ... +...+.....     .....+.....      ..........+|+.+||
T Consensus       363 wSlGviL~el~~~~~~~~~~-------~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN-------LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH-------HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999977665311       111 0111110000     00000000000      00001123458999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcc
Q 015076          336 DPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       336 ~~dp~~RPs~~eil~~le~~  355 (413)
                      +.||++|||+.++++|-...
T Consensus       435 ~~dP~kR~ta~e~L~Hpff~  454 (566)
T PLN03225        435 RFKGRQRISAKAALAHPYFD  454 (566)
T ss_pred             cCCcccCCCHHHHhCCcCcC
Confidence            99999999999999985543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=273.95  Aligned_cols=285  Identities=19%  Similarity=0.242  Sum_probs=208.6

Q ss_pred             CCCCccccHHHHHHhc-CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----C-
Q 015076           63 LGWGHWYTLRELEVST-NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----H-  134 (413)
Q Consensus        63 ~~~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h-  134 (413)
                      ...+.+.++...++-. .+|.+.++||.|.|++||+|.+. ..+.||+|+++.. ..-.+....||++|++++     | 
T Consensus        61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            3445555666665544 89999999999999999999954 5777999977433 334456677999998883     2 


Q ss_pred             --CCcccccceee----eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccC
Q 015076          135 --KNLVRLLGYCA----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI  208 (413)
Q Consensus       135 --pniv~~~~~~~----~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl  208 (413)
                        .+||++++.|.    ++.++|+|+|++ |.+|..+|.....  ..++...+..|++||+.||.|||..+  ||||.||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDl  214 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDL  214 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCC
Confidence              47999999985    567999999999 8899998876432  67999999999999999999999987  9999999


Q ss_pred             CCCcEEEc------------------------------------------------------------------------
Q 015076          209 KSSNILID------------------------------------------------------------------------  216 (413)
Q Consensus       209 kp~NIll~------------------------------------------------------------------------  216 (413)
                      ||+|||+.                                                                        
T Consensus       215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~  294 (590)
T KOG1290|consen  215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI  294 (590)
T ss_pred             CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence            99999993                                                                        


Q ss_pred             ------------------------------------------CC------------------------------------
Q 015076          217 ------------------------------------------KH------------------------------------  218 (413)
Q Consensus       217 ------------------------------------------~~------------------------------------  218 (413)
                                                                ..                                    
T Consensus       295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~  374 (590)
T KOG1290|consen  295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI  374 (590)
T ss_pred             cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence                                                      00                                    


Q ss_pred             ----------------CCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 015076          219 ----------------WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP  282 (413)
Q Consensus       219 ----------------~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~P  282 (413)
                                      -++||+|||-|+.....    .+.-+.|..|+|||++.+..|+..+||||++|++|||+||...
T Consensus       375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL  450 (590)
T KOG1290|consen  375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL  450 (590)
T ss_pred             ccccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence                            01466677666654322    2223468889999999999999999999999999999999999


Q ss_pred             CCCCCCcc---cccHHHHHHHHhhc--------C-CCCCcCC--------CCCCCC-----------CcHHHHHHHHHHH
Q 015076          283 VDYSRPPE---EVNLIEWLKKMVTN--------R-NPEGVLD--------PKLPEK-----------PTSRLLKRILLVA  331 (413)
Q Consensus       283 f~~~~~~~---~~~~~~~~~~~~~~--------~-~~~~~~~--------~~~~~~-----------~~~~~~~~l~~li  331 (413)
                      |+...-..   +...+..+...+..        + .....++        .++...           ...+...++.+++
T Consensus       451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL  530 (590)
T KOG1290|consen  451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL  530 (590)
T ss_pred             ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence            97544321   12222222222211        1 1111111        111111           2334567889999


Q ss_pred             HhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          332 LRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       332 ~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .-||+.+|++|||+.+.+++..-...
T Consensus       531 ~PmLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  531 SPMLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             HHHHhcCccccccHHHHhcCccccCC
Confidence            99999999999999999998765543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-34  Score=264.29  Aligned_cols=239  Identities=25%  Similarity=0.382  Sum_probs=194.9

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhhhccC
Q 015076           91 GYGIVYYGLLE-DNSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (413)
Q Consensus        91 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~  168 (413)
                      +||.||+|... ++..+++|.+....... ...+..|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48899999887655444 67889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccC
Q 015076          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG  248 (413)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~  248 (413)
                      .    ..+++..++.++.+++.+|.+||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            5    2389999999999999999999999   99999999999999999999999999998775432  2334567889


Q ss_pred             ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHH
Q 015076          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (413)
Q Consensus       249 y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (413)
                      |++||.+.+..++.++||||||+++|+|++|..||.......  ..    ..........       .......+...+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~-------~~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL----FKKIGKPKPP-------FPPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH----HHHHhccCCC-------CccccccCCHHHH
Confidence            999999988889999999999999999999999997532111  11    1111111110       0000111456789


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHHH
Q 015076          329 LVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       329 ~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +++.+||..+|++||++.+++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhC
Confidence            99999999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=286.39  Aligned_cols=266  Identities=22%  Similarity=0.326  Sum_probs=184.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-----------------cCCCEEEEEEeecCCchhHHHH--------------HH
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-----------------EDNSKVAVKNLLNNRGQAEREF--------------KV  124 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~  124 (413)
                      ...++|++.++||+|+||.||+|..                 ..++.||||++..........|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999999963                 2346799999865443322222              34


Q ss_pred             HHHHHhcCCCCCc-----ccccceeee--------CCeeEEEEEeccCCChhhhccCCCC--------------------
Q 015076          125 EVEAIGRVRHKNL-----VRLLGYCAE--------GAHRMLVYEYVNNGNLEQWLHGDVG--------------------  171 (413)
Q Consensus       125 e~~~l~~l~hpni-----v~~~~~~~~--------~~~~~iv~e~~~~gsL~~~l~~~~~--------------------  171 (413)
                      |+.++.+++|.++     ++++++|..        ....++||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777765543     667777643        3567999999999999999875321                    


Q ss_pred             CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccC
Q 015076          172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA  251 (413)
Q Consensus       172 ~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~a  251 (413)
                      ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            112356778899999999999999999   99999999999999999999999999997654332221222335889999


Q ss_pred             ccccccCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCCCCCcccc-----cHHHHHHHHhh
Q 015076          252 PEYASTGM--------------------L--NERSDVYSFGILIMEVISGRI-PVDYSRPPEEV-----NLIEWLKKMVT  303 (413)
Q Consensus       252 PE~~~~~~--------------------~--~~~sDvwslG~~l~elltg~~-Pf~~~~~~~~~-----~~~~~~~~~~~  303 (413)
                      ||.+....                    +  ..+.||||+||++|+|++|.. ||.........     .....+... .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-K  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-c
Confidence            99875422                    1  124799999999999999876 66432211110     000000100 0


Q ss_pred             cCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHHHHh
Q 015076          304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA---QKRPKMGHVVHMLE  353 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~eil~~le  353 (413)
                      .        ................+|+.+||..+|   .+|+|+.|+|+|..
T Consensus       458 ~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        458 G--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             c--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            0        011111222345667889999998765   78999999999854

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2e-35  Score=252.58  Aligned_cols=277  Identities=21%  Similarity=0.328  Sum_probs=210.3

Q ss_pred             ccccCCCCccccHHHHHH---hcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-
Q 015076           59 EVSHLGWGHWYTLRELEV---STNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-  133 (413)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~---~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-  133 (413)
                      .+....+..+|.+....+   ..++|++.+.+|+|.|+.||.|. ..++.+++||++.+-   ....+.+|+.+|..|. 
T Consensus        15 ~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~g   91 (338)
T KOG0668|consen   15 DVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRG   91 (338)
T ss_pred             hccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccC
Confidence            333344556677776655   45789999999999999999998 567889999988543   3566788999999996 


Q ss_pred             CCCcccccceeeeC--CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          134 HKNLVRLLGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       134 hpniv~~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      ||||+.++++..++  ....+|+||+++.+...+.       +.++...+..++.++++||.|+|+.   ||+|||+||.
T Consensus        92 g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPh  161 (338)
T KOG0668|consen   92 GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPH  161 (338)
T ss_pred             CCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcc
Confidence            99999999999775  4568999999988877765       5688899999999999999999999   9999999999


Q ss_pred             cEEEcCC-CCceEEecccceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC-CC
Q 015076          212 NILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYS-RP  288 (413)
Q Consensus       212 NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~-~~  288 (413)
                      |++||.. ..++|+|||+|.++.+...+..  .+.+..|.-||++-.- .|+..-|+|||||+|..|+..+.||-.. +.
T Consensus       162 NvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN  239 (338)
T KOG0668|consen  162 NVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  239 (338)
T ss_pred             eeeechhhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence            9999864 5699999999999987655432  2457789999988664 5899999999999999999999998543 33


Q ss_pred             cccccHHHHH------HHHhhcCCCCCcCCCCC----------------CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 015076          289 PEEVNLIEWL------KKMVTNRNPEGVLDPKL----------------PEKPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (413)
Q Consensus       289 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  346 (413)
                      .+.+..+..+      ...+....+.  +++.+                ......-...+.++++.+.|..|-.+|+|+.
T Consensus       240 ~DQLVkIakVLGt~el~~Yl~KY~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak  317 (338)
T KOG0668|consen  240 YDQLVKIAKVLGTDELYAYLNKYQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK  317 (338)
T ss_pred             HHHHHHHHHHhChHHHHHHHHHHccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence            3333222111      1111111110  11111                1111111236788999999999999999999


Q ss_pred             HHHHHH
Q 015076          347 HVVHML  352 (413)
Q Consensus       347 eil~~l  352 (413)
                      |.+.|.
T Consensus       318 Eam~Hp  323 (338)
T KOG0668|consen  318 EAMAHP  323 (338)
T ss_pred             HHhcCc
Confidence            998874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.8e-36  Score=280.43  Aligned_cols=276  Identities=21%  Similarity=0.230  Sum_probs=215.3

Q ss_pred             ccccHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC------CCCccc
Q 015076           67 HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR------HKNLVR  139 (413)
Q Consensus        67 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~  139 (413)
                      .+|.+.-.++...+|.+....|+|-|++|.+|.+. .|..||||+|..+... ...=+.|+++|++|+      --|+++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            57888888999999999999999999999999954 4779999988766433 333456999999995      348999


Q ss_pred             ccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      ++..|...+++|+|+|-+ ..+|.++|.+...+ -.|....+..++.|+..||..|-..   ||+|.||||+|||+++..
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            999999999999999998 66999999875422 4688888999999999999999998   999999999999998764


Q ss_pred             -CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          220 -NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       220 -~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                       .+||||||.|........   +.+.-+..|.|||++.+.+|+...|+||+||+||||.||+..|.+.+...-+.+..-+
T Consensus       574 ~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             ceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence             589999999987765432   2233456799999999999999999999999999999999999887654332222111


Q ss_pred             -----HHHhhcCCC-CCc--------------------------CCC------------CCCCCCcHHHHHHHHHHHHhc
Q 015076          299 -----KKMVTNRNP-EGV--------------------------LDP------------KLPEKPTSRLLKRILLVALRC  334 (413)
Q Consensus       299 -----~~~~~~~~~-~~~--------------------------~~~------------~~~~~~~~~~~~~l~~li~~c  334 (413)
                           .+++..+.+ ..-                          +.|            .+ ..........|.+|+..|
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHHHHHH
Confidence                 111111110 000                          001            01 112334567789999999


Q ss_pred             CCCCCCCCCCHHHHHHHH
Q 015076          335 VDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       335 l~~dp~~RPs~~eil~~l  352 (413)
                      |..||++|.|..+.|+|.
T Consensus       730 l~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  730 LILDPEKRITVNQALKHP  747 (752)
T ss_pred             hccChhhcCCHHHHhcCC
Confidence            999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=264.88  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=205.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC-----ee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HR  150 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~  150 (413)
                      .+.+-.+.||.|+||.||.+.+ ++|+.||+|++...-  -.....+.+|+.+|..++|.|++..+++.....     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3466778999999999999984 579999999886543  234467778999999999999999998876542     35


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      |+++|.+ ..+|..+|-..    +.++...+.-+++||++||.|||+.   +|.||||||.|+|++.+..+||||||+++
T Consensus       133 YV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence            7888988 45888888665    6899999999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH---------H
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK---------K  300 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~---------~  300 (413)
                      ..........+..+-|..|.|||++.+. .|+.+.||||.||++.||+..+.-|....+.+...++..+.         .
T Consensus       205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            8765554444555679999999988775 59999999999999999999999998877766555542211         1


Q ss_pred             HhhcCCCCCcCCCCC--C-------CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          301 MVTNRNPEGVLDPKL--P-------EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~--~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .... ...-+++...  +       ......-..+-..+.+.++.+||++|.+..+.+.++...
T Consensus       285 ACEG-Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  285 ACEG-AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             Hhhh-hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            1000 0001111110  0       011112233456778899999999999999999887553

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=244.75  Aligned_cols=208  Identities=25%  Similarity=0.362  Sum_probs=168.3

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~i  152 (413)
                      +.-+....+..||+|++|.|-+-++. +|...|+|.+...- .+....+..|+.+..+. .+|.+|.+|+........+|
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            33445556678999999999888854 68889999986543 34455677788877665 69999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      .||.| ..||..+...-......+++..+-+|+..+..||.|||++.  .+||||+||+|||++.+|++|+||||++-.+
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence            99999 56887766543333368999999999999999999999986  8999999999999999999999999999877


Q ss_pred             CCCCcceeeccccccCccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                      .+.-..  +-..|-..|||||.+..    ..|+.+|||||||+++.||.+++.||+....
T Consensus       200 ~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  200 VDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            443221  11346678999998744    3689999999999999999999999975443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=289.18  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=190.7

Q ss_pred             CCCcccEEeeeCceE-EEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEec
Q 015076           80 GFSDDKVIGEGGYGI-VYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      -|.-.+++|.|..|+ ||+|... ++.||||++....   .....+|+..|+.- .|||||++++.-.+.+..||..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            356667899999998 6899886 8899999885433   34556799999888 5999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---C--CCceEEecccceec
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---H--WNPKVSDFGLAKLL  232 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~a~~~  232 (413)
                       ..+|.+++...............+.++.|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             6699999987411111122255678899999999999998   9999999999999976   3  45899999999998


Q ss_pred             CCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..+.....  .+..||.+|+|||++....-+.++|||||||++|+.++| ..||+..-..+ .+       ++.......
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N-------Il~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN-------ILTGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh-------hhcCcccee
Confidence            76554432  456799999999999998888899999999999999985 99997332111 11       111110000


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                          .+  .+..++  +..+||.+|+.++|..||++.+|+.|
T Consensus       734 ----~L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 ----HL--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ----ee--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                11  111111  67899999999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-34  Score=274.67  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=210.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|+....+|.|.||.||+++++ .+...|+|.+......+..-+..|+-+++..+||||+.+++.+...+.++|.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467999999999999999999954 6888999999888888888888999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      |.||+|.+..+.-    +++++.++...+++.++||+|||+.   |-+|||||-.|||+++.|.+||+|||.+..+...-
T Consensus        94 cgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999988765    6899999999999999999999999   99999999999999999999999999987765432


Q ss_pred             cceeeccccccCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          237 SYITTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                       .....+.||+.|||||+.   ..+.|..++|||++|++..|+---+.|.....+      .+.+.-+.....-    .+
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~~q----pp  235 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSGFQ----PP  235 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccCCC----CC
Confidence             235668899999999975   556799999999999999999887777543222      2222222221110    11


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      .+  .........+.+++..||..+|++||+++.+|.+
T Consensus       236 ~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  236 TL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             cc--cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            11  2223456678899999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=265.97  Aligned_cols=198  Identities=24%  Similarity=0.392  Sum_probs=170.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhH--------HHHHHHHHHHhcCC---CCCccccccee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAE--------REFKVEVEAIGRVR---HKNLVRLLGYC  144 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--------~~~~~e~~~l~~l~---hpniv~~~~~~  144 (413)
                      ...+|...+.+|.|+||.|++|.++. ...|+||.+.+.+.-..        -.+..|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34569999999999999999999775 45588897765542211        13456999999997   99999999999


Q ss_pred             eeCCeeEEEEEec-cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          145 AEGAHRMLVYEYV-NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       145 ~~~~~~~iv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      ++++.+||+||-- +|-+|+++|...    ..+++.++..|++|++.|+++||++   ||||||||-+||.++.+|-+||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence            9999999999975 456999999877    6899999999999999999999999   9999999999999999999999


Q ss_pred             EecccceecCCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 015076          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVD  284 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~  284 (413)
                      +|||.+.....+.   ...++||..|.|||++.+.+| +..-|||+||++||.++....||.
T Consensus       712 idfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999998765433   455789999999999999887 456799999999999999998885

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=5.4e-33  Score=254.11  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=212.4

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      .++++.+...+++...++-+|.||.||.|.|++      .+.|.+|.+..... .....+..|.-.+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            467788889999999999999999999997653      33466776654433 34467888999999999999999999


Q ss_pred             eeee-CCeeEEEEEeccCCChhhhccCC----CCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC
Q 015076          143 YCAE-GAHRMLVYEYVNNGNLEQWLHGD----VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (413)
Q Consensus       143 ~~~~-~~~~~iv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~  217 (413)
                      ++.+ ....++++.+..-|+|..++..-    ....+.++..+...++.|++.|++|||+.   +|||.||..+|++|++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            8754 46778999999889999999721    12225678889999999999999999999   9999999999999999


Q ss_pred             CCCceEEecccceecCCCC-cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 015076          218 HWNPKVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       218 ~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~  295 (413)
                      ..++||+|=.+++.+-+.. .........+..||+||.+.+..|+.++|+||||++||||+| |+.|+-.-++.+-...+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            9999999999998653322 222223345778999999999999999999999999999998 99998655444322221


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                             .         .......+-+++.++..+|.-||...|++||++++++.-|.+.
T Consensus       512 -------k---------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 -------K---------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -------h---------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                   1         1122233445788899999999999999999999999887654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=3.2e-31  Score=235.41  Aligned_cols=211  Identities=33%  Similarity=0.589  Sum_probs=183.6

Q ss_pred             EeeeCceEEEEEEEcC-CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhh
Q 015076           87 IGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ  164 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~  164 (413)
                      ||+|.+|.||++.... +..+++|.+...... ....+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 888999988655432 35678899999999999999999999999999999999999899999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecccceecCCCCcceeecc
Q 015076          165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGSESSYITTRV  243 (413)
Q Consensus       165 ~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~  243 (413)
                      ++....   ..+++..++.++.+++++|++||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987542   3689999999999999999999999   9999999999999999 89999999999987754431 12224


Q ss_pred             ccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHH
Q 015076          244 MGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSR  322 (413)
Q Consensus       244 ~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (413)
                      .+...|++||.+... .++.++|+|+||+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            568899999998877 788999999999999999                                              


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          323 LLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        ..+.+++.+|+..+|++||++.++++++
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3477899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=244.67  Aligned_cols=264  Identities=24%  Similarity=0.274  Sum_probs=197.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC------C
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~  148 (413)
                      ..+|.-.+.+|.|.- .|..+.+. .++.||+|++...  .....+...+|+.++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777888999888 66555533 6889999987543  233445667799999999999999999998644      3


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..|+|||++ ..+|.+.+..      .++-..+..|+.|++.|++|||+.   ||+||||||+||++..+..+||.|||+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            469999999 6699998873      477788999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH------------H
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI------------E  296 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~------------~  296 (413)
                      |+..+..  ...+..+.|..|.|||++.+-.|...+||||+||++.||++|+.-|.+.+.-+....+            .
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9876443  3455677899999999999988999999999999999999999999865432221111            0


Q ss_pred             HHHHH----hhc------CCCCCc-CCCCCCCCC--cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 WLKKM----VTN------RNPEGV-LDPKLPEKP--TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ~~~~~----~~~------~~~~~~-~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .+...    +.+      ...... -|..++...  ...-+....+++.+||..||++|.++.++|.|.-.
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence            00000    000      000011 111111111  11123456788999999999999999999998543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-30  Score=234.92  Aligned_cols=199  Identities=31%  Similarity=0.474  Sum_probs=173.7

Q ss_pred             CCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEecc
Q 015076           81 FSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      |.+.+.||.|++|.||++...+ +..+++|.+...... ....+..|+..+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678899999999999999764 888999998766554 56788899999999999999999999999899999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      +++|.+++....   ..+++..++.++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|||++.........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999997652   1188999999999999999999999   9999999999999999999999999999877544311


Q ss_pred             eeeccccccCccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVDY  285 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~~l~elltg~~Pf~~  285 (413)
                      ......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            12334578899999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=228.33  Aligned_cols=249  Identities=20%  Similarity=0.388  Sum_probs=185.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccce-eeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGY-CAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~-~~~~~~~~iv~  154 (413)
                      -+.|.+.+.||+|.||.+-+|.++ ....+++|.+.... ....+|.+|...--.| .|.||+.-|+. |+..+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            456999999999999999999977 46678899775443 4456777777655455 48999998875 67778889999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc--CCCCceEEecccceec
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLL  232 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~  232 (413)
                      ||++.|+|..-+...     .+.+.....++.|++.||.|+|++   ++||||||.+||||-  +...+||||||+.+..
T Consensus       102 E~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999888653     588888999999999999999999   999999999999993  3347999999998866


Q ss_pred             CCCCcceeeccccccCccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +....    ...-+..|.+||+....     ...+.+|||.||+++|..+||++||+.. ........+|....-+.   
T Consensus       174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk---  245 (378)
T KOG1345|consen  174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRK---  245 (378)
T ss_pred             Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhccc---
Confidence            43222    12236679999976432     2467899999999999999999999833 23333444444432221   


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV  348 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei  348 (413)
                          .+++|.. ...++..+.++..+-|.+++++|--..++
T Consensus       246 ----~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  246 ----NPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ----CccCchh-hcccCHHHHHHHHHhcCCcccccchhHHH
Confidence                1122211 12355667888899999999999443333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.4e-30  Score=239.57  Aligned_cols=268  Identities=22%  Similarity=0.306  Sum_probs=197.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCC
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA  148 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  148 (413)
                      +....+.|.++.+||.|.|++||++.+.    ..+.||+|.+....  ....+..|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445678999999999999999999843    46779999886543  3455788999999994 899999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFG  227 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG  227 (413)
                      ...+||||++..+-.+++.       .++...+..+++.++.||+++|.+   |||||||||+|+|.+.. +.-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            9999999999988888874       467889999999999999999999   99999999999999764 668999999


Q ss_pred             cceecC-----------------C----------------CCc----------ceeeccccccCccCccccccC-CCCcc
Q 015076          228 LAKLLG-----------------S----------------ESS----------YITTRVMGTFGYVAPEYASTG-MLNER  263 (413)
Q Consensus       228 ~a~~~~-----------------~----------------~~~----------~~~~~~~gt~~y~aPE~~~~~-~~~~~  263 (413)
                      +|....                 .                ...          .......||++|.|||++... .-+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            987210                 0                000          011124699999999988665 46889


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCCCCcc-cccHH------HHHHHHhh-cCC--C----------------CCc----CCC
Q 015076          264 SDVYSFGILIMEVISGRIPVDYSRPPE-EVNLI------EWLKKMVT-NRN--P----------------EGV----LDP  313 (413)
Q Consensus       264 sDvwslG~~l~elltg~~Pf~~~~~~~-~~~~~------~~~~~~~~-~~~--~----------------~~~----~~~  313 (413)
                      +||||.|+++.-+++++.||-.....- ....+      ..+.+... .+.  .                ..+    +.+
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            999999999999999999986433221 11101      01111100 000  0                000    000


Q ss_pred             --C--CC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 --K--LP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 --~--~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        .  .. .....-++..+.+++.+|+..||.+|.|+++.|+|.-
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF  383 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF  383 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence              0  00 0011123446889999999999999999999998843

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=7.3e-30  Score=271.32  Aligned_cols=198  Identities=18%  Similarity=0.224  Sum_probs=141.7

Q ss_pred             cCCC-CCccccccee-------eeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc
Q 015076          131 RVRH-KNLVRLLGYC-------AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK  202 (413)
Q Consensus       131 ~l~h-pniv~~~~~~-------~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  202 (413)
                      .++| +||++++++|       .....++++|||+ +++|.++|....   ..+++..++.++.||++||+|||++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3455 6888888887       2334567889988 669999997532   4699999999999999999999999   9


Q ss_pred             eeeccCCCCcEEEcCC-------------------CCceEEecccceecCCCC---------------cceeeccccccC
Q 015076          203 VVHRDIKSSNILIDKH-------------------WNPKVSDFGLAKLLGSES---------------SYITTRVMGTFG  248 (413)
Q Consensus       203 ivH~Dlkp~NIll~~~-------------------~~~kl~DfG~a~~~~~~~---------------~~~~~~~~gt~~  248 (413)
                      |+||||||+||||+..                   +.+|++|||+++......               ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999653                   445666666665321100               000112357889


Q ss_pred             ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHH
Q 015076          249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL  328 (413)
Q Consensus       249 y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  328 (413)
                      |||||++.+..|+.++|||||||+||||++|..|+....     .....+...        .+.+..     ........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~--------~~~~~~-----~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR--------VLPPQI-----LLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh--------hcChhh-----hhcCHHHH
Confidence            999999999999999999999999999999988864211     111111100        011110     01123356


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          329 LVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       329 ~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .++.+||..+|.+||++.+|+++..
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhchh
Confidence            7888999999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.3e-28  Score=211.77  Aligned_cols=167  Identities=22%  Similarity=0.241  Sum_probs=128.2

Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      |+|.+++....   ..+++..++.++.||+.||+|||++   +      ||+|||++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            68899987542   4699999999999999999999998   6      999999999999999  99998765432   


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                         ..||+.|||||++.+..++.++|||||||++|||+||+.||.......  .....+........      +. ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-cccc
Confidence               257999999999999999999999999999999999999996443211  11111111111000      00 0011


Q ss_pred             cHHHHH--HHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          320 TSRLLK--RILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       320 ~~~~~~--~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+..  .+.+++.+||..+|++||++.++++++...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            223333  689999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-26  Score=221.47  Aligned_cols=260  Identities=18%  Similarity=0.239  Sum_probs=196.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCC--CEEEEEEeecCCchhHHHHHHHHHHHhcCC----CCCccccccee-eeCCeeEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDN--SKVAVKNLLNNRGQAEREFKVEVEAIGRVR----HKNLVRLLGYC-AEGAHRML  152 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----hpniv~~~~~~-~~~~~~~i  152 (413)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|+.++..+.    .+++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999996653  478888776553333336778888888886    36899999988 57788999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-----CCceEEecc
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-----WNPKVSDFG  227 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG  227 (413)
                      ||+.+ |.+|.++.....  ...++...+..|+.|++.+|.+||+.   |++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99999 889999886553  26799999999999999999999999   99999999999999765     358999999


Q ss_pred             cce--ecCCCCc-----c-e-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          228 LAK--LLGSESS-----Y-I-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       228 ~a~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                      +++  .+.....     . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|.+||............   
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---
Confidence            998  3321111     0 0 12356999999999999999999999999999999999999999765543222111   


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ...........         .....+..+..+...+-..+...+|....+...+.....
T Consensus       250 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  250 EKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            11111111000         111123345555555666899999999999888766533

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=220.68  Aligned_cols=167  Identities=19%  Similarity=0.233  Sum_probs=130.4

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc--CCCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCCccc-ccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVR-LLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~  145 (413)
                      .....++|.+.+.||+|+||+||+|.+.  ++..||||++...     .......+.+|+++|+.++|+|++. ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3456678999999999999999999864  4677899986533     1223556899999999999999985 4432  


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccC-CCCcEEEcCCCCceEE
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI-KSSNILIDKHWNPKVS  224 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~  224 (413)
                        +..++||||++|++|... ..       ..   ...++.++++||.|||+.   ||+|||| ||+|||++.++.++|+
T Consensus        91 --~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             --CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence              457999999999999632 11       11   146788999999999999   9999999 9999999999999999


Q ss_pred             ecccceecCCCCccee-------eccccccCccCccccccC
Q 015076          225 DFGLAKLLGSESSYIT-------TRVMGTFGYVAPEYASTG  258 (413)
Q Consensus       225 DfG~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~  258 (413)
                      |||+|+.+........       ....+++.|+|||.+...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999997754321111       245678889999988554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=199.03  Aligned_cols=260  Identities=18%  Similarity=0.231  Sum_probs=199.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv  153 (413)
                      +..+.|.+++.||+|+||.+|+|. ..+|..||||.-....  ....+..|..+.+.|+ ...|..+..+..+..+-.+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            456789999999999999999999 6679999999654332  2345677889999886 47888888889999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~  230 (413)
                      |+.+ |.+|+++++-..   ..++...++-++-|++.-++|+|.+   ++|||||||+|+|..-+   .++.|+|||+|+
T Consensus        90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9999 889999886533   4688899999999999999999999   99999999999999643   468999999998


Q ss_pred             ecCCCCcce------eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          231 LLGSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       231 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      .+.+.....      .....||..|.+--...+..-+.+.|+-|+|.+|.++.-|.+||++.......+.-+.+...-..
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            775433221      23357999999998888888889999999999999999999999987766555444444333222


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+.         .....++.++...+.-|-..--++-|...-+-+.+.
T Consensus       243 ~~ie---------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  243 TPIE---------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             CCHH---------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            1111         111223445666666677666677777666655543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.6e-26  Score=203.65  Aligned_cols=205  Identities=21%  Similarity=0.310  Sum_probs=173.0

Q ss_pred             CCCCcccEEeeeCceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      -.|+++++||+|.||.++.|. .-++..||||.-..  ......+..|.+..+.|. .++|..++-+..++.+-.+|||.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            359999999999999999998 55799999995432  334456677888888884 79999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-----CceEEeccccee
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-----NPKVSDFGLAKL  231 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~a~~  231 (413)
                      + |.+|++++.-..   ..++...++-++.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+|+.
T Consensus       106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9 889999885432   4799999999999999999999999   999999999999996544     489999999998


Q ss_pred             cCCCCcce------eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 015076          232 LGSESSYI------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV  292 (413)
Q Consensus       232 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~  292 (413)
                      +.+.....      .....||.+||+--...+..-+.+-|+-|||-|+.+.|-|.+||.+.......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK  245 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK  245 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence            75443321      23467999999999999999999999999999999999999999987655433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.9e-24  Score=203.35  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=199.5

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch---hHHHHHHHHHHHhcCCCC-CcccccceeeeCCeeEEEEEe
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ---AEREFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hp-niv~~~~~~~~~~~~~iv~e~  156 (413)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++++++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            678889999999999999976  77899988655432   467888999999999988 799999999877778999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~  235 (413)
                      +.++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||++......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777654211 2689999999999999999999999   999999999999999998 6999999999866543


Q ss_pred             Ccc-----eeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          236 SSY-----ITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       236 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ...     ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......   .........+.....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~  232 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT  232 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence            322     2355679999999999987   57889999999999999999999997655431   001111111111111


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      . .................+.+++..|+..+|..|.+..+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000002233567888999999999999998887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.7e-26  Score=231.84  Aligned_cols=256  Identities=22%  Similarity=0.274  Sum_probs=192.0

Q ss_pred             CcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhH----HHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           82 SDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAE----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ....++|.|++|.|+.+... .....+.|.....  .....    ..+..|+.+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988777633 3333444433210  11111    12556777778889999999988887766666669


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |||++ +|..++...    ..+....+..++.|++.|++|||..   ||.|||||++|++++.+|.+||+|||.+..+.-
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999999875    4688889999999999999999999   999999999999999999999999999987643


Q ss_pred             CCc---ceeeccccccCccCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          235 ESS---YITTRVMGTFGYVAPEYASTGMLNE-RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       235 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ...   .....++|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+....        ........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQR  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhcccccc
Confidence            222   3456678999999999999999886 57999999999999999999976554433220        00000011


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ....-+......++.+.+.+|.+||+.||.+|.|+++|++.-+
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            1111122334456777889999999999999999999997643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.1e-26  Score=200.94  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=192.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .+..+..+|.+...|..|+|++..+ .+++|++...  .....+.|..|.-.|+-+.||||+.+++.|..+..+.++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3445566799999999999999844 4556655332  233446788899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE--ecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS--DFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfG~a~~~~~  234 (413)
                      |+.|+|..+++...+  --++..++.+++.++++|++|||+.- +-|----|....|++|++.+++|.  |--++..   
T Consensus       269 mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             ccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---
Confidence            999999999987643  35677889999999999999999862 223333688999999999888774  3221111   


Q ss_pred             CCcceeeccccccCccCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLN---ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                           .....-.+.||+||.++..+-+   .++|+|||++++|||.|...||....+.+....+.               
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------  402 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------  402 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------
Confidence                 1112347899999999877643   57899999999999999999998766655443332               


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      -..+....+..++..+.+|+.-|+..||.+||.+..|+-.||..
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            12233334445677889999999999999999999999988864

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-25  Score=228.67  Aligned_cols=250  Identities=22%  Similarity=0.214  Sum_probs=185.2

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC-chhHHHHHHHHHH--HhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR-GQAEREFKVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +|...+.||++.|=+|.+|++++|. |+||++.+.. .-..+.+.++++-  ...+++||++++.-+.......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6888899999999999999998777 8999887655 3333444433332  4555899999999888788888999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec--CC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~--~~  234 (413)
                      .. -+|.+.+..+    +-+...+...|+.|++.||..+|..   ||+|||||.+||||+.-+.+.|+||...+..  ..
T Consensus       103 vk-hnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VK-HNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hh-hhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            94 4999999876    5688889999999999999999999   9999999999999999999999999887532  22


Q ss_pred             CCc----ceeeccccccCccCccccccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 015076          235 ESS----YITTRVMGTFGYVAPEYASTG----------M-LNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       235 ~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (413)
                      ++.    +...+.....+|.|||.+...          . .+++.||||+||++.||++ |++||...         +.+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~  245 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLL  245 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHH
Confidence            222    223333445689999977431          2 6788999999999999998 78888521         111


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...-.+....+.+-.++.+       ..++.+++.|++.||++|.++++.|+.-..
T Consensus       246 aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1111100000000011111       147889999999999999999999987433

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1e-24  Score=194.07  Aligned_cols=173  Identities=14%  Similarity=0.159  Sum_probs=135.2

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHH---------HHHHHHHHhcCCCCCcccccceee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE---------FKVEVEAIGRVRHKNLVRLLGYCA  145 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~hpniv~~~~~~~  145 (413)
                      .+..++|++.++||.|+||.||++.. ++..+|||.+..........         +.+|++.+.++.|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            35678999999999999999999766 57789999886554333222         678999999999999999988865


Q ss_pred             eC--------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC
Q 015076          146 EG--------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (413)
Q Consensus       146 ~~--------~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~  217 (413)
                      ..        ...+++|||++|.+|.++..        ++.    ....+++.+|..||+.   |++|||+||+||+++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            33        35789999999999988732        222    3456899999999999   9999999999999999


Q ss_pred             CCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHH
Q 015076          218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (413)
Q Consensus       218 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ell  277 (413)
                      +| ++|+|||...........             ..+.....|..++|+|+||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88 999999987655322110             11334445667999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.8e-23  Score=183.75  Aligned_cols=139  Identities=16%  Similarity=0.145  Sum_probs=108.7

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch--h------------------------HHHHHHHHHHHhcCCCCCc
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--A------------------------EREFKVEVEAIGRVRHKNL  137 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~hpni  137 (413)
                      .+.||+|+||.||+|...+|+.||||++......  .                        ......|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5689999999999999878999999998654211  0                        1123458999999988777


Q ss_pred             ccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchh-hhccCCceeeccCCCCcEEEc
Q 015076          138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL-HEGLEPKVVHRDIKSSNILID  216 (413)
Q Consensus       138 v~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~Dlkp~NIll~  216 (413)
                      .....+..  ...+|||||++|+++...+...    ..++...+..++.|++.+|.+| |+.   ||+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333222  2238999999887776543322    4688999999999999999999 688   999999999999998


Q ss_pred             CCCCceEEecccceec
Q 015076          217 KHWNPKVSDFGLAKLL  232 (413)
Q Consensus       217 ~~~~~kl~DfG~a~~~  232 (413)
                      + +.++|+|||+|...
T Consensus       153 ~-~~v~LiDFG~a~~~  167 (190)
T cd05147         153 D-GKLYIIDVSQSVEH  167 (190)
T ss_pred             C-CcEEEEEccccccC
Confidence            4 78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=5.1e-23  Score=213.20  Aligned_cols=254  Identities=19%  Similarity=0.196  Sum_probs=188.1

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCCcccccceeee
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAE  146 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~  146 (413)
                      +..+.++....|.|.+.||+|+||+||+|...+++.||+|.-.......-.-   =.+++.+|+   -+.|..+...+.-
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHcc
Confidence            3456678888999999999999999999998889999999776555433221   223334443   3567777777777


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-------CC
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-------HW  219 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~  219 (413)
                      .+..++|+||.+.|+|.++++..    ..+++...+.++.|+++.+++||..   +||||||||+|+||..       .-
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             CCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence            77889999999999999999855    5799999999999999999999999   9999999999999942       33


Q ss_pred             CceEEecccceecCCC-CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          220 NPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                      .++|+|||.+..+.-- ........++|-.+-++|+..|.+++..+|.|.|+.+++-||.|++-                
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------  902 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------  902 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------
Confidence            5899999999755321 12345567889999999999999999999999999999999998742                


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .  ..++.... ++..++.....+....+..   .+|..|-..=|...+|...++..
T Consensus       903 q--~~~g~~~~-~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  903 E--VKNGSSWM-VKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             H--hcCCccee-ccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHH
Confidence            1  11111111 1122333333444444444   45555555557777777777654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=176.92  Aligned_cols=186  Identities=18%  Similarity=0.140  Sum_probs=139.3

Q ss_pred             CcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch----hHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEe
Q 015076           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ----AEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      -+...|++|+||+||++.. .+.+++.+.+......    ....+.+|+++|++|+ +++|++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997766 5788887766544321    1235788999999995 5889999886    346999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccC-CCCcEEEcCCCCceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI-KSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      +.|.+|...+..           ....++.|++.+|.++|++   ||+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999888654321           1135778999999999999   9999999 799999999999999999999866543


Q ss_pred             Ccc----e--------eeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015076          236 SSY----I--------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYS  286 (413)
Q Consensus       236 ~~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~  286 (413)
                      ...    .        ......++.|++|+...-  ..--...++++.|+.+|.++|+..++-.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            310    0        011235777888874322  22225679999999999999999887543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3e-22  Score=176.43  Aligned_cols=141  Identities=20%  Similarity=0.166  Sum_probs=111.4

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch--------------------------hHHHHHHHHHHHhcCCCCC
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--------------------------AEREFKVEVEAIGRVRHKN  136 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~hpn  136 (413)
                      +.+.||+|+||.||+|...+|+.||||.+......                          ....+..|...+.++.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999999778999999988754211                          0122357889999999998


Q ss_pred             cccccceeeeCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEE
Q 015076          137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQW-LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNIL  214 (413)
Q Consensus       137 iv~~~~~~~~~~~~~iv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIl  214 (413)
                      |.....+....  .++||||++|+++... +..     ..++...+..++.|++.+|.+||+ .   ||+||||||+|||
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence            75444333322  4899999988755443 322     357788899999999999999999 8   9999999999999


Q ss_pred             EcCCCCceEEecccceecCC
Q 015076          215 IDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       215 l~~~~~~kl~DfG~a~~~~~  234 (413)
                      ++ ++.++|+|||++.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            99 78999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-24  Score=208.73  Aligned_cols=225  Identities=24%  Similarity=0.277  Sum_probs=180.9

Q ss_pred             EEeeeCceEEEEEEE----cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEecc
Q 015076           86 VIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      ++|+|.||.|++++.    ..+.-+|+|...+...  ........|..++..++ ||.++++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998862    3466688887654321  11225566888888887 9999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  238 (413)
                      ||.|...+...    ..+.+.....+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-.... 
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99999988776    4677778888888999999999999   999999999999999999999999999987644322 


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK  318 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (413)
                          .+||..|||||++.  ....++|.||||+++++|+||..||..          ..+..++..           ...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccC
Confidence                28999999999987  567899999999999999999999975          112222211           113


Q ss_pred             CcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 015076          319 PTSRLLKRILLVALRCVDPNAQKRPKM  345 (413)
Q Consensus       319 ~~~~~~~~l~~li~~cl~~dp~~RPs~  345 (413)
                      .+...+.....++..++..+|.+|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            345567778888889999999999754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=186.48  Aligned_cols=196  Identities=22%  Similarity=0.275  Sum_probs=139.0

Q ss_pred             CCCCcccccceeee---------------------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHH
Q 015076          133 RHKNLVRLLGYCAE---------------------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII  185 (413)
Q Consensus       133 ~hpniv~~~~~~~~---------------------------~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  185 (413)
                      +|||||+++.+|.+                           +..+|+||..+ ..+|.+++...     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-----CCchHHHHHHH
Confidence            59999999887632                           23568999988 45999999764     46667778899


Q ss_pred             HHHHhhhchhhhccCCceeeccCCCCcEEE--cCC--CCceEEecccceecCCCCc---cee--eccccccCccCccccc
Q 015076          186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKH--WNPKVSDFGLAKLLGSESS---YIT--TRVMGTFGYVAPEYAS  256 (413)
Q Consensus       186 ~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~--~~~kl~DfG~a~~~~~~~~---~~~--~~~~gt~~y~aPE~~~  256 (413)
                      .|+++|+.|||++   ||.|||+|.+|||+  +++  -.++|+|||+|-......-   +.+  ....|....||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  333  3478999999865432111   111  1234778899999885


Q ss_pred             cCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHH
Q 015076          257 TGM------LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV  330 (413)
Q Consensus       257 ~~~------~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  330 (413)
                      ..+      .-.|+|.|+.|.+.||+++...||...... ......+.          +---+.+    +..++..+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yq----------e~qLPal----p~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQ----------ESQLPAL----PSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhh----------hhhCCCC----cccCChHHHHH
Confidence            533      235899999999999999999999753211 11111100          0001222    22344567889


Q ss_pred             HHhcCCCCCCCCCCHHHHHHHH
Q 015076          331 ALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       331 i~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +...|+.||++|++..-....|
T Consensus       490 V~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHH
Confidence            9999999999999876554443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=6.9e-22  Score=181.21  Aligned_cols=233  Identities=21%  Similarity=0.343  Sum_probs=148.8

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCC---C-------Cccccccee--
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH---K-------NLVRLLGYC--  144 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h---p-------niv~~~~~~--  144 (413)
                      +...+.||.|+++.||.+.+. +++.+|+|.+.....   ...+.+++|.-....+.+   |       .++--++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            556789999999999999976 488999998865442   233456666655554322   1       122222221  


Q ss_pred             -------eeC---C-----eeEEEEEeccCCChhhhccC---CCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeec
Q 015076          145 -------AEG---A-----HRMLVYEYVNNGNLEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (413)
Q Consensus       145 -------~~~---~-----~~~iv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~  206 (413)
                             ...   .     ..+++|+-+ .++|.+++..   .......+....++.+..|+++.+++||..   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                   111   1     236788877 5688877632   111112344555677779999999999999   99999


Q ss_pred             cCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCcccccc--------CCCCccchhHHHHHHHHHHHh
Q 015076          207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVIS  278 (413)
Q Consensus       207 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~~l~ellt  278 (413)
                      ||+|+|++++.+|.++|+||+.....+...   .. ...+..|.+||....        -.++.+.|.|+||+++|.|.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999999887654321   11 234678999997643        247889999999999999999


Q ss_pred             CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC
Q 015076          279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR  342 (413)
Q Consensus       279 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  342 (413)
                      |..||...........                   .+  ....+.++.+..||..+|+.||++|
T Consensus       246 ~~lPf~~~~~~~~~~~-------------------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-------------------DF--SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-------------------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-------------------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999985543322111                   01  1112677889999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1.4e-21  Score=190.11  Aligned_cols=217  Identities=28%  Similarity=0.507  Sum_probs=166.1

Q ss_pred             HhcCCCCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCce-eecc
Q 015076          129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV-VHRD  207 (413)
Q Consensus       129 l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i-vH~D  207 (413)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+....   ..+++.....++++|+.||+|||..   .| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            467889999999999999999999999999999999998743   6799999999999999999999987   44 9999


Q ss_pred             CCCCcEEEcCCCCceEEecccceecCCCCc-ceeeccccccCccCccccccCC-------CCccchhHHHHHHHHHHHhC
Q 015076          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISG  279 (413)
Q Consensus       208 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslG~~l~elltg  279 (413)
                      ++..|++++....+||+|||+......... .......-..-|.|||.+....       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999999887643111 0111122355799999986642       46679999999999999999


Q ss_pred             CCCCCCCCCcccc-cHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          280 RIPVDYSRPPEEV-NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       280 ~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                      +.||......... ..+..+.+     .....+.+.+....  +....+..++..||..+|++||++..|-..++.....
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9999864433322 22222222     11222223222111  3444788999999999999999999999988876553

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6.2e-21  Score=169.30  Aligned_cols=137  Identities=16%  Similarity=0.240  Sum_probs=107.4

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-----CCCCcccccceeeeCC---ee-E
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-----RHKNLVRLLGYCAEGA---HR-M  151 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~---~~-~  151 (413)
                      +.-.++||+|+||.||.  +......+||++..........+.+|+.+++.+     .||||+++++++.++.   .. .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34457899999999995  443333479988765555567789999999999     5799999999998863   43 4


Q ss_pred             EEEEe--ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhh-chhhhccCCceeeccCCCCcEEEcCC----CCceEE
Q 015076          152 LVYEY--VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL-SYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVS  224 (413)
Q Consensus       152 iv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~  224 (413)
                      +||||  +.+++|.+++...     .+++.  ..++.+++.++ +|||++   +|+||||||+|||++..    +.++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  5579999999653     35544  35678888888 999999   99999999999999743    479999


Q ss_pred             ecccc
Q 015076          225 DFGLA  229 (413)
Q Consensus       225 DfG~a  229 (413)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=7.4e-22  Score=201.21  Aligned_cols=209  Identities=25%  Similarity=0.367  Sum_probs=149.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .-++|..+++|..|+||.||+++++. .+.+|+| +.++...     .+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-----------------
Confidence            34679999999999999999999774 5568884 4322211     110  33333445444                 


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                          |+-...++..    ++++...        +.+++|||+.   ||+|||+||+|.+|+.-|.+|++|||+.+.....
T Consensus       136 ----gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                3444444433    3455433        6789999999   9999999999999999999999999998754211


Q ss_pred             --------------CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          236 --------------SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       236 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                                    .......++||+.|.|||++..+.|...+|+|++|+++||.+.|+.||.++.+++....+      
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------  270 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------  270 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------
Confidence                          011224568999999999999999999999999999999999999999988776532221      


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP  343 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (413)
                      +...       -..+.. ...+..+..++|.+.|+.+|..|-
T Consensus       271 isd~-------i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ISDD-------IEWPEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhh-------cccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence            1110       011111 233455688899999999999996

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.2e-20  Score=167.85  Aligned_cols=142  Identities=18%  Similarity=0.140  Sum_probs=111.4

Q ss_pred             CCCcccEEeeeCceEEEEEE--EcCCCEEEEEEeecCCch------------------------hHHHHHHHHHHHhcCC
Q 015076           80 GFSDDKVIGEGGYGIVYYGL--LEDNSKVAVKNLLNNRGQ------------------------AEREFKVEVEAIGRVR  133 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  133 (413)
                      .|.+.+.||+|+||.||+|.  ..+|..||||.+......                        ....+..|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  457999999988654210                        1123567999999997


Q ss_pred             CCC--cccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc-eeeccCCC
Q 015076          134 HKN--LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKS  210 (413)
Q Consensus       134 hpn--iv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~Dlkp  210 (413)
                      +.+  +.+++++   . ..++||||++|.+|..++...    ..+....+..++.||+.+|++||+.   | |+||||||
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            532  3333332   2 358999999998887765332    3456667789999999999999999   9 99999999


Q ss_pred             CcEEEcCCCCceEEecccceecC
Q 015076          211 SNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       211 ~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 7899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=5.3e-21  Score=182.92  Aligned_cols=176  Identities=21%  Similarity=0.366  Sum_probs=132.0

Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      .++||.|++|...+|.+||.+.... ...++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            3578999999999999999754322 456788889999999999999   6   99999999999999999999999999


Q ss_pred             cceecCCCC-----cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 015076          228 LAKLLGSES-----SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       228 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +........     ........||..||+||.+.+..|+.++|||+||++|+||+. =..+|.      .   +. ....
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r---~~-t~~d  471 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------R---IA-TLTD  471 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------H---HH-hhhh
Confidence            988765443     223345679999999999999999999999999999999998 222221      0   11 0111


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV  349 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  349 (413)
                      +        .+..++.....+++.+ ..|+.+++...|.+||++.+.-
T Consensus       472 ~--------r~g~ip~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  472 I--------RDGIIPPEFLQDYPEE-YTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             h--------hcCCCChHHhhcCcHH-HHHHHHhcCCCcccCchHHHHh
Confidence            1        1222222222223322 4688899999999999655543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.7e-19  Score=160.35  Aligned_cols=134  Identities=20%  Similarity=0.332  Sum_probs=112.8

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCch--------hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      +.||+|++|.||+|.+ .+..+++|........        ....+.+|+.++..+.|++|.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 5778999976543211        123577899999999999988777777777788999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ++|++|.+++....       . .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986431       1 7889999999999999999   999999999999999 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7.5e-19  Score=155.90  Aligned_cols=141  Identities=18%  Similarity=0.131  Sum_probs=110.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch----------------------hHHHHHHHHHHHhcCCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ----------------------AEREFKVEVEAIGRVRH  134 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h  134 (413)
                      ...-|.+.+.||+|+||.||++...+++.||||.+......                      ....+..|+.++..+.+
T Consensus        13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            33348899999999999999999878999999987543210                      11235678888888877


Q ss_pred             CC--cccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          135 KN--LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       135 pn--iv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      ++  ++..++    ....++||||++|++|..+...          .....++.+++.++.++|+.   ||+||||||+|
T Consensus        93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N  155 (198)
T cd05144          93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN  155 (198)
T ss_pred             cCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence            74  333433    2345899999999998765421          23467889999999999998   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCC
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~  234 (413)
                      |++++++.++|+|||++.....
T Consensus       156 ill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=6.4e-19  Score=156.42  Aligned_cols=131  Identities=21%  Similarity=0.352  Sum_probs=106.5

Q ss_pred             EEeeeCceEEEEEEEcCCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           86 VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +||+|+||.||+|.+. +..+++|.......        .....+.+|++++..+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 67899998654321        11245678999999999887665555555666779999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +|++|.+++....    .       .++.+++.+|.+||+.   |++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998875431    1       7899999999999999   999999999999999 789999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.9e-18  Score=175.91  Aligned_cols=138  Identities=19%  Similarity=0.291  Sum_probs=111.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--c------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--G------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ...|...+.||+|+||.||+|.+... .+++|+.....  .      .....+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34457789999999999999987644 34444332211  1      123467889999999999999887777777777


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||++|++|.+++.            ....++.+++.+|.+||+.   +++||||||+|||+ +++.++|+|||++
T Consensus       411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            899999999999998874            3467899999999999999   99999999999999 6779999999998


Q ss_pred             eec
Q 015076          230 KLL  232 (413)
Q Consensus       230 ~~~  232 (413)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=8.8e-19  Score=178.20  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC--CCEEEEEEeecCC--chhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~i  152 (413)
                      ...|.+.+.||+|.|+.|-......  ...+|+|.+....  ......+..|..+-+.+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4457888889999999998777533  3446667654433  233344555777777776 9999999999999999999


Q ss_pred             EEEeccCCChhhhc-cCCCCCCCCCCHHHHHHHHHHHHhhhchhh-hccCCceeeccCCCCcEEEcCCC-CceEEecccc
Q 015076          153 VYEYVNNGNLEQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLA  229 (413)
Q Consensus       153 v~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a  229 (413)
                      +++|..|+++..-+ +...   ...+...+-.++.|+..++.|+| ..   ++.|+||||+|.+++..+ .++++|||+|
T Consensus        99 ~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999999988 4432   25666777889999999999999 77   999999999999999999 9999999999


Q ss_pred             eecCC--CCcceeecccc-ccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          230 KLLGS--ESSYITTRVMG-TFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       230 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ..+..  +........+| ++.|+|||...+. ......|+||.|+++..+++|..|+......... ...|...    .
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~----~  247 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN----K  247 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc----c
Confidence            87765  33334445678 9999999998885 4567889999999999999999999755443311 1111110    0


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                             ......+...+.....+++.+++..+|..|.+.+++-..
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                   111123344455567788889999999999998887654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=6.8e-17  Score=136.00  Aligned_cols=136  Identities=19%  Similarity=0.161  Sum_probs=113.2

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC--CCcccccceeeeCCeeEEEEEeccCC
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+.+++.+++  .++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999764 7899998754433  5678889999999976  58899988888888899999999887


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      .+..+           +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+...
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            76543           44566788999999999999853347999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=4.2e-17  Score=143.22  Aligned_cols=136  Identities=22%  Similarity=0.238  Sum_probs=96.0

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhH--HH----------------------HHHHHHHHhcCCCCC--c
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE--RE----------------------FKVEVEAIGRVRHKN--L  137 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~hpn--i  137 (413)
                      .+.||+|+||+||+|...+++.||||.+........  ..                      ...|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            568999999999999987899999998765432111  11                      123444444443322  3


Q ss_pred             ccccceeeeCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEE
Q 015076          138 VRLLGYCAEGAHRMLVYEYVNNGNLEQW-LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILI  215 (413)
Q Consensus       138 v~~~~~~~~~~~~~iv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll  215 (413)
                      .+.+++    ...++||||++++.+... +...     ... ..+..++.+++.++.++|. .   +|+|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333322    235899999998554321 1111     011 5678899999999999999 7   99999999999999


Q ss_pred             cCCCCceEEecccceecC
Q 015076          216 DKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       216 ~~~~~~kl~DfG~a~~~~  233 (413)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=1.5e-16  Score=144.86  Aligned_cols=135  Identities=19%  Similarity=0.267  Sum_probs=103.7

Q ss_pred             cEEe-eeCceEEEEEEEcCCCEEEEEEeecCC-------------chhHHHHHHHHHHHhcCCCCCc--ccccceeeeC-
Q 015076           85 KVIG-EGGYGIVYYGLLEDNSKVAVKNLLNNR-------------GQAEREFKVEVEAIGRVRHKNL--VRLLGYCAEG-  147 (413)
Q Consensus        85 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~hpni--v~~~~~~~~~-  147 (413)
                      ..|| .||.|+||.+... +..++||.+....             ......+.+|+.++..|.|++|  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4677 8888999988775 7789999774321             1223467789999999998875  5666654332 


Q ss_pred             C---eeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          148 A---HRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       148 ~---~~~iv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      .   ..++|||+++| .+|.+++...     +++..    .+.+|+.+|.+||+.   ||+|+||||+|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2   22599999997 6898887543     34543    357899999999999   9999999999999999889999


Q ss_pred             Eecccceec
Q 015076          224 SDFGLAKLL  232 (413)
Q Consensus       224 ~DfG~a~~~  232 (413)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=1.3e-15  Score=148.65  Aligned_cols=249  Identities=21%  Similarity=0.241  Sum_probs=185.0

Q ss_pred             CCCCcccEEee--eCceEEEEEEE--c-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCC-CCCcccccceeeeCCee
Q 015076           79 NGFSDDKVIGE--GGYGIVYYGLL--E-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        79 ~~y~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~  150 (413)
                      ..|.+.+.+|.  |.+|.||.+..  . ++..+|+|+-....  ......=.+|+...+.++ |+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45778889999  99999999885  3 56778988643222  122222334666666664 99999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHh----hhchhhhccCCceeeccCCCCcEEEcCC-CCceEEe
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK----GLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSD  225 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  225 (413)
                      ++-+|+| +.+|..+.+...   ..++...++..+.+...    ||.++|..   +++|-|+||.||++..+ ...+++|
T Consensus       194 fiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            9999999 678888887653   45888899999999999    99999999   99999999999999999 8899999


Q ss_pred             cccceecCCCCccee----eccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          226 FGLAKLLGSESSYIT----TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       226 fG~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      ||+...++.......    ....|...|++||+. .+.++.++|||+||.++.+..++..++.......      |    
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W----  335 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W----  335 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------c----
Confidence            999998876542211    222577889999987 5568889999999999999998876654321100      0    


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                            ..+-..-++.+.......++..++..|++.+|..|++.+.+.++
T Consensus       336 ------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  336 ------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                  00000112222232334455568889999999999999988765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=1.3e-14  Score=143.32  Aligned_cols=142  Identities=20%  Similarity=0.216  Sum_probs=97.8

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhH----------------------------------------HHHH
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE----------------------------------------REFK  123 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  123 (413)
                      .+.||.|++|.||+|+.++|+.||||+..+.-....                                        -.+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999998755421110                                        0133


Q ss_pred             HHHHHHhcC----CCCCccccccee-eeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHh-hhchhhh
Q 015076          124 VEVEAIGRV----RHKNLVRLLGYC-AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK-GLSYLHE  197 (413)
Q Consensus       124 ~e~~~l~~l----~hpniv~~~~~~-~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-aL~~LH~  197 (413)
                      .|+..+.++    ++.+-+.+-.++ ......++||||++|++|.++.....   ....   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence            455544444    222222222222 22344689999999999988764321   1122   2345555555 4678888


Q ss_pred             ccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       198 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      .   |++|+|+||.||++++++.++|+|||++..++.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.51  E-value=2.1e-14  Score=143.67  Aligned_cols=147  Identities=15%  Similarity=0.130  Sum_probs=94.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchh----------------------------------HHH
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQA----------------------------------ERE  121 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~  121 (413)
                      ....|+. +.||+|++|.||+|+.++ |+.||||++.+.-...                                  ...
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 799999999999999876 9999999886542110                                  011


Q ss_pred             ------HHHHHHHHhcC----CCCCcccccceeee-CCeeEEEEEeccCCChhhhc--cCCCCCCCCCCHHHHHHHHHHH
Q 015076          122 ------FKVEVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGT  188 (413)
Q Consensus       122 ------~~~e~~~l~~l----~hpniv~~~~~~~~-~~~~~iv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i  188 (413)
                            +..|+..+.++    .+.+.+.+-.++.+ ....++||||++|+.|.++-  .........+....+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                  22233333222    12222222222211 23457999999999997742  2221111134445555556665


Q ss_pred             HhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEecccceecCC
Q 015076          189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDFGLAKLLGS  234 (413)
Q Consensus       189 ~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~  234 (413)
                      .       ..   |++|+|+||.||+++.++    .++++|||++..++.
T Consensus       277 f-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4       34   999999999999999888    899999999987754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=1.9e-14  Score=130.49  Aligned_cols=204  Identities=20%  Similarity=0.299  Sum_probs=141.1

Q ss_pred             HHhcCCCCCcccccceeeeC-----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc
Q 015076          128 AIGRVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK  202 (413)
Q Consensus       128 ~l~~l~hpniv~~~~~~~~~-----~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  202 (413)
                      .|-.+-|.|||+++.|+.+.     ....+++||+..|+|.++|++.......+......+|+.||+.||.|||+. .+.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34445699999999998654     346899999999999999987655556788889999999999999999986 678


Q ss_pred             eeeccCCCCcEEEcCCCCceEEecccceecCCC----CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh
Q 015076          203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE----SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS  278 (413)
Q Consensus       203 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt  278 (413)
                      |+|+++..+.|++..+|-+|+.- +.-......    .........+-++|.+||.=.....+.++|||+||+...+|..
T Consensus       199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999888777742 111111100    0000111235678999997666677889999999999999988


Q ss_pred             CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       279 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +..--.....  .......+...+     ...-+ .           .-+.++.+|++..|..||+|.+++.|+
T Consensus       278 lEiq~tnseS--~~~~ee~ia~~i-----~~len-~-----------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSES--KVEVEENIANVI-----IGLEN-G-----------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcc--eeehhhhhhhhe-----eeccC-c-----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            7654221111  111000000000     00000 0           113567789999999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2.2e-13  Score=117.48  Aligned_cols=131  Identities=18%  Similarity=0.107  Sum_probs=95.0

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcc-cccceeeeCCeeEEEEEeccCCCh
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      ++.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999875 77899997644322 223456788888888655544 444433  2345899999999887


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc--CCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ...-         .   ....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6430         0   11345678999999999881  12259999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=2.6e-12  Score=127.13  Aligned_cols=167  Identities=21%  Similarity=0.240  Sum_probs=126.1

Q ss_pred             EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHH
Q 015076          100 LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE  179 (413)
Q Consensus       100 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~  179 (413)
                      ..++.+|.|...............+.+..|+.++||||+++++.+...+..|||+|.+.  .|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence            34577888877765555444556778888999999999999999999999999999983  56666643       3466


Q ss_pred             HHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccCC
Q 015076          180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM  259 (413)
Q Consensus       180 ~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  259 (413)
                      ....-+.||+.||.|||..+  +++|++|.-+.|+++..|..||++|-++........ .......-..|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            77788999999999998554  999999999999999999999999998865433221 011111123466666543222


Q ss_pred             CCccchhHHHHHHHHHHHhCC
Q 015076          260 LNERSDVYSFGILIMEVISGR  280 (413)
Q Consensus       260 ~~~~sDvwslG~~l~elltg~  280 (413)
                        -..|.|.|||++++++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              4569999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=3.1e-12  Score=111.74  Aligned_cols=137  Identities=15%  Similarity=0.137  Sum_probs=98.0

Q ss_pred             ccEEeeeCceEEEEEEEcC-------CCEEEEEEeecCC----------------------chhHHH----HHHHHHHHh
Q 015076           84 DKVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNR----------------------GQAERE----FKVEVEAIG  130 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~e~~~l~  130 (413)
                      ...||.|--+.||.|...+       +..+|||+.....                      ......    ...|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998542       4789999763210                      011222    337899998


Q ss_pred             cCCC--CCcccccceeeeCCeeEEEEEeccCCChhh-hccCCCCCCCCCCHHHHHHHHHHHHhhhchh-hhccCCceeec
Q 015076          131 RVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYL-HEGLEPKVVHR  206 (413)
Q Consensus       131 ~l~h--pniv~~~~~~~~~~~~~iv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~  206 (413)
                      ++..  -++..++++    ...+|||||+.+..+.. .+..     ..++......+..+++.+|..| |..   |+|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            8853  355566654    45689999996644422 2221     2345556677889999999998 888   99999


Q ss_pred             cCCCCcEEEcCCCCceEEecccceecC
Q 015076          207 DIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       207 Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||++.|||+++ +.+.|+|||.+....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=6.8e-13  Score=129.86  Aligned_cols=249  Identities=20%  Similarity=0.198  Sum_probs=176.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc--CCCEEEEEEeecCCchhHHH--HHHHHHHHhcC-CCCCcccccceeeeCCee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNNRGQAERE--FKVEVEAIGRV-RHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~hpniv~~~~~~~~~~~~  150 (413)
                      ....+|..+..||.|.|+.|+.+..+  ++..|++|.+.+.......+  -..|+-+...+ .|.++++++..+..-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567999999999999999988743  57789999876654332222  22355555555 488999988888877778


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecccc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLA  229 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a  229 (413)
                      ||-.|||.++++...+...    ..+.+...+.+..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||+.
T Consensus       342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            8999999999887766332    4678888999999999999999998   99999999999999886 78899999998


Q ss_pred             eecCCCCcceeeccccccCcc--CccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYV--APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ..+...    ........+++  +++......+..+.|++|||..+.+.+++..--. ..    ..   |          
T Consensus       415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~----~~---~----------  472 (524)
T KOG0601|consen  415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SG----VQ---S----------  472 (524)
T ss_pred             ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCc-cc----cc---c----------
Confidence            643211    11122334444  5556667788999999999999999998763211 10    00   0          


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..+.....+..+.  ....+..+...+...++..||.+.++..+.+..
T Consensus       473 ~~i~~~~~p~~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  473 LTIRSGDTPNLPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             eeeecccccCCCc--hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            0011111111111  114566677788999999999999887776543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=4.5e-12  Score=107.12  Aligned_cols=132  Identities=21%  Similarity=0.358  Sum_probs=101.0

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCC---ch-----hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR---GQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..+++|+-+.+|.+.+. |.++++|.-.++.   ..     ......+|++++.++.--.|..-+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 5557777543332   11     123456799999888655555544455667777899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ++|..|.+++...           ...++..+-..+.-||..   ||+|+||.++||++... .+.++|||++.+.
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCccccc
Confidence            9999999888654           256777888888999999   99999999999999887 4999999998754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=1.1e-11  Score=111.55  Aligned_cols=142  Identities=20%  Similarity=0.253  Sum_probs=108.4

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCC--CcccccceeeeC---CeeEEEEEecc
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHK--NLVRLLGYCAEG---AHRMLVYEYVN  158 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hp--niv~~~~~~~~~---~~~~iv~e~~~  158 (413)
                      +.|+.|.++.||++...+|..+++|....... .....+..|+.+++.+.+.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999877668899997654332 1345678899999998753  456677766553   35689999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc---------------------------------------
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL---------------------------------------  199 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~---------------------------------------  199 (413)
                      |.++...+..     ..++......++.+++++|+.||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9988876532     24677777788888888888888421                                       


Q ss_pred             --------------CCceeeccCCCCcEEEcC--CCCceEEeccccee
Q 015076          200 --------------EPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKL  231 (413)
Q Consensus       200 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~  231 (413)
                                    ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=1.1e-11  Score=104.37  Aligned_cols=144  Identities=17%  Similarity=0.266  Sum_probs=106.0

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--------chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ...+|-+|+-+.|+++.+. |+...||.-..+.        .-...+.++|+++|.++.--.|.--.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999886 7777777543321        122346778999998876545544444555666678999


Q ss_pred             EeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEecccce
Q 015076          155 EYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAK  230 (413)
Q Consensus       155 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~  230 (413)
                      ||++| .++.+++.....  ..........++..|-+.+.-||.+   +|||+||..+||+|..++.   +.|+|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99977 478888755321  2233333478889999999999999   9999999999999976654   5899999976


Q ss_pred             ec
Q 015076          231 LL  232 (413)
Q Consensus       231 ~~  232 (413)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            43

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.31  E-value=4e-13  Score=138.14  Aligned_cols=251  Identities=22%  Similarity=0.233  Sum_probs=174.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      +...+++.+.+.+-+|.++.++.+.-. .+...++|......   ....+....+-.++-...+|.++...--+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            456788999999999999999987733 23333444322111   11112222232333333457777766666677788


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +++++|+.+++|...++..    +..+..-+...+..+..++++||..   .+.|+|++|.|+|+..++..+++|||...
T Consensus       880 ~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            9999999999999998876    3566666677778888999999997   79999999999999999999999998443


Q ss_pred             ecCCC------------------------------CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 015076          231 LLGSE------------------------------SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR  280 (413)
Q Consensus       231 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~  280 (413)
                      ..+..                              .........||+.|.+||.+.+......+|+|++|+++++.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            22100                              001122356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 015076          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (413)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  346 (413)
                      .||....+.....      .+. +..      ...+ .-.........+++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f~------ni~-~~~------~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFE------NIL-NRD------IPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhh------ccc-cCC------CCCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998665433211      111 000      0111 11223445567788888899999998766

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.25  E-value=3.1e-10  Score=106.80  Aligned_cols=266  Identities=15%  Similarity=0.158  Sum_probs=165.7

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccce------e-eeCCeeEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGY------C-AEGAHRML  152 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~------~-~~~~~~~i  152 (413)
                      ....+.||+|+-+.+|-.--  -...+.|+..............   .|... .||-+-.=+.+      . ..+....+
T Consensus        13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecch--hhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34567899999999994431  1123456665444333332222   23332 46544331211      1 12233678


Q ss_pred             EEEeccCC-Chhhhcc--CCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          153 VYEYVNNG-NLEQWLH--GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       153 v~e~~~~g-sL~~~l~--~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|..+.+. -+..++.  .++..+....|..+++.++.++.+.+.||..   |.+-+|+.++|+|+.+++.++|.|-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            88888774 2333332  1233446688999999999999999999999   9999999999999999999999986554


Q ss_pred             eecCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCCCCC----ccccc-HHHHH
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISG-RIPVDYSRP----PEEVN-LIEWL  298 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg-~~Pf~~~~~----~~~~~-~~~~~  298 (413)
                      .....+  ......+|...|++||...     +..-+...|.|.||+++++|+.| +.||.+-..    ..... .+...
T Consensus       165 qi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            443222  2234457899999999754     23356778999999999999986 999975221    11111 11100


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCC--CCCCCCHHHHHHHHhcccC
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN--AQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~RPs~~eil~~le~~~~  357 (413)
                      .-.. ...-..-+.+.....+..-+...+..+..+|+...  +.-|||++..+..|.....
T Consensus       243 ~f~y-a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         243 RFAY-ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             eeee-chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            0000 00001111222233445556677888888898753  5689999998888766544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=2.6e-10  Score=109.85  Aligned_cols=218  Identities=16%  Similarity=0.191  Sum_probs=152.7

Q ss_pred             CceEEEEEE-EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee----eCCeeEEEEEeccC-CChhh
Q 015076           91 GYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA----EGAHRMLVYEYVNN-GNLEQ  164 (413)
Q Consensus        91 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~~iv~e~~~~-gsL~~  164 (413)
                      ...+.|++. ..+|..|++|++.-++.........-++.++++.|+|||++.++|.    .+..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345678888 4478999999995555444434445677899999999999999886    34567999999987 67776


Q ss_pred             hccCCC-----------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          165 WLHGDV-----------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       165 ~l~~~~-----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      +.....           ......++..+|.++.|+..||.++|+.   |+..+-|.+.+||++.+.+++|...|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            553221           1123578899999999999999999999   99999999999999999999998888766554


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .+..               |.+..   -.+-|.=-||.+++.|.||..--...+.     ......              
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-----~~~s~~--------------  487 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS-----TQSSHL--------------  487 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccc-----hHHHHH--------------
Confidence            3320               11111   1356889999999999998533110000     000000              


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         ......++.++.+++.-....++++ -++.+++.++
T Consensus       488 ---~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  488 ---TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ---HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence               0122346667777887777777776 6777777654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=3.3e-10  Score=98.62  Aligned_cols=126  Identities=25%  Similarity=0.288  Sum_probs=82.3

Q ss_pred             EEEEEEEcCCCEEEEEEeecCC--------------------------chhHHHHHHHHHHHhcCCCC--Ccccccceee
Q 015076           94 IVYYGLLEDNSKVAVKNLLNNR--------------------------GQAEREFKVEVEAIGRVRHK--NLVRLLGYCA  145 (413)
Q Consensus        94 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~  145 (413)
                      .||.|...++..+|||......                          ........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999764211                          00123467799999999765  456666442 


Q ss_pred             eCCeeEEEEEecc--CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhch-hhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          146 EGAHRMLVYEYVN--NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY-LHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       146 ~~~~~~iv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                         ..+|||||++  |..+..+....      ++......++.+++..+.. +|..   ||+||||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  55554443321      1133445667777775554 5787   99999999999999988 999


Q ss_pred             EEecccceecC
Q 015076          223 VSDFGLAKLLG  233 (413)
Q Consensus       223 l~DfG~a~~~~  233 (413)
                      |+|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.06  E-value=1e-09  Score=98.47  Aligned_cols=137  Identities=22%  Similarity=0.188  Sum_probs=98.1

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc----------------------hhHHHHHHHHHHHhcCCCC--
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG----------------------QAEREFKVEVEAIGRVRHK--  135 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~hp--  135 (413)
                      =+.++..||-|--+.||.|...+|.++|||.-.....                      .......+|.++|.+|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3667889999999999999999999999995432110                      1123456788899988654  


Q ss_pred             CcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE
Q 015076          136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI  215 (413)
Q Consensus       136 niv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll  215 (413)
                      .|.+.+++    +...+||||++|-.|...--         .....-.++..|+.-+.-+-..   ||||+|+.+-||++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV  235 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence            66666654    45689999998866655421         1222333444444444444455   99999999999999


Q ss_pred             cCCCCceEEecccceec
Q 015076          216 DKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       216 ~~~~~~kl~DfG~a~~~  232 (413)
                      +++|.+.++||--+...
T Consensus       236 ~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ecCCCEEEEeCcccccC
Confidence            99999999999876543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=2.2e-09  Score=99.05  Aligned_cols=140  Identities=16%  Similarity=0.089  Sum_probs=96.6

Q ss_pred             EEeeeCceEEEEEEEcCCCEEEEEEeecCCch-----------hHHHHHHHHHHHhcCCCCCc--ccccceeee-----C
Q 015076           86 VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-----------AEREFKVEVEAIGRVRHKNL--VRLLGYCAE-----G  147 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpni--v~~~~~~~~-----~  147 (413)
                      .+-.-....|+++.. +|+.+.||......-.           ....+.+|...+.+|..-+|  +..+.+...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344334444666655 4778999976432211           11136678888877743333  333444432     2


Q ss_pred             CeeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-------CC
Q 015076          148 AHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-------HW  219 (413)
Q Consensus       148 ~~~~iv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~  219 (413)
                      ...+||||++++. +|.+++.....  .+.+......++.+++..++-||..   ||+|+|+++.|||++.       ++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            3568999999885 89988853211  3456677789999999999999999   9999999999999975       46


Q ss_pred             CceEEeccccee
Q 015076          220 NPKVSDFGLAKL  231 (413)
Q Consensus       220 ~~kl~DfG~a~~  231 (413)
                      .+.|+||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.86  E-value=6.9e-10  Score=110.59  Aligned_cols=151  Identities=20%  Similarity=0.292  Sum_probs=105.0

Q ss_pred             HHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee--------eccccccCccCcccccc
Q 015076          186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT--------TRVMGTFGYVAPEYAST  257 (413)
Q Consensus       186 ~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~  257 (413)
                      .+++.||.|+|...  ++||++|.|++|.++..+..||+.|+++........+..        .-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34458999999874  999999999999999999999999998875543222111        11223567999999999


Q ss_pred             CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCC
Q 015076          258 GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD  336 (413)
Q Consensus       258 ~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  336 (413)
                      ...+.++|+|||||++|.+.. |+.-+.............             ..+..-.......++.++++-+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence            888999999999999999994 554444332222111110             000111111224566678888888999


Q ss_pred             CCCCCCCCHHHHHHH
Q 015076          337 PNAQKRPKMGHVVHM  351 (413)
Q Consensus       337 ~dp~~RPs~~eil~~  351 (413)
                      .++..||++.++...
T Consensus       251 ~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSI  265 (700)
T ss_pred             CCcccCcchhhhhcc
Confidence            999999987776554

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=3.4e-08  Score=86.69  Aligned_cols=138  Identities=15%  Similarity=0.164  Sum_probs=102.4

Q ss_pred             EeeeCceEEEEEEEcCCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCC--cccccceee---e--CCeeEEE
Q 015076           87 IGEGGYGIVYYGLLEDNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHKN--LVRLLGYCA---E--GAHRMLV  153 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~---~--~~~~~iv  153 (413)
                      -|+||.+-|+..... |..+.+|......      ......|.+|+..|..|..-+  +.++. ++.   .  .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467999999987765 4478999764211      234567888999998885322  44444 332   1  1235899


Q ss_pred             EEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC--ceEEecccce
Q 015076          154 YEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~  230 (413)
                      +|-++| .+|.+++.....  .+.+......++.+++.+++-||+.   |+.|+|+.+.|||++..+.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998865 589888855321  3567788889999999999999999   9999999999999987777  9999997655


Q ss_pred             e
Q 015076          231 L  231 (413)
Q Consensus       231 ~  231 (413)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=1.3e-08  Score=90.60  Aligned_cols=107  Identities=21%  Similarity=0.240  Sum_probs=81.8

Q ss_pred             HHHHHHHHHHHhcCCCCC--cccccceeeeC----CeeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhh
Q 015076          119 EREFKVEVEAIGRVRHKN--LVRLLGYCAEG----AHRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG  191 (413)
Q Consensus       119 ~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~----~~~~iv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~a  191 (413)
                      .....+|...+..|..-+  +.+.+++....    ...+||+|++++ .+|.+++....    ..+......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence            345666777777764322  34445554432    245899999988 48999987642    35666778999999999


Q ss_pred             hchhhhccCCceeeccCCCCcEEEcCCC---CceEEecccceec
Q 015076          192 LSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKLL  232 (413)
Q Consensus       192 L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~  232 (413)
                      ++-||..   ||+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   999999999999999887   7999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=1.4e-08  Score=101.36  Aligned_cols=142  Identities=18%  Similarity=0.205  Sum_probs=88.8

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhH----------------------------------------HHHHH
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE----------------------------------------REFKV  124 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  124 (413)
                      ..|+.++-|.||+|+.++|+.||||+..++-....                                        -.+..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999999999999998755421110                                        01223


Q ss_pred             HHHHHhcCC-----CCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc
Q 015076          125 EVEAIGRVR-----HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL  199 (413)
Q Consensus       125 e~~~l~~l~-----hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~  199 (413)
                      |+..+.++.     .++|.=-.=+++-.....++|||++|..+.++.....   ..++...+.....++.  +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence            444443331     2222111111222345689999999999988853221   2333222222222211  1111123 


Q ss_pred             CCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       200 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                        |++|+|.+|.||+++.+|.+.+.|||+....++
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              999999999999999999999999999877653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=1.2e-07  Score=85.50  Aligned_cols=140  Identities=18%  Similarity=0.186  Sum_probs=84.3

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccceeeeCCeeEEEEEeccCCC-
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYVNNGN-  161 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~iv~e~~~~gs-  161 (413)
                      ..||+|..+.||+.   .+..+++|......  ....+.+|.++++.+..-+  +.+++++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47999999999974   25567888765432  3345678999998886433  4677777777778899999998863 


Q ss_pred             hhhhc---------------------cCCCCCCCCCCHHHHHHHHHHH----------Hh-hhchhhhc-cCCceeeccC
Q 015076          162 LEQWL---------------------HGDVGPCSPLTWEIRMNIILGT----------AK-GLSYLHEG-LEPKVVHRDI  208 (413)
Q Consensus       162 L~~~l---------------------~~~~~~~~~l~~~~~~~i~~~i----------~~-aL~~LH~~-~~~~ivH~Dl  208 (413)
                      +...+                     +.-......++.. ...+..++          .. ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            22111                     1110000111100 00000000          00 01111111 1235789999


Q ss_pred             CCCcEEEcCCCCceEEeccccee
Q 015076          209 KSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       209 kp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999887 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.69  E-value=2.7e-07  Score=81.36  Aligned_cols=138  Identities=15%  Similarity=0.187  Sum_probs=91.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHH---------HHHHHHHhcCC---CCCcccccce
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREF---------KVEVEAIGRVR---HKNLVRLLGY  143 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---hpniv~~~~~  143 (413)
                      +..++|.+.+++-......|.+-... |..+++|..........+.+         .+++..+.++.   .-....++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            56788999999998887777766554 78899997755433222222         23333333332   2233332222


Q ss_pred             ee-----eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          144 CA-----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       144 ~~-----~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      ..     -....+++|||++|..|.++..        +++    .+...+.+++.-||+.   |+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            22     2234568999999988866532        222    2445667788999999   99999999999999966


Q ss_pred             CCceEEecccce
Q 015076          219 WNPKVSDFGLAK  230 (413)
Q Consensus       219 ~~~kl~DfG~a~  230 (413)
                       .++++||+..+
T Consensus       172 -~i~iID~~~k~  182 (229)
T PF06176_consen  172 -GIRIIDTQGKR  182 (229)
T ss_pred             -cEEEEECcccc
Confidence             59999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=2.3e-07  Score=82.64  Aligned_cols=151  Identities=21%  Similarity=0.205  Sum_probs=96.9

Q ss_pred             cHHHHHHhcCCCCcccE---EeeeCceEEEEEEEcCCCEEEEEEeecCCchh------------------------HHHH
Q 015076           70 TLRELEVSTNGFSDDKV---IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQA------------------------EREF  122 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~  122 (413)
                      ++..+.-..++..+..+   |+.|--+.||+|...++..+|+|++......-                        ....
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            34444445555555554   55677778999998889999999875322110                        1123


Q ss_pred             HHHHHHHhcCC--CCCcccccceeeeCCeeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-c
Q 015076          123 KVEVEAIGRVR--HKNLVRLLGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-G  198 (413)
Q Consensus       123 ~~e~~~l~~l~--hpniv~~~~~~~~~~~~~iv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~  198 (413)
                      ..|...|+++.  +=.+.+-+.+..    -.+||||+... .-.-.|..     .++....+..+..++++.+.-|-. .
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            34555565553  222333333322    26999999543 11112221     123333677788888888888877 5


Q ss_pred             cCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       199 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                         ++||+||+.-|||+. ++.+.++|||-|....
T Consensus       187 ---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 ---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             ---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence               999999999999999 7799999999887554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.62  E-value=1e-08  Score=101.43  Aligned_cols=182  Identities=18%  Similarity=0.130  Sum_probs=134.9

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC-cccccceeeeCCeeEEEEEeccCC-C
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYVNNG-N  161 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~iv~e~~~~g-s  161 (413)
                      ..-+++|+++++++.+....+....+.+...     ....-++++|.+++||| .+..++-++.+...+++|+++.++ +
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            3447789999999887443333334544222     33445888999999999 778888888889999999999776 3


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceee
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT  241 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  241 (413)
                      ....+....   ..+.......+.+.-+++|++||+.   .=+|+|    ||+..+ +..++.||+....+....  ...
T Consensus       322 ~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~  388 (829)
T KOG0576|consen  322 SALEMTVSE---IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR  388 (829)
T ss_pred             ccccCChhh---Hhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence            332222111   2344455566777788999999987   558888    777766 588999999988776543  345


Q ss_pred             ccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 015076          242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV  283 (413)
Q Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf  283 (413)
                      ...+|+.|+|||+.....+..+.|+|++|.-..++.-|.+|-
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            567899999999999999999999999998777777777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.58  E-value=7.3e-07  Score=80.58  Aligned_cols=145  Identities=21%  Similarity=0.242  Sum_probs=83.3

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC--Ccccccceee---eCCeeEEEEEecc
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGYCA---EGAHRMLVYEYVN  158 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~---~~~~~~iv~e~~~  158 (413)
                      ++.|+.|..+.||++...+ +.+++|.....  .....+..|..+++.+...  .+..++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4679999999999999876 69999976433  4556777888888877533  3455665332   3345799999999


Q ss_pred             CCChhh----------------hc---cCCCCCCCCCCHHH---------HHHH------------HHHHHh-hhchhhh
Q 015076          159 NGNLEQ----------------WL---HGDVGPCSPLTWEI---------RMNI------------ILGTAK-GLSYLHE  197 (413)
Q Consensus       159 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-aL~~LH~  197 (413)
                      |..+..                .+   +.......+.....         ....            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987777                11   11100101111110         0000            011111 2233332


Q ss_pred             c----cCCceeeccCCCCcEEEc-CCCCceEEeccccee
Q 015076          198 G----LEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKL  231 (413)
Q Consensus       198 ~----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~  231 (413)
                      .    ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    234799999999999999 555667999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=3.2e-07  Score=91.46  Aligned_cols=141  Identities=18%  Similarity=0.204  Sum_probs=88.8

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhH-------------------------------H------HHHHHH
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAE-------------------------------R------EFKVEV  126 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~e~  126 (413)
                      .+.||.-+.|.||+|+.++|..||||+.++.-....                               +      .|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            467999999999999999999999997755422110                               0      123344


Q ss_pred             HHHhcC----CCCC------cccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh
Q 015076          127 EAIGRV----RHKN------LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH  196 (413)
Q Consensus       127 ~~l~~l----~hpn------iv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH  196 (413)
                      +...++    .|-+      |.+++..  ......++||||+|..+.+.-.-..   ..++...+..-+.++.     ++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~-----~~  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAY-----LE  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHH-----HH
Confidence            433332    2333      3333322  2345689999999987766542221   2344444433333322     22


Q ss_pred             hccCCceeeccCCCCcEEEcC----CCCceEEecccceecCC
Q 015076          197 EGLEPKVVHRDIKSSNILIDK----HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       197 ~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfG~a~~~~~  234 (413)
                      .....|++|+|=+|.||+++.    ++.+.+.|||+......
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            112229999999999999984    56799999999876643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.39  E-value=1.7e-06  Score=79.21  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=51.2

Q ss_pred             EeeeCc-eEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEeccCCChhh
Q 015076           87 IGEGGY-GIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ  164 (413)
Q Consensus        87 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~  164 (413)
                      |..|.+ ..||+.... +.++++|......   ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 778988754 4678888764332   334567888887774 3345567777766667899999999987764


Q ss_pred             h
Q 015076          165 W  165 (413)
Q Consensus       165 ~  165 (413)
                      .
T Consensus        82 ~   82 (244)
T cd05150          82 L   82 (244)
T ss_pred             h
Confidence            3

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=4.6e-06  Score=89.49  Aligned_cols=79  Identities=10%  Similarity=0.255  Sum_probs=57.0

Q ss_pred             ccEEeeeCceEEEEEEEcCC---CEEEEEEeecCC-chhHHHHHHHHHHHhcCC-CCCc--ccccceeeeC---CeeEEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDN---SKVAVKNLLNNR-GQAEREFKVEVEAIGRVR-HKNL--VRLLGYCAEG---AHRMLV  153 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpni--v~~~~~~~~~---~~~~iv  153 (413)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.+|  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999886543   367778654332 123456788999999995 6654  7777777664   457899


Q ss_pred             EEeccCCCh
Q 015076          154 YEYVNNGNL  162 (413)
Q Consensus       154 ~e~~~~gsL  162 (413)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=1.9e-06  Score=72.77  Aligned_cols=130  Identities=16%  Similarity=0.252  Sum_probs=89.1

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccc-ccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR-LLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~~~~~~iv~e~~~~  159 (413)
                      .++.+.|++|.+|.||+|.+. |..+|+|.-..+  .....+..|+++|..+.--++.+ ++.+..+    ++.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence            456778999999999999997 568899965433  44567888999999887665543 4433322    466999988


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCC-CCcEEEcCCCCceEEeccccee
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK-SSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfG~a~~  231 (413)
                      -.|..+-...       +    .+-...+++.---|-..   ||-|+.|. |..++|..++.+.|+||..|..
T Consensus        97 ~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7877665321       1    22233444443344444   99999987 5555555555999999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.26  E-value=1e-05  Score=71.11  Aligned_cols=129  Identities=21%  Similarity=0.310  Sum_probs=91.3

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCC----------------chhHHHHHHHHHHHhcCC------CCCcccc
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----------------GQAEREFKVEVEAIGRVR------HKNLVRL  140 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------hpniv~~  140 (413)
                      -...||+|+.-.||  .+.++....||++....                ........+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            34579999999999  56667778899886655                122344555665555544      7889999


Q ss_pred             cceeeeCCeeEEEEEeccC------CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEE
Q 015076          141 LGYCAEGAHRMLVYEYVNN------GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (413)
Q Consensus       141 ~~~~~~~~~~~iv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl  214 (413)
                      +|+.+.+.-..+|+|.+.+      .+|.+++...     .++. .....+.++   ..||-+.   +|+.+||+|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHHHc---CCeecCCCcccEE
Confidence            9999999889999998743      2677777543     4554 344444433   4566777   8999999999999


Q ss_pred             EcCCC----CceEEe
Q 015076          215 IDKHW----NPKVSD  225 (413)
Q Consensus       215 l~~~~----~~kl~D  225 (413)
                      +....    .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            95432    477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.24  E-value=7.7e-06  Score=74.43  Aligned_cols=74  Identities=14%  Similarity=0.181  Sum_probs=45.7

Q ss_pred             cEEeeeCceE-EEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---CcccccceeeeC---CeeEEEEEec
Q 015076           85 KVIGEGGYGI-VYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK---NLVRLLGYCAEG---AHRMLVYEYV  157 (413)
Q Consensus        85 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~~~---~~~~iv~e~~  157 (413)
                      +.|+.|+... ||+.    +..+++|....  ......+..|+++++.+...   -+..+++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            4677777774 8865    34577775433  22345788899988877532   233444433322   2458899999


Q ss_pred             cCCChhh
Q 015076          158 NNGNLEQ  164 (413)
Q Consensus       158 ~~gsL~~  164 (413)
                      +|.++..
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9977743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.15  E-value=9.9e-06  Score=70.82  Aligned_cols=101  Identities=24%  Similarity=0.247  Sum_probs=81.4

Q ss_pred             HHHHHHhcCCC-CCcccccceeeeCCeeEEEEEeccCCChhhh---ccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc
Q 015076          124 VEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW---LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL  199 (413)
Q Consensus       124 ~e~~~l~~l~h-pniv~~~~~~~~~~~~~iv~e~~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~  199 (413)
                      .|.-+++.+++ +++++++|+|-.    ++|.||...+++...   +...    ...+|..+.+|+.++++.+.+|+...
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            47777888865 699999999843    789999987766432   1111    25789999999999999999999865


Q ss_pred             CCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       200 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ...+.-.|++++|+-+++++++|++|...+...
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            546888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.13  E-value=1.8e-05  Score=71.86  Aligned_cols=75  Identities=16%  Similarity=0.096  Sum_probs=47.4

Q ss_pred             ccEEeeeCceEEEEEEEcC--CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC-cccccceeeeCCeeEEEEEeccCC
Q 015076           84 DKVIGEGGYGIVYYGLLED--NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      ++.|..|-...+|++...+  +..|++|....... .......|+.+++.+...+ .++++..+.    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567788888999988664  67888996543321 1122345787887775333 344444332    24899999987


Q ss_pred             Chh
Q 015076          161 NLE  163 (413)
Q Consensus       161 sL~  163 (413)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            663

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.10  E-value=1.3e-05  Score=73.83  Aligned_cols=140  Identities=12%  Similarity=0.045  Sum_probs=76.8

Q ss_pred             EeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEEEeccCCChhhh
Q 015076           87 IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNNGNLEQW  165 (413)
Q Consensus        87 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~e~~~~gsL~~~  165 (413)
                      +..|-...+|+... ++.++++|...............|..+++.+...++ .+++....    -++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45677788998874 466788886543322211134668888888754333 33333322    3689999998765431


Q ss_pred             -----------------ccCCCCCCCCCCHH-HHHHHHHHHH---------hhhchhhhc-----cCCceeeccCCCCcE
Q 015076          166 -----------------LHGDVGPCSPLTWE-IRMNIILGTA---------KGLSYLHEG-----LEPKVVHRDIKSSNI  213 (413)
Q Consensus       166 -----------------l~~~~~~~~~l~~~-~~~~i~~~i~---------~aL~~LH~~-----~~~~ivH~Dlkp~NI  213 (413)
                                       ++.......++... .+..+..++.         ..+..+-..     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             12211111122211 1111111110         111111111     123689999999999


Q ss_pred             EEcCCCCceEEecccceec
Q 015076          214 LIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       214 ll~~~~~~kl~DfG~a~~~  232 (413)
                      ++++++ +.|+||..+..-
T Consensus       159 l~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             EEeCCC-CEEEeccccCcC
Confidence            999876 899999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.08  E-value=3.6e-05  Score=72.52  Aligned_cols=80  Identities=10%  Similarity=0.036  Sum_probs=56.8

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC---CCcccccceeee---CCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH---KNLVRLLGYCAE---GAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---pniv~~~~~~~~---~~~~~iv  153 (413)
                      ...-.+.||.|..+.||+....++ ++++|... . ......+..|+..|+.|..   -.+.++++++..   .+..+||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            344556799999999998876545 46677532 2 1233577889999988853   357778877654   3668999


Q ss_pred             EEeccCCCh
Q 015076          154 YEYVNNGNL  162 (413)
Q Consensus       154 ~e~~~~gsL  162 (413)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.99  E-value=2.4e-05  Score=83.05  Aligned_cols=198  Identities=20%  Similarity=0.232  Sum_probs=135.9

Q ss_pred             HHHHHHHHHhcCCCCCcccccceeeeCCee----EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh
Q 015076          121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH  196 (413)
Q Consensus       121 ~~~~e~~~l~~l~hpniv~~~~~~~~~~~~----~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH  196 (413)
                      ....|+..+..+.|+|++.++.+.......    .+..++|..-++...+...    ..++....+.+..++.+||+|+|
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence            345577788888999999999887554332    3456778777888877665    57888999999999999999999


Q ss_pred             hccCCceeeccCCCC---cEEEcCCCCceEE--ecccceecCCCCcceeeccccccCccCccccccCCCCc--cchhHHH
Q 015076          197 EGLEPKVVHRDIKSS---NILIDKHWNPKVS--DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE--RSDVYSF  269 (413)
Q Consensus       197 ~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwsl  269 (413)
                      +.   ...|.-|..+   +...+..+.+.++  ||+....+......  .....+..|.++|......++.  ..|+|++
T Consensus       304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence            98   5555544444   4444555666666  88888776544332  1223456688888776665554  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 015076          270 GILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV  349 (413)
Q Consensus       270 G~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  349 (413)
                      |..+..+..|..+-.....                  +..+++.        .....+.+...+|+..+.++|+++.+++
T Consensus       379 gll~~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence            9999999987654221100                  0001110        0111466777899999999999999999


Q ss_pred             HHHh
Q 015076          350 HMLE  353 (413)
Q Consensus       350 ~~le  353 (413)
                      .+.-
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            8743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.99  E-value=3.9e-05  Score=72.31  Aligned_cols=144  Identities=17%  Similarity=0.170  Sum_probs=82.9

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccce------eeeCCeeEEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  155 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~------~~~~~~~~iv~e  155 (413)
                      .+.|..|....+|+.... +..+++|....   .....+..|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            556778888899988765 44688887643   23345666777777774322  4444332      233456689999


Q ss_pred             eccCCChhhh----c----------cCC----CCC---CCCCCHHHHH----------HHHHHHHhhhchhhh----ccC
Q 015076          156 YVNNGNLEQW----L----------HGD----VGP---CSPLTWEIRM----------NIILGTAKGLSYLHE----GLE  200 (413)
Q Consensus       156 ~~~~gsL~~~----l----------~~~----~~~---~~~l~~~~~~----------~i~~~i~~aL~~LH~----~~~  200 (413)
                      |++|..+...    +          +..    ...   .....|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998765320    0          110    000   0001111110          011112233333332    123


Q ss_pred             CceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       201 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      .+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999986678999997753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.85  E-value=1.7e-05  Score=73.30  Aligned_cols=146  Identities=17%  Similarity=0.083  Sum_probs=96.3

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch----------------------hHHHHHHHHH
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ----------------------AEREFKVEVE  127 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~  127 (413)
                      .++.+.....=+.++..||-|--+-||.+.+.+|...++|.....+..                      ..-...+|..
T Consensus        83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa  162 (465)
T KOG2268|consen   83 ALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA  162 (465)
T ss_pred             HHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence            344444444457889999999999999999999999999954221100                      0112345666


Q ss_pred             HHhcCCC--CCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceee
Q 015076          128 AIGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVH  205 (413)
Q Consensus       128 ~l~~l~h--pniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH  205 (413)
                      .|+.|..  --|.+.+++    ...++|||++.|-.|.+.-+-.       ....+.   ..+..-+--|-.+   |+||
T Consensus       163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly---~~lm~~Iv~la~~---GlIH  225 (465)
T KOG2268|consen  163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPTLY---DDLMGLIVRLANH---GLIH  225 (465)
T ss_pred             HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-------ChHHHH---HHHHHHHHHHHHc---Ccee
Confidence            6666642  124444443    4568999999998887765322       122222   2222233445556   9999


Q ss_pred             ccCCCCcEEEcCCCCceEEecccceec
Q 015076          206 RDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       206 ~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +|+.--||++++++.++++||--+...
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhhcc
Confidence            999999999999999999999765443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.82  E-value=8.3e-05  Score=70.32  Aligned_cols=75  Identities=21%  Similarity=0.237  Sum_probs=47.2

Q ss_pred             cEEeeeCceEEEEEEEcC-------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLED-------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~e~  156 (413)
                      +.|..|-...+|++...+       +..+++|...... ........|..++..+...++ .+++.++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777899888654       4788899764432 222345567777777753333 344554432    368999


Q ss_pred             ccCCChhh
Q 015076          157 VNNGNLEQ  164 (413)
Q Consensus       157 ~~~gsL~~  164 (413)
                      ++|..+..
T Consensus        79 i~G~~l~~   86 (302)
T cd05156          79 IPSRTLTT   86 (302)
T ss_pred             eCCCcCCH
Confidence            98877643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.82  E-value=0.00012  Score=64.01  Aligned_cols=125  Identities=26%  Similarity=0.372  Sum_probs=87.7

Q ss_pred             CCCCcccEEeeeCc-eEEEEEEEcCCCEEEEEEeec---CC--------c----------hhHHHHHHHHHHHhcCC---
Q 015076           79 NGFSDDKVIGEGGY-GIVYYGLLEDNSKVAVKNLLN---NR--------G----------QAEREFKVEVEAIGRVR---  133 (413)
Q Consensus        79 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~---  133 (413)
                      .+++.++.||.|.- |.||++... |..+|+|.+..   ..        .          .-...|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67889999999999 999999986 77999998321   00        0          01124667888777774   


Q ss_pred             CCCc--ccccceeeeC------------------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhc
Q 015076          134 HKNL--VRLLGYCAEG------------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS  193 (413)
Q Consensus       134 hpni--v~~~~~~~~~------------------~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~  193 (413)
                      +.++  |++++|..-.                  ....||.||++...             .+..    .-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            4566  8888887321                  12367888775432             1222    23455666778


Q ss_pred             hhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       194 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89998   9999999999986     4489999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.78  E-value=7.7e-06  Score=88.52  Aligned_cols=161  Identities=14%  Similarity=0.027  Sum_probs=122.5

Q ss_pred             HHHHHHHHhcCCCCCcccccceeee--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc
Q 015076          122 FKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL  199 (413)
Q Consensus       122 ~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~  199 (413)
                      ...|...++...|+++.....-...  ....+++++|+.+|.+.+.|.++....+++....+.....+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3345555666789988877665533  34568999999999999999877665566665555555455466677766553


Q ss_pred             C--CceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHH
Q 015076          200 E--PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI  277 (413)
Q Consensus       200 ~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ell  277 (413)
                      .  .-.+|+++|+-|.+|..+-+++++++|+.+....... ..+...+++.|++|++...-.++.++|+|..|+.+|++.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            2  1258999999999999999999999999995443322 345567888999999998888999999999999999999


Q ss_pred             hCCCCC
Q 015076          278 SGRIPV  283 (413)
Q Consensus       278 tg~~Pf  283 (413)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888776

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.77  E-value=0.00037  Score=67.94  Aligned_cols=76  Identities=18%  Similarity=0.246  Sum_probs=53.3

Q ss_pred             ccEEeeeCceEEEEEEEcCC-CEEEEEEeecC-----C--chhHHHHHHHHHHHhcCC---CCCcccccceeeeCCeeEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDN-SKVAVKNLLNN-----R--GQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~i  152 (413)
                      .+.||.|.+..||++...+| +.++||.-...     .  .........|.+.|+.+.   -.++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999998766 48999975321     1  123456677888888763   2456677766  3455789


Q ss_pred             EEEeccCCC
Q 015076          153 VYEYVNNGN  161 (413)
Q Consensus       153 v~e~~~~gs  161 (413)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>PRK05231 homoserine kinase; Provisional

Probab=97.75  E-value=0.00032  Score=66.84  Aligned_cols=144  Identities=14%  Similarity=0.144  Sum_probs=76.3

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccc------eeeeCCeeEEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLG------YCAEGAHRMLVYE  155 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~------~~~~~~~~~iv~e  155 (413)
                      .+.|+.|....+|+....++ .+++|++. .  .....+..|+.+++.|...+  +.+++.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35577787788998886645 68889764 2  12233344555555543111  333332      1223456789999


Q ss_pred             eccCCChhh-----------hc---cCCCCC-------CCCCCH-HHHHH------------HHHH-HHhhhchhhh---
Q 015076          156 YVNNGNLEQ-----------WL---HGDVGP-------CSPLTW-EIRMN------------IILG-TAKGLSYLHE---  197 (413)
Q Consensus       156 ~~~~gsL~~-----------~l---~~~~~~-------~~~l~~-~~~~~------------i~~~-i~~aL~~LH~---  197 (413)
                      |++|..+..           .+   +.....       ...+.+ .....            .+.+ +...++.+..   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            998875421           11   110000       001111 11110            1111 1111222221   


Q ss_pred             -ccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       198 -~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                       ..+.++||+|+.|.|||++++...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             1345899999999999999765558999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.00056  Score=64.86  Aligned_cols=144  Identities=17%  Similarity=0.164  Sum_probs=80.0

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccce------eeeCCeeEEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  155 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~------~~~~~~~~iv~e  155 (413)
                      .+.++.|....+|++...++ .+++|......  ....+..|++++..|...+  +.+++..      ....+..+++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            56677777789998876544 67888764422  1234455666666663222  3344332      122456789999


Q ss_pred             eccCCChhhh--------------ccCCCC----CC-C--C-CCHHHHH------------HHHHHHHhhhchhhh----
Q 015076          156 YVNNGNLEQW--------------LHGDVG----PC-S--P-LTWEIRM------------NIILGTAKGLSYLHE----  197 (413)
Q Consensus       156 ~~~~gsL~~~--------------l~~~~~----~~-~--~-l~~~~~~------------~i~~~i~~aL~~LH~----  197 (413)
                      |++|..+...              ++....    .. .  . -.|....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654211              111000    00 0  0 0111000            001112233444432    


Q ss_pred             ccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       198 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ....+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            224589999999999999988767899999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.65  E-value=0.00036  Score=65.84  Aligned_cols=141  Identities=17%  Similarity=0.171  Sum_probs=96.1

Q ss_pred             CcccEEeeeCceEEEEEEEcCCCEEEEEEeec------CC--------------------chhHHHHHHHHHHHhcCCCC
Q 015076           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN------NR--------------------GQAEREFKVEVEAIGRVRHK  135 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~------~~--------------------~~~~~~~~~e~~~l~~l~hp  135 (413)
                      .+...|..|--+.||.|.-.+|..+|||++.-      ++                    .........|++.|++|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            35567888999999999988899999997621      11                    11122355688888887655


Q ss_pred             CcccccceeeeCCeeEEEEEeccCCC-hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEE
Q 015076          136 NLVRLLGYCAEGAHRMLVYEYVNNGN-LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (413)
Q Consensus       136 niv~~~~~~~~~~~~~iv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl  214 (413)
                      .|.----+..  ....|||+|+.... -.-.|..     ..++...+..+-.+++.-+.-|.+.+  ++||.||.--|+|
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            4332211111  12479999994321 1112222     35677778888888888888888776  8999999999999


Q ss_pred             EcCCCCceEEecccceec
Q 015076          215 IDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       215 l~~~~~~kl~DfG~a~~~  232 (413)
                      +.+. .+.++|-+-+.-.
T Consensus       298 yhdG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  298 YHDG-KLYIIDVSQSVEH  314 (520)
T ss_pred             EECC-EEEEEEccccccC
Confidence            9765 8999998876543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.55  E-value=0.001  Score=62.66  Aligned_cols=142  Identities=23%  Similarity=0.197  Sum_probs=86.9

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeec--CCchhHHHHHHHHHHHhcCCC--CCcccccceeeeCC--eeEEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGA--HRMLVY  154 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~--~~~iv~  154 (413)
                      ..+.+.+..|..-.+|..... ++++++. ...  ..........+|..+++.+.-  --+...+++|.++.  ..|+||
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            334444433333334444433 7778877 321  223344556678888887642  23445566676665  679999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHH-HHHHhhhchhhhc-----------------------------------
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNII-LGTAKGLSYLHEG-----------------------------------  198 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~i~~aL~~LH~~-----------------------------------  198 (413)
                      +|++|..+.+.+....     ..    ..++ ..+++.|+-||+-                                   
T Consensus       105 ~~veGe~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~  175 (321)
T COG3173         105 EWVEGEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG  175 (321)
T ss_pred             EEecceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence            9998865554443221     11    1222 2555555555532                                   


Q ss_pred             --------------------cCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          199 --------------------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       199 --------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                                          .+..++|+|+++.||+++..+-+-+.||+++..-+
T Consensus       176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                                13468999999999999999889999999987654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.46  E-value=0.0013  Score=61.32  Aligned_cols=31  Identities=32%  Similarity=0.431  Sum_probs=25.8

Q ss_pred             ceeeccCCCCcEEEcCCCC-ceEEecccceec
Q 015076          202 KVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL  232 (413)
Q Consensus       202 ~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~  232 (413)
                      .++|+|++|.|||+++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            5899999999999997555 469999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.33  E-value=0.0014  Score=63.13  Aligned_cols=143  Identities=20%  Similarity=0.194  Sum_probs=80.1

Q ss_pred             ccEEeeeCceEEEEEEEcC-----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcc-cccceeeeCCeeEEEEEec
Q 015076           84 DKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~iv~e~~  157 (413)
                      .+.|-.|-.-.+|++...+     +.+|++|.......... ....|..+++.+..-++. ++++.+..+    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3455568888899987532     35788887654332221 225678888777544433 445555332    589999


Q ss_pred             cCCChhhh-----------------ccCCCCCCC--CCCHHHHHHHHHHHH-----------------hhhchh----hh
Q 015076          158 NNGNLEQW-----------------LHGDVGPCS--PLTWEIRMNIILGTA-----------------KGLSYL----HE  197 (413)
Q Consensus       158 ~~gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i~-----------------~aL~~L----H~  197 (413)
                      ++.+|...                 +|....+..  ...+..+..+..++.                 ..+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87766421                 122111101  122333333322211                 111111    11


Q ss_pred             -ccCCceeeccCCCCcEEEcC-CCCceEEeccccee
Q 015076          198 -GLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKL  231 (413)
Q Consensus       198 -~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~  231 (413)
                       .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11236899999999999986 46799999988754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.15  E-value=0.0056  Score=58.27  Aligned_cols=141  Identities=20%  Similarity=0.249  Sum_probs=80.0

Q ss_pred             EEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC---CCccc---c----cceeeeCCeeEEEEE
Q 015076           86 VIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH---KNLVR---L----LGYCAEGAHRMLVYE  155 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---pniv~---~----~~~~~~~~~~~iv~e  155 (413)
                      .|.+ .--.+|+....+++. ++|.....  ....++..|+..|..|.-   +-.++   .    +..+..+...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556689888876666 78866544  455666778888877732   21122   1    111122237788999


Q ss_pred             eccCCChhh-hc--------------c----C----CCCCCCCCCHHH-------------HHHHHHHHHhhhchhhh--
Q 015076          156 YVNNGNLEQ-WL--------------H----G----DVGPCSPLTWEI-------------RMNIILGTAKGLSYLHE--  197 (413)
Q Consensus       156 ~~~~gsL~~-~l--------------~----~----~~~~~~~l~~~~-------------~~~i~~~i~~aL~~LH~--  197 (413)
                      |++|..+.. ..              +    .    +........|..             ......++...+..+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999987773 11              0    0    001111122220             00112222333333332  


Q ss_pred             --ccCCc---eeeccCCCCcEEEcCCCC-ceEEecccce
Q 015076          198 --GLEPK---VVHRDIKSSNILIDKHWN-PKVSDFGLAK  230 (413)
Q Consensus       198 --~~~~~---ivH~Dlkp~NIll~~~~~-~kl~DfG~a~  230 (413)
                        ..+.+   +||+|+.|+||+++.+.. +.++||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              22223   999999999999999875 8999999765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.10  E-value=0.003  Score=59.01  Aligned_cols=76  Identities=14%  Similarity=0.196  Sum_probs=46.7

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCCcccccceeeeCCeeEEEEEec
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .+-.+.|+.|....+|+.. .+++.+.||.-.   ......|..|+.-|+.|.   --.+.+++.+....+..+|||||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678989999999877 567789999765   233345667777777773   445778888887777789999999


Q ss_pred             cCC
Q 015076          158 NNG  160 (413)
Q Consensus       158 ~~g  160 (413)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.09  E-value=0.0052  Score=58.30  Aligned_cols=32  Identities=22%  Similarity=0.291  Sum_probs=28.6

Q ss_pred             CCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       200 ~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +.+++|+|+.++|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.97  E-value=0.0083  Score=58.48  Aligned_cols=81  Identities=15%  Similarity=0.192  Sum_probs=52.6

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc-------hhHHHHHHHHHHHhcCC---CCCcccccceeeeCCeeEE
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-------QAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~i  152 (413)
                      ..+.||.|....||+.... +..++||.-.....       ....+...|+..|+.+.   -.++.+++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3567899999999998864 55689996542111       12333444666676653   247778888776  44688


Q ss_pred             EEEeccC--CChhhhc
Q 015076          153 VYEYVNN--GNLEQWL  166 (413)
Q Consensus       153 v~e~~~~--gsL~~~l  166 (413)
                      +||++++  ..+.+.+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            9999976  3454444

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.96  E-value=0.0044  Score=59.32  Aligned_cols=79  Identities=16%  Similarity=0.172  Sum_probs=49.7

Q ss_pred             EEeeeCceEEEEEEEcCC-CEEEEEEeec-------CCchhHHHHHHHHHHHhcCC--CC-CcccccceeeeCCeeEEEE
Q 015076           86 VIGEGGYGIVYYGLLEDN-SKVAVKNLLN-------NRGQAEREFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        86 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--hp-niv~~~~~~~~~~~~~iv~  154 (413)
                      .||.|....||++...++ +.|+||.-..       .-.-...+...|...|+...  .| .+.+++.  .++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            478999999999997654 5799995432       11233445556777787663  34 3444443  3445567999


Q ss_pred             EeccCC-Chhhhc
Q 015076          155 EYVNNG-NLEQWL  166 (413)
Q Consensus       155 e~~~~g-sL~~~l  166 (413)
                      |+++.. .|...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998553 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.95  E-value=0.0028  Score=55.92  Aligned_cols=117  Identities=17%  Similarity=0.155  Sum_probs=72.3

Q ss_pred             eCceEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCChhhhccC
Q 015076           90 GGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG  168 (413)
Q Consensus        90 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~  168 (413)
                      ++.++.-.+..+- ....+|++..-.-. ....|..+.+++++++  .|+++..-  +.-...++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3444444443332 23456666443323 3455677888888764  46666532  44556799999943111      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          169 DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       169 ~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                             ..    ..++..=+++|.-.|+. ..+.+|||-.|+||+-|..|.+||.|=+..
T Consensus       142 -------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                   11    11222224667788864 348999999999999999999999997653

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.93  E-value=0.0047  Score=58.54  Aligned_cols=29  Identities=28%  Similarity=0.347  Sum_probs=25.7

Q ss_pred             CceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       201 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999988 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.83  E-value=0.00055  Score=67.24  Aligned_cols=49  Identities=18%  Similarity=0.253  Sum_probs=38.8

Q ss_pred             HHHHHHHHHHhcCCCCCcccccceeeeC-CeeEEEEEeccCCChhhhccCC
Q 015076          120 REFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRMLVYEYVNNGNLEQWLHGD  169 (413)
Q Consensus       120 ~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~  169 (413)
                      ..+.-..++++.+.|+|...++++.... ....+|||++ +.+|++++..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            3455567788999999999999987654 4578899999 77999988654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.75  E-value=0.0075  Score=57.77  Aligned_cols=142  Identities=18%  Similarity=0.246  Sum_probs=76.9

Q ss_pred             cEEeeeCceEEEEEEEcC----CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.|..|-.-.+|++...+    +..|++|........ .-.-.+|..+++.+..-++ .++++++.. +   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence            445558888899887543    237888866543221 1122457777777754444 345555532 2   58999977


Q ss_pred             CChhhh-----------------ccCCCCCCC--CCCHHHHHHHHHHHH----------------------hhhchh---
Q 015076          160 GNLEQW-----------------LHGDVGPCS--PLTWEIRMNIILGTA----------------------KGLSYL---  195 (413)
Q Consensus       160 gsL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i~----------------------~aL~~L---  195 (413)
                      .+|..-                 +|.......  +-.+..+..+..++.                      .-+..+   
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            655320                 122111101  112333333322221                      111111   


Q ss_pred             h-h-ccCCceeeccCCCCcEEEcC-CCCceEEeccccee
Q 015076          196 H-E-GLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKL  231 (413)
Q Consensus       196 H-~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~  231 (413)
                      . . ..+.-++|+|+.+.|||+++ ++.++|+||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 1 11124799999999999975 46899999998754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.66  E-value=0.028  Score=53.70  Aligned_cols=72  Identities=17%  Similarity=0.081  Sum_probs=44.0

Q ss_pred             eCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--ccccc---c--eeeeCCeeEEEEEeccCCCh
Q 015076           90 GGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLL---G--YCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        90 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~---~--~~~~~~~~~iv~e~~~~gsL  162 (413)
                      +.-..||+....++..+++|...... .....+..|+..+..|....  ++...   +  +...++..+.++++++|..+
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            45567899888778889999664322 34556666777776663211  22211   1  12334567889999987643

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.60  E-value=0.0055  Score=58.03  Aligned_cols=103  Identities=18%  Similarity=0.201  Sum_probs=70.8

Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      .+.|++|++- |++|.-.        ....+.++..|+.+.+..++-|....  ..-|||+.-+||||+ .|++.|+||-
T Consensus       299 ~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            4557777765 5555432        24567888999999998888888764  789999999999999 8999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHH
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF  269 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl  269 (413)
                      +++.-.....      +.-..+--|-.+.| .-+..=+||-+
T Consensus       367 lsRl~~~q~~------isy~rldhp~lF~G-~dd~QFeIYrl  401 (488)
T COG5072         367 LSRLSYSQGI------ISYNRLDHPDLFNG-VDDYQFEIYRL  401 (488)
T ss_pred             eeecccCCce------eeccccCchhhhcC-ccceeeeHHHH
Confidence            9984322211      11222334555543 33556677654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.59  E-value=0.0063  Score=54.20  Aligned_cols=30  Identities=37%  Similarity=0.511  Sum_probs=21.4

Q ss_pred             ceeeccCCCCcEEE-cCCCCceEEeccccee
Q 015076          202 KVVHRDIKSSNILI-DKHWNPKVSDFGLAKL  231 (413)
Q Consensus       202 ~ivH~Dlkp~NIll-~~~~~~kl~DfG~a~~  231 (413)
                      .++|+|+.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57999999999999 8888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=96.56  E-value=0.011  Score=54.01  Aligned_cols=80  Identities=18%  Similarity=0.108  Sum_probs=54.7

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec-cCCC
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV-NNGN  161 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~-~~gs  161 (413)
                      ....+..|..+.|+.++..+|.++++|.......... +.. ....|+..+-...|++++.-.  ..-.+++|++ ++.+
T Consensus         6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E~~-g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-EAR-GEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRS   81 (253)
T ss_pred             cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-hhh-HHhHhheeCCCCceeeecccc--ccchhhhhhccCCCc
Confidence            3345677999999999988899999997654432211 111 124477777788899987643  3457889998 5557


Q ss_pred             hhhhc
Q 015076          162 LEQWL  166 (413)
Q Consensus       162 L~~~l  166 (413)
                      |.++.
T Consensus        82 L~~~~   86 (253)
T PF04655_consen   82 LASLP   86 (253)
T ss_pred             hhhcc
Confidence            76655

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.36  E-value=0.0095  Score=57.79  Aligned_cols=81  Identities=19%  Similarity=0.165  Sum_probs=52.1

Q ss_pred             ccEEeeeCceEEEEEEEcC-CCEEEEEEeec------CCchhHHHHHHHHHHHhcCC--CC-CcccccceeeeCCeeEEE
Q 015076           84 DKVIGEGGYGIVYYGLLED-NSKVAVKNLLN------NRGQAEREFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--hp-niv~~~~~~~~~~~~~iv  153 (413)
                      .+.||.|.-..||++...+ ++.|+||.-..      ...-...+...|...|+.+.  .| .+.+++.  .++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            4578999999999998743 56799985432      12334556667888888763  35 3444543  344556789


Q ss_pred             EEeccCC-Chhhhc
Q 015076          154 YEYVNNG-NLEQWL  166 (413)
Q Consensus       154 ~e~~~~g-sL~~~l  166 (413)
                      ||+++.. .|...|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9988542 344444

>PRK06148 hypothetical protein; Provisional

Probab=96.27  E-value=0.036  Score=61.07  Aligned_cols=144  Identities=17%  Similarity=0.230  Sum_probs=77.8

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-------CCCCcccccc-----eeee-CC--e
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-------RHKNLVRLLG-----YCAE-GA--H  149 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~hpniv~~~~-----~~~~-~~--~  149 (413)
                      +.|+ |..-.+|+....++..+++|+.....  ....+..|...|..|       .-|.+++..+     .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 45577898887778889999876543  223333444555433       2334443321     1111 12  5


Q ss_pred             eEEEEEeccCCChhhhcc---------------------CC--CCCCCCCCHHH-----------------HHHHHHHHH
Q 015076          150 RMLVYEYVNNGNLEQWLH---------------------GD--VGPCSPLTWEI-----------------RMNIILGTA  189 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~---------------------~~--~~~~~~l~~~~-----------------~~~i~~~i~  189 (413)
                      .+.+++|++|..+.+...                     ..  ......+.|..                 ...++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            677999999977755210                     00  00001122211                 112222222


Q ss_pred             hhhch----hhhccCCceeeccCCCCcEEEcCCC--Cce-EEeccccee
Q 015076          190 KGLSY----LHEGLEPKVVHRDIKSSNILIDKHW--NPK-VSDFGLAKL  231 (413)
Q Consensus       190 ~aL~~----LH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~DfG~a~~  231 (413)
                      ..+.-    .-...+.++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22211    1112345899999999999999875  554 999998764

>PTZ00384 choline kinase; Provisional

Probab=96.15  E-value=0.033  Score=54.33  Aligned_cols=76  Identities=16%  Similarity=0.276  Sum_probs=44.3

Q ss_pred             cccEEeeeCceEEEEEEEcCC--CE-----EEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEE
Q 015076           83 DDKVIGEGGYGIVYYGLLEDN--SK-----VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~  154 (413)
                      ..+.|..|-...+|++...++  ..     |.++. ........-.-..|+++++.+...++ .++++.+..    +++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            344566688899999975432  22     33332 11111111122458888888865544 445555543    6999


Q ss_pred             EeccCCChh
Q 015076          155 EYVNNGNLE  163 (413)
Q Consensus       155 e~~~~gsL~  163 (413)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.23  E-value=0.23  Score=44.43  Aligned_cols=76  Identities=17%  Similarity=0.232  Sum_probs=50.4

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC---CCCCcccccceeeeCCeeEEEEEeccCC
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYVNNG  160 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~~iv~e~~~~g  160 (413)
                      .+.+.-|.--..|...+ +..++.+|.-   .......|..|+.-|+.|   +.-+|.+++.+..+.++.|+||||++-+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            34455455445554444 3556788842   233345677777766666   3456788888888999999999999886


Q ss_pred             Chh
Q 015076          161 NLE  163 (413)
Q Consensus       161 sL~  163 (413)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	413
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-55
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-47
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-25
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-06
3soa_A	444	Full-Length Human Camkii Length = 444		7e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 179/300 (59%), Gaps = 4/300 (1%)
Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ FS+                  D + VAVK L   R Q
Sbjct: 18  PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ 76
Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 77  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--EEVNL 294
            ++   V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R    ++V L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  211 bits (537), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 111/300 (37%), Positives = 176/300 (58%), Gaps = 4/300 (1%)
Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ F +                  D   VAVK L   R Q
Sbjct: 10  PEV-HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ 68
Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--EEVNL 294
            ++   V G  G++APEY STG  +E++DV+ +G++++E+I+G+   D +R    ++V L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 71  LRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           L +LE +TN F                    D +KVA+K       Q   EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             RH +LV L+G+C E    +L+Y+Y+ NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE--SSYITTRVMGTFG 248
           GL YLH      ++HRD+KS NIL+D+++ PK++DFG++K  G+E   +++   V GT G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVVKGTLG 206
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y+ PEY   G L E+SDVYSFG+++ EV+  R  +  S P E VNL EW  +   N   E
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++DP L +K     L++    A++C+  +++ RP MG V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 107/285 (37%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 71  LRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRGQAEREFKVEVEAIG 130
           L +LE +TN F                    D +KVA+K       Q   EF+ E+E + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
             RH +LV L+G+C E    +L+Y+Y+ NGNL++ L+G   P   ++WE R+ I +G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE--SSYITTRVMGTFG 248
           GL YLH      ++HRD+KS NIL+D+++ PK++DFG++K  G+E   +++   V GT G
Sbjct: 151 GLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVVKGTLG 206
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           Y+ PEY   G L E+SDVYSFG+++ EV+  R  +  S P E VNL EW  +   N   E
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++DP L +K     L++    A++C+  +++ RP MG V+  LE
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 150/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 113 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 168
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE    + + +R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 169 AFTAKISDFGLAR--ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 225
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 226 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 283
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 284 LHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 149/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 113 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 168
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE    + +  R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 169 AFTAKISDFGLAR--ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 225
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 226 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 283
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 284 LHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 148/259 (57%), Gaps = 16/259 (6%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W +R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 107 PNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 162
Query: 218 HWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
            +  K+SDFGLA+   SE      +  R++GT  Y+APE A  G +  +SD+YSFG++++
Sbjct: 163 AFTAKISDFGLAR--ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLL 219
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRC 334
           E+I+G   VD  R P+ + L    +     +  E  +D K+ +  ++  ++ +  VA +C
Sbjct: 220 EIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQC 277
Query: 335 VDPNAQKRPKMGHVVHMLE 353
           +     KRP +  V  +L+
Sbjct: 278 LHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/257 (33%), Positives = 142/257 (55%), Gaps = 12/257 (4%)
Query: 102 DNSKVAVKNLLN----NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           +N+ VAVK L         + +++F  E++   + +H+NLV LLG+ ++G    LVY Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            NG+L   L    G   PL+W  R  I  G A G+++LHE      +HRDIKS+NIL+D+
Sbjct: 104 PNGSLLDRLSCLDGT-PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDE 159
Query: 218 HWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            +  K+SDFGLA+     +  +  +R++GT  Y APE A  G +  +SD+YSFG++++E+
Sbjct: 160 AFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEI 218
Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
           I+G   VD  R P+ + L    +     +  E  +D K  +  ++  ++    VA +C+ 
Sbjct: 219 ITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLH 276
Query: 337 PNAQKRPKMGHVVHMLE 353
               KRP +  V  +L+
Sbjct: 277 EKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 70/182 (38%), Positives = 107/182 (58%), Gaps = 7/182 (3%)
Query: 104 SKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           S VAVK L+     AER  EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + LH   G    L    R+++    AKG++YLH    P +VHRD+KS N+L+DK +  
Sbjct: 121 LYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTV 178
Query: 222 KVSDFGLAKLLGSESSYITTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           KV DFGL++L    S ++ ++   GT  ++APE       NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 281 IP 282
            P
Sbjct: 237 QP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 69/182 (37%), Positives = 109/182 (59%), Gaps = 7/182 (3%)
Query: 104 SKVAVKNLLNNRGQAER--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           S VAVK L+     AER  EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + LH   G    L    R+++    AKG++YLH    P +VHR++KS N+L+DK +  
Sbjct: 121 LYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTV 178
Query: 222 KVSDFGLAKLLGSESSYITTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           KV DFGL++L    S++++++   GT  ++APE       NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 281 IP 282
            P
Sbjct: 237 QP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 96/185 (51%), Gaps = 14/185 (7%)
Query: 103 NSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           N KVA+K +      + +  + F+ EV    ++ H+N+V ++    E     LV EY+  
Sbjct: 36  NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             L +++  HG      PL+ +  +N       G+ + H+    ++VHRDIK  NILID 
Sbjct: 96  PTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDS 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
           +   K+ DFG+AK L   S   T  V+GT  Y +PE A     +E +D+YS GI++ E++
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 278 SGRIP 282
            G  P
Sbjct: 207 VGEPP 211

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 28  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 87  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 140
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
Query: 281 IPVD 284
           IP +
Sbjct: 201 IPYE 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 17/240 (7%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 30  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 89  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVI 142
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202
Query: 281 IPVDYSRPPEEVNLIE----WLKKMVTNRNPEGVLDPKLPEKP-----TSRLLKRILLVA 331
           IP +     E V  I       K  + + +   +++    E+P      SRLL+++  +A
Sbjct: 203 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIA 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 30  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 88
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 89  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 142
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202
Query: 281 IPVD 284
           IP +
Sbjct: 203 IPYE 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 33  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 92  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 145
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 146 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205
Query: 281 IPVD 284
           IP +
Sbjct: 206 IPYE 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 98/184 (53%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV+E++ +G 
Sbjct: 50  NKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 108
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 109 LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 162
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 163 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222
Query: 281 IPVD 284
           IP +
Sbjct: 223 IPYE 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 8/184 (4%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +  KVA+K +      +E +F  E E + ++ H  LV+L G C E A   LV E++ +G 
Sbjct: 31  NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L    G  +    E  + + L   +G++YL E     V+HRD+ + N L+ ++   
Sbjct: 90  LSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 143
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFG+ + +  +    +T       + +PE  S    + +SDV+SFG+L+ EV S G+
Sbjct: 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203
Query: 281 IPVD 284
           IP +
Sbjct: 204 IPYE 207

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DFGL++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 126/251 (50%), Gaps = 24/251 (9%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G  ++    M++ EY+ NG L++
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  S L     + ++ G A G+ YL        VHRD+ + NIL++ +   KVS
Sbjct: 136 FLREKDGEFSVLQL---VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T+       + APE  S       SDV+SFGI++ EV++    
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  E +K +      +G   P   + P++     I  + ++C      +R
Sbjct: 248 ---ERPYWELSNHEVMKAI-----NDGFRLPTPMDCPSA-----IYQLMMQCWQQERARR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFADIVSILD 305

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DFG ++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 131/266 (49%), Gaps = 39/266 (14%)
Query: 102 DNSKVAVKNLL--NNRGQAE-----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           D S VA+K+L+  ++ G+ E     +EF+ EV  +  + H N+V+L G       RM V 
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VM 100
Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           E+V  G+L    H  +    P+ W +++ ++L  A G+ Y+ +   P +VHRD++S NI 
Sbjct: 101 EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIF 156
Query: 215 I-----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVY 267
           +     +     KV+DF L++    +S +  + ++G F ++APE   A      E++D Y
Sbjct: 157 LQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 268 SFGILIMEVISGRIPVD-YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           SF +++  +++G  P D YS          + K    N   E  L P +PE    RL   
Sbjct: 213 SFAMILYTILTGEGPFDEYS----------YGKIKFINMIREEGLRPTIPEDCPPRLRNV 262
Query: 327 ILLVALRCVDPNAQKRPKMGHVVHML 352
           I L    C   + +KRP   ++V  L
Sbjct: 263 IEL----CWSGDPKKRPHFSYIVKEL 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 118/263 (44%), Gaps = 35/263 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           + +K L+    + +R F  EV+ +  + H N+++ +G   +      + EY+  G L   
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD 225
           +       S   W  R++     A G++YLH      ++HRD+ S N L+ ++ N  V+D
Sbjct: 98  IKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD 151
Query: 226 FGLAKLLGSESSY-------------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           FGLA+L+  E +                  V+G   ++APE  +    +E+ DV+SFGI+
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVA 331
           + E+I GR+  D    P  ++            N  G LD   P   P S        + 
Sbjct: 212 LCEII-GRVNADPDYLPRTMDF---------GLNVRGFLDRYCPPNCPPS-----FFPIT 256
Query: 332 LRCVDPNAQKRPKMGHVVHMLEA 354
           +RC D + +KRP    + H LE 
Sbjct: 257 VRCCDLDPEKRPSFVKLEHWLET 279

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY+N G+L
Sbjct: 39  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M+  +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 152 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 210 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 253
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 254 EERPTFEYLQAFLE 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 96/176 (54%), Gaps = 9/176 (5%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G    G   M+V EY+ NG+L+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G   G+ YL    +   VHRD+ + N+L+D +   KVS
Sbjct: 140 FLRTHDGQFTIMQL---VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL+++L    +++Y TT       + APE  +    +  SDV+SFG+++ EV++
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 47  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 104
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 105 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 160 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 218 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 277
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 278 FTATEGQYQPQP 289

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY+N G+L
Sbjct: 39  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M+  +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 152 VADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 210 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 253
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 254 EERPTFEYLQAFLE 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 43  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 101 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 156 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 214 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 274 FTATEGQYQPQP 285

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 45  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 102
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 103 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 157
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 158 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 215
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 216 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 275
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 276 FTATEGQYQPQP 287

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 268 FTATEGQYQPQP 279

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 46  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 103
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 104 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 158
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 159 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 217 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 276
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 277 FTATEGQFQPQP 288

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 41  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 100
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 101 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 156
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 157 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 216
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 217 FGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 47  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 106
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 107 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 162
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 163 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 222
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 223 FGVVLWEIFT 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           S VA+K L     + +R EF  E   +G+  H N++RL G        M++ E++ NG L
Sbjct: 43  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           + +L  + G  + +     + ++ G A G+ YL E      VHRD+ + NIL++ +   K
Sbjct: 103 DSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCK 156
Query: 223 VSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           VSDFGL++ L   SS  T T  +G      + APE  +       SD +S+GI++ EV+S
Sbjct: 157 VSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216
Query: 279 -GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
            G  P       + +N IE   ++           P  P+ PTS  L +++   L C   
Sbjct: 217 FGERPYWDMSNQDVINAIEQDYRL-----------PPPPDCPTS--LHQLM---LDCWQK 260
Query: 338 NAQKRPKMGHVVHMLE 353
           +   RP+   VV  L+
Sbjct: 261 DRNARPRFPQVVSALD 276

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           S VA+K L     + +R EF  E   +G+  H N++RL G        M++ E++ NG L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           + +L  + G  + +     + ++ G A G+ YL E      VHRD+ + NIL++ +   K
Sbjct: 105 DSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCK 158
Query: 223 VSDFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           VSDFGL++ L   SS  T T  +G      + APE  +       SD +S+GI++ EV+S
Sbjct: 159 VSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218
Query: 279 -GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
            G  P       + +N IE   ++           P  P+ PTS  L +++   L C   
Sbjct: 219 FGERPYWDMSNQDVINAIEQDYRL-----------PPPPDCPTS--LHQLM---LDCWQK 262
Query: 338 NAQKRPKMGHVVHMLE 353
           +   RP+   VV  L+
Sbjct: 263 DRNARPRFPQVVSALD 278

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLD------PKLPE-KPTSRLLKRILLVA 331
           RIP      PE +  +E   +MV   N PE +         + PE +PT   L+ +L   
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 332 LRCVDPNAQKRP 343
               +   Q +P
Sbjct: 268 FTATEGQYQPQP 279

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 17/190 (8%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L      A ++F+ E E +  ++H+++VR  G C EG   ++V+EY+ +G+
Sbjct: 70  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 162 LEQWL--HG----------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG          DV P  PL     + +    A G+ YL  GL    VHRD+ 
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLA 185
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+ +    K+ DFG+++ + S   Y +  R M    ++ PE          SDV+S
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 269 FGILIMEVIS 278
           FG+++ E+ +
Sbjct: 246 FGVVLWEIFT 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 43  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 101 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 156 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 214 RIPYPGMTNPEVIQNLERGYRMVRPDN 240

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 42  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 100 VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 155 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 213 RIPYPGMTNPEVIQNLERGYRMVRPDN 239

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E    +++ EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E    +++ EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 33  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 91  LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 146 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 203
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 204 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 247
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 248 EERPTFEYLQAFLE 261

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 39  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 97  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 152 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 210 RIPYPGMTNPEVIQNLERGYRMVRPDN 236

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 32  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 89
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 90  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 144
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 145 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 202
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 203 RIPYPGMTNPEVIQNLERGYRMVRPDN 229

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K +     ++ER+ F VE+  + RV H N+V+L G C       LV EY   G+L  
Sbjct: 34  VAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYN 88
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KV 223
            LHG   P    T    M+  L  ++G++YLH      ++HRD+K  N+L+       K+
Sbjct: 89  VLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFG A  + +      T   G+  ++APE       +E+ DV+S+GI++ EVI+ R P 
Sbjct: 148 CDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 284 DY---------------SRPPEEVNL---IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
           D                +RPP   NL   IE L     +++P         ++P+   + 
Sbjct: 204 DEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPS--------QRPSMEEIV 255
Query: 326 RILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYR 371
           +I+   +R   P A + P      H L   E    EP   F + YR
Sbjct: 256 KIMTHLMRYF-PGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEFYR 299

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 31  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 88
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 89  LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 143
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 144 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 201
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 202 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 245
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 246 EERPTFEYLQAFLE 259

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 128/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 38  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 95
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 96  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 150
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 151 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 208
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 209 RIPYPGMTNPEVIQNLERGYRMVRPDN 235

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K +     ++ER+ F VE+  + RV H N+V+L G C       LV EY   G+L  
Sbjct: 35  VAIKQI---ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYN 89
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KV 223
            LHG   P    T    M+  L  ++G++YLH      ++HRD+K  N+L+       K+
Sbjct: 90  VLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 148
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFG A  + +      T   G+  ++APE       +E+ DV+S+GI++ EVI+ R P 
Sbjct: 149 CDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 204
Query: 284 DY---------------SRPPEEVNL---IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
           D                +RPP   NL   IE L     +++P         ++P+   + 
Sbjct: 205 DEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPS--------QRPSMEEIV 256
Query: 326 RILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYR 371
           +I+   +R   P A + P      H L   E    EP   F + YR
Sbjct: 257 KIMTHLMRYF-PGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEFYR 300

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 37  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 94
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HRD++++NIL+    + K
Sbjct: 95  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 150 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 208 RIPYPGMTNPEVIQNLERGYRMVRPDN 234

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 291 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 403
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 404 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 462 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 505
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 506 EERPTFEYLQAFLE 519

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   + +R +F  E   +G+  H N++ L G   +    M++ E++ NG+L+ 
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G A G+ YL +      VHRD+ + NIL++ +   KVS
Sbjct: 124 FLRQNDGQFTVIQL---VGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVS 177
Query: 225 DFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           DFGL++ L  ++S  T T  +G      + APE          SDV+S+GI++ EV+S G
Sbjct: 178 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 237
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P       + +N IE               D +LP  P       +  + L C   + 
Sbjct: 238 ERPYWDMTNQDVINAIEQ--------------DYRLP--PPMDCPSALHQLMLDCWQKDR 281
Query: 340 QKRPKMGHVVHMLE 353
             RPK G +V+ L+
Sbjct: 282 NHRPKFGQIVNTLD 295

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 119/251 (47%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++ L G   +    M+V EY+ NG+L+ 
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G + G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 113 FLKKNDGQFTVIQL---VGMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVS 166
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + APE  +       SDV+S+GI++ EV+S    
Sbjct: 167 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS---- 222
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             Y   P      E   + V     EG   P   + P +     +  + L C       R
Sbjct: 223 --YGERP----YWEMTNQDVIKAVEEGYRLPSPMDCPAA-----LYQLMLDCWQKERNSR 271
Query: 343 PKMGHVVHMLE 353
           PK   +V+ML+
Sbjct: 272 PKFDEIVNMLD 282

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 9/176 (5%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     + +R +F  E   +G+  H N++RL G    G   M+V EY+ NG+L+ 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G   G+ YL    +   VHRD+ + N+L+D +   KVS
Sbjct: 140 FLRTHDGQFTIMQL---VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 225 DFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL+++L  +     T   G     + APE  +    +  SDV+SFG+++ EV++
Sbjct: 194 DFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 32  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-XIVTEYMSKGSL 89
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 90  LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 144
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 145 VADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 202
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 203 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 246
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 247 EERPTFEYLQAFLE 260

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 42  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 99
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD+ ++NIL+ ++   K
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLAAANILVGENLVCK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 155 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 212
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 213 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 256
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 257 EERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 35  TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 92
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 93  LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHRDLRAANILVGENLVCK 147
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 148 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 205
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 206 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 249
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 250 EERPTFEYLQAFLE 263

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 126/254 (49%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 208 TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSL 265
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G+ G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHRDLRAANILVGENLVCK 320
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 321 VADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C     
Sbjct: 379 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKEP 422
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 423 EERPTFEYLQAFLE 436

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
            ++VA+K L       E  F  E + + ++RH+ LV+L    +E     +V EY++ G+L
Sbjct: 209 TTRVAIKTLKPGNMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 266
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L G++G    L   + M   +  A G++Y+        VHRD++++NIL+ ++   K
Sbjct: 267 LDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHRDLRAANILVGENLVCK 321
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           V+DFGL +L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+ + G
Sbjct: 322 VADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 379
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           R+P      P  VN      + V ++   G   P  PE P S     +  +  +C   + 
Sbjct: 380 RVPY-----PGMVN------REVLDQVERGYRMPCPPECPES-----LHDLMCQCWRKDP 423
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++   LE
Sbjct: 424 EERPTFEYLQAFLE 437

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 94/176 (53%), Gaps = 20/176 (11%)
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           Q     + E +    ++H N++ L G C +  +  LV E+   G L + L G   P    
Sbjct: 48  QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--- 104
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--------KVSDFGL 228
             +I +N  +  A+G++YLH+     ++HRD+KSSNILI +            K++DFGL
Sbjct: 105 --DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162
Query: 229 AKLLGSESSYITTRV--MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A+       + TT++   G + ++APE     M ++ SDV+S+G+L+ E+++G +P
Sbjct: 163 AR-----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGLA++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 12/207 (5%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK+L      +   F  E   + +++H+ LVRL     +     ++ EY+ NG+L
Sbjct: 33  HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    LT    +++    A+G++++ E      +HR+++++NIL+    + K
Sbjct: 91  VDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANILVSDTLSCK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ G
Sbjct: 146 IADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 203
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           RIP      PE +  +E   +MV   N
Sbjct: 204 RIPYPGMTNPEVIQNLERGYRMVRPDN 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 120 FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVS 173
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 174 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 233
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 234 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 277
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 278 RPKFGQIVNMLD 289

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 127/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 95
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 96  HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 147
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 148 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 207
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 208 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 256
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 257 KRDERPSFPRILAEIE 272

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     +A+  E   E + + ++ +  +VRL+G C   A  MLV E    G L +
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 98
Query: 165 WLHG--DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +L G  +  P S +       ++   + G+ YL E      VHRD+ + N+L+      K
Sbjct: 99  FLVGKREEIPVSNVA-----ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAK 150
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +SDFGL+K LG++ SY T R  G +   + APE  +    + RSDV+S+G+ + E +S G
Sbjct: 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 280 RIPVDYSRPPEEVNLIEWLKKM 301
           + P    + PE +  IE  K+M
Sbjct: 211 QKPYKKMKGPEVMAFIEQGKRM 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 99  FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVS 152
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 153 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 212
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 213 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 256
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 257 RPKFGQIVNMLD 268

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +  R+F  E   +G+  H N++ L G   +    M++ EY+ NG+L+ 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G   G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 105 FLRKNDGRFTVIQL---VGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVS 158
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFG++++L    E++Y T        + APE  +       SDV+S+GI++ EV+S G  
Sbjct: 159 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 218
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P       + +  IE           EG   P   + P +  L +++   L C       
Sbjct: 219 PYWDMSNQDVIKAIE-----------EGYRLPPPMDCPIA--LHQLM---LDCWQKERSD 262
Query: 342 RPKMGHVVHMLE 353
           RPK G +V+ML+
Sbjct: 263 RPKFGQIVNMLD 274

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 134 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 187
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 188 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 245
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 246 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 292
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 293 PKFEQIVSILD 303

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 107 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 160
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 218
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 219 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 265
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 266 PKFEQIVSILD 276

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 122/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 28/254 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 212 HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 269
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 270 LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 324
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 325 IADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           RIP      PE +  +E   +M    N         PE+        +  + +RC     
Sbjct: 383 RIPYPGMSNPEVIRALERGYRMPRPEN--------CPEE--------LYNIMMRCWKNRP 426
Query: 340 QKRPKMGHVVHMLE 353
           ++RP   ++  +L+
Sbjct: 427 EERPTFEYIQSVLD 440

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 121/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL ++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V EY+ NG+L+ 
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL    +   VHRD+ + NILI+ +   KVS
Sbjct: 124 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVS 177
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 178 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 233
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 234 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 281
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 282 RPKFEQIVSILD 293

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L     +A+  E   E + + ++ +  +VRL+G C   A  MLV E    G L +
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 424
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L   VG    +       ++   + G+ YL E      VHR++ + N+L+      K+S
Sbjct: 425 FL---VGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKIS 478
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL+K LG++ SY T R  G +   + APE  +    + RSDV+S+G+ + E +S G+ 
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 282 PVDYSRPPEEVNLIEWLKKM 301
           P    + PE +  IE  K+M
Sbjct: 539 PYKKMKGPEVMAFIEQGKRM 558

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 28/254 (11%)
Query: 106 VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   + +R +F  E   +G+  H N++ L G   +    M++ E++ NG+L+ 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  + G  + +     + ++ G A G+ YL    +   VHR + + NIL++ +   KVS
Sbjct: 98  FLRQNDGQFTVIQL---VGMLRGIAAGMKYLA---DMNYVHRALAARNILVNSNLVCKVS 151
Query: 225 DFGLAKLLGSESSYIT-TRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           DFGL++ L  ++S  T T  +G      + APE          SDV+S+GI++ EV+S G
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 211
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P       + +N IE               D +LP  P       +  + L C   + 
Sbjct: 212 ERPYWDMTNQDVINAIE--------------QDYRLP--PPMDCPSALHQLMLDCWQKDR 255
Query: 340 QKRPKMGHVVHMLE 353
             RPK G +V+ L+
Sbjct: 256 NHRPKFGQIVNTLD 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 125/258 (48%), Gaps = 30/258 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 39  HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 96
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 97  LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 151
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 152 IADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 209
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
           RIP      PE +  +E   +M    N PE + +                 + +RC    
Sbjct: 210 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYN-----------------IMMRCWKNR 252
Query: 339 AQKRPKMGHVVHMLEAQE 356
            ++RP   ++  +L+  E
Sbjct: 253 PEERPTFEYIQSVLDDFE 270

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 39/285 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGD 388
               +                +F+  ++ S  ++ +EK++ + G+
Sbjct: 256 SFAEI--------------HQAFETMFQESSISDEVEKELGKRGE 286

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YKELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY +      +V ++    +L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 107
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 108 HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 220 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 268
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 269 KRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 126/256 (49%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 107
Query: 164 QWLHGDVGPCSPLTWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH      S   +E++  ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 108 HHLH-----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE      +   + +SDVY+FGI++ E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +IE + +        G L P L  K  S   KR+  +   C+  
Sbjct: 220 TGQLP--YSNINNRDQIIEMVGR--------GSLSPDL-SKVRSNCPKRMKRLMAECLKK 268
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 269 KRDERPSFPRILAEIE 284

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 9/176 (5%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N+V L G    G   M+V E++ NG L+ 
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L    G  + +     + ++ G A G+ YL    +   VHRD+ + NIL++ +   KVS
Sbjct: 134 FLRKHDGQFTVIQL---VGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVS 187
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL++++    E+ Y TT       + APE          SDV+S+GI++ EV+S
Sbjct: 188 DFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 39/285 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGD 388
               +                +F+  ++ S  ++ +EK++ + G+
Sbjct: 256 SFAEI--------------HQAFETMFQESSISDEVEKELGKRGE 286

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 117/256 (45%), Gaps = 27/256 (10%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 97
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 98  LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPV 283
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 152 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
               P +   L+E   +M     PEG      PEK        +  +   C   N   RP
Sbjct: 212 PGIDPSQVYELLEKDYRM---ERPEGC-----PEK--------VYELMRACWQWNPSDRP 255
Query: 344 KMGHVVHMLEA--QES 357
               +    E   QES
Sbjct: 256 SFAEIHQAFETMFQES 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 65  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 121
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 122 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 177 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 234 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 56  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 113 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 168 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 225 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/183 (33%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N+KVA+K L       E  F  E + + +++H  LV+L    +E     +V EY+N G+L
Sbjct: 33  NTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSL 90
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L    G    L   + M      A G++Y+        +HRD++S+NIL+      K
Sbjct: 91  LDFLKDGEGRALKLPNLVDMAA--QVAAGMAYIERM---NYIHRDLRSANILVGNGLICK 145
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA+L+  E +  T R    F   + APE A  G    +SDV+SFGIL+ E+++ G
Sbjct: 146 IADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 203
Query: 280 RIP 282
           R+P
Sbjct: 204 RVP 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 122/272 (44%), Gaps = 30/272 (11%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  --YRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWS--CHAPSSRRTT-LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
            +   E    I  ++    +   EG  D        SRLLK            N  +RP 
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARD------LISRLLKH-----------NPSQRPM 251
Query: 345 MGHVVHMLEAQESPSKEPSNSFQDRYRASPKN 376
           +  V+       + SK PSNS Q++  AS ++
Sbjct: 252 LREVLEHPWITANSSK-PSNS-QNKESASKQS 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 101 LR----ECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 155 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 215 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 255
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 256 DRPSFAEIHQAFETMFQES 274

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESG 387
            RP    +                +F+  ++ S  ++ +EK++ + G
Sbjct: 260 DRPSFAEI--------------HQAFETMFQESSISDEVEKELGKQG 292

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 260 DRPSFAEIHQAFETMFQES 278

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 101 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 155 DFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 215 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 255
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 256 DRPSFAEIHQAFETMFQES 274

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 14/192 (7%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L +    A ++F  E E +  ++H+++V+  G C EG   ++V+EY+ +G+
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 162 LEQWL--HG-------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           L ++L  HG       +  P + LT    ++I    A G+ YL        VHRD+ + N
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
            L+ ++   K+ DFG+++ + S   Y +    M    ++ PE          SDV+S G+
Sbjct: 159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218
Query: 272 LIMEVIS-GRIP 282
           ++ E+ + G+ P
Sbjct: 219 VLWEIFTYGKQP 230

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESG 387
            RP    +                +F+  ++ S  ++ +EK++ + G
Sbjct: 260 DRPSFAEI--------------HQAFETMFQESSISDEVEKELGKRG 292

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESG 387
            RP    +                +F+  ++ S  ++ +EK++ + G
Sbjct: 255 DRPSFAEI--------------HQAFETMFQESSISDEVEKELGKRG 287

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 38  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 149
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 150 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 207 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESG 387
            RP    +                +F+  ++ S  ++ +EK++ + G
Sbjct: 255 DRPSFAEI--------------HQAFETMFQESSISDEVEKELGKRG 287

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 245
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 246 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 293
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 294 RPKFEQIVSILD 305

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 31/254 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA 354
            RP    +    E 
Sbjct: 260 DRPSFAEIHQAFET 273

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 36  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 92
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 93  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 147
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 148 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 205 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 45  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 104 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 218 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 258
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 259 DRPSFAEIHQAFETMFQES 277

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 54  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 112
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 113 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 166
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 167 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 227 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 267
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 268 DRPSFAEIHQAFETMFQES 286

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 43  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 --YRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 155 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 212 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 31/254 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 104
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 105 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 159 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 219 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 259
Query: 341 KRPKMGHVVHMLEA 354
            RP    +    E 
Sbjct: 260 DRPSFAEIHQAFET 273

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 102 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 156 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 216 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 256
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 257 DRPSFAEIHQAFETMFQES 275

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NILI      KV DFG+A+ +    + +  T  V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 24/251 (9%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 136 FLRKHDAQFTVIQL---VGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 189
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG-- 247
Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
               RP  E++  + +K +      EG   P   + P +     +  + L C   +   R
Sbjct: 248 ---ERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNNR 294
Query: 343 PKMGHVVHMLE 353
           PK   +V +L+
Sbjct: 295 PKFEQIVSILD 305

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 255 DRPSFAEIHQAFETMFQES 273

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 26/252 (10%)
Query: 106 VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +    +  R+F  E   +G+  H N++RL G   +    M+V E + NG+L+ 
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L       + +     + ++ G A G+ YL +      VHRD+ + NILI+ +   KVS
Sbjct: 107 FLRKHDAQFTVIQ---LVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVS 160
Query: 225 DFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGL+++L    E++Y T        + +PE  +       SDV+S+GI++ EV+S    
Sbjct: 161 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---- 216
Query: 283 VDYS-RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y  RP  E++  + +K +      EG   P   + P +     +  + L C   +   
Sbjct: 217 --YGERPYWEMSNQDVIKAV-----DEGYRLPPPMDCPAA-----LYQLMLDCWQKDRNN 264
Query: 342 RPKMGHVVHMLE 353
           RPK   +V +L+
Sbjct: 265 RPKFEQIVSILD 276

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 31/253 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 100 LR----ECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 214 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 254
Query: 341 KRPKMGHVVHMLE 353
            RP    +    E
Sbjct: 255 DRPSFAEIHQAFE 267

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 102 DNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVRHKNLVRLL----GYCAEGAHRM 151
           D+  VAVK L   R    R+      F+ E +    + H  +V +          G    
Sbjct: 36  DHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 41  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 152
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           +FG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 153 NFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 210 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 101 --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S      T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---TXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 40  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 95
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 96  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS   T + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 152 DFGWS--VHAPSSRRDT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 43  KVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+  +   K++
Sbjct: 99  -VYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G  P +
Sbjct: 155 DFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
                E    I  ++    +   EG  D        SRLLK
Sbjct: 212 AHTYQETYRRISRVEFTFPDFVTEGARD------LISRLLK 246

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 93/182 (51%), Gaps = 12/182 (6%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK ++     +E EF  E + + ++ H  LV+  G C++     +V EY++NG L  +
Sbjct: 35  VAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 166 L--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
           L  HG     S L     + +     +G+++L      + +HRD+ + N L+D+    KV
Sbjct: 94  LRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV 145
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           SDFG+ + +  +    +        + APE       + +SDV++FGIL+ EV S G++P
Sbjct: 146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
Query: 283 VD 284
            D
Sbjct: 206 YD 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 30/272 (11%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 -VYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS  TT + GT  Y+ PE       +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWS--VHAPSSRRTT-LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
            +   E    I  ++    +   EG  D        SRLLK            N  +RP 
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARD------LISRLLKH-----------NPSQRPX 255
Query: 345 MGHVVHMLEAQESPSKEPSNSFQDRYRASPKN 376
           +  V+       + SK PSN  Q++  AS ++
Sbjct: 256 LREVLEHPWITANSSK-PSNC-QNKESASKQS 285

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++KVAVK +       E  F  E   +  ++H  LV+L     +     ++ E++  G+L
Sbjct: 206 HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL 263
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L  D G   PL   I  +  +  A+G++++ +      +HRD++++NIL+      K
Sbjct: 264 LDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVSASLVCK 318
Query: 223 VSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           ++DFGLA            RV   F   + APE  + G    +SDV+SFGIL+ME+++ G
Sbjct: 319 IADFGLA------------RVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 366
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-PEGVLDPKL-------PEKPTSRLLKRILLVA 331
           RIP      PE +  +E   +M    N PE + +  +        E+PT   ++ +L   
Sbjct: 367 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426
Query: 332 LRCVDPNAQKRP 343
               +   Q++P
Sbjct: 427 YTATESQXQQQP 438

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G +  
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV-- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
             + ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 99  --YRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           +FG +  + + SS  TT + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 NFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 248 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HR++ + N L+ ++   KV+
Sbjct: 307 LR----ECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVA 360
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 361 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 421 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 461
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 462 DRPSFAEIHQAFETMFQES 480

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 93  IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 44  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE--- 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 100 -VYKELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 156 DFGWSVHAPSSRR---XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 213 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       ++ E++  GNL  +
Sbjct: 287 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 345
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HR++ + N L+ ++   KV+
Sbjct: 346 LR----ECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVA 399
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP- 282
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ + G  P 
Sbjct: 400 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459
Query: 283 --VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +D S+      + E L+K      PEG      PEK        +  +   C   N  
Sbjct: 460 PGIDLSQ------VYELLEKDYRMERPEGC-----PEK--------VYELMRACWQWNPS 500
Query: 341 KRPKMGHVVHMLEA--QES 357
            RP    +    E   QES
Sbjct: 501 DRPSFAEIHQAFETMFQES 519

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +V EYV+   L   +H +     P+T +  + +I    + L++ H+     ++HRD+K +
Sbjct: 110 IVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 162
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSF 269
           NI+I      KV DFG+A+ +    + +T    V+GT  Y++PE A    ++ RSDVYS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 270 GILIMEVISGRIPVDYSRP 288
           G ++ EV++G  P     P
Sbjct: 223 GCVLYEVLTGEPPFTGDSP 241

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VAVK L  +  + E EF  E   +  ++H NLV+LLG C       +V EY+  GNL  +
Sbjct: 60  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDY 118
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L      C+    E+   ++L  A  +S   E LE K  +HRD+ + N L+ ++   KV+
Sbjct: 119 LR----ECNRE--EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVA 172
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           DFGL++L+  ++            + APE  +    + +SDV++FG+L+ E+ +
Sbjct: 173 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           V H  ++R+ G   +     ++ +Y+  G L   L       +P+       + L     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA---- 118
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      +++RD+K  NIL+DK+ + K++DFG AK +      +T  + GT  Y+A
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIA 171
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE  ST   N+  D +SFGILI E+++G  P 
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 33  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 92
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 93  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 145
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 252

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 41  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 97  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 152
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 153 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 210 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 95  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 147
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 208 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 65  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 120
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 121 -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 176
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS     + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 177 DFGWS--VHAPSSR-RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 234 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK +   R        K E+     + H+N+V+  G+  EG  + L  EY + G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +  D+G   P        ++ G      YLH G+   + HRDIK  N+L+D+  N K+S
Sbjct: 94  RIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GI--GITHRDIKPENLLLDERDNLKIS 146
Query: 225 DFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIP 282
           DFGLA +   +    +  ++ GT  YVAPE       + E  DV+S GI++  +++G +P
Sbjct: 147 DFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206
Query: 283 VD--------YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D        YS   E+   +   KK+  +  P  +L   L E P++R+
Sbjct: 207 WDQPSDSXQEYSDWKEKKTYLNPWKKI--DSAPLALLHKILVENPSARI 253

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 110
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 111 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 164
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 165 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 224
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 225 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 269
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 270 KCWHPKAEMRPSFSELVSRISA 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 111
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 112 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 165
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 166 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 225
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 226 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 270
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 271 KCWHPKAEMRPSFSELVSRISA 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 50  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 107
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 108 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 161
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 222 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 266
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 267 KCWHPKAEMRPSFSELVSRISA 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 112
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 113 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 166
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 167 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 227 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 271
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 272 KCWHPKAEMRPSFSELVSRISA 293

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 121/246 (49%), Gaps = 32/246 (13%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L    G +A  EF  E   +  + H +LVRLLG C     + LV + + +G L +
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 105
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++H    ++G    L W +++      AKG+ YL E    ++VHRD+ + N+L+    + 
Sbjct: 106 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 156
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL G E  Y          ++A E         +SDV+S+G+ I E+++ G
Sbjct: 157 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E           +G    +LP+ P   +   + +V ++C   +A
Sbjct: 217 GKPYDGIPTREIPDLLE-----------KG---ERLPQPPICTI--DVYMVMVKCWMIDA 260
Query: 340 QKRPKM 345
             RPK 
Sbjct: 261 DSRPKF 266

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 112
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 113 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 166
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 167 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 227 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 271
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 272 KCWHPKAEMRPSFSELVSRISA 293

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGN 161
            +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+
Sbjct: 35  GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 92
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    
Sbjct: 93  LVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVA 147
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR
Sbjct: 148 KVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203
Query: 281 IPVDYSRPP 289
           +P  Y R P
Sbjct: 204 VP--YPRIP 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 98/184 (53%), Gaps = 11/184 (5%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +++KVAVK L      + + F  E   +  ++H  LVRL           ++ EY+  G+
Sbjct: 36  NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L  D G    L   I  +  +  A+G++Y+        +HRD++++N+L+ +    
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE---RKNYIHRDLRAANVLVSESLMC 149
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS- 278
           K++DFGLA+++  E +  T R    F   + APE  + G    +SDV+SFGIL+ E+++ 
Sbjct: 150 KIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTY 207
Query: 279 GRIP 282
           G+IP
Sbjct: 208 GKIP 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     KV+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 39  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 94
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 95  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 150
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 151 DFGWSVHAPSSRR---AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 208 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---XXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 52  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 109
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 110 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 163
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 164 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 223
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 224 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 268
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 269 KCWHPKAEMRPSFSELVSRISA 290

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 74  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 131
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 132 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 185
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 186 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 245
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 246 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 290
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 291 KCWHPKAEMRPSFSELVSRISA 312

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 47  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 104
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 105 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 158
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L
Sbjct: 159 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 218
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 219 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 263
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 264 KCWHPKAEMRPSFSELVSRISA 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 106 VAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGN 161
            AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+
Sbjct: 79  CAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGD 136
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++D+ +  
Sbjct: 137 LRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTV 190
Query: 222 KVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           KV+DFGLA+ +  +  Y      G      ++A E   T     +SDV+SFG+L+ E+++
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
              P     P  +VN  +    ++  R    +L P+    P          V L+C  P 
Sbjct: 251 RGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPK 295
Query: 339 AQKRPKMGHVVHMLEA 354
           A+ RP    +V  + A
Sbjct: 296 AEMRPSFSELVSRISA 311

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           ++A+K +     +  +    E+     ++HKN+V+ LG  +E     +  E V  G+L  
Sbjct: 49  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108
Query: 165 WLHGDVGPC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP- 221
            L    GP   +  T       IL   +GL YLH+    ++VHRDIK  N+LI+ +    
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVL 162
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISG 279
           K+SDFG +K L   +   T    GT  Y+APE    G     + +D++S G  I+E+ +G
Sbjct: 163 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 280 RIPV-DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPN 338
           + P  +   P   +  +   K           + P++PE  ++     I    L+C +P+
Sbjct: 222 KPPFYELGEPQAAMFKVGMFK-----------VHPEIPESMSAEAKAFI----LKCFEPD 266
Query: 339 AQKR 342
             KR
Sbjct: 267 PDKR 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L    G +A  EF  E   +  + H +LVRLLG C     + LV + + +G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 128
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++H    ++G    L W +++      AKG+ YL E    ++VHRD+ + N+L+    + 
Sbjct: 129 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 179
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL G E  Y          ++A E         +SDV+S+G+ I E+++ G
Sbjct: 180 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 239
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E                 +LP+ P   +   + +V ++C   +A
Sbjct: 240 GKPYDGIPTREIPDLLE--------------KGERLPQPPICTI--DVYMVMVKCWMIDA 283
Query: 340 QKRPKM 345
             RPK 
Sbjct: 284 DSRPKF 289

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 43  KVLFKTQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 98
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+  +   K++
Sbjct: 99  -VYRELQKLSRFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +  + + SS   T + GT  Y+ PE     M +E+ D++S G+L  E + G  P +
Sbjct: 155 DFGWS--VHAPSSRRDT-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLK 325
                E    I  ++    +   EG  D        SRLLK
Sbjct: 212 AHTYQETYRRISRVEFTFPDFVTEGARD------LISRLLK 246

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 26/243 (10%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           ++A+K +     +  +    E+     ++HKN+V+ LG  +E     +  E V  G+L  
Sbjct: 35  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 94
Query: 165 WLHGDVGPC--SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP- 221
            L    GP   +  T       IL   +GL YLH+    ++VHRDIK  N+LI+ +    
Sbjct: 95  LLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVL 148
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISG 279
           K+SDFG +K L   +   T    GT  Y+APE    G     + +D++S G  I+E+ +G
Sbjct: 149 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           + P      P+       + K          + P++PE  ++     I    L+C +P+ 
Sbjct: 208 KPPFYELGEPQAAMFKVGMFK----------VHPEIPESMSAEAKAFI----LKCFEPDP 253
Query: 340 QKR 342
            KR
Sbjct: 254 DKR 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K  L   G  E + + EVE    +RH N++RL GY  +     L+ EY   G    
Sbjct: 42  KVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT--- 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            ++ ++   S    +     I   A  LSY H     +V+HRDIK  N+L+      K++
Sbjct: 98  -VYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 153
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +    S        + GT  Y+ PE     M +E+ D++S G+L  E + G+ P +
Sbjct: 154 DFGWSVHAPSSRR---DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
Query: 285 ---YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILL 329
              Y    + ++ +E+            ++   L   P+ R + R +L
Sbjct: 211 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/188 (34%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNL 162
           +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+L
Sbjct: 30  NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    K
Sbjct: 88  VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAK 142
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           VSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR+
Sbjct: 143 VSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 282 PVDYSRPP 289
           P  Y R P
Sbjct: 199 P--YPRIP 204

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 293 VLMWEIFT 300

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGN 161
            +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+
Sbjct: 44  GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    
Sbjct: 102 LVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVA 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR
Sbjct: 157 KVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212
Query: 281 IPVDYSRPP 289
           +P  Y R P
Sbjct: 213 VP--YPRIP 219

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGN 161
            +KVAVK + N+     + F  E   + ++RH NLV+LLG   E    + +V EY+  G+
Sbjct: 216 GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L       S L  +  +   L   + + YL EG     VHRD+ + N+L+ +    
Sbjct: 274 LVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVA 328
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           KVSDFGL K    E+S           + APE       + +SDV+SFGIL+ E+ S GR
Sbjct: 329 KVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384
Query: 281 IPVDYSRPP 289
           +P  Y R P
Sbjct: 385 VP--YPRIP 391

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +  +   +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTAR 173
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 234 VLMWEIFT 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 47/284 (16%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VAVK L      +ERE    E++ + ++  H+N+V LLG C       L++EY   G+L
Sbjct: 77  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 163 EQWLHGDVGPCSP-------------------LTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +L       S                    LT+E  +      AKG+ +L        
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSC 193
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGM 259
           VHRD+ + N+L+      K+ DFGLA+ + S+S+Y+   V G       ++APE    G+
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV---VRGNARLPVKWMAPESLFEGI 250
Query: 260 LNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
              +SDV+S+GIL+ E+ S G  P  Y   P + N  + ++       P           
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNP--YPGIPVDANFYKLIQNGFKMDQP----------- 297
Query: 319 PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEP 362
                 + I ++   C   +++KRP   ++   L  Q + ++E 
Sbjct: 298 --FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 239 VLMWEIFT 246

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 175
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 236 VLMWEIFT 243

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 DYLQAHAERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 31/266 (11%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D   VAVK L +    A ++F+ E E +  ++H+++V+  G C +G   ++V+EY+ +G+
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 162 LEQWL--HG-------DVGPCSP---LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L  HG       D  P      L     ++I    A G+ YL        VHRD+ 
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLA 160
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N L+  +   K+ DFG+++ + S   Y +    M    ++ PE          SDV+S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL 328
           FG+++ E+ +      Y + P       W  ++      E +   ++ E+P     K + 
Sbjct: 221 FGVILWEIFT------YGKQP-------WF-QLSNTEVIECITQGRVLERPRV-CPKEVY 265
Query: 329 LVALRCVDPNAQKRPKMGHVVHMLEA 354
            V L C     Q+R  +  +  +L A
Sbjct: 266 DVMLGCWQREPQQRLNIKEIYKILHA 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 30/255 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 63  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 120
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 121 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 223 VSDFGLAK-LLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +L  E   +  +        ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 175 VADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 235 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 279
Query: 340 QKRPKMGHVVHMLEA 354
           + RP    +V  + A
Sbjct: 280 EMRPSFSELVSRISA 294

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + + +    TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HR++ + NIL++     K+
Sbjct: 103 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRNLATRNILVENENRVKI 156
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +  Y   +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 214
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 215 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 260
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 261 -EIYMIMTECWNNNVNQRPSF 280

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + + +    TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   +++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 126/262 (48%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 111
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ YL      K VHRD+ + N ++
Sbjct: 112 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 165
Query: 216 DKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +  +   S +  T       ++A E   T     +SDV+SFG+L
Sbjct: 166 DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 225
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 226 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 270
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 271 KCWHPKAEMRPSFSELVSRISA 292

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 120 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 171
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 172 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 232 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 280
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 281 KRDERPLFPQILASIE 296

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 96
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 97  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 148
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 149 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 209 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 257
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 258 KRDERPLFPQILASIE 273

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 99/184 (53%), Gaps = 11/184 (5%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +++KVAVK L      + + F  E   +  ++H  LVRL     +     ++ E++  G+
Sbjct: 35  NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGS 93
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L  +L  D G    L   I  +  +  A+G++Y+        +HRD++++N+L+ +    
Sbjct: 94  LLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE---RKNYIHRDLRAANVLVSESLMC 148
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS- 278
           K++DFGLA+++  E +  T R    F   + APE  + G    +S+V+SFGIL+ E+++ 
Sbjct: 149 KIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTY 206
Query: 279 GRIP 282
           G+IP
Sbjct: 207 GKIP 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 118
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 119 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 170
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 171 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 231 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 279
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 280 KRDERPLFPQILASIE 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 162 LEQWLHGDVGP----C--------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    C          L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 162
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 223 FGVLLWEIFT 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 96
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 97  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 148
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 149 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 209 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 257
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 258 KRDERPLFPQILASIE 273

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY +      +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 93
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 94  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 145
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA +    S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 146 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 206 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 254
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 255 KRDERPLFPQILASIE 270

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 101 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 154
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 155 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M + R+
Sbjct: 214 --CDKSCSPSA----EFLRMMGSERD 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K  +   G  +R  + EV+   +++H +++ L  Y  +  +  LV E  +NG + +
Sbjct: 42  KMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNR 100
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L   V P S       M+ I+    G+ YLH      ++HRD+  SN+L+ ++ N K++
Sbjct: 101 YLKNRVKPFSENEARHFMHQII---TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA 154
Query: 225 DFGLAKLLG--SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           DFGLA  L    E  Y    + GT  Y++PE A+       SDV+S G +   ++ GR P
Sbjct: 155 DFGLATQLKMPHEKHYT---LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 283 VD 284
            D
Sbjct: 212 FD 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/108 (44%), Positives = 63/108 (58%), Gaps = 8/108 (7%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EI   I L T K L++L E L  K++HRDIK SNIL+D+  N K+ DFG++  L    S 
Sbjct: 125 EILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSI 180
Query: 239 ITTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRIP 282
             TR  G   Y+APE     AS    + RSDV+S GI + E+ +GR P
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E    K
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E SY+  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHGDVGP----C--------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    C          L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 101 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 154
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 212
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 213 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 258
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 259 -EIYMIMTECWNNNVNQRPSF 278

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++  Y + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 112
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++
Sbjct: 113 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCML 166
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L
Sbjct: 167 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 226
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 227 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 271
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 272 KCWHPKAEMRPSFSELVSRISA 293

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 133 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 186
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 244
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 245 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 290
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 291 -EIYMIMTECWNNNVNQRPSF 310

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 100 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 153
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 211
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 212 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 257
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 258 -EIYMIMTECWNNNVNQRPSF 277

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 107 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 160
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 218
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 219 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 264
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 265 -EIYMIMTECWNNNVNQRPSF 284

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 102 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 155
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 156 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M   R+
Sbjct: 215 --CDKSCSPSA----EFLRMMGCERD 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 30/255 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 63  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 120
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 121 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 174
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 175 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 234
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 235 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 279
Query: 340 QKRPKMGHVVHMLEA 354
           + RP    +V  + A
Sbjct: 280 EMRPSFSELVSRISA 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 106 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 159
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 217
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 218 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 263
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 264 -EIYMIMTECWNNNVNQRPSF 283

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 166
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 167 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 227 FGVLLWEIFT 236

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM---LVYEYVNNGNL 162
           VAVK L ++    +R+F+ E++ +  +    +V+  G  + G  R    LV EY+ +G L
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCL 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K
Sbjct: 114 RDFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167
Query: 223 VSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           ++DFGLAKLL  +  Y   R  G     + APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY- 226
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M   R+
Sbjct: 227 --CDKSCSPSA----EFLRMMGCERD 246

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 30/255 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 60  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 117
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 118 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 171
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 172 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 231
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 232 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 276
Query: 340 QKRPKMGHVVHMLEA 354
           + RP    +V  + A
Sbjct: 277 EMRPSFSELVSRISA 291

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 170
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 231 FGVLLWEIFT 240

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 60  DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 117
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++
Sbjct: 118 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCML 171
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L
Sbjct: 172 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 231
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 232 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 276
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 277 KCWHPKAEMRPSFSELVSRISA 298

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 108 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 161
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 219
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 220 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 265
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 266 -EIYMIMTECWNNNVNQRPSF 285

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 109 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 162
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 219
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 220 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 266
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 267 -EIYMIMTECWNNNVNQRPSF 286

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 30/255 (11%)
Query: 107 AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  Y+ +G+L
Sbjct: 62  AVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 119
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++D+ +  K
Sbjct: 120 RNFIRNETH--NPTVKDL-IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVK 173
Query: 223 VSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           V+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L+ E+++ 
Sbjct: 174 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 233
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P     P  +VN  +    ++  R    +L P+    P          V L+C  P A
Sbjct: 234 GAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VMLKCWHPKA 278
Query: 340 QKRPKMGHVVHMLEA 354
           + RP    +V  + A
Sbjct: 279 EMRPSFSELVSRISA 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 169
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 170 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 230 FGVLLWEIFT 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 32/262 (12%)
Query: 102 DNSKV--AVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYE 155
           D  K+  AVK+L  + + G+   +F  E   +    H N++ LLG C  +EG+  ++V  
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGS-PLVVLP 171
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           Y+ +G+L  ++  +    +P   ++ +   L  AKG+ +L      K VHRD+ + N ++
Sbjct: 172 YMKHGDLRNFIRNETH--NPTVKDL-IGFGLQVAKGMKFLAS---KKFVHRDLAARNCML 225
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           D+ +  KV+DFGLA+ +     +S +  T       ++A E   T     +SDV+SFG+L
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
           + E+++   P     P  +VN  +    ++  R    +L P+    P          V L
Sbjct: 286 LWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYCPDPLYE-------VML 330
Query: 333 RCVDPNAQKRPKMGHVVHMLEA 354
           +C  P A+ RP    +V  + A
Sbjct: 331 KCWHPKAEMRPSFSELVSRISA 352

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 102 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 155
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 213
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 214 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 259
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 260 -EIYMIMTECWNNNVNQRPSF 279

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 120 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 173
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 231 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 277
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 278 -EIYMIMTECWNNNVNQRPSF 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ EY+  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 120 DYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 173
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT-- 230
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 231 -YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 277
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 278 -EIYMIMTECWNNNVNQRPSF 297

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNLE 163
           VAVK L ++  +  R+F+ E+E +  ++H N+V+  G C     R   L+ E++  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
           ++L         +     +       KG+ YL      + +HRD+ + NIL++     K+
Sbjct: 105 EYLQKHKERIDHIKL---LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 158
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            DFGL K+L  +      +  G    F Y APE  +    +  SDV+SFG+++ E+ +  
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY- 216
Query: 281 IPVDYSR-PPEE---------------VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
             ++ S+ PP E                +LIE LK       P+G  D            
Sbjct: 217 --IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD------------ 262
Query: 325 KRILLVALRCVDPNAQKRPKM 345
             I ++   C + N  +RP  
Sbjct: 263 -EIYMIMTECWNNNVNQRPSF 282

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++  Y + GNL 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 164 QWLHG----------DVG--PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           ++L            D+   P   +T++  ++     A+G+ YL      K +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           N+L+ ++   K++DFGLA+ + +   Y  TT       ++APE     +   +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 271 ILIMEVIS 278
           +L+ E+ +
Sbjct: 247 VLMWEIFT 254

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 162 LEQWLHG------------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L                 P   L+ +  ++     A+G+ YL      K +HRD+ 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +     Y  TT       ++APE     +   +SDV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 279 FGVLLWEIFT 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 119
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 120 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 171
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 172 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 232 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 280
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 281 KRDERPLFPQILASIE 296

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 18/190 (9%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +KVAVK L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GN
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 162 LEQWLHGDVGPCSPLTWEIRMN------------IILGTAKGLSYLHEGLEPKVVHRDIK 209
           L ++L     P    ++    N                 A+G+ YL      K +HRD+ 
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 177
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYS 268
           + N+L+ +    K++DFGLA+ +   +    TT       ++APE     +   +SDV+S
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 269 FGILIMEVIS 278
           FG+L+ E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 111
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 112 HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 163
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 164 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 223
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS     +N  + +  MV      G L P L  K  S   K +  +   C+  
Sbjct: 224 TGQLP--YS----NINNRDQIIFMVG----RGYLSPDL-SKVRSNCPKAMKRLMAECLKK 272
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 273 KRDERPLFPQILASIE 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 28/256 (10%)
Query: 106 VAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK  N+     Q  + FK EV  + + RH N++  +GY  +     +V ++    +L 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLY 91
Query: 164 QWLHGDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             LH          +E+   ++I   TA+G+ YLH      ++HRD+KS+NI + +    
Sbjct: 92  HHLH-----IIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTV 143
Query: 222 KVSDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVI 277
           K+ DFGLA      S S+   ++ G+  ++APE       N    +SDVY+FGI++ E++
Sbjct: 144 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDP 337
           +G++P  YS       +I  + +        G L P L  K  S   K +  +   C+  
Sbjct: 204 TGQLP--YSNINNRDQIIFMVGR--------GYLSPDL-SKVRSNCPKAMKRLMAECLKK 252
Query: 338 NAQKRPKMGHVVHMLE 353
              +RP    ++  +E
Sbjct: 253 KRDERPLFPQILASIE 268

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   G    EF+ E     R++H N+V LLG   +     +++ Y ++G+L +
Sbjct: 59  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 118
Query: 165 WL-----HGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +L     H DVG         S L     ++++   A G+ YL       VVH+D+ + N
Sbjct: 119 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+    N K+SD GL + + +   Y +    +    ++APE    G  +  SD++S+G+
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 272 LIMEVIS 278
           ++ EV S
Sbjct: 236 VLWEVFS 242

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 104 SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L        + +F+ E   +    + N+V+LLG CA G    L++EY+  G+L
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 163 EQWL------------HGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
            ++L            H D+         GP  PL+   ++ I    A G++YL E    
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGP-PPLSCAEQLCIARQVAAGMAYLSER--- 193
Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-------ITTRVMGTFGYVAPEY 254
           K VHRD+ + N L+ ++   K++DFGL++ + S   Y       I  R      ++ PE 
Sbjct: 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPES 247
Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
                    SDV+++G+++ E+ S  +   Y    EEV
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+ +    + +   +  EY  NG L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HRD+K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D+YS GI+  E+I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRP 343
             V+   P    D K+  EK   RLL          +D +  KRP
Sbjct: 243 S-VSIEFPPDFDDNKMKVEKKIIRLL----------IDHDPNKRP 276

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L +   G    EF+ E     R++H N+V LLG   +     +++ Y ++G+L +
Sbjct: 42  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 165 WL-----HGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +L     H DVG         S L     ++++   A G+ YL       VVH+D+ + N
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+    N K+SD GL + + +   Y +    +    ++APE    G  +  SD++S+G+
Sbjct: 159 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
Query: 272 LIMEVIS 278
           ++ EV S
Sbjct: 219 VLWEVFS 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
             +L        D     PL     ++     A+G+++L        +HRD+ + N+L+ 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 194
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GIL+ E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 276 VIS 278
           + S
Sbjct: 255 IFS 257

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 195
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 196 ARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 255
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 256 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 300
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 163 EQWLHG------DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
             +L        D     PL     ++     A+G+++L        +HRD+ + N+L+ 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 186
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GIL+ E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 276 VIS 278
           + S
Sbjct: 247 IFS 249

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 74  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 134 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 190
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 191 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 250
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 251 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 295
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 296 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 327

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 172
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 233 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 277
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 188
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 189 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 248
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 249 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 293
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 294 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 325

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 119/240 (49%), Gaps = 26/240 (10%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           + F+ EV  + + RH N++  +GY  +  +  +V ++    +L + LH  V       ++
Sbjct: 77  QAFRNEVAVLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLH--VQETKFQMFQ 133
Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-SY 238
           + ++I   TA+G+ YLH      ++HRD+KS+NI + +    K+ DFGLA +    S S 
Sbjct: 134 L-IDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 239 ITTRVMGTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
              +  G+  ++APE          + +SDVYS+GI++ E+++G +P  +    +++   
Sbjct: 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF- 248
Query: 296 EWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                MV      G   P L +  K   + +KR  LVA  CV    ++RP    ++  +E
Sbjct: 249 -----MVG----RGYASPDLSKLYKNCPKAMKR--LVA-DCVKKVKEERPLFPQILSSIE 296

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK L  +    ERE    E++ +  +  H N+V LLG C  G   +++ EY   G+L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 164 QWLHG--DVGPCSPLTWEI------------RMNIILGTAKGLSYLHEGLEPKVVHRDIK 209
            +L    D   CS  +  I             ++     AKG+++L        +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLA 195
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYS 268
           + NIL+      K+ DFGLA+ + ++S+Y+          ++APE     +    SDV+S
Sbjct: 196 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 255
Query: 269 FGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI 327
           +GI + E+ S G  P  Y   P +    + +K+     +PE          P       +
Sbjct: 256 YGIFLWELFSLGSSP--YPGMPVDSKFYKMIKEGFRMLSPE--------HAPA-----EM 300
Query: 328 LLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
             +   C D +  KRP    +V ++E Q S S
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 30/212 (14%)
Query: 103 NSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH----RMLVYEYV 157
           N  VAVK   + ++   + E+  EV ++  ++H+N+++ +G    G        L+  + 
Sbjct: 47  NEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-------GLEPKVVHRDIKS 210
             G+L  +L  +V     ++W    +I    A+GL+YLHE       G +P + HRDIKS
Sbjct: 105 EKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 211 SNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS----- 264
            N+L+  +    ++DFGLA K    +S+  T   +GT  Y+APE     +  +R      
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 265 DVYSFGILIMEVIS----GRIPVD-YSRPPEE 291
           D+Y+ G+++ E+ S       PVD Y  P EE
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 105 KVAVKNLLNNRGQAER-----EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           KVAVK L  NR +        + K E++ +   RH ++++L    +      +V EYV+ 
Sbjct: 38  KVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           G L  ++  HG V        E R  +       + Y H  +   VVHRD+K  N+L+D 
Sbjct: 96  GELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDA 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEV 276
           H N K++DFGL+ ++ S+  ++ T   G+  Y APE  S  +      D++S G+++  +
Sbjct: 147 HMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 277 ISGRIPVDYSRPP 289
           + G +P D    P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  ++S+  T V GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 27/263 (10%)
Query: 106 VAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VA+K  L  ++    ++    E++ + ++RH+NLV LL  C +     LV+E+V++  L+
Sbjct: 53  VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD 112
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                ++ P + L +++    +     G+ + H      ++HRDIK  NIL+ +    K+
Sbjct: 113 DL---ELFP-NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKL 165
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR-- 280
            DFG A+ L +        V  T  Y APE     +   +  DV++ G L+ E+  G   
Sbjct: 166 CDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224
Query: 281 IPVDYSRPPEEVNLIEWLKKMV------TNRNP--EGVLDPKLPEK-PTSR----LLKRI 327
            P D S   +  +++  L  ++       N+NP   GV  P++ E+ P  R    L + +
Sbjct: 225 FPGD-SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283
Query: 328 LLVALRCVDPNAQKRPKMGHVVH 350
           + +A +C+  +  KRP    ++H
Sbjct: 284 IDLAKKCLHIDPDKRPFCAELLH 306

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E    K
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E S +  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKV------EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVN 158
           KVAVK L  NR Q  R   V      E++ +   RH ++++L    +  +   +V EYV+
Sbjct: 43  KVAVKIL--NR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH 218
            G L  ++  +      L  +    +      G+ Y H  +   VVHRD+K  N+L+D H
Sbjct: 100 GGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAH 152
Query: 219 WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVI 277
            N K++DFGL+ ++ S+  ++     G+  Y APE  S  +      D++S G+++  ++
Sbjct: 153 MNAKIADFGLSNMM-SDGEFLRXSC-GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210
Query: 278 SGRIPVDYSRPP 289
            G +P D    P
Sbjct: 211 CGTLPFDDDHVP 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG--YCAEGAHRMLVYEYVNNGNLE 163
           VAVK L ++    +R+F+ E++ +  +    +V+  G  Y        LV EY+ +G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
            +L             +  + I    KG+ YL      + VHRD+ + NIL++   + K+
Sbjct: 99  DFLQRHRARLDASRLLLYSSQI---CKGMEYLGSR---RCVHRDLAARNILVESEAHVKI 152
Query: 224 SDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           +DFGLAKLL  +      R  G    F Y APE  S  + + +SDV+SFG+++ E+ +  
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTY- 210
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRN 306
              D S  P      E+L+ M   R+
Sbjct: 211 --CDKSCSPSA----EFLRMMGCERD 230

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLD 106
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 107 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 157
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 158 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 218 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 261
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 262 DSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 106
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 107 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 157
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 158 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 217
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 218 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 261
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 262 DSRPKFRELI 271

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/266 (27%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S  +T V GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC+D + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLDMDVE 259
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSF 366
           KR   G    +L+ Q     +P +S 
Sbjct: 260 KR---GSAKELLQHQFLKIAKPLSSL 282

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 109
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 110 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 160
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 161 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 220
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 221 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 264
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 265 DSRPKFRELI 274

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 130
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 131 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 181
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 182 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 241
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 242 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 285
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 286 DSRPKFRELI 295

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  ++S+    V GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DF
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 176
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 177 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           V +K + +  G Q+ +     + AIG + H ++VRLLG C  G+   LV +Y+  G+L  
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 121
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +GP   L W +++      AKG+ YL E     +VHR++ + N+L+      
Sbjct: 122 HVRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 172
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +V+DFG+A LL   +   + +       ++A E    G    +SDV+S+G+ + E+++ G
Sbjct: 173 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 232
Query: 280 RIPVDYSRPPEEVNLIE 296
             P    R  E  +L+E
Sbjct: 233 AEPYAGLRLAEVPDLLE 249

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 111
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 112 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 162
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 163 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 222
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 223 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 266
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 267 DSRPKFRELI 276

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 186
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 187 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 99
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 100 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 211 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 254
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 255 DSRPKFRELI 264

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+ +    + +   +  EY  N  L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HRD+K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D+YS GI+  E+I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-----YPFSTGMERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRP 343
             V+   P    D K+  EK   RLL          +D +  KRP
Sbjct: 243 S-VSIEFPPDFDDNKMKVEKKIIRLL----------IDHDPNKRP 276

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 16/197 (8%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           V +K + +  G Q+ +     + AIG + H ++VRLLG C  G+   LV +Y+  G+L  
Sbjct: 45  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 103
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +GP   L W +++      AKG+ YL E     +VHR++ + N+L+      
Sbjct: 104 HVRQHRGALGPQLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQV 154
Query: 222 KVSDFGLAKLL-GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           +V+DFG+A LL   +   + +       ++A E    G    +SDV+S+G+ + E+++ G
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 280 RIPVDYSRPPEEVNLIE 296
             P    R  E  +L+E
Sbjct: 215 AEPYAGLRLAEVPDLLE 231

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 105 KVAVKNLLNNRGQAER-----EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
           KVAVK L  NR +        + K E++ +   RH ++++L    +      +V EYV+ 
Sbjct: 38  KVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 160 GNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           G L  ++  HG V        E R  +       + Y H  +   VVHRD+K  N+L+D 
Sbjct: 96  GELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDA 146
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEV 276
           H N K++DFGL+ ++ S+  ++     G+  Y APE  S  +      D++S G+++  +
Sbjct: 147 HMNAKIADFGLSNMM-SDGEFLRDSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 277 ISGRIPVDYSRPP 289
           + G +P D    P
Sbjct: 205 LCGTLPFDDEHVP 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG-----DVGPC-----SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L       +  P      S L+    ++     A+G+++L        +HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GI
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 255 LLWEIFS 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 27/198 (13%)
Query: 104 SKVAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           + VAVK L  N   +E R+   E   + +V H ++++L G C++    +L+ EY   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 163 EQWLHGD--VGPC------------------SPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
             +L     VGP                     LT    ++     ++G+ YL E     
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---S 170
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGML 260
           +VHRD+ + NIL+ +    K+SDFGL++ +  E S +  R  G     ++A E     + 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIY 229
Query: 261 NERSDVYSFGILIMEVIS 278
             +SDV+SFG+L+ E+++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP--------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             +L        P        LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 274 MEVIS 278
            E+ S
Sbjct: 237 WEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP--------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             +L        P        LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 274 MEVIS 278
            E+ S
Sbjct: 237 WEIFS 241

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 33/274 (12%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E++Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            C   N + RP    +V++L+    PS  P  SF
Sbjct: 268 -CWQFNPKMRPTFLEIVNLLKDDLHPSF-PEVSF 299

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ L   G  E + + E+E    +RH N++R+  Y  +     L+ E+   G L +
Sbjct: 45  KVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK 103
Query: 165 WL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
            L  HG        T+      +   A  L Y HE    KV+HRDIK  N+L+      K
Sbjct: 104 ELQKHGRFDEQRSATF------MEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154
Query: 223 VSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           ++DFG +      +  +  R M GT  Y+ PE       +E+ D++  G+L  E + G  
Sbjct: 155 IADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
Query: 282 PVD 284
           P D
Sbjct: 211 PFD 213

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 32/282 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 47  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 106
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 107 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 163
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 164 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 222
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 223 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 266
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASP 374
            C   N + RP    +V++L+    PS    + F      +P
Sbjct: 267 -CWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENKAP 307

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 163 EQWLH----GDVGPC---------------SPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +L       +GP                 PL     ++     A+G+++L        
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KNC 179
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNE 262
           +HRD+ + N+L+      K+ DFGLA+ + ++S+YI          ++APE     +   
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 263 RSDVYSFGILIMEVIS 278
           +SDV+S+GIL+ E+ S
Sbjct: 240 QSDVWSYGILLWEIFS 255

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ L   G  E + + E+E    +RH N++R+  Y  +     L+ E+   G L +
Sbjct: 46  KVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK 104
Query: 165 WL--HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
            L  HG        T+   +      A  L Y HE    KV+HRDIK  N+L+      K
Sbjct: 105 ELQKHGRFDEQRSATFMEEL------ADALHYCHER---KVIHRDIKPENLLMGYKGELK 155
Query: 223 VSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           ++DFG +      +  +  R M GT  Y+ PE       +E+ D++  G+L  E + G  
Sbjct: 156 IADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 211
Query: 282 PVD 284
           P D
Sbjct: 212 PFD 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 21/165 (12%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 84  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 137
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++  L  E   +    +GT  Y++PE       + +SD++S G+
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGL 194
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
            ++E+  GR    Y RPP  + + E L  +V N  P     PKLP
Sbjct: 195 SLVEMAVGR----YPRPP--MAIFELLDYIV-NEPP-----PKLP 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R Q  RE +V  E         +V   G         +  E+++ G+L+Q L        
Sbjct: 48  RNQIIRELQVLHEC----NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAG 99
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            +  +I   + +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G 
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQ 154
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV------DYSRP 288
               +    +GT  Y++PE       + +SD++S G+ ++E+  GR P+      + SRP
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP 214
Query: 289 PEEV-NLIEWLKKMVTNRNPEGVL 311
           P  +  L++++      + P GV 
Sbjct: 215 PMAIFELLDYIVNEPPPKLPSGVF 238

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            C   N + RP    +V++L+    PS  P  SF
Sbjct: 268 -CWQFNPKMRPTFLEIVNLLKDDLHPSF-PEVSF 299

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 178
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 239 GVLLWEIFS 247

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H+N+VRL           LV+E+++N +L++++       +P   E+ +  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 185 ILG--TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                  +GL++ HE    K++HRD+K  N+LI+K    K+ DFGLA+  G   +  ++ 
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 243 VMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           V+ T  Y AP+          S D++S G ++ E+I+G+     +   E++ LI
Sbjct: 169 VV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC+D + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLDMDVE 259
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSF 366
           KR   G    +L+ Q     +P +S 
Sbjct: 260 KR---GSAKELLQHQFLKIAKPLSSL 282

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 115
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 116 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 166
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 167 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 226
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 227 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 270
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 271 DSRPKFRELI 280

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 31/238 (13%)
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGD-VGPC 173
           +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  ++  H D +G  
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 151
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
             L W +++      AKG++YL +    ++VHRD+ + N+L+    + K++DFGLAKLLG
Sbjct: 152 YLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 202
Query: 234 S-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE 291
           + E  Y          ++A E     +   +SDV+S+G+ + E+++ G  P D   P  E
Sbjct: 203 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE 261
Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           ++ I  L+K             +LP+ P   +   + ++ ++C   +A  RPK   ++
Sbjct: 262 ISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 117 QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCS 174
           +++R+   E+E + R  +H N++ L     +G H  LV E +  G L ++ L        
Sbjct: 62  KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------Q 115
Query: 175 PLTWEIRMNIILGT-AKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLA 229
               E   + +L T  K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SR 287
           K L +E+  + T    T  +VAPE       +E  D++S GIL+  +++G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 288 PPEEV 292
            PEE+
Sbjct: 232 TPEEI 236

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 42/276 (15%)
Query: 103 NSKVAVKNL-LNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYE 155
           N  VAVK   L ++   Q+ERE    + +   ++H+NL++ +     G++      L+  
Sbjct: 38  NDFVAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAAEKRGSNLEVELWLITA 93
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE--------GLEPKVVHRD 207
           + + G+L  +L G++     +TW    ++    ++GLSYLHE        G +P + HRD
Sbjct: 94  FHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRD 148
Query: 208 IKSSNILIDKHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS-- 264
            KS N+L+       ++DFGLA +    +    T   +GT  Y+APE     +  +R   
Sbjct: 149 FKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAF 208
Query: 265 ---DVYSFGILIMEVIS----GRIPVDYSRPPEEVNL-----IEWLKKMVTNRNPEGVLD 312
              D+Y+ G+++ E++S       PVD    P E  +     +E L+++V ++     + 
Sbjct: 209 LRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIK 268
Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
               + P    L ++ +    C D +A+ R   G V
Sbjct: 269 DHWLKHPG---LAQLCVTIEECWDHDAEARLSAGCV 301

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 108
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 109 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 159
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 219
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 220 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 263
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 264 DSRPKFRELI 273

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 117 QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCS 174
           +++R+   E+E + R  +H N++ L     +G H  LV E +  G L ++ L        
Sbjct: 62  KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------Q 115
Query: 175 PLTWEIRMNIILGT-AKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLA 229
               E   + +L T  K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG A
Sbjct: 116 KFFSEREASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDY--SR 287
           K L +E+  + T    T  +VAPE       +E  D++S GIL+  +++G  P     S 
Sbjct: 173 KQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 288 PPEEV 292
            PEE+
Sbjct: 232 TPEEI 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 274 GVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 12/186 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK + + R Q  RE    EV  +    H N+V +      G    +V E++  G L 
Sbjct: 72  QVAVKKM-DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                D+   + +  E    + L   + LSYLH      V+HRDIKS +IL+      K+
Sbjct: 131 -----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKL 182
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           SDFG    +  E       ++GT  ++APE  S        D++S GI+++E+I G  P 
Sbjct: 183 SDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241
Query: 284 DYSRPP 289
            ++ PP
Sbjct: 242 -FNEPP 246

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 102
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      A+G++YL +    ++VHRD+ + N+L+    + 
Sbjct: 103 YVREHKDNIGSQYLLNWCVQI------AEGMNYLEDR---RLVHRDLAARNVLVKTPQHV 153
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLAKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 154 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 213
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 214 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 257
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 258 DSRPKFRELI 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHGDVGPCSPLTWEIRMN------------IILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L     P    ++    N                 A+G+++L        +HRD+ +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            N+L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 270 GILIMEVIS 278
           GIL+ E+ S
Sbjct: 255 GILLWEIFS 263

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 102 DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           DN+ VAVK+         + +F  E   + +  H N+VRL+G C +     +V E V  G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +L  +    + L  +  + ++   A G+ YL        +HRD+ + N L+ +   
Sbjct: 198 DFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV 251
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            K+SDFG+++    E+  +     G       + APE  + G  +  SDV+SFGIL+ E 
Sbjct: 252 LKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 277 IS 278
            S
Sbjct: 309 FS 310

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 116/244 (47%), Gaps = 19/244 (7%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV + +L++ + +A+     E++ + ++ H N+++      E     +V E  + G+L +
Sbjct: 64  KVQIFDLMDAKARAD--CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            +         +         +     L ++H     +V+HRDIK +N+ I      K+ 
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           D GL +   S+++   + V GT  Y++PE       N +SD++S G L+ E+ + + P  
Sbjct: 179 DLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF- 236
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
           Y    +++NL    KK+      E    P LP    S  L++++ +   C++P+ +KRP 
Sbjct: 237 YG---DKMNLYSLCKKI------EQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPD 284
Query: 345 MGHV 348
           + +V
Sbjct: 285 VTYV 288

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
            P  + LG+G W      E+     +  K                    VA+K ++    
Sbjct: 8   APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
               +   +L   K +    E LE K  +HRD+ + N L++     KVSDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 236 SSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD 284
               T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++P +
Sbjct: 174 EE--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 91/174 (52%), Gaps = 22/174 (12%)
Query: 120 REFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPC- 173
           R+F  E+E + ++  H N++ LLG C    +  L  EY  +GNL  +L      +  P  
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 174 -------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                  S L+ +  ++     A+G+ YL +    + +HR++ + NIL+ +++  K++DF
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADF 183
Query: 227 GLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           GL++    +  Y+  + MG     ++A E  +  +    SDV+S+G+L+ E++S
Sbjct: 184 GLSR---GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 16/187 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           KVAVK L +     E+E    E++ +  + +H+N+V LLG C  G   +++ EY   G+L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 163 EQWLHG-----DVGPCSPL---TWEIR--MNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L       +  P   +   T   R  ++     A+G+++L        +HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           +L+      K+ DFGLA+ + ++S+YI          ++APE     +   +SDV+S+GI
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 255 LLWEIFS 261

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 102 DNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEY 156
           DN+  +VAVK+L   + G    + K E+E +  + H+N+V+  G C E  G    L+ E+
Sbjct: 47  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +G+L+++L  +    + +  + ++   +   KG+ YL      + VHRD+ + N+L++
Sbjct: 107 LPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVE 160
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
                K+ DFGL K + ++    T    R    F Y APE          SDV+SFG+ +
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTL 219
Query: 274 MEVIS 278
            E+++
Sbjct: 220 HELLT 224

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 31  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 90  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 142
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 143 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200
Query: 282 PVD 284
           P +
Sbjct: 201 PYE 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 35  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 94  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 146
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 147 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 204
Query: 282 PVD 284
           P +
Sbjct: 205 PYE 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLLNNRG 116
            P  + LG+G W      E+     +  K                    VA+K ++    
Sbjct: 8   APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
            +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L         +
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
               +   +L   K +    E LE K  +HRD+ + N L++     KVSDFGL++ +  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 236 SSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD 284
               T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++P +
Sbjct: 174 E--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 38  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 91
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 92  DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 143
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 144 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 202 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 240

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 102 DNS--KVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEY 156
           DN+  +VAVK+L   + G    + K E+E +  + H+N+V+  G C E  G    L+ E+
Sbjct: 35  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 94
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +G+L+++L  +    + +  + ++   +   KG+ YL      + VHRD+ + N+L++
Sbjct: 95  LPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVE 148
Query: 217 KHWNPKVSDFGLAKLLGSESSYITT---RVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
                K+ DFGL K + ++    T    R    F Y APE          SDV+SFG+ +
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTL 207
Query: 274 MEVIS 278
            E+++
Sbjct: 208 HELLT 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 42  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 95
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 96  DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 147
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 148 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 206 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 244

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 48  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 102 DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 153
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 154 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 212 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 250

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 109
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 110 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 160
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 161 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 220
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 221 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 264
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 265 DSRPKFRELI 274

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----------- 150
           D     +K +  N  +AERE    V+A+ ++ H N+V   G C +G              
Sbjct: 35  DGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSR 89
Query: 151 ------MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
                  +  E+ + G LEQW+    G    L   + + +     KG+ Y+H     K++
Sbjct: 90  SKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLI 144
Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           +RD+K SNI +      K+ DFGL   L ++      R  GT  Y++PE  S+    +  
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RXRSKGTLRYMSPEQISSQDYGKEV 202
Query: 265 DVYSFGILIMEVI 277
           D+Y+ G+++ E++
Sbjct: 203 DLYALGLILAELL 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 102 DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           DN+ VAVK+         + +F  E   + +  H N+VRL+G C +     +V E V  G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +L  +    + L  +  + ++   A G+ YL        +HRD+ + N L+ +   
Sbjct: 198 DFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNV 251
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
            K+SDFG+++    E+  +     G       + APE  + G  +  SDV+SFGIL+ E 
Sbjct: 252 LKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308
Query: 277 IS 278
            S
Sbjct: 309 FS 310

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           N KV  K+  + +G+ ERE    +  +  +RH ++++L          ++V EY  N   
Sbjct: 47  NKKVLAKS--DMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELF 100
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           +  +  D      ++ +            + Y H     K+VHRD+K  N+L+D+H N K
Sbjct: 101 DYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRI 281
           ++DFGL+ ++ ++ +++ T   G+  Y APE  S  +      DV+S G+++  ++  R+
Sbjct: 153 IADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210
Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-PKLPEKPTSRLLKRILLV 330
           P D    P        L K ++N    GV   PK      + L+KR+L+V
Sbjct: 211 PFDDESIP-------VLFKNISN----GVYTLPKFLSPGAAGLIKRMLIV 249

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 6/167 (3%)
Query: 117 QAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPC 173
           +AE++  V EV  +  ++H N+VR      +  +  L  V EY   G+L   +       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEP--KVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
             L  E  + ++      L   H   +    V+HRD+K +N+ +D   N K+ DFGLA++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           L  +  +     +GT  Y++PE  +    NE+SD++S G L+ E+ +
Sbjct: 166 LNHDEDF-AKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 36  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 95  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 148 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 205
Query: 282 PVD 284
           P +
Sbjct: 206 PYE 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 470
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 471 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E 
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 587
Query: 298 LKKM 301
            ++M
Sbjct: 588 GERM 591

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 42  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 101 LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 153
Query: 225 DFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRI 281
           DFGL++ +  +    T+ V   F   +  PE       + +SD+++FG+L+ E+ S G++
Sbjct: 154 DFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 211
Query: 282 PVD 284
           P +
Sbjct: 212 PYE 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +G+   ++ EY+  G+    L    GP         +  
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKE 128
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           IL   KGL YLH     K +HRDIK++N+L+ +  + K++DFG+A  L +++       +
Sbjct: 129 IL---KGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV 181
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           GT  ++APE       + ++D++S GI  +E+  G  P     P   + LI
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 471
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 472 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E 
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 588
Query: 298 LKKM 301
            ++M
Sbjct: 589 GERM 592

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 45  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 104
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 105 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 161
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 162 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 221
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 222 ITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM------ 264
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
           C   N + RP    +V++L+    PS  P  SF
Sbjct: 265 CWQFNPKMRPTFLEIVNLLKDDLHPSF-PEVSF 296

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 105 KVAVKNL-LNNRGQAE-REFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-----MLVYEYV 157
           KVAVK + L+N  Q E  EF  E   +    H N++RLLG C E + +     M++  ++
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 158 NNGNLEQWL---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
             G+L  +L     + GP   +  +  +  ++  A G+ YL        +HRD+ + N +
Sbjct: 124 KYGDLHTYLLYSRLETGP-KHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCM 179
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGILI 273
           +       V+DFGL+K + S   Y   R+      ++A E  +  +   +SDV++FG+ +
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 274 MEVIS 278
            E+ +
Sbjct: 240 WEIAT 244

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----------- 150
           D     ++ +  N  +AERE    V+A+ ++ H N+V   G C +G              
Sbjct: 36  DGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNG-CWDGFDYDPETSDDSLES 90
Query: 151 -------------------MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
                               +  E+ + G LEQW+    G    L   + + +     KG
Sbjct: 91  SDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKG 148
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + Y+H     K++HRD+K SNI +      K+ DFGL   L ++     TR  GT  Y++
Sbjct: 149 VDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMS 203
Query: 252 PEYASTGMLNERSDVYSFGILIMEVI 277
           PE  S+    +  D+Y+ G+++ E++
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 163 EQWLHG---DVGPCSP-------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             +L     +  P  P       LT E  +      AKG+ +L      K +HRD+ + N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARN 178
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           IL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SFG+
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 272 LIMEVIS 278
           L+ E+ S
Sbjct: 239 LLWEIFS 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 105
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 106 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 156
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 157 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 217 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 260
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 261 DSRPKFRELI 270

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 225 ITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM------ 267
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
           C   N + RP    +V++L+    PS  P  SF
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHPSF-PEVSF 299

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 122/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 112
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 113 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 163
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 164 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 223
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++ ++C   +A
Sbjct: 224 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMVKCWMIDA 267
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 268 DSRPKFRELI 277

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 108 ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 161
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 162 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 219 SLVEMAVGRYPI----PPPDAKELELM 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I ++ H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +       +V   G         +  E+++ G+L+Q L         +  +I   +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKV 171
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
            +   KGL+YL E  + K++HRD+K SNIL++     K+ DFG++   G     +    +
Sbjct: 172 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV 226
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  Y++PE       + +SD++S G+ ++E+  GR P+    PP +   +E +
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELM 276

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 31/273 (11%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
             +  K+ DFG+ + +  ++      + +    ++APE    G+    SD++SFG+++ E
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVALR 333
           + S       +  P +    E + K V +    G LD     PE+ T   L R+      
Sbjct: 225 ITS------LAEQPYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTD--LMRM------ 267
Query: 334 CVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
           C   N   RP    +V++L+    PS  P  SF
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHPSF-PEVSF 299

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 126
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 127 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 105 KVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           KVA+K +   + Q    E   E++A+ +  H N+V             LV + ++ G++ 
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 164 QWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +   V         L       I+    +GL YLH+  +   +HRD+K+ NIL+ +  
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTF----GYVAPEYA-STGMLNERSDVYSFGILIM 274
           + +++DFG++  L +       +V  TF     ++APE        + ++D++SFGI  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---GVLDPKLPEKPTSRLLKRILLVA 331
           E+ +G  P  +  PP +V ++      + N  P    GV D ++ +K      K I L  
Sbjct: 219 ELATGAAPY-HKYPPMKVLML-----TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-- 270
Query: 332 LRCVDPNAQKRPKMGHVVHMLEAQESPSKE 361
             C+  + +KRP    ++     Q++ +KE
Sbjct: 271 --CLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 128
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 129 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 128
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 129 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 163 EQWLHGDVGPCSP-----------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
             +L        P           LT E  +      AKG+ +L      K +HRD+ + 
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFG 270
           NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 271 ILIMEVIS 278
           +L+ E+ S
Sbjct: 238 VLLWEIFS 245

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 89  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 148
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 149 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 205
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 206 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 266 FSLGYMP 272

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 93/184 (50%), Gaps = 16/184 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           VA+K ++     +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +
Sbjct: 36  VAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKVS 224
           L         +    +   +L   K +    E LE K  +HRD+ + N L++     KVS
Sbjct: 95  LR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 147
Query: 225 DFGLAKLLGSESSYITTRVMGT---FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GR 280
           DFGL++ +  +  Y ++R  G+     +  PE       + +SD+++FG+L+ E+ S G+
Sbjct: 148 DFGLSRYV-LDDEYTSSR--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204
Query: 281 IPVD 284
           +P +
Sbjct: 205 MPYE 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I ++ H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 118
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 119 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYC--AEGAHRMLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C  A  A   LV EYV  G+L
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HRD+ + N+L+D     
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA---QHYIHRDLAARNVLLDNDRLV 173
Query: 222 KVSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +  G E   +         + APE          SDV+SFG+ + E+++
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 112
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 113 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 106
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 107 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 79  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 138
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 139 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 195
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 196 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 256 FSLGYMP 262

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRL------LGYCAEGAHRMLVYEYV 157
           +VA+K          RE + +E++ + ++ H N+V        L   A     +L  EY 
Sbjct: 42  QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 101
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID- 216
             G+L ++L+     C      IR  ++   +  L YLHE    +++HRD+K  NI++  
Sbjct: 102 EGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN---RIIHRDLKPENIVLQP 157
Query: 217 --KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
             +    K+ D G AK L  +   + T  +GT  Y+APE           D +SFG L  
Sbjct: 158 GPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 215
Query: 275 EVISGRIP 282
           E I+G  P
Sbjct: 216 ECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRL------LGYCAEGAHRMLVYEYV 157
           +VA+K          RE + +E++ + ++ H N+V        L   A     +L  EY 
Sbjct: 41  QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID- 216
             G+L ++L+     C      IR  ++   +  L YLHE    +++HRD+K  NI++  
Sbjct: 101 EGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN---RIIHRDLKPENIVLQP 156
Query: 217 --KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 274
             +    K+ D G AK L  +   + T  +GT  Y+APE           D +SFG L  
Sbjct: 157 GPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 275 EVISGRIP 282
           E I+G  P
Sbjct: 215 ECITGFRP 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 123/266 (46%), Gaps = 34/266 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 47  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 106 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 155 VKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 214 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 259
Query: 341 KRPKMGHVVHMLEAQESPSKEPSNSF 366
           KR   G    +L+ Q     +P +S 
Sbjct: 260 KR---GSAKELLQHQFLKIAKPLSSL 282

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 121
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 239 FSLGYMP 245

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 69  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 128
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 129 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 185
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 186 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 246 FSLGYMP 252

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 33/274 (12%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 49  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 108
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHR++ + N ++ 
Sbjct: 109 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 166 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 224
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 225 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 268
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            C   N   RP    +V++L+    PS  P  SF
Sbjct: 269 -CWQFNPNMRPTFLEIVNLLKDDLHPSF-PEVSF 300

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 108
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +Y  
Sbjct: 109 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 121/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 239 FSLGYMP 245

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 179
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 180 GRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 240 FSLGYMP 246

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 136
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 193
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 194 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 254 FSLGYMP 260

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGD-VGPCSPLTWEIRMNIILGTAKGLS 193
           +N V+      + +   +  EY  N  L   +H + +       W +   I+    + LS
Sbjct: 75  RNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EALS 130
Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK---------LLGSE----SSYIT 240
           Y+H      ++HR++K  NI ID+  N K+ DFGLAK          L S+    SS   
Sbjct: 131 YIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 241 TRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  +GT  YVA E    TG  NE+ D YS GI+  E I       +S   E VN+++ L+
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI-----YPFSTGXERVNILKKLR 242
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +     P+   +    EK   RLL          +D +  KRP
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLL----------IDHDPNKRP 276

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 33/274 (12%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VAVK +  +    ER EF  E   +      ++VRLLG  ++G   ++V E + +G+L
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 163 EQWLH-----GDVGPCSPL-TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  P  T +  + +    A G++YL+     K VHR++ + N ++ 
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVA 164
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
             +  K+ DFG+ + +  E+ Y      G     ++APE    G+    SD++SFG+++ 
Sbjct: 165 HDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 223
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--PKLPEKPTSRLLKRILLVAL 332
           E+ S       +  P +    E + K V +    G LD     PE+ T   L R+     
Sbjct: 224 EITS------LAEQPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTD--LMRM----- 267
Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
            C   N   RP    +V++L+    PS  P  SF
Sbjct: 268 -CWQFNPNMRPTFLEIVNLLKDDLHPSF-PEVSF 299

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 54  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 113
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 114 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 170
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +   S Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 171 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 231 FSLGYMP 237

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 121/250 (48%), Gaps = 32/250 (12%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L      +A +E   E   +  V + ++ RLLG C     + L+ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 107
Query: 165 WL--HGD-VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           ++  H D +G    L W +++      AKG++YL +    ++VHRD+ + N+L+    + 
Sbjct: 108 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 158
Query: 222 KVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFG AKLLG+ E  Y          ++A E     +   +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D   P  E++ I  L+K             +LP+ P   +   + ++  +C   +A
Sbjct: 219 SKPYD-GIPASEISSI--LEK-----------GERLPQPPICTI--DVYMIMRKCWMIDA 262
Query: 340 QKRPKMGHVV 349
             RPK   ++
Sbjct: 263 DSRPKFRELI 272

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 228 GVLLWEIFS 236

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 92/185 (49%), Gaps = 15/185 (8%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 56  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 163 EQWLHGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           + +L   + P        +P +    + +    A G++YL+     K VHRD+ + N ++
Sbjct: 116 KSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILI 273
            + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++
Sbjct: 172 AEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 274 MEVIS 278
            E+ +
Sbjct: 231 WEIAT 235

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C +   +   LV EYV  G+L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HR++ + N+L+D     
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHS---QHYIHRNLAARNVLLDNDRLV 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 56  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 116 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 173 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231
Query: 275 EVIS 278
           E+ +
Sbjct: 232 EIAT 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYEYVNNGNLEQWLHGDVGP 172
           RG  E+ ++ E+  + ++ H N+V+L+    +    H  +V+E VN G + +     V  
Sbjct: 77  RGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPT 130
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA-KL 231
             PL+ +          KG+ YLH     K++HRDIK SN+L+ +  + K++DFG++ + 
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRIPVDYSRP 288
            GS++  + +  +GT  ++APE  S        +  DV++ G+ +   + G+ P    R 
Sbjct: 188 KGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 289 --------------PEEVNLIEWLKKMVT---NRNPE 308
                         P++ ++ E LK ++T   ++NPE
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE 282

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  EI   + +   +GL+YL E  + +++HRD+K S
Sbjct: 91  ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPS 144
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y+APE       + +SD++S G+
Sbjct: 145 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGL 201
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 202 SLVELAVGRYPI----PPPDAKELEAI 224

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 106 VAVKNLLNNRGQAE-REFKVEVEAIGRV-RHKNLVRLLGYCAE-GAHRMLVYEYVNNGNL 162
           VAVK L      +E R    E++ +  +  H N+V LLG C + G   M++ E+   GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 163 EQWLHGDVGPCSP------------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             +L        P            LT E  +      AKG+ +L      K +HRD+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 211 SNILIDKHWNPKVSDFGLAKLLGSESSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSF 269
            NIL+ +    K+ DFGLA+ +  +   +          ++APE     +   +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 270 GILIMEVIS 278
           G+L+ E+ S
Sbjct: 237 GVLLWEIFS 245

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 78/147 (53%), Gaps = 13/147 (8%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 81  ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 134
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 135 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWL 298
            ++E+  GR P+    PP +   +E +
Sbjct: 192 SLVEMAVGRYPI----PPPDAKELELM 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L  + G   R  +K E++ +  + H+++++  G C +   +   LV EYV  G+L
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    +G    L +  ++       +G++YLH       +HR++ + N+L+D     
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA---QHYIHRNLAARNVLLDNDRLV 156
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 48  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HR+IKS NIL+    +
Sbjct: 107 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRNIKSDNILLGMDGS 155
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S  +T V GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 156 VKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 215 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 260
Query: 341 KR 342
           KR
Sbjct: 261 KR 262

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VA++ + N + Q ++E  + E+  +   ++ N+V  L     G    +V EY+  G+L 
Sbjct: 48  EVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 106
Query: 164 QWLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
             +     D G  + +  E          + L +LH     +V+HRDIKS NIL+    +
Sbjct: 107 DVVTETCMDEGQIAAVCRE--------CLQALEFLHSN---QVIHRDIKSDNILLGMDGS 155
Query: 221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            K++DFG    +  E S   + ++GT  ++APE  +      + D++S GI+ +E+I G 
Sbjct: 156 VKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214
Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
            P     P   + LI       TN  PE     + PEK  S + +  L    RC++ + +
Sbjct: 215 PPYLNENPLRALYLI------ATNGTPE----LQNPEK-LSAIFRDFL---NRCLEMDVE 260
Query: 341 KR 342
           KR
Sbjct: 261 KR 262

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 49  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 108
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 109 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFG--YVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 166 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 224
Query: 275 EVIS 278
           E+ +
Sbjct: 225 EIAT 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 179 VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 236
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 237 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 289
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 290 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 347
Query: 285 YSRPP 289
           ++ PP
Sbjct: 348 FNEPP 352

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 47  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 106
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 107 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 163
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 164 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 222
Query: 275 EVIS 278
           E+ +
Sbjct: 223 EIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 43  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 102
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 103 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 159
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 160 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 218
Query: 275 EVIS 278
           E+ +
Sbjct: 219 EIAT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 50  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 109
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 110 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 166
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 167 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 225
Query: 275 EVIS 278
           E+ +
Sbjct: 226 EIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 49  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 108
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 109 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 165
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 166 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 224
Query: 275 EVIS 278
           E+ +
Sbjct: 225 EIAT 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 92/185 (49%), Gaps = 15/185 (8%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 46  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 105
Query: 163 EQWLHGDVGPC-------SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           + +L   + P        +P +    + +    A G++YL+     K VHRD+ + N ++
Sbjct: 106 KSYLRS-LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 161
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILI 273
            + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++
Sbjct: 162 AEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 220
Query: 274 MEVIS 278
            E+ +
Sbjct: 221 WEIAT 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 57  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 114
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 115 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 168 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 225
Query: 285 YSRPP 289
           ++ PP
Sbjct: 226 FNEPP 230

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 48  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 105
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 106 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 158
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 159 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 216
Query: 285 YSRPPEEV------NLIEWLKKM-VTNRNPEGVLDPKLPEKPTSR 322
           ++ PP +       NL   LK +   + + +G LD  L   P  R
Sbjct: 217 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 261

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 52  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 109
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 110 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 162
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 163 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 220
Query: 285 YSRPPEEV------NLIEWLKKM-VTNRNPEGVLDPKLPEKPTSR 322
           ++ PP +       NL   LK +   + + +G LD  L   P  R
Sbjct: 221 FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 265

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 59  VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 116
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 117 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 169
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 170 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 227
Query: 285 YSRPP 289
           ++ PP
Sbjct: 228 FNEPP 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 57/277 (20%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC----SPL 176
           E + EV  +  ++H N+V+      E     +V +Y   G+L + ++   G        L
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W +++ +       L ++H+    K++HRDIKS NI + K    ++ DFG+A++L S +
Sbjct: 129 DWFVQICL------ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-T 178
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI-------------------LIMEVI 277
             +    +GT  Y++PE       N +SD+++ G                    L++++I
Sbjct: 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
Query: 278 SGRIPVDYSRPPEEVNLIEWLKKMVTN---RNPE------GVLDPKLPEKPTSRLLKRIL 328
           SG      S PP  ++    L+ +V+    RNP        +L+     K   + L   L
Sbjct: 239 SG------SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 329 LVALRCV--------DPNAQKRPKMGH-VVHMLEAQE 356
           +    C+         P   KRP  G   + ++ AQ+
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           +  E+++ G+L+Q L         +  +I   + +   KGL+YL E  + K++HRD+K S
Sbjct: 100 ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 153
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NIL++     K+ DFG++   G     +    +GT  Y++PE       + +SD++S G+
Sbjct: 154 NILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 210
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
            ++E+  GR P+        + + E L  +V N  P     PKLP
Sbjct: 211 SLVEMAVGRYPI--GSGSGSMAIFELLDYIV-NEPP-----PKLP 247

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 12/185 (6%)
Query: 106 VAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK + + R Q  RE    EV  +   +H+N+V +      G    +V E++  G L  
Sbjct: 102 VAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT- 159
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
               D+   + +  E    + L   + LS LH      V+HRDIKS +IL+      K+S
Sbjct: 160 ----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 212
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG    +  E       ++GT  ++APE  S        D++S GI+++E++ G  P  
Sbjct: 213 DFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY- 270
Query: 285 YSRPP 289
           ++ PP
Sbjct: 271 FNEPP 275

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 78  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 137
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 138 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 194
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 195 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 253
Query: 275 EVIS 278
           E+ +
Sbjct: 254 EIAT 257

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTADEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 80  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 139
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 140 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 196
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +     Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 197 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 257 FSLGYMP 263

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 105 KVAVKNLLN-NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK L      Q E +F +E   I +  H+N+VR +G   +   R ++ E +  G+L+
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 164 QWLH-GDVGPCSPLTWEI--RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            +L      P  P +  +   +++    A G  YL E      +HRDI + N L+     
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 219
Query: 221 ---PKVSDFGLAKLLGSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K+ DFG+A+ +     Y      M    ++ PE    G+   ++D +SFG+L+ E+
Sbjct: 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 277 IS-GRIP 282
            S G +P
Sbjct: 280 FSLGYMP 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 117/258 (45%), Gaps = 26/258 (10%)
Query: 105 KVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           KVA+K +   + Q    E   E++A+ +  H N+V             LV + ++ G++ 
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 164 QWLHGDVGP----CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +   V         L       I+    +GL YLH+  +   +HRD+K+ NIL+ +  
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDG 153
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTF----GYVAPEYA-STGMLNERSDVYSFGILIM 274
           + +++DFG++  L +       +V  TF     ++APE        + ++D++SFGI  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---GVLDPKLPEKPTSRLLKRILLVA 331
           E+ +G  P  +  PP +V ++      + N  P    GV D ++ +K      K I L  
Sbjct: 214 ELATGAAPY-HKYPPMKVLML-----TLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-- 265
Query: 332 LRCVDPNAQKRPKMGHVV 349
             C+  + +KRP    ++
Sbjct: 266 --CLQKDPEKRPTAAELL 281

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 94/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C+ LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L    G Q    ++ E+E +  + H+++V+  G C +   +   LV EYV  G+L
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    VG    L +  ++       +G++YLH       +HR + + N+L+D     
Sbjct: 100 RDYLPRHCVGLAQLLLFAQQI------CEGMAYLHA---QHYIHRALAARNVLLDNDRLV 150
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR--MLVYEYVNNGNL 162
           VAVK L    G Q    ++ E+E +  + H+++V+  G C +   +   LV EYV  G+L
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 163 EQWL-HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
             +L    VG    L +  ++       +G++YLH       +HR + + N+L+D     
Sbjct: 101 RDYLPRHCVGLAQLLLFAQQI------CEGMAYLHA---QHYIHRALAARNVLLDNDRLV 151
Query: 222 KVSDFGLAKLLGSESSYITTRVMG---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFGLAK +     Y   R  G    F Y APE          SDV+SFG+ + E+++
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 59  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 113
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 114 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 170
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 171 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 225
Query: 276 VISGR 280
           +++GR
Sbjct: 226 LLTGR 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 48  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 102
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 103 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 159
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 160 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 214
Query: 276 VISGR 280
           +++GR
Sbjct: 215 LLTGR 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 41  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 100
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 101 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 157
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           + +  K+ DFG+ + +  ++      + +    +++PE    G+    SDV+SFG+++ E
Sbjct: 158 EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 217
Query: 276 VIS 278
           + +
Sbjct: 218 IAT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 110
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 111 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 167
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 168 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 276 VISGR 280
           +++GR
Sbjct: 223 LLTGR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +N K+++K+  +       +FK E++ I  ++++  +   G         ++YEY+ N +
Sbjct: 77  NNDKISIKSKYD-------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 162 L----EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           +    E +   D      +  ++   II       SY+H   E  + HRD+K SNIL+DK
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVM----GTFGYVAPEYAS--TGMLNERSDVYSFGI 271
           +   K+SDFG       ES Y+  + +    GT+ ++ PE+ S  +     + D++S GI
Sbjct: 188 NGRVKLSDFG-------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240
Query: 272 LIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
            +  +    +P        +++L+E    + T +N E  LD
Sbjct: 241 CLYVMFYNVVPFSL-----KISLVELFNNIRT-KNIEYPLD 275

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 100
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 157
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 158 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 276 VISGR 280
           +++GR
Sbjct: 213 LLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 100
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 101 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 157
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 158 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 212
Query: 276 VISGR 280
           +++GR
Sbjct: 213 LLTGR 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 108
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 109 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 165
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 166 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 220
Query: 276 VISGR 280
           +++GR
Sbjct: 221 LLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTA 189
           H  L  +        +   V EY+N G+L   +      D+   +    EI +       
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL------- 130
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTF 247
            GL +LH      +V+RD+K  NIL+DK  + K++DFG+ K  +LG      T    GT 
Sbjct: 131 -GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTP 183
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            Y+APE       N   D +SFG+L+ E++ G+ P 
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           +VAVK +++ R Q  RE    EV  +   +H N+V +      G    ++ E++  G L 
Sbjct: 72  QVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                D+     L  E    +     + L+YLH      V+HRDIKS +IL+      K+
Sbjct: 131 -----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           SDFG    +  +       ++GT  ++APE  S  +     D++S GI+++E++ G  P
Sbjct: 183 SDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 68  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 122
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 179
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 180 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 276 VISGR 280
           +++GR
Sbjct: 235 LLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 181 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 276 VISGR 280
           +++GR
Sbjct: 236 LLTGR 240

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 91/184 (49%), Gaps = 13/184 (7%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 43  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 102
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N  + 
Sbjct: 103 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVA 159
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIM 274
           + +  K+ DFG+ + +  E+ Y      G     +++PE    G+    SDV+SFG+++ 
Sbjct: 160 EDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 218
Query: 275 EVIS 278
           E+ +
Sbjct: 219 EIAT 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 61  RVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 115
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 116 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 172
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 173 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 227
Query: 276 VISGR 280
           +++GR
Sbjct: 228 LLTGR 232

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 181 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 235
Query: 276 VISGR 280
           +++GR
Sbjct: 236 LLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 68  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 122
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 123 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 179
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 180 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 234
Query: 276 VISGR 280
           +++GR
Sbjct: 235 LLTGR 239

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 104 SKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           ++VA+K +       ER EF  E   +      ++VRLLG  ++G   +++ E +  G+L
Sbjct: 50  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 109
Query: 163 EQWLHG-----DVGPC-SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           + +L       +  P  +P +    + +    A G++YL+     K VHRD+ + N ++ 
Sbjct: 110 KSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 166
Query: 217 KHWNPKVSDFGLAK-LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           + +  K+ DFG+ + +  ++      + +    +++PE    G+    SDV+SFG+++ E
Sbjct: 167 EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 226
Query: 276 VIS 278
           + +
Sbjct: 227 IAT 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 114
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 171
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 172 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 226
Query: 276 VISGR 280
           +++GR
Sbjct: 227 LLTGR 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 126
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 183
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 184 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 276 VISGR 280
           +++GR
Sbjct: 239 LLTGR 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 47  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 101
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 102 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 158
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 159 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 213
Query: 276 VISGR 280
           +++GR
Sbjct: 214 LLTGR 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 123
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXF 179
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 20/156 (12%)
Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG----DVGPCSPLTWEIRMNIILGTA 189
           H  L  +        +   V EY+N G+L   +      D+   +    EI +       
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL------- 129
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYITTRVMGTF 247
            GL +LH      +V+RD+K  NIL+DK  + K++DFG+ K  +LG      T    GT 
Sbjct: 130 -GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTP 182
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            Y+APE       N   D +SFG+L+ E++ G+ P 
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 114
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 115 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 171
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 172 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 226
Query: 276 VISGR 280
           +++GR
Sbjct: 227 LLTGR 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           KV  K+ +   G  E + + E+E    + H N++RL  Y  +     L+ EY   G L +
Sbjct: 54  KVLFKSQIEKEG-VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK 112
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
            L      C+    +    I+   A  L Y H     KV+HRDIK  N+L+      K++
Sbjct: 113 ELQKS---CT-FDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIA 165
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFG +       S     + GT  Y+ PE     M NE+ D++  G+L  E++ G  P +
Sbjct: 166 DFGWSV---HAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 109
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 110 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 166
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 167 DSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 276 VISGR 280
           +++GR
Sbjct: 222 LLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 105
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 106 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 162
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 163 DSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 217
Query: 276 VISGR 280
           +++GR
Sbjct: 218 LLTGR 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           K+AVK L     +   A+R ++ E+  +  ++H+N++ LL             E  N+  
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATS----LEEFNDVY 132
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 189
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N   D++S G ++ E
Sbjct: 190 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAE 244
Query: 276 VISGR 280
           +++GR
Sbjct: 245 LLTGR 249

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIR 181
           E+  +  ++HKN+VRL           LV+E+ +  +L+++    +GD+ P      EI 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIV 103
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
            + +    KGL + H      V+HRD+K  N+LI+++   K++DFGLA+  G      + 
Sbjct: 104 KSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160
Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
            V+ T  Y  P+      L   S D++S G +  E+ +   P+
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 108
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXF 164
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 108
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTF 164
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 121 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           E   E   + ++ +  +VR++G C E    MLV E    G L ++L  +      +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKN 112
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            + ++   + G+ YL E      VHRD+ + N+L+      K+SDFGL+K L ++ +   
Sbjct: 113 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 241 TRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
            +  G +   + APE  +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 126
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 183
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E   Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 184 DCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 238
Query: 276 VISGR 280
           +++GR
Sbjct: 239 LLTGR 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 24/247 (9%)
Query: 108 VKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL 166
           +K +  +R Q   E  + E+E +  + H N++++     +  +  +V E    G L + +
Sbjct: 52  IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111
Query: 167 HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKV 223
                    L+      ++      L+Y H      VVH+D+K  NIL      H   K+
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKI 168
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGLA+L  S+    +T   GT  Y+APE      +  + D++S G+++  +++G +P 
Sbjct: 169 IDFGLAELFKSDEH--STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF 225
Query: 284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
             +        +E +++  T + P   ++ +        LLK++L       DP  ++RP
Sbjct: 226 TGTS-------LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML-----TKDP--ERRP 271
Query: 344 KMGHVVH 350
               V+H
Sbjct: 272 SAAQVLH 278

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + +  G   +     ++ EY+  G+    L  + GP      E ++  
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLD----ETQIAT 128
Query: 185 IL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           IL    KGL YLH     K +HRDIK++N+L+ +H   K++DFG+A  L +++       
Sbjct: 129 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTF 184
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
           +GT  ++APE       + ++D++S GI  +E+  G  P     P + + LI
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 236

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +     + R  G   +     ++ EY+  G+       D+    PL       I
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATI 121
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    KGL YLH     + +HRDIK++N+L+ +  + K++DFG+A  L +++       +
Sbjct: 122 LREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFV 177
Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           GT  ++APE       + ++D++S GI  +E+  G  P
Sbjct: 178 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYEYVNNG 160
           KVAVK       +A    + E+     +RH+N++  +    +G        L+ +Y  NG
Sbjct: 62  KVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILI 215
           +L  +L       + L  +  + +   +  GL +LH  +     +P + HRD+KS NIL+
Sbjct: 121 SLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 216 DKHWNPKVSDFGLAKLLGSESSYI----TTRVMGTFGYVAPEYASTGMLNER------SD 265
            K+    ++D GLA    S+++ +     TRV GT  Y+ PE     +          +D
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 266 VYSFGILIMEV----ISGRIPVDYSRP 288
           +YSFG+++ EV    +SG I  +Y  P
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLP 261

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D+GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 99
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 156
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + ++ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 157 DCELKILDFGLARHTDDEMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 276 VISGR 280
           +++GR
Sbjct: 212 LLTGR 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLV-YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           E + + R+ H   V+L  +C +   ++     Y  NG L +++   +G            
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA 144
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTR 242
            I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES       
Sbjct: 145 EIVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHG-DVGPCSPLTWEIRM 182
           E+  +  + H N+++L     +  +  LV E+   G L EQ ++      C         
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA------A 149
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKLLGSESSYI 239
           NI+     G+ YLH+     +VHRDIK  NIL++      N K+ DFGL+     +  Y 
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YK 204
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
               +GT  Y+APE       NE+ DV+S G+++  ++ G  P 
Sbjct: 205 LRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 33/290 (11%)
Query: 106 VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K L  N   +A +E   E   +  V    + RLLG C     + LV + +  G L  
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLD 107
Query: 165 WLH---GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
            +    G +G    L W +++      AKG+SYL +    ++VHRD+ + N+L+    + 
Sbjct: 108 HVRENRGRLGSQDLLNWCMQI------AKGMSYLED---VRLVHRDLAARNVLVKSPNHV 158
Query: 222 KVSDFGLAKLLG-SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           K++DFGLA+LL   E+ Y          ++A E         +SDV+S+G+ + E+++ G
Sbjct: 159 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFG 218
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P D     E  +L+E           +G    +LP+ P   +   + ++ ++C   ++
Sbjct: 219 AKPYDGIPAREIPDLLE-----------KG---ERLPQPPICTI--DVYMIMVKCWMIDS 262
Query: 340 QKRPKMGHVVHMLE-AQESPSKEPSNSFQDRYRASPKNELIEKQVTESGD 388
           + RP+   +V         P +      +D   ASP +    + + E  D
Sbjct: 263 ECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDD 312

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEV 276
               K+ DFGLA+    E     T  + T  Y APE     M  N+  D++S G ++ E+
Sbjct: 161 DCELKILDFGLARHTDDE----MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 277 ISGR 280
           ++GR
Sbjct: 217 LTGR 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 29  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 84
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 85  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 139
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 140 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 199
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 200 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 254
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 255 IPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           YV    +E  LH  +    PLT E     +    +GL Y+H     +V+HRD+K SN+L+
Sbjct: 135 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 191
Query: 216 DKHWNPKVSDFGLAKLLGS---ESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGI 271
           +++   K+ DFG+A+ L +   E  Y  T  + T  Y APE   S     +  D++S G 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251
Query: 272 LIMEVISGR 280
           +  E+++ R
Sbjct: 252 IFGEMLARR 260

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 28  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 83
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 84  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 253
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 254 IPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 67  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 122
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 123 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 292
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 31  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 86
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 87  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 141
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 142 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 201
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 202 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 256
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 257 IPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           YV    +E  LH  +    PLT E     +    +GL Y+H     +V+HRD+K SN+L+
Sbjct: 136 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV 192
Query: 216 DKHWNPKVSDFGLAKLLG---SESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGI 271
           +++   K+ DFG+A+ L    +E  Y  T  + T  Y APE   S     +  D++S G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 272 LIMEVISGR 280
           +  E+++ R
Sbjct: 253 IFGEMLARR 261

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 118
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 119 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 34  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 89
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 90  EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 144
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 145 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 204
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 205 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 259
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 260 IPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 45/269 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-------AHRMLVYEYV 157
           +VAVK + ++R +     + E+     +RH+N+   LG+ A             LV +Y 
Sbjct: 54  EVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNKDNGTWTQLWLVSDYH 109
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSN 212
            +G+L  +L+        +T E  + + L TA GL++LH  +     +P + HRD+KS N
Sbjct: 110 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 164
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPEYA--STGMLN----ER 263
           IL+ K+    ++D GLA    S +  I       +GT  Y+APE    S  M +    +R
Sbjct: 165 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 224
Query: 264 SDVYSFGILIMEVIS----GRIPVDYSRP-----PEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +D+Y+ G++  E+      G I  DY  P     P + + +E ++K+V     E  L P 
Sbjct: 225 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVVC----EQKLRPN 279
Query: 315 LPEKPTSRLLKRILLVALR-CVDPNAQKR 342
           +P +  S    R++   +R C   N   R
Sbjct: 280 IPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 118 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           +A K L    G  E E  V    + +++H N+V L      G H  L+ + V+ G     
Sbjct: 51  IAKKALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---- 102
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPK 222
           L   +      T      +I      + YLH   +  +VHRD+K  N+L   +D+     
Sbjct: 103 LFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +SDFGL+K+   +   + +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
Query: 283 V 283
Sbjct: 218 F 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP----CSPLTWEI 180
           E+  + +++H NLV LL          LV+EY ++  L +      G        +TW+ 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ- 110
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
                  T + +++ H+      +HRD+K  NILI KH   K+ DFG A+LL   S Y  
Sbjct: 111 -------TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160
Query: 241 TRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
             V  T  Y +PE            DV++ G +  E++SG
Sbjct: 161 DEV-ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 116
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 117 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GLS+ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 116 IVS---ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +    ++ SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP--VVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE 179
           +E   E+  + +    ++V+  G   +     +V EY   G++   +         LT +
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTED 125
Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
               I+  T KGL YLH     + +HRDIK+ NIL++   + K++DFG+A   G  +  +
Sbjct: 126 EIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDXM 179
Query: 240 TTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             R  V+GT  ++APE       N  +D++S GI  +E+  G+ P     P   + +I
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 132
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A GL +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 133 KFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY- 188
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
                GT  Y+APE  +    +  +D +S+G+L+ E+++G +P       E + LI
Sbjct: 189 --SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 141
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 142 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DF LA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 138
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 139 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 141
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 142 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 102/241 (42%), Gaps = 43/241 (17%)
Query: 53  VAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKXXXXXXXXXXXXXXXXDNSKVAVKNLL 112
           V++VV    H   GH + ++ +EV+                           +++ + L 
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAE-------------------------RLSPEQLE 140
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
             R    RE  +  +  G   H +++ L+      +   LV++ +  G L  +L   V  
Sbjct: 141 EVREATRRETHILRQVAG---HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
               T  I  +++    + +S+LH      +VHRD+K  NIL+D +   ++SDFG +  L
Sbjct: 198 SEKETRSIMRSLL----EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 233 GSESSYITTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPVDYS 286
             E       + GT GY+APE     M        +  D+++ G+++  +++G  P  + 
Sbjct: 251 --EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308
Query: 287 R 287
           R
Sbjct: 309 R 309

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G+++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 122
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 123 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 140
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 141 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+  FGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 143
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 144 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--APVVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 138 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 112
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 170 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 131
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 186
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G+++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VAVK L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +H ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 109 MD-ANLCQVIHMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 157
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+   + ++++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 158 KSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 276 VISGRI 281
           ++ G +
Sbjct: 216 LVKGSV 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E + + R+ H   V+L     +         Y  NG L +++   +G             
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRV 243
           I+     L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES        
Sbjct: 138 IVS---ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           +GT  YV+PE  +     + SD+++ G +I ++++G  P 
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL---HGDVGPCSPLTWEIR 181
           E+  +  ++HKN+VRL           LV+E+ +  +L+++    +GD+ P      EI 
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------EIV 103
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
            + +    KGL + H      V+HRD+K  N+LI+++   K+++FGLA+  G      + 
Sbjct: 104 KSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 242 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
            V+ T  Y  P+      L   S D++S G +  E+ +   P+
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 137
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 192
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 193 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 173 -TLWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLH--GDVGPCSPLTWEI 180
           VE   +  +     +  L  C +   R+  V EYVN G+L   +   G       + +  
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 127
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
            ++I      GL +LH+     +++RD+K  N+++D   + K++DFG+ K    +   +T
Sbjct: 128 EISI------GLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VT 176
Query: 241 TR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           TR   GT  Y+APE  +     +  D +++G+L+ E+++G+ P D
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGXKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 154
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 209
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 210 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVM----FTEEDV 128
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 129 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 185 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 115
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 173 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+++L  +  +  +  LV E    G L      ++      +      I
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 155
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMK 210
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 211 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 121
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH      +VHRD+K  NIL+      K++DFGLA++   + +     V+ T  
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--DPVVVTLW 176
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  V+
Sbjct: 106 LLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  V+
Sbjct: 106 LLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 352
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE           D ++ G L+ E+I+G+ P    +   +   +E L K V        
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------- 404
Query: 311 LDPKLPEKPTSRL--LKRILLVALRCVDP 337
                PE+ + R     R L   L C DP
Sbjct: 405 -----PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           +A + L    G  E E  V    + +++H N+V L      G H  L+ + V+ G     
Sbjct: 51  IAKEALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---- 102
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPK 222
           L   +      T      +I      + YLH   +  +VHRD+K  N+L   +D+     
Sbjct: 103 LFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +SDFGL+K+   +   + +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E   I  RV GT GY+
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 352
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE           D ++ G L+ E+I+G+ P    +   +   +E L K V        
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------- 404
Query: 311 LDPKLPEKPTSRL--LKRILLVALRCVDP 337
                PE+ + R     R L   L C DP
Sbjct: 405 -----PEEYSERFSPQARSLCSQLLCKDP 428

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 129
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 130 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 185
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 186 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 243
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 244 LGMPQFLSPEAQSLLRMLFKRNP 266

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 41/255 (16%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLG-YCAEGAHRM-----LVYEYV 157
           ++A   +++  G  E E K E+  + +   H+N+    G +  +    M     LV E+ 
Sbjct: 50  QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             G++   +    G  + L  E    I     +GLS+LH+    KV+HRDIK  N+L+ +
Sbjct: 110 GAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164
Query: 218 HWNPKVSDFG----LAKLLGSESSYITTRVMGTFGYVAPEYAST-----GMLNERSDVYS 268
           +   K+ DFG    L + +G  +++I     GT  ++APE  +         + +SD++S
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 269 FGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRIL 328
            GI  +E+  G  P+    P   + LI         RNP     P+L  K  S+  +  +
Sbjct: 220 LGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA----PRLKSKKWSKKFQSFI 267
Query: 329 LVALRCVDPNAQKRP 343
                C+  N  +RP
Sbjct: 268 ---ESCLVKNHSQRP 279

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 123
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 124 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 180
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEV 276
               K+ DFGLA+    E        + T  Y APE     M  N+  D++S G ++ E+
Sbjct: 181 DCELKILDFGLARHTDDE----MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 277 ISGR 280
           ++GR
Sbjct: 237 LTGR 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+V+  +L+ ++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 123 KVEVEAIGRVRHKNLVRL-LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
           K+E + +  V H  +V+L   +  EG    L+ +++  G+L   L  +V      T E  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEV----MFTEEDV 128
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK--LLGSESSYI 239
              +   A  L +LH      +++RD+K  NIL+D+  + K++DFGL+K  +   + +Y 
Sbjct: 129 KFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY- 184
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---- 295
                GT  Y+APE  +     + +D +SFG+L+ E+++G +P       E + +I    
Sbjct: 185 --SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 296 -----------EWLKKMVTNRNP 307
                      + L +M+  RNP
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNP 265

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +++H N+V L      G H  L+ + V+ G     L   +      T      +
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRL 121
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPKVSDFGLAKLLGSESSYITT 241
           I      + YLH   +  +VHRD+K  N+L   +D+     +SDFGL+K+   +   + +
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLS 176
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
              GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++  C  LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ D GLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           +A + L    G  E E  V    + +++H N+V L      G H  L+ + V+ G     
Sbjct: 51  IAKEALEGKEGSMENEIAV----LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---- 102
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL---IDKHWNPK 222
           L   +      T      +I      + YLH   +  +VHRD+K  N+L   +D+     
Sbjct: 103 LFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +SDFGL+K+   +   + +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 160 ISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N + AVK +     +++R+   E+E + R  +H N++ L     +G +  +V E +  G 
Sbjct: 47  NMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102
Query: 162 L-EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHW 219
           L ++ L          +      ++    K + YLH      VVHRD+K SNIL +D+  
Sbjct: 103 LLDKILRQKF-----FSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESG 154
Query: 220 NP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           NP   ++ DFG AK L +E+  + T    T  +VAPE       +   D++S G+L+  +
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 277 ISGRIPVDYSRPPEE 291
           ++G  P  ++  P++
Sbjct: 214 LTGYTP--FANGPDD 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 99/187 (52%), Gaps = 15/187 (8%)
Query: 103 NSKVAVKNL-LNNRGQAE----REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV 157
           N  VA+K + L +R +A+    R    E++ +  + H N++ LL      ++  LV++++
Sbjct: 35  NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
              +LE  +  +    +P   +  M   L T +GL YLH+     ++HRD+K +N+L+D+
Sbjct: 95  ET-DLEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 147
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEV 276
           +   K++DFGLAK  GS +     +V+ T  Y APE      M     D+++ G ++ E+
Sbjct: 148 NGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 277 ISGRIPV 283
           +  R+P 
Sbjct: 207 LL-RVPF 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  ++H N+V+L          +LV+E+++  +L++ L    G    +T +   + 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK---SF 105
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L    G++Y H+    +V+HRD+K  N+LI++    K++DFGLA+  G      T  ++
Sbjct: 106 LLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISG 279
            T  Y AP+    +   +   D++S G +  E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 134 HKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           H N+VRL   C            LV+E+V+  +L  +L     P  P   E   +++   
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQL 129
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            +GL +LH     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 184
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVI 277
           Y APE           D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 24/189 (12%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
            E ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 101 MELMD-ANLXQVIQMELD-------HERMSYLLYQMLXGIKHLHSA---GIIHRDLKPSN 149
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 150 IVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 207
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 208 MGEMVRHKI 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGL 228
              LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+
Sbjct: 109 KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 40/277 (14%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHR--MLVYEYV 157
           D    A+K +L +  Q   E + E +      H N++RL+ YC    GA     L+  + 
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
             G L   +       + LT +  + ++LG  +GL  +H        HRD+K +NIL+  
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGD 169
Query: 218 HWNPKVSDFG-----LAKLLGSESSYITTRVMG---TFGYVAPEYAST---GMLNERSDV 266
              P + D G        + GS  +           T  Y APE  S     +++ER+DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 267 YSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK----LPEKPTSR 322
           +S G ++  ++ G  P D                MV  +     L  +    +P+ P   
Sbjct: 230 WSLGCVLYAMMFGEGPYD----------------MVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 323 LLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS 359
                LL ++  VDP+  +RP +  ++  LEA + P+
Sbjct: 274 SALWQLLNSMMTVDPH--QRPHIPLLLSQLEALQPPA 308

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLSQVIQME------LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE + ++ H N+++L     + +   +V E    G L      ++      +      I
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARI 126
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           R+ GT  Y+APE    G  +E+ DV+S G+++  ++SG  P 
Sbjct: 183 RI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 134 HKNLVRLLGYC--AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           H N++ L+G     EG   +L+  Y+ +G+L Q++     P    T +  ++  L  A+G
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARG 136
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR---VMGTFG 248
           + YL E    K VHRD+ + N ++D+ +  KV+DFGLA+ +     Y   +         
Sbjct: 137 MEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           + A E   T     +SDV+SFG+L+ E+++   P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L      
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AE 101
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGL 228
              LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 159 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 214 IMGEMIKGGV 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 110 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 155
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 156 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 213
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 214 MGEMVRHKI 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 104 SKVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           ++VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    
Sbjct: 69  TRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDL 127
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           +E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+LI+   + 
Sbjct: 128 METDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDL 183
Query: 222 KVSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIM 274
           K+ DFGLA++   E  +    T  + T  Y APE     MLN +      D++S G ++ 
Sbjct: 184 KICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILA 239
Query: 275 EVISGR 280
           E++S R
Sbjct: 240 EMLSNR 245

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           + S +A   +++ + + E E + VE++ +    H N+V+LL       +  ++ E+   G
Sbjct: 60  ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 119
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  +   +    PLT      +   T   L+YLH+    K++HRD+K+ NIL     +
Sbjct: 120 AVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGD 173
Query: 221 PKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYASTGMLNER-----SDVYSFGILI 273
            K++DFG++      +  I  R   +GT  ++APE        +R     +DV+S GI +
Sbjct: 174 IKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 274 MEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
           +E+       +   P  E+N +  L K+  +  P
Sbjct: 231 IEM------AEIEPPHHELNPMRVLLKIAKSEPP 258

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +  ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLXQVIQMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E
Sbjct: 160 KSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++  +I
Sbjct: 218 MVRHKI 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 43  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 101
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 102 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 147
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 148 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 206 GCIMGEMVRHKI 217

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 112 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 157
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 158 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 216 MGEMVRHKI 224

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 101 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 146
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 205 GCIMGEMVRHKI 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 30/192 (15%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
           +  VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV
Sbjct: 43  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 101
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIK 209
            E +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K
Sbjct: 102 MELM-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 147
Query: 210 SSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSF 269
            SNI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S 
Sbjct: 148 PSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 205
Query: 270 GILIMEVISGRI 281
           G ++ E++  +I
Sbjct: 206 GCIMGEMVRHKI 217

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 111 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 156
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 157 IVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 215 MGEMVRHKI 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 214 IMGEMIKGGV 223

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 34  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 93  LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 99
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 156
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 157 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 272 LIMEVISGRI 281
           ++ E+I G +
Sbjct: 215 IMGEMIKGGV 224

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 112 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 157
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 158 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 216 MGEMVRHKI 224

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EV+ + ++ H N+ +L  +  +  +  LV E    G L      ++      +      I
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARI 131
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLGSESSYITT 241
           I     G++Y H+    K+VHRD+K  N+L++   K  N ++ DFGL+     E+S    
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXK 186
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +GT  Y+APE    G  +E+ DV+S G+++  ++SG  P +
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 149 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 253 MGEMVRHKI 261

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N + AVK +     +++R+   E+E + R  +H N++ L     +G +  +V E    G 
Sbjct: 47  NXEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGE 102
Query: 162 L-EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHW 219
           L ++ L          +      ++    K + YLH      VVHRD+K SNIL +D+  
Sbjct: 103 LLDKILRQKF-----FSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESG 154
Query: 220 NP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
           NP   ++ DFG AK L +E+  + T    T  +VAPE       +   D++S G+L+   
Sbjct: 155 NPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTX 213
Query: 277 ISGRIP 282
           ++G  P
Sbjct: 214 LTGYTP 219

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           RG +  E + EV  +  +RH N++ L          +L+ E V+ G L  +L        
Sbjct: 69  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKE 124
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW-NPKVS--DFGLAK 230
            LT +     +     G+ YLH     ++ H D+K  NI L+DK+  NP++   DFG+A 
Sbjct: 125 SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
            + + + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 182 KIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSN 212
           +           D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K SN
Sbjct: 149 M-----------DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN 194
Query: 213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
           I++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G +
Sbjct: 195 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 273 IMEVISGRI 281
           + E++  +I
Sbjct: 253 MGEMVRHKI 261

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 34  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 93  LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+V+  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N   AVK +++ R +A  +   E+ A+     H N+V+L     +  H  LV E +N G 
Sbjct: 36  NQAFAVK-IISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKH 218
           L + +          +      I+      +S++H+     VVHRD+K  N+L    + +
Sbjct: 93  LFERIKKK----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDN 145
Query: 219 WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
              K+ DFG A+L   ++  + T    T  Y APE  +    +E  D++S G+++  ++S
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204
Query: 279 GRIPV-DYSRPPEEVNLIEWLKKM 301
           G++P   + R     + +E +KK+
Sbjct: 205 GQVPFQSHDRSLTCTSAVEIMKKI 228

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 111 MDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G ++ E+I
Sbjct: 162 DCTLKILDFGLARTAG--TSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 278 SGRI 281
            G +
Sbjct: 220 KGGV 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 34/203 (16%)
Query: 102 DNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLL-GYCAEGAHRML------V 153
           D+   A+K + L NR  A  +   EV+A+ ++ H  +VR    +  +     L      V
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 154 YEYVN-----NGNLEQWLHGDVGPCSPLTWE--IRMNIILGTAKGLSYLH-EGLEPKVVH 205
           Y Y+        NL+ W++G    C+    E  + ++I L  A+ + +LH +GL    +H
Sbjct: 89  YLYIQMQLCRKENLKDWMNGR---CTIEERERSVCLHIFLQIAEAVEFLHSKGL----MH 141
Query: 206 RDIKSSNILIDKHWNPKVSDFGLAKLLGS---ESSYIT--------TRVMGTFGYVAPEY 254
           RD+K SNI        KV DFGL   +     E + +T        T  +GT  Y++PE 
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 255 ASTGMLNERSDVYSFGILIMEVI 277
                 + + D++S G+++ E++
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELL 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 47  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++  C  L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 106 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCEL 162
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 163 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 280 R 280
           +
Sbjct: 218 K 218

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYVNNGN 161
           VAVK + ++R +     + E+     +RH+N++  +       H      L+  Y   G+
Sbjct: 63  VAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 121
Query: 162 LEQWLHG---DVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           L  +L     D   C        + I+L  A GL++LH  +     +P + HRD+KS NI
Sbjct: 122 LYDYLQLTTLDTVSC--------LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 173
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNE------R 263
           L+ K+    ++D GLA +    ++ +      RV GT  Y+APE     +  +      R
Sbjct: 174 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKR 232
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPPEEV 292
            D+++FG+++ EV    +S  I  DY  P  +V
Sbjct: 233 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 265

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 29/160 (18%)
Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           + L+G CAE               L++ + G      P+   I   + +   K L YL E
Sbjct: 103 MELMGTCAE--------------KLKKRMQG------PIPERILGKMTVAIVKALYYLKE 142
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY--- 254
             +  V+HRD+K SNIL+D+    K+ DFG++  L  + +    R  G   Y+APE    
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDP 198
Query: 255 --ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
              +    + R+DV+S GI ++E+ +G+ P    +   EV
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K+ DFG++  L    S 
Sbjct: 153 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSV 208
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             T   G   Y+APE  +  +     + +SD++S GI ++E+   R P D    P     
Sbjct: 209 AKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----- 263
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 264 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 303

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 356
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 107
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 165 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
           GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +  + +   +GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 251 APEYASTGMLNERS-DVYSFGILIMEVISGRIPV 283
           APE    G+  + S D +S G ++ +++ G  P 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 90/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +  C  L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 112
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 170 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEIRMN 183
           E+  + +++H+N+V L        H  LV + V+ G L ++ L   V      T +    
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-----YTEKDASL 110
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYIT 240
           +I      + YLHE     +VHRD+K  N+L    +++    ++DFGL+K+   E + I 
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIM 164
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +   GT GYVAPE  +    ++  D +S G++   ++ G  P
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           +   +A   ++  + + E E + VE+E +    H  +V+LLG         ++ E+   G
Sbjct: 42  ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101
Query: 161 NLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
            ++   L  D G   P    +   ++    + L++LH     +++HRD+K+ N+L+    
Sbjct: 102 AVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RIIHRDLKAGNVLMTLEG 154
Query: 220 NPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFG 270
           + +++DFG++    K L    S+I     GT  ++APE      + +     ++D++S G
Sbjct: 155 DIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
Query: 271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV 330
           I ++E+           P  E+N +  L K +   +P  +L P       S   +  L +
Sbjct: 210 ITLIEM------AQIEPPHHELNPMRVLLK-IAKSDPPTLLTP----SKWSVEFRDFLKI 258
Query: 331 ALRCVDPNAQKRPKMGHVV 349
           AL   D N + RP    ++
Sbjct: 259 AL---DKNPETRPSAAQLL 274

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 102 DNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNG 160
           +   +A   ++  + + E E + VE+E +    H  +V+LLG         ++ E+   G
Sbjct: 34  ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 93
Query: 161 NLEQ-WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
            ++   L  D G   P    +   ++    + L++LH     +++HRD+K+ N+L+    
Sbjct: 94  AVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RIIHRDLKAGNVLMTLEG 146
Query: 220 NPKVSDFGLA----KLLGSESSYITTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFG 270
           + +++DFG++    K L    S+I     GT  ++APE      + +     ++D++S G
Sbjct: 147 DIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLG 201
Query: 271 ILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLV 330
           I ++E+           P  E+N +  L K +   +P  +L P       S   +  L +
Sbjct: 202 ITLIEM------AQIEPPHHELNPMRVLLK-IAKSDPPTLLTP----SKWSVEFRDFLKI 250
Query: 331 ALRCVDPNAQKRPKMGHVV 349
           AL   D N + RP    ++
Sbjct: 251 AL---DKNPETRPSAAQLL 266

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----EGAHRMLVYEYV 157
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL         E    + +   +
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 112
Query: 158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
            + NL Q +  +      L  E    ++     G+ +LH      ++HRD+K SNI++  
Sbjct: 113 MDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 163
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G ++ E+I
Sbjct: 164 DCTLKILDFGLARTAG--TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221
Query: 278 SGRI 281
            G +
Sbjct: 222 KGGV 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 19/183 (10%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVA+K L     +   A+R ++ E+  +  ++H+N++ LL      +     Y++     
Sbjct: 51  KVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL--- 106
Query: 162 LEQWLHGDVGPCSPLTW--EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
           +  ++  D+     L +  E    ++    KGL Y+H      VVHRD+K  N+ +++  
Sbjct: 107 VMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC 163
Query: 220 NPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVI 277
             K+ DFGLA+   +E + Y+ TR      Y APE   + M  N+  D++S G ++ E++
Sbjct: 164 ELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 278 SGR 280
           +G+
Sbjct: 219 TGK 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
           P+T E  ++     A+G+ +L      K +HRD+ + NIL+ ++   K+ DFGLA+ +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 235 ESSYI---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE 290
              Y+    TR+     ++APE     + + +SDV+S+G+L+ E+ S G  P  Y     
Sbjct: 252 NPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP--YPGVQM 307
Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           + +    L++ +  R PE       PE         I  + L C   + ++RP+   +V 
Sbjct: 308 DEDFCSRLREGMRMRAPEY----STPE---------IYQIMLDCWHRDPKERPRFAELVE 354
Query: 351 ML 352
            L
Sbjct: 355 KL 356

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN 159
             KVA+K +   L  +       + E+  +  +RH ++++L          ++V EY   
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG- 92
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
           G L  +    +     +T +            + Y H     K+VHRD+K  N+L+D + 
Sbjct: 93  GELFDY----IVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNL 145
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVIS 278
           N K++DFGL+ ++ ++ +++ T   G+  Y APE  +  +      DV+S GI++  ++ 
Sbjct: 146 NVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
Query: 279 GRIPVD 284
           GR+P D
Sbjct: 204 GRLPFD 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 92
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 149
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 150 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 207
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 208 IMGEMVCHKI 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++  C  L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 114 LMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSEL 170
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 280 R 280
           +
Sbjct: 226 K 226

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFM--DASALTGIPLPLIKSY 108
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 166 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           +VAVK L     +   A+R ++ E+  +  ++H+N++ LL        R L  E  N+  
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVY 103
Query: 162 LEQWLHG----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK 217
           L   L G    ++     LT +    +I    +GL Y+H      ++HRD+K SN+ +++
Sbjct: 104 LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 160
Query: 218 HWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIME 275
               K+ DFGL +    E + Y+ TR      Y APE     M  N+  D++S G ++ E
Sbjct: 161 DSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 215
Query: 276 VISGR 280
           +++GR
Sbjct: 216 LLTGR 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 102 DNSKVAVKNLLNNRGQAERE-----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 156
           D  K+     +N +   ER      FK E++ +  + H  LV L     +     +V + 
Sbjct: 38  DTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID 216
           +  G+L   L  +V        E     I      L YL      +++HRD+K  NIL+D
Sbjct: 97  LLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLD 149
Query: 217 KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILI 273
           +H +  ++DF +A +L  E+  ITT + GT  Y+APE  S+      +   D +S G+  
Sbjct: 150 EHGHVHITDFNIAAMLPRETQ-ITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 274 MEVISGRIP 282
            E++ GR P
Sbjct: 208 YELLRGRRP 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 103
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 160
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++ T  + T  Y APE        E  D++S G 
Sbjct: 161 NIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 218
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 219 IMGEMVCHKI 228

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L++++  D    + +   +  + 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM--DASALTGIPLPLIKSY 109
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE-YVNNG 160
           KVA+K L     +   A+R ++ E+  +  ++H+N++ LL      +     Y+ Y+   
Sbjct: 69  KVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127
Query: 161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
            ++  L   +G     + E    ++    KGL Y+H      VVHRD+K  N+ +++   
Sbjct: 128 FMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCE 182
Query: 221 PKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVIS 278
            K+ DFGLA+   +E + Y+ TR      Y APE   + M  N+  D++S G ++ E+++
Sbjct: 183 LKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237
Query: 279 GR 280
           G+
Sbjct: 238 GK 239

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   R+   +  L  C +   R+  V E+VN G+L   +       S    E R 
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-----SRRFDEARA 126
Query: 183 NIILG-TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
                     L +LH+     +++RD+K  N+L+D   + K++DFG+ K  G  +   T 
Sbjct: 127 RFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTA 182
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVN 293
              GT  Y+APE     +     D ++ G+L+ E++ G  P +             +EV 
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 242
Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
              WL +  T     G+L   + + PT RL
Sbjct: 243 YPTWLHEDAT-----GILKSFMTKNPTMRL 267

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG    E + EV  + +V H N++ L          +L+ E V+ G L  +L      
Sbjct: 53  SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQ 108
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI-LIDKHW---NPKVSDFGL 228
              L+ E   + I     G++YLH     K+ H D+K  NI L+DK+    + K+ DFGL
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +  E       + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 166 AHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM--DASALTGIPLPLIKSY 111
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLVYEY 156
           VAVK L     N+  A+R ++ E+  +  V HKN++ LL          E     LV E 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
           ++  NL Q +H ++          RM+ +L     G+ +LH      ++HRD+K SNI++
Sbjct: 111 MD-ANLCQVIHMELD-------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 159
Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
                 K+ DFGLA+   + ++++ T  + T  Y APE           D++S G ++ E
Sbjct: 160 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 276 VISGRI 281
           ++ G +
Sbjct: 218 LVKGCV 223

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 18/162 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V+LL          LV+E+++  +L+ ++  D    + +   +  + 
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFM--DASALTGIPLPLIKSY 110
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +    +GL++ H     +V+HRD+K  N+LI+     K++DFGLA+  G         V+
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 245 GTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y APE      Y ST +     D++S G +  E+++ R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 57  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 111
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T 
Sbjct: 112 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 167
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 227
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 228 PRTLSPEAKSLLAGLLKKDPKQRL 251

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           L+ EY + G +  +L  HG +      + + R 
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-KFRQ 119
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    + Y H+    ++VHRD+K+ N+L+D   N K++DFG +          T  
Sbjct: 120 -----IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-- 169
Query: 243 VMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 113
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K  N+L+   
Sbjct: 114 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASK 166
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+ DFG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 167 ENSAPVKLGDFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 226 LLSGCLP 232

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 319
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLL-GSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L  ++  Y+        F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 102 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 147
Query: 215 IDKHWNPKVSDFGLAKLL-GSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L  ++  Y+        F + APE   T   +  SD + FG+ 
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 208 LWEMFT 213

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T 
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 108 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 153
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 214 LWEMFT 219

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E    
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERARF 109
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                   L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ + + T  
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-F 165
Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLKK 300
            GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E    
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
Query: 301 MVTNRNPEGVLDPKLPEKPTSRL 323
              +   + +L   L + P  RL
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 98  LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 143
Query: 215 IDKHWNPKVSDFGLAKLL-GSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L  ++  Y+        F + APE   T   +  SD + FG+ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 204 LWEMFT 209

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RG 141
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG   
Sbjct: 46  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--- 101
Query: 172 PCSPLTW----EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                 W    E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG
Sbjct: 102 ------WMKEKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFG 151
Query: 228 LAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +      +   T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 152 FSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +  
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNE 162
Query: 232 LGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
               +        G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 163 FTFGNK--LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 108 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 153
Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVMGT--FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L     +   +      F + APE   T   +  SD + FG+ 
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 214 LWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VAVK L   + ++ +A  +F  EV A+  + H+NL+RL G       +M V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGT--------AKGLSYLHEGLEPKVVHRDIKSSNIL 214
              L    G           + +LGT        A+G+ YL      + +HRD+ + N+L
Sbjct: 102 LDRLRKHQG-----------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLL 147
Query: 215 IDKHWNPKVSDFGLAKLL-GSESSYITTRVMGT-FGYVAPEYASTGMLNERSDVYSFGIL 272
           +      K+ DFGL + L  ++  Y+        F + APE   T   +  SD + FG+ 
Sbjct: 148 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 207
Query: 273 IMEVIS 278
           + E+ +
Sbjct: 208 LWEMFT 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           LV EY + G +  +L  HG            RM
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RM 111
Query: 183 NIILGTAK------GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
                 AK       + Y H+     +VHRD+K+ N+L+D   N K++DFG +      +
Sbjct: 112 KEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN 168
Query: 237 SYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
              T    G+  Y APE +          DV+S G+++  ++SG +P D
Sbjct: 169 KLDT--FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---G 126
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---G 130
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 101
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 102 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 154
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 155 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 127
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 128 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 180
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 181 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 96
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 97  FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 149
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 144 CAEGAHRML-VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C +   R+  V EYVN G+L   +         L  E         +  L+YLHE     
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RG 173
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           +++RD+K  N+L+D   + K++D+G+ K  G      T+   GT  Y+APE         
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 263 RSDVYSFGILIMEVISGRIPVD 284
             D ++ G+L+ E+++GR P D
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFD 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 102
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 103 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 155
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 156 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 8/137 (5%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 176
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--PE 308
           APE           D +  G+++ E++ GR+P  Y++  E++  +  ++++   R   PE
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPE 235
Query: 309 G--VLDPKLPEKPTSRL 323
              +L   L + P  RL
Sbjct: 236 AKSLLSGLLKKDPKQRL 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 8/137 (5%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 177
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN--PE 308
           APE           D +  G+++ E++ GR+P  Y++  E++  +  ++++   R   PE
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLGPE 236
Query: 309 G--VLDPKLPEKPTSRL 323
              +L   L + P  RL
Sbjct: 237 AKSLLSGLLKKDPKQRL 253

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 34/173 (19%)
Query: 132 VRHKNLVRLL----GYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           + H N+ R +       A+G    +LV EY  NG+L ++L           W     +  
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAH 118
Query: 187 GTAKGLSYLHEGL------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-------- 232
              +GL+YLH  L      +P + HRD+ S N+L+       +SDFGL+  L        
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 233 GSESSYITTRVMGTFGYVAPEYASTGMLNERS--------DVYSFGILIMEVI 277
           G E +   + V GT  Y+APE    G +N R         D+Y+ G++  E+ 
Sbjct: 179 GEEDNAAISEV-GTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 105 FLQVR-------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 157
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 158 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K+ DFG++  L  + + 
Sbjct: 109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
                 G   Y+APE  +  +     + +SD++S GI ++E+   R P D    P     
Sbjct: 167 DIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----- 219
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 220 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 259

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L YLH   E  VV+RD+K  N+++DK  + K++DFGL K  G +         GT  Y+
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 178
Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           APE           D +  G+++ E++ GR+P 
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 480 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 532
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-- 162
           KV  K ++    +     K E   +  V+H  +V L+     G    L+ EY++ G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
               + +  +   C  L  EI M         L +LH+     +++RD+K  NI+++   
Sbjct: 111 QLEREGIFMEDTACFYLA-EISM--------ALGHLHQ---KGIIYRDLKPENIMLNHQG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           + K++DFGL K    + + +T    GT  Y+APE       N   D +S G L+ ++++G
Sbjct: 159 HVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 280 RIPV 283
             P 
Sbjct: 218 APPF 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-- 162
           KV  K ++    +     K E   +  V+H  +V L+     G    L+ EY++ G L  
Sbjct: 51  KVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
               + +  +   C  L  EI M         L +LH+     +++RD+K  NI+++   
Sbjct: 111 QLEREGIFMEDTACFYLA-EISM--------ALGHLHQ---KGIIYRDLKPENIMLNHQG 158
Query: 220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 279
           + K++DFGL K    + + +T    GT  Y+APE       N   D +S G L+ ++++G
Sbjct: 159 HVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 280 RIPV 283
             P 
Sbjct: 218 APPF 221

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM 182
           EV  +  + H N+V+L           L+ EY + G +  +L  HG +      + + R 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-KFRQ 122
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    + Y H+    ++VHRD+K+ N+L+D   N K++DFG      S    +  +
Sbjct: 123 -----IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGF-----SNEFTVGGK 169
Query: 243 VMGTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVD 284
           +    G  AP YA+  +   +       DV+S G+++  ++SG +P D
Sbjct: 170 LDAFCG--APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG 171
           N    ++ F+ EV  +  + H N+V+L           LV EY + G +  +L  HG + 
Sbjct: 53  NSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                  E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG    
Sbjct: 112 -----EKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF--- 159
Query: 232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVD 284
             S       ++    G  AP YA+  +   +       DV+S G+++  ++SG +P D
Sbjct: 160 --SNEFTFGNKLDAFCG--APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 48  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 159
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 160 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218
Query: 285 YS 286
            S
Sbjct: 219 TS 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 97
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 98  YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 151
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 152 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 205
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 206 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 255
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 256 RFTELVCSL 264

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 52  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 110
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 111 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 163
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 164 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222
Query: 285 YS 286
            S
Sbjct: 223 TS 224

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 113
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 114 YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 167
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 168 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 221
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 222 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 271
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 272 RFTELVCSL 280

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 48  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 106
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 107 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 159
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGLA  +  +     T + GT  Y+APE  S    +   DV+S G ++  ++ G+ P +
Sbjct: 160 DFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218
Query: 285 YS 286
            S
Sbjct: 219 TS 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+      K+
Sbjct: 100 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 214 IMGEMVCHKI 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VAVK    +     +E F  E   +  + H ++V+L+G   E     ++ E    G L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGH 101
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
           +L  +      LT  +     L   K ++YL        VHRDI   NIL+      K+ 
Sbjct: 102 YLERNKNSLKVLTLVLYS---LQICKAMAYLES---INCVHRDIAVRNILVASPECVKLG 155
Query: 225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD 284
           DFGL++ +  E  Y  +       +++PE  +       SDV+ F + + E++S      
Sbjct: 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS------ 209
Query: 285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL-RCVDPNAQKRP 343
           + + P       WL+    N++  GVL+ K    P   L   +L   + RC D +   RP
Sbjct: 210 FGKQP-----FFWLE----NKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP 259
Query: 344 KMGHVVHML 352
           +   +V  L
Sbjct: 260 RFTELVCSL 268

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 59  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 113
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 114 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 169
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 229
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 230 PRTLSPEAKSLLAGLLKKDPKQRL 253

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  + +++H+N+V L        H  LV + V+ G L       +      T +    +
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTL 125
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITT 241
           I      + YLH      +VHRD+K  N+L    D+     +SDFGL+K+ G     + +
Sbjct: 126 IRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMS 180
Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
              GT GYVAPE  +    ++  D +S G++   ++ G  P 
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 122 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 169
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 226
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 227 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 266

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 121 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 168
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 169 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 225
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 226 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 265

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+      K+
Sbjct: 480 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKL 532
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   + Y  ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY+  G++   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 84/204 (41%), Gaps = 13/204 (6%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E   +   RH  L  L  Y  +   R+  V EY N G L  + H  +      T E   
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFTEERAR 108
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR 242
                    L YLH      VV+RDIK  N+++DK  + K++DFGL K  G         
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKX 164
Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV---DYSRPPEEVNLIEWLK 299
             GT  Y+APE           D +  G+++ E++ GR+P    D+ R  E + + E   
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 300 KMVTNRNPEGVLDPKLPEKPTSRL 323
               +   + +L   L + P  RL
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY+  G++   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ + +         YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 128 QMLLAV--------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 175
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 176 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 232
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 233 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 116/270 (42%), Gaps = 56/270 (20%)
Query: 102 DNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM--------- 151
           DN  VAVK +L      A+RE ++  E+     H N++R   +C E   +          
Sbjct: 47  DNRDVAVKRILPECFSFADREVQLLRESD---EHPNVIRY--FCTEKDRQFQYIAIELCA 101
Query: 152 -LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS 210
             + EYV   +   + H  + P         + ++  T  GL++LH      +VHRD+K 
Sbjct: 102 ATLQEYVEQKD---FAHLGLEP---------ITLLQQTTSGLAHLHS---LNIVHRDLKP 146
Query: 211 SNILI---DKHWNPK--VSDFGLAKLL--GSESSYITTRVMGTFGYVAPEYASTGMLNER 263
            NILI   + H   K  +SDFGL K L  G  S    + V GT G++APE  S       
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 264 S---DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
           +   D++S G +   VIS G  P   S           L++          LD   PEK 
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKS-----------LQRQANILLGACSLDCLHPEKH 255
Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
              ++ R L+  +  +DP  QKRP   HV+
Sbjct: 256 ED-VIARELIEKMIAMDP--QKRPSAKHVL 282

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 144 CAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSP-----LTWEIRMNIILGTAKGLSYLHE 197
           C +   R+  V EYVN G+L   +   VG            EI + +    +KG      
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKG------ 462
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                +++RD+K  N+++D   + K++DFG+ K         T    GT  Y+APE  + 
Sbjct: 463 -----IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 258 GMLNERSDVYSFGILIMEVISGRIPVD 284
               +  D ++FG+L+ E+++G+ P +
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 25/150 (16%)
Query: 144 CAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSP-----LTWEIRMNIILGTAKGLSYLHE 197
           C +   R+  V EYVN G+L   +   VG            EI + +    +KG      
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKG------ 141
Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVM-GTFGYVAPEY 254
                +++RD+K  N+++D   + K++DFG+ K    E+ +  +TT+   GT  Y+APE 
Sbjct: 142 -----IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPEI 192
Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVD 284
            +     +  D ++FG+L+ E+++G+ P +
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 106 VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K L     N+  A+R ++ E+  +  V HKN++ LL              +    +L
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 163 EQWLH-------GDVGPCSPLTWEI---RMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSS 211
           E++          D   C  +  E+   RM+ +L     G+ +LH      ++HRD+K S
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 155
Query: 212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           NI++      K+ DFGLA+  G  +S++    + T  Y APE        E  D++S G 
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGC 213
Query: 272 LIMEVISGRI 281
           ++ E++  +I
Sbjct: 214 IMGEMVCHKI 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ +         + YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 247 QMLL--------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 294
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 295 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 351
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 352 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 70  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 128
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 129 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 181
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 182 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 237
Query: 282 PVDYS 286
           P + S
Sbjct: 238 PFETS 242

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 72  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 130
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 131 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 183
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 184 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 282 PVDYS 286
           P + S
Sbjct: 240 PFETS 244

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 117 QAERE-FKVEVEAIGRVRHKNLVRLLGY---CAEGAHRM-LVYEYVNNGNLEQWL-HGDV 170
           ++ER+ FK E E +  ++H N+VR         +G   + LV E   +G L+ +L    V
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLA 229
                L    R  +     KGL +LH    P ++HRD+K  NI I     + K+ D GLA
Sbjct: 126 XKIKVLRSWCRQIL-----KGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
            L   + +     V+GT  + APE       +E  DVY+FG   +E  +   P  YS   
Sbjct: 180 TL---KRASFAKAVIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYP--YS--- 230
Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           E  N  +  +++ +   P       +PE
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIPE 258

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-------GAHRMLVYEYVN 158
           VAVK + ++R +     + E+     +RH N+   LG+ A             L+  Y  
Sbjct: 34  VAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIASDMTSRNSSTQLWLITHYHE 89
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNI 213
           +G+L  +L         L   + + + +  A GL++LH  +     +P + HRD KS N+
Sbjct: 90  HGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNV 144
Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYITT----RVMGTFGYVAPEYASTGMLNER------ 263
           L+  +    ++D GLA +    S Y+      RV GT  Y+APE     +  +       
Sbjct: 145 LVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEVLDEQIRTDCFESYKW 203
Query: 264 SDVYSFGILIMEV----ISGRIPVDYSRPP 289
           +D+++FG+++ E+    I   I  DY RPP
Sbjct: 204 TDIWAFGLVLWEIARRTIVNGIVEDY-RPP 232

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 34/228 (14%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDV----GPCSPLTW 178
           + E+E + ++ H  ++++  +  +     +V E +  G L   + G+       C    +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSE 235
           ++ +         + YLHE     ++HRD+K  N+L+         K++DFG +K+LG E
Sbjct: 261 QMLL--------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-E 308
Query: 236 SSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
           +S + T + GT  Y+APE      T   N   D +S G+++   +SG  P  +S    +V
Sbjct: 309 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQV 365
Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +L + +     N  PE  +  ++ EK    L+K++L+     VDP A+
Sbjct: 366 SLKDQITSGKYNFIPE--VWAEVSEKALD-LVKKLLV-----VDPKAR 405

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           +I   I +   K L +LH  L   V+HRD+K SN+LI+     K  DFG++  L  + + 
Sbjct: 136 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK 193
Query: 239 ITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
                 G   Y APE  +  +     + +SD++S GI  +E+   R P D    P     
Sbjct: 194 DID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP----- 246
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + LK++V   +         P+ P  +     +    +C+  N+++RP
Sbjct: 247 FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERP 286

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 106 VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K +  +  Q+  +++    EV  + ++RH N ++  G         LV EY   G+ 
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 101
Query: 163 EQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
              L     P      E+ +  +  G  +GL+YLH      ++HRD+K+ NIL+ +    
Sbjct: 102 SDLLEVHKKPLQ----EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 154
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFG A ++   + ++     GT  ++APE       G  + + DV+S GI  +E+  
Sbjct: 155 KLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 279 GRIPV 283
            + P+
Sbjct: 210 RKPPL 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 106 VAVKNLLNNRGQAEREFK---VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           VA+K +  +  Q+  +++    EV  + ++RH N ++  G         LV EY   G+ 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140
Query: 163 EQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
              L     P      E+ +  +  G  +GL+YLH      ++HRD+K+ NIL+ +    
Sbjct: 141 SDLLEVHKKPLQ----EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY---ASTGMLNERSDVYSFGILIMEVIS 278
           K+ DFG A ++   + ++     GT  ++APE       G  + + DV+S GI  +E+  
Sbjct: 194 KLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 279 GRIPV 283
            + P+
Sbjct: 249 RKPPL 253

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           VE + + +V H   +  L Y  E    + LV   +N G++   ++ +V   +P   E R 
Sbjct: 234 VEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQEPRA 291
Query: 183 NIILGTAK---GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
             I  TA+   GL +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  +  
Sbjct: 292 --IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           T    GT G++APE       +   D ++ G+ + E+I+ R P 
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 107 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 218
Query: 276 VISGR 280
           ++S R
Sbjct: 219 MLSNR 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 153
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 154 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 206
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFGLAK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 51  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 106
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 11/172 (6%)
Query: 114 NRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPC 173
           N    ++ F+ EV     + H N+V+L           LV EY + G +  +L   V   
Sbjct: 53  NSSSLQKLFR-EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL---VAHG 108
Query: 174 SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG 233
                E R          + Y H+     +VHRD+K+ N+L+D   N K++DFG +    
Sbjct: 109 RXKEKEARAKF-RQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT 164
Query: 234 SESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVD 284
             +        G   Y APE +          DV+S G+++  ++SG +P D
Sbjct: 165 FGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
            A K ++      +   + E++ +  +RH  LV L     +    +++YE+++ G L + 
Sbjct: 79  FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 138
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KV 223
           +  +    + ++ +  +  +    KGL ++HE      VH D+K  NI+   K  N  K+
Sbjct: 139 VADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 192
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGL   L  + S   T   GT  + APE A    +   +D++S G+L   ++SG  P 
Sbjct: 193 IDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P     P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 145
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 146 S---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 198
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 107 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 218
Query: 276 VISGR 280
           ++S R
Sbjct: 219 MLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 58  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 116
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 117 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 172
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 173 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 228
Query: 276 VISGR 280
           ++S R
Sbjct: 229 MLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 114 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 170 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 225
Query: 276 VISGR 280
           ++S R
Sbjct: 226 MLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 56  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 115 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 170
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 171 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 226
Query: 276 VISGR 280
           ++S R
Sbjct: 227 MLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 47  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 106 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 161
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 162 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 217
Query: 276 VISGR 280
           ++S R
Sbjct: 218 MLSNR 222

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 151
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 179
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 111 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 166
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 167 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 222
Query: 276 VISGR 280
           ++S R
Sbjct: 223 MLSNR 227

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +     T + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 183
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIP 282
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           K+  K+LL    Q E+   +E+     + H+++V   G+  +     +V E     +L +
Sbjct: 46  KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 104
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS 224
                     P        I+LG      YLH     +V+HRD+K  N+ +++    K+ 
Sbjct: 105 LHKRRKALTEPEARYYLRQIVLGC----QYLHRN---RVIHRDLKLGNLFLNEDLEVKIG 157
Query: 225 DFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           DFGLA    ++  Y   R   + GT  Y+APE  S    +   DV+S G ++  ++ G+ 
Sbjct: 158 DFGLA----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 282 PVDYS 286
           P + S
Sbjct: 214 PFETS 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 118
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREV 170
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIP 282
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 128
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 129 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 184
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 185 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 240
Query: 276 VISGR 280
           ++S R
Sbjct: 241 MLSNR 245

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
           R+F  E   +    H N++ +LG C      H  L+  ++  G+L   LH         +
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS 111
Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
             ++    L  A+G+++LH  LEP +    + S +++ID+    ++S      +   + S
Sbjct: 112 QAVK--FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARIS------MADVKFS 162
Query: 238 YITTRVMGTFGYVAPEYASTGM--LNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
           + +   M    +VAPE         N RS D++SF +L+ E+++  +P        +++ 
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSN 216
Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +E   K+      EG L P +P   +  + K + +    C++ +  KRPK   +V +LE 
Sbjct: 217 MEIGMKVAL----EG-LRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILEK 267
Query: 355 QE 356
            +
Sbjct: 268 MQ 269

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 144
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIIL 197
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 109 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 165 IXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 220
Query: 276 VISGR 280
           ++S R
Sbjct: 221 MLSNR 225

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIII 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 9/159 (5%)
Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           +  V+H  LV L            V +Y+N G L   L  +     P        I    
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI---- 148
Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
           A  L YLH      +V+RD+K  NIL+D   +  ++DFGL K    E +  T+   GT  
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 249 YVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR 287
           Y+APE       +   D +  G ++ E++ G +P  YSR
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSR 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 125 EVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           EV+ + +V  H N+++L           LV++ +  G L  +L   V      T +I M 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
            +L     L  L+      +VHRD+K  NIL+D   N K++DFG +  L          V
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSV 183
Query: 244 MGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIP 282
            GT  Y+APE     M        +  D++S G+++  +++G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 196 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI ++ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 10/180 (5%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
            A K ++      +   + E++ +  +RH  LV L     +    +++YE+++ G L + 
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KV 223
           +  +    + ++ +  +  +    KGL ++HE      VH D+K  NI+   K  N  K+
Sbjct: 245 VADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
            DFGL   L  + S   T   GT  + APE A    +   +D++S G+L   ++SG  P 
Sbjct: 299 IDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT----FEYLH 151
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 204
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 105 KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLE 163
           KV  K  +  + +     + E + +  +R    +  L Y  +   ++ L+ +Y+N G L 
Sbjct: 88  KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147
Query: 164 QWLHGDVGPCSPLTWEIRMNIILG-TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
             L            E  + I +G     L +LH+     +++RDIK  NIL+D + +  
Sbjct: 148 THL-----SQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVV 199
Query: 223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML--NERSDVYSFGILIMEVISGR 280
           ++DFGL+K   ++ +       GT  Y+AP+    G    ++  D +S G+L+ E+++G 
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
Query: 281 IP 282
            P
Sbjct: 260 SP 261

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 194 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 13/172 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L        
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGLAK 230
            LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGLA 
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
            +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 14/181 (7%)
Query: 105 KVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           KVAVK L     +   A R ++ E+  +  ++H+N++ LL             E      
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L      ++     L+ E    ++    +GL Y+H      ++HRD+K SN+ +++    
Sbjct: 114 LMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSEL 170
Query: 222 KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           ++ DFGLA+    E + Y+ TR      Y APE     M  N+  D++S G ++ E++ G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 280 R 280
           +
Sbjct: 226 K 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 106 VAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQ 164
           VA+K   N    + RE F  E   + +  H ++V+L+G   E     ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRS 99
Query: 165 WLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-VVHRDIKSSNILIDKHWNPKV 223
           +L           + + +  ++  A  LS     LE K  VHRDI + N+L+  +   K+
Sbjct: 100 FLQVR-------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 152
Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
            DFGL++ +   +    ++      ++APE  +       SDV+ FG+ + E++
Sbjct: 153 GDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +    T  + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 113 NNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP 172
           + RG +  + + EV  +  ++H N++ L          +L+ E V  G L  +L      
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AE 107
Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK----VSDFGL 228
              LT E     +     G+ YLH     ++ H D+K  NI++     PK    + DFGL
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
           A  +   + +    + GT  +VAPE  +   L   +D++S G++   ++SG  P 
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 105 KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           K+A K ++  RG  ++E  K E+  + ++ H NL++L          +LV EYV+ G L 
Sbjct: 116 KLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP- 221
             +  +    + L   + M  I    +G+ ++H+     ++H D+K  NIL +++     
Sbjct: 175 DRIIDESYNLTELDTILFMKQI---CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQI 228
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI 281
           K+ DFGLA+              GT  ++APE  +   ++  +D++S G++   ++SG  
Sbjct: 229 KIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 282 PVDYSRPPEEVNLI 295
           P       E +N I
Sbjct: 287 PFLGDNDAETLNNI 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 27/168 (16%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEIRMN 183
           EV  +  + H N+++L  +  +  +  LV E    G L ++ +H            ++ N
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-----------RMKFN 134
Query: 184 ------IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGS 234
                 II     G++YLH+     +VHRD+K  N+L+   +K    K+ DFGL+ +   
Sbjct: 135 EVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-- 189
Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E+       +GT  Y+APE       +E+ DV+S G+++  +++G  P
Sbjct: 190 ENQKKMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPP 236

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 212 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFGLAK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 14/98 (14%)
Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTF 247
           +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            Y APE     MLN +      D++S G ++ E++S R
Sbjct: 194 WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
             YLH      +++RD+K  N++ID+    KV+DFG AK +       T  + GT  Y+A
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           PE   +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT  Y+AP    
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTP 190
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFGLA+ +  +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 236 SSYITT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 278
             Y+          ++APE     +   +SDV+SFG+L+ E+ S
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 4/99 (4%)
Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           T +G+ YLH     +V+HRD+K  N+ ++   + K+ DFGLA  +  +       + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTP 206
Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
            Y+APE       +   D++S G ++  ++ G+ P + S
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN- 183
           EV  +  ++H N+V L           LV+EY++  +L+Q+L  D G        I M+ 
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNI------INMHN 101
Query: 184 ---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
               +    +GL+Y H     KV+HRD+K  N+LI++    K++DFGLA+     +    
Sbjct: 102 VKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 241 TRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
             V+ T  Y  P+    ST   + + D++  G +  E+ +GR     S   E+++ I
Sbjct: 159 NEVV-TLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 113 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +       + T  Y APE     MLN +      D++S G ++ E
Sbjct: 169 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 224
Query: 276 VISGR 280
           ++S R
Sbjct: 225 MLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 105 KVAVKNL--LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL 162
           +VA+K +    ++   +R  + E++ + R RH+N++ +           +   Y+    +
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK 222
           E  L+  +     L+ +     +    +GL Y+H      V+HRD+K SN+L++   + K
Sbjct: 114 ETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 223 VSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 275
           + DFGLA++   +  +       + T  Y APE     MLN +      D++S G ++ E
Sbjct: 170 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAE 225
Query: 276 VISGR 280
           ++S R
Sbjct: 226 MLSNR 230

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 37  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 96
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 97  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 142
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 143 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 200
Query: 278 SGRIP 282
            G  P
Sbjct: 201 VGYPP 205

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 38  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 98  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 143
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 144 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 278 SGRIP 282
            G  P
Sbjct: 202 VGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 38  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 98  AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 143
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 144 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 278 SGRIP 282
            G  P
Sbjct: 202 VGYPP 206

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLE 163
           VAVK +   RG A  E  V+ E I    +RH N+VR         H  ++ EY + G L 
Sbjct: 48  VAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104
Query: 164 QWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-- 221
           + +  + G  S          +L    G+SY H     ++ HRD+K  N L+D    P  
Sbjct: 105 ERI-CNAGRFSEDEARFFFQQLLS---GVSYCHSM---QICHRDLKLENTLLDGSPAPRL 157
Query: 222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGR 280
           K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ G 
Sbjct: 158 KICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 281 IPVDYSRPPEE 291
            P +    P +
Sbjct: 216 YPFEDPEEPRD 226

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EY   G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N++ID+    +V+DFG AK +       T  + GT  Y+APE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V L+          LV+E++   +L++ L  +         +I +  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L   +G+++ H+    +++HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y AP+    +   +   D++S G +  E+I+G+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 43  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 101 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 153
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 154 RLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 211
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 212 GAYP--FEDPEEPKNFRKTIHRIL 233

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYAHAM---QVAHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAK--LLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEV 276
             K++DFG +K  +L S+        +GT  Y+APE       + + +DV+S G+ +  +
Sbjct: 155 RLKIADFGYSKASVLHSQPK----SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210
Query: 277 ISGRIPVDYSRPPEEVNLIEWLKKMV 302
           + G  P  +  P E  N  + + +++
Sbjct: 211 LVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+  +  + H N+V L+          LV+E++   +L++ L  +         +I +  
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           +L   +G+++ H+    +++HRD+K  N+LI+     K++DFGLA+  G      T  V+
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 245 GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGR 280
            T  Y AP+    +   +   D++S G +  E+I+G+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 111 LLNNRGQAEREF-KVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+F K+E EA    +++H N+VRL     E +   LV++ V  G L     
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + ++Y H      +VHR++K  N+L+    K
Sbjct: 121 AREFYSEADASHC-----------IQQILESIAYCHSN---GIVHRNLKPENLLLASKAK 166
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
               K++DFGLA  +    ++      GT GY++PE       ++  D+++ G+++  ++
Sbjct: 167 GAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
Query: 278 SGRIP 282
            G  P
Sbjct: 225 VGYPP 229

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 28/190 (14%)
Query: 103 NSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA------EGAHRMLV 153
            +KVA+K L     +   A+R ++ E+  +  +RH+N++ LL          +     LV
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-IILGTAKGLSYLHEGLEPKVVHRDIKSSN 212
             ++     +   H  +G       E R+  ++    KGL Y+H      ++HRD+K  N
Sbjct: 109 MPFMGTDLGKLMKHEKLG-------EDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGN 158
Query: 213 ILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFG 270
           + +++    K+ DFGLA+   SE    + TR      Y APE     M   +  D++S G
Sbjct: 159 LAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVG 213
Query: 271 ILIMEVISGR 280
            ++ E+I+G+
Sbjct: 214 CIMAEMITGK 223

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           LV+L     + ++  +V EYV  G +   L        P        I+L       YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 158
Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 +++RD+K  N+LID+    +V+DFG AK +       T  + GT   +APE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEIIL 211
Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           +   N+  D ++ G+LI E+ +G  P    +P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 118 AEREFKVEVEAIGRVRHKNLVRLLG--YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSP 175
            E   K E++ + R+RHKN+++L+   Y  E     +V EY   G  E     D  P   
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKR 105
Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
                          GL YLH      +VH+DIK  N+L+      K+S  G+A+ L   
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 236 SSYITTRV-MGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRIPVD 284
           ++  T R   G+  +  PE A+        + D++S G+ +  + +G  P +
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 59  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 115
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K   +L+   
Sbjct: 116 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 168
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+  FG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 169 ENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 227
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 228 LLSGCLP 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           V V    ++ G +  + K E      ++H ++V LL   +      +V+E+++  +L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--- 113
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP-------KVVHRDIKSSNILIDKH 218
                  C  +        +   A    Y+ + LE         ++HRD+K   +L+   
Sbjct: 114 -------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 166
Query: 219 WNP---KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
            N    K+  FG+A  LG ES  +    +GT  ++APE        +  DV+  G+++  
Sbjct: 167 ENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 276 VISGRIP 282
           ++SG +P
Sbjct: 226 LLSGCLP 232

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+      K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+ DFG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 155 RLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 213 GAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           + E+  + R+ H N+++L           LV E V  G L   +  + G  S       +
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAV 154
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP------KVSDFGLAKLLGSES 236
             IL   + ++YLHE     +VHRD+K  N+L   +  P      K++DFGL+K++  E 
Sbjct: 155 KQIL---EAVAYLHEN---GIVHRDLKPENLL---YATPAPDAPLKIADFGLSKIV--EH 203
Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
             +   V GT GY APE           D++S GI+   ++ G  P
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
           ++HRD+K  N+L+DKH + K++DFG    +           +GT  Y++PE   +    G
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 106 VAVKNLLN---NRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR--MLVYEYVNN 159
           VAVK + +   N   A+R F+ E+  +  +  H+N+V LL        R   LV++Y   
Sbjct: 37  VAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY--- 92
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
             +E  LH  V   + L    +  ++    K + YLH G    ++HRD+K SNIL++   
Sbjct: 93  --METDLHA-VIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAEC 146
Query: 220 NPKVSDFGLAKLL--------------------GSESSYITTRVMGTFGYVAPE-YASTG 258
           + KV+DFGL++                        +   I T  + T  Y APE    + 
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 259 MLNERSDVYSFGILIMEVISGR 280
              +  D++S G ++ E++ G+
Sbjct: 207 KYTKGIDMWSLGCILGEILCGK 228

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYIT- 240
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++    +++S  T 
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 241 -----TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
                T  + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L     
Sbjct: 63  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 122
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---K 217
             E +   D   C           I    + ++++H+     +VHRD+K  N+L+    K
Sbjct: 123 AREYYSEADASHC-----------IHQILESVNHIHQH---DIVHRDLKPENLLLASKCK 168
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 169 GAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYIL 226
Query: 277 ISGRIP 282
           + G  P
Sbjct: 227 LVGYPP 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E  H  L+++ V  G L    
Sbjct: 53  KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI 112
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--- 216
              E +   D   C           I    + + + H   +  VVHRD+K  N+L+    
Sbjct: 113 VAREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRDLKPENLLLASKL 158
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 159 KGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 276 VISGRIP 282
           ++ G  P
Sbjct: 217 LLVGYPP 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 98/250 (39%), Gaps = 54/250 (21%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH--------------- 167
           K EV  + ++ H N+ RL     +  +  LV E  + G+L   L+               
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 168 -GDVGPCSPLTWE--------------------IRMNIILGTAKGLSYLHEGLEPKVVHR 206
              + PC     E                    +  NI+      L YLH      + HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192
Query: 207 DIKSSNILI--DKHWNPKVSDFGLAK---LLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           DIK  N L   +K +  K+ DFGL+K    L +   Y  T   GT  +VAPE  +T   N
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT--N 250
Query: 262 E----RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE-GVLDPKLP 316
           E    + D +S G+L+  ++ G +P       + ++ +  L K +   NP   VL P L 
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSP-LA 307
Query: 317 EKPTSRLLKR 326
               S LL R
Sbjct: 308 RDLLSNLLNR 317

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL---GSESSYIT- 240
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++    +++S  T 
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 241 -----TRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
                T  + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L    
Sbjct: 35  KIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--- 216
              E +   D   C           I    + + + H   +  VVHRD+K  N+L+    
Sbjct: 95  VAREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRDLKPENLLLASKC 140
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYI 198
Query: 276 VISGRIP 282
           ++ G  P
Sbjct: 199 LLVGYPP 205

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVIS 278
             K+  FG +K     S   +T  +GT  Y+APE       + + +DV+S G+ +  ++ 
Sbjct: 155 RLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 279 GRIPVDYSRPPEEVNLIEWLKKMV 302
           G  P  +  P E  N  + + +++
Sbjct: 213 GAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 18/168 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +   +H+N++ +       +       Y+    ++  LH  +     L+ +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-TQMLSDDHIQYF 117
Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-----------G 233
           I  T + +  LH      V+HRD+K SN+LI+ + + KV DFGLA+++           G
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 234 SESSYITTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGR 280
            +S  +    + T  Y APE   T     R+ DV+S G ++ E+   R
Sbjct: 175 QQSGMV--EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 10/163 (6%)
Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           K E+  + ++ H  L+ L     +    +L+ E+++ G L   +  +    S       +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VI 152
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLLGSESSYIT 240
           N +    +GL ++HE     +VH DIK  NI+ +  K  + K+ DFGLA  L  +   I 
Sbjct: 153 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 207
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPV 283
                T  + APE      +   +D+++ G+L   ++SG  P 
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 103 NSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           N  VAVK +   RG+  +   K E+     +RH N+VR         H  +V EY + G 
Sbjct: 44  NELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L + +  + G  S          ++    G+SY H     +V HRD+K  N L+D    P
Sbjct: 102 LFERI-CNAGRFSEDEARFFFQQLIS---GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 222 --KVSDFGLAKLLGSESSYITTR---VMGTFGYVAPEYASTGMLNER-SDVYSFGILIME 275
             K+  FG +K     SS + ++    +GT  Y+APE       + + +DV+S G+ +  
Sbjct: 155 RLKICAFGYSK-----SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 276 VISGRIPVDYSRPPEEVNLIEWLKKMV 302
           ++ G  P  +  P E  N  + + +++
Sbjct: 210 MLVGAYP--FEDPEEPKNFRKTIHRIL 234

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 103/254 (40%), Gaps = 49/254 (19%)
Query: 120 REFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG-----DVGPCS 174
           + FK EV A  + RH+N+V  +G C    H  ++        L   +       DV    
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLL 232
            +  EI         KG+ YLH      ++H+D+KS N+  D   N KV  +DFGL  + 
Sbjct: 134 QIAQEI--------VKGMGYLH---AKGILHKDLKSKNVFYD---NGKVVITDFGLFSIS 179
Query: 233 G---SESSYITTRVM-GTFGYVAPEYASTGM---------LNERSDVYSFGILIMEVISG 279
           G   +       R+  G   ++APE                ++ SDV++ G +  E+ + 
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
             P   ++P E +     + +M T       + P L +    + +  ILL    C     
Sbjct: 240 EWPFK-TQPAEAI-----IWQMGTG------MKPNLSQIGMGKEISDILLF---CWAFEQ 284
Query: 340 QKRPKMGHVVHMLE 353
           ++RP    ++ MLE
Sbjct: 285 EERPTFTKLMDMLE 298

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST----G 258
            +HRD+K  N+L+DK  + K++DFG    +  E        +GT  Y++PE   +    G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/84 (40%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           VVHRDIK  NILID +    K+ DFG   LL  E     T   GT  Y  PE+ S    +
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYH 216
Query: 262 E-RSDVYSFGILIMEVISGRIPVD 284
              + V+S GIL+ +++ G IP +
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFE 240

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E  H  L+++ V  G L     
Sbjct: 43  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---K 217
             E +   D   C           I    + + + H   +  VVHR++K  N+L+    K
Sbjct: 103 AREYYSEADASHC-----------IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLK 148
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL 206
Query: 277 ISGRIP 282
           + G  P
Sbjct: 207 LVGYPP 212

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 111 LLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
           ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L     
Sbjct: 36  IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 95
Query: 163 --EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DK 217
             E +   D   C           I    + +++ H      +VHRD+K  N+L+    K
Sbjct: 96  AREYYSEADASHC-----------IQQILESVNHCHLN---GIVHRDLKPENLLLASKSK 141
Query: 218 HWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 276
               K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  +
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYIL 199
Query: 277 ISGRIPV 283
           + G  P 
Sbjct: 200 LVGYPPF 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 30/187 (16%)
Query: 110 NLLNNRGQAEREF-KVEVEA-IGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL---- 162
            ++N +  + R+  K+E EA I R+ +H N+VRL    +E     LV++ V  G L    
Sbjct: 35  KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 94
Query: 163 ---EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---D 216
              E +   D   C           I    + +++ H      +VHRD+K  N+L+    
Sbjct: 95  VAREYYSEADASHC-----------IQQILESVNHCHLN---GIVHRDLKPENLLLASKS 140
Query: 217 KHWNPKVSDFGLA-KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 275
           K    K++DFGLA ++ G + ++      GT GY++PE        +  D+++ G+++  
Sbjct: 141 KGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 276 VISGRIP 282
           ++ G  P
Sbjct: 199 LLVGYPP 205

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 37/79 (46%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
            HRD+K  NIL+       + DFG+A     E        +GT  Y APE  S      R
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 264 SDVYSFGILIMEVISGRIP 282
           +D+Y+   ++ E ++G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY-----ASTG 258
           VHRDIK  NIL+D + + +++DFG    L  + +  ++  +GT  Y++PE         G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 96
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 97  DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 153
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPE-------YAST 257
              D+    +     +SDFGL K L S  S   T +    GT G+ APE         + 
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
             L    D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 260

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEH 231

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEH 232

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 239
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 240 GRSAAVWSLGILLYDMVCGDIPFEH 264

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEH 251

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 191 GRSAAVWSLGILLYDMVCGDIPFEHD 216

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEH 245

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEH 244

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEH 259

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 214
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 215 GRSAAVWSLGILLYDMVCGDIPFEH 239

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEH 217

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 262 ERS-DVYSFGILIMEVISGRIPVDY 285
            RS  V+S GIL+ +++ G IP ++
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEH 216

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/249 (21%), Positives = 112/249 (44%), Gaps = 30/249 (12%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML-----VYEYV 157
           + +VA+K ++    Q+ +    E++ I R+ H N+V++         ++      + E  
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 158 NNGNLEQWLHGDVGPC---SPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           +   +++++  D+       PL  E     +    +GL Y+H      V+HRD+K +N+ 
Sbjct: 96  SVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLF 152
Query: 215 ID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML------NERSDVY 267
           I+ +    K+ DFGLA+++    S+   +   + G V   Y S  +L       +  D++
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209
Query: 268 SFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL---------DPKLPEK 318
           + G +  E+++G+     +   E++ LI     +V   + + +L         D   P K
Sbjct: 210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHK 269
Query: 319 PTSRLLKRI 327
           P ++LL  I
Sbjct: 270 PLTQLLPGI 278

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 203 VVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           V+HRDIK  NILID      K+ DFG   LL      + T   GT  Y  PE+      +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 262 ERS-DVYSFGILIMEVISGRIPVDYS 286
            RS  V+S GIL+ +++ G IP ++ 
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHD 213

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEI 180
           FK E+E +  + H N++RL     +     LV E    G L E+ +H  V   S      
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--- 109
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNP-KVSDFGLAKLLGSESS 237
              I+      ++Y H+     V HRD+K  N L   D   +P K+ DFGLA        
Sbjct: 110 --RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGK 163
Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
            + T+V GT  YV+P+    G+     D +S G+++  ++ G  P  +S P +
Sbjct: 164 MMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTD 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL--EQWLHGDVGPCSPLTWEIRM 182
           EV  + ++ H N+++L  +  +  +  LV E    G L  E  L       S +   + M
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF---SEVDAAVIM 110
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYI 239
             +L    G +YLH+     +VHRD+K  N+L++        K+ DFGL+     E    
Sbjct: 111 KQVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 162
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
               +GT  Y+APE       +E+ DV+S G+++  ++ G  P
Sbjct: 163 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPP 204

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-EQWLHGDVGPCSPLTWEI 180
           FK E+E +  + H N++RL     +     LV E    G L E+ +H  V   S      
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--- 126
Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNP-KVSDFGLAKLLGSESS 237
              I+      ++Y H   +  V HRD+K  N L   D   +P K+ DFGLA        
Sbjct: 127 --RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGK 180
Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
            + T+V GT  YV+P+    G+     D +S G+++  ++ G  P  +S P +
Sbjct: 181 MMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTD 229

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E E + ++ HKN+V+L     E    H++L+ E+   G+L   L  +      L     +
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL 115
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSY 238
            ++     G+++L E     +VHR+IK  NI+     D     K++DFG A+ L  +  +
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 239 ITTRVMGTFGYVAPEYASTGMLNE--------RSDVYSFGILIMEVISGRIPVDYSRPPE 290
           ++  + GT  Y+ P+     +L +          D++S G+      +G +P      P 
Sbjct: 173 VS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 291 EVNLIEWLKKMVTNRNPEGVL 311
                E + K++T + P G +
Sbjct: 231 RNK--EVMYKIITGK-PSGAI 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 114
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 115 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 171
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPEY---ASTGMLN 261
              D+    +     +SDFGL K L S        +    GT G+ APE    ++   L 
Sbjct: 172 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLT 231
Query: 262 ERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
              D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 232 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 274

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 114
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----- 215
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 115 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 171
Query: 216 ---DKHWNPK-----VSDFGLAKLLGSESSYITTRV---MGTFGYVAPEY---ASTGMLN 261
              D+    +     +SDFGL K L S        +    GT G+ APE    ++   L 
Sbjct: 172 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLT 231
Query: 262 ERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
              D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 232 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-----G 258
           VHRDIK  N+L+D + + +++DFG    +  + +  ++  +GT  Y++PE         G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 259 MLNERSDVYSFGILIMEVISGRIPV 283
                 D +S G+ + E++ G  P 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R  +E  F+     + ++ HK+LV   G C  G   +LV E+V  G+L+ +L  +   C 
Sbjct: 53  RNYSESFFEA-ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CI 110
Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL-- 232
            + W++ +   L  A     +H   E  ++H ++ + NIL+ +  + K  +    KL   
Sbjct: 111 NILWKLEVAKQLAAA-----MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 233 GSESSYITTRVMGT-FGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
           G   + +   ++     +V PE       LN  +D +SFG  + E+ SG
Sbjct: 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 96  FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 150
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 151 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 236 SSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 112 FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 166
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 167 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 236 SSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 279

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 122 FKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
           F+VE + A   +    +V L G   EG    +  E +  G+L Q +   +G C P   E 
Sbjct: 110 FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-QMG-CLP---ED 164
Query: 181 RMNIILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSE 235
           R    LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G  
Sbjct: 165 RALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 236 SSYITTRVM-GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
            S +T   + GT  ++APE       + + D++S   +++ +++G  P   Y R P
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 277

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWE--IR 181
           V++  +     KN V  L   +   +  +  +     NL+ W++     CS    E  + 
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR---CSLEDREHGVC 166
Query: 182 MNIILGTAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT 240
           ++I +  A+ + +LH +GL    +HRD+K SNI        KV DFGL   +  +    T
Sbjct: 167 LHIFIQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 241 TRV-----------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 277
                         +GT  Y++PE       + + D++S G+++ E++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL--EQWLHGDVGPCSPLTWEIRM 182
           EV  + ++ H N+++L  +  +  +  LV E    G L  E  L       S +   + M
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF---SEVDAAVIM 127
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYI 239
             +L    G +YLH+     +VHRD+K  N+L++        K+ DFGL+     E    
Sbjct: 128 KQVLS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGK 179
Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
               +GT  Y+APE       +E+ DV+S G+++  ++ G  P
Sbjct: 180 MKERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPP 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 107 AVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCA-------EGAHRMLVYEYVN 158
           A+K LL+N  +  R    EV  + ++  H N+V+     +        G    L+   + 
Sbjct: 57  ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH 218
            G L ++L   +    PL+ +  + I   T + + ++H   +P ++HRD+K  N+L+   
Sbjct: 117 KGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQ 174
Query: 219 WNPKVSDFGLAKLLGSESSY---ITTRVM--------GTFGYVAPEYA---STGMLNERS 264
              K+ DFG A  +     Y      R +         T  Y  PE     S   + E+ 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 265 DVYSFGILIMEVISGRIPVD-----------YSRPPEEV--NLIEWLKKMVTNRNPE 308
           D+++ G ++  +   + P +           YS PP +    +   L + +   NPE
Sbjct: 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 125 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 176
Query: 250 V 250
           V
Sbjct: 177 V 177

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 178
Query: 250 V 250
           V
Sbjct: 179 V 179

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 178
Query: 250 V 250
           V
Sbjct: 179 V 179

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
           R  +E  F+     + ++ HK+LV   G C  G   +LV E+V  G+L+ +L  +   C 
Sbjct: 53  RNYSESFFEA-ASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKN-CI 110
Query: 175 PLTWEIRMNIILGTAKGLSY-LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL- 232
            + W++ +      AK L++ +H   E  ++H ++ + NIL+ +  + K  +    KL  
Sbjct: 111 NILWKLEV------AKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 233 -GSESSYITTRVMGT-FGYVAPEYASTGM-LNERSDVYSFGILIMEVISG 279
            G   + +   ++     +V PE       LN  +D +SFG  + E+ SG
Sbjct: 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H ++VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGY 249
            Y+H      +VH DIK SNI I +   P       A   G E  + + +VM   G  G+
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNA-----ASEEGDEDDWASNKVMFKIGDLGH 180
Query: 250 V 250
           V
Sbjct: 181 V 181

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 12/132 (9%)
Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP--CSPLTWEIR 181
           +E+  + RV H N++++L          LV E   +G L+ +   D  P    PL   I 
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIF 136
Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
             ++  +A G   L +     ++HRDIK  NI+I + +  K+ DFG A  L  E   +  
Sbjct: 137 RQLV--SAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFY 187
Query: 242 RVMGTFGYVAPE 253
              GT  Y APE
Sbjct: 188 TFCGTIEYCAPE 199

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           E E + ++ HKN+V+L     E    H++L+ E+   G+L   L  +      L     +
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFL 115
Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSY 238
            ++     G+++L E     +VHR+IK  NI+     D     K++DFG A+ L  +  +
Sbjct: 116 IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 239 ITTRVMGTFGYVAPEYASTGMLNE--------RSDVYSFGILIMEVISGRIPVDYSRPPE 290
           +   + GT  Y+ P+     +L +          D++S G+      +G +P      P 
Sbjct: 173 VX--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 291 EVNLIEWLKKMVTNRNPEGVL 311
                E + K++T + P G +
Sbjct: 231 RNK--EVMYKIITGK-PSGAI 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 20/140 (14%)
Query: 151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR-----MNIILGTAKGLSYLHEGLEPKVVH 205
           +L+ EY   G +          C P   E+      + +I    +G+ YLH+     +VH
Sbjct: 105 ILILEYAAGGEI-------FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVH 154
Query: 206 RDIKSSNILIDKHW---NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
            D+K  NIL+   +   + K+ DFG+++ +G         +MGT  Y+APE  +   +  
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITT 212
Query: 263 RSDVYSFGILIMEVISGRIP 282
            +D+++ GI+   +++   P
Sbjct: 213 ATDMWNIGIIAYMLLTHTSP 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 103 NSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           + + AVK +    G        EVE + + + H+N++ L+ +  E     LV+E +  G+
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97
Query: 162 LEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN 220
           +   +H           E+  ++++   A  L +LH      + HRD+K  NIL + H N
Sbjct: 98  ILSHIHK-----RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCE-HPN 148
Query: 221 P----KVSDFGLA---KLLGSESSYITTRVM---GTFGYVAPEYA-----STGMLNERSD 265
                K+ DFGL    KL G  S   T  ++   G+  Y+APE          + ++R D
Sbjct: 149 QVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 266 VYSFGILIMEVISGRIP 282
           ++S G+++  ++SG  P
Sbjct: 209 LWSLGVILYILLSGYPP 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+ A   +    +V L G   EG    +  E +  G+L Q L  + G C P   E R   
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLP---EDRALY 189
Query: 185 ILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSESSYI 239
            LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G   S +
Sbjct: 190 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 240 T-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T   + GT  ++APE       + + DV+S   +++ +++G  P
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 107 AVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQW 165
           AVK +    G +      EVE + + + +KN++ L+ +  +     LV+E +  G++   
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 166 LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNP-K 222
           +                 ++   A  L +LH      + HRD+K  NIL +  +  +P K
Sbjct: 102 IQKQ----KHFNEREASRVVRDVAAALDFLHT---KGIAHRDLKPENILCESPEKVSPVK 154
Query: 223 VSDFGLAK--LLGSESSYITTRVM----GTFGYVAPEYA-----STGMLNERSDVYSFGI 271
           + DF L     L +  + ITT  +    G+  Y+APE            ++R D++S G+
Sbjct: 155 ICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGV 214
Query: 272 LIMEVISGRIP 282
           ++  ++SG  P
Sbjct: 215 VLYIMLSGYPP 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/192 (22%), Positives = 89/192 (46%), Gaps = 19/192 (9%)
Query: 105 KVAVKNLLNNRGQAE--REFKVEVEAIGRVRHKNLVRLLGYCAEGAHR------MLVYEY 156
           KVAVK L  +   +    EF  E   +    H ++ +L+G       +      M++  +
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 157 VNNGNLEQWLHGDVGPCSP--LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           + +G+L  +L       +P  L  +  +  ++  A G+ YL        +HRD+ + N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCM 169
Query: 215 IDKHWNPKVSDFGLAKLLGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 271
           + +     V+DFGL++ + S   Y     +++     ++A E  +  +    SDV++FG+
Sbjct: 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGV 227
Query: 272 LIMEVIS-GRIP 282
            + E+++ G+ P
Sbjct: 228 TMWEIMTRGQTP 239

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 106 VAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY-VNNGNLE 163
           VAVK +L +    A  E K+  E+     H N++R   YC+E   R L     + N NL+
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY--YCSETTDRFLYIALELCNLNLQ 96
Query: 164 QWLHGDVGPCSPLTWEIRMN---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---- 216
             +         L  +   N   ++   A G+++LH     K++HRD+K  NIL+     
Sbjct: 97  DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSR 153
Query: 217 ---------KHWNPKVSDFGLAKLLGSESSYITTRV---MGTFGYVAPE-------YAST 257
                    ++    +SDFGL K L S        +    GT G+ APE         + 
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPV--DYSRPPEEVNLIEWLKKM 301
             L    D++S G +   ++S G+ P    YSR    +  I  L +M
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEM 260

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 126 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 181
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 182 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRM--LVYEYVN 158
           +N KV VK L   +   + + K E++ +  +R   N++ L     +   R   LV+E+VN
Sbjct: 61  NNEKVVVKIL---KPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 117
Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-K 217
           N + +Q         +   ++IR   +    K L Y H      ++HRD+K  N++ID +
Sbjct: 118 NTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE 167
Query: 218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV 276
           H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S G ++  +
Sbjct: 168 HRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 277 ISGRIPV 283
           I  + P 
Sbjct: 226 IFRKEPF 232

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 125 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 127 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 182
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 183 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 128 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 183
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 184 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 177
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 29/169 (17%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPL 176
           E++ +  ++H+N+V L+  C   A           LV+++  + +L   L   +   +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG--- 233
             +  M ++L    GL Y+H     K++HRD+K++N+LI +    K++DFGLA+      
Sbjct: 126 EIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 234 -SESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEV 276
            S+ +    RV+ T  Y  PE     +L ER      D++  G ++ E+
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 222 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 177
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 178 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 175
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 176 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 121 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 176
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 177 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 172 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 227
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 228 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S +T
Sbjct: 136 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 191
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T     + YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 192 TPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 111 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N+LID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 219 GCMLASMIFRKEPF 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 188 TAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
           T   L++LH +GL    VH D+K +NI +      K+ DFGL   LG+  +       G 
Sbjct: 166 TLLALAHLHSQGL----VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GD 219
Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEV 276
             Y+APE    G     +DV+S G+ I+EV
Sbjct: 220 PRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +S   
Sbjct: 120 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 174
Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T    T  YVAPE       ++  D++S G+++  ++ G  P
Sbjct: 175 TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E+ A   +    +V L G   EG    +  E +  G+L Q L  + G C P   E R   
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQG-CLP---EDRALY 170
Query: 185 ILGTA-KGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLL---GSESSYI 239
            LG A +GL YLH     +++H D+K+ N+L+    +   + DFG A  L   G     +
Sbjct: 171 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 240 T-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP-VDYSRPP 289
           T   + GT  ++APE       + + DV+S   +++ +++G  P   + R P
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP 279

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 136 NLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGL 192
           N+++L+    +   +   LV+EY+NN + +Q           LT ++IR   +    K L
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRF-YMYELLKAL 145
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
            Y H      ++HRD+K  N++ID      ++ D+GLA+       Y   RV   + +  
Sbjct: 146 DYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKG 200
Query: 252 PE-YASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE      M +   D++S G ++  +I  R P 
Sbjct: 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS 211
           LV+E+VNN + +Q         +   ++IR   +    K L Y H      ++HRD+K  
Sbjct: 111 LVFEHVNNTDFKQLYQ------TLTDYDIRF-YMYEILKALDYCHSM---GIMHRDVKPH 160
Query: 212 NILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-YASTGMLNERSDVYSF 269
           N++ID +H   ++ D+GLA+       Y   RV   + +  PE      M +   D++S 
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 270 GILIMEVISGRIPV 283
           G ++  +I  + P 
Sbjct: 219 GCMLASMIFRKEPF 232

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L  +    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 48  VAIKKVLQGKAFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 159
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 213
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 214 AELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L  +    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 48  VAIKKVLQGKAFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 104 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 159
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 213
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 214 AELLLGQ 220

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 136 NLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGL 192
           N+++L+    +   +   LV+EY+NN + +Q           LT ++IR   +    K L
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY-------QILTDFDIRF-YMYELLKAL 150
Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
            Y H      ++HRD+K  N++ID      ++ D+GLA+       Y   RV   + +  
Sbjct: 151 DYCHS---KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEY-NVRVASRY-FKG 205
Query: 252 PE-YASTGMLNERSDVYSFGILIMEVISGRIPV 283
           PE      M +   D++S G ++  +I  R P 
Sbjct: 206 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 61  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 116
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 117 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 172
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 173 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 226
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 227 AELLLGQ 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 76  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 131
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 132 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 187
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 188 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 241
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 242 AELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 82  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 193
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 194 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 247
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 248 AELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 106 VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------LVYEYVNN 159
           VA+K +L ++    RE ++    + ++ H N+VRL  +      +       LV +YV  
Sbjct: 84  VAIKKVLQDKRFKNRELQI----MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 139
Query: 160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW 219
                  H      +     +++  +    + L+Y+H      + HRDIK  N+L+D   
Sbjct: 140 TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT 195
Query: 220 NP-KVSDFGLAKLL---GSESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILI 273
              K+ DFG AK L       SYI +R      Y APE  + +T   +   DV+S G ++
Sbjct: 196 AVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSS-IDVWSAGCVL 249
Query: 274 MEVISGR 280
            E++ G+
Sbjct: 250 AELLLGQ 256
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	413
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-177
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-169
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-137
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-64
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-62
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-60
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-54
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-04
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  496 bits (1280), Expect = e-177
 Identities = 123/307 (40%), Positives = 193/307 (62%), Gaps = 4/307 (1%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ 117
           PEV HLG    ++LREL+V+++ FS+  ++G GG+G VY G L D + VAVK L   R Q
Sbjct: 10  PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68

Query: 118 A-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
             E +F+ EVE I    H+NL+RL G+C     R+LVY Y+ NG++   L        PL
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
            W  R  I LG+A+GL+YLH+  +PK++HRD+K++NIL+D+ +   V DFGLAKL+  + 
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--VNL 294
           +++TT V GT G++APEY STG  +E++DV+ +G++++E+I+G+   D +R   +  V L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           ++W+K ++  +  E ++D  L        +++++ VAL C   +  +RPKM  VV MLE 
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

Query: 355 QESPSKE 361
                + 
Sbjct: 309 DGLAERW 315

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  475 bits (1225), Expect = e-169
 Identities = 116/313 (37%), Positives = 181/313 (57%), Gaps = 4/313 (1%)

Query: 42  GNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE 101
           G+     +     A+          +   L +LE +TN F    +IG G +G VY G+L 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 102 DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN 161
           D +KVA+K       Q   EF+ E+E +   RH +LV L+G+C E    +L+Y+Y+ NGN
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP 221
           L++ L+G   P   ++WE R+ I +G A+GL YLH      ++HRD+KS NIL+D+++ P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178

Query: 222 KVSDFGLAKL-LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
           K++DFG++K     + ++++T V GT GY+ PEY   G L E+SDVYSFG+++ EV+  R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
             +  S P E VNL EW  +   N   E ++DP L +K     L++    A++C+  +++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 341 KRPKMGHVVHMLE 353
            RP MG V+  LE
Sbjct: 299 DRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  393 bits (1013), Expect = e-137
 Identities = 102/303 (33%), Positives = 173/303 (57%), Gaps = 21/303 (6%)

Query: 67  HWYTLRELEVSTNGFSDDK------VIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----G 116
           H ++  EL+  TN F +         +GEGG+G+VY G + +N+ VAVK L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL 176
           + +++F  E++ + + +H+NLV LLG+ ++G    LVY Y+ NG+L   L    G   PL
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           +W +R  I  G A G+++LH   E   +HRDIKS+NIL+D+ +  K+SDFGLA+     +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 237 -SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI 295
            + +T+R++GT  Y+APE    G +  +SD+YSFG++++E+I+G   VD  R P+   L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL 244

Query: 296 EWLKKMVTNRNP-EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +  +++       E  +D K+ +   S  ++ +  VA +C+     KRP +  V  +L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 355 QES 357
             +
Sbjct: 304 MTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  285 bits (731), Expect = 2e-94
 Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 38/315 (12%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAI 129
               L   +      +V   G +G V+   L  N  VAVK +   + +   + + EV ++
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72

Query: 130 GRVRHKNLVRLLGYCAEGAH----RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
             ++H+N+++ +G    G        L+  +   G+L  +L       + ++W    +I 
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIA 127

Query: 186 LGTAKGLSYLHE-------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
              A+GL+YLHE       G +P + HRDIKS N+L+  +    ++DFGLA    +  S 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 239 I-TTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
             T   +GT  Y+APE     +  +     R D+Y+ G+++ E+ S     D       +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 293 NLIEWL---------KKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKR 342
              E +         +++V ++       P L +       +  +      C D +A+ R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 343 PKMGHVVHMLEAQES 357
              G V   +   + 
Sbjct: 304 LSAGCVGERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (562), Expect = 7e-69
 Identities = 71/330 (21%), Positives = 117/330 (35%), Gaps = 53/330 (16%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE--AIG 130
           E  +  +     ++IG G YG VY G L D   VAVK          + F  E     + 
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62

Query: 131 RVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
            + H N+ R +              +LV EY  NG+L ++L           W     + 
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLA 117

Query: 186 LGTAKGLSYLHE------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS----- 234
               +GL+YLH         +P + HRD+ S N+L+       +SDFGL+  L       
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 235 --ESSYITTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISGRIPVDY 285
             E        +GT  Y+APE     +         ++ D+Y+ G++  E+      +  
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 286 SRPPEEVNL-----------IEWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVAL 332
                E  +            E ++ +V+         PK PE  K  S  ++ +     
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIE 293

Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKEP 362
            C D +A+ R         +       +  
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  215 bits (549), Expect = 3e-67
 Identities = 82/313 (26%), Positives = 146/313 (46%), Gaps = 27/313 (8%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR- 115
           +P   +L +       ++++     +  + IG G +G V+       S VAVK L+    
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF 73

Query: 116 -GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
             +   EF  EV  + R+RH N+V  +G   +  +  +V EY++ G+L + LH   G   
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGARE 132

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            L    R+++    AKG++YLH    P +VHR++KS N+L+DK +  KV DFGL++L  +
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-A 190

Query: 235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
            +   +    GT  ++APE       NE+SDVYSFG+++ E+ + + P  +      +N 
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP--W----GNLNP 244

Query: 295 IEWLKKMVTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
            + +   V  +        ++P       + +++        C      KRP    ++ +
Sbjct: 245 AQVV-AAVGFKC----KRLEIPRNLNPQVAAIIE-------GCWTNEPWKRPSFATIMDL 292

Query: 352 LEAQESPSKEPSN 364
           L      +  P N
Sbjct: 293 LRPLIKSAVPPPN 305

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 4e-64
 Identities = 82/329 (24%), Positives = 137/329 (41%), Gaps = 41/329 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
            +       ++V+G G +G+V          VA+K + +      + F VE+  + RV H
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            N+V+L G C       LV EY   G+L   LHG   P    T    M+  L  ++G++Y
Sbjct: 61  PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           LH      ++HRD+K  N+L+       K+ DFG A  + +      T   G+  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPE 173

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  +E+ DV+S+GI++ EVI+ R P  +    +E+    +      +        P
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--F----DEIGGPAFRIMWAVHNG----TRP 223

Query: 314 KLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE-------AQESPSKEPS 363
            L +   KP   L+        RC   +  +RP M  +V ++          + P + P 
Sbjct: 224 PLIKNLPKPIESLMT-------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276

Query: 364 NSF---QDRYRASPKNELIEKQVTESGDN 389
                  +  R  P  +  E     S D+
Sbjct: 277 QHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 1e-63
 Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 44/314 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +V+G+G +G        +  + + +K L+    + +R F  EV+ +  + H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +      + EY+  G L   +       S   W  R++     A G++YLH      +
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-------------VMGTFGYV 250
           +HRD+ S N L+ ++ N  V+DFGLA+L+  E +                  V+G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 251 APEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           APE  +    +E+ DV+SFGI++ E+I          P      +          N  G 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGF 239

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE---------AQESPSKE 361
           LD   P             + +RC D + +KRP    + H LE             P  E
Sbjct: 240 LDRYCPPNCPPSFFP----ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295

Query: 362 PSN-SFQDRYRASP 374
             +  F + YR   
Sbjct: 296 QLDRGFWETYRRGE 309

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (515), Expect = 2e-62
 Identities = 79/302 (26%), Positives = 143/302 (47%), Gaps = 46/302 (15%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAE-------REFK 123
           R   ++ N    +K IG+GG+G+V+ G L++D S VA+K+L+    + E       +EF+
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            EV  +  + H N+V+L G         +V E+V  G+L   L        P+ W +++ 
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNPKVSDFGLAKLLGSESSY 238
           ++L  A G+ Y+     P +VHRD++S NI +           KV+DFGL++    +S +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181

Query: 239 ITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRIPVDYS-RPPEEVNLI 295
             + ++G F ++APE   A      E++D YSF +++  +++G  P  +      ++  I
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFI 239

Query: 296 EWLKKMVTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML 352
                M+        L P +PE        +++        C   + +KRP   ++V  L
Sbjct: 240 N----MIREEG----LRPTIPEDCPPRLRNVIE-------LCWSGDPKKRPHFSYIVKEL 284

Query: 353 EA 354
             
Sbjct: 285 SE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (510), Expect = 5e-62
 Identities = 61/293 (20%), Positives = 120/293 (40%), Gaps = 38/293 (12%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAI 129
           +   +     +    + E   G ++ G     + + VK L       +  R+F  E   +
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 130 GRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
               H N++ +LG C      H  L+  ++  G+L   LH   G    +     +   L 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            A+G+++LH  LEP +    + S +++ID+    ++S   +        S+ +   M   
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAP 172

Query: 248 GYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
            +VAPE             +D++SF +L+ E+++  +P  +     +++ +E   K+   
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--F----ADLSNMEIGMKVALE 226

Query: 305 RNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                 L P +P       S+L+K        C++ +  KRPK   +V +LE 
Sbjct: 227 G-----LRPTIPPGISPHVSKLMK-------ICMNEDPAKRPKFDMIVPILEK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (506), Expect = 2e-61
 Identities = 74/296 (25%), Positives = 138/296 (46%), Gaps = 42/296 (14%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL----NNRGQAEREFKVEVEAI 129
           LE+     + +++IG GG+G VY        +VAVK        +  Q     + E +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
             ++H N++ L G C +  +  LV E+   G L + L G       +  +I +N  +  A
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDK--------HWNPKVSDFGLAKLLGSESSYITT 241
           +G++YLH+     ++HRD+KSSNILI +        +   K++DFGLA+      +   +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
              G + ++APE     M ++ SDV+S+G+L+ E+++G +P  +      ++ +      
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F----RGIDGLAVA-YG 225

Query: 302 VTNRNPEGVLDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           V        L   +P    +P ++L++        C +P+   RP   +++  L  
Sbjct: 226 VAMNK----LALPIPSTCPEPFAKLME-------DCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (504), Expect = 9e-61
 Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 30/293 (10%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVE 127
              + E+     +  + IG G +G VY G    +  VAVK L       Q  + FK EV 
Sbjct: 15  AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
            + + RH N++  +GY        +V ++    +L   LH      +    +  ++I   
Sbjct: 73  VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGT 246
           TA+G+ YLH      ++HRD+KS+NI + +    K+ DFGLA        S+   ++ G+
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

Query: 247 FGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
             ++APE      +   + +SDVY+FGI++ E+++G++P       +++       +MV 
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVG 239

Query: 304 NRNPEGVLDPKLPEKPTS--RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                G L P L +  ++  + +KR++     C+     +RP    ++  +E 
Sbjct: 240 R----GSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  197 bits (503), Expect = 2e-60
 Identities = 67/317 (21%), Positives = 123/317 (38%), Gaps = 44/317 (13%)

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVE 127
            L+E ++        ++IG+G +G VY+G    + +VA++ +   R      + FK EV 
Sbjct: 24  FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
           A  + RH+N+V  +G C    H  ++        L   +         L       I   
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM--- 244
             KG+ YLH      ++H+D+KS N+  D +    ++DFGL  + G   +      +   
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 245 -GTFGYVAPEYASTGML---------NERSDVYSFGILIMEVISGRIPVDYSR-PPEEVN 293
            G   ++APE                ++ SDV++ G +  E+ +   P  +   P E + 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAI- 251

Query: 294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                            + P L +    + +  IL   L C     ++RP    ++ MLE
Sbjct: 252 ------IWQMGTG----MKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298

Query: 354 A---QESPSKEPSNSFQ 367
               +      P + ++
Sbjct: 299 KLPKRNRRLSHPGHFWK 315

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  189 bits (483), Expect = 2e-57
 Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 44/299 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE--AIGRVRHKNLVRLLG 142
           + +G+G YG V+ G       VAVK       + E+ +  E E      +RH+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 143 YCAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                 H      L+  Y   G+L  +L       + L     + I+L  A GL++LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 199 LE-----PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM---GTFGYV 250
           +      P + HRD+KS NIL+ K+    ++D GLA +    ++ +        GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 251 APE------YASTGMLNERSDVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIE 296
           APE              +R D+++FG+++ EV    +      DY  P  +V       E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 297 WLKKMVTNRN--PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            ++K+V      P   +  +    PT   L +++     C   N   R     +   L 
Sbjct: 245 DMRKVVCVDQQRPN--IPNRWFSDPTLTSLAKLM---KECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (477), Expect = 3e-56
 Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 38/297 (12%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
            K IG+G YG V+ G      KVAVK +     +A    + E+     +RH+N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 144 CAEGAHR----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-- 197
             +G        L+ +Y  NG+L  +L       + L  +  + +   +  GL +LH   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 198 ---GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVA 251
                +P + HRD+KS NIL+ K+    ++D GLA    S+++ +       +GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 252 PE------YASTGMLNERSDVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIEW 297
           PE        +       +D+YSFG+++ EV    +      +Y  P  ++       E 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           ++++V  +     L P  P + +S   L+++  +   C   N   R     V   L 
Sbjct: 275 MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  181 bits (461), Expect = 7e-54
 Identities = 80/341 (23%), Positives = 136/341 (39%), Gaps = 66/341 (19%)

Query: 45  SGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS 104
           SG GSG  +                  R + +        + IG+G +G V+ G      
Sbjct: 26  SGSGSGLPLLV-----------QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGE 66

Query: 105 KVAVKNLLNNRGQAEREFKVEVE--AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVN 158
           +VAVK       + ER +  E E      +RH+N++  +              LV +Y  
Sbjct: 67  EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123

Query: 159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE-----PKVVHRDIKSSNI 213
           +G+L  +L+        +T E  + + L TA GL++LH  +      P + HRD+KS NI
Sbjct: 124 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 214 LIDKHWNPKVSDFGLAKLLGSESSYIT---TRVMGTFGYVAPE------YASTGMLNERS 264
           L+ K+    ++D GLA    S +  I       +GT  Y+APE              +R+
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

Query: 265 DVYSFGILIMEVISGRIPV----DYSRPPEEVN----LIEWLKKMVTNRNPEGVLDPKLP 316
           D+Y+ G++  E+           DY  P  ++      +E ++K+V  +     L P +P
Sbjct: 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIP 294

Query: 317 EK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            +       R++ +I+     C   N   R     +   L 
Sbjct: 295 NRWQSCEALRVMAKIM---RECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (377), Expect = 3e-41
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 38/280 (13%)

Query: 85  KVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLVRLLG 142
           + IG G +G V+ G L  DN+ VAVK+         + +F  E   + +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
            C +     +V E V  G+   +L  +      L  +  + ++   A G+ YL       
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SKC 233

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGML 260
            +HRD+ + N L+ +    K+SDFG+++   ++  Y  +  +        APE  + G  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 261 NERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTN----RNPEGVLDPK 314
           +  SDV+SFGIL+ E  S G  P  Y     ++       ++ V        PE      
Sbjct: 293 SSESDVWSFGILLWETFSLGASP--YPNLSNQQT------REFVEKGGRLPCPELC---- 340

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            P+      + R++    +C      +RP    +   L++
Sbjct: 341 -PDA-----VFRLM---EQCWAYEPGQRPSFSTIYQELQS 371

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (369), Expect = 6e-41
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 35/270 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           D  IG G +  VY GL  E   +VA              + FK E E +  ++H N+VR 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 141 LGYCAEGAHRM----LVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSY 194
                          LV E + +G L+ +L           +  ++  +      KGL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQF 144

Query: 195 LHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           LH    P ++HRD+K  NI I     + K+ D GLA L  +  +     V+GT  ++APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE 200

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  +E  DVY+FG+ ++E+ +   P  YS   E  N  +  ++ VT+        P
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP--YS---ECQNAAQIYRR-VTSGVK-----P 248

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
              +K     +K I+     C+  N  +R 
Sbjct: 249 ASFDKVAIPEVKEII---EGCIRQNKDERY 275

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (363), Expect = 4e-40
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 11/203 (5%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
              +G GG   VY       N KVA+K +      + +  + F+ EV    ++ H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           ++    E     LV EY+    L +++        PL+ +  +N       G+ + H+  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             ++VHRDIK  NILID +   K+ DFG+AK L   S   T  V+GT  Y +PE A    
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 260 LNERSDVYSFGILIMEVISGRIP 282
            +E +D+YS GI++ E++ G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (371), Expect = 8e-40
 Identities = 78/286 (27%), Positives = 133/286 (46%), Gaps = 27/286 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
             +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           +E     +V EY++ G+L  +L G+ G    L     +++    A G++Y+        V
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYV 302

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD++++NIL+ ++   KV+DFGLA+L+                + APE A  G    +S
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P       E ++ +E            G   P  PE P S  
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------RGYRMPCPPECPES-- 409

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLE---AQESPSKEPSNSF 366
           L  ++    +C     ++RP   ++   LE       P  +P  + 
Sbjct: 410 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  143 bits (363), Expect = 1e-39
 Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 31/308 (10%)

Query: 85  KVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G+G +G V             + VAVK L ++    +R+F+ E++ +  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G       +   LV EY+ +G L  +L               +       KG+ YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKGMEYLGS 145

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + VHRD+ + NIL++   + K++DFGLAKLL  +  Y   R  G     + APE  
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD-- 312
           S  + + +SDV+SFG+++ E+ +        S   E + ++   + +        +L+  
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 313 ---PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDR 369
              P  P  P       +  +   C  P+ Q RP    +   L+   S            
Sbjct: 261 QRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLDMLWS---GSRGCETHA 312

Query: 370 YRASPKNE 377
           + A P+ +
Sbjct: 313 FTAHPEGK 320

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  141 bits (357), Expect = 3e-39
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 18/228 (7%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ 117
           P  + LG+G W      E+     +  K +G G +G+V YG       VA+K +      
Sbjct: 9   PSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSM 61

Query: 118 AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT 177
           +E EF  E + +  + H+ LV+L G C +     ++ EY+ NG L  +L           
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQ 118

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +  + +     + + YL      + +HRD+ + N L++     KVSDFGL++ +  +  
Sbjct: 119 TQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDE 174

Query: 238 YITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
           Y T+ V   F      PE       + +SD+++FG+L+ E+ S G++P
Sbjct: 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (366), Expect = 8e-39
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 35/294 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNS-KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G YG VY G+ +  S  VAVK L         EF  E   +  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C       ++ E++  GNL  +L         ++  + + +    +  + YL    +   
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLN 261
           +HR++ + N L+ ++   KV+DFGL++L+       T      F     APE  +    +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 262 ERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
            +SDV++FG+L+ E+ + G  P       +   L+E   +M               E+P 
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------------ERPE 442

Query: 321 --SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA---QESPSKEPSNSFQDR 369
                +  ++     C   N   RP    +    E    + S S E       R
Sbjct: 443 GCPEKVYELM---RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 493

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 9e-39
 Identities = 78/286 (27%), Positives = 133/286 (46%), Gaps = 27/286 (9%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
             +G+G +G V+ G     ++VA+K L       E  F  E + + ++RH+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
           +E     +V EY++ G+L  +L G+ G    L     +++    A G++Y+        V
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD++++NIL+ ++   KV+DFGLA+L+                + APE A  G    +S
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 265 DVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
           DV+SFGIL+ E+ + GR+P       E ++ +E            G   P  PE P S  
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------RGYRMPCPPECPES-- 492

Query: 324 LKRILLVALRCVDPNAQKRPKMGHVVHMLEA---QESPSKEPSNSF 366
           L  ++    +C     ++RP   ++   LE       P  +P  + 
Sbjct: 493 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  139 bits (353), Expect = 1e-38
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLV 138
           DK +G G +G V  G  +       VAVK L N       + E   E   + ++ +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           R++G C   +  MLV E    G L ++L         +  +  + ++   + G+ YL E 
Sbjct: 82  RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAS 256
                VHRD+ + N+L+      K+SDFGL+K L ++ +Y   +  G +   + APE  +
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 257 TGMLNERSDVYSFGILIMEVIS-GRIP 282
               + +SDV+SFG+L+ E  S G+ P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 1e-38
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 12/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG G +G+V+ G   +  KVA+K +      +E +F  E E + ++ H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            E A   LV E++ +G L  +L    G       E  + + L   +G++YL    E  V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACVI 126

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLNE 262
           HRD+ + N L+ ++   KVSDFG+ + +       T+     F     +PE  S    + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFG+L+ EV S G+IP
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (349), Expect = 4e-38
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           D  +G G +G V  G+     K   VA+K L          E   E + + ++ +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L+G C   A  MLV E    G L ++L G       +       ++   + G+ YL E  
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-- 128

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYAST 257
               VHRD+ + N+L+      K+SDFGL+K LG++ SY T R  G +   + APE  + 
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIP 282
              + RSDV+S+G+ + E +S G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (353), Expect = 6e-38
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 30/288 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRGQAER-EFKVEVEAI 129
           E+     S DKV+G G +G V  G L    +    VA+K L     + +R +F  E   +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           G+  H N++RL G   +    M+V EY+ NG+L+ +L          T    + ++ G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIA 157

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
            G+ YL    +   VHRD+ + NILI+ +   KVSDFGL ++L  +     T   G    
Sbjct: 158 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 250 --VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
              +PE  +       SDV+S+GI++ EV+S G  P       + +  ++          
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---------- 264

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            EG   P   + P       +  + L C   +   RPK   +V +L+ 
Sbjct: 265 -EGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (349), Expect = 9e-38
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 14/207 (6%)

Query: 84  DKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           +K+IG G  G V YG L    + +  VA+K L     + +R +F  E   +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           RL G    G   M+V EY+ NG+L+ +L    G     T    + ++ G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLS-- 168

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYAS 256
            +   VHRD+ + N+L+D +   KVSDFGL+++L  +     T   G       APE  +
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 257 TGMLNERSDVYSFGILIMEVIS-GRIP 282
               +  SDV+SFG+++ EV++ G  P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (349), Expect = 1e-37
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KV+G G +G VY GL     +     VA+K L          E   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            RLLG C   +   L+ + +  G L  ++               +N  +  AKG++YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
               ++VHRD+ + N+L+    + K++DFGLAKLLG+E         G      ++A E 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               +   +SDV+S+G+ + E+++ G  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (344), Expect = 1e-37
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVE 125
           GH       E+     +  K +G G +G+V  G  +    VAVK +      +E EF  E
Sbjct: 1   GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
            + + ++ H  LV+  G C++     +V EY++NG L  +L         L     + + 
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMC 110

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
               +G+++L      + +HRD+ + N L+D+    KVSDFG+ + +  +  Y  + V  
Sbjct: 111 YDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQY-VSSVGT 165

Query: 246 TFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            F     APE       + +SDV++FGIL+ EV S G++P
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (354), Expect = 2e-37
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 30/285 (10%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
             E+       +K +G G +G V+      ++KVAVK +      +   F  E   +  +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H  LV+L     +     ++ E++  G+L  +L  D G  S       ++     A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--V 250
           +++ +      +HRD++++NIL+      K++DFGLA+++  ++ Y T R    F     
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEY-TAREGAKFPIKWT 352

Query: 251 APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPE 308
           APE  + G    +SDV+SFGIL+ME+++ GRIP  Y      EV  I  L++        
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV--IRALER-------- 400

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           G   P+    P    L  I+   +RC     ++RP   ++  +L+
Sbjct: 401 GYRMPRPENCPEE--LYNIM---MRCWKNRPEERPTFEYIQSVLD 440

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (343), Expect = 3e-37
 Identities = 65/288 (22%), Positives = 113/288 (39%), Gaps = 32/288 (11%)

Query: 84  DKVIGEGGYGIVYYGLL----EDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
            + +G+G +G+V  G           VAVK L   + ++ +A  +F  EV A+  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           L+RL G         +V E    G+L   L    G     T        +  A+G+ YL 
Sbjct: 83  LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT---LSRYAVQVAEGMGYLE 138

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEY 254
                + +HRD+ + N+L+      K+ DFGL + L     +   +      +   APE 
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             T   +  SD + FG+ + E+ + G+ P       + ++ I+           EG   P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----------KEGERLP 245

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKE 361
           +  + P       I  V ++C     + RP    +   L   +     
Sbjct: 246 RPEDCPQD-----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (343), Expect = 7e-37
 Identities = 72/318 (22%), Positives = 132/318 (41%), Gaps = 38/318 (11%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNL 137
            KV+G G +G V+ G+     +     V +K + +  G Q+ +     + AIG + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VRLLG C  G+   LV +Y+  G+L   +    G   P      +N  +  AKG+ YL E
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
                +VHR++ + N+L+      +V+DFG+A LL  +   +            ++A E 
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
              G    +SDV+S+G+ + E+++ G  P    R  E  +L+E           +G    
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-----------KGERLA 237

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE--AQESPS-KEPSNSFQDRY 370
           +            + +V ++C   +   RP    + +     A++ P             
Sbjct: 238 QPQICTID-----VYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGI 292

Query: 371 RASPKNELIEKQVTESGD 388
              P+   +  +  E  +
Sbjct: 293 APGPEPHGLTNKKLEEVE 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  135 bits (343), Expect = 7e-37
 Identities = 73/328 (22%), Positives = 140/328 (42%), Gaps = 42/328 (12%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   E EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER E
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------HGDVGPCSP 175
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L        +    +P
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            +    + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

Query: 236 SSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP 289
             Y      G  G +     +PE    G+    SDV+SFG+++ E+ +    P       
Sbjct: 192 DYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSN 246

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           E+V       + V      G+LD   P+     +L  ++     C   N + RP    ++
Sbjct: 247 EQV------LRFVMEG---GLLDK--PDN-CPDMLFELM---RMCWQYNPKMRPSFLEII 291

Query: 350 HMLEAQESPSKEPSNSFQDRYRASPKNE 377
             ++ +  P     + +       P+ E
Sbjct: 292 SSIKEEMEPGFREVSFYYSEENKLPEPE 319

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  138 bits (350), Expect = 8e-37
 Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           V          W       ++       + IG+G +G V  G     +KVAVK +     
Sbjct: 177 VAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KND 227

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVYEYVNNGNLEQWLHGDVGPCSP 175
              + F  E   + ++RH NLV+LLG   E      +V EY+  G+L  +L       S 
Sbjct: 228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SV 285

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L  +  +   L   + + YL        VHRD+ + N+L+ +    KVSDFGL K     
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 337

Query: 236 SSYITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSR-PPEE 291
               +T+  G       APE       + +SDV+SFGIL+ E+ S GR+P  Y R P ++
Sbjct: 338 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKD 394

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
           V  +  ++K        G         P +  +  ++     C   +A  RP    +   
Sbjct: 395 V--VPRVEK--------GYKMDAPDGCPPA--VYDVM---KNCWHLDAATRPTFLQLREQ 439

Query: 352 LE 353
           LE
Sbjct: 440 LE 441

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  135 bits (341), Expect = 9e-37
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            +++G GG   V+    L D+  VAVK    +L  +     R F+ E +    + H  +V
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV 75

Query: 139 RLLGY-CAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            +     AE     L Y   EYV+   L   +H +     P+T +  + +I    + L++
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNF 131

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT--RVMGTFGYVAP 252
            H+     ++HRD+K +NI+I      KV DFG+A+ +    + +T    V+GT  Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIP 282
           E A    ++ RSDVYS G ++ EV++G  P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  134 bits (339), Expect = 1e-36
 Identities = 64/201 (31%), Positives = 111/201 (55%), Gaps = 12/201 (5%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + +G G +G V+ G    ++KVAVK+L      +   F  E   + +++H+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     ++ EY+ NG+L  +L    G    LT    +++    A+G++++ E      +
Sbjct: 78  TQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLNE 262
           HRD++++NIL+    + K++DFGLA+L+  ++ Y T R    F     APE  + G    
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 263 RSDVYSFGILIMEVIS-GRIP 282
           +SDV+SFGIL+ E+++ GRIP
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 1e-36
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 84  DKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KVIG G +G VY G+L     +    VA+K L     + +R +F  E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +RL G  ++    M++ EY+ NG L+++L    G     +    + ++ G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLA- 164

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYA 255
                 VHRD+ + NIL++ +   KVSDFGL+++L  +     T   G       APE  
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIP 282
           S       SDV+SFGI++ EV++ G  P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (338), Expect = 1e-36
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 33/293 (11%)

Query: 85  KVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G YG VY G+ +  +  VAVK L         EF  E   +  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
           C       ++ E++  GNL  +L         ++  + + +    +  + YL    +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNF 132

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYASTGMLN 261
           +HRD+ + N L+ ++   KV+DFGL++L+       T      F     APE  +    +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 262 ERSDVYSFGILIMEVIS-GRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            +SDV++FG+L+ E+ + G  P  Y      +V   E L+K             +    P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV--YELLEK--------DYRMERPEGCP 238

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA---QESPSKEPSNSFQDR 369
                +++  +   C   N   RP    +    E    + S S E       R
Sbjct: 239 -----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  134 bits (339), Expect = 2e-36
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVK----NLLNNRGQAEREFKVEVEAIGRVRHKN 136
            +++G GG G VY    ED  +   VA+K     L ++     R  + E    GR++  +
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPH 95

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +V +  +        +    +N  +L   L        PL     + I+      L   H
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAH 151

Query: 197 E-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
             G      HRD+K  NIL+       + DFG+A     E        +GT  Y+APE  
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 256 STGMLNERSDVYSFGILIMEVISGRIP 282
           S      R+D+Y+   ++ E ++G  P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (337), Expect = 2e-36
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 24/230 (10%)

Query: 57  VPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG 116
           V          W       ++       + IG+G +G V  G     +KVAVK +     
Sbjct: 5   VAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KND 55

Query: 117 QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVYEYVNNGNLEQWLHGDVGPCSP 175
              + F  E   + ++RH NLV+LLG   E      +V EY+  G+L  +L       S 
Sbjct: 56  ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SV 113

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           L  +  +   L   + + YL        VHRD+ + N+L+ +    KVSDFGL K     
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 165

Query: 236 SSYITTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               +T+  G       APE       + +SDV+SFGIL+ E+ S GR+P
Sbjct: 166 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  133 bits (337), Expect = 3e-36
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V     +         VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G C     R   L+ EY+  G+L  +L         +     +       KG+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGT 132

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + +HRD+ + NIL++     K+ DFGL K+L  +  +   +  G     + APE  
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
           +    +  SDV+SFG+++ E+ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (337), Expect = 3e-36
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 17/218 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           + +GEG +G V     +        +VAVK+L    G     + K E+E +  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C E       L+ E++ +G+L+++L  +    +      ++   +   KG+ YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMDYLG 143

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEY 254
                + VHRD+ + N+L++     K+ DFGL K + ++  Y T +        + APE 
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE 291
                    SDV+SFG+ + E+++             +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (337), Expect = 5e-36
 Identities = 74/312 (23%), Positives = 129/312 (41%), Gaps = 42/312 (13%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +G G +G VY G +          +VAVK L     + +  +F +E   I +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGYV- 250
           L E      +HRDI + N L+         K+ DFG+A+ +   S Y      G    + 
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLP 208

Query: 251 ----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                PE    G+   ++D +SFG+L+ E+ S G +P   S+  +EV       + VT+ 
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV------LEFVTSG 261

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNS 365
              G +DP  P+      + RI+    +C     + RP    ++  +E         + +
Sbjct: 262 ---GRMDP--PKN-CPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 312

Query: 366 FQDRYRASPKNE 377
               Y    + E
Sbjct: 313 LPIEYGPLVEEE 324

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (336), Expect = 6e-36
 Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKV-EVEAIGRVRHKNLVRL 140
           K IG G +  VY    L D   VA+K   + +      R   + E++ + ++ H N+++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                E     +V E  + G+L + +         +         +     L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------Y 254
            +V+HRDIK +N+ I      K+ D GL +   S+++   + V GT  Y++PE      Y
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP---EEVNLIEWLKKMVTNRNPEGVL 311
                 N +SD++S G L+ E+ +        + P   +++NL    KK+     P    
Sbjct: 214 ------NFKSDIWSLGCLLYEMAAL-------QSPFYGDKMNLYSLCKKIEQCDYPP--- 257

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP------KMGHVVHMLEAQESPSKEPS 363
              LP    S  L++++     C++P+ +KRP       +   +H   A         
Sbjct: 258 ---LPSDHYSEELRQLV---NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (348), Expect = 6e-36
 Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 33/294 (11%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           D  +G G +G V  G+     K   VA+K L          E   E + + ++ +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L+G C   A  MLV E    G L ++L G       +       ++   + G+ YL E  
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-- 454

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY--VAPEYAST 257
               VHR++ + N+L+      K+SDFGL+K LG++ SY T R  G +     APE  + 
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 258 GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
              + RSDV+S+G+ + E +S G+ P    + PE +  IE  K+M              P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----------ECPP 562

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA---QESPSKEPSNSFQ 367
           E P       +  +   C     + RP    V   + A     +   E  ++ +
Sbjct: 563 ECP-----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (333), Expect = 8e-36
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 52/297 (17%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +GE  +G VY G L      E    VA+K L +      R EF+ E     R++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNII 185
           V LLG   +     +++ Y ++G+L ++L              D    S L     ++++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---- 241
              A G+ YL       VVH+D+ + N+L+    N K+SD GL + + +   Y       
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 242 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW 297
              R M      APE    G  +  SD++S+G+++ EV S G  P       ++V     
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDV----- 239

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
             +M+ NR    VL    P+      +  ++   + C +    +RP+   +   L A
Sbjct: 240 -VEMIRNR---QVLPC--PDD-CPAWVYALM---IECWNEFPSRRPRFKDIHSRLRA 286

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (333), Expect = 2e-35
 Identities = 70/294 (23%), Positives = 123/294 (41%), Gaps = 48/294 (16%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             +GEG +G V+          +D   VAVK L      A ++F+ E E +  ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL-----------HGDVGPCSPLTWEIRMNIILG 187
           R  G C EG   ++V+EY+ +G+L ++L            G+     PL     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            A G+ YL        VHRD+ + N L+ +    K+ DFG+++ + S   Y     +G  
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGGR 219

Query: 248 GYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKK 300
             +      PE          SDV+SFG+++ E+ + G+ P  +      E   I+ + +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTEA--IDCITQ 275

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
                     L+   P       +  I+     C     Q+R  +  V   L+A
Sbjct: 276 G-------RELER--PRA-CPPEVYAIM---RGCWQREPQQRHSIKDVHARLQA 316

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (334), Expect = 3e-35
 Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 44/306 (14%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
           + +G G +G VY G +          +VAVK L     + +  +F +E   I +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLH---GDVGPCSPLTWEIRMNIILGTAKGLSY 194
           VR +G   +   R ++ E +  G+L+ +L          S L     +++    A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGYV- 250
           L E      +HRDI + N L+         K+ DFG+A+ +     Y      G    + 
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249

Query: 251 ----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
                PE    G+   ++D +SFG+L+ E+ S G +P   S+  +EV       + VT+ 
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV------LEFVTSG 302

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE--AQESPSKEPS 363
              G +DP  P+      + RI+    +C     + RP    ++  +E   Q+      +
Sbjct: 303 ---GRMDP--PKN-CPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 353

Query: 364 NSFQDR 369
              +  
Sbjct: 354 LPIEYG 359

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 3e-35
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 85  KVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G V     +         VAVK L ++  +  R+F+ E+E +  ++H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 140 LLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
             G C     R   L+ EY+  G+L  +L         +     +       KG+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLGT 163

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEYA 255
               + +HRD+ + NIL++     K+ DFGL K+L  +  Y   +  G     + APE  
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 256 STGMLNERSDVYSFGILIMEVIS 278
           +    +  SDV+SFG+++ E+ +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (329), Expect = 4e-35
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 40/285 (14%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 139 RLLGYCAEGAH-RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG------YVA 251
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  Y    V    G      ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200

Query: 252 PEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEG 309
            E   T     +SDV+SFG+L+ E+++ G  P  Y      ++    +L +         
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI--TVYLLQ-------GR 249

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            L    PE      L  ++   L+C  P A+ RP    +V  + A
Sbjct: 250 RLLQ--PEY-CPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (329), Expect = 4e-35
 Identities = 70/300 (23%), Positives = 130/300 (43%), Gaps = 49/300 (16%)

Query: 85  KVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG +G V+          +D   VAVK L +    A ++F+ E E +  ++H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNIIL 186
           +  G C +G   ++V+EY+ +G+L ++L                     L     ++I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A G+ YL        VHRD+ + N L+  +   K+ DFG+++ + S   Y     +G 
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193

Query: 247 FGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKK 300
              +      PE          SDV+SFG+++ E+ + G+ P  +     EV  IE + +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEV--IECITQ 250

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA--QESP 358
                    VL+   P     + +  ++   L C     Q+R  +  +  +L A  + +P
Sbjct: 251 G-------RVLER--PRV-CPKEVYDVM---LGCWQREPQQRLNIKEIYKILHALGKATP 297

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 4e-35
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F +  V+G+G +G V       D+   A+K  + +  +       EV  +  + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 140 LLGYCAEGAHRM-------------LVYEYVNNGNLEQWLHGDVGPCSP-LTWEIRMNII 185
                 E  + +             +  EY  NG L   +H +         W +   I+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI------ 239
                 LSY+H      ++HRD+K  NI ID+  N K+ DFGLAK +      +      
Sbjct: 127 EA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 240 --------TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
                   T+ + GT  YVA E    TG  NE+ D+YS GI+  E+I             
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +  +  LKK+   R+      P        ++ K+I+      +D +  KRP
Sbjct: 231 GMERVNILKKL---RSVSIEFPPDFD-DNKMKVEKKII---RLLIDHDPNKRP 276

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 5e-35
 Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 34/282 (12%)

Query: 84  DKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           D+VIG+G +G+VY+G   D      + A+K+L       +   F  E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 139 RLLGYCAEGA-HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            L+G          ++  Y+ +G+L Q++          T +  ++  L  A+G+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYLAE 142

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV---APEY 254
               K VHRD+ + N ++D+ +  KV+DFGLA+ +     Y   +       V   A E 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLD 312
             T     +SDV+SFG+L+ E+++ G  P  Y    P ++    +L         +G   
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFDL--THFLA--------QGRRL 247

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           P+    P       +  V  +C + +   RP    +V  +E 
Sbjct: 248 PQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (331), Expect = 5e-35
 Identities = 68/319 (21%), Positives = 136/319 (42%), Gaps = 32/319 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREF-KVEVEAIGRVRHKNLVRLL 141
           + IGEG +G        ED  +  +K + ++     ERE  + EV  +  ++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               E     +V +Y   G+L + ++   G       +  ++  +     L ++H+    
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---R 144

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           K++HRDIKS NI + K    ++ DFG+A++L S        + GT  Y++PE       N
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYN 203

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
            +SD+++ G ++ E+ +        +   E   ++ L   + + +      P +     S
Sbjct: 204 NKSDIWALGCVLYELCTL-------KHAFEAGSMKNLVLKIISGSF-----PPVSLH-YS 250

Query: 322 RLLKRILLVALRCVDPNAQKRP------KMGHVVHMLEAQESPSKEPSNSFQDRYRASPK 375
             L+ ++    +    N + RP      + G +   +E   SP +  +  F  +  +   
Sbjct: 251 YDLRSLV---SQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP-QLIAEEFCLKTFSKFG 306

Query: 376 NELIEKQVTESGDNSTNET 394
           ++ I  +   SG NS +  
Sbjct: 307 SQPIPAKRPASGQNSISVM 325

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 6e-35
 Identities = 75/308 (24%), Positives = 126/308 (40%), Gaps = 48/308 (15%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNL-LNNRGQAER-EF 122
             L ++ +  N     K++GEG +G V  G L+     + KVAVK + L+N  Q E  EF
Sbjct: 24  NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF 83

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEG-----AHRMLVYEYVNNGNLEQWL--HGDVGPCSP 175
             E   +    H N++RLLG C E         M++  ++  G+L  +L           
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
           +  +  +  ++  A G+ YL        +HRD+ + N ++       V+DFGL+K + S 
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

Query: 236 SSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-S 286
             Y   R+       +      A E  +  +   +SDV++FG+ + E+ + G  P  Y  
Sbjct: 201 DYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPG 252

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
               E+   ++L      + PE  LD           L  I+     C   +   RP   
Sbjct: 253 VQNHEM--YDYLLHGHRLKQPEDCLDE----------LYEIM---YSCWRTDPLDRPTFS 297

Query: 347 HVVHMLEA 354
            +   LE 
Sbjct: 298 VLRLQLEK 305

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (330), Expect = 6e-35
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 19/223 (8%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNL 137
            KV+G G +G VY GL     +     VA+K L          E   E   +  V + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            RLLG C   +   L+ + +  G L  ++               +N  +  AKG++YL +
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT---FGYVAPEY 254
               ++VHRD+ + N+L+    + K++DFGLAKLLG+E         G      ++A E 
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE 296
               +   +SDV+S+G+ + E+++ G  P D     E  +++E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (328), Expect = 9e-35
 Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 41/307 (13%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL---LEDNSKVAVKNLLNNRGQAEREFKVEVEA 128
             + +    +   + +GEGG+  V   L   L D    A+K +L +  Q   E + E + 
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVD--LVEGLHDGHFYALKRILCHEQQDREEAQREADM 79

Query: 129 IGRVRHKNLVRLLGYCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLT-WEIRMN 183
                H N++RL+ YC           L+  +   G L   +       + LT  +I + 
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LW 138

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           ++LG  +GL  +H        HRD+K +NIL+     P + D G               +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 244 M--------GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV 292
                     T  Y APE     S  +++ER+DV+S G ++  ++ G  P D      + 
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

Query: 293 NLIEWLKKMVTNRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
                +   V N+         +P+ P  S  L ++L      +  +  +RP +  ++  
Sbjct: 256 -----VALAVQNQ-------LSIPQSPRHSSALWQLL---NSMMTVDPHQRPHIPLLLSQ 300

Query: 352 LEAQESP 358
           LEA + P
Sbjct: 301 LEALQPP 307

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  129 bits (327), Expect = 1e-34
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 39/300 (13%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK-----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           + +GEG +G V     +  +      VAVK L  + G   R  +K E++ +  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 139 RLLGYCAEGAHR--MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +  G C +       LV EYV  G+L  +L       + L     +       +G++YLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF--GYVAPEY 254
                  +HRD+ + N+L+D     K+ DFGLAK +     Y   R  G     + APE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 255 ASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                    SDV+SFG+ + E+++             E+  I              +   
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ----------GQMTVL 258

Query: 314 KLPEKPTS--RLLK------RILLVALRCVDPNAQKRPKMGHVVHMLEA--QESPSKEPS 363
           +L E      RL +       +  +   C +  A  RP   +++ +L+   ++   + PS
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  128 bits (324), Expect = 2e-34
 Identities = 58/305 (19%), Positives = 115/305 (37%), Gaps = 47/305 (15%)

Query: 84  DKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK 135
           ++ +G+G +  ++ G+            ++V +K L          F      + ++ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           +LV   G C  G   +LV E+V  G+L+ +L  +   C  + W++ +      A  + +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNP--------KVSDFGLAKLLGSESSYITTRVMGTF 247
               E  ++H ++ + NIL+ +  +         K+SD G++  +      +  R+    
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184

Query: 248 GYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR 305
               PE       LN  +D +SFG  + E+ S G  P+       ++   E         
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--------- 232

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNS 365
             +    P       + L+         C+D     RP    ++  L +  +P   P  S
Sbjct: 233 --DRHQLPAPKAAELANLI-------NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283

Query: 366 FQDRY 370
               +
Sbjct: 284 HHHHH 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (323), Expect = 3e-34
 Identities = 56/267 (20%), Positives = 106/267 (39%), Gaps = 51/267 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G GG+G+V+      D+   A+K + L NR  A  +   EV+A+ ++ H  +VR   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 143 YCAEGAHRM------------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
              E                 +  +     NL+ W++G           + ++I L  A+
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAE 129

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM------ 244
            + +LH      ++HRD+K SNI        KV DFGL   +  +    T          
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 245 -----GTFGYVAPEYASTGMLNERSDVYSFGILIME-----------------VISGRIP 282
                GT  Y++PE       + + D++S G+++ E                 V + + P
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFP 246

Query: 283 VDYSR-PPEEVNLIEWLKKMVTNRNPE 308
             +++  P E  +++ +     + +P 
Sbjct: 247 PLFTQKYPCEYVMVQDM----LSPSPM 269

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (324), Expect = 4e-34
 Identities = 60/307 (19%), Positives = 122/307 (39%), Gaps = 45/307 (14%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS----KVAVKNL-LNNRGQAERE-F 122
             L ++ +    F+  +++G+G +G V    L+       KVAVK L  +    ++ E F
Sbjct: 13  EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEG------AHRMLVYEYVNNGNLEQWL--HGDVGPCS 174
             E   +    H ++ +L+G              M++  ++ +G+L  +L          
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
            L  +  +  ++  A G+ YL        +HRD+ + N ++ +     V+DFGL++ + S
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 235 ESSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SR 287
              Y      G    +     A E  +  +    SDV++FG+ + E+++ G+ P  Y   
Sbjct: 190 GDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGI 243

Query: 288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
              E+    +L            L    P +     +  ++    +C   + ++RP    
Sbjct: 244 ENAEI--YNYLIG-------GNRLKQ--PPE-CMEEVYDLM---YQCWSADPKQRPSFTC 288

Query: 348 VVHMLEA 354
           +   LE 
Sbjct: 289 LRMELEN 295

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (321), Expect = 4e-34
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS----KVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           ++++GEG +G VY G+  ++      VAVK    +     + +F  E   +  + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +L+G   E     ++ E    G L  +L  +      LT    +   L   K ++YL   
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES- 131

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
                VHRDI   NIL+      K+ DFGL++ +  E  Y  +       +++PE  +  
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 259 MLNERSDVYSFGILIMEVIS-GRIP 282
                SDV+ F + + E++S G+ P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (336), Expect = 4e-34
 Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 49/267 (18%)

Query: 86  VIGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLLG 142
            I  GG G +Y       +   V +K L+++     +     E + +  V H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 143 YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +             +V EYV   +L++           L     +  +L     LSYLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS 200

Query: 198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
            GL    V+ D+K  NI++ +    K+ D G    + S        + GT G+ APE   
Sbjct: 201 IGL----VYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR 250

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP 316
           TG     +D+Y+ G  +  +       +  R  + +              PE     K  
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPTRN-GRYVDGL--------------PEDDPVLKTY 294

Query: 317 EKPTSRLLKRILLVALRCVDPNAQKRP 343
           +        R+L    R +DP+ ++R 
Sbjct: 295 DS-----YGRLL---RRAIDPDPRQRF 313

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  126 bits (319), Expect = 8e-34
 Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 51/258 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           ++IG GG+G V+      D     +K +  N  +AERE    V+A+ ++ H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72

Query: 144 CAEGAHRM----------------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
                +                  +  E+ + G LEQW+    G    L   + + +   
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQ 130

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
             KG+ Y+H     K+++RD+K SNI +      K+ DFGL   L ++     TR  GT 
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTL 185

Query: 248 GYVAPEYASTGMLNERSDVYSFGI-----------------LIMEVISGRIPVDYSRPPE 290
            Y++PE  S+    +  D+Y+ G+                    ++  G I   +    +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFD--KK 243

Query: 291 EVNLIEWLKKMVTNRNPE 308
           E  L+   +K++ ++ PE
Sbjct: 244 EKTLL---QKLL-SKKPE 257

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (324), Expect = 1e-33
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAER-EFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 139 RLLGYCAEGAH-RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV-----AP 252
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +  + +     T   +     A 
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265

Query: 253 EYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGV 310
           E   T     +SDV+SFG+L+ E+++ G  P  Y      ++    +L +          
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDI--TVYLLQ-------GRR 314

Query: 311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           L    PE     L +    V L+C  P A+ RP    +V  + A
Sbjct: 315 LLQ--PEYCPDPLYE----VMLKCWHPKAEMRPSFSELVSRISA 352

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  126 bits (318), Expect = 1e-33
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 13/220 (5%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNL-LNNRGQAEREFK 123
            + R+ E+        + IGEG +G V+ G+          VA+K            +F 
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   + +  H ++V+L+G         ++ E    G L  +L          +    + 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LIL 120

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++ 
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
                ++APE  +       SDV+ FG+ + E++  G  P
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (315), Expect = 2e-33
 Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 24/266 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRVRHKNLVRLL 141
             IG G YG         D   +  K L   +  +AE++  V EV  +  ++H N+VR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 142 GYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-- 197
               +  +  L  V EY   G+L   +         L  E  + ++      L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
                V+HRD+K +N+ +D   N K+ DFGLA++L  ++S+  T V GT  Y++PE  + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
              NE+SD++S G L+ E+ +         PP      + L   +           ++P 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL-------MPPFTAFSQKELAGKIREGKF-----RRIPY 238

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
           +  S  L  I+    R ++     RP
Sbjct: 239 R-YSDELNEII---TRMLNLKDYHRP 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 3e-33
 Identities = 76/263 (28%), Positives = 121/263 (46%), Gaps = 23/263 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
            V+G+G YGIVY G  L +  ++A+K +     +  +    E+     ++HKN+V+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
            +E     +  E V  G+L   L    GP       I         +GL YLH+    ++
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDN---QI 143

Query: 204 VHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--YASTGML 260
           VHRDIK  N+LI+ +    K+SDFG +K L   +    T   GT  Y+APE         
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
            + +D++S G  I+E+ +G+ P  +        L E    M   +     + P++PE   
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMF--KVGMFKVHPEIPES-M 251

Query: 321 SRLLKRILLVALRCVDPNAQKRP 343
           S   K  +   L+C +P+  KR 
Sbjct: 252 SAEAKAFI---LKCFEPDPDKRA 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (327), Expect = 5e-33
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 13/220 (5%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNNRGQAEREFK 123
            + R+ E+        + IGEG +G V+ G+          VA+K            +F 
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   + +  H ++V+L+G   E     ++ E    G L  +L          +    + 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLAS---LIL 495

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++ 
Sbjct: 496 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
                ++APE  +       SDV+ FG+ + E++  G  P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 6e-33
 Identities = 74/322 (22%), Positives = 136/322 (42%), Gaps = 57/322 (17%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAER-EFK 123
           + E   +  +  K +GEG +G V             ++   VAVK L ++  + +  +  
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88

Query: 124 VEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDV 170
            E+E +  + +HKN++ LLG C +     ++ EY + GNL ++L              + 
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK 230
            P   +T++  ++     A+G+ YL      K +HRD+ + N+L+ ++   K++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

Query: 231 LLGSESSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
            + +   Y  T         M      APE     +   +SDV+SFG+L+ E+ + G  P
Sbjct: 206 DINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 283 VDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
             Y   P EE+   + LK+      P    +           L  ++     C      +
Sbjct: 260 --YPGIPVEEL--FKLLKEGHRMDKPANCTNE----------LYMMM---RDCWHAVPSQ 302

Query: 342 RPKMGHVVHMLEAQESPSKEPS 363
           RP    +V  L+   + +    
Sbjct: 303 RPTFKQLVEDLDRILTLTTNEE 324

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (314), Expect = 8e-33
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 72/311 (23%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRVRHKN 136
            K +GEG +G V              + VAVK L  N   +E  +   E   + +V H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--------------------HGDVGPCSPL 176
           +++L G C++    +L+ EY   G+L  +L                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T    ++     ++G+ YL    E K+VHRD+ + NIL+ +    K+SDFGL++ +  E 
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 237 SYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SR 287
           SY+         + M      A E     +   +SDV+SFG+L+ E+++ G  P  Y   
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGI 256

Query: 288 PPEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKR 342
           PPE +     LK    M               E+P   S  + R++   L+C      KR
Sbjct: 257 PPERL--FNLLKTGHRM---------------ERPDNCSEEMYRLM---LQCWKQEPDKR 296

Query: 343 PKMGHVVHMLE 353
           P    +   LE
Sbjct: 297 PVFADISKDLE 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (316), Expect = 1e-32
 Identities = 74/327 (22%), Positives = 136/327 (41%), Gaps = 57/327 (17%)

Query: 58  PEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVK 109
           P ++ +         + E   +  +  K +GEG +G V             ++   VAVK
Sbjct: 60  PMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 119

Query: 110 NLLNNRGQAER-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNL----- 162
            L ++  + +  +   E+E +  + +HKN++ LLG C +     ++ EY + GNL     
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 179

Query: 163 -------EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI 215
                  E     +  P   +T++  ++     A+G+ YL      K +HRD+ + N+L+
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236

Query: 216 DKHWNPKVSDFGLAKLLGSESSYITTRV-------MGTFGYVAPEYASTGMLNERSDVYS 268
            ++   K++DFGLA+ + +   Y  T         M      APE     +   +SDV+S
Sbjct: 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWS 290

Query: 269 FGILIMEVIS-GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR 326
           FG+L+ E+ + G  P  Y   P EE+   + LK+      P    +              
Sbjct: 291 FGVLMWEIFTLGGSP--YPGIPVEEL--FKLLKEGHRMDKPANCTN-------------E 333

Query: 327 ILLVALRCVDPNAQKRPKMGHVVHMLE 353
           + ++   C      +RP    +V  L+
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLD 360

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  123 bits (310), Expect = 3e-32
 Identities = 75/319 (23%), Positives = 118/319 (36%), Gaps = 63/319 (19%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   + E   +     K +G G +G V                VAVK L      +E   
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76

Query: 122 FKVEVEAIGRV-RHKNLVRLLGYC-AEGAHRMLVYEYVNNGNLEQWL------------H 167
              E++ +  +  H N+V LLG C   G   M++ E+   GNL  +L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 168 GDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
            +      LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 193

Query: 228 LAKLLGSESSYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 279
           LA+ +  +  Y+         + M      APE     +   +SDV+SFG+L+ E+ S G
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247

Query: 280 RIPVDYSRPPEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRC 334
             P  Y     +      LK+   M                 P   +  + + +   L C
Sbjct: 248 ASP--YPGVKIDEEFCRRLKEGTRM---------------RAPDYTTPEMYQTM---LDC 287

Query: 335 VDPNAQKRPKMGHVVHMLE 353
                 +RP    +V  L 
Sbjct: 288 WHGEPSQRPTFSELVEHLG 306

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (308), Expect = 5e-32
 Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 64/313 (20%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            K +G G +G V           +    VAVK L  +    ER     E++ +  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--------------HGDVGPCSPLTWEIR 181
           N+V LLG C  G   +++ EY   G+L  +L                       L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           ++     AKG+++L        +HRD+ + NIL+      K+ DFGLA+ + ++S+Y+  
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 242 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVN 293
                  + M      APE     +    SDV+S+GI + E+ S G  P  Y   P +  
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMPVDSK 256

Query: 294 LIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRPKMGHV 348
             + +K+   M                 P      +  I+     C D +  KRP    +
Sbjct: 257 FYKMIKEGFRM---------------LSPEHAPAEMYDIM---KTCWDADPLKRPTFKQI 298

Query: 349 VHMLEAQESPSKE 361
           V ++E Q S S  
Sbjct: 299 VQLIEKQISESTN 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (309), Expect = 6e-32
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 84  DKVIGEGGYGIVYYGLL---EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHKNLV 138
             VIGEG +G V    +         A+K +     + +  +F  E+E + ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIRMNIIL 186
            LLG C    +  L  EY  +GNL  +L                   S L+ +  ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             A+G+ YL    + + +HRD+ + NIL+ +++  K++DFGL++           + MG 
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 247 F--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
               ++A E  +  +    SDV+S+G+L+ E++S G  P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (309), Expect = 6e-32
 Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 58/318 (18%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFK 123
           L  LE   N     + IGEG +G V+          E  + VAVK L        + +F+
Sbjct: 39  LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------------- 166
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 167 ---HGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                      PL+   ++ I    A G++YL E    K VHRD+ + N L+ ++   K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215

Query: 224 SDFGLAKLLGSESSYITTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS 278
           +DFGL++ + S   Y           +      PE          SDV+++G+++ E+ S
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

Query: 279 -GRIPVDY-SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVD 336
            G  P  Y     EEV         V +     +L    PE      L  ++     C  
Sbjct: 272 YGLQP--YYGMAHEEV------IYYVRDG---NILAC--PEN-CPLELYNLM---RLCWS 314

Query: 337 PNAQKRPKMGHVVHMLEA 354
                RP    +  +L+ 
Sbjct: 315 KLPADRPSFCSIHRILQR 332

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 9e-32
 Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 45/277 (16%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+GG+   +     +     A K    +LL    Q E+   +E+     + H+++V 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 79

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT-WEIRMNIILGTAKGLSYLH 196
             G+  +     +V E     +L +             LT  E R   +     G  YLH
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEAR-YYLRQIVLGCQYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRD+K  N+ +++    K+ DFGLA  +  +       + GT  Y+APE  S
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 188

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKL 315
               +   DV+S G ++  ++ G       +PP E   L E   ++  N       +  +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKN-------EYSI 234

Query: 316 PE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           P+      + L++++L         +   RP +  ++
Sbjct: 235 PKHINPVAASLIQKML-------QTDPTARPTINELL 264

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (307), Expect = 2e-31
 Identities = 78/319 (24%), Positives = 134/319 (42%), Gaps = 69/319 (21%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            KV+G G +G V             + +VAVK L      +ER     E++ + ++  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-------------------HGDVGPCSPL 176
           N+V LLG C       L++EY   G+L  +L                     +    + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           T+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFGLA+ + S+S
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 237 SYITT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP 288
           +Y+         + M      APE    G+   +SDV+S+GIL+ E+ S G  P  Y   
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGI 278

Query: 289 PEEVNLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRP 343
           P + N  + ++    M               ++P   +  +  I+     C   +++KRP
Sbjct: 279 PVDANFYKLIQNGFKM---------------DQPFYATEEIYIIM---QSCWAFDSRKRP 320

Query: 344 KMGHVVHMLEAQESPSKEP 362
              ++   L  Q + ++E 
Sbjct: 321 SFPNLTSFLGCQLADAEEA 339

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (301), Expect = 3e-31
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 43/271 (15%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G VY     +    +A+K L    L   G   +  + EVE    +RH N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L GY  +     L+ EY   G + + L       S    +     I   A  LSY H   
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS-- 127

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEYASTG 258
             +V+HRDIK  N+L+      K++DFG +    S         + GT  Y+ PE     
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGR 182

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           M +E+ D++S G+L  E + G       +PP E     E  K++         ++   P+
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG-------KPPFEANTYQETYKRISR-------VEFTFPD 228

Query: 318 KPTS---RLLKRILLVALRCVDPNAQKRPKM 345
             T     L+ R+L         N  +RP +
Sbjct: 229 FVTEGARDLISRLL-------KHNPSQRPML 252

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  121 bits (306), Expect = 4e-31
 Identities = 78/335 (23%), Positives = 137/335 (40%), Gaps = 68/335 (20%)

Query: 84  DKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-R 133
            K +GEG +G V                +KVAVK L ++  + +  +   E+E +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL------------HGDVGPCSPLTWEIR 181
           HKN++ LLG C +     ++ EY + GNL ++L            +    P   L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +     Y  T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 242 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY-SRPPEEV 292
                  + M      APE     +   +SDV+SFG+L+ E+ + G  P  Y   P EE+
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEEL 302

Query: 293 NLIEWLKK---MVTNRNPEGVLDPKLPEKPT--SRLLKRILLVALRCVDPNAQKRPKMGH 347
              + LK+   M               +KP+  +  L  ++     C      +RP    
Sbjct: 303 --FKLLKEGHRM---------------DKPSNCTNELYMMM---RDCWHAVPSQRPTFKQ 342

Query: 348 VVHMLEAQ-ESPSKEPSNSFQDRYRASPKNELIEK 381
           +V  L+      S +    +   +         E 
Sbjct: 343 LVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (302), Expect = 5e-31
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 35/225 (15%)

Query: 84  DKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-EFKVEVEAIGRV-RHK 135
            K +G G +G V           +   KVAVK L +     E+     E++ +  + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----------HGDVGPCSPLTWEIRMNII 185
           N+V LLG C  G   +++ EY   G+L  +L                 S  +    ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT---- 241
              A+G+++L        +HRD+ + N+L+      K+ DFGLA+ + ++S+YI      
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 242 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP 282
              + M      APE     +   +SDV+S+GIL+ E+ S G  P
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (299), Expect = 5e-31
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 38/273 (13%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
            ++G+G +  VY    +    +VA+K      +   G  +R  + EV+   +++H +++ 
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILE 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  Y  +  +  LV E  +NG + ++L   V P S    E R + +     G+ YLH   
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE--NEAR-HFMHQIITGMLYLHS-- 130

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              ++HRD+  SN+L+ ++ N K++DFGLA  L        T + GT  Y++PE A+   
Sbjct: 131 -HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPE- 317
               SDV+S G +   ++ G       RPP +   +   L K+V         D ++P  
Sbjct: 189 HGLESDVWSLGCMFYTLLIG-------RPPFDTDTVKNTLNKVVLA-------DYEMPSF 234

Query: 318 --KPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
                  L+ ++L         N   R  +  V
Sbjct: 235 LSIEAKDLIHQLL-------RRNPADRLSLSSV 260

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (301), Expect = 8e-31
 Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 45/277 (16%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+GG+   +     +     A K    +LL    Q E+   +E+     + H+++V 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 105

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT-WEIRMNIILGTAKGLSYLH 196
             G+  +     +V E     +L +             LT  E R   +     G  YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEAR-YYLRQIVLGCQYLH 158

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                +V+HRD+K  N+ +++    K+ DFGLA  +  +       + GT  Y+APE  S
Sbjct: 159 R---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLS 214

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKL 315
               +   DV+S G ++  ++ G       +PP E   L E   ++  N       +  +
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCLKETYLRIKKN-------EYSI 260

Query: 316 PE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           P+      + L++++L         +   RP +  ++
Sbjct: 261 PKHINPVAASLIQKML-------QTDPTARPTINELL 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  118 bits (297), Expect = 1e-30
 Identities = 59/292 (20%), Positives = 107/292 (36%), Gaps = 61/292 (20%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRV-RHKN 136
           F + + IG G +G V+  +   D    A+K       G  + +  + EV A   + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
           +VR     AE  H ++  EY N G+L   +  +    S        +++L   +GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNP-------------------KVSDFGLAKLLGSESS 237
                 +VH DIK SNI I +   P                   K+ D G    + S   
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 238 YITTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEE 291
                  G   ++A E     +L E       +D+++  + ++              P  
Sbjct: 190 EE-----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE------PLPRN 233

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            +      ++   R P       +P+   S+    +L      + P+ ++RP
Sbjct: 234 GDQW---HEIRQGRLPR------IPQV-LSQEFTELL---KVMIHPDPERRP 272

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 2e-30
 Identities = 35/294 (11%), Positives = 70/294 (23%), Gaps = 49/294 (16%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVRHKNLVR 139
            + +  G   +V+    +E     A+K       N             A  R+  ++   
Sbjct: 67  VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 140 LLGYCAEGA--------------------------HRMLVYEYV--NNGNLEQWLHGDVG 171
                                              + +L+      +   L   L     
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186

Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
                       +     +  + L       +VH      N+ I       + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 232 LGSESSYITTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP 289
           +G+              Y   E+  AST       + +  G+ I  V    +P     P 
Sbjct: 244 VGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            + +      ++    +        LP+     L+ R L       D   ++R 
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPD-FVKTLIGRFL-----NFDR--RRRL 345

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (300), Expect = 4e-30
 Identities = 69/279 (24%), Positives = 109/279 (39%), Gaps = 34/279 (12%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F    V+G G  G + Y  + DN  VAVK +L      A+RE ++  E+     H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
                 +   + +  E      L++++               + ++  T  GL++LH   
Sbjct: 83  YFCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 200 EPKVVHRDIKSSNILI-----DKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAP 252
              +VHRD+K  NILI            +SDFGL K L       + R  V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 253 EY---ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           E              D++S G +   VIS            + N+               
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----------LLGAC 245

Query: 310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            LD   PEK    + + ++    + +  + QKRP   HV
Sbjct: 246 SLDCLHPEKHEDVIARELI---EKMIAMDPQKRPSAKHV 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (293), Expect = 7e-30
 Identities = 69/272 (25%), Positives = 105/272 (38%), Gaps = 42/272 (15%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV-EVEAIGRV-RHKN 136
           F     +G G YG V+     ED    AVK      RG  +R  K+ EV +  +V +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            VRL     EG    L  E     +L+Q         + L        +  T   L++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH 174

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE--- 253
                 +VH D+K +NI +      K+ DFGL   LG+  +       G   Y+APE   
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ 229

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
             Y         +DV+S G+ I+EV            P      + L++        G L
Sbjct: 230 GSY------GTAADVFSLGLTILEVACNM------ELPHGGEGWQQLRQ--------GYL 269

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            P+      S  L+ +L   +  ++P+ + R 
Sbjct: 270 PPEFTAG-LSSELRSVL---VMMLEPDPKLRA 297

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 2e-29
 Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 26/252 (10%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
             ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKL 72

Query: 141 LGY--CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                     H++L+ E+   G+L   L  +      L     + ++     G+++L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 199 LEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
               +VHR+IK  NI+     D     K++DFG A+ L  +     +   GT  Y+ P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDM 186

Query: 255 ASTGML--------NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
               +L            D++S G+      +G +P      P      E + K++T + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKP 244

Query: 307 PEGVLDPKLPEK 318
              +   +  E 
Sbjct: 245 SGAISGVQKAEN 256

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 45/278 (16%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-- 146

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-VMGTFGYVAPE------ 253
             +VH D+K +N LI      K+ DFG+A  +  +++ +     +GT  Y+ PE      
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
                  S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   +  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE- 258

Query: 309 GVLDPKLPEKPTS---RLLKRILLVALRCVDPNAQKRP 343
                + P+ P      +LK  L       DP   +R 
Sbjct: 259 ----IEFPDIPEKDLQDVLKCCL-----KRDPK--QRI 285

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (289), Expect = 4e-29
 Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 41/276 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL         +    R +      + +  +H+   
Sbjct: 75  YDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-- 127

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAPE----- 253
             +VH D+K +N LI      K+ DFG+A  +   + S    ++V GT  Y+ PE     
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDM 184

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
                   S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   + 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE 239

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 + P+ P  + L+ +L     C+  + ++R 
Sbjct: 240 -----IEFPDIP-EKDLQDVL---KCCLKRDPKQRI 266

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  115 bits (290), Expect = 7e-29
 Identities = 54/252 (21%), Positives = 102/252 (40%), Gaps = 26/252 (10%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
             ++G+G    V+ G   +     A+K  N ++     + + + E E + ++ HKN+V+L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKL 72

Query: 141 LGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
                E   R   L+ E+   G+L   L  +      L     + ++     G+++L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 199 LEPKVVHRDIKSSNILI----DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
               +VHR+IK  NI+     D     K++DFG A+ L  +     +   GT  Y+ P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDM 186

Query: 255 ASTGML--------NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
               +L            D++S G+      +G +P      P      E + K++T + 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKP 244

Query: 307 PEGVLDPKLPEK 318
              +   +  E 
Sbjct: 245 SGAISGVQKAEN 256

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  113 bits (284), Expect = 2e-28
 Identities = 67/363 (18%), Positives = 129/363 (35%), Gaps = 65/363 (17%)

Query: 45  SGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDN 103
            GG SG   +  V +   LG      +R            +V+ EGG+  VY    +   
Sbjct: 7   LGGASGRDQSDFVGQTVELG-ELRLRVR------------RVLAEGGFAFVYEAQDVGSG 53

Query: 104 SKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM-------LVYE 155
            + A+K LL+N  +  R    EV  + ++  H N+V+     + G           L+  
Sbjct: 54  REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113

Query: 156 YVNNGNLEQWLHGDVGPCSPLT-WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
            +  G L ++L   +    PL+   +   I   T + + ++H   +P ++HRD+K  N+L
Sbjct: 114 ELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLL 170

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYITTRVM-----------GTFGYVAPE---YASTGML 260
           +      K+ DFG A  +     Y  +               T  Y  PE     S   +
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230

Query: 261 NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT 320
            E+ D+++ G ++  +   + P +           +  K  + N          +P   T
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFE-----------DGAKLRIVNGK------YSIPPHDT 273

Query: 321 -SRLLKRILLVALRCVDPNAQKRPK----MGHVVHMLEAQESPSKEPSNSFQDRYRASPK 375
              +   ++      +  N ++R      +  +  +  A+    K P     ++      
Sbjct: 274 QYTVFHSLI---RAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330

Query: 376 NEL 378
             L
Sbjct: 331 ATL 333

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (284), Expect = 2e-28
 Identities = 56/296 (18%), Positives = 109/296 (36%), Gaps = 56/296 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK-----------------NLLNNRGQAEREFKVEVE 127
           + + +G +  +     +DN   A+K                 N   +      +FK E++
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL----HGDVGPCSPLTWEIRMN 183
            I  ++++  +   G         ++YEY+ N ++ ++       D      +  ++   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           II       SY+H      + HRD+K SNIL+DK+   K+SDFG ++        I    
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-S 210

Query: 244 MGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            GT+ ++ PE+ S        + D++S GI +  +    +P        +++L+E    +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFNNI 265

Query: 302 V-------TNRNPEGVLDPKLPEKPTSR--------LLKRILLVALRCVDPNAQKR 342
                    +RN             ++          LK  L         N  +R
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL-------RKNPAER 314

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  116 bits (291), Expect = 3e-28
 Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 36/286 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL 141
            + +G GG+G V   +  +   +VA+K          RE + +E++ + ++ H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 142 ------GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGL 192
                    A     +L  EY   G+L ++L+     C  L    IR  ++ I      L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SAL 134

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYITTRVMGTFGY 249
            YLHE    +++HRD+K  NI++         K+ D G AK L  +    T  V GT  Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQY 189

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI----------EWLK 299
           +APE           D +SFG L  E I+G  P   +  P + +             +  
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249

Query: 300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                +    +  P       +  L+R L   L       ++R   
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQ--RQRGTD 292

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (280), Expect = 3e-28
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 41/267 (15%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G+G +G VY     ++   +A+K L    L   G   +  + E+E    +RH N++R
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILR 78

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           +  Y  +     L+ E+   G L + L            +     +   A  L Y HE  
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE-- 132

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
             KV+HRDIK  N+L+      K++DFG +    + S    T + GT  Y+ PE      
Sbjct: 133 -RKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIEGKT 188

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
            +E+ D++  G+L  E + G        PP +  +  E  +++V        +D K P  
Sbjct: 189 HDEKVDLWCAGVLCYEFLVG-------MPPFDSPSHTETHRRIVN-------VDLKFPPF 234

Query: 319 PTS---RLLKRILLVALRCVDPNAQKR 342
            +     L+ ++L         +  +R
Sbjct: 235 LSDGSKDLISKLL-------RYHPPQR 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 4e-28
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 39/275 (14%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--VRL 140
           K IG GG   V+  L E     A+K  NL     Q    ++ E+  + +++  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             Y     +  +V E   N +L  WL        P  WE + +      + +  +H+   
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDP--WERK-SYWKNMLEAVHTIHQH-- 174

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR-VMGTFGYVAPE------ 253
             +VH D+K +N LI      K+ DFG+A  +  +++ +     +G   Y+ PE      
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
                  S   ++ +SDV+S G ++  +  G+ P       + +N I  L  ++   +  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHE- 286

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                + P+ P  + L+ +L     C+  + ++R 
Sbjct: 287 ----IEFPDIP-EKDLQDVL---KCCLKRDPKQRI 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  111 bits (280), Expect = 7e-28
 Identities = 52/283 (18%), Positives = 104/283 (36%), Gaps = 44/283 (15%)

Query: 67  HWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVE 125
           HW T +              +G G +G V+     +   + AVK +     + E     E
Sbjct: 58  HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + A   +    +V L G   EG    +  E +  G+L Q +         L  +  +  +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYITTR-- 242
               +GL YLH     +++H D+K+ N+L+    +   + DFG A  L  +    +    
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 243 --VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             + GT  ++APE       + + D++S   +++ +++G        P  +        K
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLK 267

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
           + +   P      ++P    + L  + +      +      R 
Sbjct: 268 IASEPPPI----REIPPS-CAPLTAQAI---QEGLRKEPVHRA 302

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (273), Expect = 3e-27
 Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           ++  + IG+G  G VY  + +    +VA++ +   +   +     E+  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
            L     G    +V EY+  G+L      DV   + +  E ++  +     + L +LH  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              +V+HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +  
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
               + D++S GI+ +E+I G  P  Y    P        L  + TN        P+L  
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRA-----LYLIATN-GT-----PELQN 238

Query: 318 KPT-SRLLKRILLVALRCVDPNAQKRP 343
               S + +  L   L  +D   +KR 
Sbjct: 239 PEKLSAIFRDFLNRCL-EMDV--EKRG 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 3e-27
 Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 30/267 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
                 IGEG  GIV          +VAVK +   + Q       EV  +   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
           +      G    ++ E++  G L      D+     L  E ++  +     + L+YLH  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHA- 159

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               V+HRDIKS +IL+      K+SDFG    +  +     + V GT  ++APE  S  
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
           +     D++S GI+++E++ G  P  Y    P +      +K++  +  P     PKL  
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP--YFSDSPVQA-----MKRLRDS-PP-----PKLKN 263

Query: 318 KPT-SRLLKRILLVALRCVDPNAQKRP 343
               S +L+  L   L   DP  Q+R 
Sbjct: 264 SHKVSPVLRDFLERML-VRDP--QERA 287

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 4e-27
 Identities = 40/302 (13%), Positives = 79/302 (26%), Gaps = 64/302 (21%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVR--- 133
                V+G+            E      V            A ++ K EV  +  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 134 ----------------------HKNLVRLLGYCAEGAHRMLV----YEYVNNGNLEQWLH 167
                                  K ++R+     +               N     + L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 168 GDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDF 226
                   L    R+ + L   + L+ LH  G    +VH  ++  +I++D+     ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 227 GLAKLLGSESSYITTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRI 281
                 G+ +     R        A            ++    D ++ G+ I  +    +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
           P             EW+ +              +P+ P   LL+  L           + 
Sbjct: 316 PNTDDAALG---GSEWIFR----------SCKNIPQ-PVRALLEGFL-------RYPKED 354

Query: 342 RP 343
           R 
Sbjct: 355 RL 356

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (272), Expect = 5e-27
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 26/278 (9%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGR 131
           +EV  +       +G G YG+V     +     +AVK +      Q ++   ++++   R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 132 -VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
            V     V   G         +  E ++  +L+++    +     +  +I   I +   K
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYV 250
            L +LH   +  V+HRD+K SN+LI+     K+ DFG++  L            G   Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176

Query: 251 APE----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
           APE      +    + +SD++S GI ++E+   R P  Y          + LK++V    
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP--Y---DSWGTPFQQLKQVVEE-- 229

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                 P+LP    S         + +C+  N+++RP 
Sbjct: 230 ----PSPQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (276), Expect = 9e-27
 Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 45/292 (15%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSKVAVKNLL-NNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           +K++G G  G V +        VAVK +L +    A  E K+  E+     H N++R   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRYYC 76

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRM-NIILGTAKGLSYLHEGL 199
                    +  E   N NL+  +           L  E    +++   A G+++LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 200 EPKVVHRDIKSSNILID-------------KHWNPKVSDFGLAKLLGSESSYITTRVM-- 244
             K++HRD+K  NIL+              ++    +SDFGL K L S  S   T +   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 245 -GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE 296
            GT G+ APE         +   L    D++S G +   ++S        +   E N+  
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI-- 250

Query: 297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            ++ + +    + + D  L  + T  L+ +++       DP   KRP    V
Sbjct: 251 -IRGIFSLDEMKCLHDRSLIAEATD-LISQMI-----DHDPL--KRPTAMKV 293

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 3e-26
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 29/266 (10%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           F+  + IG+G +G V+ G+       VA+K +     + E E  + E+  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
           +  G   +     ++ EY+  G+       D+    PL       I+    KGL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              K +HRDIK++N+L+ +H   K++DFG+A  L        T  +GT  ++APE     
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194

Query: 259 MLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
             + ++D++S GI  +E+  G  P  +S   P +V        ++   NP     P L E
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP--HSELHPMKVLF------LIPKNNP-----PTL-E 240

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRP 343
              S+ LK  +   L   +P    RP
Sbjct: 241 GNYSKPLKEFVEACL-NKEP--SFRP 263

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  106 bits (266), Expect = 5e-26
 Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 28/283 (9%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAI 129
           +  + +     D   IG G YG V   +       +AVK + +   + E++   ++++ +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 130 GR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
            R      +V+  G         +  E ++    + + +        +  EI   I L T
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L++L E    K++HRDIK SNIL+D+  N K+ DFG++  L    S   TR  G   
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRP 190

Query: 249 YVAPE----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           Y+APE     AS    + RSDV+S GI + E+ +GR P        +          V  
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVK 244

Query: 305 RNPEGVLDPKLPEKPT---SRLLKRILLVALRCVDPNAQKRPK 344
            +P     P+L        S        V   C+  +  KRPK
Sbjct: 245 GDP-----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 6e-26
 Identities = 37/201 (18%), Positives = 77/201 (38%), Gaps = 46/201 (22%)

Query: 143 YCAEGAHRMLVY---EYVNNGNLEQWLHGDVGPCSP---LTWEIRMNIILGTAKGLSYLH 196
                + ++ +Y   +     NL+ W++           +   I + I       + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH 181

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT-----------TRVMG 245
                 ++HRD+K SNI        KV DFGL   +  +    T           T  +G
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGI-----------------LIMEVISGRIPVDYS-R 287
           T  Y++PE       + + D++S G+                 +I +V + + P+ ++ +
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQK 298

Query: 288 PPEEVNLIEWLKKMVTNRNPE 308
            P+E  +++ +     + +P 
Sbjct: 299 YPQEHMMVQDM----LSPSPT 315

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 4/103 (3%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G GG+G+V+      D+   A+K + L NR  A  +   EV+A+ ++ H  +VR   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR--Y 69

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + A        ++   +    +    D    SP   +     I
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (265), Expect = 9e-26
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 11/252 (4%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREF-KVEVEAI 129
           +  E+  + F     +G G  G+V+    + +  V A K +      A R     E++ +
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
                  +V   G         +  E+++ G+L+Q L         +  +I   + +   
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           KGL+YL E  + K++HRD+K SNIL++     K+ DFG++  L    S   + V GT  Y
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
           ++PE       + +SD++S G+ ++E+  GR P+      E   +     +      P  
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 310 VLDPKLPEKPTS 321
              P  P     
Sbjct: 257 PRTPGRPLNKFG 268

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (265), Expect = 1e-25
 Identities = 42/303 (13%), Positives = 86/303 (28%), Gaps = 73/303 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLL---NNRGQAEREFKVEVEAIGRVR------- 133
            V+G+            E      V            A ++ K EV  +  +R       
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 134 ------------------HKNLVRLLGYCAEGAHRMLVYEY----VNNGNLEQWLHGDVG 171
                              K ++R+     +       + Y     N     + L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 172 PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL 231
               L    R+ + L   + L+ LH      +VH  ++  +I++D+     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 232 LGSESSYITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGR 280
            G+           + G+  PE  +             ++    D ++ G++I  +    
Sbjct: 256 DGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ 340
           +P+        +   EW+ +   N  P+ V            LL+  L           +
Sbjct: 311 LPIT---KDAALGGSEWIFRSCKNI-PQPVRA----------LLEGFL-------RYPKE 349

Query: 341 KRP 343
            R 
Sbjct: 350 DRL 352

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 3e-25
 Identities = 34/239 (14%), Positives = 80/239 (33%), Gaps = 40/239 (16%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS------KVAVKNLLNNRGQAEREFKVE 125
            E ++ +       ++GEG +  VY     D +      K  +K     +     EF + 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114

Query: 126 VEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL-HGDVGPCSPLTWEIR 181
            + + R++       ++           +LV E  + G L   +      P   +   + 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-----------KVSDFGLAK 230
           ++  +     +  +H+    +++H DIK  N ++   +              + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 231 LLGS--ESSYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            +    + +  T +   T G+   E     ML+ +      D +     +  ++ G   
Sbjct: 232 DMKLFPKGTIFTAKC-ETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (258), Expect = 3e-25
 Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 75/287 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG YG V   +       VAVK       ++     ++E    +     + H+N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +  G+  EG  + L  EY + G L   +                 M           ++ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVM 244
           G    + YLH      + HRDIK  N+L+D+  N K+SDFGLA +    +    +     
Sbjct: 117 G----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168

Query: 245 GTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  YVAPE     +L  R       DV+S GI++  +++G +P D     +  +  +  
Sbjct: 169 GTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEY 218

Query: 299 KKMVTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
                     NP   +D          LL +IL         N   R
Sbjct: 219 SDWKEKKTYLNPWKKIDSAP-----LALLHKIL-------VENPSAR 253

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 5e-25
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           F   + +GEG YG VY  +  E    VA+K +        +E   E+  + +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
             G   +     +V EY   G++   +       +    E  +  IL  T KGL YLH  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT----EDEIATILQSTLKGLEYLHFM 144

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              + +HRDIK+ NIL++   + K++DFG+A  L    +   T + GT  ++APE     
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200

Query: 259 MLNERSDVYSFGILIMEVISGRIP 282
             N  +D++S GI  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (257), Expect = 5e-25
 Identities = 72/313 (23%), Positives = 118/313 (37%), Gaps = 54/313 (17%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
            ++GEG YG V   L  E   + AVK      L      E   K E++ + R+RHKN+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 140 LLG--YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR---MNIILGTAKGLSY 194
           L+   Y  E     +V EY   G  E               +       +I G    L Y
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV--CQAHGYFCQLIDG----LEY 124

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGTFGYVAP 252
           LH      +VH+DIK  N+L+      K+S  G+A+ L   +      T   G+  +  P
Sbjct: 125 LHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180

Query: 253 EYASTGMLNE--RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV 310
           E A+        + D++S G+ +  + +G  P +        N+ +  + +         
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKLFENIGKG------ 228

Query: 311 LDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHV-------VHMLEAQESPSK 360
               +P     P S LLK +L       +    KR  +  +            A+     
Sbjct: 229 -SYAIPGDCGPPLSDLLKGML-------EYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280

Query: 361 EPSNSFQDRYRAS 373
            PS   +DR+R+ 
Sbjct: 281 PPSPDTKDRWRSM 293

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 6e-25
 Identities = 42/209 (20%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +     +G+G +G VY     E  +  A K +     +   ++ VE+E +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYLHEG 198
           LLG         ++ E+   G ++  +       +    E ++ ++     + L++LH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHSK 136

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
              +++HRD+K+ N+L+    + +++DFG++           +  +GT  ++APE     
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192

Query: 259 ML-----NERSDVYSFGILIMEVISGRIP 282
            +     + ++D++S GI ++E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  102 bits (255), Expect = 2e-24
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 31/282 (10%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAERE-FKVEVEAI 129
           +  +   N   +   +G G  G V+         V AVK +  +  + E +   ++++ +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 130 GR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
            +      +V+  G         +  E +     +           P+   I   + +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ----GPIPERILGKMTVAI 133

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFG 248
            K L YL E  +  V+HRD+K SNIL+D+    K+ DFG++  L         R  G   
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAA 189

Query: 249 YVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
           Y+APE       +    + R+DV+S GI ++E+ +G+ P    +   EV     L K++ 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ 244

Query: 304 NRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPK 344
              P     P LP     S   +    V   C+  + +KRPK
Sbjct: 245 E-EP-----PLLPGHMGFSGDFQS--FVK-DCLTKDHRKRPK 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 2e-24
 Identities = 74/357 (20%), Positives = 124/357 (34%), Gaps = 82/357 (22%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + +GEG YG V   +       VAVK       ++     ++E    +     + H+N+V
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +  G+  EG  + L  EY + G L   +                 M           ++ 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL--LGSESSYITTRVM 244
           G    + YLH      + HRDIK  N+L+D+  N K+SDFGLA +    +    +     
Sbjct: 117 G----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168

Query: 245 GTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL 298
           GT  YVAPE     +L  R       DV+S GI++  +++G +P D     +  +  +  
Sbjct: 169 GTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEY 218

Query: 299 KKMVTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV------- 348
                     NP   +D          LL +IL         N   R  +  +       
Sbjct: 219 SDWKEKKTYLNPWKKIDSAP-----LALLHKIL-------VENPSARITIPDIKKDRWYN 266

Query: 349 VHMLEAQESPSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQH 405
             + +  + P        +     S   +        +  + T  +G         H
Sbjct: 267 KPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH 323

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 7e-24
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 37/277 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLV 138
           F   +++G G YG VY G  ++     A+K +++  G  E E K E+  + +   H+N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 139 RLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
              G +  +    M     LV E+   G++   +       + L  E    I     +GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGL 142

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           S+LH+    KV+HRDIK  N+L+ ++   K+ DFG++  L        T  +GT  ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198

Query: 253 E-----YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRN 306
           E            + +SD++S GI  +E+  G        PP  +++ +  L  +  N  
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLCDMHPMRALFLIPRN-P 250

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                 P+L  K  S+  +  +   L   +    +RP
Sbjct: 251 A-----PRLKSKKWSKKFQSFIESCL-VKNH--SQRP 279

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (251), Expect = 1e-23
 Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 41/256 (16%)

Query: 41  PGNGSGGGSGDQVAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL 100
           P NG      D    V+  ++  G     T  + E++   +++ KVIG G +G+V+   L
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIA---YTNCKVIGNGSFGVVFQAKL 61

Query: 101 EDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRM------LV 153
            ++ +VA+K +L      ++ FK  E++ +  V+H N+V L  +      +       LV
Sbjct: 62  VESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI 213
            EYV    + +           +   +    +    + L+Y+H      + HRDIK  N+
Sbjct: 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNL 172

Query: 214 LIDKHWNP-KVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEYASTGMLNERS----- 264
           L+D      K+ DFG AK+L +     SYI +R      Y APE     +    +     
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPEL----IFGATNYTTNI 223

Query: 265 DVYSFGILIMEVISGR 280
           D++S G ++ E++ G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 70/283 (24%), Positives = 127/283 (44%), Gaps = 39/283 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLV 138
           +   +VIG G   +V          KVA+K +   + Q   +    E++A+ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 139 RLLGYCAEGAHRMLVYEYVNNG---NLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSY 194
                        LV + ++ G   ++ + +       S +  E  +  IL    +GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF-G---YV 250
           LH+      +HRD+K+ NIL+ +  + +++DFG++  L +       +V  TF G   ++
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 251 APE-------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSR-PPEEVNLIEWLKKMV 302
           APE       Y      + ++D++SFGI  +E+ +G  P  Y + PP +V     L   +
Sbjct: 194 APEVMEQVRGY------DFKADIWSFGITAIELATGAAP--YHKYPPMKV-----LMLTL 240

Query: 303 TNRNP--EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            N  P  E  +  K   K   +  ++++ + L   DP  +KRP
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCL-QKDP--EKRP 280

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 78  TNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN 136
            + F  +++ G+G +G V  G        VA+K ++ +     RE +  ++ +  + H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 137 LVRLLGY-CAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           +V+L  Y    G          +V EYV +  L +               +    +    
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSES---SYITTRVMG 245
           + +  LH      V HRDIK  N+L+++     K+ DFG AK L       +YI +R   
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196

Query: 246 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
              Y APE     +   +      D++S G +  E++ G 
Sbjct: 197 ---YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 43/225 (19%), Positives = 73/225 (32%), Gaps = 18/225 (8%)

Query: 71  LRELEVSTNGFSDDKVIGEG--GYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVE 125
           +         +    VIG+G      V           V V+  NL     +     + E
Sbjct: 17  MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           +       H N+V             +V  ++  G+ +  +         +       I+
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
            G  K L Y+H       VHR +K+S+ILI       +S       + S           
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 246 TFGYV------APEYASTGML--NERSDVYSFGILIMEVISGRIP 282
               V      +PE     +   + +SD+YS GI   E+ +G +P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 38/272 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK---VEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +  +  Q+  +++    EV  + ++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL-GTAKGLSYL 195
            ++  G         LV EY   G+    L     P      E+ +  +  G  +GL+YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
           H      ++HRD+K+ NIL+ +    K+ DFG A ++   +S++     GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222

Query: 254 -YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP-EEVNLIEWLKKMVTNRNPEGVL 311
                G  + + DV+S GI  +E+          +PP   +N +  L  +  N       
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAMSALYHIAQN-ES---- 270

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
            P L     S   +  +   L    P  Q RP
Sbjct: 271 -PALQSGHWSEYFRNFVDSCL-QKIP--QDRP 298

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKV-EVEAIGRVRHKNLV 138
           ++D KVIG G +G+VY   L +    VA+K +L      ++ FK  E++ + ++ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110

Query: 139 RLLGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RL  +      +       LV +YV    + +           L        +    + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSES---SYITTRVMGTFG 248
           +Y+H      + HRDIK  N+L+D      K+ DFG AK L       SYI +R      
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           Y APE     +          DV+S G ++ E++ G+
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLV 138
             IGEG YG+V+     +    VA+K         +    K     E+  + +++H NLV
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL          LV+EY ++  +   L             ++ +I   T + +++ H+ 
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH--LVK-SITWQTLQAVNFCHKH 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE----- 253
                +HRD+K  NILI KH   K+ DFG A+LL   S Y    V  T  Y +PE     
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177

Query: 254 --YASTGMLNERSDVYSFGILIMEVISGR 280
             Y    +     DV++ G +  E++SG 
Sbjct: 178 TQY-GPPV-----DVWAIGCVFAELLSGV 200

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 88/309 (28%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVE------------- 125
             IG+G YG+V       DN+  A+K      L+   G   R                  
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 126 -VEAIGR-------VRHKNLVRLLGY----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPC 173
            +E + +       + H N+V+L            H  +V+E VN G +      +V   
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTL 131

Query: 174 SPLT----WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA 229
            PL+         ++I G    + YLH     K++HRDIK SN+L+ +  + K++DFG++
Sbjct: 132 KPLSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNER--------SDVYSFGILIMEVISGRI 281
                  + ++  V GT  ++APE      L+E          DV++ G+ +   + G+ 
Sbjct: 185 NEFKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 282 PVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPT-----SRLLKRILLVALRCVD 336
           P        +  ++    K+ +          + P++P        L+ R+L       D
Sbjct: 239 PFM------DERIMCLHSKIKSQ-------ALEFPDQPDIAEDLKDLITRML-------D 278

Query: 337 PNAQKRPKM 345
            N + R  +
Sbjct: 279 KNPESRIVV 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLV 138
            ++GEG YG+V      +    VA+K         + +  K     E++ + ++RH+NLV
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL  C +     LV+E+V++  +   L             ++   +     G+ + H  
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQ--VVQ-KYLFQIINGIGFCHSH 143

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
               ++HRDIK  NIL+ +    K+ DFG A+ L +        V  T  Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 30/209 (14%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IGEG YG V+     E +  VA+K +   R   + E        E+  +  ++HKN+VRL
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                      LV+E+ +  +L+++     G   P   +  +  +L   KGL + H    
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR-- 120

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------- 253
             V+HRD+K  N+LI+++   K+++FGLA+  G      +  V+ T  Y  P+       
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIP 282
           Y ST +     D++S G +  E+ +   P
Sbjct: 179 Y-STSI-----DMWSAGCIFAELANAGRP 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 32/231 (13%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREF 122
           W  L    +  + F D +V+G GG+G V+   ++   K+ A K L    L  R   +   
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA- 232

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
            VE + + +V  + +V L  Y  E    + LV   +N G++   ++           E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290

Query: 182 MN-----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
                  I+ G    L +LH+     +++RD+K  N+L+D   N ++SD GLA  L +  
Sbjct: 291 AIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +       GT G++APE     +L         D ++ G+ + E+I+ R P
Sbjct: 344 TKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 29/206 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRLL 141
           +GEG YG+VY         VA+K +   R  AE E        E+  +  + H N+V L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                     LV+E++   +L++ L  +         +I +  +L   +G+++ H+    
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH--- 138

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-------Y 254
           +++HRD+K  N+LI+     K++DFGLA+  G      T  V+ T  Y AP+       Y
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197

Query: 255 ASTGMLNERSDVYSFGILIMEVISGR 280
            ST +     D++S G +  E+I+G+
Sbjct: 198 -STSV-----DIWSIGCIFAEMITGK 217

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 73/313 (23%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           K IG+G +  V     +    +VA+K +   +       K+  EV  +  + H N+V+L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILGTA 189
                     L+ EY + G +  +L  HG            RM           I+    
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVSA-- 126

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
             + Y H+    ++VHRD+K+ N+L+D   N K++DFG +    +    +     G   Y
Sbjct: 127 --VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPY 179

Query: 250 VAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
            APE     +   +       DV+S G+++  ++SG +P D        NL E  ++++ 
Sbjct: 180 AAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVL- 227

Query: 304 NRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV-------VHMLEAQ 355
                G    P         LLKR L      ++P   KR  +  +           E +
Sbjct: 228 ----RGKYRIPFYMSTDCENLLKRFL-----VLNP--IKRGTLEQIMKDRWINAGHEEDE 276

Query: 356 ESPSKEPSNSFQD 368
             P  EP     D
Sbjct: 277 LKPFVEPELDISD 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 36/212 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE--------REFKVEVEAIGRVRHKNL 137
           +G G Y  VY GL       VA+K +   +  +E        RE  +  E    ++H+N+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKE----LKHENI 65

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           VRL           LV+E+++N +L++++           L   +         +GL++ 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
           HE    K++HRD+K  N+LI+K    K+ DFGLA+  G   +  ++ V+ T  Y AP+  
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGR 280
                Y ST +     D++S G ++ E+I+G+
Sbjct: 181 MGSRTY-STSI-----DIWSCGCILAEMITGK 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 29/206 (14%)

Query: 87  IGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRLL 141
           IGEG YG+VY          A+K +   R + E E        E+  +  ++H N+V+L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                    +LV+E+++  +L++ L    G    +T +  +  +L    G++Y H+    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR--- 119

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-------Y 254
           +V+HRD+K  N+LI++    K++DFGLA+  G      T  ++ T  Y AP+       Y
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178

Query: 255 ASTGMLNERSDVYSFGILIMEVISGR 280
            ST +     D++S G +  E+++G 
Sbjct: 179 -STTI-----DIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 27/207 (13%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKV----EVEAIGRVRHKNLVRL 140
           +GEG +  VY       N  VA+K + L +R +A+         E++ +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
           L      ++  LV++++   +LE  +  +    +P   +  M + L   +GL YLH+   
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQH-- 131

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE------- 253
             ++HRD+K +N+L+D++   K++DFGLAK  GS +   T +V+ T  Y APE       
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARM 189

Query: 254 YASTGMLNERSDVYSFGILIMEVISGR 280
           Y   G+     D+++ G ++ E++   
Sbjct: 190 Y-GVGV-----DMWAVGCILAELLLRV 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 69/256 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKV--EVEAIGRVRHK-- 135
            ++G GG+G VY G+ + DN  VA+K    + +++ G+     +V  EV  + +V     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNN-GNLEQWL--HGDVGPCSPLTWEIRMN--------- 183
            ++RLL +       +L+ E      +L  ++   G             +          
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------------ALQEELARSFFW 156

Query: 184 -IILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITT 241
            ++    + + + H      V+HRDIK  NILID      K+ DFG   LL  + +  T 
Sbjct: 157 QVL----EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD 207

Query: 242 RVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVD---------YS 286
              GT  Y  PE      +         + V+S GIL+ +++ G IP +           
Sbjct: 208 FD-GTRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 261

Query: 287 RP----PEEVNLIEWL 298
                  E  +LI W 
Sbjct: 262 FRQRVSSECQHLIRWC 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            K +G G YG V        + + A+K     +    +  +   EV  +  + H N+++L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
             +  +  +  LV E    G L   +                 II     G++YLH+   
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155

Query: 201 PKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
             +VHRD+K  N+L+   +K    K+ DFGL+ +       +  R+ GT  Y+APE    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAPE-VLR 211

Query: 258 GMLNERSDVYSFGILIMEVISGRIP 282
              +E+ DV+S G+++  +++G  P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 54/254 (21%), Positives = 92/254 (36%), Gaps = 63/254 (24%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           LE S+  +S  K +G G +GIV     +E   + A+K +L +     RE  +    +  +
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI----MKVL 57

Query: 133 RHKNLVRLL------GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            H N+++L+      G       +         G      +         +    +N+I+
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 187 G-------------------------------TAKGLSYLHEGLEPKVVHRDIKSSNILI 215
                                             + + ++H      + HRDIK  N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLV 174

Query: 216 DKHWNP-KVSDFGLAKLLGSES---SYITTRVMGTFGYVAPEYASTGMLNERS-----DV 266
           +   N  K+ DFG AK L       +YI +R      Y APE     ML         D+
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSIDL 225

Query: 267 YSFGILIMEVISGR 280
           +S G +  E+I G+
Sbjct: 226 WSIGCVFGELILGK 239

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAE--------REFKVEVEAIGRVRHKN 136
           IG G YG VY          VA+K++ + N G           RE  +    +    H N
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR-LEAFEHPN 75

Query: 137 LVRLLGYCAEGAHR-----MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           +VRL+  CA           LV+E+V+  +L  +L  D  P   L  E   +++    +G
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRG 132

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L +LH      +VHRD+K  NIL+      K++DFGLA++   + +  T  V+ T  Y A
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWYRA 187

Query: 252 PE------YASTGMLNERSDVYSFGILIMEVISGR 280
           PE      Y +T +     D++S G +  E+   +
Sbjct: 188 PEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 32/197 (16%)

Query: 72  RELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEV 126
           ++L  ++  F+D     + IG G Y +    +    N + AVK +  ++     E    +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66

Query: 127 EAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP-----CSPLTWEI 180
           E + R  +H N++ L     +G +  +V E +  G L   +            S + + I
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTI 125

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP---KVSDFGLAKLLGSES 236
                    K + YLH      VVHRD+K SNIL +D+  NP   ++ DFG AK L +E+
Sbjct: 126 --------TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 237 SYITTRVMGTFGYVAPE 253
             + T    T  +VAPE
Sbjct: 175 GLLMTPC-YTANFVAPE 190

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           +V+G+G +G V          + AVK      +  +   E     EV+ + ++ H N+++
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIMK 90

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           L  +  +  +  LV E    G L   +          +      II     G++Y+H+  
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN- 145

Query: 200 EPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
             K+VHRD+K  N+L+    K  N ++ DFGL+      S  +  ++ GT  Y+APE   
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-GTAYYIAPE-VL 200

Query: 257 TGMLNERSDVYSFGILIMEVISGRIP 282
            G  +E+ DV+S G+++  ++SG  P
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPP 226

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 63/253 (24%), Positives = 93/253 (36%), Gaps = 61/253 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKV--EVEAIGRVR---- 133
            ++G+GG+G V+ G  L D  +VA+K    N +              EV  + +V     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 134 HKNLVRLLGYCAEGAHRMLVYEYVNNGN-LEQWL--HGDVGPCSPLTWEIRMN------- 183
           H  ++RLL +       MLV E       L  ++   G             +        
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------------PLGEGPSRCF 144

Query: 184 ---IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP-KVSDFGLAKLLGSESSYI 239
              ++      + + H      VVHRDIK  NILID      K+ DFG   LL       
Sbjct: 145 FGQVVAA----IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPY 195

Query: 240 TTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVD---------YSRP- 288
           T    GT  Y  PE+ S        + V+S GIL+ +++ G IP +            P 
Sbjct: 196 TDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPA 254

Query: 289 ---PEEVNLIEWL 298
              P+   LI   
Sbjct: 255 HVSPDCCALIRRC 267

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.2 bits (224), Expect = 1e-19
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 33/230 (14%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNLLNNRGQAEREF---K 123
           W  L    V+ N F   +V+G+GG+G V    +    K+ A K L   R +  +      
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
            E + + +V  + +V L  Y  E    + LV   +N G+L+  ++       P   E R 
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288

Query: 183 -----NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
                 I  G    L  LH     ++V+RD+K  NIL+D H + ++SD GLA  +  E  
Sbjct: 289 VFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQ 340

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            I  RV GT GY+APE     ++         D ++ G L+ E+I+G+ P
Sbjct: 341 TIKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 69/285 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G G +G V  G       KVAVK      + +     +  K E++ +   RH ++++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIK 75

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILG 187
           L    +      +V EYV+ G L  ++  HG            R+           I+  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL-- 121

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
               + Y H      VVHRD+K  N+L+D H N K++DFGL+ ++       T+   G+ 
Sbjct: 122 --SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 174

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y APE     +++ R       D++S G+++  ++ G +P D      + ++    KK+
Sbjct: 175 NYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPTLFKKI 223

Query: 302 VTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                  GV   P+   +  + LL  +L         +  KR  +
Sbjct: 224 R-----GGVFYIPEYLNRSVATLLMHML-------QVDPLKRATI 256

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 46/200 (23%), Positives = 87/200 (43%), Gaps = 32/200 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           +V+G G +  V+           A+K +  +    +   + E+  + +++H+N+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---------NIILGTAKGLSY 194
                H  LV + V+ G L   +             +            +I      + Y
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVKY 121

Query: 195 LHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           LHE     +VHRD+K  N+L    +++    ++DFGL+K+   ++  ++T   GT GYVA
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVA 175

Query: 252 PEYASTGMLNERSDVYSFGI 271
           PE  +    ++  D +S G+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGV 195

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 36/212 (16%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           +GEG YG VY  +    N  VA+K +   R + E E        EV  +  ++H+N++ L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                      L++EY      E  L   +     ++  +  + +     G+++ H    
Sbjct: 99  KSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS--- 150

Query: 201 PKVVHRDIKSSNILIDKHWNP-----KVSDFGLAKLLGSESSYITTRVMGTFGYVAPE-- 253
            + +HRD+K  N+L+           K+ DFGLA+  G      T  ++ T  Y  PE  
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEIL 209

Query: 254 -----YASTGMLNERSDVYSFGILIMEVISGR 280
                Y ST +     D++S   +  E++   
Sbjct: 210 LGSRHY-STSV-----DIWSIACIWAEMLMKT 235

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 13/197 (6%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
           +VIG+G + +V   +  E   + AVK        ++ G +  + K E      ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL   +      +V+E+++  +L   +          +  +  + +    + L Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 199 LEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
               ++HRD+K   +L+   +     K+  FG+A  LG        RV GT  ++APE  
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205

Query: 256 STGMLNERSDVYSFGIL 272
                 +  DV+  G++
Sbjct: 206 KREPYGKPVDVWGCGVI 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 38/206 (18%)

Query: 70  TLRELEVSTNGFSDD----KVIGEGGYGIVYYGLLEDNS---KVAVK----NLLNNRGQA 118
           T+ +  V      D+    K +G G  G V   L  +     KVA++             
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVK--LAFERKTCKKVAIRIISKRKFAIGSAR 179

Query: 119 ERE----FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVG- 171
           E +     + E+E + ++ H  ++++  +     +  +V E +  G L   +  +  +  
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE 238

Query: 172 -PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFG 227
             C    +++           + YLHE     ++HRD+K  N+L+   ++    K++DFG
Sbjct: 239 ATCKLYFYQM--------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287

Query: 228 LAKLLGSESSYITTRVMGTFGYVAPE 253
            +K+LG E+S + T   GT  Y+APE
Sbjct: 288 HSKILG-ETSLMRTLC-GTPTYLAPE 311

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 37/210 (17%)

Query: 87  IGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAE--------REFKVEVEAIGRVRHKNL 137
           +GEG Y  VY G  +     VA+K +   R + E        RE  +  +    ++H N+
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKD----LKHANI 62

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           V L           LV+EY++  +L+Q+L       +    ++ +  +L   +GL+Y H 
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR 118

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE---- 253
               KV+HRD+K  N+LI++    K++DFGLA+     +      V+ T  Y  P+    
Sbjct: 119 ---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174

Query: 254 ---YASTGMLNERSDVYSFGILIMEVISGR 280
              Y ST +     D++  G +  E+ +GR
Sbjct: 175 STDY-STQI-----DMWGVGCIFYEMATGR 198

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 35/279 (12%), Positives = 81/279 (29%), Gaps = 60/279 (21%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKNL 137
               G       +     D +   +VA+  +       +   +E       + R+    +
Sbjct: 36  LIFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            R+L      A  ++V E++  G+L++       P         +  +   A      H 
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP------VGAIRAMQSLAAAADAAHR 147

Query: 198 -GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
            G    V       S + +        S  G   L                  +      
Sbjct: 148 AG----VALSIDHPSRVRV--------SIDGDVVL-------------AYPATMPDA--- 179

Query: 257 TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE-GVLDPKL 315
               N + D+   G  +  ++  R P+  +     +      ++    +  E   +D  +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQPIEPADIDRDI 232

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           P + ++        VA R V  +   R     ++++++ 
Sbjct: 233 PFQISA--------VAARSVQGDGGIRSA-STLLNLMQQ 262

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 87  IGEGGYGIVYYG--LLEDNSKVAVKNL-LNNRGQ-----AEREFKVEVEAIGRVRHKNLV 138
           IGEG YG V+    L      VA+K + +    +       RE  V    +    H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETFEHPNVV 77

Query: 139 RLL----GYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           RL         +   ++ LV+E+V+  +L  +L  D  P   +  E   +++    +GL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           +LH     +VVHRD+K  NIL+      K++DFGLA++   + +  T+ V+ T  Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWYRAPE 189

Query: 254 ------YASTGMLNERSDVYSFGILIMEVISGR 280
                 Y +T +     D++S G +  E+   +
Sbjct: 190 VLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 40/217 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++GEG +  V        S+  A+K L    +    +       E + + R+ H   V+
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHPFFVK 94

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-------------IIL 186
           L     +         Y  NG L +++              ++              I+ 
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVS 141

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-G 245
                L YLH      ++HRD+K  NIL+++  + +++DFG AK+L  ES         G
Sbjct: 142 A----LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 246 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           T  YV+PE  +     + SD+++ G +I ++++G  P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 11/193 (5%)

Query: 84  DKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKNLVRLL 141
            + +G G +G V+         +  +K +  +R Q   E  + E+E +  + H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
               +  +  +V E    G L + +         L+      ++      L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 202 KVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
            VVH+D+K  NIL      H   K+ DFGLA+L      + T    GT  Y+APE     
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA-GTALYMAPEVFK-R 200

Query: 259 MLNERSDVYSFGI 271
            +  + D++S G+
Sbjct: 201 DVTFKCDIWSAGV 213

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 49/226 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-------------NLLNNRGQAEREFKVEVEAIG 130
           + +G G YG V        +S+ A+K             +   N  +   E   E+  + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWE 179
            + H N+++L     +  +  LV E+   G L           E     D          
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC----DAANI------ 151

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSES 236
             M  IL    G+ YLH+     +VHRDIK  NIL+   +   N K+ DFGL+     + 
Sbjct: 152 --MKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
                  +GT  Y+APE       NE+ DV+S G+++  ++ G  P
Sbjct: 204 KL--RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 77/288 (26%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           K IG G +G+            VAVK +   RG A  E  V  E+     +RH N+VR  
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFK 82

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILGTA 189
                  H  ++ EY + G L + +   G            R +          ++    
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS--- 127

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
            G+SY H     ++ HRD+K  N L+D    P  K+ DFG +K      S   + V GT 
Sbjct: 128 -GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTP 181

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y+APE     +L  +      +DV+S G+ +  ++ G  P +      +       +K 
Sbjct: 182 AYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRDYRKT 230

Query: 302 VTNRNPEGVL--DPKLPEKP-----TSRLLKRILLVALRCVDPNAQKR 342
           +     + +L     +P+          L+ RI          +   R
Sbjct: 231 I-----QRILSVKYSIPDDIRISPECCHLISRIF-------VADPATR 266

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 36/228 (15%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQ-----AERE 121
             + ++ N FS  ++IG GG+G VY     D  K+ A+K L    +  +        ER 
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
               +  +       +V +  Y      ++  + + +N G+L   L    G  S    E 
Sbjct: 242 M---LSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS----EA 292

Query: 181 RMN-----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            M      IILG    L ++H      VV+RD+K +NIL+D+H + ++SD GLA     +
Sbjct: 293 DMRFYAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345

Query: 236 SSYITTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRIP 282
             +    V GT GY+APE    G+  + S D +S G ++ +++ G  P
Sbjct: 346 KPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 48/220 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
            ++G+G +G V          + AVK  N  + + +       EVE + ++ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               + +   +V E    G L           E     D            +  +     
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARI--------IKQVFS--- 132

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+     +++ +  R+ GT 
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTA 187

Query: 248 GYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIP 282
            Y+APE     Y      +E+ DV+S G+++  ++SG  P
Sbjct: 188 YYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 50/207 (24%), Positives = 73/207 (35%), Gaps = 46/207 (22%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             IG G +G V   +      + A K +     +    FK E+E +  + H N++RL   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 144 CAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
             +     LV E    G L           E     D            M  +L     +
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARI--------MKDVL---SAV 119

Query: 193 SYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
           +Y H+     V HRD+K  N L          K+ DFGLA         + T+V GT  Y
Sbjct: 120 AYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKV-GTPYY 174

Query: 250 VAPE-----YASTGMLNERSDVYSFGI 271
           V+P+     Y          D +S G+
Sbjct: 175 VSPQVLEGLY------GPECDEWSAGV 195

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 54/282 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + +G G Y  V+  + + +N KV VK L    + + +RE K+     G     N++ L  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG---GPNIITLAD 98

Query: 143 YCAEGAHRMLVY--EYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGLSYLHE 197
              +   R      E+VNN + +Q           LT ++IR  M  IL   K L Y H 
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHS 148

Query: 198 GLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                ++HRD+K  N++ID +H   ++ D+GLA+       Y   RV  +  +  PE   
Sbjct: 149 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRYFKGPEL-- 201

Query: 257 TGMLNERS-----DVYSFGILIMEVISGRIPV----DYSRPPEEVNLI----------EW 297
             +++ +      D++S G ++  +I  + P     D     +++  I          ++
Sbjct: 202 --LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTEDLYDY 256

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
           + K     +P    +  L      R  + +       V P A
Sbjct: 257 IDKYNIELDPR--FNDILGRHSRKRWERFVHSENQHLVSPEA 296

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 19/213 (8%)

Query: 69  YTLRELEVSTNGFSD----DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAERE 121
           Y  + +EV      D     + +G G +G+V+     + +       K +       +  
Sbjct: 37  YVPQPVEVKQGSVYDYYDILEELGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYT 94

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
            K E+  + ++ H  L+ L     +    +L+ E+++ G L   +         ++    
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEV 151

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYI 239
           +N +    +GL ++HE     +VH DIK  NI+ +       K+ DFGLA  L  +    
Sbjct: 152 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208

Query: 240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
                 T  + APE      +   +D+++ G+L
Sbjct: 209 V--TTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 36/190 (18%)

Query: 87  IGEGGYGIVYYG---LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNL 137
           +G G YG VY       +D+   A+K +            + + A   +      +H N+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80

Query: 138 VRLLGYCAEGAHR--MLVYEYVNNGNLEQWLH-----GDVGPCSPLTWEIRMNIILGTAK 190
           + L       A R   L+++Y  + +L   +              L   +  +++     
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSES---SYITTRV 243
           G+ YLH      V+HRD+K +NIL+          K++D G A+L  S     + +   V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 244 MGTFGYVAPE 253
           + TF Y APE
Sbjct: 197 V-TFWYRAPE 205

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 66/282 (23%), Positives = 122/282 (43%), Gaps = 69/282 (24%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
             +G G +G V  G       KVAVK      + +     +  + E++ +   RH ++++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIK 80

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IILG 187
           L    +  +   +V EYV+ G L  ++  +G            R++          I+  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQIL-- 126

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
              G+ Y H      VVHRD+K  N+L+D H N K++DFGL+ ++ S+  ++ T   G+ 
Sbjct: 127 --SGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSP 179

Query: 248 GYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            Y APE     +++ R       D++S G+++  ++ G +P D      + ++    KK+
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHVPTLFKKI 228

Query: 302 VTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
                 +G+   P+        LLK +L         +  KR
Sbjct: 229 C-----DGIFYTPQYLNPSVISLLKHML-------QVDPMKR 258

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 42/217 (19%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           DK +GEG + I    +  + N   AVK +        ++   E+ A+     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               +  H  LV E +N G L           E               E    I+     
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117

Query: 191 GLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
            +S++H+     VVHRD+K  N+L  D++ N   K+ DFG A+L   ++  + T    T 
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRIP 282
            Y APE  +    +E  D++S G++   M  +SG++P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLN--NRGQAEREFKVEVEA---------I 129
           ++  + I  G YG V  G+  +   VA+K + N  + G+                    +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 130 GRVRHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
               H N++ L   +       M    LV E +   +L Q +H        ++ +     
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYF 139

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITT 241
           +     GL  LHE     VVHRD+   NIL+  + +  + DF LA+   ++++   Y+T 
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 242 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           R      Y APE     ++  +      D++S G ++ E+ + +
Sbjct: 197 RW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 53/263 (20%), Positives = 93/263 (35%), Gaps = 67/263 (25%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--------NLLNNRGQAEREFKVEVEAIGRVRHK 135
             +G G +G V+  +  E N +V VK                   +  +E+  + RV H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 136 NLVRLLGYCAEGAHRMLVYEY-----------VNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           N++++L          LV E              +  L++ L       S +  ++    
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------ASYIFRQL---- 139

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
                  + YL       ++HRDIK  NI+I + +  K+ DFG A  L     + T    
Sbjct: 140 ----VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--C 190

Query: 245 GTFGYVAPEYASTGMLNERS------DVYSFGILIMEVISGRIPVD---------YSRP- 288
           GT  Y APE     +L          +++S G+ +  ++    P              P 
Sbjct: 191 GTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY 245

Query: 289 ---PEEVNLIEWLKKMVTNRNPE 308
               E ++L+     ++    PE
Sbjct: 246 LVSKELMSLV---SGLL-QPVPE 264

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 30/186 (16%)

Query: 84  DKVIGEGGYGIVYYGLLEDNS---KVAVK----NLLNNRGQAERE----FKVEVEAIGRV 132
            K +G G  G V   L  +     KVA+K             E +     + E+E + ++
Sbjct: 15  SKTLGSGACGEVK--LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILGTAK 190
            H  ++++  +     +  +V E +  G L   +  +        L              
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLL 125

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            + YLHE     ++HRD+K  N+L+   ++    K++DFG +K+LG E+S + T   GT 
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTP 180

Query: 248 GYVAPE 253
            Y+APE
Sbjct: 181 TYLAPE 186

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 72  RELEVSTNGFSD----DKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKV 124
           + +E+  +   D     + +G G +G+V+   + + +     A K ++      +   + 
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRK 203

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E++ +  +RH  LV L     +    +++YE+++ G L + +  +      ++ +  +  
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEY 260

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-DKHWNP-KVSDFGLAKLLGSESSYITTR 242
           +    KGL ++HE      VH D+K  NI+   K  N  K+ DFGL   L  + S     
Sbjct: 261 MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KV 315

Query: 243 VMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
             GT  + APE A    +   +D++S G+L
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 54/248 (21%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             IG+G YG+V   +  +  +  A+K      +     +     K EV  + ++ H N+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNL----------------EQWLHGDVGPCSPLTWEIRM 182
           RL     +  +  LV E  + G+L                   +   + PC     E   
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 183 NIILGTAK--------------------GLSYLHEGLEPKVVHRDIKSSNILI--DKHWN 220
             I G  +                     L YLH      + HRDIK  N L   +K + 
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208

Query: 221 PKVSDFGLAKLLGS----ESSYITTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIM 274
            K+ DFGL+K        E   +TT+  GT  +VAPE    +      + D +S G+L+ 
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 275 EVISGRIP 282
            ++ G +P
Sbjct: 268 LLLMGAVP 275

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 28/194 (14%)

Query: 77  STNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVK---------NLLNNRGQAEREF 122
           ST+GF ++    +++G G   +V   +      + AVK                +     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 123 KVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWE 179
             EV+ + +V  H N+++L           LV++ +  G L  +L           L+ +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEK 124

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI 239
               I+    + +  LH+     +VHRD+K  NIL+D   N K++DFG +  L      +
Sbjct: 125 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKL 180

Query: 240 TTRVMGTFGYVAPE 253
                GT  Y+APE
Sbjct: 181 REVC-GTPSYLAPE 193

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIG 130
           E+    +     +G G YG V   +      KVA+K L     +   A+R ++ E+  + 
Sbjct: 21  ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78

Query: 131 RVRHKNLVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
            ++H+N++ LL  +    + R      LV  ++   +L++ +          + E    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRV 243
           +    KGL Y+H      VVHRD+K  N+ +++    K+ DFGLA+   +E + Y+ TR 
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188

Query: 244 MGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
                Y APE     +L+        D++S G ++ E+++G+
Sbjct: 189 -----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + + K IG G  GIV        +  VA+K L     N+  A+R ++ E+  +  V HKN
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  +          LV E ++  NL Q +         L  E    ++     
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 175

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTF 247
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G+      Y+ TR     
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228

Query: 248 GYVAPEYASTGMLNER----SDVYSFGILIMEVISGRI 281
            Y APE     +L        D++S G ++ E++  +I
Sbjct: 229 -YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKV----EVEAIGRVRHKNLVRL 140
           IG+G +G V+     +   KVA+K +     + E+E F +    E++ +  ++H+N+V L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 141 LGYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +  C   A           LV+++  + +L   L          T      ++     GL
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGL 137

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG----SESSYITTRVMGTFG 248
            Y+H     K++HRD+K++N+LI +    K++DFGLA+       S+ +  T RV+ T  
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLW 193

Query: 249 YVAPE 253
           Y  PE
Sbjct: 194 YRPPE 198

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 40/199 (20%)

Query: 76  VSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEA 128
           ++   F+++    + +G+G + +V   + +    + A   +   +  A    K+  E   
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLT 177
              ++H N+VRL    +E  H  L+++ V  G L           E     D   C    
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHC---- 115

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGS 234
               +  IL     + + H+     VVHR++K  N+L+    K    K++DFGLA  +  
Sbjct: 116 ----IQQILE---AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

Query: 235 ESSYITTRVMGTFGYVAPE 253
           E         GT GY++PE
Sbjct: 166 EQQAWFGFA-GTPGYLSPE 183

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 48/209 (22%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLL 141
            ++G+G +G V          + AVK +       +       EVE + ++ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               + +   +V E    G L           E     D            +  +     
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARI--------IKQVFS--- 132

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
           G++Y+H+     +VHRD+K  NIL+   +K  + K+ DFGL+      +     R+ GT 
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTA 187

Query: 248 GYVAPE-----YASTGMLNERSDVYSFGI 271
            Y+APE     Y      +E+ DV+S G+
Sbjct: 188 YYIAPEVLRGTY------DEKCDVWSAGV 210

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + + K IG G  GIV           VA+K L     N+  A+R ++ E+  +  V HKN
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  + +        +V E ++  NL Q +         L  E    ++     
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTF 247
           G+ +LH      ++HRD+K SNI++      K+ DFGLA+  G+      Y+ TR     
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGR 280
            Y APE        E  D++S G ++ E+I G 
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV      + S   + A K         +R    RE  + EV  + +V H 
Sbjct: 18  EELGSGQFAIVK--KCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-------EQWLHGDVGPCSPLTWEIRMNIILGT 188
           N++ L          +L+ E V+ G L       E     +            +  IL  
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQILD- 126

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVM 244
             G++YLH     K+ H D+K  NI++     P    K+ DFGLA  +     +    + 
Sbjct: 127 --GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IF 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGIL 272
           GT  +VAPE  +   L   +D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 33/231 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           L+E+ +  + F   KVIG G +  V    ++   +V A+K +    +  RG+    F+ E
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTW------ 178
            + +     + + +L  +  +  + + LV EY   G+L   L    G   P         
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169

Query: 179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
           EI M         +  +H       VHRDIK  NIL+D+  + +++DFG    L ++ + 
Sbjct: 170 EIVM--------AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERSDVY-------SFGILIMEVISGRIP 282
            +   +GT  Y++PE          +  Y       + G+   E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 70/283 (24%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
            + +GEG +G V      +   KVA+K     LL       R  + E+  +  +RH +++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHII 72

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMN----------IIL 186
           +L          ++V EY   G L  ++                RM           II 
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYIVEKK------------RMTEDEGRRFFQQII- 118

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                + Y H     K+VHRD+K  N+L+D + N K++DFGL+ ++   +   T+   G+
Sbjct: 119 ---CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGS 170

Query: 247 FGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
             Y APE     ++N +       DV+S GI++  ++ GR+P D      +  +    KK
Sbjct: 171 PNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNLFKK 219

Query: 301 MVTNRNPEGVLD-PKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
           +        V   P         L++R++         +  +R
Sbjct: 220 VN-----SCVYVMPDFLSPGAQSLIRRMI-------VADPMQR 250

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + D + +G G YG V   +     +KVA+K L     +   A+R ++ E+  +  +RH+N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +  +          LV  ++   +L + +         L  +    ++    K
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGY 249
           GL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE + Y+ TR      Y
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            APE     +LN        D++S G ++ E+I+G+
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 46/213 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV            + A K      L ++R    RE  + EV  +  +RH 
Sbjct: 11  EELGSGQFAIVR--KCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNI 184
           N++ L          +L+ E V+ G L           E     +            +  
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED----EATQF--------LKQ 116

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYIT 240
           IL    G+ YLH     ++ H D+K  NI++     P    K+ DFG+A  + + + +  
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
             + GT  +VAPE  +   L   +D++S G++ 
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           + +   +G G YG V      +   +VAVK L     +   A+R ++ E+  +  ++H+N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89

Query: 137 LVRLLG-YCAEGAHRM-----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAK 190
           ++ LL  +    +        LV        +   L+ ++  C  LT +    +I    +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLN-NIVKCQKLTDDHVQFLIYQILR 143

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE-SSYITTRVMGTFGY 249
           GL Y+H      ++HRD+K SN+ +++    K+ DFGLA+    E + Y+ TR      Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            APE     MLN        D++S G ++ E+++GR
Sbjct: 196 RAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + IV      + S   + A K         +R    RE  + EV  + +V H 
Sbjct: 18  EELGSGQFAIVK--KCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-------EQWLHGDVGPCSPLTWEIRMNIILGT 188
           N++ L          +L+ E V+ G L       E     +            +  IL  
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------IKQILD- 126

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVM 244
             G++YLH     K+ H D+K  NI++     P    K+ DFGLA  +     +    + 
Sbjct: 127 --GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IF 179

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGIL 272
           GT  +VAPE  +   L   +D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 37/205 (18%), Positives = 83/205 (40%), Gaps = 40/205 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           + +G G +GIV+     + S       K  +  +G  +   K E+  +   RH+N++ L 
Sbjct: 11  EDLGRGEFGIVH--RCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 142 GYCAEGAHRMLVYEYVNNGNL------------EQWLHGDVGPCSPLTWEIRMNIILGTA 189
                    ++++E+++  ++            E+    ++           ++ +    
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNER----EIVSY--------VHQVC--- 112

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
           + L +LH      + H DI+  NI+     +   K+ +FG A+ L    ++    +    
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAP 167

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL 272
            Y APE     +++  +D++S G L
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTL 192

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 79.1 bits (196), Expect = 9e-17
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 42/217 (19%)

Query: 78  TNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIG 130
           +  FSD+    + +G+G + +V   +      + A K +   +  A    K+  E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 131 RVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWE 179
           +++H N+VRL     E +   LV++ V  G L           E          S     
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-------DASHC--- 110

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSES 236
             +  IL   + ++Y H      +VHR++K  N+L   K      K++DFGLA  +  +S
Sbjct: 111 --IQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS 161

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFG-IL 272
                   GT GY++PE       ++  D+++ G IL
Sbjct: 162 EAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 47/220 (21%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLL 141
           + V+GEG +  V   + L  + + AVK +    G        EVE + + + H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
            +  E     LV+E +  G++           E          S +  ++        A 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-------EASVVVQDV--------AS 122

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL--GSESSYITTRVM- 244
            L +LH      + HRD+K  NIL    ++    K+ DF L   +    + S I+T  + 
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 245 ---GTFGYVAPE-----YASTGMLNERSDVYSFG-IL-IM 274
              G+  Y+APE          + ++R D++S G IL I+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 33/200 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G G   IVY           A+K L   +   ++  + E+  + R+ H N+++L   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM---------NIILGTAKGLSY 194
                   LV E V  G L   +             +           + +    + ++Y
Sbjct: 117 FETPTEISLVLELVTGGELFDRI-------------VEKGYYSERDAADAVKQILEAVAY 163

Query: 195 LHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           LHE     +VHRD+K  N+L      +   K++DFGL+K++      + T   GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GTPGYCA 218

Query: 252 PEYASTGMLNERSDVYSFGI 271
           PE           D++S GI
Sbjct: 219 PEILRGCAYGPEVDMWSVGI 238

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 45/192 (23%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--------NLLNNRGQAEREFKVEVEAIGRVR-H 134
            VIG G   +V   +      + AVK               +     + E   + +V  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIR-- 181
            +++ L+      +   LV++ +  G L           E+              E R  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK--------------ETRSI 205

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
           M  +L   + +S+LH      +VHRD+K  NIL+D +   ++SDFG +  L      +  
Sbjct: 206 MRSLL---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRE 258

Query: 242 RVMGTFGYVAPE 253
              GT GY+APE
Sbjct: 259 LC-GTPGYLAPE 269

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRHKNLV 138
           + D K +G GG G+V+  +  + + +VA+K + L +    +   + E++ I R+ H N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71

Query: 139 RLLG-YCAEGAHRMLVYEYVNNGN--------LEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           ++       G+        +   N        +E  L  +V    PL  E     +    
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLLEEHARLFMYQLL 130

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSESS-------YITT 241
           +GL Y+H      V+HRD+K +N+ I+      K+ DFGLA+++    S        + T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 242 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           +      Y +P      +L+  +     D+++ G +  E+++G+
Sbjct: 188 K-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 40/226 (17%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN--NRGQAEREFKVEVEAIGR 131
           +V    +++   IGEG YG+V       +  +VA+K +    ++   +R  + E++ + R
Sbjct: 24  DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81

Query: 132 VRHKNLVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            RH+N++ +     A    +M    +V +      +E  L+  +     L+ +     + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLY-KLLKTQHLSNDHICYFLY 135

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-------YI 239
              +GL Y+H      V+HRD+K SN+L++   + K+ DFGLA++   +         Y+
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 240 TTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 280
            TR      Y APE     MLN +      D++S G ++ E++S R
Sbjct: 193 ATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 46/212 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNS---KVAVK-----NLLNNRGQAERE-FKVEVEAIGRVRHK 135
           + +G G + +V      + S   + A K        ++R    RE  + EV  +  ++H 
Sbjct: 17  EELGSGQFAVVK--KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNI 184
           N++ L          +L+ E V  G L           E+    +            +  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEF--------LKQ 122

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYIT 240
           IL    G+ YLH     ++ H D+K  NI++     P    K+ DFGLA  +   + +  
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 272
             + GT  +VAPE  +   L   +D++S G++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 37/186 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKV--EVEAIGRVRHKNLVRLL 141
           + +G+G + +V   +      + A K +   +  A    K+  E     +++H N+VRL 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 142 GYCAEGAHRMLVYEYVNNGNL-----------EQWLHGDVGPCSPLTWEIRMNIILGTAK 190
               E +   LV++ V  G L           E     D   C        +  IL   +
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA----DASHC--------IQQIL---E 139

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            ++Y H      +VHR++K  N+L+    K    K++DFGLA  +  +S        GT 
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTP 194

Query: 248 GYVAPE 253
           GY++PE
Sbjct: 195 GYLSPE 200

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           F    ++GEG YG+V           VA+K     +    A R  + E++ +   +H+N+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71

Query: 138 VRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           + +      +         ++ E      ++  LH  V     L+ +     I  T + +
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQEL-----MQTDLH-RVISTQMLSDDHIQYFIYQTLRAV 125

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF---GY 249
             LH      V+HRD+K SN+LI+ + + KV DFGLA+++   ++  +           +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 250 V------APEYASTGMLNERS-----DVYSFGILIMEVISGR 280
           V      APE     ML         DV+S G ++ E+   R
Sbjct: 183 VATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 36/230 (15%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           +R+L +    +   KVIG G +G V     +   KV A+K L    +  R  +   F  E
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEE 119

Query: 126 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
            + +       +V+L  Y  +    + +V EY+  G+L   +                ++
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165

Query: 185 ILGTAK--------GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
               A+         L  +H       +HRD+K  N+L+DK  + K++DFG    +  E 
Sbjct: 166 PEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 237 SYITTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRIP 282
                  +GT  Y++PE        G      D +S G+ + E++ G  P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 51/238 (21%)

Query: 62  HLGWGHWYTLRELEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNR 115
           H   G     +  E      +DD     +V+G G  G V          K A+K LL + 
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS 65

Query: 116 GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYVNNGNL--------- 162
            +A +E     +A G     ++V +L       H      ++ E +  G L         
Sbjct: 66  PKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122

Query: 163 ----EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDK 217
               E+         + +  +I           + +LH      + HRD+K  N+L   K
Sbjct: 123 QAFTER-------EAAEIMRDI--------GTAIQFLHSH---NIAHRDVKPENLLYTSK 164

Query: 218 HWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
             +   K++DFG AK     +  + T    T  YVAPE       ++  D++S G+++
Sbjct: 165 EKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 37/192 (19%), Positives = 74/192 (38%), Gaps = 18/192 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +    +IG G YG V       +   VA+K +L    +    +R  + E+  + R+ H +
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113

Query: 137 LVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           +V++L     +   +     +V E       +            LT      ++     G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + Y+H      ++HRD+K +N L+++  + KV DFGLA+ +    +  +   +       
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 252 PEYASTGMLNER 263
                    N +
Sbjct: 226 NLVTFPHTKNLK 237

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 31/229 (13%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVE 125
           ++++ +    F   KVIG G +G V    L++  KV A+K L    +  R +    F+ E
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREE 124

Query: 126 VEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR-- 181
            + +     K +  L  + A  +  +  LV +Y   G+L   L            E    
Sbjct: 125 RDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMAR 178

Query: 182 ---MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
                +++     +  +H+      VHRDIK  NIL+D + + +++DFG    L  + + 
Sbjct: 179 FYLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 239 ITTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRIP 282
            ++  +GT  Y++PE         G      D +S G+ + E++ G  P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 23/201 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAERE-FKVEVEAIGRVRHKN 136
            S  +++G G +G V+    E+ +   K+A K ++  RG  ++E  K E+  + ++ H N
Sbjct: 91  VSKTEILGGGRFGQVH--KCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLT-WEIR--MNIILGTAKGLS 193
           L++L          +LV EYV+ G L   +   +     LT  +    M  I     G+ 
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIR 201

Query: 194 YLHEGLEPKVVHRDIKSSNIL-IDKHWNP-KVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           ++H+     ++H D+K  NIL +++     K+ DFGLA+              GT  ++A
Sbjct: 202 HMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLA 256

Query: 252 PEYASTGMLNERSDVYSFGIL 272
           PE  +   ++  +D++S G++
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVI 277

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 48/237 (20%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVRHKN 136
           +    +IG G YG VY          VA+K +     +    +R  + E+  + R++   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86

Query: 137 LVRLLG-YCAEGAHRM----LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           ++RL      +   +     +V E       +  L         LT E    I+     G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF---- 247
            +++HE     ++HRD+K +N L+++  + KV DFGLA+ + SE        +       
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 248 -----------GYV------APEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
                       +V      APE     +L + +     D++S G +  E+++    
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 30/205 (14%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLNNRGQAEREFKV--EVEAIGRVRH-KN 136
             K +G G + +V        S   + A K L   R   +   ++  E+  +   +    
Sbjct: 33  TSKELGRGKFAVVR--QCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGP------CSPLTWEIRMNIILGTAK 190
           ++ L       +  +L+ EY   G +      ++           L     +  IL    
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE--- 142

Query: 191 GLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTF 247
           G+ YLH+     +VH D+K  NIL    +     K+ DFG+++ +G         +MGT 
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTP 197

Query: 248 GYVAPEYASTGMLNERSDVYSFGIL 272
            Y+APE  +   +   +D+++ GI+
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGII 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 50/232 (21%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAI 129
           +V+ + F   + IG+G +G V      D  K+ A+K +       R +    FK E++ +
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIM 69

Query: 130 GRVRHKNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----- 183
             + H  LV L  Y  +    M +V + +  G+L    H        L   +        
Sbjct: 70  QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYH--------LQQNVHFKEETVK 118

Query: 184 -----IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY 238
                +++     L YL      +++HRD+K  NIL+D+H +  ++DF +A +L  E+  
Sbjct: 119 LFICELVMA----LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170

Query: 239 ITTRVMGTFGYVAPEYASTGMLNERS--------DVYSFGILIMEVISGRIP 282
             T + GT  Y+APE     M + R         D +S G+   E++ GR P
Sbjct: 171 -ITTMAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 24/269 (8%)

Query: 97  YGLLEDN--SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 154
           +G L     SK         +G   R+ K  V AI     + L  +    +  +   +  
Sbjct: 111 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170

Query: 155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL 214
           + +++   E+           LT E  +      AKG+ +L      K +HRD+ + NIL
Sbjct: 171 KSLSDVEEEEAPEDL--YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 225

Query: 215 IDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 273
           + +    K+ DFGLA+ +  +  Y+          ++APE     +   +SDV+SFG+L+
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

Query: 274 MEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVAL 332
            E+ S G  P  Y     +      LK+    R P+                  +    L
Sbjct: 286 WEIFSLGASP--YPGVKIDEEFCRRLKEGTRMRAPDYTTPE-------------MYQTML 330

Query: 333 RCVDPNAQKRPKMGHVVHMLEAQESPSKE 361
            C      +RP    +V  L      + +
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 34/220 (15%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 110

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNL----EQWLHGDVGPCSPLTWE 179
           A       ++VR++       A     ++V E ++ G L    +             T  
Sbjct: 111 ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD------QAFTER 161

Query: 180 IRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFGLAKLLGSES 236
               I+    + + YLH      + HRD+K  N+L   K  N   K++DFG AK   S +
Sbjct: 162 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL--IM 274
           S  T     T  YVAPE       ++  D++S G++  I+
Sbjct: 219 SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 48/220 (21%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G +G V     +   +  A+K L    +  + +       E   +   RH  L  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTA 69

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGT 188
           L  Y  +   R+  V EY N G L  + H        L+ E              I+   
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSA- 117

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTF 247
              L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ +  T +   GT 
Sbjct: 118 ---LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169

Query: 248 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            Y+APE     +L +       D +  G+++ E++ GR+P
Sbjct: 170 EYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 63/259 (24%), Positives = 103/259 (39%), Gaps = 40/259 (15%)

Query: 42  GNGSGGGSGDQ---VAAVVPEVSHLGWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYG 98
           GN +    G +   V   + +        W T  +     + F   K +G G +G V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 99  LLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 153
             +++    A+K L    +    Q E     E   +  V    LV+L     + ++  +V
Sbjct: 61  KHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGTAKGLSYLHEGLEPKV 203
            EYV  G  E + H        L    R +          I+L       YLH      +
Sbjct: 120 MEYVAGG--EMFSH--------LRRIGRFSEPHARFYAAQIVLT----FEYLHSL---DL 162

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           ++RD+K  N+LID+    +V+DFG AK +       T  + GT   +APE   +   N+ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKA 218

Query: 264 SDVYSFGILIMEVISGRIP 282
            D ++ G+LI E+ +G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 46/232 (19%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLN---NRGQAEREFKVEVEAIGRVR-HK 135
           +   K +G+G YGIV+  +       VAVK + +   N   A+R F+ E+  +  +  H+
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHE 69

Query: 136 NLVRLLG-YCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           N+V LL    A+    + LV++Y+   +L   +  +      L    +  ++    K + 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIK 123

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF------ 247
           YLH G    ++HRD+K SNIL++   + KV+DFGL++   +         +         
Sbjct: 124 YLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 248 --------GYV------APEYASTGMLNERS-----DVYSFGILIMEVISGR 280
                    YV      APE     +L         D++S G ++ E++ G+
Sbjct: 181 DDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           K++G+G +G V     +   +  A+K L    +  + +       E   +   RH  L  
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTA 212

Query: 140 LLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAKGLS 193
           L  Y  +   R+  V EY N G L   L  +      +  E R       I+      L 
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSA----LD 262

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAP 252
           YLH      VV+RD+K  N+++DK  + K++DFGL K    + +  T +   GT  Y+AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAP 318

Query: 253 EYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           E     +L +       D +  G+++ E++ GR+P
Sbjct: 319 E-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 52/224 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVK-----NLLNNRGQAEREFKVEVEAIGRVRHK 135
           +V+G+GGYG V+        +  K+ A+K      ++ N        K E   +  V+H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHP 81

Query: 136 NLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------I 184
            +V L+ Y  +   ++ L+ EY++ G L   L            E              I
Sbjct: 82  FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER----------EGIFMEDTACFYLAEI 130

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
            +     L +LH+     +++RD+K  NI+++   + K++DFGL K    + +   T   
Sbjct: 131 SMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTF 181

Query: 245 -GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
            GT  Y+APE     +L         D +S G L+ ++++G  P
Sbjct: 182 CGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           KVIG+G +G V     +      AVK L    +  + + +    E  V ++    V+H  
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPF 100

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L  +  + A ++  V +Y+N G L   L  +   C     E R       I      
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER--CFL---EPRARFYAAEIASA--- 151

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L YLH      +V+RD+K  NIL+D   +  ++DFGL K     +S  TT    GT  Y
Sbjct: 152 -LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEY 205

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L+++      D +  G ++ E++ G  P
Sbjct: 206 LAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 33/213 (15%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
            V+G+G +G V     +   ++ AVK L    +      E    E +V        +   
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP---GKPPF 403

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           L +L   C +   R+  V EYVN G+L   +        P        I +G    L +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFL 458

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGYVAPEY 254
                  +++RD+K  N+++D   + K++DFG+ K    +    TT+   GT  Y+APE 
Sbjct: 459 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPE- 512

Query: 255 ASTGMLNERS-----DVYSFGILIMEVISGRIP 282
               ++  +      D ++FG+L+ E+++G+ P
Sbjct: 513 ----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 52/223 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKN 136
           KV+G+G +G V+        D  ++ A+K L    L  R +     K+E + +  V H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------II 185
           +V+L  Y  +   ++ L+ +++  G+L  +          L+ E+             + 
Sbjct: 88  IVKLH-YAFQTEGKLYLILDFLRGGDL--FTR--------LSKEVMFTEEDVKFYLAELA 136

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM- 244
           L     L +LH      +++RD+K  NIL+D+  + K++DFGL+K               
Sbjct: 137 LA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFC 187

Query: 245 GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           GT  Y+APE     ++N R      D +SFG+L+ E+++G +P
Sbjct: 188 GTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.0 bits (162), Expect = 3e-12
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 49/219 (22%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           + +G G +G V+      N +  A+K L    +    Q E     E   +  V H  ++R
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFIIR 70

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------IILGTA 189
           + G   +     ++ +Y+  G L  +          L    R            + L   
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGEL--FSL--------LRKSQRFPNPVAKFYAAEVCLA-- 118

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFG 248
             L YLH      +++RD+K  NIL+DK+ + K++DFG AK +        T  + GT  
Sbjct: 119 --LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168

Query: 249 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           Y+APE     +++ +      D +SFGILI E+++G  P
Sbjct: 169 YIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           K++G+G +G V+    +  ++  A+K L    +      E    E +V   A     H  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---WEHPF 79

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           L  +     +    +  V EY+N G+L   +      C       R       IILG   
Sbjct: 80  LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIILG--- 130

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L +LH      +V+RD+K  NIL+DK  + K++DFG+ K      +   T    GT  Y
Sbjct: 131 -LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDY 184

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L  +      D +SFG+L+ E++ G+ P
Sbjct: 185 IAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +VIG G Y  V    L+   ++ A+K +    +N+    +    E  V  +A     H  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 71

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L   C +   R+  V EYVN G+L   +         L  E         I L    
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISLA--- 122

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L+YLHE     +++RD+K  N+L+D   + K++D+G+ K         TT    GT  Y
Sbjct: 123 -LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 176

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L         D ++ G+L+ E+++GR P
Sbjct: 177 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +V+G+G +G V    +++   + AVK L    +      E    E ++   A     H  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA---RNHPF 85

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           L +L   C +   R+  V E+VN G+L   +            E R       II     
Sbjct: 86  LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD----EARARFYAAEIISA--- 136

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L +LH+     +++RD+K  N+L+D   + K++DFG+ K         TT    GT  Y
Sbjct: 137 -LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDY 190

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L E       D ++ G+L+ E++ G  P
Sbjct: 191 IAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 52/226 (23%)

Query: 85  KVIGEGGYGIVY---YGLLEDNSKV-AVK-----NLLNNRGQAEREFKVEVEAIGRVRHK 135
           KV+G G YG V+        D  K+ A+K      ++      E   + E + +  +R  
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQS 118

Query: 136 N-LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN---------- 183
             LV L  Y  +   ++ L+ +Y+N G L  + H        L+   R            
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--------LSQRERFTEHEVQIYVGE 167

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
           I+L     L +LH+     +++RDIK  NIL+D + +  ++DFGL+K   ++ +      
Sbjct: 168 IVLA----LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220

Query: 244 MGTFGYVAPEYASTGMLNERS-------DVYSFGILIMEVISGRIP 282
            GT  Y+AP+     ++           D +S G+L+ E+++G  P
Sbjct: 221 CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 2e-11
 Identities = 48/320 (15%), Positives = 92/320 (28%), Gaps = 83/320 (25%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVK--------NLLNNRGQAEREFKVEVE 127
           + T      + IGEG +G V+  +  D++ VA+K         +  +  +   E   E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 128 ---------AIGRVRHKNLVRLLG-YCAEGAH---------------------------- 149
                         R +  + L   +C +G++                            
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 150 -RMLVYEYVNNGN-LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD 207
              +V E+   G  LEQ            +     +I+      L+        +  HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187

Query: 208 IKSSNILIDKHWNPKVSDFGLAKLLGSESS--------YITTRVMGTFGYV-----APEY 254
           +   N+L+ K    K+      K     S         Y  +R+      V       E 
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN------LIEWLKKMVTNRNPE 308
             TG  + + D+Y         +       +       N      L + + K +T +   
Sbjct: 248 LFTGDGDYQFDIYRL-------MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300

Query: 309 GVLDPKLPEKPTSRLLKRIL 328
                K  ++      + +L
Sbjct: 301 NTPAMKQIKRKIQEFHRTML 320

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
           +VIG G Y  V    L+   ++ A++ +    +N+    +    E  V  +A     H  
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 114

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN-----IILGTAK 190
           LV L   C +   R+  V EYVN G+L   +         L  E         I L    
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISLA--- 165

Query: 191 GLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM-GTFGY 249
            L+YLHE     +++RD+K  N+L+D   + K++D+G+ K         TT    GT  Y
Sbjct: 166 -LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 219

Query: 250 VAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           +APE     +L         D ++ G+L+ E+++GR P
Sbjct: 220 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKV-AVKNL----LNNRGQAER---EFKVEVEAIGRVRHKN 136
            V+G+G +G V     +   ++ AVK L    +      E    E +V        +   
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP---GKPPF 82

Query: 137 LVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN----------II 185
           L +L   C +   R+  V EYVN G+L   +              R            I 
Sbjct: 83  LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ----------VGRFKEPHAVFYAAEIA 131

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM- 244
           +G    L +L       +++RD+K  N+++D   + K++DFG+ K    +    TT+   
Sbjct: 132 IG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFC 182

Query: 245 GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRIP 282
           GT  Y+APE     ++  +      D ++FG+L+ E+++G+ P
Sbjct: 183 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 51/248 (20%), Positives = 101/248 (40%), Gaps = 48/248 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAEREFKV-------EVEAIGRVR 133
           + +G G +  V+    + +N+ VA+K +  +      AE E K+       +      + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 134 HKNLVRLLGY----CAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLTWEIRMNIILG 187
             ++++LL +       G H ++V+E V   NL   +  +   G       +I   ++LG
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP------KVSDFGLAKLLGSE-SSYIT 240
               L Y+H      ++H DIK  N+L++   +P      K++D G A       ++ I 
Sbjct: 144 ----LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 241 TRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
           TR      Y +PE      +         +D++S   LI E+I+G    +          
Sbjct: 198 TRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 295 IEWLKKMV 302
            + + +++
Sbjct: 247 DDHIAQII 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 35/233 (15%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAERE 121
              Y ++  E   + +  D +IG+G +G V       +   VA+K + N      QA+ E
Sbjct: 42  YD-YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100

Query: 122 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT 177
            ++   +          +V L  +     H  LV+E ++  NL   L      G    LT
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT 159

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNPKVSDFGLAKLLGSE 235
            +    +       L +L    E  ++H D+K  NIL+   K    K+ DFG +  LG  
Sbjct: 160 RKFAQQMCTA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 236 -SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRI 281
              YI +R    F Y +PE      Y      +   D++S G +++E+ +G  
Sbjct: 215 IYQYIQSR----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGEP 256

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 48/183 (26%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 66

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNL-------------EQWLHGDV 170
           A       ++VR++       A     ++V E ++ G L             E+    + 
Sbjct: 67  ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EA 119

Query: 171 GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL-IDKHWNP--KVSDFG 227
                      M  I    + + YLH      + HRD+K  N+L   K  N   K++DFG
Sbjct: 120 SEI--------MKSIG---EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 228 LAK 230
            AK
Sbjct: 166 FAK 168

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 24/158 (15%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            K IG G +G +  G  L  N  VA+K   + +   Q   E++   +         + ++
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQV 70

Query: 141 LGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGT--AKGLSYLHE 197
             +   G +  +V E +  G +LE         C   T+ ++  +++       + Y+H 
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLEDLFDL----CDR-TFSLKTVLMIAIQLISRMEYVHS 123

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVS-----DFGLAK 230
                +++RD+K  N LI +  N         DF LAK
Sbjct: 124 ---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 28/160 (17%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVKN--LLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            + IGEG +G+++ G  L +N +VA+K     ++  Q   E++      G      +  +
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNV 71

Query: 141 LGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAK----GLSYL 195
             +  EG H +LV + +  G +LE  L       S  T       +   AK     +  +
Sbjct: 72  YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQSI 122

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPK-----VSDFGLAK 230
           HE     +V+RDIK  N LI +  +       V DFG+ K
Sbjct: 123 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 37/233 (15%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNN---RGQAERE 121
           G  Y     +     +   KVIG+G +G V      + +  VA+K + N      QA  E
Sbjct: 85  GS-YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE 143

Query: 122 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPLT 177
            ++   +    +    N++ +L       H  + +E ++  NL + +  +   G   PL 
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLV 202

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSE 235
            +   +I+    + L  LH+    +++H D+K  NIL+ +      KV DFG +      
Sbjct: 203 RKFAHSIL----QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 236 -SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRI 281
             +YI +R    F Y APE      Y          D++S G ++ E+++G  
Sbjct: 256 VYTYIQSR----F-YRAPEVILGARY------GMPIDMWSLGCILAELLTGYP 297

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 3e-07
 Identities = 48/348 (13%), Positives = 104/348 (29%), Gaps = 102/348 (29%)

Query: 99  LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM------- 151
           L  DN   A  N+  +R Q   + +   +A+  +R    V + G        +       
Sbjct: 119 LYNDNQVFAKYNV--SRLQPYLKLR---QALLELRPAKNVLIDG--------VLGSGKTW 165

Query: 152 LVYEYVNNGNLEQ-------WLHGDVGPC-SP---------------LTWEIRMNIILGT 188
           +  +   +  ++        WL  ++  C SP                 W  R +     
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWL--NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD-FGL-AKLLGSESSYITTRVMGT 246
              +  +   L   +  +  ++  +++    N K  + F L  K+L      +TTR    
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL------LTTRFKQV 277

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI-EWLKKMVTNR 305
             +++    +   L+  S   +                   P E  +L+ ++L       
Sbjct: 278 TDFLSAATTTHISLDHHSMTLT-------------------PDEVKSLLLKYL------- 311

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQ-------KRPKMGHVVHM-LEAQES 357
                    LP +  +   +R+ ++A    D  A           K+  ++   L   E 
Sbjct: 312 ---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE- 367

Query: 358 PSKEPSNSFQDRYRAS---PKNELIEKQVTES--GDNSTNETGVHTNE 400
                   ++  +      P +  I   +      D   ++  V  N+
Sbjct: 368 -----PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 2e-05
 Identities = 70/439 (15%), Positives = 125/439 (28%), Gaps = 129/439 (29%)

Query: 10  RQALLLPLEEESPTGYNKIHVHIGKDNRICYPGNGSGGGSGDQVAAVVPEVSHLGWGHWY 69
           RQALL    E  P     + +  G              GSG    A              
Sbjct: 141 RQALL----ELRPAKN--VLID-GV------------LGSGKTWVA-------------- 167

Query: 70  TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN-RGQAEREFKVEVEA 128
               L+V        KV  +  + I +  L   NS   V  +L     Q +  +    + 
Sbjct: 168 ----LDVC----LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 129 IGRVRHK------NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPL--TWEI 180
              ++ +       L RLL       + +LV   V N     W   ++  C  L  T   
Sbjct: 220 SSNIKLRIHSIQAELRRLLKS-KPYENCLLVLLNVQNAKA--WNAFNLS-CKILLTTRFK 275

Query: 181 RMNIILGTAKG----LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES 236
           ++   L  A      L +    L P       +  ++L+ K+ + +  D      L  E 
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPD------EVKSLLL-KYLDCRPQD------LPREV 322

Query: 237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRI----PVDYSRP---- 288
                R +        +  +T    +     +   L   +I   +    P +Y +     
Sbjct: 323 LTTNPRRLSIIAESIRDGLAT---WDNWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRL 378

Query: 289 ---PEEVNLIEWLKKMVTNRNPEGVL-------DPKLPEKPTSRLLKRILLVALRCVDPN 338
              P   ++            P  +L                ++L K  L+         
Sbjct: 379 SVFPPSAHI------------PTILLSLIWFDVIKSDVMVVVNKLHKYSLV--------- 417

Query: 339 AQKRPKMGHV-VHML--EAQESPSKEPS--NSFQDRY---RASPKNELIEKQVTESGDN- 389
            +K+PK   + +  +  E +     E +   S  D Y   +    ++LI   +    D  
Sbjct: 418 -EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL----DQY 472

Query: 390 STNETGVHTNETRWQHQEF 408
             +  G H        +  
Sbjct: 473 FYSHIGHHLKNIE-HPERM 490

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 33/169 (19%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVA---VKNLLNNRGQAEREFKVE-----VEAIGRVRHK 135
           K IG GG+G++Y         K A   VK      G    E K        + I +   +
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 136 NLVRLLG-----YC-----AEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLT-WEIRMN 183
             +  LG               ++R +V E +  G +L++ + G  G     T  ++ + 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIR 159

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAK 230
           ++      L Y+HE    + VH DIK++N+L+      +V  +D+GL+ 
Sbjct: 160 ML----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 40/241 (16%), Positives = 72/241 (29%), Gaps = 64/241 (26%)

Query: 85  KVIGEGGYGIVYYGL---------LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK 135
                   GI+Y                 K ++K L    G+   E      A   ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 136 NLVRLLG----------YC--AEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRM 182
              +L                 +  +R LV   +  G +L+  L              R 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD----VSPKHVLSERS 160

Query: 183 NIILGT--AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLLGSESSY 238
            + +       L +LHE    + VH ++ + NI +D     +V  + +G A        Y
Sbjct: 161 VLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF------RY 211

Query: 239 ITTRV------------MGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRI 281
             +               G       E+ S  +        RSD+ S G  +++ + G +
Sbjct: 212 CPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266

Query: 282 P 282
           P
Sbjct: 267 P 267

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 47/257 (18%), Positives = 86/257 (33%), Gaps = 74/257 (28%)

Query: 87  IGEGGYGIVYYGL-LEDNSKVAVK---NLLNNRGQAEREFKVEVEAIGRVR-----HKNL 137
           +G G +  V+    ++    VA+K   +  +    A  E ++  +++          + +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVRNSDPNDPNREMV 103

Query: 138 VRLLGY----CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           V+LL         G H  +V+E V   +L +W+         L       II    +GL 
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 194 YLHEGLEPKVVHRDIKSSNILI-------------------------------------- 215
           YLH   + +++H DIK  NIL+                                      
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 216 -----------DKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNER 263
                       +    K++D G A  +    +  I TR      Y + E       N  
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273

Query: 264 SDVYSFGILIMEVISGR 280
           +D++S   +  E+ +G 
Sbjct: 274 ADIWSTACMAFELATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 64/241 (26%)

Query: 85  KVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAEREFKV-----EVEAIGRVR 133
             IG+GG+G +Y         +  ++   VK   ++ G    E K      + E I +  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 134 HKNLVRLLG----------YCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPL--TWEI 180
               ++ LG               ++R ++ +    G +L++ ++             ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAKRFSRKTVLQL 157

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV--SDFGLAKLLGSESSY 238
            + I+      L Y+HE    + VH DIK+SN+L++     +V   D+GLA        Y
Sbjct: 158 SLRIL----DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY------RY 204

Query: 239 ITTRVM------------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRI 281
               V             GT      E+ S    N      R D+   G  +++ ++G +
Sbjct: 205 CPEGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259

Query: 282 P 282
           P
Sbjct: 260 P 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 34/162 (20%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL--- 137
            + IG G +G +Y G  +    +VA+K   +     Q   E K+         +K +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGG 64

Query: 138 ---VRLLGYCAEGAHRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGT--AKG 191
                +    AEG + ++V E +  G +LE     D+       + ++  ++L       
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISR 117

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPK---VSDFGLAK 230
           + Y+H       +HRD+K  N L+          + DFGLAK
Sbjct: 118 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 37/155 (23%), Positives = 65/155 (41%), Gaps = 20/155 (12%)

Query: 84  DKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
            + IG G +G +Y G  ++ N +VA+K  N+     Q   E K+     G      +  +
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNV 68

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT--AKGLSYLHEG 198
             +  EG + +LV + +   +LE   +      S     ++  ++L       + ++H  
Sbjct: 69  RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS-----LKTVLMLADQMINRVEFVHS- 121

Query: 199 LEPKVVHRDIKSSNILIDKHWNPK---VSDFGLAK 230
                +HRDIK  N L+          + DFGLAK
Sbjct: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 49/251 (19%), Positives = 84/251 (33%), Gaps = 55/251 (21%)

Query: 66  GHWYTLRELEVSTNGFSDDKVIGEGGYGIVY--YGLLEDNSKVAVKNLLNN---RGQAER 120
           GH    R  +     +     +GEG +G V          S+VA+K + N    R  A  
Sbjct: 7   GH-LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL 65

Query: 121 EFKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWL--HGDVGPCSPL 176
           E  V  +++   +      V +  +     H  + +E +   N  ++L  +       P 
Sbjct: 66  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPH 124

Query: 177 TWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--------------- 221
              +   +       L +LHE    ++ H D+K  NIL                      
Sbjct: 125 VRHMAYQLC----HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177

Query: 222 ----KVSDFGLAKLLGSE-SSYITTRVMGTFGYVAPE------YASTGMLNERSDVYSFG 270
               +V+DFG A       ++ + TR      Y  PE      +       +  DV+S G
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIG 226

Query: 271 ILIMEVISGRI 281
            ++ E   G  
Sbjct: 227 CILFEYYRGFT 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	413
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.54
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.25
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.11
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.89
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.82
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.74
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.66
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.2
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.69
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.11
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.1
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.41
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	82.94

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-60  Score=450.09  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=210.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|.+.+.||+|+||+||+|+++      ++..||||++........+.|.+|+++|++++|||||+++++|.++..+
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4567888999999999999999864      3678999999877666778899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          151 MLVYEYVNNGNLEQWLHGDVG-----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      +||||||++|+|.++++....           ...++++..++.|+.||+.||+|||++   +||||||||+||||++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence            999999999999999976431           124699999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEW  297 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~  297 (413)
                      .+||+|||+++........ .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||......+      .
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------~  269 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------A  269 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------H
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------H
Confidence            9999999999876443322 2345679999999999999999999999999999999999 899997554322      2


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      +..+.....      ...    +..++.++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       270 ~~~i~~g~~------~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          270 IDCITQGRE------LER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHHHTCC------CCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCC------CCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            222222211      111    2234567899999999999999999999999998864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-59  Score=445.45  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=216.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      ..|++.+.||+|+||+||+|.++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999976 68899999997665555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      +||+|.+++...     .+++..+..++.||+.||+|||++   |||||||||+||||+.+|.+||+|||+|+.......
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999999753     699999999999999999999999   999999999999999999999999999998754433


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+      .+..+.....      +.+  
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------~~~--  290 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLP------PRL--  290 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSC------CCC--
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCC------CCC--
Confidence             2455789999999999999999999999999999999999999997544322      1222222111      111  


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....++.++.+||.+||..||++|||+.|+++|-...
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            22334667899999999999999999999999985544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-60  Score=442.92  Aligned_cols=261  Identities=25%  Similarity=0.442  Sum_probs=216.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|.+.+.||+|+||+||+|.+.      ++..||||++........+.|.+|+++|++++|||||++++++.+++.+
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3567999999999999999999864      3677999999877666778899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          151 MLVYEYVNNGNLEQWLHGDV---------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      +||||||++|+|.++|....         .....+++..++.|+.||+.||+|||++   +||||||||+||||++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            99999999999999996532         2235799999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ||+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+      .+.
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------~~~  241 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE  241 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            999999998765433322 233568999999999999999999999999999999999 899997654322      222


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .+.....      ..    .+..++.++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       242 ~i~~~~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          242 CITQGRV------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCC------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222211      11    12235567899999999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.7e-60  Score=449.00  Aligned_cols=253  Identities=21%  Similarity=0.365  Sum_probs=208.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++++.||+|+||+||+|++. +++.||||++....  ......+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            478999999999999999999965 68899999997653  334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |||+||+|.++|.....  ..+++..++.|+.||+.||+|||++   |||||||||+||||+.+|.+||+|||+|+....
T Consensus       103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999965432  4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.      ...+..+.....+      .
T Consensus       178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~------~  244 (350)
T 4b9d_A          178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSFP------P  244 (350)
T ss_dssp             HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCC------C
T ss_pred             Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCCC------C
Confidence            22 223456899999999999999999999999999999999999999976542      2223333332211      1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          ....++.++.+||.+||+.||++|||+.|++++-
T Consensus       245 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  278 (350)
T 4b9d_A          245 ----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG  278 (350)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                1223566789999999999999999999999873

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-59  Score=438.14  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=210.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      |++..++|++.+.||+|+||+||+|+++  ..||||++....  ....+.|.+|+.+|++++|||||++++++.+ +.++
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            3567789999999999999999999875  369999886433  3445689999999999999999999998865 5689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||||+||+|.++|....   ..+++..++.|+.||+.||+|||++   +||||||||+||||++++.+||+|||+|+.
T Consensus       108 iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            9999999999999997653   5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc-ceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          232 LGSESS-YITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ...... ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+....      +...+.....
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~  255 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYA  255 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCC
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC
Confidence            653322 23345689999999999864   4689999999999999999999999976543221      1222222211


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                          .+.++ .....++..+.+||.+||+.||++|||+.+|+++|+.++.
T Consensus       256 ----~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          256 ----SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                11111 2223456778999999999999999999999999988754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.6e-60  Score=442.72  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=212.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++++.||+|+||+||+|+++ +++.||||++.+..   ......+.+|+++|+.++|||||++++++.+++.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999965 68899999986532   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||||+||+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+||||+.++.+||+|||+|+.+.
T Consensus       111 mEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCC-cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SES-SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ... .....+.+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+..      ..+..+....       
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~-------  250 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKLE-------  250 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            432 23345678999999999999999999999999999999999999999755422      2222333221       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ..++    ..++.++.+||.+||..||++|||+.|++.+
T Consensus       251 ~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             CCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             CCCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            1122    2345678999999999999999999986543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-58  Score=438.92  Aligned_cols=252  Identities=18%  Similarity=0.204  Sum_probs=209.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .+.|++.+.||+|+||.||+|+++ +|+.||||++......     .+|+.+++.++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456889999999999999999975 6889999998754322     3599999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~  235 (413)
                      |+||+|.++|...    ..+++..+..++.||+.||+|||++   +||||||||+||||+.+| .+||+|||+|+.....
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999765    5799999999999999999999999   999999999999999987 5999999999987543


Q ss_pred             Ccc----eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          236 SSY----ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       236 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...    .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...........+      ........  
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~~--  276 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPIR--  276 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGGG--
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCch--
Confidence            221    123467999999999999999999999999999999999999999876554432221      22111100  


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                            ..+..++..+.++|.+||..||++|||+.||+++|...
T Consensus       277 ------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          277 ------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                  11223566789999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9e-59  Score=437.26  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=213.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ...++++.+.||+|+||+||+|.+.      +++.||||++.... ....+.|.+|+.++++++|||||++++++.+++.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            4456788899999999999999863      45789999986543 3445789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~  217 (413)
                      ++||||||++|+|.++|.....            ....+++..++.|+.||+.||+|||++   +||||||||+||||++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965321            124699999999999999999999999   9999999999999999


Q ss_pred             CCCceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 015076          218 HWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       218 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~  295 (413)
                      ++.+||+|||+|+....... ......+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.+..+   . 
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~-  256 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V-  256 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H-
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H-
Confidence            99999999999986643322 22344679999999999999999999999999999999998 899997654322   1 


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                        +.. +..+..     ..    .+..++..+.+||.+||+.||++||||.+|+++|+..
T Consensus       257 --~~~-i~~~~~-----~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 --VEM-IRNRQV-----LP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHH-HHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHH-HHcCCC-----CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              222 222211     11    1223566789999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-58  Score=447.51  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=216.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +.|++.+.||+|+||.||+|.++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 68899999997766666677889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      +||+|.+++...     .+++..+..|+.||+.||+|||++   |||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999999753     699999999999999999999999   999999999999999999999999999998754433


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...      .+..+.....      +.+  
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------~~~--  367 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLP------PRL--  367 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC------CCC--
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCC------CCC--
Confidence             2455789999999999999999999999999999999999999997544322      2222222211      111  


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....++..+.+||.+||..||++|||+.|+++|-...
T Consensus       368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence            11223566789999999999999999999999985543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-58  Score=426.25  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=202.8

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee----CCeeEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  153 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~iv  153 (413)
                      |++.+.||+|+||+||+|.+. ++..||+|++....  ......+.+|+.+|++++|||||++++++.+    +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999965 58889999986543  3445678999999999999999999999865    3568999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEcC-CCCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDK-HWNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfG~a~  230 (413)
                      ||||+||+|.+++.+.    ..+++..+..|+.||+.||+|||++   +  ||||||||+||||+. +|.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999865    5799999999999999999999998   7  999999999999984 7899999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .....   ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......     . +...+.....   
T Consensus       181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~-~~~~i~~~~~---  247 (290)
T 3fpq_A          181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVK---  247 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCC---
T ss_pred             eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----H-HHHHHHcCCC---
Confidence            65432   2455789999999998865 69999999999999999999999997543221     1 1122222111   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           +...+...+.++.+||.+||..||++|||+.++++|-.
T Consensus       248 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          248 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                 11112223456889999999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7e-58  Score=423.12  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=196.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++.+.||+|+||+||+|.+. +++.||||.+....   ......+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999964 68999999986543   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||| +|+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 68999998765    5799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..  ...+.+||+.|||||++.+..| +.++|||||||++|+|+||+.||...+..      .....+.... .      
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~~-~------  229 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNGV-Y------  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-C------
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC-C------
Confidence            32  2345689999999999998876 57999999999999999999999754321      2222222211 1      


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .++    ..++.++.+|+.+||+.||++|||+.|+++|-..
T Consensus       230 ~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          230 TLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             CCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             CCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence            111    2245678999999999999999999999998543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.5e-58  Score=430.13  Aligned_cols=251  Identities=23%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .++|++++.||+|+||+||+|+..    .++.||||.+....  ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            367999999999999999999863    46789999986542  122346778999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||||+||+|.+++.+.    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+|+.
T Consensus       103 ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            999999999999999875    5799999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...... ...+.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+      .+..+....      
T Consensus       176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~------  242 (304)
T 3ubd_A          176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAK------  242 (304)
T ss_dssp             -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC------
T ss_pred             ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCC------
Confidence            543322 2445789999999999999999999999999999999999999997654322      222222221      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                       ..++    ..++.++.+||.+||+.||++|||     ++|+++|-.
T Consensus       243 -~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          243 -LGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             -CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             -CCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence             1111    234567899999999999999998     468887643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.5e-57  Score=433.04  Aligned_cols=269  Identities=27%  Similarity=0.407  Sum_probs=220.2

Q ss_pred             ccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCC-CCcccc
Q 015076           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRH-KNLVRL  140 (413)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-pniv~~  140 (413)
                      +....|++..++|++.+.||+|+||+||+|.+..      ++.||||.+..... ...+.+.+|+.+|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4567788899999999999999999999998653      24699999876543 345678999999999965 999999


Q ss_pred             cceeee-CCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeecc
Q 015076          141 LGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD  207 (413)
Q Consensus       141 ~~~~~~-~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D  207 (413)
                      +++|.. +..++||||||++|+|.++|.....            ....+++..++.++.||++||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            999866 4678999999999999999965321            124689999999999999999999999   999999


Q ss_pred             CCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 015076          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDY  285 (413)
Q Consensus       208 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~  285 (413)
                      |||+|||+++++.+||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999977544333 3345679999999999999999999999999999999998 9999986


Q ss_pred             CCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......      +...+..+..     ...+    ..++.++.++|.+||+.||++|||+.+|+++|+.+
T Consensus       291 ~~~~~~------~~~~i~~g~~-----~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          291 VKIDEE------FCRRLKEGTR-----MRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCCSHH------HHHHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHH------HHHHHHcCCC-----CCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            553321      1122222111     1112    22456788999999999999999999999999865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-55  Score=413.75  Aligned_cols=267  Identities=25%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC----eeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~iv~  154 (413)
                      .+|.+.+.||+|+||+||+|+++ |+.||||++.... ........|+..+..++|||||++++++.+++    .+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            35788999999999999999985 8899999885432 22223345666677889999999999997653    579999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-----CCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      |||++|+|.++++..     ++++..++.++.|++.||+|||++.     .++||||||||+||||+.++.+||+|||+|
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999764     6999999999999999999999752     348999999999999999999999999999


Q ss_pred             eecCCCCcce---eeccccccCccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCccc--------c
Q 015076          230 KLLGSESSYI---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--------V  292 (413)
Q Consensus       230 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~--------~  292 (413)
                      +.........   ....+||+.|||||++.+.      .++.++|||||||+||||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8775443321   2345799999999998764      367899999999999999999887754322110        0


Q ss_pred             cHHHHHHHHhhcCCCCCcCCCCCCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          293 NLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .....+...+...    .+++.++.. .....+..+.+|+.+||+.||++||||.+|++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1112222222211    223333322 23456778999999999999999999999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-54  Score=408.21  Aligned_cols=252  Identities=22%  Similarity=0.408  Sum_probs=192.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC--------
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--------  148 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--------  148 (413)
                      ++|++++.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35999999999999999999965 68899999986544 344567889999999999999999999986543        


Q ss_pred             ----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          149 ----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       149 ----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                          .+|||||||++|+|.+++..... ....++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                47999999999999999976521 13456677899999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCcc-----------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 015076          225 DFGLAKLLGSESSY-----------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (413)
Q Consensus       225 DfG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~  293 (413)
                      |||+|+........           ...+.+||+.|||||++.+..|+.++|||||||+||||++   ||...     ..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence            99999876543221           1234579999999999999999999999999999999996   77521     11


Q ss_pred             HHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ....+..... .        .++ ......+..+.+||.+||+.||++|||+.+++++-
T Consensus       233 ~~~~~~~~~~-~--------~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~  281 (299)
T 4g31_A          233 RVRTLTDVRN-L--------KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA  281 (299)
T ss_dssp             HHHHHHHHHT-T--------CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHhc-C--------CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            1222222111 1        111 11233445678899999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-53  Score=411.68  Aligned_cols=266  Identities=23%  Similarity=0.340  Sum_probs=207.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee------CCe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  149 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~  149 (413)
                      ++|++++.||+|+||+||+|+++ +|+.||||++....  ......+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 68999999986543  2344578899999999999999999998754      367


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|||||||+ |+|.+++...    ..+++..+..++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 6899999765    5899999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCC---cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          230 KLLGSES---SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       230 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      +.+....   .....+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+   .......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCC
Confidence            8764321   2223457899999999998775 5699999999999999999999999876543322222   2221111


Q ss_pred             CCCCc--------------CCCCCCCC---CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          306 NPEGV--------------LDPKLPEK---PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       306 ~~~~~--------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....              +....+..   ....++.++.+||.+||..||++|||+.|+|+|-...
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            10000              00000000   0012356788999999999999999999999986543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-52  Score=426.06  Aligned_cols=256  Identities=20%  Similarity=0.308  Sum_probs=218.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.++ +|+.||||.+..........+.+|+.+|+.++|||||+++++|.+...+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999965 6889999999877766777889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC--CCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH--WNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~  234 (413)
                      |+||+|.++|....   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999986543   4799999999999999999999999   99999999999999854  8899999999998865


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+..+.      +..+....       ..
T Consensus       310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~-------~~  374 (573)
T 3uto_A          310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCD-------WN  374 (573)
T ss_dssp             TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTC-------CC
T ss_pred             CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCC-------CC
Confidence            433  3456899999999999999999999999999999999999999976543221      22222211       11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ++......++..+.+||.+||..||++|||+.|+++|-..
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence            2222233456778999999999999999999999998543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5e-52  Score=400.28  Aligned_cols=264  Identities=19%  Similarity=0.263  Sum_probs=202.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||+||+|+++    .++.||||.+....  ....+.+|+++|+.+ +||||+++++++.+.+++|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3578999999999999999999853    36789999886543  345677899999988 6999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~  230 (413)
                      ||||||++|+|.+++.       .+++..+..++.||+.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+
T Consensus        97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999983       589999999999999999999999   99999999999999876 799999999998


Q ss_pred             ecCCCCc---------------------------ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCC
Q 015076          231 LLGSESS---------------------------YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIP  282 (413)
Q Consensus       231 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~P  282 (413)
                      .......                           ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            6543221                           112345799999999999776 489999999999999999999999


Q ss_pred             CCCCCCcccccHHHHHHHHhh----------------------------------cC-C-CCC----cCCCCCCCCCcHH
Q 015076          283 VDYSRPPEEVNLIEWLKKMVT----------------------------------NR-N-PEG----VLDPKLPEKPTSR  322 (413)
Q Consensus       283 f~~~~~~~~~~~~~~~~~~~~----------------------------------~~-~-~~~----~~~~~~~~~~~~~  322 (413)
                      |.......  ..+..+.....                                  .. . ...    .............
T Consensus       247 f~~~~~~~--~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          247 FYKASDDL--TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCHH--HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            96544321  11111111000                                  00 0 000    0000000011223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          323 LLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       323 ~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ++.++.+|+.+||..||++|||+.|+++|-..
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            45678899999999999999999999988543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-51  Score=391.74  Aligned_cols=281  Identities=40%  Similarity=0.716  Sum_probs=247.1

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ++....++|++.+.||+|+||.||+|.++++..||||++..........+.+|+.+++.++||||+++++++...+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34456789999999999999999999988899999999877766677889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++.........+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999977654445799999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........+.............+
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43222 22334568999999999999999999999999999999999999998877777777777766666666666777


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ++.+.......++..+.+++.+||+.||++|||+.+++++|+...
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            777777778889999999999999999999999999999998753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.3e-52  Score=421.97  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=208.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHH---HHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAER---EFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      +..++|+++++||+|+||+||+|+++ +|+.||||++.+..   .....   ....++.+++.++|||||+++++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            35678999999999999999999965 68899999986432   11122   2334567788889999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      .+|||||||+||+|.++|...    ..+++..+..++.||+.||+|||++   |||||||||+||||+.+|.+||+|||+
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999865    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      |+......   ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.........   ........  
T Consensus       339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~~--  410 (689)
T 3v5w_A          339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMA--  410 (689)
T ss_dssp             CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHCC--
T ss_pred             eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCCC--
Confidence            99875432   345689999999999965 5799999999999999999999999976544332221   22222211  


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                           ..+    +..++.++.+||.+||..||++|++     +.+|++|-.
T Consensus       411 -----~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          411 -----VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             -----CCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             -----CCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                 111    2235667899999999999999998     789988743

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.5e-51  Score=389.40  Aligned_cols=293  Identities=40%  Similarity=0.759  Sum_probs=251.2

Q ss_pred             CCCccccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccc
Q 015076           64 GWGHWYTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        64 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      +....+++.++.+..++|++.+.||+|+||.||+|...++..||||++...... ....+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            444567889999999999999999999999999999878999999988654322 2236888999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ++......++||||+++++|.+++.........+++..++.++.|++.||+|||++...||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987665556799999999999999999999997666899999999999999999999


Q ss_pred             EEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--CcccccHHHHHHH
Q 015076          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR--PPEEVNLIEWLKK  300 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~--~~~~~~~~~~~~~  300 (413)
                      |+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .........++..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999999876555555555679999999999999999999999999999999999999996321  1233445566666


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ...........+..+........+..+.+++.+||+.||.+|||+.+|+++|+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            66666666677777777778889999999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.9e-49  Score=371.46  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=215.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||+||+|.+ .+++.||||.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999995 46889999999776666677889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++++|.+++...     .+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999764     589999999999999999999999   99999999999999999999999999998775443


Q ss_pred             cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          237 SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|..||........      ..........        .
T Consensus       171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~--------~  235 (297)
T 3fxz_A          171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP--------E  235 (297)
T ss_dssp             C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC--------C
T ss_pred             c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC--------C
Confidence            3 23446799999999999999999999999999999999999999975443221      1111111111        1


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......++..+.+++.+||+.||++|||+.+++++....
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            112334566789999999999999999999999875543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-49  Score=372.22  Aligned_cols=268  Identities=28%  Similarity=0.453  Sum_probs=207.7

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..+.+..++|++.+.||+|+||+||+|.+. +..||||++....  ......+.+|+.++++++||||+++++++.....
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            344566788999999999999999999874 8889999886554  2334678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEcCCCCceEEecc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      .++||||+++++|.+++..... ...+++..++.++.||+.||+|||++   |  |+||||||+|||++.++.+||+|||
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999999976421 12389999999999999999999999   8  9999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ..........
T Consensus       185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~  257 (309)
T 3p86_A          185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCKR  257 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCCC
T ss_pred             CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCC
Confidence            998654322 123345789999999999999999999999999999999999999975543221      1111111110


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCC
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~  360 (413)
                           ..    ....++..+.++|.+||..||++|||+.+|++.|+.......
T Consensus       258 -----~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          258 -----LE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             -----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             -----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                 11    122345678999999999999999999999999998765443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-48  Score=370.72  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=209.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 688999998865432 334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999999765    4699999999999999999999999   9999999999999999999999999999865422


Q ss_pred             Cc-ceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          236 SS-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       236 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..    .....         
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~----~~~~~---------  224 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWKEK---------  224 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH----HHHTT---------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH----HHhcc---------
Confidence            21 22334679999999999987775 77999999999999999999999765433211 11    11111         


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .........++..+.+|+.+||..||++|||+.+++++....
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence            111122334566788999999999999999999999986554

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=369.19  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=214.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|.+..........+.+|+.+++.++||||+++++++.++...++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3567999999999999999999975 588899999877677777889999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        88 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999999997643   5799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             Ccce-------------eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc---cHHHHHH
Q 015076          236 SSYI-------------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV---NLIEWLK  299 (413)
Q Consensus       236 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~---~~~~~~~  299 (413)
                      ....             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........   .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211             11457999999999999999999999999999999999999998754433211   1111111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ..         .        ...++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       242 ~~---------~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          242 RY---------C--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HT---------C--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc---------C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            10         0        0112345889999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.8e-49  Score=374.11  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=211.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            457899999999999999999997 478999999986542  34456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999999765    4799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ....  ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..      ...........      
T Consensus       166 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~------  231 (328)
T 3fe3_A          166 VGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRGKY------  231 (328)
T ss_dssp             SSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC------
T ss_pred             CCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC------
Confidence            4322  3456799999999999888875 7999999999999999999999765422      22222222111      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       .++    ..++..+.+|+.+||..||.+|||+.+++++...
T Consensus       232 -~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~  268 (328)
T 3fe3_A          232 -RIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI  268 (328)
T ss_dssp             -CCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred             -CCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence             111    1245568899999999999999999999988543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-48  Score=361.97  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=216.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +..++|++.+.||+|+||.||+|.++++..||+|.+..... ....+.+|+.+++.++||||+++++++......++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45678999999999999999999998888999998865543 34668899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999997642   3699999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......      ..........      . 
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~------~-  224 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHR------L-  224 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCC------C-
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCCC------C-
Confidence            4444444556788999999999899999999999999999999 999997544321      1111111110      0 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                         ..+..++..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               1111234568899999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.1e-49  Score=364.03  Aligned_cols=259  Identities=27%  Similarity=0.451  Sum_probs=215.7

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .+..++|++.+.||+|+||.||+|.+.++..||+|++..... ....+.+|+.++++++||||+++++++.+....++||
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            345678999999999999999999998888999998875543 3467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999997653   4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......      ..........      .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~~------~  226 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFR------L  226 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC------C
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCcc------C
Confidence            33323334456788999999999999999999999999999999 999997544321      1222211110      1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                          .....++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          227 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                111223566889999999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.4e-48  Score=371.83  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=212.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .+.|++.+.||+|+||.||+|.++ ++..||+|.+......      ....+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 6889999998764322      356788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEec
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  226 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999765    5799999999999999999999999   999999999999998877    7999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++........  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+      .+..+.... 
T Consensus       164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~-  234 (361)
T 2yab_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVS-  234 (361)
T ss_dssp             SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-
T ss_pred             CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-
Confidence            99988754322  344679999999999999999999999999999999999999997654221      122222111 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                            ..++......++..+.+||.+||..||++|||+.+++++...
T Consensus       235 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  276 (361)
T 2yab_A          235 ------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (361)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             ------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence                  011111112345678999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=369.09  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=210.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            4567999999999999999999974    34469999987653 344567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+++.
T Consensus       127 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            9999999999999996543   4799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......      ..........  
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~--  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYR--  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCC--
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCC--
Confidence            7543222  1223346778999999999999999999999999999999 999997544322      1122211111  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                              ......++..+.+++.+||..||++|||+.+|++.|+.+.
T Consensus       273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                    1112234567899999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-48  Score=371.15  Aligned_cols=252  Identities=24%  Similarity=0.290  Sum_probs=210.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|+.+ +++.||||.+....   ......+..|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            3568999999999999999999975 68899999986532   2345667889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++..
T Consensus        83 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            99999999999999765    4799999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+....       
T Consensus       156 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-------  221 (337)
T 1o6l_A          156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-------  221 (337)
T ss_dssp             CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------
T ss_pred             ccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            33222 234567999999999999999999999999999999999999999754322      1122222211       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                      ..++    ..++..+.++|.+||+.||++||     ++.+|++|..
T Consensus       222 ~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence            1111    23456789999999999999999     8999998743

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.5e-48  Score=373.84  Aligned_cols=262  Identities=25%  Similarity=0.429  Sum_probs=213.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +..++|++.+.||+|+||.||+|.+.        ++..||||.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            45678999999999999999999853        345699998865533 3456788999999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcE
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI  213 (413)
                      ..+..|+||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   ||+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            99999999999999999999976431            124589999999999999999999999   999999999999


Q ss_pred             EEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCccc
Q 015076          214 LIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEE  291 (413)
Q Consensus       214 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~  291 (413)
                      |++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999999876543322 1233457889999999999999999999999999999999 9999976543221


Q ss_pred             ccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         ..    .+.....     .    ..+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       315 ---~~----~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          315 ---FK----LLKEGHR-----M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ---HH----HHHTTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HH----HHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11    1111111     1    112235567899999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.5e-48  Score=363.05  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=210.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            4578999999999999999999965 68899999886543   3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    .++++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus        89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999999765    4799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ...........     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-----  230 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVP-----  230 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCC-----
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCC-----
Confidence            5443333445679999999999999999999999999999999999999997544221      11122221111     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcccC
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQES  357 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~le~~~~  357 (413)
                       .........++..+.+++.+||..||++|| ++.++.+.|+....
T Consensus       231 -~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          231 -NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence             000011223456789999999999999999 89999999987643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-48  Score=363.50  Aligned_cols=258  Identities=22%  Similarity=0.389  Sum_probs=212.0

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++..++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            455678999999999999999999998888999998875543 3467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999997643   4699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.......      .........      ..
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~------~~  240 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGL------RL  240 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC------CC
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhccc------CC
Confidence            33222333456788999999998999999999999999999998 999997544321      111211111      01


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .....++..+.+++.+||+.||++|||+.+++++|+.+
T Consensus       241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                11122345688999999999999999999999999865

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.2e-47  Score=359.96  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=212.7

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      |...+.||+|+||.||+|... +|+.||||.+..........+.+|+.+++.++||||+++++++......++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            777889999999999999976 6899999999877666677889999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      ++|.+++...     .+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++......... 
T Consensus       127 ~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  197 (321)
T 2c30_A          127 GALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  197 (321)
T ss_dssp             CBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             CCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-
Confidence            9999998653     699999999999999999999999   9999999999999999999999999999877543322 


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ..........      +.+  ..
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~------~~~--~~  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRLRDSPP------PKL--KN  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSC------CCC--TT
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC------CCc--Cc
Confidence            344579999999999999999999999999999999999999997543221      1222221111      111  11


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...++..+.+++.+||+.||++|||+.+++++....
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            233556789999999999999999999999986544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-48  Score=373.55  Aligned_cols=258  Identities=19%  Similarity=0.303  Sum_probs=209.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-----chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .++|++.+.||+|+||.||+|.++ +++.||||++....     ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            456999999999999999999965 68899999885421     224577889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEeccc
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGL  228 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~  228 (413)
                      +||||+++++|.+++.........+++..++.++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999888764322224689999999999999999999999   9999999999999987655   99999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      +........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....       ...........  
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~--  249 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKY--  249 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCC--
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCC--
Confidence            988765332 23445799999999999999999999999999999999999999975321       11222222111  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           .........++..+.+||.+||..||++|||+.+++++..
T Consensus       250 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          250 -----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW  289 (351)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             -----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence                 0000011234567899999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-47  Score=362.04  Aligned_cols=266  Identities=20%  Similarity=0.285  Sum_probs=209.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||+||+|.+.+++.||+|++....  ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            57899999999999999999999889999999986543  2234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++ +|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9964 8888876643   4699999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC---
Q 015076          236 SSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL---  311 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  311 (413)
                      ... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...   .+.............   
T Consensus       173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGT
T ss_pred             ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhh
Confidence            222 333568999999999876 568999999999999999999999998765543322   222222221111000   


Q ss_pred             ---------CCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 ---------DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ---------~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                               ........    ...++.++.+|+.+||..||++|||+.+++++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                     00000000    11234678899999999999999999999987543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=373.53  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=205.5

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .+..++|++.+.||+|+||.||+|+++ +++.||||++....   ......+..|+.+++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            355789999999999999999999976 58899999986542   23445677899999988 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+||||+++|+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999999765    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+      ....+.....   
T Consensus       172 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~---  241 (353)
T 3txo_A          172 KEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEV---  241 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC---
T ss_pred             eecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC---
Confidence            8643222 22445679999999999999999999999999999999999999997554322      2222222211   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHh
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVHMLE  353 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~le  353 (413)
                          .++    ..++..+.+++.+||..||++||++      .+|++|..
T Consensus       242 ----~~p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          242 ----VYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             ----CCC----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence                111    1245668899999999999999998      88888743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8e-47  Score=368.20  Aligned_cols=256  Identities=19%  Similarity=0.252  Sum_probs=213.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999975 6888999998776666667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC--CCCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~  234 (413)
                      +++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.  .+.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999997643   4699999999999999999999999   9999999999999974  46799999999998765


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ..+..+.....       .
T Consensus       204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~~-------~  268 (387)
T 1kob_A          204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDW-------E  268 (387)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCC-------C
T ss_pred             Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------C
Confidence            432  23346899999999999999999999999999999999999999754322      11222222111       1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ++......++..+.++|.+||..||++|||+.+++++...
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence            1112223356678999999999999999999999998544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=362.71  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=211.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+.....      .....+.+|+.+++.++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            346999999999999999999976 588999998865432      2457788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEec
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  226 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999765    5799999999999999999999999   999999999999999887    7999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||........      +....... 
T Consensus       163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~-  233 (326)
T 2y0a_A          163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN-  233 (326)
T ss_dssp             TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHTC-
T ss_pred             CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhcC-
Confidence            99988754332  2345799999999999999999999999999999999999999975432211      11111111 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                            ..++......++..+.+++.+||..||++|||+.+++++...
T Consensus       234 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  275 (326)
T 2y0a_A          234 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  275 (326)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             ------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence                  111111112345678899999999999999999999998543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-47  Score=368.65  Aligned_cols=254  Identities=18%  Similarity=0.290  Sum_probs=211.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||.||+|.++ ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999975 58899999987653  234467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---CceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~  231 (413)
                      ||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++   .+||+|||++..
T Consensus       108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998765    5799999999999999999999999   999999999999998654   599999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      .....+....      
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~------  246 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGA------  246 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC------
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC------
Confidence            654322  33467999999999999999999999999999999999999999754321      1112222111      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                       ..++......++..+.+||.+||..||++|||+.+++++..
T Consensus       247 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          247 -YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             -CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             -CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence             11122223345677899999999999999999999998854

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-47  Score=361.48  Aligned_cols=256  Identities=16%  Similarity=0.257  Sum_probs=212.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 5778999987644 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC--CCCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~  234 (413)
                      +++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.  ++.+||+|||++.....
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999997643   4699999999999999999999999   9999999999999987  78999999999988754


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......      .+........       .
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-------~  221 (321)
T 1tki_A          157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY-------T  221 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------C
T ss_pred             CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCC-------C
Confidence            432  344568999999999999889999999999999999999999997544221      1222222111       1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ++......++..+.+++.+||..||++|||+.+++++..-.
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence            11111123466789999999999999999999999986554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-47  Score=366.47  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=208.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+ .++..||||++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            57899999999999999999996 468899999886432   12235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+ +|+|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 78999988765    4799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ....  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........               +..
T Consensus       160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~  222 (336)
T 3h4j_B          160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNS  222 (336)
T ss_dssp             TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCS
T ss_pred             CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHc
Confidence            4332  344579999999999988776 7899999999999999999999975543321110               000


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..  ...+..++..+.+|+.+||..||.+|||+.+++++....
T Consensus       223 ~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          223 CV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             SC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             CC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            00  011223456788999999999999999999999986543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-47  Score=363.86  Aligned_cols=270  Identities=25%  Similarity=0.375  Sum_probs=211.3

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC----eeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~  151 (413)
                      +..++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.+++.++||||+++++++....    .++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            45678999999999999999999876 7899999885443 33445566899999999999999999998744    469


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-------CCceeeccCCCCcEEEcCCCCceEE
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-------EPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                      +||||+++|+|.+++...     .+++..++.++.||+.||+|||+..       ..+|+||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999999764     5999999999999999999999751       2389999999999999999999999


Q ss_pred             ecccceecCCCCcc-eeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH---
Q 015076          225 DFGLAKLLGSESSY-ITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---  295 (413)
Q Consensus       225 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~---  295 (413)
                      |||+++........ ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+..........   
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999877543322 1233578999999999976     35667899999999999999999999865443221111   


Q ss_pred             ------HHHHHHhhcCCCCCcCCCCCCC-CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          296 ------EWLKKMVTNRNPEGVLDPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       296 ------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                            ..+.........    .+.++. ......+..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  111111111111    111111 122346677999999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=370.45  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=210.8

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +..++|++.+.||+|+||.||+|.+. ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+....+
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44678999999999999999999966 57889999886432   233467888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+.||+|..++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||++..
T Consensus        92 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence            999999999999999875    5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......  ....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||..............+.   ...   
T Consensus       165 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~---  236 (384)
T 4fr4_A          165 LPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTV---  236 (384)
T ss_dssp             CCTTCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCC---
T ss_pred             ccCCCc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hcc---
Confidence            754322  345679999999999864   458999999999999999999999998655443332222211   111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~l  352 (413)
                          ..+    +..++..+.+||.+||..||.+||+ +.+|+++.
T Consensus       237 ----~~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp  273 (384)
T 4fr4_A          237 ----VTY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP  273 (384)
T ss_dssp             ----CCC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred             ----cCC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence                111    1234567899999999999999998 78887753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.4e-48  Score=375.87  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=213.1

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +.+..++|++.+.||+|+||.||+|.+. ++..||||.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            4456778999999999999999999976 688999998865432 33456888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       189 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            9999999999999997542   3689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccee-eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          232 LGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       232 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ......... ....++..|+|||++.+..++.++|||||||++|||++ |..||........       ...+.....  
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--  333 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGGR--  333 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTCC--
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC--
Confidence            543321111 11235778999999998999999999999999999998 9999975542211       111221111  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         ..    .+..++..+.++|.+||+.||++|||+.+|++.|+.+.
T Consensus       334 ---~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 ---LP----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               01    11224567889999999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.3e-48  Score=385.54  Aligned_cols=263  Identities=24%  Similarity=0.450  Sum_probs=217.0

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..+++..++|++.+.||+|+||.||+|.++++..||||.+.... .....+.+|+.+++.++||||+++++++. ....+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            44567788899999999999999999999888899999987544 34678899999999999999999999987 56789


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       259 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999975421  3688999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .............+|..|+|||++....++.++|||||||+||||++ |+.||.+....+   .   .........    
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~---~~~i~~~~~----  403 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---IRALERGYR----  403 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H---HHHHHHTCC----
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHcCCC----
Confidence            65332222233446788999999998999999999999999999999 999997554322   1   111111111    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                        .    ..+..++..+.+||.+||..||++|||+.+|++.|+....
T Consensus       404 --~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 --M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence              0    1122355678999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=355.04  Aligned_cols=271  Identities=21%  Similarity=0.296  Sum_probs=216.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC--eeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999976 58899999986543 234567788999999999999999999987655  78999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE----cCCCCceEEecccc
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a  229 (413)
                      |||+++++|.+++..... ...+++..++.++.||+.||+|||++   ||+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999976432 13499999999999999999999999   99999999999999    77788999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYAS--------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +.......  .....||+.|+|||++.        +..++.++|||||||++|+|++|+.||..........  ..+...
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~  239 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI  239 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHHHH
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHHHH
Confidence            88755432  23456899999999886        5778999999999999999999999997554433221  222222


Q ss_pred             hhcCCCC---Cc---------C--CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          302 VTNRNPE---GV---------L--DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       302 ~~~~~~~---~~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .......   .+         +  .-.........+...+.+++.+||+.||++|||+.+++++.....
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            2221110   00         0  011122445778889999999999999999999999999987654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.7e-46  Score=350.55  Aligned_cols=281  Identities=36%  Similarity=0.664  Sum_probs=226.8

Q ss_pred             ccccHHHHHHhcCCCCcc------cEEeeeCceEEEEEEEcCCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCC
Q 015076           67 HWYTLRELEVSTNGFSDD------KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKN  136 (413)
Q Consensus        67 ~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpn  136 (413)
                      ..|++.++....+.|...      +.||+|+||.||+|.. ++..||||++....    ......+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            446778888888887766      9999999999999987 48899999886532    344677889999999999999


Q ss_pred             cccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc
Q 015076          137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (413)
Q Consensus       137 iv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~  216 (413)
                      |+++++++...+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++   ||+||||||+|||++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            99999999999999999999999999999864321 24699999999999999999999999   999999999999999


Q ss_pred             CCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH
Q 015076          217 KHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       217 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~  295 (413)
                      .++.+||+|||++......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999999876543222 2334578999999998865 5889999999999999999999999876554433222


Q ss_pred             HHHHHHhhc-CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          296 EWLKKMVTN-RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       296 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .  ...... ......++..+. .....++..+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus       247 ~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 K--EEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             H--HHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             H--HHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1  111111 111222333332 345677889999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-47  Score=358.17  Aligned_cols=258  Identities=21%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ++..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ......+.+|+.+++.++||||+++++++. .+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            3456789999999999999999999653    3469999876543 344567889999999999999999999985 456


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence            899999999999999997653   4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.   ..   .+.....  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~---~i~~~~~--  235 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RIENGER--  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---HHHTTCC--
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH---HHHcCCC--
Confidence            8775443333334457889999999998999999999999999999997 9999986543322   11   1111110  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .    .....++..+.+++.+||..||++|||+.+++++|+.+
T Consensus       236 ----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 ----L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                0    11123456788999999999999999999999999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=354.76  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=214.3

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +..++|++.+.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            45678999999999999999999998888999998876543 34678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            999999999997653   4689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .........++..|+|||++.+..++.++||||||+++|+|++ |+.||.......      ..........      . 
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~------~-  224 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFR------L-  224 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC------C-
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCc------C-
Confidence            2222233456789999999998999999999999999999999 899997543221      1222221110      1 


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         .....++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          225 ---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               111223567889999999999999999999999998753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=362.35  Aligned_cols=250  Identities=25%  Similarity=0.338  Sum_probs=211.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|.+....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            3567999999999999999999975 68899999986532   2334667889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++..
T Consensus        84 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             EECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence            99999999999999865    4799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      .....+....       
T Consensus       157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-------  219 (318)
T 1fot_A          157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE-------  219 (318)
T ss_dssp             SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC-------
T ss_pred             CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------
Confidence            432    33467999999999999999999999999999999999999999754322      2222333221       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le~  354 (413)
                      ..++    ..++..+.+++.+||..||++||     ++.+|++|-..
T Consensus       220 ~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          220 LRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             CCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence            1111    22456788999999999999999     89999987443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4e-47  Score=357.01  Aligned_cols=266  Identities=22%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee--CC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~  148 (413)
                      +..++|++.+.||+|+||.||+|++     .++..||||++..........+.+|+.+++.++||||+++++++..  ..
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3457899999999999999999984     2578899999987766667789999999999999999999998854  35


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            6899999999999999997653   3599999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc---------ccccHHHH
Q 015076          229 AKLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP---------EEVNLIEW  297 (413)
Q Consensus       229 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~---------~~~~~~~~  297 (413)
                      +.........  ......++..|+|||++.+..++.++|||||||++|+|++|..||......         ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9876543221  122345778899999999999999999999999999999999998632110         00011111


Q ss_pred             HHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ....+.....         ......++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       241 ~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          241 LIELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111111         1112235567899999999999999999999999998753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.1e-47  Score=371.55  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=208.4

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .+..++|++.++||+|+||+||+|+++ +++.||||++.+...   .....+..|..+++.+ +||||+++++++.+...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            345678999999999999999999976 577899999875432   2234577889998876 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +++||||+++|+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeeccee
Confidence            99999999999999999765    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccc--ccHHHHHHHHhhcCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE--VNLIEWLKKMVTNRNP  307 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~  307 (413)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ......+...+.... 
T Consensus       201 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-  278 (396)
T 4dc2_A          201 KEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-  278 (396)
T ss_dssp             BCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-
T ss_pred             eecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-
Confidence            8633222 224557899999999999999999999999999999999999999975432211  111111222222111 


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHh
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVHMLE  353 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~le  353 (413)
                           ..++    ..++..+.+||.+||+.||++||++      .+|++|..
T Consensus       279 -----~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          279 -----IRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             -----CCCC----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             -----cCCC----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence                 1111    2245678899999999999999985      78887743

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-47  Score=371.41  Aligned_cols=258  Identities=29%  Similarity=0.463  Sum_probs=200.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+.... ......+.+|+.++++++||||+++++++......+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            4568999999999999999999864    46679999986543 344567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            9999999999999997653   4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcce--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.......      ..... ....  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~i-~~~~--  267 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAV-DEGY--  267 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHHH-HTTE--
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HcCC--
Confidence            65432211  122345778999999999999999999999999999998 999997543221      11111 1110  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                             .......++..+.+++.+||+.||++||++.+|++.|+...
T Consensus       268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                   00112234567899999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.7e-47  Score=355.01  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=201.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--------------------------hHHHHHHHHHHH
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--------------------------AEREFKVEVEAI  129 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l  129 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+......                          ....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3578999999999999999999965 5788999988654311                          124678899999


Q ss_pred             hcCCCCCcccccceeee--CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeecc
Q 015076          130 GRVRHKNLVRLLGYCAE--GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD  207 (413)
Q Consensus       130 ~~l~hpniv~~~~~~~~--~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D  207 (413)
                      +.++||||+++++++.+  ....++||||+++++|.+++..     ..+++..++.++.||+.||+|||++   ||+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            99999999999999986  5789999999999999987654     4799999999999999999999999   999999


Q ss_pred             CCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCC
Q 015076          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVD  284 (413)
Q Consensus       208 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~~l~elltg~~Pf~  284 (413)
                      |||+|||++.++.+||+|||++........ ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987754332 234457999999999997765   4788999999999999999999997


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ....      ........... .      .+  .....++..+.+++.+||+.||++|||+.+++++.
T Consensus       242 ~~~~------~~~~~~~~~~~-~------~~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          242 DERI------MCLHSKIKSQA-L------EF--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             CSSH------HHHHHHHHHCC-C------CC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             CccH------HHHHHHHhccc-C------CC--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            5432      11122221111 1      00  11122456789999999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.4e-47  Score=375.07  Aligned_cols=255  Identities=19%  Similarity=0.252  Sum_probs=209.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+.....  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            467999999999999999999965 688899999876542  33457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc---CCCCceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~  231 (413)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999766    5799999999999999999999999   999999999999998   457899999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ....+.....     
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~-----  230 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIKAGAY-----  230 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC-----
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhCCC-----
Confidence            654332 2344679999999999999999999999999999999999999997543221      1222221111     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        .++......++..+.+|+.+||+.||++|||+.+++++..
T Consensus       231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence              1111122335667899999999999999999999999843

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-46  Score=354.01  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=204.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCCcccccceeee----CCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~----~~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+ ++..||||++...   ....+..|.+++..  ++||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            356899999999999999999988 5889999988543   33444556665555  799999999998654    3568


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh--------hccCCceeeccCCCCcEEEcCCCCce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--------EGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ++||||+++|+|.+++..     ..+++..++.++.||+.||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            999999999999999964     36999999999999999999999        87   999999999999999999999


Q ss_pred             EEecccceecCCCCcce---eeccccccCccCccccccC------CCCccchhHHHHHHHHHHHhC----------CCCC
Q 015076          223 VSDFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISG----------RIPV  283 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~~l~elltg----------~~Pf  283 (413)
                      |+|||+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765433322   2234789999999999776      455799999999999999999          8888


Q ss_pred             CCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC-CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          284 DYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..........  ..+........    ..+.++. .....++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       234 ~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSF--EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcch--hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            6544332221  11222221111    1111111 12345788899999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.7e-48  Score=371.14  Aligned_cols=269  Identities=26%  Similarity=0.393  Sum_probs=216.8

Q ss_pred             ccHHHHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccc
Q 015076           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRL  140 (413)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~  140 (413)
                      +....+++..++|++.+.||+|+||.||+|.+.      +++.||||++..... .....+.+|+.+++.+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            456778888999999999999999999999842      356799999876433 3446789999999999 78999999


Q ss_pred             cceeeeCC-eeEEEEEeccCCChhhhccCCCCC-----------------------------------------------
Q 015076          141 LGYCAEGA-HRMLVYEYVNNGNLEQWLHGDVGP-----------------------------------------------  172 (413)
Q Consensus       141 ~~~~~~~~-~~~iv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  172 (413)
                      ++++.+.+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 489999999999999999765321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          173 ---------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       173 ---------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                                     ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12289999999999999999999999   999999999999999999999999999987644332


Q ss_pred             c-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          238 Y-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.........  .    ..+.....     ...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~----~~~~~~~~-----~~~  317 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGTR-----MRA  317 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H----HHHHHTCC-----CCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H----HHHHcCCC-----CCC
Confidence            2 2334568999999999999999999999999999999998 99999765543221  1    11111111     111


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          ...++..+.+++.+||..||++|||+.+|+++|+.+
T Consensus       318 ----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          318 ----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                122445688999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-47  Score=379.30  Aligned_cols=266  Identities=21%  Similarity=0.258  Sum_probs=215.0

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ++++.+..++|++.++||+|+||+||+|+++. ++.||||++.....   .....+..|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34455677899999999999999999999764 67899998864321   122347789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ...+++||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999997642   5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      |+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.  ...
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~  297 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHK  297 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--THH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--hcc
Confidence            999877655544445578999999999986     5679999999999999999999999998654332221111  000


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHhc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLEA  354 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~le~  354 (413)
                      ...         .++.. ...++..+.+||.+||..+|++  ||++.++++|...
T Consensus       298 ~~~---------~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          298 ERF---------QFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             HHC---------CCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             ccc---------cCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            000         01110 1124567889999999988888  9999999998544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-47  Score=375.15  Aligned_cols=264  Identities=20%  Similarity=0.277  Sum_probs=214.9

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      +.++.+..++|++.+.||+|+||.||+|+++ ++..||+|++....   ......+..|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445567789999999999999999999976 57889999886422   1122347789999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ...+|+||||++||+|.+++...     .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999753     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |+++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.....      ..+.
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~  286 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIM  286 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHH
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHHH
Confidence            999887655444445678999999999997765    889999999999999999999999765432221      1221


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHhcc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQK--RPKMGHVVHMLEAQ  355 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~le~~  355 (413)
                      .....     ..++  ....++..+.+||.+||..+|.+  ||++.+|++|....
T Consensus       287 ~~~~~-----~~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          287 NHKNS-----LTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             THHHH-----CCCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             hcccc-----ccCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            11000     0011  11124567889999999999988  99999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-47  Score=354.48  Aligned_cols=264  Identities=21%  Similarity=0.330  Sum_probs=205.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||.||+|.+.+++.||+|++......  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            579999999999999999999988999999998654322  236678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +++ +|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            965 9999887643   4689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC------
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG------  309 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  309 (413)
                      . ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.   ...+...........      
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhc
Confidence            2 12334689999999998764 589999999999999999999999976542221   111222211111000      


Q ss_pred             --cCCCCCCC-------CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          310 --VLDPKLPE-------KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       310 --~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ..++.+..       .....++..+.+|+.+||+.||++|||+.+++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence              00111100       011234567889999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.4e-48  Score=369.24  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=208.4

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCC
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGA  148 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~  148 (413)
                      ..+..++|++.+.||+|+||.||+|+++ +++.||||.+....   ......+..|..+++.+ +||||+++++++.+..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            4567889999999999999999999976 57889999986542   23345677888888876 8999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..|+||||++||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999999765    4799999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...      ....+....   
T Consensus       165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~---  234 (345)
T 1xjd_A          165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN---  234 (345)
T ss_dssp             CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC---
T ss_pred             hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC---
Confidence            986532222 2445689999999999999999999999999999999999999997554321      122222211   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG-HVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~l  352 (413)
                          ..++    ..++..+.++|.+||..||++||++. +|++|.
T Consensus       235 ----~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp  271 (345)
T 1xjd_A          235 ----PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  271 (345)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             ----CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence                1111    22456788999999999999999998 887664

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.3e-46  Score=367.06  Aligned_cols=257  Identities=20%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             cCCCCcc-cEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHH-hcCCCCCcccccceeee----CCee
Q 015076           78 TNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        78 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~----~~~~  150 (413)
                      .++|.+. ++||+|+||+||+|.+. ++..||||++...     ..+.+|+.++ +..+||||+++++++..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567776 78999999999999965 6888999988532     3456677776 44589999999999875    5678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEecc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG  227 (413)
                      |+||||+++|+|.+++.....  ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999976421  4699999999999999999999999   9999999999999987   7889999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~  306 (413)
                      +++.......  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+.   . ..
T Consensus       210 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~-~~  283 (400)
T 1nxk_A          210 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---M-GQ  283 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---H-TC
T ss_pred             cccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---c-Cc
Confidence            9987653322  34467899999999999999999999999999999999999999865543221 1111111   1 11


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                            ..++......++..+.+||.+||..||++|||+.+++++.....
T Consensus       284 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          284 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence                  01111122335677899999999999999999999999866543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-47  Score=354.53  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=215.5

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .++++..++|++.+.||+|+||.||+|.+.++..||+|.+.... .....+.+|+.+++.++||||+++++++.. +..+
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            34566778999999999999999999998888899999886543 345678899999999999999999999874 4589


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++.....  ..+++..++.++.|++.||+|||++   ||+||||||+|||+++++.+||+|||++..
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            99999999999999975321  2689999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |+.||......+      ..........    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~----  228 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYR----  228 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC----
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccC----
Confidence            76543333334457889999999988899999999999999999999 999997544221      1111111110    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                        .    .....++..+.+++.+||..||++|||+.++++.|+...
T Consensus       229 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          229 --M----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --C----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              1    111234567899999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.7e-47  Score=352.57  Aligned_cols=251  Identities=27%  Similarity=0.488  Sum_probs=198.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc----hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG----QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. +..||||.+.....    .....+.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            4678999999999999999999986 88899998865432    234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc---eeeccCCCCcEEEcC--------CCCc
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK---VVHRDIKSSNILIDK--------HWNP  221 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~  221 (413)
                      ||||+++++|.+++..     ..+++..++.++.|++.||+|||++   +   |+||||||+|||++.        ++.+
T Consensus        84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999864     3699999999999999999999999   7   999999999999986        6789


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      ||+|||++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      .....
T Consensus       156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~  226 (271)
T 3dtc_A          156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV  226 (271)
T ss_dssp             EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH
T ss_pred             EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhh
Confidence            999999998664332   223468999999999999999999999999999999999999997543211      11111


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .....         .......++..+.+++.+||+.||++|||+.+++++|+.
T Consensus       227 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          227 AMNKL---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hcCCC---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11111         111223345678999999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=362.02  Aligned_cols=255  Identities=21%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+....  ....+.+|+.++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567999999999999999999976 57889999886543  34567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEecccceec
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFGLAKLL  232 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~  232 (413)
                      |+++++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999765    4699999999999999999999999   9999999999999975   889999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........     ..........      
T Consensus       202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~------  268 (349)
T 2w4o_A          202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY------  268 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC------
T ss_pred             Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC------
Confidence            4322  23345789999999999999999999999999999999999999975443211     1122222111      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       .........++..+.+|+.+||..||++|||+.+++++...
T Consensus       269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  309 (349)
T 2w4o_A          269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV  309 (349)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence             01111123355678999999999999999999999997543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3e-47  Score=365.28  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=215.9

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccccccee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~  144 (413)
                      ..+.+..++|++.+.||+|+||.||+|.+..      +..||||.+.... ......+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445667899999999999999999999752      4789999887553 33456789999999999999999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCCC--------------------CCCCCHHHHHHHHHHHHhhhchhhhccCCcee
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGP--------------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV  204 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv  204 (413)
                      ...+..++||||+++++|.+++......                    ...+++..++.++.||+.||+|||++   ||+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            9999999999999999999999763211                    14799999999999999999999999   999


Q ss_pred             eccCCCCcEEEcCCCCceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCC
Q 015076          205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIP  282 (413)
Q Consensus       205 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~P  282 (413)
                      ||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999986643221 11233567899999999999999999999999999999999 9999


Q ss_pred             CCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       283 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      |......+      ..... ......     .    ....++..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus       277 ~~~~~~~~------~~~~~-~~~~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          277 YYGMAHEE------VIYYV-RDGNIL-----A----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTSCHHH------HHHHH-HTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCChHH------HHHHH-hCCCcC-----C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            97543221      11122 211110     1    112345678999999999999999999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.7e-47  Score=362.45  Aligned_cols=258  Identities=23%  Similarity=0.319  Sum_probs=208.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++|++.+.||+|+||.||+|+++ +++.||||++....   ......+..|+.+++.+ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999976 57889999987542   23445678899999887 89999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999765    4799999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc--cHHHHHHHHhhcCCCCCc
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  310 (413)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .....+...+.....   
T Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            3222 1234567999999999999999999999999999999999999999753322111  111112222221111   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM------GHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~le  353 (413)
                         .++    ..++..+.+++.+||..||++||++      .++++|-.
T Consensus       237 ---~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          237 ---RIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             ---CCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence               111    2345678899999999999999995      78887743

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=370.05  Aligned_cols=264  Identities=26%  Similarity=0.420  Sum_probs=215.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      ++..++|.+.+.||+|+||.||+|.+.        .+..||||++..... .....+.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            456678999999999999999999853        235799999876533 3446788999999999 899999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      ...+..++||||+++++|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999976431            124699999999999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654322 12233457889999999999999999999999999999999 999997544221


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                            ... .+.....     .    .....++..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus       302 ------~~~-~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 ------LFK-LLKEGHR-----M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             ------HHH-HHHTTCC-----C----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHH-HHHcCCC-----C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                  111 1221111     1    1112345678999999999999999999999999988754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.7e-47  Score=359.29  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=215.1

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      +++..++|.+.+.||+|+||.||+|.+.      ++..||||.+.... ......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3456778999999999999999999862      34679999886543 3445678899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCC--------------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVG--------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~  206 (413)
                      .+..++||||+++++|.+++.....                    ....+++..++.++.||+.||+|||++   ||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999976432                    113489999999999999999999999   99999


Q ss_pred             cCCCCcEEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015076          207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD  284 (413)
Q Consensus       207 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~  284 (413)
                      ||||+|||++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998775443322 223457889999999999999999999999999999999 999997


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .......   ..    .+.....     .    .....++..+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus       255 ~~~~~~~---~~----~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          255 GIPPERL---FN----LLKTGHR-----M----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TCCGGGH---HH----HHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHH---HH----HhhcCCc-----C----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6554322   11    1111111     1    112234567899999999999999999999999998753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=375.81  Aligned_cols=266  Identities=21%  Similarity=0.246  Sum_probs=214.3

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceee
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~  145 (413)
                      .+++..+..++|++.+.||+|+||.||+|+.+ +++.||||++.+...   .....+..|+.++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34555667889999999999999999999975 688999999865321   22234778999999999999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      +...+|+||||++||+|.+++.+..   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            9999999999999999999997642   3699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                      ||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+...
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9999887655443344568999999999987       457899999999999999999999999765433221111100


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHhc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR---PKMGHVVHMLEA  354 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~eil~~le~  354 (413)
                      ....           .++ .....++.++.+||.+||. +|.+|   |++.+|++|-..
T Consensus       286 ~~~~-----------~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          286 KEHL-----------SLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HHHC-----------CCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             ccCc-----------CCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            0000           000 0112345678999999999 99998   699999998543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.8e-47  Score=364.39  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=208.8

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .+..++|++.+.||+|+||.||+|+++. ++.||||++....   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            3567899999999999999999999764 7789999986542   23445678899999988 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+||||++||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999999765    4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+....    
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~----  237 (353)
T 2i0e_A          169 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN----  237 (353)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC----
T ss_pred             cccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC----
Confidence            8643222 2244567999999999999999999999999999999999999999754322      2222222221    


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~l  352 (413)
                         ..++    ..++..+.+||.+||..||.+||+     +.+|++|.
T Consensus       238 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~  278 (353)
T 2i0e_A          238 ---VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  278 (353)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred             ---CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence               1111    234567899999999999999995     68888774

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-47  Score=379.58  Aligned_cols=262  Identities=26%  Similarity=0.436  Sum_probs=210.1

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .+++..++|++.+.||+|+||.||+|.++.+..||||.+.... .....+.+|+.+++.++||||+++++++.+ ...++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            4556678899999999999999999999888889999887544 345678999999999999999999999876 67899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            9999999999999975321  3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+      ..........     
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~-----  399 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR-----  399 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC-----
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC-----
Confidence            5433222333456889999999999999999999999999999999 999997554322      1112111110     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                       .    ..+..++..+.++|.+||+.||++|||+.+|++.|+....
T Consensus       400 -~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 -M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             0    1122355678999999999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-46  Score=352.89  Aligned_cols=266  Identities=21%  Similarity=0.282  Sum_probs=206.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++.+.||+|+||+||+|.+. +++.||||++....  ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999975 58889999987543  2344678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++ +|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9965 5655554432   5799999999999999999999999   9999999999999999999999999999877533


Q ss_pred             CcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc---C
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV---L  311 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  311 (413)
                      .. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......  ......+............   .
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence            22 233456899999999987766 899999999999999999988886433221  1222222222211111000   0


Q ss_pred             ---C---------CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 ---D---------PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ---~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         +         ..........++..+.+|+.+||+.||++|||+.+++++-..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence               0         000011122356678899999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.7e-46  Score=365.37  Aligned_cols=271  Identities=17%  Similarity=0.199  Sum_probs=208.8

Q ss_pred             hcCCCCcccEEeee--CceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEG--GYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|  +||.||+|.+. ++..||||++....  ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35679999999999  99999999976 68899999987543  344567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999976422  4699999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCc------ceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          232 LGSESS------YITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       232 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      ......      .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||............  +.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~  255 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVP  255 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcCCCC
Confidence            422111      11122468999999999987  67999999999999999999999999765443321110  000000


Q ss_pred             c----C------------------CCCCcC---------CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          304 N----R------------------NPEGVL---------DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       304 ~----~------------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .    .                  .....+         ...........++..+.+||.+||+.||++|||+.+++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            0    0                  000000         00000012233556789999999999999999999999885


Q ss_pred             hc
Q 015076          353 EA  354 (413)
Q Consensus       353 e~  354 (413)
                      ..
T Consensus       336 ~f  337 (389)
T 3gni_B          336 FF  337 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.3e-47  Score=364.42  Aligned_cols=249  Identities=23%  Similarity=0.279  Sum_probs=210.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+....   ......+.+|+.+++.++||||+++++++.+....|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3568999999999999999999975 68899999986532   2334678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus       119 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence            99999999999999765    4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      .....+....       
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-------  254 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-------  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCC-------
Confidence            543    23457999999999999999999999999999999999999999754322      2222222221       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~le  353 (413)
                      ..++    ..++..+.++|.+||+.||.+||+     +.+|+++..
T Consensus       255 ~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          255 VRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             CCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence            1111    224567899999999999999998     899998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-47  Score=383.79  Aligned_cols=262  Identities=23%  Similarity=0.396  Sum_probs=217.7

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .+++...+|++.+.||+|+||.||+|.++. +..||||.+.... .....+.+|+.+|++++||||+++++++......+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            345567789999999999999999999774 7889999886543 34677899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999999975421  4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .............++..|+|||++.+..++.++|||||||+||||++ |..||........   ...    +....    
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~----  436 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YEL----LEKDY----  436 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH----HHTTC----
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCC----
Confidence            75443332333456789999999999999999999999999999999 9999986553321   111    11111    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                           ....+..++..+.+||.+||+.||++|||+.+|++.|+...
T Consensus       437 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                 11112234567899999999999999999999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.5e-47  Score=359.04  Aligned_cols=266  Identities=21%  Similarity=0.377  Sum_probs=198.7

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC-CC---EEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ++.+..++|++.+.||+|+||.||+|.+.. +.   .||||.+...  .......+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344567789999999999999999999653 32   7999988654  34456788999999999999999999999987


Q ss_pred             CCee------EEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          147 GAHR------MLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       147 ~~~~------~iv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      ....      ++||||+++++|.+++....  .....+++..++.++.||+.||+|||++   ||+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            7655      99999999999999985432  1123689999999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~  296 (413)
                      +.+||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.........    
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~----  249 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----  249 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH----
Confidence            999999999998764433221 223456789999999999999999999999999999999 99999865543221    


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                        .........          .....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       250 --~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          250 --NYLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             --HHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              111111110          1122345678999999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.7e-47  Score=356.66  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=218.4

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .+++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            445677889999999999999999999764 7789999886543 44567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+||+++.++.+||+|||++..
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            99999999999999976422  5699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .............+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...+.    ...    
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~----~~~----  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE----KDY----  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH----TTC----
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----ccC----
Confidence            76554444445567889999999999999999999999999999999 9999976543322   11111    110    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .......++..+.+++.+||..||.+|||+.++++.|+..
T Consensus       230 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                 1111223456789999999999999999999999998865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=370.67  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=210.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4567999999999999999999953      35679999886543 3445578889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCC---CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---CceE
Q 015076          150 RMLVYEYVNNGNLEQWLHGDV---GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKV  223 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  223 (413)
                      .++||||+++|+|.+++....   .....+++..++.++.||+.||+|||++   ||+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999997532   1224689999999999999999999999   999999999999999555   4999


Q ss_pred             EecccceecCCCC-cceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 015076          224 SDFGLAKLLGSES-SYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       224 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.......      .....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~i  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence            9999997542211 112233567899999999999999999999999999999998 999997554221      12222


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ......          .....++..+.+|+.+||+.||++|||+.+|+++|+...
T Consensus       300 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          300 TSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            211110          112234556889999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.8e-47  Score=361.52  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE----cCCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCCcccccceeeeC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  147 (413)
                      +..++|++.+.||+|+||.||+|+.    .++..||+|++....    ......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            3457899999999999999999996    468899999986542    23345677899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      +..++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999999999765    4689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ..+..+....  
T Consensus       167 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~--  237 (327)
T 3a62_A          167 LCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCK--  237 (327)
T ss_dssp             CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC--
T ss_pred             cccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC--
Confidence            9976433221 234467999999999999999999999999999999999999999754422      1222222211  


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEA  354 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le~  354 (413)
                           ..++    ..++..+.+++.+||..||++||     ++.++++|...
T Consensus       238 -----~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          238 -----LNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             -----CCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             -----CCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence                 1111    12456788999999999999999     78899988544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.6e-47  Score=365.19  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+|+.+++.++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            568999999999999999999976 688999998865432 335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC--ceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~  234 (413)
                      +++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999765    4799999999999999999999999   9999999999999987765  99999999975432


Q ss_pred             CCcceeeccccccCccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..  ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  ...+........       
T Consensus       171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~-------  239 (361)
T 3uc3_A          171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY-------  239 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC-------
T ss_pred             cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC-------
Confidence            22  1234569999999999988887665 89999999999999999999865543322  222222222111       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .+  .....++..+.+||.+||..||++|||+.++++|...
T Consensus       240 ~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          240 SI--PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             CC--CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred             CC--CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence            11  1111245678899999999999999999999998654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.1e-46  Score=349.44  Aligned_cols=253  Identities=28%  Similarity=0.524  Sum_probs=205.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchh-------HHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA-------EREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.......       ...+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3578999999999999999999964 68899999886543221       157889999999999999999999987765


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEcCCCC-----c
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWN-----P  221 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~  221 (413)
                        ++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +  |+||||||+|||++.++.     +
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence              79999999999999886543   5799999999999999999999999   8  999999999999988776     9


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCcccc--ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ||+|||+++.....    .....||+.|+|||++  ....++.++|||||||++|+|++|+.||........    ....
T Consensus       169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~  240 (287)
T 4f0f_A          169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFIN  240 (287)
T ss_dssp             EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHH
T ss_pred             EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHH
Confidence            99999999854332    3446789999999998  445688999999999999999999999976543322    1112


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .......     .+    .....++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       241 ~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 MIREEGL-----RP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHSCC-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHhccCC-----CC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            2221111     11    1122345678999999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-46  Score=359.15  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+. ++.    +||+|.+.... ......+.+|+.+++.++||||+++++++..+. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            3567999999999999999999964 344    35888775432 345577899999999999999999999998765 7


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+.+|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            89999999999999997653   5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.........       ..+..... 
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~-  237 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER-  237 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC-
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCC-
Confidence            77543322 2233456889999999999999999999999999999999 99999865443221       11111110 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                              ......++..+.+++.+||+.||++|||+.+++++|+...
T Consensus       238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                    0111224557889999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=374.49  Aligned_cols=254  Identities=29%  Similarity=0.419  Sum_probs=209.9

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC-eeEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLV  153 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~iv  153 (413)
                      ++..++|++.+.||+|+||.||+|.+. +..||||.+....  ....+.+|+.++++++||||+++++++.... ..++|
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            456678999999999999999999986 7799999986543  4567889999999999999999999987654 78999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999999976421  3479999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..    .....++..|+|||++.+..++.++|||||||+||||++ |..||......+...      . +.....     
T Consensus       341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------~-i~~~~~-----  404 (450)
T 1k9a_A          341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------R-VEKGYK-----  404 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH------H-HHTTCC-----
T ss_pred             cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------H-HHcCCC-----
Confidence            32    122356889999999999999999999999999999998 999998665433221      1 111110     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .    ..+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       405 ~----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          405 M----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1    112235567899999999999999999999999998764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=364.53  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=203.8

Q ss_pred             cccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      ..+.||+|+||.||+|... ++..||+|++..........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999965 688999999987766677789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE--cCCCCceEEecccceecCCCCcce
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI--DKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      |.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            999886543   4689999999999999999999999   99999999999999  5667899999999998754432  


Q ss_pred             eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCC
Q 015076          240 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP  319 (413)
Q Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (413)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+      .+..+.....       .++...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~-------~~~~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW-------DLEDEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------CSCSGG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC-------CCChhh
Confidence            233468999999999999999999999999999999999999997654321      2222222211       111111


Q ss_pred             cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       320 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ...++..+.+||.+||..||.+|||+.+++++..
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            2335667899999999999999999999999754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-46  Score=372.70  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=210.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|.+.+.||+|+||.||+|.+. ++..||||++....   ......+.+|+.+++.++||||+++++++......++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4578999999999999999999976 78999999986542   1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus        94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999765    5799999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .....  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......      ....+.... .    
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~-~----  233 (476)
T 2y94_A          167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDGI-F----  233 (476)
T ss_dssp             CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHTTC-C----
T ss_pred             ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCC-c----
Confidence            54322  344579999999999988775 689999999999999999999997554322      122222111 0    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ..    +..++..+.+|+.+||..||++|||+.+|+++..
T Consensus       234 --~~----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          234 --YT----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             --CC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             --CC----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence              11    1123456889999999999999999999998743

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-47  Score=362.50  Aligned_cols=266  Identities=27%  Similarity=0.420  Sum_probs=213.2

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +++..++|++.+.||+|+||.||+|.+.      .+..||||.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4566788999999999999999999962      35579999986543 23446788999999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCC-------------------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeec
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGP-------------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~  206 (413)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.||+.||+|||++   ||+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            999999999999999999999765321                   12489999999999999999999999   99999


Q ss_pred             cCCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015076          207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD  284 (413)
Q Consensus       207 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~  284 (413)
                      ||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876443322 2334567889999999999999999999999999999998 999997


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .......      +...+.....     .    .....++..+.+++.+||..||.+|||+.+|+++|+....
T Consensus       277 ~~~~~~~------~~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDAN------FYKLIQNGFK-----M----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSHH------HHHHHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHHH------HHHHHhcCCC-----C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            6543321      1112221111     1    1112245678999999999999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-46  Score=358.08  Aligned_cols=259  Identities=17%  Similarity=0.199  Sum_probs=211.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+ .+++.||||.+.....  ...+..|+.+++.+ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46899999999999999999996 4688899998865432  23577899999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC-----ceEEecccce
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-----PKVSDFGLAK  230 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~a~  230 (413)
                      |+ +++|.+++....   ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 999999997642   5799999999999999999999999   9999999999999998887     9999999998


Q ss_pred             ecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          231 LLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       231 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      ........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76443221      123567999999999999999999999999999999999999999876544433333322221111


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ... ..+        ...++ .+.+++..||..||.+||++.+|++.|+..
T Consensus       239 ~~~-~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 TPI-EVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             SCH-HHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCH-HHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            000 000        01123 789999999999999999999999998765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.7e-46  Score=349.83  Aligned_cols=263  Identities=17%  Similarity=0.220  Sum_probs=214.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +..++|++.+.||+|+||.||+|.+ .+++.||||.+....  ....+.+|+.+++.+ +|+|++++++++......++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3457899999999999999999996 468889999886443  234577899999999 799999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC-----ceEEeccc
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-----PKVSDFGL  228 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~  228 (413)
                      |||+ +++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.     +||+|||+
T Consensus        85 ~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999 999999997653   4699999999999999999999999   9999999999999987776     99999999


Q ss_pred             ceecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          229 AKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       229 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      +.........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9877543221      1244579999999999999999999999999999999999999998765444333333222221


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ........         ...++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       238 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          238 QSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            11110000         1124567899999999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.3e-46  Score=357.10  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=186.8

Q ss_pred             ccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEEEeccCCC
Q 015076           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .+.||+|+||.||+|.+. +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 6889999998543   3456778999999997 9999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---CceEEecccceecCCCCcc
Q 015076          162 LEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKVSDFGLAKLLGSESSY  238 (413)
Q Consensus       162 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~  238 (413)
                      |.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++   .+||+|||++........ 
T Consensus        93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            99999876    5799999999999999999999999   999999999999998765   799999999987654332 


Q ss_pred             eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          239 ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV-NLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .....+..+ .....      .++.
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~------~~~~  237 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDF------SFEG  237 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCC------CCCS
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCC------CCCc
Confidence            233456899999999999999999999999999999999999999865432211 122222222 21111      1111


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....++..+.+|+.+||..||++|||+.+++++....
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            12234567899999999999999999999999875543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.6e-46  Score=355.46  Aligned_cols=268  Identities=22%  Similarity=0.371  Sum_probs=194.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999965 688999999865432 234667889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          156 YVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |++ ++|.+++....  .....+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999885431  1124689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC---C
Q 015076          234 SESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE---G  309 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~  309 (413)
                      ..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.   ...+..........   .
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence            33221 234568999999999876 4689999999999999999999999986543322   22222221111000   0


Q ss_pred             -----cCCCCC----CCC--------CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          310 -----VLDPKL----PEK--------PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       310 -----~~~~~~----~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           ...+.+    +..        ....++..+.+++.+||+.||++|||+.+++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence                 000000    000        01123567899999999999999999999998744

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-47  Score=367.25  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=210.1

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE----cCCCEEEEEEeecCC----chhHHHHHHHHHHHhcC-CCCCcccccceeee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNLLNNR----GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE  146 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~  146 (413)
                      +..++|++.+.||+|+||.||+|+.    .+++.||||++....    ......+..|+.+++.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            3457899999999999999999997    368899999885432    22334566789999999 69999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ....++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeC
Confidence            99999999999999999999765    4799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      |+++.............+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.........  ..........
T Consensus       204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~  281 (355)
T 1vzo_A          204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS  281 (355)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC
T ss_pred             CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc
Confidence            9998765443333445679999999999976  34789999999999999999999999765433222  1222222221


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le~~  355 (413)
                      .       +.+    ...++..+.+||.+||..||++||     |+.+++++....
T Consensus       282 ~-------~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          282 E-------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             C-------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             C-------CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            1       111    122455688999999999999999     999999987544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.6e-46  Score=347.88  Aligned_cols=257  Identities=21%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-C-------CEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-N-------SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      ..++|++.+.||+|+||.||+|.+.. +       ..||+|.+..........+.+|+.+++.++||||+++++++..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            45689999999999999999998553 3       469999987766677788999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC--------
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--------  220 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------  220 (413)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            9999999999999999997653   3499999999999999999999999   9999999999999998887        


Q ss_pred             ceEEecccceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          221 PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       221 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      +||+|||++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.......     ....
T Consensus       160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~~~  229 (289)
T 4fvq_A          160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RKLQ  229 (289)
T ss_dssp             EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHH
T ss_pred             eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HHHH
Confidence            999999998754321     23457899999999987 779999999999999999999554443222111     1111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCCC
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKE  361 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~~  361 (413)
                      ......        .++..    .+..+.+++.+||+.||++|||+.+++++|+.+..+...
T Consensus       230 ~~~~~~--------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          230 FYEDRH--------QLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             HHHTTC--------CCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             HhhccC--------CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            111111        11111    123478899999999999999999999999988665443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.1e-46  Score=354.60  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=210.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+......      ....+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456999999999999999999976 6889999998654321      357789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEec
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  226 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999765    5799999999999999999999999   999999999999999887    7999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+      .+....... 
T Consensus       164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~-  234 (321)
T 2a2a_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVS-  234 (321)
T ss_dssp             TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-
T ss_pred             ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc-
Confidence            99987754322  234568999999999999999999999999999999999999997543221      111211110 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                            ..++......++..+.+++.+||..||++|||+.+++++..
T Consensus       235 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          235 ------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             ------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             ------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence                  01111111224567899999999999999999999998744

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-46  Score=345.61  Aligned_cols=254  Identities=20%  Similarity=0.335  Sum_probs=208.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC--CeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~  151 (413)
                      +..++|++.+.||+|+||.||+|.++ +..||||.+....  ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            34578999999999999999999986 8889999987653  34456789999999999999999999999877  7889


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEcCCCCceEEecccc
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +||||+++++|.+++.....  ..+++..++.++.||+.||+|||+.   +  |+||||||+|||++.++.++|+|||++
T Consensus        86 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence            99999999999999987532  3689999999999999999999998   8  999999999999999999999999987


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .....      ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.......      ..........
T Consensus       161 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~  228 (271)
T 3kmu_A          161 FSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGL  228 (271)
T ss_dssp             CTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCC
T ss_pred             eeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCC
Confidence            64322      2346899999999998765544   7999999999999999999997543221      1222222211


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .     +.+    ...++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       229 ~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          229 R-----PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1     111    2234567899999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-46  Score=355.58  Aligned_cols=265  Identities=26%  Similarity=0.412  Sum_probs=215.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEE------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +++..++|++.+.||+|+||.||+|.+      .++..||||.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            455677899999999999999999985      2456799999875543 3456788999999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCC--------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVG--------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      .++..++||||+++++|.+++.....              ....+++..++.++.||+.||+|||++   ||+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            99999999999999999999976431              113589999999999999999999999   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999877544332 2233457889999999999999999999999999999999 99999765433


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ...  .    ........     .    .....++..+.+++.+||..||.+|||+.+++++|+...
T Consensus       255 ~~~--~----~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 SKF--Y----KMIKEGFR-----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHH--H----HHHHHTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHH--H----HHhccCCC-----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            211  1    11111110     1    111234567899999999999999999999999998753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.9e-46  Score=345.75  Aligned_cols=253  Identities=21%  Similarity=0.274  Sum_probs=209.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456999999999999999999976 4678999999876666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccceecC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  233 (413)
                      +++++|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||+   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999988765    4699999999999999999999999   99999999999999   788899999999998775


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ....  .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.......      ..........       
T Consensus       161 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~-------  224 (277)
T 3f3z_A          161 PGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGTF-------  224 (277)
T ss_dssp             TTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------
T ss_pred             Cccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC-------
Confidence            4332  3345689999999998654 8999999999999999999999997543221      1112211110       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+......++..+.+++.+||+.||++|||+.+++++..
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            1111111134567899999999999999999999998744

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-46  Score=349.59  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      +..++|++.+.||+|+||.||+|.+..    +..||+|.+.... ......+.+|+.+++.++||||+++++++.++ ..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            345789999999999999999998543    2359999887653 34556788999999999999999999998754 56


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            89999999999999997643   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ..............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||........   ...+..   ...   
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~---~~~---  232 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEK---GDR---  232 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHH---TCC---
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhc---CCC---
Confidence            765443333344557889999999998999999999999999999998 9999975543322   211111   110   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         ..    ....++..+.+++.+||..||++|||+.+++++|+.+
T Consensus       233 ---~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 ---LP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ---CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence               00    1112446688999999999999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-45  Score=352.39  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=202.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC-------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA-------  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-------  148 (413)
                      .++|++.+.||+|+||.||+|.++ ++..||||++.... ......+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356999999999999999999976 78899999987543 345678899999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEEeccCCChhhhccCCCCCCCCCCH
Q 015076          149 --------------------------------------------------HRMLVYEYVNNGNLEQWLHGDVGPCSPLTW  178 (413)
Q Consensus       149 --------------------------------------------------~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~  178 (413)
                                                                        ..++|||||++++|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              37999999999999999986532 234677


Q ss_pred             HHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc-----------ceeecccccc
Q 015076          179 EIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS-----------YITTRVMGTF  247 (413)
Q Consensus       179 ~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~gt~  247 (413)
                      ..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++........           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78999999999999999999   999999999999999999999999999988754421           1123356999


Q ss_pred             CccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHH
Q 015076          248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRI  327 (413)
Q Consensus       248 ~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  327 (413)
                      .|+|||++.+..++.++|||||||++|+|++|..|+.        .......... ..        .+ ..........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~-~~--------~~-~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVR-NL--------KF-PLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHH-TT--------CC-CHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhh-cc--------CC-CcccccCChhH
Confidence            9999999999999999999999999999999876642        1111111111 11        11 11234456678


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          328 LLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       328 ~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .+++.+||+.||++|||+.+++++.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhch
Confidence            9999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-46  Score=358.47  Aligned_cols=256  Identities=22%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||.||+|.++ ++..||||.+......    ..+|++++.++ +||||+++++++.++...|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3467999999999999999999976 5788999998765433    23577777777 7999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC----CCceEEecccce
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAK  230 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~  230 (413)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||+.+.    +.+||+|||++.
T Consensus        96 E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999765    5799999999999999999999999   99999999999998543    349999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||............   ..+.... .   
T Consensus       169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~~-~---  240 (342)
T 2qr7_A          169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSGK-F---  240 (342)
T ss_dssp             ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHCC-C---
T ss_pred             cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccCC-c---
Confidence            7654332 234467899999999998888999999999999999999999999754332222222   2222211 1   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .++......++..+.+|+.+||..||++|||+.+++++...
T Consensus       241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence               11112223456778999999999999999999999988554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9e-47  Score=375.29  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=201.8

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +..++|++.+.||+|+||.||+|.+. ++..||||++...   .......+..|+.+++.++||||+++++++...+..+
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            45678999999999999999999965 6889999998653   2233456778999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +||||+++++|.+++...    ..+++..++.++.||+.||+|||+ .   ||+||||||+|||++.++.+||+|||+++
T Consensus       225 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999999765    479999999999999999999998 7   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ....+....     
T Consensus       298 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-----  365 (446)
T 4ejn_A          298 EGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE-----  365 (446)
T ss_dssp             TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-----
T ss_pred             eccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-----
Confidence            6433222 2344679999999999999999999999999999999999999997544221      122222211     


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLEA  354 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le~  354 (413)
                        ..++    ..++..+.+||.+||+.||.+||     ++.++++|...
T Consensus       366 --~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          366 --IRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             --CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             --CCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence              1111    12456788999999999999999     99999987543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=355.11  Aligned_cols=268  Identities=24%  Similarity=0.331  Sum_probs=210.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee----eCCee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA----EGAHR  150 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~  150 (413)
                      +..++|++.+.||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++.    .....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3456899999999999999999996 578899999987776667788999999999999999999999986    34578


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++.........+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976322236799999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCcc--------eeeccccccCccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          231 LLGSESSY--------ITTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       231 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ........        ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........ ....   
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---  258 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL---  258 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH---
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH---
Confidence            65321110        011235799999999987654   78999999999999999999999953211110 1111   


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCCC
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSK  360 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~~  360 (413)
                       .....         ........++..+.+++.+||+.||.+|||+.+++++|+.+..+..
T Consensus       259 -~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          259 -AVQNQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             -HHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             -Hhhcc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence             11110         0001112345678999999999999999999999999998765433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.7e-46  Score=354.64  Aligned_cols=262  Identities=20%  Similarity=0.297  Sum_probs=209.2

Q ss_pred             HHHhcCCCCcc-cEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCC-CCCcccccceeeeCC
Q 015076           74 LEVSTNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGA  148 (413)
Q Consensus        74 ~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~  148 (413)
                      .+...++|.+. +.||+|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.+. ||||+++++++....
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34456678887 89999999999999966 58899999886542  334677889999999994 699999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEe
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSD  225 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  225 (413)
                      ..++||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             eEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999865422  5799999999999999999999999   9999999999999987   78999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........      ........
T Consensus       178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~  249 (327)
T 3lm5_A          178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLNISQVN  249 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC
T ss_pred             CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHHHHhcc
Confidence            999987754322  2345789999999999999999999999999999999999999975443221      11111111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                             ...+......++..+.+++.+||+.||++|||+.+++++....
T Consensus       250 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          250 -------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             -------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             -------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence                   1111122233556788999999999999999999999886543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-46  Score=349.51  Aligned_cols=262  Identities=29%  Similarity=0.495  Sum_probs=199.6

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ++..++|++.+.||+|+||.||+|.+.  ..||+|.+....  ......+.+|+.+++.++||||++++++. .....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            455678999999999999999999864  359999886543  34456789999999999999999999965 4556899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            999999999999996543   5799999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC-cceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          233 GSES-SYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       233 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .... ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||........  ..    .........
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~  244 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGRGSLS  244 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHHTSCC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhcccccC
Confidence            4321 12223456899999999986   66788999999999999999999999975543221  11    111111111


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                          +.+ ......++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       245 ----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 ----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                110 1112335577999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=351.45  Aligned_cols=266  Identities=24%  Similarity=0.341  Sum_probs=205.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++.....  .....+.+|+.+++.++||||+++++++......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999976 588999998865543  23466788999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999999988765    4699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc---------
Q 015076          235 ESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN---------  304 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------  304 (413)
                      .... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+   ......         
T Consensus       155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          155 PSDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI---RKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHHHH
T ss_pred             cccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhccccccccccc
Confidence            3322 334568999999999876 66899999999999999999999999765543322211   111110         


Q ss_pred             --C-CCCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          305 --R-NPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       305 --~-~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        . .......+......     ...++..+.+++.+||+.||++|||+.+++++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  288 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF  288 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence              0 00000000000000     12345678899999999999999999999988543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-46  Score=355.09  Aligned_cols=265  Identities=22%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|... ++..||||++...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3457999999999999999999964 6889999998653   23445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++.........+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999865322225799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||......    .......... ...     
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~-----  255 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-CDY-----  255 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-TCS-----
T ss_pred             cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-ccC-----
Confidence            44322 123356899999999999999999999999999999999999999754322    1122222211 111     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                         +......++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence               1111223456789999999999999999999999999887543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-45  Score=344.37  Aligned_cols=255  Identities=18%  Similarity=0.292  Sum_probs=210.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++....  ......+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999965 58899999986543  334467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~  231 (413)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999988765    4799999999999999999999999   9999999999999987655   99999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ..........     
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~-----  224 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAY-----  224 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-----
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHHhccc-----
Confidence            654332  234578999999999999999999999999999999999999997543221      1111111111     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        ..+......++..+.+++.+||+.||++|||+.+++++..-
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence              11111122345678999999999999999999999997543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.9e-47  Score=357.95  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=197.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCC----e
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----H  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~  149 (413)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++.....   .....+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 4688899999876432   33457889999999999999999999987654    3


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            49999999999999999765    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence            876443221  2234568999999999999999999999999999999999999997544321      11122221110


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                             .+......++..+.+++.+||+.||++||++.+++.+
T Consensus       238 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          238 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             -------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                   0001112245678999999999999999977776654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-46  Score=349.00  Aligned_cols=252  Identities=27%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4578999999999999999999966 56789999886532   2234578889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999765    4699999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ....   .....||+.|+|||++.+..++.++||||||+++|+|++|..||........      ........       
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-------  223 (279)
T 3fdn_A          160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVE-------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-------
T ss_pred             Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHHHhCC-------
Confidence            3322   2345689999999999999999999999999999999999999975432211      11111111       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..++    ..++..+.+++.+||+.||++|||+.+++++..-.
T Consensus       224 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          224 FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             CCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             CCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence            1111    12445688999999999999999999999986544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=345.91  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=188.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+ .++..||||.+....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999996 468899999886432   12246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999997653   4799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........      ....       .+.
T Consensus       164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-------~~~  229 (278)
T 3cok_A          164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVL-------ADY  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-------SCC
T ss_pred             CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhh-------ccc
Confidence            33221 233568999999999999999999999999999999999999997654332111      0000       011


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..    +..++..+.+++.+||+.||++|||+.+++++..
T Consensus       230 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          230 EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence            11    1234567889999999999999999999998644

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-46  Score=357.64  Aligned_cols=264  Identities=26%  Similarity=0.433  Sum_probs=213.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccce
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~  143 (413)
                      +.+..++|++.+.||+|+||.||+|.+.        ++..||||.+.... ......+.+|+.+++.+ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3456788999999999999999999863        46689999886553 33456788999999999 89999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      +...+..++||||+++++|.+++.....            ....+++..++.++.||+.||+|||++   ||+||||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence            9999999999999999999999976532            113489999999999999999999999   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            9999999999999999998775443221 223456889999999988899999999999999999999 99999754322


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      +      ........ ..     ..    ....++..+.+++.+||..||.+|||+.++++.|+.+.
T Consensus       267 ~------~~~~~~~~-~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          267 E------LFKLLKEG-HR-----MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             H------HHHHHHHT-CC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H------HHHHHhcC-CC-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1      11111111 10     11    11234567899999999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3e-46  Score=356.39  Aligned_cols=268  Identities=24%  Similarity=0.351  Sum_probs=214.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee--eCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~  149 (413)
                      ..++|++.+.||+|+||.||+|.+     .++..||||++..........+.+|+.+++.++||||+++++++.  +...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            356799999999999999999984     357789999998777667778999999999999999999999886  4567


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            899999999999999997643   3699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc--------ccccHHHHHH
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVNLIEWLK  299 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~--------~~~~~~~~~~  299 (413)
                      .........  ......||..|+|||++.+..++.++|||||||++|+|++|..||......        ........+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            987544332  123345788899999999999999999999999999999999998632211        0001111111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCCC
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPS  359 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~~  359 (413)
                      .......         .......++..+.+++.+||+.||++|||+.+++++|+......
T Consensus       255 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHhhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2222111         11122335567899999999999999999999999999875433

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-46  Score=357.99  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=203.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+. ++.    +||+|.+.... ......+.+|+.+++.++||||+++++++. ....
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            3568999999999999999999965 344    37888764432 223345677999999999999999999986 4568


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence            99999999999999997653   4688999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........ ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...........       +..... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~-  235 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------LEKGER-  235 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------HHTTCB-
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------HHcCCC-
Confidence            77543322 2334567889999999999999999999999999999999 9999986554332111       111110 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                          ...    ...++..+.+++.+||..||++|||+.+++++|+...
T Consensus       236 ----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          236 ----LAQ----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ----CCC----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ----CCC----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                000    1112335778999999999999999999999998764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.4e-47  Score=383.83  Aligned_cols=262  Identities=26%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .+++..++|++.+.||+|+||.||+|.++.+..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            4456677899999999999999999999888889999987554 345678999999999999999999999876 67899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       339 v~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            9999999999999975321  3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ............++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+      .+..+. ....    
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~-~~~~----  482 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVE-RGYR----  482 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHH-TTCC----
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-cCCC----
Confidence            4322222233456789999999999999999999999999999999 999997554321      112211 1110    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                       .    .....++..+.+||.+||+.||++|||+.+|++.|+....
T Consensus       483 -~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 -M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence             0    1112345678999999999999999999999999998743

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=358.95  Aligned_cols=257  Identities=22%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCC--CCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~  151 (413)
                      +..++|++.+.||+|+||.||+|.+.++..||||++....  ......+.+|+.+++.++|  |||+++++++......+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3456799999999999999999998889999999987543  3344678899999999976  99999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +|||+ .+++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+++.
T Consensus        86 lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99995 588999999875    5799999999999999999999999   999999999999997 56899999999987


Q ss_pred             cCCCCcc-eeeccccccCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          232 LGSESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       232 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ....... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....     ....+.
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~  231 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH  231 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH
Confidence            6543322 2334679999999999865           6789999999999999999999999974322     222222


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ........     ..++..    ....+.+|+.+||+.||.+|||+.+++++....
T Consensus       232 ~~~~~~~~-----~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          232 AIIDPNHE-----IEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HHHCTTSC-----CCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHhcCCcc-----cCCccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            22221111     111111    235688999999999999999999999986654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-46  Score=359.35  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=209.4

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----CCCccccccee
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----HKNLVRLLGYC  144 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~~~~~  144 (413)
                      +++..+..++|++.+.||+|+||.||+|.+. ++..||||++... ......+..|+.+++.+.     ||||+++++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            3445566789999999999999999999974 6888999988543 344556777999999886     99999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-------
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-------  217 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------  217 (413)
                      ...+..++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.       
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence            9999999999999 9999999976532  4699999999999999999999999   9999999999999975       


Q ss_pred             ------------------CCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhC
Q 015076          218 ------------------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG  279 (413)
Q Consensus       218 ------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg  279 (413)
                                        ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence                              788999999999875432    2345789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccHHHHHHHHhhcCC-----------CCCcC-----CCCCCCCCc-H---------------HHHHHH
Q 015076          280 RIPVDYSRPPEEVNLIEWLKKMVTNRN-----------PEGVL-----DPKLPEKPT-S---------------RLLKRI  327 (413)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-----~~~~~~~~~-~---------------~~~~~l  327 (413)
                      +.||......+....   +........           ....+     ....+.... .               .....+
T Consensus       256 ~~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          256 SLLFRTHEHMEHLAM---MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SCSCCCSSHHHHHHH---HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCCCcHHHHHHH---HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999976543222211   111111000           00000     000010000 0               011567


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          328 LLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       328 ~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .+|+.+||+.||++|||+.+++++-
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~hp  357 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLKHK  357 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcCc
Confidence            7999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=345.26  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=210.2

Q ss_pred             hcCCCCccc-EEeeeCceEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|.+.+ .||+|+||.||+|.+.   ++..||||.+.... ......+.+|+.+++.++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            356677776 9999999999999853   57789999987653 34556788999999999999999999999 456689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            9999999999999997543   5699999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .........  ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+.   .   .. +..... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~---~~-i~~~~~-  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M---AF-IEQGKR-  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H---HH-HHTTCC-
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H---HH-HhcCCc-
Confidence            754433222  22356889999999988899999999999999999998 9999976543221   1   11 111111 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                          ..    ....++..+.+++.+||..||++||++.+++++|+...
T Consensus       232 ----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          232 ----ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11    11234567899999999999999999999999998763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=352.30  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=203.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+. ++.    +||+|.+... .......+.+|+.+++.++||||+++++++.... .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            3578999999999999999999965 344    3577776543 3445678899999999999999999999998765 7


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||+|+.+++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            89999999999999997653   4799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........       .+..... 
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~~-  237 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER-  237 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC-
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCC-
Confidence            76433221 1233456889999999999999999999999999999999 999997655433211       1111110 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                              ......++..+.+++.+||..||.+|||+.++++.|+....
T Consensus       238 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 --------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                    01122245568899999999999999999999999988643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.9e-46  Score=348.73  Aligned_cols=263  Identities=22%  Similarity=0.381  Sum_probs=208.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeC--Ce
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG--AH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~  149 (413)
                      ...|++.+.||+|+||.||+|.+     .++..||+|++.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45699999999999999999984     357889999986543 33456788999999999999999999999876  67


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            899999999999999996543   4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC--------CcccccHHHHHH
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR--------PPEEVNLIEWLK  299 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~--------~~~~~~~~~~~~  299 (413)
                      .........  ......||..|+|||++.+..++.++|||||||++|+|++|..|+....        +.........+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            887654332  2234567888999999999999999999999999999999999864221        011111111122


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ........         ......++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus       254 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          254 NTLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            22221111         111223456789999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-46  Score=350.77  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=201.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....   .....+.+|+.+++.++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999975 678899998865432   234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999999765    4799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|+.||......       .+...+......    
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----  253 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----
Confidence            544333334457899999999999999999999999999999999999999754321       112222221110    


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcccC
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQES  357 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~le~~~~  357 (413)
                         +......++..+.+++.+||..||++|| ++.++++.|+....
T Consensus       254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence               0011123445688999999999999999 99999999987643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=352.01  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc-----hhHHHHHHHHHHHhcC---CCCCcccccceeee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG-----QAEREFKVEVEAIGRV---RHKNLVRLLGYCAE  146 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~  146 (413)
                      +..++|++.+.||+|+||+||+|.+ .+++.||||++.....     .....+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567899999999999999999996 4688999998864321     1223555677777666   49999999999977


Q ss_pred             CC-----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCc
Q 015076          147 GA-----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       147 ~~-----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                      ..     ..++||||+. ++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            54     5799999996 699999976532  3499999999999999999999999   99999999999999999999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      ||+|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...+...
T Consensus       160 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~  234 (308)
T 3g33_A          160 KLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDL  234 (308)
T ss_dssp             EECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHH
T ss_pred             EEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence            9999999986643322  3446789999999999999999999999999999999999999976543222   2222222


Q ss_pred             hhcCCCCCc----------CCCCCCC---CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          302 VTNRNPEGV----------LDPKLPE---KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       302 ~~~~~~~~~----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .........          +....+.   .....++..+.+|+.+||+.||++|||+.+++++-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            211111000          0000000   001134567899999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-46  Score=354.83  Aligned_cols=269  Identities=21%  Similarity=0.407  Sum_probs=216.3

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      ...++++..++|++.+.||+|+||.||+|.+.      .+..||||.+..... .....+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33455677889999999999999999999854      367799998865433 34457889999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID  216 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~  216 (413)
                      ++.+....++||||+++++|.+++....      .....+++..++.++.||+.||+|||++   ||+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            9999999999999999999999986421      1114679999999999999999999999   999999999999999


Q ss_pred             CCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccH
Q 015076          217 KHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNL  294 (413)
Q Consensus       217 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~  294 (413)
                      .++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......     
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  247 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----  247 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence            9999999999999865432221 1223456889999999999999999999999999999999 89999754322     


Q ss_pred             HHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                       .......... ..         .....++..+.+++.+||+.||++|||+.+++++|+....
T Consensus       248 -~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 -QVLRFVMEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHHHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             1112222111 10         1112345678899999999999999999999999998644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3e-45  Score=340.50  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=209.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457999999999999999999976 68899999986543 3445778899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++...    ..+++..++.++.|++.||+|||++   ||+|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999999765    4799999999999999999999999   9999999999999999999999999999865432


Q ss_pred             Cc-ceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          236 SS-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       236 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .    ........       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~~-------  226 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y----SDWKEKKT-------  226 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H----HHHHTTCT-------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H----HHhhhccc-------
Confidence            21 12234568999999999987765 77999999999999999999999765432211 1    11111110       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        .......++..+.+++.+||..||++|||+.+++++..
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence              01122345667889999999999999999999998744

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=352.97  Aligned_cols=259  Identities=29%  Similarity=0.459  Sum_probs=204.8

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcC-----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLED-----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      +..++|.+.+.||+|+||.||+|.+..     +..||||.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345679999999999999999998653     2359999987553 3345578899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             cEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence            999999999999999997643   4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          230 KLLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       230 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+      ....+.....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~  268 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFR  268 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHCCCc
Confidence            876543221  1222346788999999999999999999999999999999 999997543221      1122211111


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                            .    .....++..+.+++.+||+.||++||++.+++++|+...
T Consensus       269 ------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          269 ------L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             ------C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  0    111234567899999999999999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.6e-46  Score=351.23  Aligned_cols=263  Identities=21%  Similarity=0.281  Sum_probs=204.2

Q ss_pred             CCCCcc-cEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      +.|++. +.||+|+||.||+|.+. ++..||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            568874 78999999999999954 6889999999776666677888999999885 79999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEecccceec
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDFGLAKLL  232 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~  232 (413)
                      |+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999765    4799999999999999999999999   9999999999999988776   999999998765


Q ss_pred             CCCCc------ceeeccccccCccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH-------
Q 015076          233 GSESS------YITTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL-------  294 (413)
Q Consensus       233 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~-------  294 (413)
                      .....      ......+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+....       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211      11223468999999999875     5688999999999999999999999986543321100       


Q ss_pred             -HHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          295 -IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       295 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       ...+...+.....      .++......++..+.+|+.+||..||++|||+.+++++..-
T Consensus       245 ~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence             0111111111110      11111112245678999999999999999999999998553

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=349.40  Aligned_cols=257  Identities=29%  Similarity=0.477  Sum_probs=200.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ..++|++.+.||+|+||.||+|.+. +..||||.+...  .....+.+|+.++++++||||+++++++.+  ..++||||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            3567999999999999999999986 788999988533  445678899999999999999999998874  47999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC-ceEEecccceecCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN-PKVSDFGLAKLLGSE  235 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~~  235 (413)
                      +++++|.+++.... ....+++..++.++.|+++||+|||+....||+||||||+|||++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            99999999997652 1135789999999999999999999921129999999999999998887 799999999765432


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ......... ...     +  
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~-----~--  223 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTR-----P--  223 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCC-----C--
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCC-----C--
Confidence                223458999999999999999999999999999999999999997543321    111111111 111     1  


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                        .....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       224 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             --CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             --CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              1112345678899999999999999999999999988654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=353.41  Aligned_cols=249  Identities=24%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++.....  ........|+..+..+ +||||+++++++.++...++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3467999999999999999999976 688999998765432  2333444555555444 89999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+ +++|.+++....   ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999 779998886643   4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|||++|..||....      .   .... ...       
T Consensus       208 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~---~~~~-~~~-------  267 (311)
T 3p1a_A          208 GTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G---WQQL-RQG-------  267 (311)
T ss_dssp             C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H---HHHH-TTT-------
T ss_pred             ccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H---HHHH-hcc-------
Confidence            54322  334568999999999876 79999999999999999999976664221      0   1111 111       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                       ..+......++..+.+++.+||+.||++|||+.+++++..
T Consensus       268 -~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          268 -YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             -CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence             1111112234567899999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=355.83  Aligned_cols=266  Identities=22%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchh-HHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQA-EREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||.||+|.+. ++..||||++....... ...+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            67999999999999999999976 68899999886443221 12345699999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      ++ ++|.+++....   ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            96 58998887653   4699999999999999999999999   99999999999999999999999999998664332


Q ss_pred             cceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC---cCC
Q 015076          237 SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG---VLD  312 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  312 (413)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.   ...+...........   ...
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhc
Confidence            2 2233568999999999876 5689999999999999999999999986543322   222222222111100   000


Q ss_pred             ---------CCCCCC----CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 ---------PKLPEK----PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ---------~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                               +.....    ....++..+.+|+.+||+.||++|||+.+++++....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence                     000000    0112456788999999999999999999999986543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=355.37  Aligned_cols=267  Identities=18%  Similarity=0.267  Sum_probs=202.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCCchh-----------HHHHHHHHHHHhcCCCCCccccc
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNRGQA-----------EREFKVEVEAIGRVRHKNLVRLL  141 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpniv~~~  141 (413)
                      ..++|++.+.||+|+||.||+|.+.    .+..+|||.+.......           ...+..|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3578999999999999999999975    56789999887654321           12356788899999999999999


Q ss_pred             ceeee----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC
Q 015076          142 GYCAE----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK  217 (413)
Q Consensus       142 ~~~~~----~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~  217 (413)
                      +++..    ....++||||+ +++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence            99887    78899999999 99999999865    3799999999999999999999999   9999999999999998


Q ss_pred             CC--CceEEecccceecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 015076          218 HW--NPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (413)
Q Consensus       218 ~~--~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~  289 (413)
                      ++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  9999999999876432111      113457899999999999999999999999999999999999999643222


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ...  ...............+. ...   ....++..+.+++.+||..||++|||+.+|++.|+....
T Consensus       267 ~~~--~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 PVA--VQTAKTNLLDELPQSVL-KWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHH--HHHHHHHHHHTTTHHHH-HHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHH--HHHHHHhhcccccHHHH-hhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111  11111111111110000 000   001345678999999999999999999999999997654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.2e-46  Score=376.07  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=213.5

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +..++|++.++||+|+||.||+|.++ ++..||||++....   ......+.+|+.+|+.++||||+++++++.+.+.++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45678999999999999999999975 68899999986532   233456788999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||++||+|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++.
T Consensus       261 lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence            99999999999999876431  3599999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+  ........      
T Consensus       336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~~~~------  405 (576)
T 2acx_A          336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVKEVP------  405 (576)
T ss_dssp             CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHHHCC------
T ss_pred             cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhhccc------
Confidence            754332  33457999999999999999999999999999999999999999865433221111  11111111      


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                       ..+    ...++..+.+||.+||..||.+||     ++.+|++|-.
T Consensus       406 -~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          406 -EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             -CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             -ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence             111    123456789999999999999999     7899998744

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-45  Score=344.53  Aligned_cols=258  Identities=29%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCC----CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccccccee-eeCCeeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDN----SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~  151 (413)
                      ..+|++.+.||+|+||.||+|.+..+    ..+|+|.+.... ......+.+|+.++++++||||+++++++ ..+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            45689999999999999999985432    258999886543 34456788999999999999999999985 5567889


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            9999999999999997643   5689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc---eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          232 LGSESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       232 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .......   ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||..........      ....... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~------~~~~~~~-  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQGRR-  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH------HHHTTCC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH------HHhcCCC-
Confidence            6443221   1233457889999999999999999999999999999999 566665444332211      1111110 


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                           .    .....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       251 -----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          251 -----L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 0    1112234568999999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-46  Score=362.80  Aligned_cols=249  Identities=24%  Similarity=0.288  Sum_probs=197.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHH-HhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++|++.+.||+|+||.||+|+++ ++..||||++.....   .....+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999976 578899999865432   233455667666 577899999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||++||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999765    4789999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..      .....+.....      
T Consensus       190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~------  256 (373)
T 2r5t_A          190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL------  256 (373)
T ss_dssp             BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSCC------
T ss_pred             ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhccc------
Confidence            3222 1244568999999999999999999999999999999999999999754322      22222222211      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG----HVVHM  351 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~----eil~~  351 (413)
                       .++    ..++..+.+||.+||+.||.+||++.    +|++|
T Consensus       257 -~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          257 -QLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             -CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             -CCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence             111    12456788999999999999999974    56555

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-46  Score=355.62  Aligned_cols=267  Identities=19%  Similarity=0.282  Sum_probs=199.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++.....  .....+.+|+.+++.++||||+++++++......++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999965 688899998865432  224567789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-----CCCCceEEecc
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-----KHWNPKVSDFG  227 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DfG  227 (413)
                      ||||++ ++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++     ..+.+||+|||
T Consensus       111 v~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            999996 5999999776    4699999999999999999999999   999999999999994     44559999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+..   ..+........
T Consensus       183 ~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL---FKIFEVLGLPD  258 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCC
T ss_pred             CccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH---HHHHHHhCCCc
Confidence            99876533222 3335689999999998774 4899999999999999999999999765432221   11111111111


Q ss_pred             CCCc--------CC---CCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PEGV--------LD---PKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~~~--------~~---~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ....        ..   +......     ...++..+.+|+.+||+.||++|||+.+++++-..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence            0000        00   0000010     11145678899999999999999999999987554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-46  Score=355.68  Aligned_cols=264  Identities=22%  Similarity=0.269  Sum_probs=206.4

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC-----CchhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-----RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|.+...     .......+.+|+.+++.++||||+++++++.+..
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            344677999999999999999999965 6788999988643     2345567889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCC------------------------------------CCCCCHHHHHHHHHHHHhhh
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGP------------------------------------CSPLTWEIRMNIILGTAKGL  192 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~aL  192 (413)
                      ..++||||+++++|.+++......                                    ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521100                                    12346788899999999999


Q ss_pred             chhhhccCCceeeccCCCCcEEEcCCC--CceEEecccceecCCCC---cceeeccccccCccCcccccc--CCCCccch
Q 015076          193 SYLHEGLEPKVVHRDIKSSNILIDKHW--NPKVSDFGLAKLLGSES---SYITTRVMGTFGYVAPEYAST--GMLNERSD  265 (413)
Q Consensus       193 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sD  265 (413)
                      +|||+.   +|+||||||+|||++.++  .+||+|||++.......   ........||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998776  89999999998753321   112344578999999999865  67899999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH
Q 015076          266 VYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM  345 (413)
Q Consensus       266 vwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  345 (413)
                      ||||||++|+|++|+.||......+      ..........       .+.......++..+.+++.+||..||.+|||+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999999999999999997554322      1222222111       11112223356778999999999999999999


Q ss_pred             HHHHHHHhc
Q 015076          346 GHVVHMLEA  354 (413)
Q Consensus       346 ~eil~~le~  354 (413)
                      .+++++...
T Consensus       326 ~~~l~hp~~  334 (345)
T 3hko_A          326 MRALQHPWI  334 (345)
T ss_dssp             HHHHHSHHH
T ss_pred             HHHhcChhh
Confidence            999998544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.4e-46  Score=352.96  Aligned_cols=269  Identities=26%  Similarity=0.385  Sum_probs=216.2

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEE------cCCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCccccc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLL  141 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~  141 (413)
                      ....+.+..++|++.+.||+|+||.||+|.+      .+++.||||.+..... .....+.+|+.+++.+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            4556677788999999999999999999984      2457899999876543 3446788999999999 799999999


Q ss_pred             ceeeeC-CeeEEEEEeccCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccC
Q 015076          142 GYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGP------------CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDI  208 (413)
Q Consensus       142 ~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dl  208 (413)
                      +++... ...++||||+++++|.+++......            ...+++..++.++.||+.||.|||++   ||+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            998765 4589999999999999999765321            12389999999999999999999999   9999999


Q ss_pred             CCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 015076          209 KSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYS  286 (413)
Q Consensus       209 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~  286 (413)
                      ||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999876543332 2334567899999999999999999999999999999998 99999765


Q ss_pred             CCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ......  .    ..+.....     ...    ...++..+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus       255 ~~~~~~--~----~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEEF--C----RRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHHH--H----HHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHH--H----HHhccCcc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            433211  1    11111110     111    1123456889999999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.2e-46  Score=347.92  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=201.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56999999999999999999965 68899999987653 33467888999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccceecC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  233 (413)
                      +++++|.+++.........+++..++.++.||+.||+|||++   ||+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999998854322225799999999999999999999999   99999999999999   456789999999998764


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ....  .....||+.|+|||++. ..++.++|||||||++|+|++|+.||........      .............   
T Consensus       179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~---  246 (285)
T 3is5_A          179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEPNYAV---  246 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCCCC---
T ss_pred             Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCCccccc---
Confidence            4322  33456899999999885 5689999999999999999999999975442211      1111111110000   


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           ....++..+.+++.+||+.||++|||+.+++++-.
T Consensus       247 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          247 -----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             -------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             -----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence                 00113456889999999999999999999998743

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-45  Score=366.44  Aligned_cols=262  Identities=23%  Similarity=0.277  Sum_probs=199.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------  147 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------  147 (413)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999965 5888999998754  334456788999999999999999999998654      


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...|+||||+++ +|.+.+..      .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            457999999965 56666642      489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +++......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....   +...+.....
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~---i~~~lg~p~~  284 (464)
T 3ttj_A          210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---VIEQLGTPCP  284 (464)
T ss_dssp             CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCSCCH
T ss_pred             eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCH
Confidence            998765432  23446799999999999999999999999999999999999999986553222111   1111110000


Q ss_pred             --------------------C-----CcCCCC-CCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          308 --------------------E-----GVLDPK-LPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       308 --------------------~-----~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                                          .     ..+... ++.  ......+..+.+|+.+||..||++|||+.|+++|..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence                                0     000000 000  011223667899999999999999999999999854

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-45  Score=356.56  Aligned_cols=267  Identities=17%  Similarity=0.236  Sum_probs=204.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCCchhHH-----------HHHHHHHHHhcCCCCCccc
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNRGQAER-----------EFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~hpniv~  139 (413)
                      ..++|++.+.||+|+||.||+|.+..      +..||||.+.........           .+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999999764      367999988765432211           2334666788889999999


Q ss_pred             ccceeeeC----CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE
Q 015076          140 LLGYCAEG----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI  215 (413)
Q Consensus       140 ~~~~~~~~----~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll  215 (413)
                      +++++...    ...++||||+ +++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998764    5689999999 999999997643   4799999999999999999999999   99999999999999


Q ss_pred             c--CCCCceEEecccceecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015076          216 D--KHWNPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSR  287 (413)
Q Consensus       216 ~--~~~~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~  287 (413)
                      +  .++.+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  8899999999999876432211      1133459999999999999999999999999999999999999998543


Q ss_pred             CcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          288 PPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .....  .......... ....+++..++   ...++..+.+++..||..||++||++.+|++.|+...
T Consensus       266 ~~~~~--~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          266 KDPKY--VRDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             TCHHH--HHHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCHHH--HHHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            32211  1111111100 00111111110   0123457899999999999999999999999988753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-45  Score=360.96  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCC--CCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~iv  153 (413)
                      ..+|++.+.||+|+||.||+|...++..||||++....  ......+.+|+.+++.++  ||||+++++++...+.+++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            34599999999999999999998889999999986543  344567899999999996  59999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      || +.+++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||+++...
T Consensus       135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 5588999999875    4789999999999999999999999   999999999999996 5799999999998765


Q ss_pred             CCCcc-eeeccccccCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          234 SESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       234 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      ..... .....+||+.|+|||++.+           ..++.++|||||||+||+|++|+.||.....     ....+...
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~  280 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI  280 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHH
Confidence            43222 2344679999999999865           4689999999999999999999999974332     12222222


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......     ..++..    .+..+.+||.+||..||++|||+.+++++....
T Consensus       281 ~~~~~~-----~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          281 IDPNHE-----IEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             HCTTSC-----CCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             hCcccc-----CCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            221111     111111    245688999999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-45  Score=343.91  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+.....      .....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356999999999999999999976 688999998865432      2367789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEec
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  226 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            9999999999999999764    4799999999999999999999999   999999999999998877    7999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......      ......... 
T Consensus       157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-  227 (283)
T 3bhy_A          157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVN-  227 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-
T ss_pred             ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcc-
Confidence            99987654322  234568999999999999999999999999999999999999997543221      111111111 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                            ...+......++..+.+++.+||..||++|||+.+++++.
T Consensus       228 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          228 ------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             ------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             ------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence                  0111111122356789999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-45  Score=370.15  Aligned_cols=259  Identities=21%  Similarity=0.275  Sum_probs=213.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.++||+|+||.||+|+++ +++.||||++....   ......+..|+.+++.++||||+++++++.....+|+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            4578999999999999999999975 68899999986542   2234578889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||++||+|.+++.........+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++..
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999876543335799999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ............       
T Consensus       340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-------  409 (543)
T 3c4z_A          340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-------  409 (543)
T ss_dssp             CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-------
T ss_pred             cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-------
Confidence            54332 23445799999999999999999999999999999999999999986543221  122222222211       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHML  352 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~l  352 (413)
                      ..+    +..++..+.+||.+||..||++||++     .+|++|.
T Consensus       410 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp  450 (543)
T 3c4z_A          410 VTY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP  450 (543)
T ss_dssp             CCC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred             cCC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence            111    12345678899999999999999964     7788764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=357.37  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=205.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+.....        .....+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            467999999999999999999965 678899999876531        12335677999999999999999999999999


Q ss_pred             eeEEEEEeccCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          149 HRMLVYEYVNNG-NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       149 ~~~iv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ..++||||+.+| +|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999776 999999876    5799999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++........  .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......            .    
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~----  237 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V----  237 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T----
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H----
Confidence            9988754432  334578999999999988876 88999999999999999999999632110            0    


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                           ....  ..+..++..+.+|+.+||+.||++|||+.+++++...
T Consensus       238 -----~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          238 -----EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             -----TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             -----hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                 0000  1111245678999999999999999999999998553

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.1e-46  Score=356.83  Aligned_cols=252  Identities=19%  Similarity=0.321  Sum_probs=210.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999976 4778999988654   234456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999998765    4799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+      .........       .
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-------~  258 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-------Y  258 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-------C
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC-------C
Confidence            3322 2334568999999999999999999999999999999999999997543221      111111111       0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .++    ..+...+.+++.+||+.||++|||+.+++++...
T Consensus       259 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          259 SIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            111    1234568899999999999999999999987543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=357.39  Aligned_cols=256  Identities=28%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             CCCcccEEeeeCceEEEEEEEc--CC--CEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceee-eCCeeEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE--DN--SKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~iv  153 (413)
                      .|++.+.||+|+||.||+|.+.  ++  ..||+|.+.... ......+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4778899999999999999854  22  358999876533 345578899999999999999999999864 45688999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999997653   4689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcc---eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          234 SESSY---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       234 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      .....   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....      ......   
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------~~~~~~---  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQGRR---  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH------HHTTCC---
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH------HHcCCC---
Confidence            32211   1223457889999999999999999999999999999999 7778875544332111      111110   


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                         .    ..+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       315 ---~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          315 ---L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               0    1112245678999999999999999999999999988643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9e-46  Score=347.20  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=208.7

Q ss_pred             HHHhcCCCCccc-EEeeeCceEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC
Q 015076           74 LEVSTNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG  147 (413)
Q Consensus        74 ~~~~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~  147 (413)
                      +.+..++|.+.+ .||+|+||.||+|.+.   .+..||||.+....  ......+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            344567899988 9999999999999642   46779999886543  23356789999999999999999999999 56


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      +..++||||+++++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            7789999999999999999875    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          228 LAKLLGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       228 ~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      ++...........  ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.......       +...+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~  235 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK  235 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHc
Confidence            9988755433222  22346788999999988889999999999999999999 999997544321       1111221


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...     ..    ....++..+.+++.+||+.||++|||+.++++.|+..
T Consensus       236 ~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          236 GER-----MG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TCC-----CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCC-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111     11    1223456789999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-45  Score=352.53  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCE--EEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSK--VAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..  +|+|.+.... ......+.+|+.+++++ +||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3567999999999999999999965 4554  4899886532 33445788999999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          152 LVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      +||||+++++|.+++....            .....+++..++.++.||+.||+|||++   ||+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999997653            2224799999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~  298 (413)
                      .+||+|||++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......      ...
T Consensus       180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~  251 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY  251 (327)
T ss_dssp             CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH
T ss_pred             eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHH
Confidence            99999999987433211  1222356889999999998889999999999999999998 99999754422      112


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ........      .    .....++..+.+++.+||..||++|||+.+++++|+....
T Consensus       252 ~~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          252 EKLPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HHGGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcCCC------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            22211110      1    1122345678999999999999999999999999987644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-46  Score=362.84  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCC-CCCcccccceeeeC--Ce
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEG--AH  149 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~--~~  149 (413)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.+. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999965 6889999988543  3344567788999999997 99999999999754  47


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+||||++ ++|..++...     .+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999996 6899998753     689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCC--------------------cceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          230 KLLGSES--------------------SYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       230 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                      +......                    .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8753211                    111234579999999999876 6799999999999999999999999986553


Q ss_pred             cccccHHHHHHHHhhcCCCCCc---C------------------CCCCCCC------------CcHHHHHHHHHHHHhcC
Q 015076          289 PEEVNLIEWLKKMVTNRNPEGV---L------------------DPKLPEK------------PTSRLLKRILLVALRCV  335 (413)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~---~------------------~~~~~~~------------~~~~~~~~l~~li~~cl  335 (413)
                      ......   +...+.......+   .                  .......            ....++..+.+|+.+||
T Consensus       237 ~~~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          237 MNQLER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             HHHHHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             HHHHHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            322211   1111111100000   0                  0000000            00023457889999999


Q ss_pred             CCCCCCCCCHHHHHHHHh
Q 015076          336 DPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       336 ~~dp~~RPs~~eil~~le  353 (413)
                      ..||++|||+.++++|..
T Consensus       314 ~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          314 QFNPNKRISANDALKHPF  331 (388)
T ss_dssp             CSSGGGSCCHHHHTTSTT
T ss_pred             ccCcccCCCHHHHhCCHH
Confidence            999999999999998844

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.6e-45  Score=340.53  Aligned_cols=261  Identities=18%  Similarity=0.244  Sum_probs=209.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccccccee-eeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+ .+++.||||.+.....  ...+.+|+.+++.++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 5688999998865433  23578899999999988877666655 66788899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccceec
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~  232 (413)
                      |+ +++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||++...
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 999999997443   4799999999999999999999999   99999999999999   48889999999999876


Q ss_pred             CCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          233 GSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       233 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543321      12345789999999999999999999999999999999999999987655444333333222111110


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ..         .....++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       239 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          239 IE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hH---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            00         001123467899999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-45  Score=355.85  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             CCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      +.|++.+.||+|+||.||+|.. .++..||||++.....   .....+.+|+.+++.++||||+++++++..+...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4489999999999999999996 4688899999875432   23357889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+. |+|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9996 68888775432   5799999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCcceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          235 ESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .     ....||+.|+|||++.   ...++.++|||||||++|+|++|+.||......      ..+.........    
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~----  271 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP----  271 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC----
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCC----
Confidence            2     2357899999999884   567899999999999999999999999754321      222222222211    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           ......++..+.++|.+||+.||++|||+.+++++....
T Consensus       272 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          272 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence                 111123456688999999999999999999999986654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-45  Score=349.45  Aligned_cols=266  Identities=24%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCA  145 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~  145 (413)
                      .++.+..++|.+.+.||+|+||.||+|.+.    .+..||+|.+....  ......+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344566788999999999999999999854    24479999886543  334467889999999999999999999987


Q ss_pred             eCC-----eeEEEEEeccCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          146 EGA-----HRMLVYEYVNNGNLEQWLHGDV--GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       146 ~~~-----~~~iv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      ...     ..++||||+++++|.+++....  .....+++..++.++.||+.||.|||++   ||+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654     3599999999999999984321  1225799999999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~  296 (413)
                      +.+||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||........   ..
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH
Confidence            999999999998764432211 223456889999999999999999999999999999999 8999976543321   11


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         .......      .    .....++..+.+++.+||..||++|||+.+++++|+.+.
T Consensus       261 ---~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          261 ---YLLHGHR------L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ---HHHTTCC------C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHcCCC------C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1111110      1    112234567899999999999999999999999998753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-46  Score=347.56  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=208.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceee--eCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~i  152 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999975 68889999987543  344567889999999999999999999874  4678999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc-----eeeccCCCCcEEEcCCCCceEEecc
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK-----VVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ||||+++++|.+++.........+++..++.++.||+.||+|||+.   +     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999976433335699999999999999999999998   8     9999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....+.. ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~-~~~  233 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIRE-GKF  233 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-TCC
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhh-ccc
Confidence            9987654322 123356899999999999999999999999999999999999999754321      11112211 111


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           ..+    ...++..+.+++.+||+.||++|||+.+|++++...
T Consensus       234 -----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          234 -----RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -----ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                 111    123456789999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.9e-45  Score=341.82  Aligned_cols=262  Identities=18%  Similarity=0.242  Sum_probs=206.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccccccee-eeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||.+.....  ...+..|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            357899999999999999999996 4688899998654432  23467799999999988877776655 6778889999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  231 (413)
                      ||+ +++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999 999999997543   4699999999999999999999999   99999999999999   7889999999999987


Q ss_pred             cCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          232 LGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       232 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      .......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6543321      1234578999999999999999999999999999999999999998766554444433322221111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ...         .....++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       238 ~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          238 PIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             CHH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhh---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            000         000123467899999999999999999999999998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-45  Score=364.86  Aligned_cols=269  Identities=20%  Similarity=0.249  Sum_probs=191.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeee-----CCe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~  149 (413)
                      .++|++.+.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+|+.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999965 6889999998653  23345678899999999999999999999843     357


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|+||||+ +++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 67999999765    5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCc--------------------------ceeeccccccCccCcccc-ccCCCCccchhHHHHHHHHHHHh----
Q 015076          230 KLLGSESS--------------------------YITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVIS----  278 (413)
Q Consensus       230 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~~l~ellt----  278 (413)
                      +.......                          ......+||+.|+|||++ .+..++.++|||||||+||||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            87642211                          112345789999999976 56679999999999999999999    


Q ss_pred             -------CCCCCCCCCCcc-----------------cccHHHHHHHHhhcCCCC--------------CcCCCCCC---C
Q 015076          279 -------GRIPVDYSRPPE-----------------EVNLIEWLKKMVTNRNPE--------------GVLDPKLP---E  317 (413)
Q Consensus       279 -------g~~Pf~~~~~~~-----------------~~~~~~~~~~~~~~~~~~--------------~~~~~~~~---~  317 (413)
                             |+++|.+.....                 ....+..+...+......              ..+.....   .
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   666675543210                 011111111111110000              00000000   0


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ......+..+.+|+.+||..||++|||+.|+++|-..
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence            0112235678899999999999999999999998554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-45  Score=347.25  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=207.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457999999999999999999975 6889999999766555566788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccceecC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  233 (413)
                      +++++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||+   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998765    4689999999999999999999999   99999999999999   778899999999997654


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....+.....       
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~-------  224 (304)
T 2jam_A          161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYY-------  224 (304)
T ss_dssp             CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCC-------
T ss_pred             CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC-------
Confidence            321   23346899999999999999999999999999999999999999754321      11222222111       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .++......++..+.+++.+||..||++|||+.+++++...
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            11111122345678999999999999999999999987544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-45  Score=344.84  Aligned_cols=252  Identities=19%  Similarity=0.315  Sum_probs=210.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999976 57789999886542   34456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999998765    4799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+      .........       .
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-------~  232 (294)
T 2rku_A          167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-------Y  232 (294)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------C
T ss_pred             cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhcc-------C
Confidence            3322 2334568999999999999999999999999999999999999997543221      111111111       0


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .++    ..++..+.+++.+||+.||++|||+.+++++...
T Consensus       233 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          233 SIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             CCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence            111    1234568899999999999999999999987544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=356.77  Aligned_cols=272  Identities=21%  Similarity=0.283  Sum_probs=216.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC--eeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999976 58899999986543 234567788999999999999999999988654  78999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE----cCCCCceEEecccc
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVSDFGLA  229 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a  229 (413)
                      |||+++++|.+++...... ..+++..++.++.||+.||+|||++   ||+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999764321 3499999999999999999999999   99999999999999    77778999999999


Q ss_pred             eecCCCCcceeeccccccCccCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +.......  .....||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........  ...+...
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~  239 (396)
T 4eut_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (396)
T ss_dssp             EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred             eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence            87754332  334568999999998865        56788999999999999999999999754433222  1222333


Q ss_pred             hhcCCCCCc------------C--CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          302 VTNRNPEGV------------L--DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       302 ~~~~~~~~~------------~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ........+            +  ...........+...+.+++.+||+.||++|||+.++++.++.+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            332211000            0  0111223447788899999999999999999999999999877643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.9e-45  Score=345.74  Aligned_cols=259  Identities=23%  Similarity=0.391  Sum_probs=207.9

Q ss_pred             CCcccEEeeeCceEEEEEEEc-----CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeee--CCeeEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-----DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRML  152 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~i  152 (413)
                      |++.+.||+|+||.||++.+.     +++.||||++..... .....+.+|+.+++.++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            499999999999999988643     577899999876543 445678999999999999999999999987  467899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++++|.+++...     .+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999764     599999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc--------ccccHHHHHHHHh
Q 015076          233 GSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP--------EEVNLIEWLKKMV  302 (413)
Q Consensus       233 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~  302 (413)
                      ......  ......+|..|+|||++.+..++.++|||||||++|+|++|..||......        ........+...+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            654332  123345788899999999999999999999999999999999998642211        0000111112222


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ....         .......++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       265 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          265 ERGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            2111         11122334567899999999999999999999999998753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-46  Score=363.92  Aligned_cols=245  Identities=13%  Similarity=0.189  Sum_probs=192.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecC---CchhHHHHHHHH---HHHhcCCCCCccccc-------ce
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNN---RGQAEREFKVEV---EAIGRVRHKNLVRLL-------GY  143 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~hpniv~~~-------~~  143 (413)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...   .......+.+|+   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36689999999999999999995 56899999998743   334567788999   555666899999998       55


Q ss_pred             eeeCC-----------------eeEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHhhhchhhhccCCce
Q 015076          144 CAEGA-----------------HRMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV  203 (413)
Q Consensus       144 ~~~~~-----------------~~~iv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i  203 (413)
                      +...+                 ..++||||+ +|+|.+++.....   ....+++..++.|+.||+.||+|||++   ||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 378999999 6899999975310   012344688889999999999999999   99


Q ss_pred             eeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccC-----------CCCccchhHHHHHH
Q 015076          204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFGIL  272 (413)
Q Consensus       204 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~~  272 (413)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986433    2344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       273 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +|+|++|+.||...........+               .. ..     ..++..+.+||.+||+.||++|||+.+++++.
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~---------------~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWI---------------FR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGG---------------GS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             HHHHHHCCCCCcccccccchhhh---------------hh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            99999999999754432221111               00 00     12346788999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-45  Score=355.04  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=209.6

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            4568999999999999999999976 68889999887653 344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+..  ||+||||||+|||++.++.+||+|||++.....
T Consensus       111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999765    46999999999999999999999832  799999999999999999999999999875432


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH-------------------
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI-------------------  295 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~-------------------  295 (413)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............                   
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1   123457899999999999999999999999999999999999999754422211100                   


Q ss_pred             -----------------HHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          296 -----------------EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       296 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                       ..+.....         ...+......++..+.+|+.+||..||++|||+.+++++...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  328 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVN---------EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI  328 (360)
T ss_dssp             ------------CCCHHHHHHHHHH---------SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhc---------cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence                             00111110         011111222345678999999999999999999999988554

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-44  Score=346.58  Aligned_cols=269  Identities=26%  Similarity=0.415  Sum_probs=213.0

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhc--CCCCCcccccceeeeC
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGR--VRHKNLVRLLGYCAEG  147 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~~  147 (413)
                      ++.......++|++.+.||+|+||.||+|.+. ++.||||.+...   ....+..|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            44445566788999999999999999999985 889999988533   34566778888877  7899999999999877


Q ss_pred             C----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh--------hccCCceeeccCCCCcEEE
Q 015076          148 A----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--------EGLEPKVVHRDIKSSNILI  215 (413)
Q Consensus       148 ~----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--------~~~~~~ivH~Dlkp~NIll  215 (413)
                      .    ..++||||+++++|.+++...     .+++..++.++.|++.||+|||        +.   +|+||||||+|||+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            5    789999999999999999753     6899999999999999999999        77   99999999999999


Q ss_pred             cCCCCceEEecccceecCCCCcc---eeeccccccCccCccccccCC------CCccchhHHHHHHHHHHHhC-------
Q 015076          216 DKHWNPKVSDFGLAKLLGSESSY---ITTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG-------  279 (413)
Q Consensus       216 ~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~~l~elltg-------  279 (413)
                      +.++.+||+|||++.........   ......||+.|+|||++.+..      ++.++|||||||++|+|++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999877544332   123457899999999987752      34789999999999999999       


Q ss_pred             ---CCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCC-CcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          280 ---RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK-PTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       280 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         ..||........ .... +...+....    +.+.++.. ........+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       261 ~~~~~p~~~~~~~~~-~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SVEE-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CHHH-HHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cHHH-HHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               788865443221 1111 122221111    11222211 2346778899999999999999999999999999876


Q ss_pred             c
Q 015076          356 E  356 (413)
Q Consensus       356 ~  356 (413)
                      .
T Consensus       335 ~  335 (342)
T 1b6c_B          335 S  335 (342)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-45  Score=343.60  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=210.0

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999976 56789999886532   223467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+||+++.++.+||+|||++..
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            999999999999999765    4699999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .....   .....|++.|+|||++.+..++.++||||||+++|+|++|..||.......      ........ .     
T Consensus       164 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~-~-----  228 (284)
T 2vgo_A          164 APSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNV-D-----  228 (284)
T ss_dssp             CSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT-C-----
T ss_pred             Ccccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhcc-c-----
Confidence            64322   234568999999999999999999999999999999999999997543221      11222211 1     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       ..++    ..++..+.+++.+||..||.+|||+.+++++...
T Consensus       229 -~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          229 -LKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             -CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             -cCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence             1111    2245678899999999999999999999987543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-45  Score=369.36  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=211.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457999999999999999999976 68899999986542   34567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~  230 (413)
                      |||+.+++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999765    5799999999999999999999999   99999999999999   567889999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......+      .+..+.....    
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~----  244 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKY----  244 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC----
T ss_pred             Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC----
Confidence            7654332  234579999999999866 69999999999999999999999997654322      1222222111    


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .+.......++..+.+||.+||..||++|||+.+++++...
T Consensus       245 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          245 ---TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             ---CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             ---CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence               11112233456789999999999999999999999998654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=343.97  Aligned_cols=269  Identities=27%  Similarity=0.438  Sum_probs=206.2

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC--CCCCcccccceeeeC---
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV--RHKNLVRLLGYCAEG---  147 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~hpniv~~~~~~~~~---  147 (413)
                      ......++|++.+.||+|+||.||+|.+. +..||||++....   ...+..|.+++..+  +||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445678999999999999999999986 8899999885432   23344455555554  899999999999877   


Q ss_pred             -CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-----CCceeeccCCCCcEEEcCCCCc
Q 015076          148 -AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNP  221 (413)
Q Consensus       148 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~  221 (413)
                       ...++||||+++++|.+++...     .+++..++.++.|++.||+|||++.     ..+|+||||||+|||++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             7899999999999999999654     6999999999999999999999751     2389999999999999999999


Q ss_pred             eEEecccceecCCCCcce---eeccccccCccCccccccCCCCcc------chhHHHHHHHHHHHhC----------CCC
Q 015076          222 KVSDFGLAKLLGSESSYI---TTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISG----------RIP  282 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~~l~elltg----------~~P  282 (413)
                      ||+|||++..........   .....||+.|+|||++.+..++.+      +|||||||++|||++|          ..|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999998765433221   124579999999999988776665      9999999999999999          666


Q ss_pred             CCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC-CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE-KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       283 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      |..........  ...........    ..+.++. .....++..+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus       262 ~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          262 YHDLVPSDPSY--EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTSCSSCCH--HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhhcCCCCch--hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            65443322211  11222221111    1122221 123468888999999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=340.16  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEcC-CC---EEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee-EEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLV  153 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~-~iv  153 (413)
                      .|.+.++||+|+||.||+|.+.+ +.   .||+|.+..... .....+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46667999999999999998532 22   699998865433 4456788999999999999999999999876555 999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+.+++|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999997643   5789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCc---ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          234 SESS---YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       234 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ....   .......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.......  .....    ......   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~----~~~~~~---  246 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHF----LAQGRR---  246 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHH----HHTTCC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHH----hhcCCC---
Confidence            3221   11233467889999999999999999999999999999999655543322221  11111    111110   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                            ......++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  01112244678999999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.5e-45  Score=360.87  Aligned_cols=256  Identities=21%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ...++|.+.+.||+|+||.||+|.+. ++..||||++.....        .....+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34688999999999999999999965 578999999865421        112347889999999999999999999854


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---CceE
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---NPKV  223 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  223 (413)
                       ...++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence             5579999999999999998765    5799999999999999999999999   999999999999997544   5999


Q ss_pred             EecccceecCCCCcceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      +|||+++......  .....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........  ...    
T Consensus       284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----  355 (419)
T 3i6u_A          284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----  355 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----
T ss_pred             eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----
Confidence            9999998765432  2344679999999999853   5688999999999999999999999975443222  111    


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .+.....      .........++..+.+++.+||..||++|||+.+++++..
T Consensus       356 ~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          356 QITSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             HHHTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHhcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence            1111110      0000111234567899999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=350.69  Aligned_cols=270  Identities=23%  Similarity=0.290  Sum_probs=204.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+......     ....+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999965 5889999988643221     123677899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++ +|.+++....   ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999965 8888887643   4688899999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......   ...+...........
T Consensus       161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTT
T ss_pred             eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhh
Confidence            7654322 23345789999999998664 589999999999999999999999976543221   111111111111100


Q ss_pred             c----------CCCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          310 V----------LDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       310 ~----------~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .          .....+..+    ...++..+.+||.+||..||++|||+.+++++......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            0          000111111    12345678999999999999999999999998765443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.5e-45  Score=340.67  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=203.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee----CCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~  150 (413)
                      ...|++.+.||+|+||.||+|.+. ++..||+|.+....  ......+.+|+.+++.++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345889999999999999999965 57789999886543  3445678899999999999999999998865    4668


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEc-CCCCceEEecc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILID-KHWNPKVSDFG  227 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG  227 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||+|||+.   +  |+||||||+|||++ .++.+||+|||
T Consensus       105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            9999999999999999765    4789999999999999999999998   8  99999999999997 78899999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++.......   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......     ........ ...
T Consensus       178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~~  247 (290)
T 1t4h_A          178 LATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTS-GVK  247 (290)
T ss_dssp             GGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTT-TCC
T ss_pred             Ccccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHHHhc-cCC
Confidence            997654332   33456899999999886 458999999999999999999999997543221     11122211 111


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                              +.......+..+.+++.+||+.||++|||+.+++++..
T Consensus       248 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          248 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             --------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence                    11112223356899999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.3e-45  Score=343.87  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=210.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .+.|++.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356999999999999999999965 68899999986553 3456788899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++..     ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999865     3699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ......... .     +.+
T Consensus       173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-----~~~  239 (303)
T 3a7i_A          173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNN-P-----PTL  239 (303)
T ss_dssp             BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-C-----CCC
T ss_pred             cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHhhcCC-C-----CCC
Confidence            22 2334568999999999999999999999999999999999999997543221      111111111 1     111


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          ...++..+.+++.+||..||++|||+.+++++....
T Consensus       240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence                122445688999999999999999999999986543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.6e-46  Score=353.55  Aligned_cols=269  Identities=25%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||||++.....  .....+.+|+.+++.++||||+++++++......++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3567999999999999999999976 588999998865543  3345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|..++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++....
T Consensus       103 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999999998887655    4699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHH-hh
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL--------KKM-VT  303 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~--------~~~-~~  303 (413)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+...        ... ..
T Consensus       176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            4322 23345689999999998775 6899999999999999999999999765433221111000        000 00


Q ss_pred             cCCCCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          304 NRNPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       304 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .........+.+....     ...++..+.+|+.+||+.||++|||+.+++++-.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            0000111111111111     1134677999999999999999999999998754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=375.31  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             hcCCCCccc-EEeeeCceEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDK-VIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..+++.+.+ .||+|+||.||+|.++   ++..||||.+.... ......+.+|+++|+.++||||+++++++.. +..+
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            344555555 8999999999999864   45579999987643 3456789999999999999999999999976 5689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +||||+++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       412 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             EEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            9999999999999997543   5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccee--eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSYIT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .........  ....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+..      . .+..... 
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------~-~i~~~~~-  557 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------A-FIEQGKR-  557 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH------H-HHHTTCC-
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------H-HHHcCCC-
Confidence            654322211  22345689999999999999999999999999999998 99999866543211      1 1111111 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .    ..+..++..+.+||.+||..||++||++.+|++.|+..
T Consensus       558 ----~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 ----M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ----C----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1    11223556789999999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-45  Score=341.51  Aligned_cols=254  Identities=24%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .+..++|++.+.||+|+||.||+|.+. +++.||||.+....   ......+.+|+.+++.++||||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            345678999999999999999999976 68899999886432   23345788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+|+||||+|||++.++.+||+|||++.
T Consensus        87 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999999999765    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      .......  .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......      .......... .  
T Consensus       160 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~--  228 (276)
T 2h6d_A          160 MMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRGGV-F--  228 (276)
T ss_dssp             CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C--
T ss_pred             ccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCc-c--
Confidence            7654322  233568999999999988765 68999999999999999999999754321      1112221111 0  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          .++    ..++..+.+++.+||+.||++|||+.+++++-..
T Consensus       229 ----~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          229 ----YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             ----cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence                111    1234568899999999999999999999997543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=351.84  Aligned_cols=258  Identities=22%  Similarity=0.346  Sum_probs=191.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCccccccee--------e
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYC--------A  145 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~--------~  145 (413)
                      +...+|++.+.||+|+||.||+|.+. +++.||||++..........+.+|+.+++.+. ||||+++++++        .
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            44567999999999999999999965 68899999997777677778899999999996 99999999988        3


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEcCCCCceE
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl  223 (413)
                      .....++||||+. |+|.+++..... ...+++..++.++.||+.||+|||++   +  |+||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            4456899999995 799988864211 14699999999999999999999998   8  999999999999999999999


Q ss_pred             EecccceecCCCCcce-----------eeccccccCccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 015076          224 SDFGLAKLLGSESSYI-----------TTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~  289 (413)
                      +|||++..........           .....||+.|+|||++   .+..++.++|||||||++|+|++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432211           1134589999999998   5677899999999999999999999999643321


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ..      ...             .............+.+++.+||+.||++|||+.+++++|+....
T Consensus       260 ~~------~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 RI------VNG-------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh------hcC-------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            10      000             00011111123347889999999999999999999999988754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.7e-45  Score=359.11  Aligned_cols=269  Identities=20%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Ce
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  149 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++...  .......+.+|+.+|+.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999965 5778999998653  234456788999999999999999999998766     57


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .|+||||++ ++|.+++...    ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999995 6999999765    5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcc---------------------eeeccccccCccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC---
Q 015076          230 KLLGSESSY---------------------ITTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRIPVD---  284 (413)
Q Consensus       230 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~~l~elltg~~Pf~---  284 (413)
                      +........                     .....+||+.|+|||++ ....++.++|||||||++|||++|..||.   
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            876543211                     12456799999999986 56679999999999999999998554443   


Q ss_pred             --------CCCCcc--------------cccHHHHHHHHhhcCCCCC--------------cCCCCCCCC---CcHHHHH
Q 015076          285 --------YSRPPE--------------EVNLIEWLKKMVTNRNPEG--------------VLDPKLPEK---PTSRLLK  325 (413)
Q Consensus       285 --------~~~~~~--------------~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~---~~~~~~~  325 (413)
                              +.....              ....+..+...+.......              .+....+..   ....++.
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence                    222100              0011111111111110000              000000000   0012456


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          326 RILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       326 ~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .+.+|+.+||..||++|||+.+++++...
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  365 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYL  365 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence            78999999999999999999999998544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9e-46  Score=353.80  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=213.3

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcC-C-----CEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLED-N-----SKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      .+++..++|++.+.||+|+||.||+|.+.. +     ..||+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345667899999999999999999999653 2     3799998866543 3456788999999999 899999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC----------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEE
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG----------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl  214 (413)
                      ...+..++||||+++|+|.+++.....          ....+++..++.++.||+.||+|||++   ||+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999864210          124689999999999999999999999   9999999999999


Q ss_pred             EcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 015076          215 IDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEV  292 (413)
Q Consensus       215 l~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~  292 (413)
                      ++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999999866433222 2233457889999999999999999999999999999998 99999765433211


Q ss_pred             cHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          293 NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                            .........     ...    ...++..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus       277 ------~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 ------YKLVKDGYQ-----MAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ------HHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHhcCCC-----CCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                  111111110     111    112345788999999999999999999999999865

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-45  Score=366.84  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=209.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||+||+|.+. ++..||||++...  .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356999999999999999999975 6889999998543  2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc---CCCCceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~  231 (413)
                      ||+.+++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++   .++.+||+|||++..
T Consensus       101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999988765    4799999999999999999999999   999999999999995   456799999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ......  ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+      .+..+.....     
T Consensus       174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-----  239 (486)
T 3mwu_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKY-----  239 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-----
T ss_pred             CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-----
Confidence            654322  334579999999999875 59999999999999999999999997554322      1222222111     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                        .+.......++..+.++|.+||..||.+|||+.+++++......
T Consensus       240 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          240 --AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             --CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             --CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence              11112233456778999999999999999999999998655443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7e-45  Score=366.22  Aligned_cols=253  Identities=21%  Similarity=0.330  Sum_probs=203.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .++|++.+.||+|+||+||+|.++ ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346999999999999999999976 68889999987543  233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEeccccee
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLAKL  231 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~  231 (413)
                      |||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++..   +.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988765    4799999999999999999999999   99999999999999764   4599999999987


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ......  ....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+      .+..+.....     
T Consensus       189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-----  254 (494)
T 3lij_A          189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKY-----  254 (494)
T ss_dssp             CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-----
T ss_pred             CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-----
Confidence            754322  34457999999999886 569999999999999999999999997654322      1222222111     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        .++......++..+.+||.+||..||.+|||+.+++++..
T Consensus       255 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          255 --TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             --CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             --CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence              1111112335667899999999999999999999998743

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-45  Score=354.93  Aligned_cols=272  Identities=21%  Similarity=0.272  Sum_probs=204.4

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc-----------hhHHHHHHHHHHHhcCCCCCcc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG-----------QAEREFKVEVEAIGRVRHKNLV  138 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~hpniv  138 (413)
                      .+.++....++|++.+.||+|+||.||+|.+.++..||||++.....           .....+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677788899999999999999999999988899999998854321           1236788999999999999999


Q ss_pred             cccceeee-----CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcE
Q 015076          139 RLLGYCAE-----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNI  213 (413)
Q Consensus       139 ~~~~~~~~-----~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NI  213 (413)
                      ++++++..     ....++||||+. ++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            99999843     346899999996 68888887543   4799999999999999999999999   999999999999


Q ss_pred             EEcCCCCceEEecccceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 015076          214 LIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV  292 (413)
Q Consensus       214 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~  292 (413)
                      |++.++.+||+|||++........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999986543322  334568999999998877 67999999999999999999999999865432221


Q ss_pred             cHHHHHHHHhhcCCC---------------CCcCCCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          293 NLIEWLKKMVTNRNP---------------EGVLDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       293 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .   .+.........               .... ...+...    ...++..+.+|+.+||..||++|||+.+++++..
T Consensus       244 ~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          244 N---KIVEVVGTPKIEDVVMFSSPSARDYLRNSL-SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             H---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCC-CCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             H---HHHHHcCCCChHHhhhccchhhhHHHHhhc-ccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            1   11111110000               0000 0011111    1123456889999999999999999999998855


Q ss_pred             c
Q 015076          354 A  354 (413)
Q Consensus       354 ~  354 (413)
                      .
T Consensus       320 f  320 (362)
T 3pg1_A          320 F  320 (362)
T ss_dssp             G
T ss_pred             h
Confidence            4

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=348.12  Aligned_cols=269  Identities=26%  Similarity=0.398  Sum_probs=201.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHH--HHhcCCCCCcccccceee-----eCC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVE--AIGRVRHKNLVRLLGYCA-----EGA  148 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~hpniv~~~~~~~-----~~~  148 (413)
                      +..++|++.+.||+|+||.||+|.. ++..||||++....   ...+..|.+  .+..++||||+++++.+.     ...
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            4568899999999999999999987 48899999886433   233333444  455689999999997543     334


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc------CCceeeccCCCCcEEEcCCCCce
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL------EPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ..++||||+++|+|.+++...     ..++..++.++.||+.||+|||+..      ..+|+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            678999999999999999764     4689999999999999999999763      22899999999999999999999


Q ss_pred             EEecccceecCCCCc-------ceeeccccccCccCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          223 VSDFGLAKLLGSESS-------YITTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       223 l~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                      |+|||++........       .......||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653221       11234569999999999977       4567899999999999999999777644332


Q ss_pred             cccc-cH----------HHHHHHHhhcCCCCCcCCCCCCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          289 PEEV-NL----------IEWLKKMVTNRNPEGVLDPKLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       289 ~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .... ..          ...+.........    .+.++.  .....++..+.+||.+||+.||++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            2111 00          0111111211111    112211  12345777899999999999999999999999999987


Q ss_pred             cC
Q 015076          356 ES  357 (413)
Q Consensus       356 ~~  357 (413)
                      ..
T Consensus       317 l~  318 (336)
T 3g2f_A          317 MM  318 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.5e-46  Score=344.65  Aligned_cols=253  Identities=29%  Similarity=0.422  Sum_probs=200.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee-CCeeEEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVY  154 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~iv~  154 (413)
                      +..++|++.+.||+|+||.||+|.+. +..||||.+....  ....+.+|+.+++.++||||+++++++.. ....++||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            45678999999999999999999875 8899999886443  45678899999999999999999998654 45789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999975421  2388999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..    ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........   .   .. +....       
T Consensus       170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~---~~-~~~~~-------  231 (278)
T 1byg_A          170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V---PR-VEKGY-------  231 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H---HH-HTTTC-------
T ss_pred             cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HH-HhcCC-------
Confidence            21    22357889999999999999999999999999999998 9999975543221   1   11 11111       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                        .......++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence              11112234567899999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=346.60  Aligned_cols=264  Identities=22%  Similarity=0.387  Sum_probs=211.4

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE-----cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC--e
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL-----EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA--H  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~  149 (413)
                      ..++|++.+.||+|+||.||+|.+     .++..||||++..........+.+|+.+++.++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            456799999999999999999984     357889999998776667778999999999999999999999886543  7


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++++|.+++....   ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            899999999999999997653   4699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcce--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC---------cccccHHHHH
Q 015076          230 KLLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP---------PEEVNLIEWL  298 (413)
Q Consensus       230 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~---------~~~~~~~~~~  298 (413)
                      ..........  .....++..|+|||++.+..++.++|||||||++|+|++|..||.....         .........+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            8875543321  1234567889999999988899999999999999999999999853210         0000111111


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+.....         ......++..+.++|.+||..||++|||+.+|++.|+.+
T Consensus       273 ~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          273 IELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            122221111         011223456789999999999999999999999999865

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.6e-45  Score=352.10  Aligned_cols=259  Identities=20%  Similarity=0.322  Sum_probs=209.5

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcC-CCCCcccccc
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRV-RHKNLVRLLG  142 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~hpniv~~~~  142 (413)
                      ......++|++.+.||+|+||.||+|.+. +|..||||++.....        .....+.+|+.+++.+ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            33445578999999999999999999975 689999998865431        1235678899999998 7999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      ++......++||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   ||+|+||||+|||++.++.+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999764    4799999999999999999999999   999999999999999999999


Q ss_pred             EEecccceecCCCCcceeeccccccCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 015076          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~  296 (413)
                      |+|||++........  .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||......      .
T Consensus       241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~  312 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L  312 (365)
T ss_dssp             ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred             EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H
Confidence            999999987754332  334679999999998863      35889999999999999999999999754321      1


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..........       .........++..+.+++.+||..||++|||+.+++++..
T Consensus       313 ~~~~i~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          313 MLRMIMEGQY-------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             HHHHHHHTCC-------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHHHHhCCC-------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            1122211110       0000001123456889999999999999999999998743

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-45  Score=367.02  Aligned_cols=256  Identities=22%  Similarity=0.323  Sum_probs=207.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-------------hhHHHHHHHHHHHhcCCCCCcccccc
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-------------QAEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      ..++|++.+.||+|+||+||+|.+. ++..||||.+.....             .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999975 578899999865431             23467889999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC---
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW---  219 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---  219 (413)
                      ++.+....++|||||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999998765    4799999999999999999999999   999999999999998776   


Q ss_pred             CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      .+||+|||++........  .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+      .+.
T Consensus       187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~  257 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIK  257 (504)
T ss_dssp             SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred             cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence            699999999988754322  34457999999999986 469999999999999999999999998654322      122


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+.....       .++......++..+.+|+.+||..||.+|||+.+++++..-.
T Consensus       258 ~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          258 KVEKGKY-------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             HHHHCCC-------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHcCCC-------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            2222111       001011123456789999999999999999999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-45  Score=358.94  Aligned_cols=267  Identities=21%  Similarity=0.268  Sum_probs=200.0

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee------
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------  146 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------  146 (413)
                      ++...++|++.+.||+|+||.||+|.+ .++..||||++......    ..+|+.+++.++||||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345678899999999999999999996 46889999998655322    2369999999999999999999843      


Q ss_pred             --------------------------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhch
Q 015076          147 --------------------------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY  194 (413)
Q Consensus       147 --------------------------------~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~  194 (413)
                                                      ....++||||++ ++|.+.+.........+++..++.++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            344889999997 58777765422222579999999999999999999


Q ss_pred             hhhccCCceeeccCCCCcEEEc-CCCCceEEecccceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHH
Q 015076          195 LHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGIL  272 (413)
Q Consensus       195 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~  272 (413)
                      ||+.   ||+||||||+|||++ .++.+||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999998 688999999999987754332  3345689999999998775 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccccHHHHHHHHhhc----------CCCCCcCCCCCCCC-----CcHHHHHHHHHHHHhcCCC
Q 015076          273 IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN----------RNPEGVLDPKLPEK-----PTSRLLKRILLVALRCVDP  337 (413)
Q Consensus       273 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~  337 (413)
                      +|+|++|+.||.+....+....+   ......          .......-+.....     ....++..+.+|+.+||..
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i---~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRI---IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999865433222111   111110          00000000111111     1122456689999999999


Q ss_pred             CCCCCCCHHHHHHHHh
Q 015076          338 NAQKRPKMGHVVHMLE  353 (413)
Q Consensus       338 dp~~RPs~~eil~~le  353 (413)
                      ||++|||+.+++++-.
T Consensus       309 dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          309 EPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SGGGSCCHHHHHTSGG
T ss_pred             ChhhCCCHHHHhcCHH
Confidence            9999999999998743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=351.11  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  148 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999974 68899999985532  334567889999999999999999999987653      


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..|+||||+ +++|.+++...     .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 88999998753     689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC-
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (413)
                      ++.....    ....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......   +........ 
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~~~~  247 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPPA  247 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCH
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCH
Confidence            9876532    234578999999999877 6799999999999999999999999986543222111   111111000 


Q ss_pred             -----------------CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 -----------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                       ........+. ......+..+.+|+.+||..||++|||+.++++|...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f  311 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  311 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence                             0000000000 0112235678899999999999999999999998543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.8e-45  Score=380.07  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=209.9

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~  149 (413)
                      .+..++|++.++||+|+||.||+|.++ +++.||||++....   ......+..|..++..+ +||||+.+++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            356788999999999999999999966 57789999986532   23345677899999988 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +||||||+++|+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+||||+.++.+||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999999865    4799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      +....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..      .....+....    
T Consensus       490 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~----  558 (674)
T 3pfq_A          490 KENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN----  558 (674)
T ss_dssp             EECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSC----
T ss_pred             eccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC----
Confidence            86433222 245578999999999999999999999999999999999999999765432      2222222211    


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-----GHVVHML  352 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~l  352 (413)
                         ..++    ..++.++.+||.+||..||++||++     .+|++|.
T Consensus       559 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~  599 (674)
T 3pfq_A          559 ---VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  599 (674)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred             ---CCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence               1111    2356678999999999999999997     8888764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=353.10  Aligned_cols=262  Identities=16%  Similarity=0.199  Sum_probs=205.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC---------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccc---------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED---------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR---------  139 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~---------  139 (413)
                      .++|++.+.||+|+||.||+|.+..         +..||||.+...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999764         778999988654     35678999999999999998         


Q ss_pred             ------ccceeee-CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          140 ------LLGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       140 ------~~~~~~~-~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                            +++++.. ....++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  4555555 67889999999 9999999976421  4799999999999999999999999   99999999999


Q ss_pred             EEEcCCC--CceEEecccceecCCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015076          213 ILIDKHW--NPKVSDFGLAKLLGSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (413)
Q Consensus       213 Ill~~~~--~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~  284 (413)
                      ||++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876432211      1233578999999999999999999999999999999999999997


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ...... ..............  .......   .....++..+.+++.+||..||++|||+.+|++.|+.+.
T Consensus       270 ~~~~~~-~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          270 NCLPNT-EDIMKQKQKFVDKP--GPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GGTTCH-HHHHHHHHHHHHSC--CCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCcCH-HHHHHHHHhccCCh--hhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            654222 11122222221111  1111110   011224567899999999999999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.6e-45  Score=351.01  Aligned_cols=267  Identities=20%  Similarity=0.274  Sum_probs=205.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeee--------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------  146 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            467999999999999999999974 688999998865432  234567789999999999999999999876        


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      .+..++||||+++ +|.+.+....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            4568999999965 7777776543   4699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCc---ceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          227 GLAKLLGSESS---YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       227 G~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |++........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......   ..+....
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~  245 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLC  245 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh
Confidence            99987653221   12234568999999998876 45899999999999999999999999865433222   2222222


Q ss_pred             hcCCCCCcCCC--------------CCCCCCcHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          303 TNRNPEGVLDP--------------KLPEKPTSR-----LLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       303 ~~~~~~~~~~~--------------~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..... .....              .........     ....+.+|+.+||..||++|||+.+++++-...
T Consensus       246 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          246 GSITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             CCCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            11111 00000              000000111     134578999999999999999999999986654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=336.72  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=205.3

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|....+||+|+||.||+|.+. ++..||||.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            3455666779999999999999964 678899999887766667788999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEecccceecCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~  234 (413)
                      |+++++|.+++..... ...+++..++.++.||+.||+|||++   ||+|+||||+|||++. ++.+||+|||++.....
T Consensus       100 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          100 QVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             CCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             eCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999976432 13567899999999999999999999   9999999999999987 88999999999987654


Q ss_pred             CCcceeeccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ... ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........    .........      ..
T Consensus       176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~  244 (295)
T 2clq_A          176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMFK------VH  244 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHHHC------CC
T ss_pred             CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcccc------cc
Confidence            322 123456899999999987654  88999999999999999999999964332211    111111111      01


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +.+    ...++..+.+++.+||+.||++|||+.+++++-..
T Consensus       245 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          245 PEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             CCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            111    12345678899999999999999999999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.4e-44  Score=344.94  Aligned_cols=260  Identities=20%  Similarity=0.266  Sum_probs=204.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeee--CCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+ .+++.||||.+...   ....+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46799999999999999999996 46889999988543   3466888999999997 9999999999987  6778999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~  232 (413)
                      |||+++++|.+++.       .+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||++...
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999984       488999999999999999999999   999999999999999776 8999999999876


Q ss_pred             CCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH---------Hh
Q 015076          233 GSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK---------MV  302 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~---------~~  302 (413)
                      .....  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........  ....+..         .+
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHH
Confidence            54332  334568999999999877 6799999999999999999999999964432211  1100000         00


Q ss_pred             hcC--------------CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          303 TNR--------------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       303 ~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...              .....+...........++..+.+||.+||+.||++|||+.+++++...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            000              0000011111122233356789999999999999999999999997543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-45  Score=348.77  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=206.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE------cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..++|++.+.||+|+||.||+|.+      .++..||||.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            456799999999999999999983      246789999986543 3445678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceE
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVG---PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKV  223 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl  223 (413)
                      .++||||+++++|.+++.....   ....+++..++.++.||+.||.|||++   ||+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999976432   124589999999999999999999999   9999999999999984   445999


Q ss_pred             EecccceecCCCCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 015076          224 SDFGLAKLLGSESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKM  301 (413)
Q Consensus       224 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  301 (413)
                      +|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......      .....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEFV  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHHH
Confidence            99999975533221 12233567899999999999999999999999999999998 999997543221      11112


Q ss_pred             hhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          302 VTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .....      .    .....++..+.+++.+||..||.+|||+.+|+++|+...
T Consensus       259 ~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGGR------M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCC------C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            11111      0    112234567889999999999999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.7e-44  Score=349.04  Aligned_cols=265  Identities=24%  Similarity=0.293  Sum_probs=196.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  148 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            578999999999999999999965 57889999987542  334567889999999999999999999987654      


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||++ ++|.+++..      .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            7899999996 578888753      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH------------
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE------------  296 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~------------  296 (413)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.            
T Consensus       174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98764322  2334578999999999999999999999999999999999999997654321111000            


Q ss_pred             ----HHHHHhhcCCC-CC-----cCCC-CCCC--CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 ----WLKKMVTNRNP-EG-----VLDP-KLPE--KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ----~~~~~~~~~~~-~~-----~~~~-~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                          .+......... ..     .+.. ..+.  ......+..+.+|+.+||..||++|||+.+++++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                00000000000 00     0000 0000  0122346789999999999999999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-44  Score=347.89  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=208.9

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch-----------------hHHHHHHHHHHHhcCCCCCccc
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ-----------------AEREFKVEVEAIGRVRHKNLVR  139 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~hpniv~  139 (413)
                      ..++|++.+.||+|+||.||+|.+ ++..||||.+......                 ....+.+|+.+++.++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            467899999999999999999999 7999999988643211                 1177889999999999999999


Q ss_pred             ccceeeeCCeeEEEEEeccCCChhhh------ccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCc
Q 015076          140 LLGYCAEGAHRMLVYEYVNNGNLEQW------LHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSN  212 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~N  212 (413)
                      +++++.+.+..++||||+++++|.++      +....  ...+++..++.++.||+.||+|||+ .   ||+||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            99999999999999999999999999      54421  2679999999999999999999999 8   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNE-RSDVYSFGILIMEVISGRIPVDYSRPPE  290 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~~l~elltg~~Pf~~~~~~~  290 (413)
                      ||++.++.+||+|||++......   ......||..|+|||++.+. .++. ++|||||||++|+|++|..||.......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999876433   23446789999999999887 6666 9999999999999999999998654421


Q ss_pred             cccHHHHHHHHhhcCCCCCcC------CCCC---CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          291 EVNLIEWLKKMVTNRNPEGVL------DPKL---PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           ........ .......      .+..   .......++..+.+++.+||+.||.+|||+.+++++..
T Consensus       260 -----~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          260 -----ELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             -----HHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             -----HHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence                 11112211 1110000      0000   00011335667899999999999999999999998744

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.5e-45  Score=340.90  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=202.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+....  ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357999999999999999999976 78899999987542  34456778899999998 899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---------------
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---------------  218 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---------------  218 (413)
                      |||+++++|.+++.........+++..++.++.||+.||+|||++   ||+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999975422224689999999999999999999999   99999999999999844               


Q ss_pred             ----CCceEEecccceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCccccc
Q 015076          219 ----WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVN  293 (413)
Q Consensus       219 ----~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~  293 (413)
                          ..+||+|||++.......     ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+....      
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence                478999999998775432     23589999999998776 56789999999999999999987764221      


Q ss_pred             HHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          294 LIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ..   .... ....     +.++    ..++..+.+++.+||+.||++|||+.+++++...
T Consensus       236 ~~---~~~~-~~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  283 (289)
T 1x8b_A          236 QW---HEIR-QGRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL  283 (289)
T ss_dssp             HH---HHHH-TTCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred             HH---HHHH-cCCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence            11   1111 1111     1111    2245678999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-45  Score=345.15  Aligned_cols=270  Identities=21%  Similarity=0.344  Sum_probs=191.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +.+..++|++.+.||+|+||.||+|.+ .++..||||.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            456788999999999999999999995 468899999875443 334567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCC----CCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          152 LVYEYVNNGNLEQWLHGD----VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      +||||+++++|.+++...    ......+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            999999999999998631    11125699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCc----ceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          228 LAKLLGSESS----YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       228 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      ++........    .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........      ....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~  240 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL  240 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh
Confidence            9976643221    11234568999999999866 56899999999999999999999999765433211      1111


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ... ................++..+.+++.+||+.||.+|||+.+++++..
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          241 QND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             TSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             ccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            111 11110000001111234567889999999999999999999998743

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=341.44  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999976 58899999886543  34567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.||+.||.|||+.   ||+|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999986332   5799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCC
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL  315 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (413)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ...........      . 
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~------~-  244 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPPP------T-  244 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC------C-
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCc------c-
Confidence            22 2334568999999999999999999999999999999999999997543211      11111111110      0 


Q ss_pred             CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       316 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       ......++..+.+++.+||..||.+|||+.+++++....
T Consensus       245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence             112233456789999999999999999999999875543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-45  Score=344.62  Aligned_cols=259  Identities=23%  Similarity=0.346  Sum_probs=192.8

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      +..++|++.+.||+|+||.||+|.+. +++.||||++.....  .....+..+...++.++||||+++++++.+++..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            45678999999999999999999964 688899999865432  222344555566888899999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||++ ++|.+++.........+++..++.++.||+.||+|||++.  ||+||||||+|||++.++.+||+|||++...
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999996 5887777542222257999999999999999999999842  8999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .....  .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||......     ...+......... 
T Consensus       161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-  232 (290)
T 3fme_A          161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP-  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC-
T ss_pred             ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC-
Confidence            54322  2334689999999996    5667899999999999999999999999743322     1112222222111 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                              ......++..+.+++.+||+.||++|||+.+++++..
T Consensus       233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~  269 (290)
T 3fme_A          233 --------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF  269 (290)
T ss_dssp             --------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             --------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence                    1112234567899999999999999999999998654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-44  Score=338.90  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=209.6

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---------chhHHHHHHHHHHHhcCC-CCCcccccceee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---------GQAEREFKVEVEAIGRVR-HKNLVRLLGYCA  145 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~  145 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+....         ......+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999975 57889999986543         122456788999999995 999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                      .....++||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   ||+|+||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999765    4799999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      ||++........  .....||+.|+|||++.      ...++.++|||||||++|+|++|..||......      ....
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~  239 (298)
T 1phk_A          168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLR  239 (298)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred             ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHH
Confidence            999987654332  33456899999999885      456889999999999999999999999754321      1112


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .......       ..+......++..+.+++.+||..||++|||+.+++++-.
T Consensus       240 ~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          240 MIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             HHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            2222111       1111222345677999999999999999999999998644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-44  Score=355.57  Aligned_cols=265  Identities=18%  Similarity=0.215  Sum_probs=205.0

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC------CCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV------RHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~~~~~~~~~  149 (413)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++... ......+..|+.+++.+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3567999999999999999999965 5788999988643 23345666787777766      57899999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC--ceEEecc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN--PKVSDFG  227 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG  227 (413)
                      .++||||+. ++|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999995 699998876532  4599999999999999999999999   9999999999999999887  9999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC-
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (413)
                      ++......    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....   +........ 
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~---i~~~~~~p~~  320 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC---MIELLGMPSQ  320 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCH
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCCH
Confidence            99875432    2345789999999999999999999999999999999999999986653322211   111111000 


Q ss_pred             -----------------CCC------cCC----------------CCCCCCCcH-----HHHHHHHHHHHhcCCCCCCCC
Q 015076          307 -----------------PEG------VLD----------------PKLPEKPTS-----RLLKRILLVALRCVDPNAQKR  342 (413)
Q Consensus       307 -----------------~~~------~~~----------------~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~R  342 (413)
                                       ...      ..+                .........     .....+.+||.+||+.||++|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence                             000      000                000000000     114568899999999999999


Q ss_pred             CCHHHHHHHHhcc
Q 015076          343 PKMGHVVHMLEAQ  355 (413)
Q Consensus       343 Ps~~eil~~le~~  355 (413)
                      ||+.|++++....
T Consensus       401 pta~e~L~Hpw~~  413 (429)
T 3kvw_A          401 MTPGQALRHPWLR  413 (429)
T ss_dssp             CCHHHHHTSTTTC
T ss_pred             CCHHHHhCChhhc
Confidence            9999999986544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.7e-45  Score=338.98  Aligned_cols=249  Identities=23%  Similarity=0.431  Sum_probs=205.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee---------
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE---------  146 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~---------  146 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....    .+.+|+.+++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456999999999999999999976 788999999875542    45679999999999999999998854         


Q ss_pred             -------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          147 -------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       147 -------~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                             ....++||||+++++|.+++.....  ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   4557999999999999999965422  4799999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK  299 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~  299 (413)
                      .+||+|||++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...        .....
T Consensus       160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFT  229 (284)
T ss_dssp             EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHH
T ss_pred             CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHH
Confidence            999999999987754332  23356899999999999999999999999999999999999887411        11111


Q ss_pred             HHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          300 KMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      . +....        ++    ..++..+.+++.+||+.||++|||+.+++++|+....
T Consensus       230 ~-~~~~~--------~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          230 D-LRDGI--------IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             H-HHTTC--------CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             H-hhccc--------cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            1 11111        11    1234568899999999999999999999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.5e-45  Score=356.10  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=198.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC------eeE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRM  151 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------~~~  151 (413)
                      ..+|++.+.||+|+||.||+|.+..+..||+|++......    ..+|+.+++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4569999999999999999999887778999988755432    235999999999999999999985433      378


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-CCCCceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~  230 (413)
                      +||||++++ +...+.........+++..++.++.||+.||+|||++   ||+||||||+|||++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            999999764 4333321111125799999999999999999999999   999999999999999 78999999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-----
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN-----  304 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----  304 (413)
                      .......  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+   ......     
T Consensus       191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI---IKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHH
T ss_pred             cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHH
Confidence            7754332  2345689999999998765 5899999999999999999999999865533222111   111100     


Q ss_pred             -----CCCCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          305 -----RNPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       305 -----~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                           .......-+......     ...++.++.+|+.+||..||++|||+.++++|-..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence                 000000001111111     11245678999999999999999999999998543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-45  Score=345.01  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=204.1

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+..........+..|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3567999999999999999999976 588899999876666667788999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+++++|.+++....   ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999886532   4699999999999999999999999   9999999999999999999999999987543211


Q ss_pred             CcceeeccccccCccCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          236 SSYITTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                       ........||+.|+|||++     .+..++.++|||||||++|+|++|..||......      ............   
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---  240 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDPP---  240 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC---
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCCc---
Confidence             1112334689999999988     4677899999999999999999999999754322      112222221111   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           .......++..+.+++.+||..||++|||+.+++++..
T Consensus       241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  278 (302)
T 2j7t_A          241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF  278 (302)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred             -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence                 11123345667899999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=337.18  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=201.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCCCCccccccee--eeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRHKNLVRLLGYC--AEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~--~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+....    ......+.+|+.+++.++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999964 68899999886432    23456788999999999999999999998  455688


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||++++ |.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999776 7776654322  5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCC-cceeeccccccCccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          231 LLGSES-SYITTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       231 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ...... ........||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......      ......... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~-~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGKG-SY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHC-CC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhcC-CC
Confidence            765322 22233456899999999987644  478999999999999999999999754321      111222111 11


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                            .++    ..++..+.+++.+||..||++|||+.+++++....
T Consensus       231 ------~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          231 ------AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             ------CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred             ------CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence                  111    12445688999999999999999999999985543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-44  Score=373.49  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=199.2

Q ss_pred             cEEeeeCceEEEEEEEc---CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||.||+|.+.   .+..||||++....  ......+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   45679999886543  3346789999999999999999999999965 458899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcc-
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-  238 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  238 (413)
                      |+|.+++...    ..+++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999765    5799999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             -eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          239 -ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       239 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                       ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.       ...+.....     .   
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~-----~---  591 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER-----M---  591 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC-----C---
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC-----C---
Confidence             1223456789999999999999999999999999999998 9999976543221       111221111     1   


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                       ..+..++..+.+||.+||+.||++|||+.+|++.|+..
T Consensus       592 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             11223556789999999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-45  Score=342.57  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc--CCC--EEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE--DNS--KVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||||.+...   .......+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999853  233  5899987654   2345567889999999999999999999998765 8


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++++|.+++....   ..+++..++.++.||+.||.|||++   +|+|+||||+|||++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            99999999999999997643   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcce--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          231 LLGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .........  .....+|..|+|||++.+..++.++|||||||++|+|++ |+.||......      ............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCC
Confidence            875443221  223457889999999998889999999999999999999 99999755422      122222221111


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                               ......++..+.+++.+||..||++|||+.+++++|+....
T Consensus       244 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          244 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                     01122345678999999999999999999999999987643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-44  Score=345.61  Aligned_cols=266  Identities=22%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Cee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999965 67789999986543 33446788999999999999999999998655     468


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+. ++|.+++...     .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999996 5999998653     699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcce--eeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          231 LLGSESSYI--TTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       231 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+   .........
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence            765332211  234578999999998654 45899999999999999999999999876544332222   111111000


Q ss_pred             CCc---C----------CCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGV---L----------DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~---~----------~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...   .          .+......    ...++..+.+|+.+||..||++|||+.+++++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            000   0          00000000    112356789999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-44  Score=351.27  Aligned_cols=255  Identities=11%  Similarity=0.041  Sum_probs=185.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHH---HHHhcCCCCCccccc-------cee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEV---EAIGRVRHKNLVRLL-------GYC  144 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~hpniv~~~-------~~~  144 (413)
                      ..|++.+.||+|+||.||+|.+. +++.||||++.....   .....+.+|+   .+|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45899999999999999999965 688899999977543   3345667774   55555 799988755       333


Q ss_pred             eeC-----------------CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHH------HHHHHHHHhhhchhhhccCC
Q 015076          145 AEG-----------------AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR------MNIILGTAKGLSYLHEGLEP  201 (413)
Q Consensus       145 ~~~-----------------~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~  201 (413)
                      ...                 ...++||||++ ++|.+++....   ..+.+..+      +.++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            322                 34799999997 89999997642   23444555      67889999999999999   


Q ss_pred             ceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhC
Q 015076          202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISG  279 (413)
Q Consensus       202 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg  279 (413)
                      ||+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||+||+|++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999976432    223457799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          280 RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       280 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      +.||..........        .............+.......++..+.+||.+||+.||++|||+.+++++..
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            99998664321110        0000000011111111222345678999999999999999999999987643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-44  Score=353.92  Aligned_cols=270  Identities=19%  Similarity=0.223  Sum_probs=207.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC--------CCCccccccee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR--------HKNLVRLLGYC  144 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~~~~~~  144 (413)
                      ..+..++|++.+.||+|+||+||+|.+. +++.||||++... ......+.+|+.+++.++        |+||+++++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            3445688999999999999999999965 5778999988643 344567788999998885        78899999998


Q ss_pred             e----eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-
Q 015076          145 A----EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-  219 (413)
Q Consensus       145 ~----~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-  219 (413)
                      .    .....++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++.  ||+||||||+|||++.++ 
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence            7    566889999999 5566666644321  46999999999999999999999853  899999999999998775 


Q ss_pred             ------------------------------------------------CceEEecccceecCCCCcceeeccccccCccC
Q 015076          220 ------------------------------------------------NPKVSDFGLAKLLGSESSYITTRVMGTFGYVA  251 (413)
Q Consensus       220 ------------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~a  251 (413)
                                                                      .+||+|||++......    .....||+.|+|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a  261 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence                                                            7999999999876533    233568999999


Q ss_pred             ccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH---HHHHHhhcCC---------CCCcCCC------
Q 015076          252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---WLKKMVTNRN---------PEGVLDP------  313 (413)
Q Consensus       252 PE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~------  313 (413)
                      ||++.+..++.++|||||||+||+|++|+.||.............   .+........         ....+..      
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            999999999999999999999999999999998766543322221   1211111100         0000000      


Q ss_pred             --CC-----------CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 --KL-----------PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 --~~-----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ..           ........+..+.+|+.+||+.||++|||+.+++++-.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence              00           00124567788999999999999999999999998743

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.9e-45  Score=375.86  Aligned_cols=261  Identities=21%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE  146 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~  146 (413)
                      ..+++..++|++.+.||+|+||.||+|.+..    +..||||.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3455667889999999999999999998643    4569999876543 3344678899999999999999999999854


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                       +..++||||+++|+|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence             56899999999999999997543   4689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      |+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+      .+..+....
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~~  609 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGE  609 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHTC
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCC
Confidence            9998775544333344557889999999999999999999999999999997 999997554322      112222111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..      ..    +..++..+.+++.+||..||++|||+.+|++.|+.+
T Consensus       610 ~~------~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          610 RL------PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             CC------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            10      11    123456788999999999999999999999999865

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.4e-44  Score=353.85  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee------CCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~~  150 (413)
                      ..+|++.+.||+|+||.||+|.+. ++..||||++......    ..+|+++++.++||||+++++++..      ...+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346999999999999999999975 5889999998654322    3369999999999999999998843      2346


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-CCceEEecccc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLA  229 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a  229 (413)
                      ++||||+++ +|.+++.........+++..++.++.||+.||+|||++   ||+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999965 66665543211225799999999999999999999999   99999999999999965 56899999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh-----
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-----  303 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----  303 (413)
                      +.......  .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+....+  + ..+.     
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i--~-~~lg~p~~~  279 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI--I-KVLGTPTRE  279 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H-HHHCSCCHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-HHhCCCCHH
Confidence            87654332  2345789999999998765 7999999999999999999999999865432221111  1 1110     


Q ss_pred             -----cCCCCCcCCCCCCCCC-----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          304 -----NRNPEGVLDPKLPEKP-----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       304 -----~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                           .........+.+....     ....+.++.+|+.+||..||++|||+.++++|...
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence                 1111111111111111     11235678999999999999999999999987543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-44  Score=344.28  Aligned_cols=254  Identities=21%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--------hhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--------QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+.....        .....+.+|+.+++.++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999975 578899998864321        12235788999999999999999999987665


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEe
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSD  225 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  225 (413)
                       .++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             89999999999999998765    5799999999999999999999999   9999999999999987665   99999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      ||++.......  ......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  ....+..  
T Consensus       161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~--  234 (322)
T 2ycf_A          161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS--  234 (322)
T ss_dssp             CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH--
T ss_pred             Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh--
Confidence            99998775432  123456899999999874   56789999999999999999999999976543322  1111111  


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ...      .........++..+.+++.+||..||++|||+.+++++..
T Consensus       235 --~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~  277 (322)
T 2ycf_A          235 --GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  277 (322)
T ss_dssp             --TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             --Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence              110      0000111224567899999999999999999999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-44  Score=350.52  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=187.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC------C
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG------A  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~  148 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999964 68889999986532  33456788999999999999999999998654      5


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++|||++ +++|.+++..     ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 7899998865     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....   ..+...+.....
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~  251 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGA  251 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCH
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCH
Confidence            9875432    234578999999999877 67999999999999999999999999865432221   111111111000


Q ss_pred             C---CcC----------CCCCCCCCc----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          308 E---GVL----------DPKLPEKPT----SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       308 ~---~~~----------~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .   .+.          -+..+....    ...+..+.+|+.+||..||++|||+.+++++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~  315 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  315 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence            0   000          000000110    1124568899999999999999999999998543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=345.35  Aligned_cols=255  Identities=15%  Similarity=0.162  Sum_probs=204.5

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEE------EcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCCccccccee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYC  144 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~  144 (413)
                      +.+..++|.+.+.||+|+||.||+|.      ...++.||||.+....   ...+..|+.+++.++   |+||+.+++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            44567889999999999999999994      4468889999886543   445667788777776   99999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC------
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG-PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK------  217 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~------  217 (413)
                      ...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++   ||+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999974211 125799999999999999999999999   9999999999999998      


Q ss_pred             -----CCCceEEecccceecCC-CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCccc
Q 015076          218 -----HWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE  291 (413)
Q Consensus       218 -----~~~~kl~DfG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~  291 (413)
                           ++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 89999999999976532 222234556799999999999999999999999999999999999999964322110


Q ss_pred             ccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcc
Q 015076          292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR-PKMGHVVHMLEAQ  355 (413)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~eil~~le~~  355 (413)
                      .                  +...+....   ....+.+++..||+.+|.+| |++.++.+.|+..
T Consensus       294 ~------------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 K------------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             E------------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             e------------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            0                  011111112   24457788899999999999 5788888777764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=343.42  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeee------C
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAE------G  147 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~------~  147 (413)
                      ...++|++.+.||+|+||.||+|.+. ++..||||.+.... .....+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            35678999999999999999999974 68899999886543 3346788899999998 79999999999976      5


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...++||||+++++|.+++.....  ..+++..++.++.||+.||+|||+.   ||+|+||||+|||++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence            688999999999999999976421  4689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      ++........ ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......      ......
T Consensus       175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~  247 (326)
T 2x7f_A          175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP  247 (326)
T ss_dssp             TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH
T ss_pred             CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhh
Confidence            9987643221 123456899999999986     5678999999999999999999999997543221      111222


Q ss_pred             hcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          303 TNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .....         ......++..+.+++.+||..||++|||+.+++++...
T Consensus       248 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~  290 (326)
T 2x7f_A          248 RNPAP---------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI  290 (326)
T ss_dssp             HSCCC---------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred             cCccc---------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence            21111         11112245678999999999999999999999987543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.6e-44  Score=356.08  Aligned_cols=260  Identities=19%  Similarity=0.256  Sum_probs=208.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEE-cCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC-CCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||.||+|.+ .++..||||++......  ..+..|+.+++.++| ++|..+..++......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999996 46889999987654322  346789999999987 555566666778889999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE---cCCCCceEEecccceec
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~  232 (413)
                      |+ +++|.+++....   ..+++..++.|+.||+.||+|||++   +|+||||||+||||   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 999999997533   4799999999999999999999999   99999999999999   68899999999999877


Q ss_pred             CCCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          233 GSESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       233 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ......      ......||+.|+|||++.+..++.++|||||||+||+|++|+.||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543321      12256799999999999999999999999999999999999999987665443333332222211111


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...+         ...++.++.+++..||..||++||++.+|++.|+.+
T Consensus       237 ~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1000         012346789999999999999999999999988764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=350.79  Aligned_cols=272  Identities=18%  Similarity=0.249  Sum_probs=188.1

Q ss_pred             CCCc-ccEEeeeCceEEEEEEEc---CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee--eCCeeEEE
Q 015076           80 GFSD-DKVIGEGGYGIVYYGLLE---DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLV  153 (413)
Q Consensus        80 ~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~iv  153 (413)
                      .|++ +++||+|+||.||+|.++   ++..||||++....  ....+.+|+.+|+.++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4666 558999999999999965   47789999886443  2345778999999999999999999995  46789999


Q ss_pred             EEeccCCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE----cCCCCceEE
Q 015076          154 YEYVNNGNLEQWLHGDV-----GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI----DKHWNPKVS  224 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  224 (413)
                      |||+. ++|.+++....     .....+++..++.++.||+.||+|||++   ||+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99995 58887774211     1113599999999999999999999999   99999999999999    677899999


Q ss_pred             ecccceecCCCCc--ceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcc------cccHH
Q 015076          225 DFGLAKLLGSESS--YITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPE------EVNLI  295 (413)
Q Consensus       225 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~------~~~~~  295 (413)
                      |||+++.......  ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......      ....+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987653221  123446789999999998774 58999999999999999999999997654321      01112


Q ss_pred             HHHHHHhhcCCCCCcCC----------------CCCCCCCcH--------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          296 EWLKKMVTNRNPEGVLD----------------PKLPEKPTS--------RLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       296 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--------~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      ..+...+........-.                .........        .....+.+||.+||..||.+|||+.++++|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            22222221111000000                000000000        013467899999999999999999999999


Q ss_pred             HhcccC
Q 015076          352 LEAQES  357 (413)
Q Consensus       352 le~~~~  357 (413)
                      -.....
T Consensus       335 p~f~~~  340 (405)
T 3rgf_A          335 PYFLED  340 (405)
T ss_dssp             GGGTSS
T ss_pred             hhhccC
Confidence            766543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=346.77  Aligned_cols=264  Identities=24%  Similarity=0.351  Sum_probs=204.8

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA  148 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~  148 (413)
                      ++++++..++|++.+.||+|+||.||+|.+..  .+|+|.+....  ......+.+|+.+++.++||||+++++++....
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34556778899999999999999999999764  49999886442  222345677999999999999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++ ++.+||+|||+
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999997653   4689999999999999999999999   999999999999998 67999999999


Q ss_pred             ceecCCCCc----ceeeccccccCccCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH
Q 015076          229 AKLLGSESS----YITTRVMGTFGYVAPEYAST---------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       229 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~  295 (413)
                      +........    .......||+.|+|||++.+         ..++.++|||||||++|+|++|+.||.......     
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----  250 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----  250 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            876532111    11223458999999999864         457899999999999999999999997543221     


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccCC
Q 015076          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP  358 (413)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~~  358 (413)
                       ...... ........        ...++..+.+++.+||..||++|||+.++++.|+.+...
T Consensus       251 -~~~~~~-~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 -IIWQMG-TGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -HHHHHH-TTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -HHHHhc-cCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             111111 11111111        112334588999999999999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=338.06  Aligned_cols=265  Identities=21%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceee-----------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCA-----------  145 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----------  145 (413)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..........+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999976 48889999998776666778899999999999999999998873           


Q ss_pred             ---eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-CCCCc
Q 015076          146 ---EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNP  221 (413)
Q Consensus       146 ---~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  221 (413)
                         .....++||||++ ++|.+++..     ..+++..++.++.||+.||+|||++   ||+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               4467899999996 699999864     3689999999999999999999999   999999999999997 56789


Q ss_pred             eEEecccceecCCCCc--ceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 015076          222 KVSDFGLAKLLGSESS--YITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~  298 (413)
                      ||+|||++........  .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...........   +
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---I  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence            9999999987643211  11233457999999998865 6789999999999999999999999986543221111   1


Q ss_pred             HHHhhcC----------CCCC-----cCCCCCC-CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          299 KKMVTNR----------NPEG-----VLDPKLP-EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       299 ~~~~~~~----------~~~~-----~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .......          ....     ...+..+ ......++..+.+++.+||+.||++|||+.+++++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            1100000          0000     0000000 00011245678999999999999999999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-43  Score=336.89  Aligned_cols=263  Identities=20%  Similarity=0.281  Sum_probs=206.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEE-c-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC------CcccccceeeeC
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLL-E-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK------NLVRLLGYCAEG  147 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp------niv~~~~~~~~~  147 (413)
                      +..++|++.+.||+|+||.||+|.+ . ++..||||++... ......+.+|+.+++.++|+      +|+++++++...
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            3457899999999999999999986 3 5788999988543 34456778899999888655      599999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC----------
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK----------  217 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~----------  217 (413)
                      +..++||||+ +++|.+++.....  .++++..++.++.||+.||+|||++   ||+||||||+|||++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999 8899999876532  4689999999999999999999999   9999999999999987          


Q ss_pred             ---------CCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 015076          218 ---------HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP  288 (413)
Q Consensus       218 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~  288 (413)
                               ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     668999999999875433    2345789999999999999999999999999999999999999986543


Q ss_pred             cccccHHHHHHHHhhcCCC--------CCcC-------C--------------C-CCCCCCcHHHHHHHHHHHHhcCCCC
Q 015076          289 PEEVNLIEWLKKMVTNRNP--------EGVL-------D--------------P-KLPEKPTSRLLKRILLVALRCVDPN  338 (413)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~--------~~~~-------~--------------~-~~~~~~~~~~~~~l~~li~~cl~~d  338 (413)
                      .+....   +.........        ....       .              + ..........+..+.+|+.+||+.|
T Consensus       240 ~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          240 KEHLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             HHHHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            322211   1111110000        0000       0              0 0000112345778999999999999


Q ss_pred             CCCCCCHHHHHHHH
Q 015076          339 AQKRPKMGHVVHML  352 (413)
Q Consensus       339 p~~RPs~~eil~~l  352 (413)
                      |.+|||+.|++++-
T Consensus       317 P~~Rpt~~ell~hp  330 (339)
T 1z57_A          317 PAKRITLREALKHP  330 (339)
T ss_dssp             TTTSCCHHHHTTSG
T ss_pred             cccccCHHHHhcCH
Confidence            99999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.6e-44  Score=333.05  Aligned_cols=255  Identities=21%  Similarity=0.299  Sum_probs=207.2

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ...++|++.+.||+|+||.||+|.+. +++.||||.+....  ......+.+|+.++++++||||+++++++......++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34568999999999999999999976 68899999986543  3346678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC---CCceEEecccc
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH---WNPKVSDFGLA  229 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a  229 (413)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999988654    4689999999999999999999999   99999999999999764   46999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ........  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......      ............  
T Consensus       172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--  240 (287)
T 2wei_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA--  240 (287)
T ss_dssp             GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--
T ss_pred             eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC--
Confidence            87654322  233458999999998865 4899999999999999999999999754322      112222221110  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          310 VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       310 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                           .+......++..+.+++.+||..||++|||+.+++++..
T Consensus       241 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             -----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             -----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence                 011111234567899999999999999999999998643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-43  Score=342.38  Aligned_cols=260  Identities=22%  Similarity=0.323  Sum_probs=200.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee---
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR---  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~---  150 (413)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++....  ......+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999999965 68889999986543  23356788999999999999999999999877655   


Q ss_pred             ---EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          151 ---MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       151 ---~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                         ++||||+. ++|.+++.      ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999996 68888874      3589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      +++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...   .+........
T Consensus       190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~  262 (371)
T 4exu_A          190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPG  262 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred             cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCc
Confidence            99865432    234578999999999877 679999999999999999999999997654322111   1111110000


Q ss_pred             CCCcCC--------------CCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          307 PEGVLD--------------PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       307 ~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       .....              +..+...    ...++..+.+|+.+||+.||++|||+.+++++...
T Consensus       263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  327 (371)
T 4exu_A          263 -TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  327 (371)
T ss_dssp             -HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             -HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence             00000              0000000    11235678999999999999999999999988554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-43  Score=343.10  Aligned_cols=272  Identities=18%  Similarity=0.221  Sum_probs=193.2

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC---
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA---  148 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---  148 (413)
                      ......++|++.+.||+|+||.||+|.+. ++..||||++...... ......+++.++.++||||+++++++....   
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            44567789999999999999999999975 6889999988654322 234556788888889999999999986533   


Q ss_pred             ----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh--hccCCceeeccCCCCcEEEcC-CCCc
Q 015076          149 ----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH--EGLEPKVVHRDIKSSNILIDK-HWNP  221 (413)
Q Consensus       149 ----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~  221 (413)
                          ..++||||+++ +|...+.........+++..++.++.|++.||.|||  +.   ||+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                27899999976 555444321112257899999999999999999999  88   9999999999999997 8999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........   +..
T Consensus       172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~---~~~  246 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE---IVR  246 (360)
T ss_dssp             EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH
T ss_pred             EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH---HHH
Confidence            9999999987654332  33456899999999986654 89999999999999999999999986543322211   111


Q ss_pred             HhhcC------------CCCCcCCCC-C-----CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          301 MVTNR------------NPEGVLDPK-L-----PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       301 ~~~~~------------~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      .....            ......... .     ........+..+.+|+.+||+.||.+|||+.+++++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            11100            000000000 0     001111246789999999999999999999999988544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-44  Score=341.39  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--chhHHHHHHHHHHHhcCC--CCCcccccceeeeC
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEG  147 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~  147 (413)
                      +.+.+..++|++.+.||+|+||.||+|.+.++..||||.+....  ......+.+|+.+++.++  ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            33455667899999999999999999998889999999986543  344567889999999997  59999999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          148 AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       148 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                      ...++||| +.+++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||+++ +.+||+|||
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999 5588999999865    4789999999999999999999999   9999999999999965 799999999


Q ss_pred             cceecCCCCcc-eeeccccccCccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHH
Q 015076          228 LAKLLGSESSY-ITTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI  295 (413)
Q Consensus       228 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~  295 (413)
                      ++......... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....     ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HH
Confidence            99876543221 1234568999999999865           4688999999999999999999999974332     11


Q ss_pred             HHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          296 EWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..+.........     ..++..    .+..+.+++.+||..||++|||+.+++++....
T Consensus       247 ~~~~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          247 SKLHAIIDPNHE-----IEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             HHHHHHHCTTSC-----CCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHhcccc-----cCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence            222222221111     111111    245688999999999999999999999886543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-43  Score=332.37  Aligned_cols=254  Identities=27%  Similarity=0.384  Sum_probs=196.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee----------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----------  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------  146 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+... ......+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            356999999999999999999965 6889999988543 3445678899999999999999999998754          


Q ss_pred             ---CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceE
Q 015076          147 ---GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV  223 (413)
Q Consensus       147 ---~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  223 (413)
                         ....++||||+++++|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence               456799999999999999997542   4678899999999999999999999   9999999999999999999999


Q ss_pred             EecccceecCCCC-------------cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 015076          224 SDFGLAKLLGSES-------------SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (413)
Q Consensus       224 ~DfG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~  289 (413)
                      +|||++.......             ........||+.|+|||++.+. .++.++|||||||++|+|++   ||...   
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---  231 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---  231 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence            9999998664321             1112345689999999998764 68999999999999999998   55321   


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ............ .      ...++.......+..+.+++.+||+.||.+|||+.+++++..
T Consensus       232 --~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          232 --MERVNILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             --HHHHHHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             --hhHHHHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence              111122222211 1      111222233344566889999999999999999999998743

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.4e-43  Score=340.21  Aligned_cols=270  Identities=21%  Similarity=0.251  Sum_probs=204.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CC-----Ccccccceee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HK-----NLVRLLGYCA  145 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~~~~~~~  145 (413)
                      ......++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+.+++.++ |+     +|+.+++++.
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            33445689999999999999999999966 5778999988643 334456777888888774 44     4899999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc--CCCCceE
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKV  223 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl  223 (413)
                      .....++||||++ ++|.+++.....  ..+++..++.++.||+.||.|||.+ ..||+||||||+|||++  .++.+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999995 599999876432  4689999999999999999999942 12999999999999995  4778999


Q ss_pred             EecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 015076          224 SDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT  303 (413)
Q Consensus       224 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  303 (413)
                      +|||+++.....    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....   +.....
T Consensus       203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---i~~~~~  275 (382)
T 2vx3_A          203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK---IVEVLG  275 (382)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHC
T ss_pred             EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhC
Confidence            999999887543    2345789999999999999999999999999999999999999986543322211   111111


Q ss_pred             cCC-----------------CCCcC------CC----CCC-----------------------CCCcHHHHHHHHHHHHh
Q 015076          304 NRN-----------------PEGVL------DP----KLP-----------------------EKPTSRLLKRILLVALR  333 (413)
Q Consensus       304 ~~~-----------------~~~~~------~~----~~~-----------------------~~~~~~~~~~l~~li~~  333 (413)
                      ...                 +...+      +.    ..+                       ..........+.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            000                 00000      00    000                       00112234578999999


Q ss_pred             cCCCCCCCCCCHHHHHHHHhc
Q 015076          334 CVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       334 cl~~dp~~RPs~~eil~~le~  354 (413)
                      ||+.||++|||+.+++++-..
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFF  376 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGG
T ss_pred             hcCCChhhCCCHHHHhcCccc
Confidence            999999999999999987543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.3e-44  Score=339.31  Aligned_cols=266  Identities=24%  Similarity=0.324  Sum_probs=202.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEE--cCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCCcccccceee----
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLL--EDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCA----  145 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~----  145 (413)
                      ..++|++.+.||+|+||.||+|.+  .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            357899999999999999999997  3577899998864322  1122445566666655   8999999999987    


Q ss_pred             -eCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEE
Q 015076          146 -EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVS  224 (413)
Q Consensus       146 -~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  224 (413)
                       .....++||||++ ++|.+++.....  ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5577899999996 699999876432  3589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          225 DFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       225 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      |||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+......
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence            999998664322  2334568999999999999999999999999999999999999997654322   12112221111


Q ss_pred             CCCCC----------cCCC---CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          305 RNPEG----------VLDP---KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       305 ~~~~~----------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .....          .+..   .........++..+.+|+.+||..||++|||+.+++++-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            10000          0000   0000111235567889999999999999999999998744

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-43  Score=338.58  Aligned_cols=258  Identities=19%  Similarity=0.232  Sum_probs=178.7

Q ss_pred             hcCCCCccc-EEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee----CCee
Q 015076           77 STNGFSDDK-VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        77 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~  150 (413)
                      ..++|.+.+ +||+|+||.||+|.+. +++.||||++.... ...   ......++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788854 6999999999999976 68899999886432 222   223334566789999999999876    4568


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEecc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG  227 (413)
                      ++||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            999999999999999976532  4799999999999999999999999   9999999999999976   4459999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||............   .......  
T Consensus       177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~--  248 (336)
T 3fhr_A          177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG--  248 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc--
Confidence            998764322   23456899999999998888999999999999999999999999755432211100   0000000  


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          ...++......++..+.+|+.+||..||++|||+.+++++....
T Consensus       249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence                01111122234567789999999999999999999999986543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=338.80  Aligned_cols=259  Identities=21%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe-----
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH-----  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-----  149 (413)
                      .++|.+.+.||+|+||.||+|.+. ++..||||.+....  ......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999975 68889999986543  2335678899999999999999999999987654     


Q ss_pred             -eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          150 -RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       150 -~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                       .++||||+. ++|.+++.      ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999996 68888874      2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC--
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR--  305 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--  305 (413)
                      +......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..   ..+.......  
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~  245 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGT  245 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCH
Confidence            9865432    233568999999999877 67899999999999999999999999765432211   1111110000  


Q ss_pred             ----------------CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          306 ----------------NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       306 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                                      .........+. .....++..+.+++.+||..||++|||+.+++++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  309 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  309 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                            00000001111 1122356678999999999999999999999987543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-43  Score=341.66  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=204.3

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Cee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~  150 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999976 58889999986443 33455778899999999999999999987654     678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+. ++|.+++...     .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999996 6999988753     699999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCcc---------eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          231 LLGSESSY---------ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       231 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ........         ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......   ...+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence            76532211         1123468999999998754 6789999999999999999999999986543221   111111


Q ss_pred             HhhcCCCCCcCC--------------CCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          301 MVTNRNPEGVLD--------------PKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       301 ~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ............              +..+...    ...++..+.+|+.+||..||++|||+.+++++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            111111000000              0000000    113456788999999999999999999999975543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.2e-43  Score=347.52  Aligned_cols=256  Identities=23%  Similarity=0.284  Sum_probs=192.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +.|.+.++||+|+||+||.+...+|+.||||++....   ...+.+|+.+++.+ +||||+++++++.++...++|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4466678999999999987777779999999886532   34567899999876 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCC---CCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC-------------CCc
Q 015076          158 NNGNLEQWLHGDVGPCSP---LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH-------------WNP  221 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~  221 (413)
                      + |+|.+++.........   ..+..++.++.||+.||+|||++   ||+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999765321111   13335678999999999999999   99999999999999754             479


Q ss_pred             eEEecccceecCCCCcc---eeeccccccCccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 015076          222 KVSDFGLAKLLGSESSY---ITTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPE  290 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~  290 (413)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999987654322   1234579999999999865       668999999999999999999 999996443221


Q ss_pred             cccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                          ..    .......    .+.........++..+.++|.+||+.||++|||+.+|+++..
T Consensus       248 ----~~----i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          248 ----SN----IIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             ----HH----HHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             ----HH----HhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence                11    1111110    011222334567889999999999999999999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-42  Score=335.19  Aligned_cols=269  Identities=19%  Similarity=0.229  Sum_probs=203.5

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----------CCCccccccee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----------HKNLVRLLGYC  144 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~  144 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+... ......+.+|+.++++++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3568999999999999999999964 6888999988643 334566788999988876           89999999998


Q ss_pred             eeCC----eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---
Q 015076          145 AEGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---  217 (413)
Q Consensus       145 ~~~~----~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---  217 (413)
                      ....    ..++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++.  ||+||||||+|||++.   
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            7654    789999999 8899999976432  46999999999999999999999842  8999999999999953   


Q ss_pred             ---CCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH
Q 015076          218 ---HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL  294 (413)
Q Consensus       218 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~  294 (413)
                         .+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               347999999999876532    2334689999999999999999999999999999999999999986553322111


Q ss_pred             HHH---HHHHhhcC------------------CC-CCcCCCCC---------CCCCcHHHHHHHHHHHHhcCCCCCCCCC
Q 015076          295 IEW---LKKMVTNR------------------NP-EGVLDPKL---------PEKPTSRLLKRILLVALRCVDPNAQKRP  343 (413)
Q Consensus       295 ~~~---~~~~~~~~------------------~~-~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RP  343 (413)
                      ...   +...+...                  .. ..+.....         .......++..+.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            111   11111100                  00 00000000         0123456788899999999999999999


Q ss_pred             CHHHHHHHHhcc
Q 015076          344 KMGHVVHMLEAQ  355 (413)
Q Consensus       344 s~~eil~~le~~  355 (413)
                      |+.+++++....
T Consensus       327 t~~ell~hp~f~  338 (373)
T 1q8y_A          327 DAGGLVNHPWLK  338 (373)
T ss_dssp             CHHHHHTCGGGT
T ss_pred             CHHHHhhChhhh
Confidence            999999986544

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.5e-43  Score=332.39  Aligned_cols=263  Identities=26%  Similarity=0.368  Sum_probs=184.1

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHH-HHhcCCCCCcccccceeeeCCeeE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      .+..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+..|+. +++.++||||+++++++...+..+
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            345688999999999999999999975 688899999876532 33344555555 778889999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCC-CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          152 LVYEYVNNGNLEQWLHGDV-GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      +||||+++ +|.+++.... .....+++..++.++.|++.||.|||+..  ||+||||||+|||++.++.+||+|||++.
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            99999965 8877775310 01157999999999999999999999853  89999999999999999999999999998


Q ss_pred             ecCCCCcceeeccccccCccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      .......  .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||........     .+....    
T Consensus       175 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~----  243 (327)
T 3aln_A          175 QLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV----  243 (327)
T ss_dssp             C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC----
T ss_pred             ecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh----
Confidence            7643322  2334689999999998    456789999999999999999999999975332110     000000    


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                        ....+.++......++..+.+++.+||..||++|||+.+++++..
T Consensus       244 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  288 (327)
T 3aln_A          244 --KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF  288 (327)
T ss_dssp             --CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             --cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence              001112222222335667899999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-42  Score=332.89  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=203.6

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CC-CEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC------cccccceeeeCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DN-SKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN------LVRLLGYCAEGA  148 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~~~~~~~~~~  148 (413)
                      ..++|++.+.||+|+||.||+|.+. ++ ..||+|.+... ......+..|+.+++.++|++      ++.+++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            4578999999999999999999975 34 57999988543 344567788999999887655      889999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEE-------------
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILI-------------  215 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll-------------  215 (413)
                      ..++||||+ +++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 6677777654321  4699999999999999999999999   99999999999999             


Q ss_pred             ------cCCCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 015076          216 ------DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPP  289 (413)
Q Consensus       216 ------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~  289 (413)
                            +.++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  66789999999999875433    23457899999999999999999999999999999999999999865432


Q ss_pred             ccccHHHHHHHHhhcCCCCCc----------------CCC---------------CCCCCCcHHHHHHHHHHHHhcCCCC
Q 015076          290 EEVNLIEWLKKMVTNRNPEGV----------------LDP---------------KLPEKPTSRLLKRILLVALRCVDPN  338 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~----------------~~~---------------~~~~~~~~~~~~~l~~li~~cl~~d  338 (413)
                      ....   .+...... .+...                .+.               .............+.+|+.+||+.|
T Consensus       246 ~~~~---~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          246 EHLV---MMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HHHH---HHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHH---HHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            2211   11111110 00000                000               0000112345668899999999999


Q ss_pred             CCCCCCHHHHHHHHh
Q 015076          339 AQKRPKMGHVVHMLE  353 (413)
Q Consensus       339 p~~RPs~~eil~~le  353 (413)
                      |++|||+.+++++-.
T Consensus       322 P~~Rpt~~e~l~hp~  336 (355)
T 2eu9_A          322 PAQRITLAEALLHPF  336 (355)
T ss_dssp             TTTSCCHHHHTTSGG
T ss_pred             hhhCcCHHHHhcChh
Confidence            999999999998744

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=331.82  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=194.6

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcC----CCCCcccccce
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRV----RHKNLVRLLGY  143 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~hpniv~~~~~  143 (413)
                      +...++|++.+.||+|+||.||+|.+. ++..||||.+......      ....+..|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345678999999999999999999864 6889999988654321      223355688888887    89999999999


Q ss_pred             eeeCCeeEEEEEe-ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-CCCCc
Q 015076          144 CAEGAHRMLVYEY-VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNP  221 (413)
Q Consensus       144 ~~~~~~~~iv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  221 (413)
                      +...+..++|||+ +.+++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 7889999999765    4699999999999999999999999   999999999999999 88999


Q ss_pred             eEEecccceecCCCCcceeeccccccCccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          222 KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       222 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      ||+|||++.......   .....||..|+|||++.+..+. .++|||||||++|+|++|+.||....            .
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------E  244 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------H
Confidence            999999998775432   2345689999999998777664 58999999999999999999996321            0


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....       ..+    ...++..+.++|.+||+.||++|||+.+++++....
T Consensus       245 ~~~~~-------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          245 ILEAE-------LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             HHHTC-------CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             Hhhhc-------cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            11110       011    122455788999999999999999999999975543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=344.58  Aligned_cols=252  Identities=26%  Similarity=0.328  Sum_probs=191.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ...+|.+.++||+|+||+||.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            44569999999999999977655667999999998654332   245699999998 79999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---C--CCceEEecccce
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---H--WNPKVSDFGLAK  230 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~a~  230 (413)
                      ||. |+|.+++....   ..+.+..++.++.||+.||+|||++   ||+||||||+|||++.   +  ..+||+|||+++
T Consensus        99 ~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             CCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             CCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            995 69999997654   2345556788999999999999999   9999999999999953   2  357799999998


Q ss_pred             ecCCCCc--ceeeccccccCccCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          231 LLGSESS--YITTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      .......  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||.......       .......
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~  244 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGA  244 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhcc
Confidence            7654322  1234467999999999997   4567889999999999999999 999996432211       1111111


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ... .      ...........+.+||.+||+.||++|||+.+|+++.
T Consensus       245 ~~~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          245 CSL-D------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             CCC-T------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             CCc-c------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            111 0      1112234566688999999999999999999999763

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-43  Score=337.24  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=203.3

Q ss_pred             ccHHHHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch------hHHHHHHHHHHHhcCC--CCCccc
Q 015076           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ------AEREFKVEVEAIGRVR--HKNLVR  139 (413)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv~  139 (413)
                      .+..+.....++|++.+.||+|+||.||+|.+. ++..||||.+......      ....+..|+.+++.++  ||||++
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            344556677889999999999999999999964 6788999998654321      2234567899999986  599999


Q ss_pred             ccceeeeCCeeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc-C
Q 015076          140 LLGYCAEGAHRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-K  217 (413)
Q Consensus       140 ~~~~~~~~~~~~iv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~-~  217 (413)
                      +++++...+..++|||++.+ ++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++ +
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence            99999999999999999976 8999999765    5799999999999999999999999   999999999999999 7


Q ss_pred             CCCceEEecccceecCCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 015076          218 HWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       218 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~  296 (413)
                      ++.+||+|||++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....         
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------  253 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------  253 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred             CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence            8899999999998775432   234568999999999877765 688999999999999999999996321         


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                         .......       .+    ...++..+.+++.+||..||++|||+.+|+++...
T Consensus       254 ---~~~~~~~-------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          254 ---EIIRGQV-------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             ---HHHHCCC-------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             ---hhhcccc-------cc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence               1111110       01    11234578899999999999999999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-42  Score=363.32  Aligned_cols=239  Identities=22%  Similarity=0.331  Sum_probs=194.3

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc--CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe---
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE--DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH---  149 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~---  149 (413)
                      +..++|++.+.||+|+||.||+|.+.  +++.||||.+.... ......+..|+.+++.++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            44588999999999999999999975  57889999886543 3445678899999999999999999999987655   


Q ss_pred             --eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecc
Q 015076          150 --RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG  227 (413)
Q Consensus       150 --~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  227 (413)
                        .||||||++|++|.+++..      .+++..++.++.||+.||.|||++   ||+||||||+|||++.+ .+||+|||
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence              7999999999999987753      589999999999999999999999   99999999999999986 99999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +++.....     ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......                 
T Consensus       227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            99877543     3356899999999987654 899999999999999999998886321110                 


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHh
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM-GHVVHMLE  353 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-~eil~~le  353 (413)
                            .............+.++|.+||+.||++||+. .++...|.
T Consensus       284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                  00112223345678999999999999999964 44544444

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=325.79  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=186.6

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch--hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ--AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ...++|++.+.||+|+||.||+|.+. +++.||||.+......  ....+..+..+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            34578999999999999999999975 6889999998765432  22344555567888899999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||+ ++.+..+.....   ..+++..++.++.||+.||.|||+ .   ||+||||||+|||++.++.+||+|||++..
T Consensus       102 v~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999 556666554322   479999999999999999999998 6   899999999999999999999999999976


Q ss_pred             cCCCCcceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ......  .....||+.|+|||++.     ...++.++|||||||++|+|++|+.||......     ...+........
T Consensus       175 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~  247 (318)
T 2dyl_A          175 LVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP  247 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC
T ss_pred             ccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC
Confidence            643322  23356899999999984     556889999999999999999999999753321     122222222211


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .      .++.  ...++..+.+++.+||..||.+|||+.+++++..
T Consensus       248 ~------~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          248 P------LLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             C------CCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             C------CCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence            1      1111  1124567889999999999999999999998643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.2e-42  Score=353.66  Aligned_cols=266  Identities=22%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeee------CCe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~  149 (413)
                      .++|++.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.+++.++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999964 6888999988654 33445678899999999999999999998765      677


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCC---ceEEec
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWN---PKVSDF  226 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  226 (413)
                      .++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            8999999999999999976432 24689999999999999999999999   9999999999999997765   899999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccH---HHHHHHHhh
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL---IEWLKKMVT  303 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~  303 (413)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........   .........
T Consensus       169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99987754332  3445789999999999999999999999999999999999999975321100000   000000000


Q ss_pred             cCCCCCc--CCC--CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 015076          304 NRNPEGV--LDP--KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV  349 (413)
Q Consensus       304 ~~~~~~~--~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil  349 (413)
                      .......  +..  ..+......++..+.+++.+||..||++|||+.+++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0000000  001  112234456788999999999999999999998744

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.1e-41  Score=313.77  Aligned_cols=231  Identities=13%  Similarity=0.083  Sum_probs=186.2

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.....   .....+.+|+.+++.++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999976 488899999876533   334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||++|++|.+++...      .....+..++.||+.||+|||++   ||+||||||+|||++.++.+||+++|     
T Consensus       109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            99999999999999542      35557889999999999999999   99999999999999999999997443     


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                                      |++       .++.++|||||||++|+|++|+.||............            .....
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~  219 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTA  219 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTT
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhc
Confidence                            333       3688999999999999999999999866543211000            00000


Q ss_pred             CCCC--CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          313 PKLP--EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       313 ~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      ....  ......++..+.+++.+||+.||++| |+.++++.|+....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0000  01112345678999999999999999 99999999988654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-41  Score=325.33  Aligned_cols=247  Identities=15%  Similarity=0.131  Sum_probs=190.9

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCC--------chhHHHHHHHHHHHhcCC--------------
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNR--------GQAEREFKVEVEAIGRVR--------------  133 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~--------------  133 (413)
                      +..++|++.+.||+|+||.||+|++ +++.||||++....        ......+.+|+.+++.++              
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3456799999999999999999998 58899999987553        223367788888888876              


Q ss_pred             ------------CCCcccccceeee-------------CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 015076          134 ------------HKNLVRLLGYCAE-------------GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT  188 (413)
Q Consensus       134 ------------hpniv~~~~~~~~-------------~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i  188 (413)
                                  ||||+++++++..             ....++||||+++|++.+.+.+     ..+++..++.++.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence                        6666666666664             7889999999999977776643     368999999999999


Q ss_pred             Hhhhchhh-hccCCceeeccCCCCcEEEcCCC--------------------CceEEecccceecCCCCcceeecccccc
Q 015076          189 AKGLSYLH-EGLEPKVVHRDIKSSNILIDKHW--------------------NPKVSDFGLAKLLGSESSYITTRVMGTF  247 (413)
Q Consensus       189 ~~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~  247 (413)
                      +.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....      ..+||+
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~  241 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence            99999999 88   999999999999999887                    8999999999876532      246899


Q ss_pred             CccCccccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHH
Q 015076          248 GYVAPEYASTGMLNERSDVYSFGIL-IMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKR  326 (413)
Q Consensus       248 ~y~aPE~~~~~~~~~~sDvwslG~~-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (413)
                      .|+|||++.+.. +.++||||||++ .+++++|..||...     ................    ...........++.+
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRK  311 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhcc----CcccchhhhhhcCHH
Confidence            999999998766 899999998877 77788899998410     0001111122211111    111122234568889


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHH-HHH
Q 015076          327 ILLVALRCVDPNAQKRPKMGHVV-HML  352 (413)
Q Consensus       327 l~~li~~cl~~dp~~RPs~~eil-~~l  352 (413)
                      +.+||.+||+.|     |+.+++ +|-
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~Hp  333 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQHS  333 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred             HHHHHHHHhccC-----CHHHHHhcCC
Confidence            999999999976     999999 763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-40  Score=310.46  Aligned_cols=234  Identities=18%  Similarity=0.255  Sum_probs=182.6

Q ss_pred             cCCCCcc-cEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHH-hcCCCCCcccccceeee----CCee
Q 015076           78 TNGFSDD-KVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        78 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~----~~~~  150 (413)
                      .++|.+. ++||+|+||.||+|.+. ++..||||.+...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4557776 78999999999999964 6889999988532     3456688877 66689999999999877    6788


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEecc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG  227 (413)
                      ++||||+++++|.+++.....  ..+++..++.++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            999999999999999976532  4699999999999999999999999   9999999999999998   7889999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ++....                       +..++.++|||||||++|+|++|+.||.........           ....
T Consensus       166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~  211 (299)
T 3m2w_A          166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK  211 (299)
T ss_dssp             TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred             cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence            986542                       234678999999999999999999999754322110           0000


Q ss_pred             CCcCCCCC--CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKL--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..+.....  +......++..+.+++.+||+.||++|||+.+++++....
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            01111111  1111123567899999999999999999999999976543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-41  Score=331.76  Aligned_cols=243  Identities=14%  Similarity=0.159  Sum_probs=183.9

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCC-CCcccccce----------
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRH-KNLVRLLGY----------  143 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-pniv~~~~~----------  143 (413)
                      ..|+..++||+|+||.||+|.+. +++.||||++.....   ...+.+.+|+.+++.++| +|...+..+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34788899999999999999954 688999998864332   224678899999999976 332222111          


Q ss_pred             -----------eee-----CCeeEEEEEeccCCChhhhccCC---CCCCCCCCHHHHHHHHHHHHhhhchhhhccCCcee
Q 015076          144 -----------CAE-----GAHRMLVYEYVNNGNLEQWLHGD---VGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV  204 (413)
Q Consensus       144 -----------~~~-----~~~~~iv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~iv  204 (413)
                                 +..     ....+++|+++ +++|.+++...   ......+++..++.++.||+.||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                       111     12357777766 78999988411   11124688899999999999999999999   999


Q ss_pred             eccCCCCcEEEcCCCCceEEecccceecCCCCcceeeccccccCccCcccc----------ccCCCCccchhHHHHHHHH
Q 015076          205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA----------STGMLNERSDVYSFGILIM  274 (413)
Q Consensus       205 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslG~~l~  274 (413)
                      ||||||+|||++.++.+||+|||+++.....    ....+| +.|+|||++          .+..++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999999875432    344567 999999998          5566889999999999999


Q ss_pred             HHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          275 EVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       275 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                      +|++|+.||...........               ++...      ..++..+.+||.+||+.||++|||+.+++++
T Consensus       309 elltg~~Pf~~~~~~~~~~~---------------~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEW---------------IFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGG---------------GGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchhhhHHH---------------HHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999975543222111               11100      0234678999999999999999998888765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.6e-34  Score=289.73  Aligned_cols=184  Identities=14%  Similarity=0.074  Sum_probs=130.8

Q ss_pred             EeeeCceEEEEEE-EcCCCEEEEEEeecCC----------chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeEEEE
Q 015076           87 IGEGGYGIVYYGL-LEDNSKVAVKNLLNNR----------GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        87 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++.|++|.+..++ .--|..+++|.+....          ....+++.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5566666666554 3347789999986542          12345789999999999 6999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      ||++|++|.++|...    ++++..   .|+.||+.||+|||++   |||||||||+||||+++|.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999876    467654   5889999999999999   999999999999999999999999999987754


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP  282 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~P  282 (413)
                      ... ...+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332 2445689999999999865 467789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.7e-29  Score=255.74  Aligned_cols=184  Identities=16%  Similarity=0.216  Sum_probs=146.0

Q ss_pred             CcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCch--------hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQ--------AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ...++||+|+||.||+|.. .+..+++|+.......        ..+.+.+|++++++++||||+.+..++......+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 4788999987543211        134578999999999999999766666677788999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999865            468999999999999999   9999999999999999  99999999999876


Q ss_pred             CCCcce------eeccccccCccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 015076          234 SESSYI------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRIPV  283 (413)
Q Consensus       234 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~~l~elltg~~Pf  283 (413)
                      ......      .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++-+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            532211      235679999999999977  56888899999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.4e-26  Score=212.23  Aligned_cols=154  Identities=18%  Similarity=0.113  Sum_probs=123.8

Q ss_pred             HHHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc------------------hhHHHHHHHHHHHhcC
Q 015076           71 LRELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------------------QAEREFKVEVEAIGRV  132 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l  132 (413)
                      +..+......|.+.+.||+|+||.||+|.+.++..||||.+.....                  .....+.+|+.+++.+
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3344445566778899999999999999997789999998854321                  1345688999999999


Q ss_pred             CCCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       133 ~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      +  | +++.+++.. +..++||||++|++|.+ +..          .....++.|++.||.|||+.   ||+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            9  5 777776644 55699999999999998 422          12357999999999999999   99999999999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcceeeccccccCccCcccccc
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST  257 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  257 (413)
                      ||++ ++.+||+|||+++.              +..++|||++..
T Consensus       224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            9999 99999999999863              445789998743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=8.9e-22  Score=180.81  Aligned_cols=137  Identities=20%  Similarity=0.177  Sum_probs=106.4

Q ss_pred             CCCcccEEeeeCceEEEEEEE-cCCCE--EEEEEeecCCch------------------------hHHHHHHHHHHHhcC
Q 015076           80 GFSDDKVIGEGGYGIVYYGLL-EDNSK--VAVKNLLNNRGQ------------------------AEREFKVEVEAIGRV  132 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  132 (413)
                      -|.+.+.||+|+||.||+|.+ .+|..  ||||.+......                        ....+..|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999997 67888  999986433111                        123678899999999


Q ss_pred             CCCCc--ccccceeeeCCeeEEEEEeccC-C----ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhh-hccCCcee
Q 015076          133 RHKNL--VRLLGYCAEGAHRMLVYEYVNN-G----NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH-EGLEPKVV  204 (413)
Q Consensus       133 ~hpni--v~~~~~~~~~~~~~iv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH-~~~~~~iv  204 (413)
                      .|+++  +.++++    ...++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   ||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv  193 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV  193 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence            88764  333332    356899999942 4    66665432       224457889999999999999 88   999


Q ss_pred             eccCCCCcEEEcCCCCceEEecccceec
Q 015076          205 HRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       205 H~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||||+|||++.  .++|+|||+|...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=6.7e-19  Score=168.63  Aligned_cols=141  Identities=15%  Similarity=0.090  Sum_probs=99.4

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc--------------hhHHH--------HHHHHHHHhcCCC
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--------------QAERE--------FKVEVEAIGRVRH  134 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h  134 (413)
                      ...=|++.+.||.|+||.||+|...+|+.||||++.....              .....        ...|...|.++.+
T Consensus        93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            3334999999999999999999988899999998643210              00111        1234455555533


Q ss_pred             CCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEE
Q 015076          135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNIL  214 (413)
Q Consensus       135 pniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIl  214 (413)
                      .++. +...+.. ...+|||||++|++|..+...        +  ....++.||+.+|.+||+.   |||||||||.|||
T Consensus       173 ~gv~-vp~p~~~-~~~~LVME~i~G~~L~~l~~~--------~--~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL  237 (397)
T 4gyi_A          173 EGFP-VPEPIAQ-SRHTIVMSLVDALPMRQVSSV--------P--DPASLYADLIALILRLAKH---GLIHGDFNEFNIL  237 (397)
T ss_dssp             TTCS-CCCEEEE-ETTEEEEECCSCEEGGGCCCC--------S--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             cCCC-CCeeeec-cCceEEEEecCCccHhhhccc--------H--HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence            3321 1111111 123799999999888776432        1  2356789999999999999   9999999999999


Q ss_pred             EcCCCC----------ceEEecccceec
Q 015076          215 IDKHWN----------PKVSDFGLAKLL  232 (413)
Q Consensus       215 l~~~~~----------~kl~DfG~a~~~  232 (413)
                      +++++.          +.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            988763          789999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=6.6e-14  Score=128.29  Aligned_cols=147  Identities=14%  Similarity=0.055  Sum_probs=113.3

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv  153 (413)
                      .....+|++...++.|+.+.||++... +..+++|............+..|+.+++.+. +..+.++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            334567999999999999999998754 6889999876432122345778999998884 67788899999888899999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc----------------------------------
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL----------------------------------  199 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~----------------------------------  199 (413)
                      |||++|.+|.+.+...         .....++.+++++|+.||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999998764211         123467888999999999810                                  


Q ss_pred             ----------------------CCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          200 ----------------------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       200 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                                            ...++|+|++|.|||+++++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                  13689999999999998765567999997653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=8.4e-13  Score=120.37  Aligned_cols=138  Identities=17%  Similarity=0.120  Sum_probs=98.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~iv~e~  156 (413)
                      .+|.+..+.+.|..+.||++...+|..+++|.....   ....+..|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            345554443456669999998766788999986543   2234667888888885444  55688888877889999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-------------------------------------
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-------------------------------------  199 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-------------------------------------  199 (413)
                      ++|.+|.  ..       ...   ...++.++++.|+.||+..                                     
T Consensus        97 i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           97 VPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             cCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            9998884  21       111   1256677777777777641                                     


Q ss_pred             ------------------CCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          200 ------------------EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       200 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                                        ...++|+|++|.|||+++++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              12399999999999998775567999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=1.6e-11  Score=117.71  Aligned_cols=146  Identities=12%  Similarity=0.142  Sum_probs=108.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEcCCCEEEEEEee--cCC-chhHHHHHHHHHHHhcCC--CCCcccccceeeeC---CeeE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLL--NNR-GQAEREFKVEVEAIGRVR--HKNLVRLLGYCAEG---AHRM  151 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~---~~~~  151 (413)
                      .....+.|+.|.++.||++... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..|
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CCceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            3445678999999999998865 4678888664  222 122346778999998886  45578888888766   4579


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc--------------------------------
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--------------------------------  199 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--------------------------------  199 (413)
                      +||||++|..+.+...      ..++......++.++++.|+.||+..                                
T Consensus       118 ~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            9999999988754221      34778888899999999999999721                                


Q ss_pred             -----------------------CCceeeccCCCCcEEEcCCCC--ceEEecccceec
Q 015076          200 -----------------------EPKVVHRDIKSSNILIDKHWN--PKVSDFGLAKLL  232 (413)
Q Consensus       200 -----------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~  232 (413)
                                             ...++|+|+++.|||++.++.  +.|+||+.+...
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                   247999999999999997754  589999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.19  E-value=8.3e-12  Score=116.91  Aligned_cols=183  Identities=19%  Similarity=0.184  Sum_probs=121.0

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCC--cccccceeeeCC---eeEEEEEec
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKN--LVRLLGYCAEGA---HRMLVYEYV  157 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~~~~~~~~~~---~~~iv~e~~  157 (413)
                      .+.++.|.+..||++.    ..+++|...  .......+..|+.+|+.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4579999999999763    568888653  2234567888999998773 322  334444433332   348999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc---------------------------------------
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG---------------------------------------  198 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~---------------------------------------  198 (413)
                      +|.+|.....      ..++...+..++.++++.|+.||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988875332      2466777778888888888888851                                       


Q ss_pred             ----------------cCCceeeccCCCCcEEEcC--CCCceEEecccceecCCCCcceeeccccccCc---cCcccccc
Q 015076          199 ----------------LEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGSESSYITTRVMGTFGY---VAPEYAST  257 (413)
Q Consensus       199 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  257 (413)
                                      ....++|+|++|.||++++  ...+.|+||+.+......... ..    ...+   ..|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~----~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-IS----LMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HT----TCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HH----HHhhccccCHHHHHH
Confidence                            1135899999999999998  455789999998765332110 00    0111   22222110


Q ss_pred             -----CC---------CCccchhHHHHHHHHHHHhCCCCC
Q 015076          258 -----GM---------LNERSDVYSFGILIMEVISGRIPV  283 (413)
Q Consensus       258 -----~~---------~~~~sDvwslG~~l~elltg~~Pf  283 (413)
                           +.         .....+.|+++.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 00         112368999999999999998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=6.2e-08  Score=90.54  Aligned_cols=139  Identities=17%  Similarity=0.160  Sum_probs=95.9

Q ss_pred             cccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---Ccccccceee-eCCeeEEEEEecc
Q 015076           83 DDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK---NLVRLLGYCA-EGAHRMLVYEYVN  158 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~-~~~~~~iv~e~~~  158 (413)
                      -.+.++.|....||+.    +..+++|..  ........+..|+.+|+.+.+.   .+.+++.+.. ..+..++||||++
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            3467888999999987    567888864  2334456788999999998642   2455555553 3456789999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc----------------------------------------
Q 015076          159 NGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG----------------------------------------  198 (413)
Q Consensus       159 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~----------------------------------------  198 (413)
                      |.+|.....      ..++......++.++++.|+.||+.                                        
T Consensus        97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            988876321      1234455555555555555555532                                        


Q ss_pred             -----------------cCCceeeccCCCCcEEEcC---CCCc-eEEecccceecC
Q 015076          199 -----------------LEPKVVHRDIKSSNILIDK---HWNP-KVSDFGLAKLLG  233 (413)
Q Consensus       199 -----------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~DfG~a~~~~  233 (413)
                                       ....++|+|++|.|||++.   ++.+ .|+||+.+...+
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                             1235799999999999987   4554 899999887643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=1e-07  Score=87.16  Aligned_cols=143  Identities=16%  Similarity=0.104  Sum_probs=96.3

Q ss_pred             hcCCCCcccEEeeeCce-EEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYG-IVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv  153 (413)
                      ...+|+.. .+..|..+ .||+.... ++..+++|.-..   .....+..|..+|+.+. +--|.+++.++.+.+..++|
T Consensus        23 ~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           23 DLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             HHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             cccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            33445433 45556555 68988754 466789997542   23456778998888774 32367788888888999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc-----------------------------------
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG-----------------------------------  198 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----------------------------------  198 (413)
                      ||+++|.++.+.....        ......+..+++..|+.||+.                                   
T Consensus        99 me~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            9999998876654321        111233455555555555532                                   


Q ss_pred             --------------------cCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          199 --------------------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       199 --------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                                          ....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                012379999999999999876677999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.54  E-value=7.5e-08  Score=91.85  Aligned_cols=81  Identities=11%  Similarity=0.030  Sum_probs=54.1

Q ss_pred             ccEE-eeeCceEEEEEEEc-------CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCC-C--CCcccccceeeeC--
Q 015076           84 DKVI-GEGGYGIVYYGLLE-------DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVR-H--KNLVRLLGYCAEG--  147 (413)
Q Consensus        84 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~--  147 (413)
                      .+.| +.|....+|+....       ++..+++|......   ......+..|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999988754       25678888654322   001234667888777774 2  3466777776554  


Q ss_pred             -CeeEEEEEeccCCChhh
Q 015076          148 -AHRMLVYEYVNNGNLEQ  164 (413)
Q Consensus       148 -~~~~iv~e~~~~gsL~~  164 (413)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.27  E-value=4.3e-06  Score=78.81  Aligned_cols=142  Identities=18%  Similarity=0.251  Sum_probs=78.7

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----CCCccccc-c--eeeeCCeeEEEEEe
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----HKNLVRLL-G--YCAEGAHRMLVYEY  156 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~~-~--~~~~~~~~~iv~e~  156 (413)
                      +.|+.|..+.||++...++ .+++|.....    ...+..|+.+++.|.     .|.++... +  +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999887644 5899987542    123334455554442     24333321 1  12346778999999


Q ss_pred             ccCCChh--------------hhccC---CCC-CC------CCCCHHHH-------------------------------
Q 015076          157 VNNGNLE--------------QWLHG---DVG-PC------SPLTWEIR-------------------------------  181 (413)
Q Consensus       157 ~~~gsL~--------------~~l~~---~~~-~~------~~l~~~~~-------------------------------  181 (413)
                      ++|.++.              ..++.   ... +.      ..-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986553              01111   000 00      00122110                               


Q ss_pred             HHHHHHHHhhhchhhh----------ccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          182 MNIILGTAKGLSYLHE----------GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       182 ~~i~~~i~~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345666653          1234899999999999998888899999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.25  E-value=1.6e-06  Score=83.85  Aligned_cols=76  Identities=14%  Similarity=0.156  Sum_probs=48.5

Q ss_pred             cccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-------hhHHHHHHHHHHHhcCCC--CC-cccccceeeeCCeeE
Q 015076           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-------QAEREFKVEVEAIGRVRH--KN-LVRLLGYCAEGAHRM  151 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--pn-iv~~~~~~~~~~~~~  151 (413)
                      ..+.||.|.++.||++... +++.++||.......       .....+..|.++++.+..  +. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3568999999999999754 467899997643211       122345678888877632  33 3345543  344568


Q ss_pred             EEEEeccCC
Q 015076          152 LVYEYVNNG  160 (413)
Q Consensus       152 iv~e~~~~g  160 (413)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.23  E-value=4.8e-06  Score=76.78  Aligned_cols=82  Identities=17%  Similarity=0.210  Sum_probs=58.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC---CcccccceeeeCCeeEEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK---NLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~~~~~~~iv  153 (413)
                      ......-.+.+|.|..+.||+....+|+.|++|+...........+..|+..|+.|..-   -+.+++.+.    .-++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            44556667889999999999999999999999976554444445677898888877422   234444432    24789


Q ss_pred             EEeccCCCh
Q 015076          154 YEYVNNGNL  162 (413)
Q Consensus       154 ~e~~~~gsL  162 (413)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999977643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.11  E-value=1.3e-05  Score=74.73  Aligned_cols=77  Identities=16%  Similarity=0.164  Sum_probs=59.8

Q ss_pred             CcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC---CCCcccccceeeeCCeeEEEEEecc
Q 015076           82 SDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYVN  158 (413)
Q Consensus        82 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~iv~e~~~  158 (413)
                      .-.+.|+.|....+|+... ++..+++|.....   ....+..|+..|+.|.   ...+.+++.+....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456799999999999876 4678899976532   3556788888888773   3567888888877788999999999


Q ss_pred             CCCh
Q 015076          159 NGNL  162 (413)
Q Consensus       159 ~gsL  162 (413)
                      |..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.99  E-value=2e-05  Score=68.34  Aligned_cols=99  Identities=17%  Similarity=0.110  Sum_probs=65.3

Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCccee
Q 015076          161 NLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT  240 (413)
Q Consensus       161 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  240 (413)
                      +|.++|....   .++++.++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|+|-+.+ +.+.          
T Consensus        34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            7888887654   69999999999999999987762110  111233457999999999988764 1110          


Q ss_pred             eccccccCccCccccccCCCCccchhHHHHHHHHHHHhC
Q 015076          241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG  279 (413)
Q Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg  279 (413)
                         .....+.+||... ...+.+.=|||||+++|..+--
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence               1133467888763 3456788999999999998863

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.89  E-value=1.7e-05  Score=77.27  Aligned_cols=76  Identities=9%  Similarity=0.099  Sum_probs=47.2

Q ss_pred             CceeeccCCCCcEEEcCCCCceEEecccceecCCCCcceeecccc--ccCccCccccccC---CCCccchhHHHHHHHHH
Q 015076          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG--TFGYVAPEYASTG---MLNERSDVYSFGILIME  275 (413)
Q Consensus       201 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwslG~~l~e  275 (413)
                      ..++|+|++|.|||++.++ ++|+||+.+.........  .....  ...|++|+.....   .-....++..+...+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            4899999999999998876 999999998765322110  00111  2345666544311   11223455677777777


Q ss_pred             HHhC
Q 015076          276 VISG  279 (413)
Q Consensus       276 lltg  279 (413)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.87  E-value=5.3e-05  Score=70.76  Aligned_cols=145  Identities=14%  Similarity=0.097  Sum_probs=75.7

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC--cccccce------eeeCCeeEEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE  155 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~------~~~~~~~~iv~e  155 (413)
                      .+.|+.|....+|++...++ .+++|......  ....+..|+.+++.+...+  +.+++..      ....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            34567788889999887655 68889775421  1223445666666553111  2333321      123456789999


Q ss_pred             eccCCChhhh--------------ccCC----CCCC-CCCC---HHHHHHH------------HHHHHhhhchhhh----
Q 015076          156 YVNNGNLEQW--------------LHGD----VGPC-SPLT---WEIRMNI------------ILGTAKGLSYLHE----  197 (413)
Q Consensus       156 ~~~~gsL~~~--------------l~~~----~~~~-~~l~---~~~~~~i------------~~~i~~aL~~LH~----  197 (413)
                      |++|..+...              ++..    .... ....   |...+.-            ...+...++.|..    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9988654220              1110    0000 0011   1111000            0012223333332    


Q ss_pred             ccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       198 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ..+.+++|+|+++.|||+++++.+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1234799999999999999875568999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.82  E-value=4.4e-05  Score=74.58  Aligned_cols=73  Identities=19%  Similarity=0.256  Sum_probs=48.7

Q ss_pred             ccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~  154 (413)
                      .+.|+.|....+|++...+        +..+++|+.....  ....+..|+.+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578889899999998653        4788999763321  11344568888887753333 556665543    3899


Q ss_pred             EeccCCCh
Q 015076          155 EYVNNGNL  162 (413)
Q Consensus       155 e~~~~gsL  162 (413)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.79  E-value=3.7e-05  Score=71.22  Aligned_cols=141  Identities=13%  Similarity=0.079  Sum_probs=74.3

Q ss_pred             ccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEEEec-cCCC
Q 015076           84 DKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYV-NNGN  161 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~e~~-~~gs  161 (413)
                      .+.|+.|....+|++     ..+++|+....... ......|+.+++.+...++ .+++.+.  .+.-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678999999999988     56888876443111 1112346666666532222 3555443  33347899999 6655


Q ss_pred             hhhh------------------ccCCCCCC-CCCC-HHHHHHHHHHH--------------Hhhhc----hhhh-ccCCc
Q 015076          162 LEQW------------------LHGDVGPC-SPLT-WEIRMNIILGT--------------AKGLS----YLHE-GLEPK  202 (413)
Q Consensus       162 L~~~------------------l~~~~~~~-~~l~-~~~~~~i~~~i--------------~~aL~----~LH~-~~~~~  202 (413)
                      |...                  ++...... .... +..+..+...+              ...+.    .|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5320                  11111000 0011 11111111110              00011    1100 11336


Q ss_pred             eeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       203 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ++|+|+.+.||+ ..++.+.|+||..+....
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            899999999999 566688999999887543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.74  E-value=0.00013  Score=68.17  Aligned_cols=144  Identities=15%  Similarity=0.102  Sum_probs=80.4

Q ss_pred             cEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCC--Ccccccce-----eeeCCeeEEEEEec
Q 015076           85 KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHK--NLVRLLGY-----CAEGAHRMLVYEYV  157 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~-----~~~~~~~~iv~e~~  157 (413)
                      ..|+ |....||++...+|..+++|...... .....+..|..+++.+...  .+++++..     ....+..+++|+|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 88889998877667789999875332 2344566677777666321  23444432     22345668899999


Q ss_pred             cCCChhh-----h---------ccC----CCC-CCCCCCHHHH----------------------HHHHHHHHhhhchhh
Q 015076          158 NNGNLEQ-----W---------LHG----DVG-PCSPLTWEIR----------------------MNIILGTAKGLSYLH  196 (413)
Q Consensus       158 ~~gsL~~-----~---------l~~----~~~-~~~~l~~~~~----------------------~~i~~~i~~aL~~LH  196 (413)
                      +|..+..     +         ++.    ... ......+...                      ...+..++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8755421     0         111    000 0011222111                      011111111111111


Q ss_pred             -hccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          197 -EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       197 -~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                       ......++|+|+++.|||++ + .+.|+||+.+...
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence             01234789999999999999 4 8899999887654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.66  E-value=9.4e-05  Score=70.80  Aligned_cols=143  Identities=15%  Similarity=0.115  Sum_probs=82.0

Q ss_pred             ccEEeeeCceEEEEEEEc--------CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCeeEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLE--------DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~iv~  154 (413)
                      .+.|..|-...+|++...        ++..+++|+.-.. ......+.+|.++++.|. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888889998864        2478899875221 123445567888888774 2223556666544    2999


Q ss_pred             EeccCCChhhh-----------------ccCCCC--CCCCC-CHHHHHHHHHHHHhh-------------------hchh
Q 015076          155 EYVNNGNLEQW-----------------LHGDVG--PCSPL-TWEIRMNIILGTAKG-------------------LSYL  195 (413)
Q Consensus       155 e~~~~gsL~~~-----------------l~~~~~--~~~~l-~~~~~~~i~~~i~~a-------------------L~~L  195 (413)
                      ||++|.+|..-                 |+....  ...+. -+..+..+..++...                   +..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988665421                 111111  01111 244555555444221                   1222


Q ss_pred             hh-----ccCCceeeccCCCCcEEEcCC----CCceEEeccccee
Q 015076          196 HE-----GLEPKVVHRDIKSSNILIDKH----WNPKVSDFGLAKL  231 (413)
Q Consensus       196 H~-----~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~  231 (413)
                      ..     .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            21     113468999999999999876    7899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.61  E-value=0.00016  Score=67.93  Aligned_cols=33  Identities=36%  Similarity=0.286  Sum_probs=28.4

Q ss_pred             CceeeccCCCCcEEEcCC----CCceEEecccceecC
Q 015076          201 PKVVHRDIKSSNILIDKH----WNPKVSDFGLAKLLG  233 (413)
Q Consensus       201 ~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~~~  233 (413)
                      ..++|||+.+.|||++.+    +.+.|+||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            489999999999999874    678999999887654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.53  E-value=0.00074  Score=63.61  Aligned_cols=32  Identities=22%  Similarity=0.308  Sum_probs=28.3

Q ss_pred             CceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       201 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ..++|+|+.+.||++++++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999887654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.53  E-value=0.0001  Score=70.31  Aligned_cols=74  Identities=15%  Similarity=0.061  Sum_probs=42.3

Q ss_pred             ccEEeeeCceEEEEEEEcC---------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC-cccccceeeeCCeeEEE
Q 015076           84 DKVIGEGGYGIVYYGLLED---------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~iv  153 (413)
                      .+.|+.|..-.+|++...+         +..+++|+....... ......|..+++.+...+ +.++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4567788888999998653         267888865432211 112345777777664333 34555443  2  2689


Q ss_pred             EEeccCCCh
Q 015076          154 YEYVNNGNL  162 (413)
Q Consensus       154 ~e~~~~gsL  162 (413)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.50  E-value=0.00039  Score=68.31  Aligned_cols=74  Identities=12%  Similarity=0.063  Sum_probs=46.3

Q ss_pred             ccEEeeeCceEEEEEEEcC-CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEEEeccCCC
Q 015076           84 DKVIGEGGYGIVYYGLLED-NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYVNNGN  161 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~e~~~~gs  161 (413)
                      .+.|+.|-...+|++...+ +..+++|+........ -....|+.+++.|...++ .++++++..    .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4578889899999998764 4678888663322111 112468888887764444 456666532    35999998865


Q ss_pred             h
Q 015076          162 L  162 (413)
Q Consensus       162 L  162 (413)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.69  E-value=0.0028  Score=61.46  Aligned_cols=74  Identities=12%  Similarity=0.111  Sum_probs=45.9

Q ss_pred             ccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCC-cccccceeeeCCeeEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~iv~  154 (413)
                      .+.|..|-...+|++...+        +..+++++..... ...-...+|..+++.+..-+ ..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778889999998653        5788888753322 11112245777777664222 345554332    27899


Q ss_pred             EeccCCCh
Q 015076          155 EYVNNGNL  162 (413)
Q Consensus       155 e~~~~gsL  162 (413)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.11  E-value=0.0076  Score=58.03  Aligned_cols=30  Identities=23%  Similarity=0.377  Sum_probs=25.1

Q ss_pred             ceeeccCCCCcEEE------cCCCCceEEeccccee
Q 015076          202 KVVHRDIKSSNILI------DKHWNPKVSDFGLAKL  231 (413)
Q Consensus       202 ~ivH~Dlkp~NIll------~~~~~~kl~DfG~a~~  231 (413)
                      .++|+|+.+.|||+      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      3456799999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.10  E-value=0.36  Score=41.68  Aligned_cols=116  Identities=9%  Similarity=0.108  Sum_probs=79.7

Q ss_pred             CCCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCc
Q 015076          133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSN  212 (413)
Q Consensus       133 ~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~N  212 (413)
                      .||+++.. .+-.+.+.+.|.++.-+  +...+-.-     ..++....++++.+|+....+++..     +|-=|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            57888876 45566666666665433  22222221     3578899999999999988777754     778899999


Q ss_pred             EEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015076          213 ILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (413)
Q Consensus       213 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~  284 (413)
                      |+++.++.+++.-.|+-..+                  +|.     .++...=+-.+=|++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999877653222                  221     11222334567889999999998874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.41  E-value=0.8  Score=39.60  Aligned_cols=115  Identities=8%  Similarity=0.055  Sum_probs=77.2

Q ss_pred             CCCCcccccceeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhc-hhhhccCCceeeccCCCC
Q 015076          133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS-YLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       133 ~hpniv~~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~-~LH~~~~~~ivH~Dlkp~  211 (413)
                      .||++  -..+-.+++.+.|.++.-+++.=+..+       ..++...+++++.+|+.... +++..     +|-=|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence            57877  334446667676766654333222233       25788999999999998877 67654     77789999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVD  284 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~  284 (413)
                      ||+++.++.+++.-.|+-..                  ++|.-     .+..-=+-++=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987775322                  22221     1112224467788888998888774

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=82.94  E-value=6.9  Score=36.01  Aligned_cols=142  Identities=11%  Similarity=0.030  Sum_probs=72.9

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccce--------------e--
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY--------------C--  144 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~--------------~--  144 (413)
                      ++.++.+-.|. +.||.+.. ++..|+||..   .....+.+-.++...-.+.-|+..-+...              -  
T Consensus        71 v~~I~~s~~Gs-tgvff~~t-d~~~~VVK~s---~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~~  145 (342)
T 1cja_A           71 FKGIERSEKGT-EGLFFVET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKS  145 (342)
T ss_dssp             EEEEEECCSTT-SCEEEEEE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred             eeEEEeccCCC-CCeEEEEe-CCCEEEEeCc---HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence            44445555555 45555555 4778999943   23344455555555555666653211100              0  


Q ss_pred             ------eeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-CCce-eeccCCCCcEEEc
Q 015076          145 ------AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-EPKV-VHRDIKSSNILID  216 (413)
Q Consensus       145 ------~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-~~~i-vH~Dlkp~NIll~  216 (413)
                            .....++++|+|.+|..|...-.....  ..+.......+..  +-++..+..+. +... .+.--.+.|||++
T Consensus       146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~--~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~  221 (342)
T 1cja_A          146 FRVITTLANQANILLMELVRGITLNKLTTTSAP--EVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLS  221 (342)
T ss_dssp             SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHH--HHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred             hHHHHHhhcccceehhhhcCCCccccchhhhhh--hhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEe
Confidence                  012356799999988776654322100  0122222222111  22344444332 1111 1123578999997


Q ss_pred             CCCC-ceEEeccccee
Q 015076          217 KHWN-PKVSDFGLAKL  231 (413)
Q Consensus       217 ~~~~-~kl~DfG~a~~  231 (413)
                      +++. +.++|-+++..
T Consensus       222 ~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          222 ERGATVVPIDSKIIPL  237 (342)
T ss_dssp             SBTTCEEECSCCCCCC
T ss_pred             CCCCeEEEEcCCcccc
Confidence            7554 88899888754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	413
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 6e-72
 Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 22/285 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           + E+     +  + IG G +G VY G    +  V + N+     Q  + FK EV  + + 
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RH N++  +GY        +V ++    +L   LH              ++I   TA+G+
Sbjct: 62  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGM 117

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES-SYITTRVMGTFGYVA 251
            YLH      ++HRD+KS+NI + +    K+ DFGLA +    S S+   ++ G+  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 252 PEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           PE          + +SDVY+FGI++ E+++G++P       +++  +             
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------R 224

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           G L P L +   S   K +  +   C+     +RP    ++  +E
Sbjct: 225 GYLSPDLSKVR-SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 8e-69
 Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 22/281 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
           E EV        + +G G +G V+ G    ++KVAVK  L     +   F  E   + ++
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           +H+ LVRL     +     ++ EY+ NG+L  +L    G    LT    +++    A+G+
Sbjct: 66  QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           +++ E      +HRD++++NIL+    + K++DFGLA+L+                + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
           E  + G    +SDV+SFGIL+ E+++         P   +   E ++ +   R    V  
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLE--RGYRMVRP 232

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
              PE         +  +   C     + RP   ++  +LE
Sbjct: 233 DNCPE--------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-65
 Identities = 69/269 (25%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG G +G+V+ G   +  KVA+K  +     +E +F  E E + ++ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            E A   LV+E++ +G L  +L    G  +    E  + + L   +G++YL E     V+
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE---ACVI 123

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L+ ++   KVSDFG+ + +  +    +T       + +PE  S    + +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           DV+SFG+L+ EV S       +R   E  ++E +                 P   ++ + 
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTG---------FRLYKPRLASTHVY 232

Query: 325 KRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +    +   C     + RP    ++  L 
Sbjct: 233 Q----IMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 1e-65
 Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 22/269 (8%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           K +G G +G+V YG       VA+K ++     +E EF  E + +  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 145 AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVV 204
            +     ++ EY+ NG L  +L            +  + +     + + YL      + +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 205 HRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERS 264
           HRD+ + N L++     KVSDFGL++ +  +    +        +  PE       + +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 265 DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLL 324
           D+++FG+L+ E+ S         P E     E  + +         L    P   + ++ 
Sbjct: 183 DIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQG------LRLYRPHLASEKVY 231

Query: 325 KRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                +   C    A +RP    ++  + 
Sbjct: 232 T----IMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 4e-65
 Identities = 70/292 (23%), Positives = 127/292 (43%), Gaps = 30/292 (10%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYC 144
           + IG+G +G V+ G      +VAVK + ++R +     + E+     +RH+N++  +   
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 145 AEG----AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL- 199
            +         LV +Y  +G+L  +L+        +T E  + + L TA GL++LH  + 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 200 ----EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI---TTRVMGTFGYVAP 252
               +P + HRD+KS NIL+ K+    ++D GLA    S +  I       +GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 253 EYASTGM------LNERSDVYSFGILIMEVISGRIP----VDYSRPPEEVNLIEWLKKMV 302
           E     +        +R+D+Y+ G++  E+           DY  P  ++   +   + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 303 TNRNPEGVLDPKLPEKPTSR-LLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
                E  L P +P +  S   L+ +  +   C   N   R     +   L 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (526), Expect = 2e-64
 Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 39/303 (12%)

Query: 69  YTLRELEVSTNGFSD---------DKVIGEGGYGIVYYGLLEDNSK----VAVKNL-LNN 114
           +T  +   +   F+          ++VIG G +G V  G L+   K    VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 115 RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS 174
             +  R+F  E   +G+  H N++ L G   +    M++ E++ NG+L+ +L  + G   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 175 PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS 234
             T    + ++ G A G+ YL +      VHRD+ + NIL++ +   KVSDFGL++ L  
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 235 ESSYITTR----VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPE 290
           ++S  T            + APE          SDV+S+GI++ EV+S         P  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235

Query: 291 EVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
           ++   + +  +  +              P       +  + L C   +   RPK G +V+
Sbjct: 236 DMTNQDVINAIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 351 MLE 353
            L+
Sbjct: 286 TLD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-63
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 25/294 (8%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRV 132
             E+       +  +G+G +G V+ G     ++VA+K  L     +   F  E + + ++
Sbjct: 11  AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69

Query: 133 RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGL 192
           RH+ LV+L    +E     +V EY++ G+L  +L G+ G    L     +++    A G+
Sbjct: 70  RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGM 126

Query: 193 SYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           +Y+        VHRD++++NIL+ ++   KV+DFGLA+L+                + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
           E A  G    +SDV+SFGIL+ E+ +            EV     L ++           
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMP--CP 236

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE---AQESPSKEPS 363
           P+ PE         +  +  +C     ++RP   ++   LE       P  +P 
Sbjct: 237 PECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 9e-63
 Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 29/290 (10%)

Query: 72  RELEVSTNGFS-DDKVIGEGGYGIVYYGLLEDNSK---VAVKNLLNNRGQAERE-FKVEV 126
           ++L +  +     D  +G G +G V  G+     K   VA+K L     +A+ E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 127 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
           + + ++ +  +VRL+G C +    MLV E    G L ++L G       +       ++ 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VM 244
             + G+ YL E      VHRD+ + N+L+      K+SDFGL+K LG++ SY T R    
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
               + APE  +    + RSDV+S+G+ + E +S         P +++   E +  +   
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG 228

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
           +  E    P+ P +     L  ++     C     + RP    V   + A
Sbjct: 229 KRME--CPPECPPE-----LYALM---SDCWIYKWEDRPDFLTVEQRMRA 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-62
 Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 44/304 (14%)

Query: 74  LEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGR 131
           +E+  + F     +G G  G+V+          +A K + L  +     +   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
                +V   G         +  E+++ G+L+Q L         +  +I   + +   KG
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKG 116

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L+YL E  + K++HRD+K SNIL++     K+ DFG++  L      +    +GT  Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 171

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVD-------------------YSRPPEEV 292
           PE       + +SD++S G+ ++E+  GR P+                       PP   
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 293 NLIEWLKKMVTNRNPEGVL-----------DPKLPEKPTSRLLKRILLVALRCVDPNAQK 341
                L     +  P   +            PKLP    S   +  +    +C+  N  +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV---NKCLIKNPAE 288

Query: 342 RPKM 345
           R  +
Sbjct: 289 RADL 292

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 4e-62
 Identities = 74/311 (23%), Positives = 123/311 (39%), Gaps = 46/311 (14%)

Query: 71  LRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNL-LNNRGQAEREFK 123
           L  LE   N     + IGEG +G V+          E  + VAVK L        + +F+
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG--------------- 168
            E   +    + N+V+LLG CA G    L++EY+  G+L ++L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 169 -----DVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKV 223
                      PL+   ++ I    A G++YL E    K VHRD+ + N L+ ++   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 224 SDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIP 282
           +DFGL++ + S   Y           ++ PE          SDV+++G+++ E+ S  + 
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 283 VDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKR 342
             Y    EEV  I +            V D  +   P       +  +   C       R
Sbjct: 242 PYYGMAHEEV--IYY------------VRDGNILACP-ENCPLELYNLMRLCWSKLPADR 286

Query: 343 PKMGHVVHMLE 353
           P    +  +L+
Sbjct: 287 PSFCSIHRILQ 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 45/309 (14%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK------VAVKNLLNNRGQAERE-FKVEVE 127
           E         KV+G G +G V        SK      VAVK L      +ERE    E++
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92

Query: 128 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS------------ 174
            + ++  H+N+V LLG C       L++EY   G+L  +L       S            
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 175 -------PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                   LT+E  +      AKG+ +L        VHRD+ + N+L+      K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 228 LAKLLGSESSYIT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
           LA+ + S+S+Y+          ++APE    G+   +SDV+S+GIL+ E+ S  +     
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---- 265

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
            P   + +     K++ N           P   T  +      +   C   +++KRP   
Sbjct: 266 -PYPGIPVDANFYKLIQNG-----FKMDQPFYATEEIYI----IMQSCWAFDSRKRPSFP 315

Query: 347 HVVHMLEAQ 355
           ++   L  Q
Sbjct: 316 NLTSFLGCQ 324

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-61
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 29/287 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNS-----KVAVKNLLNNRGQAER-EFKVEVEA 128
           E+  +  +  KVIG G +G VY G+L+ +S      VA+K L     + +R +F  E   
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 129 IGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGT 188
           +G+  H N++RL G  ++    M++ EY+ NG L+++L          +    + ++ G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119

Query: 189 AKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL--GSESSYITTRVMGT 246
           A G+ YL        VHRD+ + NIL++ +   KVSDFGL+++L    E++Y T+     
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
             + APE  S       SDV+SFGI++ EV++      +     EV              
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            + + D      P       I  + ++C      +RPK   +V +L+
Sbjct: 223 MKAINDGFRLPTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (500), Expect = 7e-61
 Identities = 62/282 (21%), Positives = 119/282 (42%), Gaps = 22/282 (7%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK-VAVKNLLNNRGQAEREFKVEVEAIGR 131
           + E+     +    +G G YG VY G+ +  S  VAVK L  +  + E EF  E   +  
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
           ++H NLV+LLG C       ++ E++  GNL  +L         ++  + + +    +  
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           + YL +      +HRD+ + N L+ ++   KV+DFGL++L+  ++            + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE  +    + +SDV++FG+L+ E+ +  +         +V  +               L
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------------L 229

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
           +     +      +++  +   C   N   RP    +    E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 71/280 (25%), Positives = 114/280 (40%), Gaps = 28/280 (10%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH 134
            ++       + IG+G +G V  G     +KVAVK +        + F  E   + ++RH
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59

Query: 135 KNLVRLLGYCAEGAHRM-LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
            NLV+LLG   E    + +V EY+  G+L  +L       S L  +  +   L   + + 
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
           YL        VHRD+ + N+L+ +    KVSDFGL K   S              + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPE 170

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  + +SDV+SFGIL+ E+ S         P   + L + + ++      +     
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMD----- 220

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P+     + +    V   C   +A  RP    +   LE
Sbjct: 221 -APDGCPPAVYE----VMKNCWHLDAAMRPSFLQLREQLE 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 30/280 (10%)

Query: 84  DKVIGEGGYGIVYYGLLEDNSK----VAVKNLLNNRGQAE-REFKVEVEAIGRVRHKNLV 138
           ++VIG G +G VY+G L DN       AVK+L       E  +F  E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 139 RLLGYCAEG-AHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
            LLG C       ++V  Y+ +G+L  ++  +       T +  +   L  AKG+ +L  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 148

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE---SSYITTRVMGTFGYVAPEY 254
               K VHRD+ + N ++D+ +  KV+DFGLA+ +  +   S +  T       ++A E 
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
             T     +SDV+SFG+L+ E+++   P     P  +VN  +    ++  R         
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL------ 254

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            PE     L +    V L+C  P A+ RP    +V  + A
Sbjct: 255 QPEYCPDPLYE----VMLKCWHPKAEMRPSFSELVSRISA 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 40/311 (12%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAERE-FKV 124
            + E   N  S  K +G G +G V           +    VAVK L  +    ERE    
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 125 EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCS--------- 174
           E++ +  +  H N+V LLG C  G   +++ EY   G+L  +L                 
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 175 -----PLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA 229
                 L  E  ++     AKG+++L        +HRD+ + NIL+      K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 230 KLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRP 288
           + + ++S+Y +         ++APE     +    SDV+S+GI + E+ S         P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
            +         KM+             PE   + +      +   C D +  KRP    +
Sbjct: 253 VD-----SKFYKMIKEG-----FRMLSPEHAPAEMYD----IMKTCWDADPLKRPTFKQI 298

Query: 349 VHMLEAQESPS 359
           V ++E Q S S
Sbjct: 299 VQLIEKQISES 309

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 4e-59
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 32/279 (11%)

Query: 83  DDKVIGEGGYGIVYYGLLEDNS---KVAVKNLLN--NRGQAEREFKVEVEAIGRVRHKNL 137
           +DK +G G +G V  G  +       VAVK L N  N    + E   E   + ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           VR++G C E    MLV E    G L ++L         +  +  + ++   + G+ YL E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTR--VMGTFGYVAPEYA 255
                 VHRD+ + N+L+      K+SDFGL+K L ++ +Y   +        + APE  
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 256 STGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK 314
           +    + +SDV+SFG+L+ E  S G+ P    +  E   ++E  ++              
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------MG 230

Query: 315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
            P      +      +   C   + + RP    V   L 
Sbjct: 231 CPAGCPREMYD----LMNLCWTYDVENRPGFAAVELRLR 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 5e-59
 Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 24/272 (8%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             IG G YG         D   +  K  +  +     ++    EV  +  ++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 142 GYCAEGAHRML--VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
               +  +  L  V EY   G+L   +         L  E  + ++      L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 200 E--PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
           +    V+HRD+K +N+ +D   N K+ DFGLA++L  ++S+     +GT  Y++PE  + 
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE 317
              NE+SD++S G L+ E+ +   P          +  E   K+   +     +  +  +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFRR--IPYRYSD 240

Query: 318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
           +     L  I+    R ++     RP +  ++
Sbjct: 241 E-----LNEII---TRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (489), Expect = 7e-59
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 35/310 (11%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKN 136
           FSD + IG G +G VY+   + ++  VA+K +        +  ++   EV  + ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 LVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
            ++  G         LV EY      +           PL       +  G  +GL+YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH 132

Query: 197 EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAS 256
                 ++HRD+K+ NIL+ +    K+ DFG A ++           +GT  ++APE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 257 T---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
               G  + + DV+S GI  +E+   +       P   +N +  L  +  N        P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SP 232

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV-HMLEAQESPSKEPSNSFQDRYRA 372
            L     S   +  +     C+    Q RP    ++ H    +E P     +  Q    A
Sbjct: 233 ALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289

Query: 373 SPKNELIEKQ 382
             + + ++ +
Sbjct: 290 VRELDNLQYR 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 65/313 (20%), Positives = 125/313 (39%), Gaps = 39/313 (12%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSK---VAVKNL-LNNRGQAEREFKVEVEAIG 130
            +  N      VIGEG +G V    ++ +      A+K +         R+F  E+E + 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 131 RV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHG------------DVGPCSPLT 177
           ++  H N++ LLG C    +  L  EY  +GNL  +L                   S L+
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 178 WEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +  ++     A+G+ YL +    + +HRD+ + NIL+ +++  K++DFGL++       
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW 297
              T       ++A E  +  +    SDV+S+G+L+ E++S         P   +   E 
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL 235

Query: 298 LKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE--AQ 355
            +K+      E       P      +      +  +C      +RP    ++  L    +
Sbjct: 236 YEKLPQGYRLE------KPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 356 ESPSKEPSNSFQD 368
           E  +   +  ++ 
Sbjct: 286 ERKTYVNTTLYEK 298

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-57
 Identities = 70/317 (22%), Positives = 130/317 (41%), Gaps = 31/317 (9%)

Query: 81  FSDDKVIGEGGYGIVYYGLLEDNS-----KVAVKNL-LNNRGQAEREFKVEVEAIGRVRH 134
           F   KV+G G +G VY GL           VA+K L      +A +E   E   +  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
            ++ RLLG C       L+ + +  G L  ++            +  +N  +  AKG++Y
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS-ESSYITTRVMGTFGYVAPE 253
           L +    ++VHRD+ + N+L+    + K++DFGLAKLLG+ E  Y          ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                +   +SDV+S+G+ + E+++         P + +   E    +           P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEKGERLP--QPP 236

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE--AQESPSKEPSNSFQDRYR 371
                        + ++ ++C   +A  RPK   ++      A++          +  + 
Sbjct: 237 ICTID--------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 372 ASPKNELIEKQVTESGD 388
            SP +    + + +  D
Sbjct: 289 PSPTDSNFYRALMDEED 305

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 9e-57
 Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 38/285 (13%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLN---NRGQAEREFKV 124
           + L + E+        + +G+G +G VY     +    +A+K L      +   E + + 
Sbjct: 3   WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           EVE    +RH N++RL GY  +     L+ EY   G + + L       S    +     
Sbjct: 56  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
           I   A  LSY H     +V+HRDIK  N+L+      K++DFG +    S      T + 
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLC 165

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           GT  Y+ PE     M +E+ D++S G+L  E + G+ P + +   E    I         
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------- 218

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVV 349
                 ++   P+   +   + ++    R +  N  +RP +  V+
Sbjct: 219 ------VEFTFPDF-VTEGARDLI---SRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-56
 Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 27/287 (9%)

Query: 73  ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNS----KVAVKNLLNNRGQAERE-FKVEVE 127
           + E+        + IGEG +G V+ G+          VA+K   N    + RE F  E  
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 128 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILG 187
            + +  H ++V+L+G   E     ++ E    G L  +L         L     +     
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQ 116

Query: 188 TAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTF 247
            +  L+YL      + VHRDI + N+L+  +   K+ DFGL++ +   + Y  ++     
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            ++APE  +       SDV+ FG+ + E++   +      P + V   + + ++      
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERL 228

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
              + P  P       L  ++    +C   +  +RP+   +   L  
Sbjct: 229 P--MPPNCPPT-----LYSLM---TKCWAYDPSRRPRFTELKAQLST 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 31/275 (11%)

Query: 84  DKVIGEGGYGIVYYGLL-EDNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRL 140
           D  IG G +  VY GL  E   +VA   L + +      + FK E E +  ++H N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 141 LGYCAEGA----HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLH 196
                         +LV E + +G L+ +L         +  ++  +      KGL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129

Query: 197 EGLEPKVVHRDIKSSNILI-DKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
               P ++HRD+K  NI I     + K+ D GLA L  +        V+GT  ++APE  
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMY 185

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
                +E  DVY+FG+ ++E+ +   P  YS       +   +   V          P  
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGV---------KPAS 233

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH 350
            +K     +K I+     C+  N  +R  +  +++
Sbjct: 234 FDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 7e-56
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 27/267 (10%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
             +G+G +G VY     E +   A K +     +   ++ VE++ +    H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                +  ++ E+   G ++  +        PLT      +   T   L+YLH   + K+
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGML--- 260
           +HRD+K+ NIL     + K++DFG++           + + GT  ++APE          
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 261 --NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEK 318
             + ++DV+S GI ++E+     P        E+N +  L K+  +  P      +    
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEPPTLAQPSRWSSN 244

Query: 319 PTSRLLKRILLVALRCVDPNAQKRPKM 345
                 K  L    +C++ N   R   
Sbjct: 245 -----FKDFL---KKCLEKNVDARWTT 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-55
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 31/281 (11%)

Query: 85  KVIGEGGYGIVYYGLLEDNSK----VAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNL 137
           + +G+G +G+V  G  +  S     VAVK L   + ++ +A  +F  EV A+  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           +RL G       +M V E    G+L   L    G              +  A+G+ YL  
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY--ITTRVMGTFGYVAPEYA 255
               + +HRD+ + N+L+      K+ DFGL + L     +  +       F + APE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKL 315
            T   +  SD + FG+ + E+ +         P   +N  + L K+              
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER-----LPR 236

Query: 316 PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML-EAQ 355
           PE     +      V ++C     + RP    +   L EAQ
Sbjct: 237 PEDCPQDIYN----VMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-55
 Identities = 68/315 (21%), Positives = 141/315 (44%), Gaps = 33/315 (10%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLL------EDNSKVAVKNLLNNRGQAER-E 121
           Y   E EV+    +  + +G+G +G+VY G+       E  ++VA+K +       ER E
Sbjct: 10  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------GDVGPCSP 175
           F  E   +      ++VRLLG  ++G   +++ E +  G+L+ +L        +    +P
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 176 LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE 235
            +    + +    A G++YL+     K VHRD+ + N ++ + +  K+ DFG+ + +   
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 236 SSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNL 294
             Y    + +    +++PE    G+    SDV+SFG+++ E+ +         P + ++ 
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSN 241

Query: 295 IEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA 354
            + L+          V++  L +KP       +  +   C   N + RP    ++  ++ 
Sbjct: 242 EQVLRF---------VMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

Query: 355 QESPS-KEPSNSFQD 368
           +  P  +E S  + +
Sbjct: 292 EMEPGFREVSFYYSE 306

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-54
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 24/262 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG+G  G VY  + +    +VA++ +   +   +     E+  +   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
              G    +V EY+  G+L   +       + +       +     + L +LH     +V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 204 VHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNER 263
           +HRDIKS NIL+    + K++DFG    +  E S  +T V GT  ++APE  +      +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 264 SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRL 323
            D++S GI+ +E+I G  P          N +  L  + TN  PE     KL       +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSA-----I 245

Query: 324 LKRILLVALRCVDPNAQKRPKM 345
            +  L    RC+D + +KR   
Sbjct: 246 FRDFL---NRCLDMDVEKRGSA 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-53
 Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 29/276 (10%)

Query: 81  FSDD----KVIGEGGYGIVYYG-LLEDNSKVAVKNL-LNNRGQAEREFKVEVEAIGRVRH 134
           F +D    + +GEG YG V           VAVK + +          K E+     + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           +N+V+  G+  EG  + L  EY + G L   +  D+G    +              G+ Y
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVY 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPE 253
           LH      + HRDIK  N+L+D+  N K+SDFGLA +    +   +  ++ GT  YVAPE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 254 YASTGMLN-ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                  + E  DV+S GI++  +++G +P D      +       KK   N        
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-------- 227

Query: 313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHV 348
              P K        +L    + +  N   R  +  +
Sbjct: 228 ---PWKKIDSAPLALL---HKILVENPSARITIPDI 257

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 4e-52
 Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 39/307 (12%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYGL------LEDNSKVAVKNLLNNRGQAE-RE 121
           Y   + E   +     K +G G +G V                VAVK L      +E R 
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62

Query: 122 FKVEVEAIGR-VRHKNLVRLLGYCAE-GAHRMLVYEYVNNGNLEQWLHGDVGPCSP---- 175
              E++ +     H N+V LLG C + G   M++ E+   GNL  +L        P    
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 176 --------LTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFG 227
                   LT E  +      AKG+ +L      K +HRD+ + NIL+ +    K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 228 LAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYS 286
           LA+ +  +  Y+          ++APE     +   +SDV+SFG+L+ E+ S        
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---- 235

Query: 287 RPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
            P   V + E   + +           + P+  T  + +      L C      +RP   
Sbjct: 236 -PYPGVKIDEEFCRRLKEGTR-----MRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFS 285

Query: 347 HVVHMLE 353
            +V  L 
Sbjct: 286 ELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 6e-52
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 41/302 (13%)

Query: 75  EVSTNGFSDDKVIGEGGYGIVYYGLL--------EDNSKVAVKNLLNNRGQAE-REFKVE 125
           E+  +     K +GEG +G V                +KVAVK L ++  + +  +   E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68

Query: 126 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLH------------GDVGP 172
           +E +  + +HKN++ LLG C +     ++ EY + GNL ++L                 P
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 173 CSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL 232
              L+ +  ++     A+G+ YL      K +HRD+ + N+L+ +    K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 233 GSESSYITTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEE 291
                Y  T        ++APE     +   +SDV+SFG+L+ E+ +          P  
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYP 239

Query: 292 VNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM 351
              +E L K++   +         P   T+ L      +   C      +RP    +V  
Sbjct: 240 GVPVEELFKLLKEGHR-----MDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQLVED 290

Query: 352 LE 353
           L+
Sbjct: 291 LD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (438), Expect = 6e-51
 Identities = 53/264 (20%), Positives = 108/264 (40%), Gaps = 24/264 (9%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +G+V+        +  A K ++      +   + E++ +  +RH  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
             +    +++YE+++ G L + +  +      ++ +  +  +    KGL ++HE      
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NY 145

Query: 204 VHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
           VH D+K  NI+     +   K+ DFGL   L  + S   T   GT  + APE A    + 
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVG 203

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
             +D++S G+L   ++SG  P       E +  +         ++ +  +D        S
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---------KSCDWNMDDSAFSG-IS 253

Query: 322 RLLKRILLVALRCVDPNAQKRPKM 345
              K  +    + +  +   R  +
Sbjct: 254 EDGKDFI---RKLLLADPNTRMTI 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-49
 Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 29/279 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAE---REFKVEVEAIGRVRHKNLVRL 140
           K++GEG +  V     L  + + A+K L       E        E + + R+ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 141 LGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLE 200
                +         Y  NG L +++                         L YLH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG--- 126

Query: 201 PKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGM 259
             ++HRD+K  NIL+++  + +++DFG AK+L  ES        +GT  YV+PE  +   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
             + SD+++ G +I ++++G        P    N     +K++        L+   PEK 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK-------LEYDFPEK- 232

Query: 320 TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESP 358
                + ++    + +  +A KR     +      +  P
Sbjct: 233 FFPKARDLV---EKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 58/353 (16%), Positives = 123/353 (34%), Gaps = 31/353 (8%)

Query: 68  WYTLRELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREF 122
            Y  + +EV      D     + +G G +G+V+  +          K +       +   
Sbjct: 14  KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 73

Query: 123 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRM 182
           K E+  + ++ H  L+ L     +    +L+ E+++ G L   +  +      ++    +
Sbjct: 74  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVI 130

Query: 183 NIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYIT 240
           N +    +GL ++HE     +VH DIK  NI+ +       K+ DFGLA  L  +   I 
Sbjct: 131 NYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IV 185

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
                T  + APE      +   +D+++ G+L   ++SG  P       E +  +     
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV----- 240

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH---MLEAQES 357
               +  +   D        S   K  +      +    +KR  +   +    +     +
Sbjct: 241 ----KRCDWEFDEDAFSS-VSPEAKDFI---KNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

Query: 358 PSKEPSNSFQDRYRASPKNELIEKQVTESGDNSTNETGVHTNETRWQHQEFQK 410
            +    +S  ++ R   K +  +    +                  ++Q +  
Sbjct: 293 LTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDS 345

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 1e-47
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 31/287 (10%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVR 133
           ++ +   +++G GG   V+    L  +  VAVK L   L         F+ E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 134 HKNLVRLLGYCAE----GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
           H  +V +          G    +V EYV+   L   +H       P+T +  + +I    
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI--TTRVMGTF 247
           + L++ H+     ++HRD+K +NI+I      KV DFG+A+ +    + +  T  V+GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 248 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP 307
            Y++PE A    ++ RSDVYS G ++ EV++G  P     P            +  +  P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIP 233

Query: 308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-MGHVVHMLE 353
                  L        L  ++   L+ +  N + R +    +   L 
Sbjct: 234 PSARHEGLSAD-----LDAVV---LKALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (411), Expect = 6e-47
 Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 32/279 (11%)

Query: 77  STNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNR---GQAEREFKVEVEAIGRV 132
           + N FS  ++IG GG+G VY     +     A+K L   R    Q E     E   +  V
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 133 R---HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
                  +V +            + + +N G+L   L                 I     
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI----I 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGY 249
            GL ++H      VV+RD+K +NIL+D+H + ++SD GLA     +        +GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171

Query: 250 VAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE 308
           +APE    G+  +  +D +S G ++ +++ G  P    +  ++  +      M       
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224

Query: 309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
                +LP+   S  L+ +L      +  +  +R     
Sbjct: 225 ---AVELPDS-FSPELRSLL---EGLLQRDVNRRLGCLG 256

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 9e-47
 Identities = 49/303 (16%), Positives = 114/303 (37%), Gaps = 25/303 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +GIV+  +          K  +  +G  +   K E+  +   RH+N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 144 CAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKV 203
                  ++++E+++  ++ + ++        L     ++ +    + L +LH      +
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNI 123

Query: 204 VHRDIKSSNILIDKHWNP--KVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            H DI+  NI+     +   K+ +FG A+ L    ++          Y APE     +++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTS 321
             +D++S G L+  ++SG  P       + +  I          N E   D +  ++  S
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------MNAEYTFDEEAFKE-IS 231

Query: 322 RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSFQDRYRASPKNELIEK 381
                 +    R +    + R      +     ++   +  +   +        + LI+K
Sbjct: 232 IEAMDFV---DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

Query: 382 QVT 384
            + 
Sbjct: 289 DLN 291

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-45
 Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 30/264 (11%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGRV-RHKNLVR 139
           K++G+G +G V+     + N   A+K L  +    + +     VE   +     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 140 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL 199
           +        +   V EY+N G+L   +      C                 GL +LH   
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-- 121

Query: 200 EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGM 259
              +V+RD+K  NIL+DK  + K++DFG+ K      +   T   GT  Y+APE      
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQK 179

Query: 260 LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKP 319
            N   D +SFG+L+ E++ G+ P       E   L   ++            +P  P   
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMD----------NPFYPRW- 225

Query: 320 TSRLLKRILLVALRCVDPNAQKRP 343
             +  K +L   ++      +KR 
Sbjct: 226 LEKEAKDLL---VKLFVREPEKRL 246

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (394), Expect = 5e-45
 Identities = 61/307 (19%), Positives = 115/307 (37%), Gaps = 29/307 (9%)

Query: 72  RELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAI 129
           ++ E   + +    V+G G +  V           VA+K +     + +    + E+  +
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 130 GRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 189
            +++H N+V L      G H  L+ + V+ G L   +          T      +I    
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVL 117

Query: 190 KGLSYLHEGLEPKVVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
             + YLH   +  +VHRD+K  N+L    D+     +SDFGL+K+    S  + +   GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGT 172

Query: 247 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN 306
            GYVAPE  +    ++  D +S G++   ++ G  P       +    I           
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI---------LK 223

Query: 307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM--LEAQESPSKEPSN 364
            E   D    +   S   K  +      ++ + +KR      +    +    +  K    
Sbjct: 224 AEYEFDSPYWDD-ISDSAKDFI---RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279

Query: 365 SFQDRYR 371
           S  ++ +
Sbjct: 280 SVSEQIK 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (392), Expect = 6e-45
 Identities = 52/275 (18%), Positives = 106/275 (38%), Gaps = 21/275 (7%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLG 142
           + IGEG YG+VY          A+K   L             E+  +  ++H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
                   +LV+E+++    +     +      L      + +L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RR 120

Query: 203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNE 262
           V+HRD+K  N+LI++    K++DFGLA+  G      T  ++  +         +   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 263 RSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--------PK 314
             D++S G +  E+++G          +++  I  +     ++N   V +          
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 315 LPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
               P    LK +    +    + +  +  +R   
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 6e-45
 Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 45/287 (15%)

Query: 81  FSDD----KVIGEGGYGIVYYGL-LEDNSKVAVKNL---------LNNRGQAEREFKVEV 126
           F ++    +++G G   +V   +      + AVK +              +       EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 127 EAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNII 185
           + + +V  H N+++L           LV++ +  G L  +L   V     L+ +    I+
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIM 116

Query: 186 LGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMG 245
               + +  LH+     +VHRD+K  NIL+D   N K++DFG +  L          V G
Sbjct: 117 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCG 171

Query: 246 TFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLK 299
           T  Y+APE     M +         D++S G+++  +++G  P  + +    + +I    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--- 228

Query: 300 KMVTNRNPEGVLDPKLPEKPT-SRLLKRILLVALRCVDPNAQKRPKM 345
                    G      PE    S  +K ++    R +    QKR   
Sbjct: 229 --------SGNYQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTA 264

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 69/334 (20%), Positives = 134/334 (40%), Gaps = 29/334 (8%)

Query: 78  TNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE-FKVEVEAIGRVRHK 135
              +++   IGEG YG+V       +  +VA+K +     Q   +    E++ + R RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           N++ +           +   Y+    +   L+  +     L+ +     +    +GL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYIT--TRVMGTFGYVAPE 253
           H      V+HRD+K SN+L++   + K+ DFGLA++   +  +    T  + T  Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 254 YASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD 312
                    +S D++S G ++ E++S R         +++N I  +    +  +   +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 313 ----------PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKMGHVVHM------L 352
                     P   + P +RL       AL    + +  N  KR ++   +         
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

Query: 353 EAQESPSKEPSNSFQDRYRASPKNELIEKQVTES 386
           +  + P  E    F       PK +L E    E+
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKEKLKELIFEET 336

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 65/329 (19%), Positives = 131/329 (39%), Gaps = 37/329 (11%)

Query: 74  LEVSTNGFSDD-----KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVE 127
           L++  N   DD     +V+G G  G V          K A+K +L +  +A RE ++   
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60

Query: 128 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
           A    +  ++VR++       A     ++V E ++ G L   +          T      
Sbjct: 61  AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASE 115

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNP---KVSDFGLAKLLGSESSYIT 240
           I+    + + YLH      + HRD+K  N+L          K++DFG AK   S +S  T
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172

Query: 241 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK 300
                T  YVAPE       ++  D++S G+++  ++ G  P   +       +   +K 
Sbjct: 173 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKT 227

Query: 301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVH---MLEAQES 357
            +     E    P       S  +K ++      +     +R  +   ++   ++++ + 
Sbjct: 228 RIRMGQYE---FPNPEWSEVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKV 281

Query: 358 PSKEPSNSFQDRYRASPKNELIEKQVTES 386
           P + P ++ +       + E +++++T +
Sbjct: 282 P-QTPLHTSRVLKEDKERWEDVKEEMTSA 309

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 62/279 (22%), Positives = 118/279 (42%), Gaps = 39/279 (13%)

Query: 69  YTLRELEVSTNGFSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNL---LNNRGQAEREFKV 124
           Y+L++ ++        + +G G +G V+      +    A+K L   +  R +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 125 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNI 184
           E   +  V H  ++R+ G   +     ++ +Y+  G L   L       +P+       +
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113

Query: 185 ILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVM 244
                     L       +++RD+K  NIL+DK+ + K++DFG AK +       T  + 
Sbjct: 114 -------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLC 162

Query: 245 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
           GT  Y+APE  ST   N+  D +SFGILI E+++G        P  + N ++  +K++  
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNA 216

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP 343
                  + + P    +  +K +L    R +  +  +R 
Sbjct: 217 -------ELRFPPF-FNEDVKDLL---SRLITRDLSQRL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (381), Expect = 3e-43
 Identities = 49/280 (17%), Positives = 97/280 (34%), Gaps = 29/280 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + IG G +G +Y G  +    +VA+K           +  +E +    ++    +  + +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 144 C-AEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           C AEG + ++V E +     + +           + +  + +       + Y+H      
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KN 123

Query: 203 VVHRDIKSSNILI---DKHWNPKVSDFGLAKLLGSESSYI------TTRVMGTFGYVAPE 253
            +HRD+K  N L+    K     + DFGLAK      ++          + GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                  + R D+ S G ++M    G +P    +   +    E + +      P  VL  
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMSTPIEVLCK 242

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
             P +         L     C       +P   ++  +  
Sbjct: 243 GYPSE-----FATYL---NFCRSLRFDDKPDYSYLRQLFR 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-43
 Identities = 56/280 (20%), Positives = 105/280 (37%), Gaps = 21/280 (7%)

Query: 81  FSDDKVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNL 137
           F   + IGEG YG+VY          VA+K   L             E+  +  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           V+LL          LV+E+++    +     D    + +   +  + +    +GL++ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 198 GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYAST 257
               +V+HRD+K  N+LI+     K++DFGLA+  G      T  V+  +          
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 258 GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD----- 312
              +   D++S G +  E+++ R         +++  I             GV       
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 313 ---PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
              PK   +  S+++  +         + +  +  KR   
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 66/312 (21%), Positives = 117/312 (37%), Gaps = 38/312 (12%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVK-----NLLNNRGQAEREFKVEVEAIGRVRHKNLV 138
             +GEG +  VY       N  VA+K     +    +    R    E++ +  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 139 RLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG 198
            LL      ++  LV++++                  LT       +L T +GL YLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 199 LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTG 258
               ++HRD+K +N+L+D++   K++DFGLAK  GS +   T +V  T  Y APE     
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 259 ML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-------NRNPEGV 310
            +     D+++ G ++ E++     +      +++  I       T          P+ V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 311 LDPKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKMGHVVHMLEAQESPSKEPSNSF 366
                P  P   +        L         N   R          +A +         F
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT------ATQALKMK------YF 283

Query: 367 QDRYRASPKNEL 378
            +R   +P  +L
Sbjct: 284 SNRPGPTPGCQL 295

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-42
 Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 29/283 (10%)

Query: 81  FSDDKVIGEGGYGIVYYG-LLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR 139
           ++D KVIG G +G+VY   L +    VA+K +L ++    RE    ++ + ++ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 77

Query: 140 LLGYCAEGAHRM------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
           L  +      +       LV +YV         H        L        +    + L+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLA 136

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAP 252
           Y+H      + HRDIK  N+L+D      K+ DFG AK L        + +   +     
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192

Query: 253 EYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT-------NR 305
                       DV+S G ++ E++ G+         +++  I  +    T       N 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 306 NPEGVLDPKLPEKPTSRLLKRIL---LVAL--RCVDPNAQKRP 343
           N      P++   P +++ +       +AL  R ++     R 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 33/272 (12%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL------LNNRGQAEREFKVEVEAIGRVRHKNL 137
           + +G G + +V          + A K +       + RG +  + + EV  +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE 197
           + L          +L+ E V  G L  +L         LT E     +     G+ YLH 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH- 130

Query: 198 GLEPKVVHRDIKSSNILIDKHWNP----KVSDFGLAKLLGSESSYITTRVMGTFGYVAPE 253
               ++ H D+K  NI++     P    K+ DFGLA  +   + +    + GT  +VAPE
Sbjct: 131 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186

Query: 254 YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
             +   L   +D++S G++   ++SG  P       E +  +  +     +         
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT--- 243

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                  S L K  +    R +  + +KR  +
Sbjct: 244 -------SALAKDFI---RRLLVKDPKKRMTI 265

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 24/280 (8%)

Query: 85  KVIGEGGYGIVYYG--LLEDNSKVAVKNLLNNRGQAEREFKVEVEA-----IGRVRHKNL 137
             IGEG YG V+    L      VA+K +    G+         E      +    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 138 VRLLGYCAEGAHRMLVYEYVNNGNLEQW--LHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
           VRL   C            +   +++Q    + D  P   +  E   +++    +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 196 HEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYA 255
           H     +VVHRD+K  NIL+      K++DFGLA++   + +   T V+ T  Y APE  
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187

Query: 256 STGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI----------EWLKKMVTNR 305
                    D++S G +  E+   +     S   +++  I          +W + +   R
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
                   +  EK  + + +    + L+C+  N  KR   
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (364), Expect = 7e-41
 Identities = 47/282 (16%), Positives = 95/282 (33%), Gaps = 31/282 (10%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLG 142
           + IGEG +G+++ G  L +N +VA+K     R     + + E      +     +  +  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK 202
           +  EG H +LV + +     +             + +            +  +HE     
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 203 VVHRDIKSSNILIDKHWNP-----KVSDFGLAKLLGSESS------YITTRVMGTFGYVA 251
           +V+RDIK  N LI +  +       V DFG+ K      +           + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
                    + R D+ + G + M  + G +P    +        E + +   +      L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-EL 240

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE 353
               PE+       + +       +      P   ++  +  
Sbjct: 241 CAGFPEE-----FYKYM---HYARNLAFDATPDYDYLQGLFS 274

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 8e-40
 Identities = 65/275 (23%), Positives = 100/275 (36%), Gaps = 29/275 (10%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE---FKVEVEAIGR 131
           V+ N F   K++G+G +G V            A+K L      A+ E      E   +  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 132 VRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKG 191
            RH  L  L            V EY N G L   L          T E            
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVA 251
           L YLH      VV+RDIK  N+++DK  + K++DFGL K   S+ +       GT  Y+A
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173

Query: 252 PEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL 311
           PE           D +  G+++ E++ GR       P    +     + ++         
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220

Query: 312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG 346
           + + P    S   K +L      +  + ++R   G
Sbjct: 221 EIRFPRT-LSPEAKSLL---AGLLKKDPKQRLGGG 251

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 55/277 (19%), Positives = 104/277 (37%), Gaps = 23/277 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
           + IGEG YG V+     E +  VA+K   L ++          E+  +  ++HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                     LV+E+ +    + +   +         EI  + +    KGL + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            V+HRD+K  N+LI+++   K+++FGLA+  G      +  V+  +           + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEV--NLIEWLKKMVTNRNPEGVLDPKLPEKP 319
              D++S G +  E+ +   P+      ++    +   L      + P     P     P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 320 TSRLLKRILLVA-----------LRCVDPNAQKRPKM 345
                  ++ V               +  N  +R   
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 4e-37
 Identities = 57/291 (19%), Positives = 112/291 (38%), Gaps = 37/291 (12%)

Query: 85  KVIGEGGYGIVYYG-LLEDNSKVAVKNLL--NNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             IG+G +G V+     +   KVA+K +L  N +         E++ +  ++H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 142 GYCAEGAHRM--------LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLS 193
             C   A           LV+++  +       +  V         +   +       L+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-------LN 128

Query: 194 YLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS---YITTRVMGTFGYV 250
            L+     K++HRD+K++N+LI +    K++DFGLA+      +      T  + T  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 251 APEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG 309
            PE            D++  G ++ E+ +    +  +    ++ LI  L   +T      
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 310 VLDPKLPE-----KPTSRLLKRILLVAL----------RCVDPNAQKRPKM 345
           V + +L E     K   R +K  L   +          + +  +  +R   
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-36
 Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 43/272 (15%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE------FKVEVEAIGRVR--HK 135
            ++G GG+G VY G+ + DN  VA+K++  +R     E        +EV  + +V     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 136 NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYL 195
            ++RLL +       +L+ E             + G    L  E+  +      + + + 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHC 126

Query: 196 HEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           H      V+HRDIK  NILID +    K+ DFG   LL      + T   GT  Y  PE+
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEW 180

Query: 255 ASTGMLNERS-DVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP 313
                 + RS  V+S GIL+ +++ G IP ++        +                   
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---------------FRQ 225

Query: 314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKM 345
           ++  +      + ++     C+      RP  
Sbjct: 226 RVSSE-----CQHLI---RWCLALRPSDRPTF 249

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-36
 Identities = 53/298 (17%), Positives = 114/298 (38%), Gaps = 27/298 (9%)

Query: 69  YTLRELEVSTNGFSDD----KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAERE 121
           +  +E+  +           + +G G YG V   +     +KVA+K            + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 122 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIR 181
              E+  +  +RH+N++ LL             ++           G +     L  +  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 182 MNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITT 241
             ++    KGL Y+H      ++HRD+K  N+ +++    K+ DFGLA+   SE   +T 
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTG 177

Query: 242 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKM 301
            V+  +        +     +  D++S G ++ E+I+G+     S   +++  I  +   
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 302 VTNRNPEGVLD----------PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRPKM 345
                 + +            P+L +K  + +L     +A+    + +  +A++R   
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 3e-34
 Identities = 64/283 (22%), Positives = 120/283 (42%), Gaps = 31/283 (10%)

Query: 76  VSTNGFSDDKVIGEGGYGIVYYGLL----EDNSKVAVKNL----LNNRGQAEREFKVEVE 127
           V    F   KV+G G YG V+        +     A+K L    +  + +     + E +
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 128 AIGRVRHK-NLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIIL 186
            +  +R    LV L           L+ +Y+N G L   L          T       + 
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136

Query: 187 GTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGT 246
                L +LH+     +++RDIK  NIL+D + +  ++DFGL+K   ++ +       GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 247 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN 304
             Y+AP+    G    ++  D +S G+L+ E+++G  P  ++   E+ +  E  ++++ +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251

Query: 305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGH 347
                  +P  P++  S L K ++    R +  + +KR   G 
Sbjct: 252 -------EPPYPQE-MSALAKDLI---QRLLMKDPKKRLGCGP 283

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 9e-34
 Identities = 63/281 (22%), Positives = 103/281 (36%), Gaps = 32/281 (11%)

Query: 68  WYTLRELEVSTNGFSDDKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAERE---FK 123
           W T  +     + F   K +G G +G V      E  +  A+K L   +    ++     
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89

Query: 124 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMN 183
            E   +  V    LV+L     + ++  +V EYV  G +   L          +      
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARF 145

Query: 184 IILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRV 243
                     YLH      +++RD+K  N+LID+    +V+DFG AK         T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTL 198

Query: 244 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVT 303
            GT   +APE   +   N+  D ++ G+LI E+ +G  P    +P +    I   K    
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---- 254

Query: 304 NRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK 344
                     + P    S  LK +L      +  +  KR  
Sbjct: 255 ---------VRFPSH-FSSDLKDLL---RNLLQVDLTKRFG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 52/276 (18%), Positives = 109/276 (39%), Gaps = 23/276 (8%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVK--NLLNNRGQAEREFKVEVEAIGRVRHKNLVRLL 141
             +G G YG V      +   +VAVK  +         +    E+  +  ++H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 142 GYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEP 201
                        +     +L      ++  C  LT +    +I    +GL Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140

Query: 202 KVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLN 261
            ++HRD+K SN+ +++    K+ DFGLA+    E   +T  V   +        +    N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYN 197

Query: 262 ERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD--------- 312
           +  D++S G ++ E+++GR     +   +++ LI  L         + +           
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257

Query: 313 -PKLPEKPTSRLLKRILLVAL----RCVDPNAQKRP 343
             ++P+   + +      +A+    + +  ++ KR 
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 1e-30
 Identities = 60/292 (20%), Positives = 114/292 (39%), Gaps = 37/292 (12%)

Query: 68  WYTLRELEVSTNGFSD---DKVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFK 123
           ++      V      D    + +G G Y  V+  + + +N KV VK L   +   +++ K
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77

Query: 124 VEVEAIGRVR-HKNLVRLLGYCAEGAHRM--LVYEYVNNGNLEQWLHGDVGPCSPLTWEI 180
            E++ +  +R   N++ L     +   R   LV+E+VNN + +Q           LT   
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130

Query: 181 RMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID-KHWNPKVSDFGLAKLLGSESSYI 239
               +    K L Y H      ++HRD+K  N++ID +H   ++ D+GLA+       Y 
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 240 TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEV------ 292
               + +  +  PE      M +   D++S G ++  +I  + P  +     +       
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 293 -----NLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNA 339
                +L +++ K     +P    +  L      R  + +       V P A
Sbjct: 246 VLGTEDLYDYIDKYNIELDPR--FNDILGRHSRKRWERFVHSENQHLVSPEA 295

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-29
 Identities = 76/344 (22%), Positives = 128/344 (37%), Gaps = 58/344 (16%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNL---LNNRGQAEREFKVEVEAIGRVRHKNLVRL 140
           K IG G  GIV        +  VA+K L     N+  A+R    E+  +  V HKN++ L
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNHKNIISL 81

Query: 141 LGYCA------EGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           L          E     LV E ++    +               E    ++     G+ +
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKH 134

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEY 254
           LH      ++HRD+K SNI++      K+ DFGLA+  G+  S++ T  + T  Y APE 
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189

Query: 255 ASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLI---------EWLKKMVTNR 305
                  E  D++S G ++ E++  +I        ++ N +         E++KK+    
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 306 NPEGVLDPKLPEKPTSRLLKRILLVAL----------------RCVDPNAQKRPKMG--- 346
                  PK       +L    L  A                 + +  +  KR  +    
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 347 -----HVVHMLEAQESPSKEPSNSFQDRYRASPK--NELIEKQV 383
                +V +     E+P  +  +   D    + +   ELI K+V
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 8e-26
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 18/233 (7%)

Query: 85  KVIGEGGYGIVYYGL-LEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGY 143
           + +G G +  V+    + +N+ VA+K +  ++   E   + E++ + RV   +  +    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSM 77

Query: 144 CAEGAHRMLVYEYVNNGNLEQW------------LHGDVGPCSPLTWEIRMNIILGTAKG 191
            A    ++L +      N                          +       I      G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 192 LSYLHEGLEPKVVHRDIKSSNILIDKH-WNPKVSDFGLAKLLGSESSYIT-TRVMGTFGY 249
           L Y+H      ++H DIK  N+L++       +    +A L  +       T  + T  Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 250 VAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV 302
            +PE          +D++S   LI E+I+G    +           + + +++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.3 bits (218), Expect = 4e-21
 Identities = 28/163 (17%), Positives = 54/163 (33%), Gaps = 21/163 (12%)

Query: 85  KVIGEGGYGIVYYGLLEDNSKVAVK----------NLLNNRGQAEREFKVEVEAIGRVRH 134
           K++GEG    V+    E   +  VK           +   R   +  F V      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 135 KNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSY 194
           + L +L G          VY +  N  L + +         +       ++    + ++ 
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 195 LHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS 237
            +      +VH D+   N+L+ +     + DF  +  +G E  
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	413
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.41
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.83
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.63
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-57  Score=418.41  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++.+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|+.+++.++|||||++++++.+++..|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999975 688999999865532 334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999765    5799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             Cc-ceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          236 SS-YITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       236 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .. ......+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.........  .   ......         
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~---~~~~~~---------  222 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y---SDWKEK---------  222 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--H---HHHHTT---------
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--H---HHHhcC---------
Confidence            22 22345689999999999988876 57899999999999999999999755432211  1   111111         


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .........++.++.+|+.+||+.||++|||+.|++++-.
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            1111223345677889999999999999999999988744

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=423.31  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=215.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999964 68999999987666566778999999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      +||+|.+++...     .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+.......
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999988653     699999999999999999999999   999999999999999999999999999998754433


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPE  317 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (413)
                       .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+...      .+........+        ..
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~  236 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------EL  236 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CC
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CC
Confidence             2345679999999999999999999999999999999999999997544222      12222222111        11


Q ss_pred             CCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          318 KPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       318 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..+..++..+.+||.+||+.||++|||+.|+++|-.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            223446678999999999999999999999998744

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=417.63  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=211.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++.+.||+|+||+||+|+++ +++.||+|++....   ......+.+|+.+++.++|||||++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            357999999999999999999975 68899999886432   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|....
T Consensus        85 mEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ...   .....||+.|||||++.+..++.++|||||||+||+|++|+.||.+.+..+      .+.......       .
T Consensus       158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~  221 (263)
T d2j4za1         158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-------F  221 (263)
T ss_dssp             CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------C
T ss_pred             CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-------C
Confidence            432   344679999999999999999999999999999999999999997544222      122222211       1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .++    ..++.++.+|+.+||+.||++|||+.|+++|-.
T Consensus       222 ~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         222 TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             CCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence            111    234567899999999999999999999998643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=418.59  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=202.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .++|++.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|++++++++|||||++++++..++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46799999999999999999999888899999886543 44567899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            9999999987653   5789999999999999999999999   999999999999999999999999999987765544


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....      ...+........      ... 
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~------~~~-  223 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR------LYK-  223 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHHTCC------CCC-
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHHhcCC------CCC-
Confidence            444456789999999999999999999999999999999995 555543221      111222222111      111 


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                         +..++.++.+|+.+||+.||++|||+++|+++|+.+
T Consensus       224 ---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 ---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               122346789999999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-57  Score=419.91  Aligned_cols=263  Identities=28%  Similarity=0.454  Sum_probs=208.4

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecC--CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNN--RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      |++..++|++.+.||+|+||+||+|+++  ..||||++...  .....+.+.+|+.++++++|||||++++++.+ ..++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            3456788999999999999999999864  36999988644  34456788999999999999999999998765 4689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +|||||++|+|.+++....   ..+++..++.++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            9999999999999997653   4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc-ceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          232 LGSESS-YITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ...... .......||+.|||||++.+   ..|+.++|||||||+||||+||+.||.........      ...+.....
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~  227 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYL  227 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSC
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCC
Confidence            654322 23345679999999999864   35899999999999999999999999765433221      111111111


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                          .+.+ ......++..+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       228 ----~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         228 ----SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ----CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                1110 1122335567999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=419.26  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=197.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee--CCeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~iv  153 (413)
                      ++|++.+.||+|+||+||+|+++ +|+.||||.+....  ......+.+|++++++++|||||++++++.+  ...+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999965 68899999986553  3345678899999999999999999998864  4568999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc--CCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL--EPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||++|+|.+++.........+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653222257999999999999999999999871  01399999999999999999999999999988


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      ...... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+      ....+... ...   
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~-~~~---  232 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREG-KFR---  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHT-CCC---
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHHcC-CCC---
Confidence            754332 2345679999999999999999999999999999999999999997544221      12222221 111   


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHM  351 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~  351 (413)
                        .+    +..++.++.+|+.+||+.||++|||+.|++++
T Consensus       233 --~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 --RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              11    22355678999999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=409.04  Aligned_cols=254  Identities=22%  Similarity=0.390  Sum_probs=216.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      .++|++.+.||+|+||+||+|+++++..||||++..... ..+.+.+|+.++++++||||+++++++.++..+++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            468999999999999999999998888999999876543 4567999999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++|+|.+++....   ..+++..++.++.||++||+|||+.   ||+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999976553   4789999999999999999999999   999999999999999999999999999987765544


Q ss_pred             ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          238 YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.      ...+. ....     .   
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~~i~-~~~~-----~---  220 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIA-QGLR-----L---  220 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHHHH-TTCC-----C---
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HHHHH-hCCC-----C---
Confidence            44445678999999999999999999999999999999998 8999976653321      12221 1110     1   


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                       ..+..++..+.+||.+||+.||++|||+++|+++|..
T Consensus       221 -~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             1112344678999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-57  Score=418.83  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=212.2

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEec
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYV  157 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~  157 (413)
                      +.|++++.||+|+||+||+|++. ++..||||++........+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45899999999999999999975 68889999998776666778899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++|+|.+++....   ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999976532   4799999999999999999999999   99999999999999999999999999997653221 


Q ss_pred             ceeeccccccCccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          238 YITTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       238 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ......+||+.|+|||++.     +..|+.++|||||||++|+|+||+.||...+..+..      .........     
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~~~~-----  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSEPP-----  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHSCCC-----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCC-----
Confidence            1233467999999999883     456899999999999999999999999866543321      222222111     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         ....+..++.++.+||.+||+.||++|||+.|+++|-
T Consensus       234 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         234 ---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             ---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             ---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence               1122345667899999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-57  Score=417.18  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=213.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ++++..++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            4556678899999999999999999999888899999886543 345678999999999999999999998865 45799


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+++|+|.+++.....  ..+++..++.|+.||++||+|||++   +|+||||||+||||++++.+||+|||+|+..
T Consensus        85 v~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence            9999999999998765421  3599999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ............||+.|||||++.++.++.++|||||||++|||+||..|+......     ...+..+.. ..     .
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~~-~~-----~  228 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLER-GY-----R  228 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHT-TC-----C
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHh-cC-----C
Confidence            655444445567899999999999999999999999999999999965554322221     111222211 11     1


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ...    +..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       229 ~~~----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 MVR----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            111    223456789999999999999999999999998853

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.3e-56  Score=424.32  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=215.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++++.||+|+||.||+|.+. +|+.||||++..........+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999965 6899999998877666677888999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc--CCCCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID--KHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~  234 (413)
                      |+||+|.+++....   .++++..++.|+.||+.||+|||++   ||+||||||+||||+  .++.+||+|||+|.....
T Consensus       108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999998876543   4799999999999999999999999   999999999999997  578999999999998865


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+...      .+..+....       ..
T Consensus       182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~-------~~  246 (352)
T d1koba_         182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD-------WE  246 (352)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC-------CC
T ss_pred             CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            433  344578999999999999999999999999999999999999997554322      222222211       11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ++......++.++.+||.+||+.||.+|||+.|+++|-
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp  284 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  284 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            22222334567789999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-57  Score=421.38  Aligned_cols=262  Identities=22%  Similarity=0.385  Sum_probs=218.5

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      +|++..++|++.+.||+|+||+||+|.++ +++.||||++..+. ...+.+.+|+.+|++++|||||++++++.+++..+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            45667788999999999999999999976 57889999886544 34567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      ||||||++|+|.+++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||++++.+||+|||+|+.
T Consensus        90 iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999865422  5799999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcC
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVL  311 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (413)
                      .............||+.|+|||++.+..|+.++|||||||++|||++|..||........      +...+....     
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~-----  233 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDY-----  233 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC-----
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCC-----
Confidence            765554444555689999999999999999999999999999999997777643332211      112222211     


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          312 DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       312 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ..    ..+..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       234 ~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         234 RM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11    11223456789999999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-56  Score=414.91  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=201.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC-CC---EEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED-NS---KVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .++|++.++||+|+||+||+|.++. ++   .||||.+.... ....+.+.+|+.+|++++|||||++++++..++.+++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4678899999999999999999753 22   58899876543 3445679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      |||||++|+|.+++....   ..+++..++.++.||++||+|||++   +|+||||||+||||+.++.+||+|||+++..
T Consensus       105 v~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            999999999999887653   4799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcce----eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          233 GSESSYI----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       233 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .......    .....||+.|||||++.++.++.++|||||||+||||+| |+.||......+      .+..+..... 
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~~-  251 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYR-  251 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC-
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC-
Confidence            5432211    122457899999999999999999999999999999998 899997554322      1222222111 


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .    ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       252 -----~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         252 -----L----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----C----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 1    11223566789999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-55  Score=419.20  Aligned_cols=255  Identities=20%  Similarity=0.305  Sum_probs=216.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            458999999999999999999975 6889999999877666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC--CCCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK--HWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~  234 (413)
                      |+||+|.+++....   ..+++..++.++.||+.||+|||++   |||||||||+|||++.  ++.+||+|||+++....
T Consensus       105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999986543   4799999999999999999999999   9999999999999954  57899999999998765


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+      .+..+....       ..
T Consensus       179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~  243 (350)
T d1koaa2         179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-------WN  243 (350)
T ss_dssp             TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-------CC
T ss_pred             ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------CC
Confidence            433  344679999999999999999999999999999999999999997554322      122222211       11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ++......++..+.+||.+||..||++|||+.|+++|-.
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            222233446678999999999999999999999999843

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=422.30  Aligned_cols=267  Identities=21%  Similarity=0.330  Sum_probs=210.4

Q ss_pred             HhcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           76 VSTNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        76 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +..++|++.+.||+|+||+||+|++. ++..||+|++.... ......+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            44678999999999999999999975 67889999987553 34456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      ||||+||+|.+++.+.    ..+++..+..++.||+.||.|||+ +   ||+||||||+|||++.++.+||+|||+|+..
T Consensus        83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            9999999999999765    479999999999999999999996 5   8999999999999999999999999999866


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH-HHHHHhhcC------
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE-WLKKMVTNR------  305 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~------  305 (413)
                      ...   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+......... .........      
T Consensus       156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            322   2345689999999999999999999999999999999999999998655332110000 000000000      


Q ss_pred             ---C-CCC----------------cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          306 ---N-PEG----------------VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       306 ---~-~~~----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                         . ...                +.....+..+...++.++.+|+.+||..||++|||+.|+++|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence               0 000                0000011111222456789999999999999999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=405.74  Aligned_cols=247  Identities=25%  Similarity=0.416  Sum_probs=201.3

Q ss_pred             CCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee----CCeeEEE
Q 015076           81 FSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV  153 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~iv  153 (413)
                      |++.+.||+|+||+||+|.+. ++..||+|.+....  ......+.+|+++|++++|||||++++++.+    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            367788999999999999975 57889999986543  3345678899999999999999999999865    4567999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCc--eeeccCCCCcEEEc-CCCCceEEecccce
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK--VVHRDIKSSNILID-KHWNPKVSDFGLAK  230 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~  230 (413)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+|+
T Consensus        91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999765    5799999999999999999999998   7  99999999999996 57899999999998


Q ss_pred             ecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          231 LLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      .....   .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.......     .....+ .....   
T Consensus       164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i-~~~~~---  230 (270)
T d1t4ha_         164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV-TSGVK---  230 (270)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH-TTTCC---
T ss_pred             eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHH-HcCCC---
Confidence            65433   2345689999999999865 59999999999999999999999997543221     111222 21111   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                           +.......+.++.+||.+||+.||++|||+.|+++|-
T Consensus       231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             -----CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence                 1111222445688999999999999999999999863

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=415.53  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~  154 (413)
                      ++|++++.||+|+||+||+|+++ +++.||||++....   ......+.+|+.++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 68899999986432   234467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCC
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGS  234 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  234 (413)
                      |||+||+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||+++++.+||+|||+|+....
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999998765    5799999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCc-ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          235 ESS-YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+...      ....+....       .
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-------~  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLE-------Y  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-------C
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCC-------C
Confidence            322 22345679999999999999999999999999999999999999997544221      222222211       1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      .++    ..++.++.+||.+||+.||++|||++|++++.
T Consensus       228 ~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         228 DFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             CCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             CCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            112    23456789999999999999999999976543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-55  Score=414.75  Aligned_cols=254  Identities=21%  Similarity=0.302  Sum_probs=196.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .+.|++.+.||+|+||+||+|+++ +++.||||.+..... .....+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466999999999999999999975 688999999875532 334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc---CCCCceEEecccceec
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLL  232 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~  232 (413)
                      ||+||+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||+.   +++.+||+|||+|+..
T Consensus        88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999765    5799999999999999999999999   999999999999994   5789999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      .....  ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.......      .........       
T Consensus       161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-------  225 (307)
T d1a06a_         161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAE-------  225 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTC-------
T ss_pred             cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccC-------
Confidence            54322  344679999999999999999999999999999999999999997543221      122222211       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ..++......++.++.+|+.+||+.||++|||+.|+++|..
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            11111222345677899999999999999999999999743

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=405.08  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=209.6

Q ss_pred             hcCCCCcccE-EeeeCceEEEEEEEc---CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKV-IGEGGYGIVYYGLLE---DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|.+.+. ||+|+||.||+|.++   ++..||||.+.... ......+.+|+++|++++|||||++++++.. +.++
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            3456777775 999999999999864   34579999986553 3445789999999999999999999999865 4579


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          152 LVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                      +|||||++|+|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            9999999999999986543   5799999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcce--eeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          232 LGSESSYI--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       232 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ........  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+.   .   . .+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~---~-~i~~~~~-  230 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M---A-FIEQGKR-  230 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H---H-HHHTTCC-
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---H---H-HHHcCCC-
Confidence            76544322  233568999999999999999999999999999999998 9999986543321   1   1 1222111 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          ...    +..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       231 ----~~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 ----MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                111    223556789999999999999999999999988754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=416.99  Aligned_cols=263  Identities=27%  Similarity=0.427  Sum_probs=211.8

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcC-C-----CEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceee
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLED-N-----SKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCA  145 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~  145 (413)
                      +++..++|+++++||+|+||+||+|++.. +     ..||+|.+.... ......+.+|+.+++++ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            34566789999999999999999999653 2     268999886543 33445788899999988 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeec
Q 015076          146 EGAHRMLVYEYVNNGNLEQWLHGDVG-------------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHR  206 (413)
Q Consensus       146 ~~~~~~iv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~  206 (413)
                      +.+..++|||||++|+|.++|.....                   ....+++..++.++.||+.||+|||++   +||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999976432                   123589999999999999999999999   99999


Q ss_pred             cCCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015076          207 DIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVD  284 (413)
Q Consensus       207 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~  284 (413)
                      ||||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876544332 2344668999999999999999999999999999999998 899998


Q ss_pred             CCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          285 YSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      +......      +...+.....     .    ..+..++.++.+||.+||+.||++|||++||+++|..
T Consensus       269 ~~~~~~~------~~~~~~~~~~-----~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         269 GIPVDAN------FYKLIQNGFK-----M----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TCCCSHH------HHHHHHTTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHH------HHHHHhcCCC-----C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            6554322      1222222211     1    1122345678999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=412.42  Aligned_cols=251  Identities=24%  Similarity=0.294  Sum_probs=212.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      ..++|++++.||+|+||.||+|+++ +++.||||++.+..   ......+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence            4578999999999999999999965 68999999986532   2345678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      |||||+||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+|+..
T Consensus        83 v~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence            99999999999999876    5799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...      .........       
T Consensus       156 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~-------  221 (337)
T d1o6la_         156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-------  221 (337)
T ss_dssp             CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------
T ss_pred             ccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCC-------
Confidence            44322 2445789999999999999999999999999999999999999998654322      122222211       


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHML  352 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~l  352 (413)
                      ..++    ..++.++.+||.+||+.||++||+     +.++++|-
T Consensus       222 ~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp  262 (337)
T d1o6la_         222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             CCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence            1112    234567889999999999999995     88999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-55  Score=410.57  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=206.3

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      .|+.++.||+|+||+||+|++. ++..||||++.....   .....+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            3999999999999999999965 677899999876543   233568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ||.+|+|..++...    .++++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|..... 
T Consensus        96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999998776655    5799999999999999999999999   999999999999999999999999999986543 


Q ss_pred             CcceeeccccccCccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          236 SSYITTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                          .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||......      ..+........+     
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~-----  232 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-----  232 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-----
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-----
Confidence                234579999999999864   45899999999999999999999999754322      222233322211     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                          ......++..+.+||.+||+.||++|||+.++++|-.
T Consensus       233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence                1112234567899999999999999999999998743

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=405.64  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=211.8

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC------chhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR------GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++++.||+|+||+||+|+++ +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.++..+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999975 68899999986532      22357889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC----CceEEec
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW----NPKVSDF  226 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  226 (413)
                      |||||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999765    4799999999999999999999999   999999999999998776    4899999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      |++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+      .+..+.... 
T Consensus       162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-  232 (293)
T d1jksa_         162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVN-  232 (293)
T ss_dssp             TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-
T ss_pred             hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcC-
Confidence            99988754432  344578999999999999999999999999999999999999998654322      122222111 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                            ..++......++..+.+||.+||+.||++|||++++++|-.
T Consensus       233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                  11111112234567899999999999999999999998743

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=407.61  Aligned_cols=262  Identities=25%  Similarity=0.396  Sum_probs=207.3

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      +++..++|++++.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            345567899999999999999999999888899999986543 445779999999999999999999999865 557999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++|+|..++.....  ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++...
T Consensus        90 ~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence            999999999998865321  4699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ...........||+.|+|||++.++.++.++|||||||++|||++|..||......     ...+..+.....      .
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~~~~------~  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYR------M  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC------C
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCC------C
Confidence            44443344467899999999999999999999999999999999976665433221     111222211111      1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                          .....+++++.++|.+||+.||++|||+.+|+++|+..-.
T Consensus       234 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         234 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                1122345678999999999999999999999999987543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=399.73  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=200.3

Q ss_pred             cEEeeeCceEEEEEEEcC---CCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEeccC
Q 015076           85 KVIGEGGYGIVYYGLLED---NSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNN  159 (413)
Q Consensus        85 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~~~~  159 (413)
                      +.||+|+||+||+|.++.   ++.||||++....  ....+.+.+|+.+|++++|||||++++++..+ ..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998643   4579999886432  33456799999999999999999999998654 57899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCcce
Q 015076          160 GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSYI  239 (413)
Q Consensus       160 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  239 (413)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999876    5799999999999999999999999   99999999999999999999999999999875443332


Q ss_pred             e--eccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCC
Q 015076          240 T--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLP  316 (413)
Q Consensus       240 ~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (413)
                      .  ....||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+   .   . ..+..+..     ..  
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~---~-~~i~~~~~-----~~--  230 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V---T-AMLEKGER-----MG--  230 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---H-HHHHTTCC-----CC--
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H---H-HHHHcCCC-----CC--
Confidence            2  23568999999999999999999999999999999998 899997554221   1   1 12222111     11  


Q ss_pred             CCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          317 EKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       317 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                        .+..++.++.+||.+||+.||++|||+++|++.|+.
T Consensus       231 --~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence              122355678999999999999999999999988764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=402.90  Aligned_cols=259  Identities=28%  Similarity=0.458  Sum_probs=203.4

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcCC-----CEEEEEEeecCCc-hhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLEDN-----SKVAVKNLLNNRG-QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      ..+.|++.++||+|+||.||+|.++.+     ..||||++..... .....+.+|+.++++++|||||++++++.+....
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            346799999999999999999996542     3699999865443 3445788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+.++++.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999999886553   5799999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCc--ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          231 LLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       231 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      .......  .......||+.|||||++.++.++.++|||||||++|||++|..||.......     ..+. .+..+.  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~-~i~~~~--  230 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMK-AINDGF--  230 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH-HHHTTC--
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHHH-HHhccC--
Confidence            7644322  22233568999999999999999999999999999999999766654332221     1111 222211  


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                         .+    ..+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       231 ---~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         231 ---RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             ---CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence               11    112235567899999999999999999999999998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=402.84  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcC----CCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLED----NSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ++..++|++.+.||+|+||.||+|.+..    +..||||.+.... ......+.+|+.++++++||||+++++++.+ +.
T Consensus         3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~   81 (273)
T d1mp8a_           3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP   81 (273)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence            3456789999999999999999998653    3458899875443 3345678999999999999999999999864 67


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .++||||+++|+|.+++....   ..+++..++.++.||++||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence            899999999999999876543   5799999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      +..............||+.|+|||++.+..++.++|||||||++|||++ |..||......+.   ..   .+. .... 
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~---~i~-~~~~-  227 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RIE-NGER-  227 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---HHH-TTCC-
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH---HHH-cCCC-
Confidence            8876544444555678999999999999999999999999999999998 8999976654332   11   111 1111 


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                          .    ..+..++..+.+||.+||..||++|||+.+|+++|+.+
T Consensus       228 ----~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 ----L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1    11223556789999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.6e-54  Score=404.22  Aligned_cols=247  Identities=25%  Similarity=0.347  Sum_probs=210.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++++.||+|+||+||+|+++ +|+.||||++....   ....+.+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            457999999999999999999975 68899999986432   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||||+||+|..++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+|+...
T Consensus        83 mE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence            9999999999999876    5789999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..    ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+..      ...........       
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~-------  218 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAEL-------  218 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCC-------
T ss_pred             cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCCC-------
Confidence            43    33467999999999999999999999999999999999999999754432      22223222211       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHML  352 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~l  352 (413)
                      .++    ..++.++.+++.+||..||.+|+     |++++++|.
T Consensus       219 ~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         219 RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence            111    22456788999999999999996     899999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=401.78  Aligned_cols=254  Identities=16%  Similarity=0.249  Sum_probs=211.5

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .++|++++.||+|+||+||+|.++ +++.||||.+.... .....+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            578999999999999999999976 57789999886554 3445688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC--CCceEEecccceecCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH--WNPKVSDFGLAKLLGS  234 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~  234 (413)
                      |+||+|.+++....   ..+++..++.|+.||+.||+|||++   ||+||||||+|||++.+  ..+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999997653   4799999999999999999999999   99999999999999854  4799999999998754


Q ss_pred             CCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          235 ESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      ...  .....+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||...+..+      .+..+.....       .
T Consensus       157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~-------~  221 (321)
T d1tkia_         157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY-------T  221 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-------C
T ss_pred             CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-------C
Confidence            332  344568999999999999999999999999999999999999997654322      1222222111       1


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ++......++.++.+||.+||..||++|||+.|+++|-.
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  260 (321)
T d1tkia_         222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            111111235667899999999999999999999999743

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-53  Score=391.28  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=211.2

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---------hhHHHHHHHHHHHhcCC-CCCcccccceeee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---------QAEREFKVEVEAIGRVR-HKNLVRLLGYCAE  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~  146 (413)
                      .++|++.+.||+|+||+||+|++. +++.||||++.....         .....+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999965 688899999865432         12346788999999997 9999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ++..|||||||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999999765    5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcceeeccccccCccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKK  300 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~  300 (413)
                      |+++.......  .....||+.|+|||.+.+      ..++.++|||||||++|+|++|+.||.+.+...      ....
T Consensus       155 G~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~  226 (277)
T d1phka_         155 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRM  226 (277)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH
T ss_pred             hheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHH
Confidence            99998765432  344679999999998853      347889999999999999999999998654322      1222


Q ss_pred             HhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          301 MVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      +....       ..++......++.++.+|+.+||+.||++|||+.||++|-
T Consensus       227 i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         227 IMSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             HHHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHhCC-------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            22211       1122233445677899999999999999999999998873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-53  Score=399.57  Aligned_cols=267  Identities=25%  Similarity=0.381  Sum_probs=215.6

Q ss_pred             cHHHHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCch-hHHHHHHHHHHHhcCCCCCcccccc
Q 015076           70 TLRELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRGQ-AEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        70 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      .+.++++..++|++.+.||+|+||+||+|+++      ++..||||++...... ....+.+|+.+|+.++||||+++++
T Consensus         4 ~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             chhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            35566777889999999999999999999964      2467999998755433 4567999999999999999999999


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCC--------------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCc
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDV--------------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPK  202 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~  202 (413)
                      ++......+++|||+++|+|.+++....                    .....+++..++.|+.||+.||+|||++   +
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            9999999999999999999999986432                    1123589999999999999999999999   9


Q ss_pred             eeeccCCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCC-
Q 015076          203 VVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-  280 (413)
Q Consensus       203 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~-  280 (413)
                      ||||||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999999866443222 234467899999999999999999999999999999999985 


Q ss_pred             CCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          281 IPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       281 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .||......+      ....+ ..+..     +..    +..++.++.+|+.+||+.||++||||.+|+++|+.+
T Consensus       241 ~p~~~~~~~e------~~~~v-~~~~~-----~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         241 QPYYGMAHEE------VIYYV-RDGNI-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             CTTTTSCHHH------HHHHH-HTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCCHHH------HHHHH-HcCCC-----CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            5676543322      12222 22211     111    223456789999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.6e-53  Score=403.99  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc---hhHHHH---HHHHHHHhcCCCCCcccccceeeeCCe
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG---QAEREF---KVEVEAIGRVRHKNLVRLLGYCAEGAH  149 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~hpniv~~~~~~~~~~~  149 (413)
                      ..++|++.++||+|+||.||+|++. +|+.||||++.....   .....+   ..++.+++.++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            3578999999999999999999975 688999999854321   112223   345778888899999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      +|||||||+||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+|
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeecee
Confidence            99999999999999999765    5789999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      +......   ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||...........   .. .....   
T Consensus       155 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~-~~~~~---  224 (364)
T d1omwa3         155 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DR-MTLTM---  224 (364)
T ss_dssp             EECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HH-HSSSC---
T ss_pred             eecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH-hcccC---
Confidence            9775432   344579999999999865 5689999999999999999999999986554332211   11 11111   


Q ss_pred             CcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 015076          309 GVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPK-----MGHVVHML  352 (413)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~l  352 (413)
                         ..    ..+..++.++.+||.+||+.||++|||     ++++++|-
T Consensus       225 ---~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp  266 (364)
T d1omwa3         225 ---AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  266 (364)
T ss_dssp             ---CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred             ---CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence               01    112235567899999999999999999     69999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-53  Score=404.94  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=210.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      .++|++++.||+|+||.||+|+++ +|+.||||++....   ......+.+|+.+|+.++|||||++++++......++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            367999999999999999999975 68999999986432   23345788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+.+|+|..++...    ..+++..++.++.||+.||.|||++   +||||||||+|||++.+|.+||+|||+|+...
T Consensus       120 ~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            9999999999999765    4799999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      ..    .....||+.|||||++.+..++.++|||||||++|+|+||+.||.+.+..      .....+.....       
T Consensus       193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~-------  255 (350)
T d1rdqe_         193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGKV-------  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-------
T ss_pred             cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcCCC-------
Confidence            43    23467999999999999999999999999999999999999999754322      22222222211       


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                      .+    +..++.++.+||.+||..||.+|+     |++++++|-.
T Consensus       256 ~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         256 RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             CC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence            11    123456789999999999999994     8999998743

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=393.62  Aligned_cols=254  Identities=29%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             HHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee-CCeeEEE
Q 015076           75 EVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLV  153 (413)
Q Consensus        75 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~iv  153 (413)
                      ++..++|++.+.||+|+||.||+|.++ |..||||++...  ...+.+.+|+.++++++||||+++++++.+ .+.+++|
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            355678999999999999999999986 778999988543  345678999999999999999999998854 4668999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      |||+++|+|.+++.....  ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            999999999999965321  3589999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLD  312 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (413)
                      ..    .....+|..|+|||++.++.++.++|||||||++|||+| |+.||......+   ....    +.+..     .
T Consensus       155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~-----~  218 (262)
T d1byga_         155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGY-----K  218 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTC-----C
T ss_pred             CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCC-----C
Confidence            33    223457899999999999999999999999999999998 788887554332   2221    11111     1


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          313 PKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       313 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      +.+    +..++.++.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       219 ~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            112    2234467889999999999999999999999998653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=397.43  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCC----EEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNS----KVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML  152 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~i  152 (413)
                      .+|+++++||+|+||+||+|.+. +|+    +||+|.+... .....+.+.+|+.++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            57999999999999999999965 343    5899987643 334567899999999999999999999999875 4678


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +|||+.+++|.+++....   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            889999999999887653   5799999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCCCCc
Q 015076          233 GSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV  310 (413)
Q Consensus       233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (413)
                      ...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+....+.   ...+.    .+..   
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~----~~~~---  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILE----KGER---  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHH----HTCC---
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----cCCC---
Confidence            544332 2234568999999999999999999999999999999998 8999876553332   21111    1110   


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                        .    ..+..++..+.+|+.+||..||++|||+.+|+++|+..
T Consensus       232 --~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 --L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --C----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence              1    11123456789999999999999999999999998765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-52  Score=389.24  Aligned_cols=258  Identities=25%  Similarity=0.374  Sum_probs=205.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHhcCCCCCcccccceeeeCC----e
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----H  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~  149 (413)
                      .++|++.+.||+|+||+||+|.+. +++.||||.+....   ......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999965 68889999986543   233457889999999999999999999987643    4


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .|+|||||+|++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            79999999999999988765    5799999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCc--ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          230 KLLGSESS--YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       230 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ........  ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..      ..+...+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC
Confidence            76643322  2234467999999999999999999999999999999999999999754422      222233332211


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-KMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~le~~  355 (413)
                             .+......++..+.++|.+||+.||++|| |++++++.|..+
T Consensus       233 -------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                   11111223556789999999999999999 899998888754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=391.77  Aligned_cols=262  Identities=23%  Similarity=0.260  Sum_probs=202.6

Q ss_pred             cccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCch-----hHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           83 DDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQ-----AEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        83 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      .+++||+|+||+||+|+++ +|+.||||++......     ....+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999965 6889999988654322     124678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +.++++..++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9888877776544    5789999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc-----
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV-----  310 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  310 (413)
                      .. ....+||+.|+|||++... .|+.++|||||||++|||++|..||.+....+.   ...+............     
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTS
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhc
Confidence            22 3345799999999988654 589999999999999999999999976553322   2222222211111000     


Q ss_pred             -----CCCCCCCCCc----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          311 -----LDPKLPEKPT----SRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       311 -----~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                           .....+....    ...+.++.+|+.+||+.||++|||+.|+++|-...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence                 0011111111    12356789999999999999999999999975443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=396.29  Aligned_cols=269  Identities=26%  Similarity=0.376  Sum_probs=204.9

Q ss_pred             ccHHHHHHhcCCCCcccEEeeeCceEEEEEEEcC------CCEEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccc
Q 015076           69 YTLRELEVSTNGFSDDKVIGEGGYGIVYYGLLED------NSKVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRL  140 (413)
Q Consensus        69 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~  140 (413)
                      +....+++..++|++.+.||+|+||.||+|.+..      ++.||||.+.... ......+..|..++.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3556777888999999999999999999998542      3579999886543 33445677788777776 68999999


Q ss_pred             cceeeeC-CeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeecc
Q 015076          141 LGYCAEG-AHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRD  207 (413)
Q Consensus       141 ~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~D  207 (413)
                      ++++... ..+++|||||++|+|.+++.....            ....+++..++.++.||++||+|||++   +|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence            9987654 568999999999999999965321            124589999999999999999999999   999999


Q ss_pred             CCCCcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCC
Q 015076          208 IKSSNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDY  285 (413)
Q Consensus       208 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg-~~Pf~~  285 (413)
                      |||+||||+.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| ..||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322 23446799999999999999999999999999999999986 567765


Q ss_pred             CCCcccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          286 SRPPEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      ......      +...+..+..     ...    +..++.++.++|.+||+.||++|||+.+|+++|+.+
T Consensus       240 ~~~~~~------~~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         240 VKIDEE------FCRRLKEGTR-----MRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CCCSHH------HHHHHHHTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHH------HHHHHhcCCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            443321      1112222111     111    122456789999999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=395.56  Aligned_cols=254  Identities=21%  Similarity=0.279  Sum_probs=203.7

Q ss_pred             cCCCCccc-EEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhc-CCCCCcccccceeee----CCee
Q 015076           78 TNGFSDDK-VIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGR-VRHKNLVRLLGYCAE----GAHR  150 (413)
Q Consensus        78 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~----~~~~  150 (413)
                      .++|.+.+ +||+|+||+||+|++. +++.||||++...     ..+.+|+.++.+ ++|||||+++++|.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46798864 6999999999999964 6889999988532     346678888654 589999999999865    4678


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC---CCCceEEecc
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK---HWNPKVSDFG  227 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG  227 (413)
                      |||||||+||+|.+++.....  ..+++..++.|+.||+.||+|||++   ||+||||||+|||++.   .+.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999976422  4799999999999999999999999   9999999999999985   4569999999


Q ss_pred             cceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          228 LAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       228 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      +|+.......  ....+||+.|||||++.+..|+.++|||||||+||+|+||+.||.+.+.......+   ...+.    
T Consensus       160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~----  230 (335)
T d2ozaa1         160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIR----  230 (335)
T ss_dssp             TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC----
T ss_pred             eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHh----
Confidence            9998765433  34467999999999999999999999999999999999999999765443221111   00000    


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                        .....++......++.++.+||.+||+.||++|||+.|+++|-
T Consensus       231 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  273 (335)
T d2ozaa1         231 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  273 (335)
T ss_dssp             --SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred             --cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence              0011223333456778899999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=398.95  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=205.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC---chhHHHHHHHHHHHh-cCCCCCcccccceeeeCCeeEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR---GQAEREFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRMLV  153 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~iv  153 (413)
                      ++|++++.||+|+||+||+|.++ +++.||||++.+..   ......+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67999999999999999999975 68889999986532   223345556666654 68999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecC
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  233 (413)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999765    5799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCC
Q 015076          234 SESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDP  313 (413)
Q Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (413)
                      .... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....      +..+... .      +
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~-~------~  220 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMD-N------P  220 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC-C------C
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC-C------C
Confidence            4332 23446799999999999999999999999999999999999999986543221      2222221 1      1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 015076          314 KLPEKPTSRLLKRILLVALRCVDPNAQKRPKMG-HVVHM  351 (413)
Q Consensus       314 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~  351 (413)
                      .++    ..++.++.+||.+||..||++|||+. ++++|
T Consensus       221 ~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         221 FYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             CCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            111    23456789999999999999999995 78765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=390.73  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEcC--C--CEEEEEEeecC---CchhHHHHHHHHHHHhcCCCCCcccccceeeeCCee
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLED--N--SKVAVKNLLNN---RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~  150 (413)
                      .++|++.+.||+|+||.||+|++..  +  ..||||.+...   .....+.+.+|+.+|++++||||+++++++.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            4679999999999999999998542  2  36899987653   234456789999999999999999999999764 67


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                      ++||||+++|+|.+++....   ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            89999999999999886543   4699999999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCcc--eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          231 LLGSESSY--ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       231 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      ........  ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+      .+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~  233 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGER  233 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCC
Confidence            87544332  2233457889999999999999999999999999999998 899997544322      22222222211


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                               ......++..+.+||.+||+.||++|||+.+|++.|+..
T Consensus       234 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     111223456789999999999999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=392.06  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=206.7

Q ss_pred             hcCCCCcccEEeeeCceEEEEEEEcC-CC--EEEEEEeecCC-chhHHHHHHHHHHHhcC-CCCCcccccceeeeCCeeE
Q 015076           77 STNGFSDDKVIGEGGYGIVYYGLLED-NS--KVAVKNLLNNR-GQAEREFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM  151 (413)
Q Consensus        77 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~  151 (413)
                      ..++|++.++||+|+||.||+|.+++ +.  .||||++.... ....+.+.+|+++|+++ +|||||++++++.+++.++
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            35789999999999999999999653 44  47888875443 33456789999999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC
Q 015076          152 LVYEYVNNGNLEQWLHGDV------------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW  219 (413)
Q Consensus       152 iv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~  219 (413)
                      +||||+++|+|.++|....            .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            9999999999999997541            2235799999999999999999999999   999999999999999999


Q ss_pred             CceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCcccccHHHHH
Q 015076          220 NPKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-IPVDYSRPPEEVNLIEWL  298 (413)
Q Consensus       220 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~-~Pf~~~~~~~~~~~~~~~  298 (413)
                      .+||+|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|. .||...+..      ...
T Consensus       165 ~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~~  236 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY  236 (309)
T ss_dssp             CEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH
T ss_pred             ceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------HHH
Confidence            999999999986543222  23356899999999999999999999999999999999975 567544321      122


Q ss_pred             HHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          299 KKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      ..+....      .+.    .+..++.++.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       237 ~~i~~~~------~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         237 EKLPQGY------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHGGGTC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhcC------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222211      111    12235567999999999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=390.04  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=209.4

Q ss_pred             HHHhcCCCCcccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCcccccce
Q 015076           74 LEVSTNGFSDDKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGY  143 (413)
Q Consensus        74 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~  143 (413)
                      +++..++|++++.||+|+||.||+|+...        +..||||++..+.. .....+.+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            44667899999999999999999998542        23699999876553 3446788898888888 79999999999


Q ss_pred             eeeCCeeEEEEEeccCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCC
Q 015076          144 CAEGAHRMLVYEYVNNGNLEQWLHGDVG------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSS  211 (413)
Q Consensus       144 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~  211 (413)
                      +.++...++|||||++|+|.+++.....            ....+++..++.++.||+.||+|||++   +||||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence            9999999999999999999999965431            124689999999999999999999999   9999999999


Q ss_pred             cEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 015076          212 NILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRPP  289 (413)
Q Consensus       212 NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~~  289 (413)
                      |||++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |..||......
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999999999999999999877543322 2344568999999999999999999999999999999998 78888654432


Q ss_pred             ccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          290 EEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .       +...+..+..     +.    .+..++.++.+||.+||+.||++|||+.||++.|+.+
T Consensus       245 ~-------~~~~i~~~~~-----~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 E-------LFKLLKEGHR-----MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             H-------HHHHHHTTCC-----CC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-------HHHHHHcCCC-----CC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1       1122222211     11    1223456789999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=391.10  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=214.9

Q ss_pred             HHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCCc-hhHHHHHHHHHHHhcC-CCCCccccccee
Q 015076           73 ELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNRG-QAEREFKVEVEAIGRV-RHKNLVRLLGYC  144 (413)
Q Consensus        73 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~  144 (413)
                      .+++..++|++.+.||+|+||.||+|.+.      .+..||||++..... .....+.+|+.+++.+ +|||||++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            34566789999999999999999999853      345799999876543 3455788999999999 699999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCCC--------------CCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCC
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDVG--------------PCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKS  210 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp  210 (413)
                      .++...++|||||++|+|.+++.....              ....+++..+..++.||+.||+|||++   +|+||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence            999999999999999999999865421              224689999999999999999999999   999999999


Q ss_pred             CcEEEcCCCCceEEecccceecCCCCcc-eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 015076          211 SNILIDKHWNPKVSDFGLAKLLGSESSY-ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRIPVDYSRP  288 (413)
Q Consensus       211 ~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~ellt-g~~Pf~~~~~  288 (413)
                      +|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999987654332 3344678999999999999999999999999999999999 5555654443


Q ss_pred             cccccHHHHHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          289 PEEVNLIEWLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .+..      ...+....     .+    ..+..++..+.+||.+||+.||++|||+.+|+++|+.+
T Consensus       254 ~~~~------~~~i~~~~-----~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 DSKF------YKMIKEGF-----RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SHHH------HHHHHHTC-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH------HHHHhcCC-----CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2221      11222111     11    11223456789999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=383.60  Aligned_cols=264  Identities=21%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++++.||+|+||+||+|.+. +++.||||++.....  .....+.+|+++|++++|||||++++++.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999964 688999999854432  234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      |+.++.+........   ..+++..++.++.||+.||+|||++   |||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            996544443333322   5799999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC---CCc-
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP---EGV-  310 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~-  310 (413)
                      .. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....   +.........   ... 
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR---IFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH---HHHhcCCCchhhccccc
Confidence            32 233457999999999876665 57899999999999999999999986543221111   1111111000   000 


Q ss_pred             ----CCCCC---CCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          311 ----LDPKL---PEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       311 ----~~~~~---~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                          .....   ....    ...++.++.+|+.+||+.||++|||+.|+++|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~  284 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP  284 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence                00000   0000    112346789999999999999999999999983

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-51  Score=382.56  Aligned_cols=263  Identities=20%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc--hhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG--QAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||+||+|++++++.||||++.....  .....+.+|+.+|++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999999999999999865432  2346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSES  236 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  236 (413)
                      +.++.+..+....    ..+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9877777776554    5799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCc-----
Q 015076          237 SYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGV-----  310 (413)
Q Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  310 (413)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+..   ..+............     
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhh
Confidence            2 23345689999999988654 5799999999999999999999999765432221   111111111100000     


Q ss_pred             -------C---CCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          311 -------L---DPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       311 -------~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                             .   .+.........++..+.+|+.+||+.||++|||++|+++|-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                   0   00000111223456788999999999999999999999764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=389.81  Aligned_cols=266  Identities=21%  Similarity=0.403  Sum_probs=215.3

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEc------CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCccccccee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLE------DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYC  144 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~  144 (413)
                      ++|++..++|++.+.||+|+||.||+|.++      .+..||||++.... ......+.+|+.++++++||||+++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            345677789999999999999999999864      25679999986543 33445688999999999999999999999


Q ss_pred             eeCCeeEEEEEeccCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCC
Q 015076          145 AEGAHRMLVYEYVNNGNLEQWLHGDV------GPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKH  218 (413)
Q Consensus       145 ~~~~~~~iv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~  218 (413)
                      ..+...++||||+++|+|.+++....      .....+++..+..++.|+++||.|||++   +|+||||||+|||++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence            99999999999999999999885321      1224579999999999999999999999   99999999999999999


Q ss_pred             CCceEEecccceecCCCCcce-eeccccccCccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCcccccHHH
Q 015076          219 WNPKVSDFGLAKLLGSESSYI-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RIPVDYSRPPEEVNLIE  296 (413)
Q Consensus       219 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg-~~Pf~~~~~~~~~~~~~  296 (413)
                      +++||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+..      +
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~  243 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q  243 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H
Confidence            999999999998764432222 2334689999999999999999999999999999999998 4777644322      2


Q ss_pred             HHHHHhhcCCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhccc
Q 015076          297 WLKKMVTNRNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQE  356 (413)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~  356 (413)
                      .+..+.... .     .    ..+..++..+.++|.+||+.||++|||+.+|+++|+...
T Consensus       244 ~~~~i~~~~-~-----~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         244 VLRFVMEGG-L-----L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHTTC-C-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHhCC-C-----C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            222222211 1     1    111234567999999999999999999999999998763

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-51  Score=382.60  Aligned_cols=253  Identities=28%  Similarity=0.413  Sum_probs=203.4

Q ss_pred             ccEEeeeCceEEEEEEEcCC----CEEEEEEeecC-CchhHHHHHHHHHHHhcCCCCCcccccceeee-CCeeEEEEEec
Q 015076           84 DKVIGEGGYGIVYYGLLEDN----SKVAVKNLLNN-RGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYEYV  157 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~iv~e~~  157 (413)
                      .++||+|+||+||+|++..+    ..||||++... .......+.+|+++|++++||||+++++++.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999996532    25899998643 34455789999999999999999999999765 56899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCCCc
Q 015076          158 NNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSESS  237 (413)
Q Consensus       158 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  237 (413)
                      ++|+|.+++....   ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999987654   5688999999999999999999999   999999999999999999999999999987654322


Q ss_pred             c---eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCCcCCCC
Q 015076          238 Y---ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEGVLDPK  314 (413)
Q Consensus       238 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (413)
                      .   ......||+.|+|||.+.+..++.++|||||||++|||+||..||........     ..........      +.
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-----~~~~i~~g~~------~~  254 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQGRR------LL  254 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC------CC
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHcCCC------CC
Confidence            1   12235689999999999999999999999999999999998888764332211     1122222111      11


Q ss_pred             CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcccC
Q 015076          315 LPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQES  357 (413)
Q Consensus       315 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~~~  357 (413)
                      .    +..++..+.+||.+||+.||++|||+.||+++|+.+..
T Consensus       255 ~----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         255 Q----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1    12245678999999999999999999999999988753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=384.06  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             CCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeeeCC----eeEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY  154 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~iv~  154 (413)
                      .+|.+.+.||+|+||.||+|++. |..||||++.... ........|+..+..++||||+++++++...+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            35788899999999999999974 8899999885432 22222334556667789999999999987643    679999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhcc-----CCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          155 EYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGL-----EPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       155 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      |||++|+|.+++++.     .+++..++.++.|++.||+|||+..     ..||+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999764     6999999999999999999999621     239999999999999999999999999999


Q ss_pred             eecCCCCcc---eeeccccccCccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCccc--------c
Q 015076          230 KLLGSESSY---ITTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRIPVDYSRPPEE--------V  292 (413)
Q Consensus       230 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~--------~  292 (413)
                      +........   ......||+.|+|||++.+..      ++.++|||||||+||||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            877543322   223467999999999987643      67789999999999999999988754332111        0


Q ss_pred             cHHHHHHHHhhcCCCCCcCCCCCCCCC-cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          293 NLIEWLKKMVTNRNPEGVLDPKLPEKP-TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....+.......    .+++.++... .......+.+|+.+||+.||++|||+.||+++|+.+
T Consensus       236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1112222222211    1223332222 345667799999999999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=381.03  Aligned_cols=243  Identities=25%  Similarity=0.397  Sum_probs=199.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCc------hhHHHHHHHHHHHhcCC--CCCcccccceeeeCC
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRG------QAEREFKVEVEAIGRVR--HKNLVRLLGYCAEGA  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~  148 (413)
                      .++|++.++||+|+||+||+|++. +++.||||++.....      .....+.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999965 688999999865321      11233567999999886  899999999999999


Q ss_pred             eeEEEEEeccC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-CCCceEEec
Q 015076          149 HRMLVYEYVNN-GNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-HWNPKVSDF  226 (413)
Q Consensus       149 ~~~iv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  226 (413)
                      ..++||||+.+ +++.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 6788887655    5799999999999999999999999   9999999999999985 478999999


Q ss_pred             ccceecCCCCcceeeccccccCccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          227 GLAKLLGSESSYITTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      |+|+......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+            ......
T Consensus       156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~  220 (273)
T d1xwsa_         156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ  220 (273)
T ss_dssp             TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC
T ss_pred             ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc
Confidence            9998764332   345679999999999987765 567899999999999999999996421            111111


Q ss_pred             CCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          306 NPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .       .+    ...++.++.+||.+||..||++|||++|++++-.
T Consensus       221 ~-------~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         221 V-------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             C-------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             c-------CC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            0       11    1124567899999999999999999999998743

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=382.35  Aligned_cols=265  Identities=24%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-C-CCEEEEEEeecCCc--hhHHHHHHHHHHHhcC---CCCCcccccceeee----
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-D-NSKVAVKNLLNNRG--QAEREFKVEVEAIGRV---RHKNLVRLLGYCAE----  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~----  146 (413)
                      .++|++++.||+|+||+||+|++. + ++.||||++.....  .....+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 55689999864321  1222345566666555   89999999999853    


Q ss_pred             -CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEe
Q 015076          147 -GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSD  225 (413)
Q Consensus       147 -~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  225 (413)
                       ....+++|||+.++++........   ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             357899999998877665544332   5789999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcC
Q 015076          226 FGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNR  305 (413)
Q Consensus       226 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  305 (413)
                      ||+++......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+..   ..+.......
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCC
Confidence            99988654332  234567999999999999999999999999999999999999999865533222   1122221111


Q ss_pred             CCCC----------cCCCCC---CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          306 NPEG----------VLDPKL---PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       306 ~~~~----------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      ....          ......   .......++..+.+|+.+||+.||++|||+.|+++|..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence            0000          000000   00112234567889999999999999999999998743

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=371.54  Aligned_cols=268  Identities=19%  Similarity=0.235  Sum_probs=201.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee--------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE--------  146 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--------  146 (413)
                      .++|++++.||+|+||+||+|++. +|+.||||++....  ......+.+|+.+|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            467999999999999999999965 78999999885442  2344667889999999999999999998754        


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEec
Q 015076          147 GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDF  226 (413)
Q Consensus       147 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  226 (413)
                      ....++||||+.++.+..+....    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            35689999999877766555444    5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCcc---eeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 015076          227 GLAKLLGSESSY---ITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV  302 (413)
Q Consensus       227 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~  302 (413)
                      |+++........   .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....   ...+....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhc
Confidence            999876533221   22335799999999998765 689999999999999999999999976543222   22222222


Q ss_pred             hcCCCCC---cCCC----------CCCCCCcH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          303 TNRNPEG---VLDP----------KLPEKPTS-----RLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       303 ~~~~~~~---~~~~----------~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .......   ....          ........     .....+++|+.+||+.||++|||+.|+++|-...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence            2111100   0000          00000001     1134567899999999999999999999986544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=377.43  Aligned_cols=263  Identities=23%  Similarity=0.256  Sum_probs=196.4

Q ss_pred             CCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCcccccceeee------CCeeEE
Q 015076           80 GFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GAHRML  152 (413)
Q Consensus        80 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~~~~i  152 (413)
                      +|...++||+|+||+||+|++. +++.||||++......    +.+|+.+|++++||||++++++|..      ..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5889999999999999999975 6889999998765432    2369999999999999999999853      345799


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEeccccee
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKL  231 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~  231 (413)
                      |||||+++.+..+... ......+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999976544333321 11125799999999999999999999999   999999999999999775 799999999988


Q ss_pred             cCCCCcceeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH---------HHHHH
Q 015076          232 LGSESSYITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE---------WLKKM  301 (413)
Q Consensus       232 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~---------~~~~~  301 (413)
                      ......  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.         .+...
T Consensus       173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            754433  334578999999998765 568999999999999999999999997654322211110         01111


Q ss_pred             hhc---CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          302 VTN---RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       302 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                      ...   ...................+.++.+|+.+||..||++|||+.|+++|-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            000   000000000000111223456789999999999999999999999873

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=374.14  Aligned_cols=259  Identities=22%  Similarity=0.306  Sum_probs=197.7

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCC------
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA------  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~------  148 (413)
                      .++|++++.||+|+||+||+|.+. +++.||||++....  ......+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999975 68899999986542  234557889999999999999999999987654      


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      .+|+||||+ +.+|..++..     ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            569999999 6788887764     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC-
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN-  306 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  306 (413)
                      |+.....    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+........   ........ 
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPA  240 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCH
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH---HhccCCCcH
Confidence            9887543    2345789999999998764 5789999999999999999999999765432221111   11000000 


Q ss_pred             -----------------CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          307 -----------------PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       307 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                                       ........+ ......++..+.+||.+||..||++|||+.|+++|-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~  303 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  303 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                             000000000 0111223456889999999999999999999999843

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=374.32  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=209.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc----CCCEEEEEEeecCC----chhHHHHHHHHHHHhcCCC-CCcccccceeeeCC
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE----DNSKVAVKNLLNNR----GQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGA  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~  148 (413)
                      .++|++++.||+|+||+||+|...    +|+.||||.+....    ......+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            467999999999999999999852    47889999885432    2334567789999999966 89999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      ..+++|||+.+|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999776    4688999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCC
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRN  306 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  306 (413)
                      ++..............|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...........+.  ....... 
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~~-  252 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSE-  252 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHCC-
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccCC-
Confidence            988765555445567799999999998764  47889999999999999999999998776554433332  1111111 


Q ss_pred             CCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh
Q 015076          307 PEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRP-----KMGHVVHMLE  353 (413)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~le  353 (413)
                            ..    .+..++.++.+|+.+||++||++||     |++|+++|..
T Consensus       253 ------~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         253 ------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             ------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             ------CC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence                  11    1223567889999999999999999     4889988633

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=374.53  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC-chhHHHHHHHHHHHhcCCCCCcccccceeeeCC----eeEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR-GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRML  152 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~----~~~i  152 (413)
                      ++|++++.||+|+||+||+|.++ +++.||||++.... ......+.+|+.+|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999964 78999999986543 334567889999999999999999999986653    2345


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceec
Q 015076          153 VYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLL  232 (413)
Q Consensus       153 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  232 (413)
                      +++|+.+|+|.+++...     .+++..++.++.||+.||+|||++   |||||||||+|||++.++.+||+|||++...
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667799999999753     699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc--eeeccccccCccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC
Q 015076          233 GSESSY--ITTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG  309 (413)
Q Consensus       233 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (413)
                      ......  .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+.....   ...........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhh
Confidence            543221  2344679999999999844 56789999999999999999999999765432221111   11110000000


Q ss_pred             -------------cCCCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 015076          310 -------------VLDPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHML  352 (413)
Q Consensus       310 -------------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~l  352 (413)
                                   ...+......    ...++.++.+|+.+||+.||++|||+.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                         0000000000    112345688999999999999999999999873

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=359.54  Aligned_cols=265  Identities=20%  Similarity=0.268  Sum_probs=209.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeCCeeEEEEE
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~iv~e  155 (413)
                      ++|++++.||+|+||+||+|++. +++.||||++....  ......+.+|+.+|+.++||||+++++++......++||+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            68999999999999999999965 68889999986543  3446788899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccceecCCC
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKLLGSE  235 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  235 (413)
                      ++.+++|..++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999998888765    5789999999999999999999999   9999999999999999999999999999987544


Q ss_pred             CcceeeccccccCccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCCC-----
Q 015076          236 SSYITTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPEG-----  309 (413)
Q Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  309 (413)
                      ... .....+++.|+|||++.... ++.++|||||||++|||++|+.||.......  .....+...........     
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence            322 33345788999999887665 6899999999999999999999975433221  11222222211110000     


Q ss_pred             ----------cCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          310 ----------VLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       310 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                                .............++..+.+|+.+||+.||++|||++|+++|-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence                      00000111122334567889999999999999999999998743

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-48  Score=361.96  Aligned_cols=259  Identities=18%  Similarity=0.220  Sum_probs=198.7

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCccc-ccceeeeCCeeEEEEEe
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNLVR-LLGYCAEGAHRMLVYEY  156 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~~~~~~iv~e~  156 (413)
                      ++|++.+.||+|+||.||+|++. +++.||||.+.....  ...+..|+++++.++|+|++. +.+++.+....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999965 688899998765432  235778999999998776554 55666788899999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEc---CCCCceEEecccceecC
Q 015076          157 VNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILID---KHWNPKVSDFGLAKLLG  233 (413)
Q Consensus       157 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~  233 (413)
                      + +++|...+....   ..+++..+..++.|++.||+|||++   ||+||||||+|||++   .+..++|+|||+|+...
T Consensus        85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9 567766665432   5799999999999999999999999   999999999999985   35579999999999875


Q ss_pred             CCCcc------eeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCC
Q 015076          234 SESSY------ITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNP  307 (413)
Q Consensus       234 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  307 (413)
                      .....      ......||+.|||||++.+..++.++|||||||++|||+||+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43221      234467999999999999999999999999999999999999999876554433333222211111000


Q ss_pred             CCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          308 EGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .         .....++.++.+++..||..||++||++.++.+.|+..
T Consensus       238 ~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             h---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0         00112456789999999999999999999988877654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.2e-48  Score=366.09  Aligned_cols=259  Identities=20%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeee--CCeeEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV  153 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~--~~~~~iv  153 (413)
                      .++|++++.||+|+||+||+|++. +++.||||++....   ...+.+|+.+|+.++ ||||+++++++..  ...+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            467999999999999999999975 68889999985432   456788999999995 9999999999874  4568999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCC-CceEEecccceec
Q 015076          154 YEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHW-NPKVSDFGLAKLL  232 (413)
Q Consensus       154 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~  232 (413)
                      ||||.+++|..+.       ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+|...
T Consensus       111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999998764       3689999999999999999999999   999999999999998665 5899999999887


Q ss_pred             CCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh---------
Q 015076          233 GSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMV---------  302 (413)
Q Consensus       233 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------  302 (413)
                      .....  .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.........  ...+...+         
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhh
Confidence            54432  3445789999999998765 4799999999999999999999999765432211  11111110         


Q ss_pred             h---cCCC---CCc--------CCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          303 T---NRNP---EGV--------LDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       303 ~---~~~~---~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                      .   ....   ...        ............++.++.+||.+||..||++|||++|+++|-.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            0   0000   000        0011122223345677899999999999999999999998754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.7e-48  Score=361.59  Aligned_cols=260  Identities=17%  Similarity=0.221  Sum_probs=209.1

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC-CCcccccceeeeCCeeEEEEE
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE  155 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~iv~e  155 (413)
                      .++|++++.||+|+||+||+|++. +++.||||.+....  ....+..|+++++.++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            578999999999999999999965 67889999875443  22346678888988865 899999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcC-----CCCceEEecccce
Q 015076          156 YVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDK-----HWNPKVSDFGLAK  230 (413)
Q Consensus       156 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~a~  230 (413)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||++   ||+||||||+|||++.     .+.+||+|||+|+
T Consensus        82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 789999887653   4799999999999999999999999   9999999999999964     5679999999998


Q ss_pred             ecCCCCc------ceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 015076          231 LLGSESS------YITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTN  304 (413)
Q Consensus       231 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  304 (413)
                      .......      ......+||+.|||||++.+..++.++|||||||++|||+||+.||.+............+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            7643221      1233467999999999999999999999999999999999999999876655444333322222111


Q ss_pred             CCCCCcCCCCCCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcc
Q 015076          305 RNPEGVLDPKLPEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEAQ  355 (413)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~~  355 (413)
                      .....+         ...++.++.+++..|+..+|++||+++.+.+.|+..
T Consensus       235 ~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            111111         112345688999999999999999999988887664

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-47  Score=362.39  Aligned_cols=264  Identities=22%  Similarity=0.254  Sum_probs=194.9

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeee------CC
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAE------GA  148 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~------~~  148 (413)
                      .++|+++++||+|+||+||+|++. +|+.||||++....  ......+.+|+.+++.++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999976 68899999997543  3344578899999999999999999999853      46


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEeccc
Q 015076          149 HRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGL  228 (413)
Q Consensus       149 ~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  228 (413)
                      .+|+|||||.++.+ +.+.      ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.++++|||+
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            88999999966544 4443      3589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHH------------
Q 015076          229 AKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIE------------  296 (413)
Q Consensus       229 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~------------  296 (413)
                      ++......  .....++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.            
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            88765432  2344578999999999999999999999999999999999999997654222111110            


Q ss_pred             ----HHHHHhhcCCCCC------cCCCC-C--CCCCcHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 015076          297 ----WLKKMVTNRNPEG------VLDPK-L--PEKPTSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLE  353 (413)
Q Consensus       297 ----~~~~~~~~~~~~~------~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le  353 (413)
                          .............      ..... .  ........+..+.+|+.+||..||++|||++|+|+|-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw  313 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  313 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence                0011111110000      00000 0  01112346778999999999999999999999998853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=364.05  Aligned_cols=261  Identities=21%  Similarity=0.309  Sum_probs=198.6

Q ss_pred             cCCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCC--chhHHHHHHHHHHHhcCCCCCcccccceeeeC-----Ce
Q 015076           78 TNGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNR--GQAEREFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH  149 (413)
Q Consensus        78 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~  149 (413)
                      .++|++++.||+|+||+||+|++. +|+.||||++....  ......+.+|+.+|+.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999965 68899999986543  23445788999999999999999999998533     33


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCceEEecccc
Q 015076          150 RMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLA  229 (413)
Q Consensus       150 ~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  229 (413)
                      .+++|+|+.+|+|.+++...     .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            46667778899999999653     699999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCcceeeccccccCccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcCCCC
Q 015076          230 KLLGSESSYITTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEWLKKMVTNRNPE  308 (413)
Q Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  308 (413)
                      ......    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+   ......... 
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~-  240 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGA-  240 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCH-
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCh-
Confidence            765322    3445789999999987665 4689999999999999999999999765432222111   111110000 


Q ss_pred             CcC--------------CCCCCCCC----cHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 015076          309 GVL--------------DPKLPEKP----TSRLLKRILLVALRCVDPNAQKRPKMGHVVHMLEA  354 (413)
Q Consensus       309 ~~~--------------~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~le~  354 (413)
                      ...              ....+...    ...++..+.+||.+||..||++|||+.|+++|-..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence            000              00000000    11235668899999999999999999999997543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-41  Score=324.34  Aligned_cols=267  Identities=19%  Similarity=0.189  Sum_probs=192.6

Q ss_pred             CCCCcccEEeeeCceEEEEEEEc-CCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----------CCCcccccceeee
Q 015076           79 NGFSDDKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----------HKNLVRLLGYCAE  146 (413)
Q Consensus        79 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~~~~~~~~  146 (413)
                      ++|+++++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999975 68899999986543 33456777888887774           5789999988754


Q ss_pred             --CCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhh-ccCCceeeccCCCCcEEEcCCCC---
Q 015076          147 --GAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHE-GLEPKVVHRDIKSSNILIDKHWN---  220 (413)
Q Consensus       147 --~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---  220 (413)
                        ....+++|+++..+......... .....+++..+..++.||+.||+|||+ .   ||+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              45667777777554432222111 112578999999999999999999998 6   9999999999999987654   


Q ss_pred             ---ceEEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 015076          221 ---PKVSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRIPVDYSRPPEEVNLIEW  297 (413)
Q Consensus       221 ---~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l~elltg~~Pf~~~~~~~~~~~~~~  297 (413)
                         ++++|||.+......    ....+||+.|+|||++....++.++|||||||++++|++|+.||..............
T Consensus       168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               899999999876432    2345799999999999999999999999999999999999999976543222211111


Q ss_pred             HH---HHhhc------------------CCCCCcCCC-C---------CCCCCcHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 015076          298 LK---KMVTN------------------RNPEGVLDP-K---------LPEKPTSRLLKRILLVALRCVDPNAQKRPKMG  346 (413)
Q Consensus       298 ~~---~~~~~------------------~~~~~~~~~-~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  346 (413)
                      +.   ..+..                  ......... .         .........+..+.+|+.+||..||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            11   11110                  000000000 0         01123456778899999999999999999999


Q ss_pred             HHHHHHhc
Q 015076          347 HVVHMLEA  354 (413)
Q Consensus       347 eil~~le~  354 (413)
                      |+|+|-..
T Consensus       324 e~L~Hp~f  331 (362)
T d1q8ya_         324 GLVNHPWL  331 (362)
T ss_dssp             HHHTCGGG
T ss_pred             HHhcCccc
Confidence            99988543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=195.28  Aligned_cols=170  Identities=16%  Similarity=0.145  Sum_probs=121.2

Q ss_pred             CCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCc------------------hhHHHHHHHHHHHhcCCCCCcccccc
Q 015076           81 FSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRG------------------QAEREFKVEVEAIGRVRHKNLVRLLG  142 (413)
Q Consensus        81 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~hpniv~~~~  142 (413)
                      +.+++.||+|+||.||+|.+.+|+.||||.+.....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999997643210                  01223456888899999999988876


Q ss_pred             eeeeCCeeEEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhccCCceeeccCCCCcEEEcCCCCce
Q 015076          143 YCAEGAHRMLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEGLEPKVVHRDIKSSNILIDKHWNPK  222 (413)
Q Consensus       143 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  222 (413)
                      +..    .+++|||+++..+..+           +...+..++.|++.+|+|||++   ||+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            532    3799999987665442           2233567899999999999999   99999999999999976 589


Q ss_pred             EEecccceecCCCCcceeeccccccCccCccccccCCCCccchhHHHHHHH
Q 015076          223 VSDFGLAKLLGSESSYITTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI  273 (413)
Q Consensus       223 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~~l  273 (413)
                      |+|||+|.............  .+... -.+. ..+.|+.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99999998765332210000  00000 0011 235688899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=5.9e-09  Score=92.79  Aligned_cols=150  Identities=15%  Similarity=0.070  Sum_probs=99.5

Q ss_pred             HHHHHhcCCCCcccEEeeeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-CCCcccccceeeeCCee
Q 015076           72 RELEVSTNGFSDDKVIGEGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR  150 (413)
Q Consensus        72 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~  150 (413)
                      .++......|++.+..+-++.+.||+... ++..+++|+...........+..|...++.+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34555567788777655555678998764 46678889776544333445666777776663 33356778888888999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc--------------------------------
Q 015076          151 MLVYEYVNNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG--------------------------------  198 (413)
Q Consensus       151 ~iv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~--------------------------------  198 (413)
                      ++||++++|.++.+.....      ..   ...++.++++.|+.||+.                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998876544221      11   122334444444444421                                


Q ss_pred             ------------------------cCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          199 ------------------------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       199 ------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                                              ....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    012479999999999999876667999997764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.41  E-value=5.1e-07  Score=79.38  Aligned_cols=131  Identities=18%  Similarity=0.100  Sum_probs=83.7

Q ss_pred             EEeeeC-ceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCC--CCcccccceeeeCCeeEEEEEeccCCCh
Q 015076           86 VIGEGG-YGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        86 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      .+..|. .+.||+....++..+++|.......   ..+..|+..++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344454 3678999887788889997644432   235556776666532  2356778877888889999999988766


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHhhhchhhhc--------------------------------------------
Q 015076          163 EQWLHGDVGPCSPLTWEIRMNIILGTAKGLSYLHEG--------------------------------------------  198 (413)
Q Consensus       163 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~--------------------------------------------  198 (413)
                      ....         ....   .++.++.+.|+-||+.                                            
T Consensus        94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            4421         1111   1122233333333311                                            


Q ss_pred             -----------cCCceeeccCCCCcEEEcCCCCceEEeccccee
Q 015076          199 -----------LEPKVVHRDIKSSNILIDKHWNPKVSDFGLAKL  231 (413)
Q Consensus       199 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  231 (413)
                                 ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       122489999999999999876677999997653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.83  E-value=2.1e-05  Score=73.61  Aligned_cols=77  Identities=14%  Similarity=0.135  Sum_probs=46.8

Q ss_pred             ccEEeeeCceEEEEEEEc-CCCEEEEEEeecC-------CchhHHHHHHHHHHHhcCC--CC-CcccccceeeeCCeeEE
Q 015076           84 DKVIGEGGYGIVYYGLLE-DNSKVAVKNLLNN-------RGQAEREFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRML  152 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~--hp-niv~~~~~~~~~~~~~i  152 (413)
                      .+.||.|....||++... +++.++||.-...       ......+...|...|+.+.  -| .+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999854 4678999965321       1112233455777776552  23 34455543  4455689


Q ss_pred             EEEeccCCCh
Q 015076          153 VYEYVNNGNL  162 (413)
Q Consensus       153 v~e~~~~gsL  162 (413)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.63  E-value=0.00012  Score=66.29  Aligned_cols=70  Identities=16%  Similarity=0.090  Sum_probs=45.7

Q ss_pred             ceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-----cccc--ceeeeCCeeEEEEEeccCCCh
Q 015076           92 YGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-----VRLL--GYCAEGAHRMLVYEYVNNGNL  162 (413)
Q Consensus        92 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~--~~~~~~~~~~iv~e~~~~gsL  162 (413)
                      --.||++...+|..+++|...... ....++..|...+..|...+|     +..-  ..+......+.++++++|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            457999998889999999765443 345567778887777642221     1111  123456677899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.29  E-value=0.00042  Score=64.44  Aligned_cols=74  Identities=19%  Similarity=0.259  Sum_probs=48.5

Q ss_pred             ccEEeeeCceEEEEEEEcC--------CCEEEEEEeecCCchhHHHHHHHHHHHhcCCCCCc-ccccceeeeCCeeEEEE
Q 015076           84 DKVIGEGGYGIVYYGLLED--------NSKVAVKNLLNNRGQAEREFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY  154 (413)
Q Consensus        84 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~iv~  154 (413)
                      ++.|+.|-.=.+|++...+        ...|.+++.- .. .......+|..+++.+.-.++ .++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568888888999998654        2456666553 22 223345678888887753343 467776653    6899


Q ss_pred             EeccCCChh
Q 015076          155 EYVNNGNLE  163 (413)
Q Consensus       155 e~~~~gsL~  163 (413)
                      ||++|.+|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999875553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.0087  Score=53.12  Aligned_cols=157  Identities=11%  Similarity=0.016  Sum_probs=78.6

Q ss_pred             HHHHHHhcCCCCcccEEe-----eeCceEEEEEEEcCCCEEEEEEeecCCchhHHHHHHHHHHHhcCC-----CCCcccc
Q 015076           71 LRELEVSTNGFSDDKVIG-----EGGYGIVYYGLLEDNSKVAVKNLLNNRGQAEREFKVEVEAIGRVR-----HKNLVRL  140 (413)
Q Consensus        71 ~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~~  140 (413)
                      ..++.-...+|.++++..     .|---+.|+....+| ++++|+.....  ....+..|+.++..|.     .|..+..
T Consensus         5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence            455665667787755544     555567899887655 58999774432  2234445666666653     2222222


Q ss_pred             cc---eeeeCCeeEEEEEeccCCChhhhc--------------c----CCCCC-CCCCCHHHH-----------------
Q 015076          141 LG---YCAEGAHRMLVYEYVNNGNLEQWL--------------H----GDVGP-CSPLTWEIR-----------------  181 (413)
Q Consensus       141 ~~---~~~~~~~~~iv~e~~~~gsL~~~l--------------~----~~~~~-~~~l~~~~~-----------------  181 (413)
                      .+   +..-......++.++.+.......              +    ..... .........                 
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            11   122345566777777664332111              0    00000 000000000                 


Q ss_pred             -HHHHHHHHhhhchhh-hccCCceeeccCCCCcEEEcCCCCceEEecccce
Q 015076          182 -MNIILGTAKGLSYLH-EGLEPKVVHRDIKSSNILIDKHWNPKVSDFGLAK  230 (413)
Q Consensus       182 -~~i~~~i~~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  230 (413)
                       ...+..+...+...+ ...+.|+||+|+.++||+++++...-|+||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             011111111111111 1124589999999999999988767899999875